<?xml version="1.0" encoding="UTF-8"?>
<valueSets>
   <valueSet xmlns:cpm="urn:hl7-eu:cpm"
             xmlns:pharm="urn:hl7-org:pharm"
             xmlns:epsos="urn:epsos-org:ep:medication"
             xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
             id="1.3.6.1.4.1.12559.11.10.1.3.1.42.24"
             name="epSOSActiveIngredient"
             displayName="epSOSActiveIngredient"
             effectiveDate="2019-12-23T16:20:21"
             officialReleaseDate="2017-11-07T14:06:21"
             statusCode="deprecated"
             versionLabel="201912">
      <desc language="en-US">epSOSActiveIngredient</desc>
      <sourceCodeSystem id="2.16.840.1.113883.6.73"
                        identifierName="WHO Anatomical Therapeutic Chemical classification"
                        canonicalUri="urn:oid:2.16.840.1.113883.6.73"
                        canonicalUriDSTU2="urn:oid:2.16.840.1.113883.6.73"
                        canonicalUriSTU3="urn:oid:2.16.840.1.113883.6.73"
                        canonicalUriR4="urn:oid:2.16.840.1.113883.6.73"/>
      <publishingAuthority name="epSOS">
                <addrLine>http://www.epSOS.eu</addrLine>
            </publishingAuthority>
      <conceptList>
                <concept code="A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ALIMENTARY TRACT AND METABOLISM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ALIMENTARY TRACT AND METABOLISM"
                         type="fsn">ALIMENTARY TRACT AND METABOLISM</designation>
                    <desc language="en-US">ALIMENTARY TRACT AND METABOLISM</desc>
                </concept>
                <concept code="A01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="STOMATOLOGICAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="STOMATOLOGICAL PREPARATIONS"
                         type="fsn">STOMATOLOGICAL PREPARATIONS</designation>
                    <desc language="en-US">STOMATOLOGICAL PREPARATIONS</desc>
                </concept>
                <concept code="A01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="STOMATOLOGICAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="STOMATOLOGICAL PREPARATIONS"
                         type="fsn">STOMATOLOGICAL PREPARATIONS</designation>
                    <desc language="en-US">STOMATOLOGICAL PREPARATIONS</desc>
                </concept>
                <concept code="A01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Caries prophylactic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Caries prophylactic agents"
                         type="fsn">Caries prophylactic agents</designation>
                    <desc language="en-US">Caries prophylactic agents</desc>
                </concept>
                <concept code="A01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium fluoride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium fluoride" type="fsn">sodium fluoride</designation>
                    <desc language="en-US">sodium fluoride</desc>
                </concept>
                <concept code="A01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium monofluorophosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium monofluorophosphate"
                         type="fsn">sodium monofluorophosphate</designation>
                    <desc language="en-US">sodium monofluorophosphate</desc>
                </concept>
                <concept code="A01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olaflur"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olaflur" type="fsn">olaflur</designation>
                    <desc language="en-US">olaflur</desc>
                </concept>
                <concept code="A01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stannous fluoride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="stannous fluoride" type="fsn">stannous fluoride</designation>
                    <desc language="en-US">stannous fluoride</desc>
                </concept>
                <concept code="A01AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A01AA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium fluoride, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium fluoride, combinations"
                         type="fsn">sodium fluoride, combinations</designation>
                    <desc language="en-US">sodium fluoride, combinations</desc>
                </concept>
                <concept code="A01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinfectives and antiseptics for local oral treatment"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiinfectives and antiseptics for local oral treatment"
                         type="fsn">Antiinfectives and antiseptics for local oral treatment</designation>
                    <desc language="en-US">Antiinfectives and antiseptics for local oral treatment</desc>
                </concept>
                <concept code="A01AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrogen peroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrogen peroxide" type="fsn">hydrogen peroxide</designation>
                    <desc language="en-US">hydrogen peroxide</desc>
                </concept>
                <concept code="A01AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorhexidine" type="fsn">chlorhexidine</designation>
                    <desc language="en-US">chlorhexidine</desc>
                </concept>
                <concept code="A01AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amphotericin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amphotericin B" type="fsn">amphotericin B</designation>
                    <desc language="en-US">amphotericin B</desc>
                </concept>
                <concept code="A01AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polynoxylin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polynoxylin" type="fsn">polynoxylin</designation>
                    <desc language="en-US">polynoxylin</desc>
                </concept>
                <concept code="A01AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="domiphen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="domiphen" type="fsn">domiphen</designation>
                    <desc language="en-US">domiphen</desc>
                </concept>
                <concept code="A01AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyquinoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyquinoline" type="fsn">oxyquinoline</designation>
                    <desc language="en-US">oxyquinoline</desc>
                </concept>
                <concept code="A01AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="A01AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miconazole" type="fsn">miconazole</designation>
                    <desc language="en-US">miconazole</desc>
                </concept>
                <concept code="A01AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="natamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="natamycin" type="fsn">natamycin</designation>
                    <desc language="en-US">natamycin</desc>
                </concept>
                <concept code="A01AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="various"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="various" type="fsn">various</designation>
                    <desc language="en-US">various</desc>
                </concept>
                <concept code="A01AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexetidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexetidine" type="fsn">hexetidine</designation>
                    <desc language="en-US">hexetidine</desc>
                </concept>
                <concept code="A01AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracycline" type="fsn">tetracycline</designation>
                    <desc language="en-US">tetracycline</desc>
                </concept>
                <concept code="A01AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzoxonium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzoxonium chloride" type="fsn">benzoxonium chloride</designation>
                    <desc language="en-US">benzoxonium chloride</desc>
                </concept>
                <concept code="A01AB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tibezonium iodide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tibezonium iodide" type="fsn">tibezonium iodide</designation>
                    <desc language="en-US">tibezonium iodide</desc>
                </concept>
                <concept code="A01AB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepartricin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepartricin" type="fsn">mepartricin</designation>
                    <desc language="en-US">mepartricin</desc>
                </concept>
                <concept code="A01AB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metronidazole" type="fsn">metronidazole</designation>
                    <desc language="en-US">metronidazole</desc>
                </concept>
                <concept code="A01AB18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clotrimazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clotrimazole" type="fsn">clotrimazole</designation>
                    <desc language="en-US">clotrimazole</desc>
                </concept>
                <concept code="A01AB19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium perborate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium perborate" type="fsn">sodium perborate</designation>
                    <desc language="en-US">sodium perborate</desc>
                </concept>
                <concept code="A01AB21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlortetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlortetracycline" type="fsn">chlortetracycline</designation>
                    <desc language="en-US">chlortetracycline</desc>
                </concept>
                <concept code="A01AB22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxycycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxycycline" type="fsn">doxycycline</designation>
                    <desc language="en-US">doxycycline</desc>
                </concept>
                <concept code="A01AB23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="minocycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="minocycline" type="fsn">minocycline</designation>
                    <desc language="en-US">minocycline</desc>
                </concept>
                <concept code="A01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids for local oral treatment"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids for local oral treatment"
                         type="fsn">Corticosteroids for local oral treatment</designation>
                    <desc language="en-US">Corticosteroids for local oral treatment</desc>
                </concept>
                <concept code="A01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamcinolone" type="fsn">triamcinolone</designation>
                    <desc language="en-US">triamcinolone</desc>
                </concept>
                <concept code="A01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="A01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="A01AC54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone, combinations"
                         type="fsn">prednisolone, combinations</designation>
                    <desc language="en-US">prednisolone, combinations</desc>
                </concept>
                <concept code="A01AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other agents for local oral treatment"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other agents for local oral treatment"
                         type="fsn">Other agents for local oral treatment</designation>
                    <desc language="en-US">Other agents for local oral treatment</desc>
                </concept>
                <concept code="A01AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinephrine" type="fsn">epinephrine</designation>
                    <desc language="en-US">epinephrine</desc>
                </concept>
                <concept code="A01AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzydamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzydamine" type="fsn">benzydamine</designation>
                    <desc language="en-US">benzydamine</desc>
                </concept>
                <concept code="A01AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylsalicylic acid" type="fsn">acetylsalicylic acid</designation>
                    <desc language="en-US">acetylsalicylic acid</desc>
                </concept>
                <concept code="A01AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adrenalone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adrenalone" type="fsn">adrenalone</designation>
                    <desc language="en-US">adrenalone</desc>
                </concept>
                <concept code="A01AD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amlexanox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amlexanox" type="fsn">amlexanox</designation>
                    <desc language="en-US">amlexanox</desc>
                </concept>
                <concept code="A01AD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="becaplermin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="becaplermin" type="fsn">becaplermin</designation>
                    <desc language="en-US">becaplermin</desc>
                </concept>
                <concept code="A01AD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="various"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="various" type="fsn">various</designation>
                    <desc language="en-US">various</desc>
                </concept>
                <concept code="A02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR ACID RELATED DISORDERS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR ACID RELATED DISORDERS"
                         type="fsn">DRUGS FOR ACID RELATED DISORDERS</designation>
                    <desc language="en-US">DRUGS FOR ACID RELATED DISORDERS</desc>
                </concept>
                <concept code="A02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTACIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTACIDS" type="fsn">ANTACIDS</designation>
                    <desc language="en-US">ANTACIDS</desc>
                </concept>
                <concept code="A02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Magnesium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Magnesium compounds" type="fsn">Magnesium compounds</designation>
                    <desc language="en-US">Magnesium compounds</desc>
                </concept>
                <concept code="A02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium carbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium carbonate" type="fsn">magnesium carbonate</designation>
                    <desc language="en-US">magnesium carbonate</desc>
                </concept>
                <concept code="A02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium oxide" type="fsn">magnesium oxide</designation>
                    <desc language="en-US">magnesium oxide</desc>
                </concept>
                <concept code="A02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium peroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium peroxide" type="fsn">magnesium peroxide</designation>
                    <desc language="en-US">magnesium peroxide</desc>
                </concept>
                <concept code="A02AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium hydroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium hydroxide" type="fsn">magnesium hydroxide</designation>
                    <desc language="en-US">magnesium hydroxide</desc>
                </concept>
                <concept code="A02AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium silicate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium silicate" type="fsn">magnesium silicate</designation>
                    <desc language="en-US">magnesium silicate</desc>
                </concept>
                <concept code="A02AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aluminium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Aluminium compounds" type="fsn">Aluminium compounds</designation>
                    <desc language="en-US">Aluminium compounds</desc>
                </concept>
                <concept code="A02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium hydroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium hydroxide" type="fsn">aluminium hydroxide</designation>
                    <desc language="en-US">aluminium hydroxide</desc>
                </concept>
                <concept code="A02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="algeldrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="algeldrate" type="fsn">algeldrate</designation>
                    <desc language="en-US">algeldrate</desc>
                </concept>
                <concept code="A02AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium phosphate" type="fsn">aluminium phosphate</designation>
                    <desc language="en-US">aluminium phosphate</desc>
                </concept>
                <concept code="A02AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydroxialumini sodium carbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydroxialumini sodium carbonate"
                         type="fsn">dihydroxialumini sodium carbonate</designation>
                    <desc language="en-US">dihydroxialumini sodium carbonate</desc>
                </concept>
                <concept code="A02AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium acetoacetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium acetoacetate" type="fsn">aluminium acetoacetate</designation>
                    <desc language="en-US">aluminium acetoacetate</desc>
                </concept>
                <concept code="A02AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aloglutamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aloglutamol" type="fsn">aloglutamol</designation>
                    <desc language="en-US">aloglutamol</desc>
                </concept>
                <concept code="A02AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium glycinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium glycinate" type="fsn">aluminium glycinate</designation>
                    <desc language="en-US">aluminium glycinate</desc>
                </concept>
                <concept code="A02AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A02AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Calcium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Calcium compounds" type="fsn">Calcium compounds</designation>
                    <desc language="en-US">Calcium compounds</desc>
                </concept>
                <concept code="A02AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium carbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium carbonate" type="fsn">calcium carbonate</designation>
                    <desc language="en-US">calcium carbonate</desc>
                </concept>
                <concept code="A02AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium silicate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium silicate" type="fsn">calcium silicate</designation>
                    <desc language="en-US">calcium silicate</desc>
                </concept>
                <concept code="A02AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A02AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations and complexes of aluminium, calcium and magnesium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations and complexes of aluminium, calcium and magnesium compounds"
                         type="fsn">Combinations and complexes of aluminium, calcium and magnesium compounds</designation>
                    <desc language="en-US">Combinations and complexes of aluminium, calcium and magnesium compounds</desc>
                </concept>
                <concept code="A02AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ordinary salt combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ordinary salt combinations"
                         type="fsn">ordinary salt combinations</designation>
                    <desc language="en-US">ordinary salt combinations</desc>
                </concept>
                <concept code="A02AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magaldrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magaldrate" type="fsn">magaldrate</designation>
                    <desc language="en-US">magaldrate</desc>
                </concept>
                <concept code="A02AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="almagate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="almagate" type="fsn">almagate</designation>
                    <desc language="en-US">almagate</desc>
                </concept>
                <concept code="A02AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrotalcite"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrotalcite" type="fsn">hydrotalcite</designation>
                    <desc language="en-US">hydrotalcite</desc>
                </concept>
                <concept code="A02AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="almasilate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="almasilate" type="fsn">almasilate</designation>
                    <desc language="en-US">almasilate</desc>
                </concept>
                <concept code="A02AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antacids with antiflatulents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antacids with antiflatulents"
                         type="fsn">Antacids with antiflatulents</designation>
                    <desc language="en-US">Antacids with antiflatulents</desc>
                </concept>
                <concept code="A02AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magaldrate and antiflatulents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="magaldrate and antiflatulents"
                         type="fsn">magaldrate and antiflatulents</designation>
                    <desc language="en-US">magaldrate and antiflatulents</desc>
                </concept>
                <concept code="A02AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ordinary salt combinations and antiflatulents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ordinary salt combinations and antiflatulents"
                         type="fsn">ordinary salt combinations and antiflatulents</designation>
                    <desc language="en-US">ordinary salt combinations and antiflatulents</desc>
                </concept>
                <concept code="A02AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antacids with antispasmodics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antacids with antispasmodics"
                         type="fsn">Antacids with antispasmodics</designation>
                    <desc language="en-US">Antacids with antispasmodics</desc>
                </concept>
                <concept code="A02AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antacids with sodium bicarbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antacids with sodium bicarbonate"
                         type="fsn">Antacids with sodium bicarbonate</designation>
                    <desc language="en-US">Antacids with sodium bicarbonate</desc>
                </concept>
                <concept code="A02AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antacids, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antacids, other combinations"
                         type="fsn">Antacids, other combinations</designation>
                    <desc language="en-US">Antacids, other combinations</desc>
                </concept>
                <concept code="A02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)"
                         type="fsn">DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)</designation>
                    <desc language="en-US">DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)</desc>
                </concept>
                <concept code="A02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="H2-receptor antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="H2-receptor antagonists" type="fsn">H2-receptor antagonists</designation>
                    <desc language="en-US">H2-receptor antagonists</desc>
                </concept>
                <concept code="A02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cimetidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cimetidine" type="fsn">cimetidine</designation>
                    <desc language="en-US">cimetidine</desc>
                </concept>
                <concept code="A02BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ranitidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ranitidine" type="fsn">ranitidine</designation>
                    <desc language="en-US">ranitidine</desc>
                </concept>
                <concept code="A02BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="famotidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="famotidine" type="fsn">famotidine</designation>
                    <desc language="en-US">famotidine</desc>
                </concept>
                <concept code="A02BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nizatidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nizatidine" type="fsn">nizatidine</designation>
                    <desc language="en-US">nizatidine</desc>
                </concept>
                <concept code="A02BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="niperotidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="niperotidine" type="fsn">niperotidine</designation>
                    <desc language="en-US">niperotidine</desc>
                </concept>
                <concept code="A02BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="roxatidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="roxatidine" type="fsn">roxatidine</designation>
                    <desc language="en-US">roxatidine</desc>
                </concept>
                <concept code="A02BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ranitidine bismuth citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ranitidine bismuth citrate"
                         type="fsn">ranitidine bismuth citrate</designation>
                    <desc language="en-US">ranitidine bismuth citrate</desc>
                </concept>
                <concept code="A02BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lafutidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lafutidine" type="fsn">lafutidine</designation>
                    <desc language="en-US">lafutidine</desc>
                </concept>
                <concept code="A02BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cimetidine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cimetidine, combinations" type="fsn">cimetidine, combinations</designation>
                    <desc language="en-US">cimetidine, combinations</desc>
                </concept>
                <concept code="A02BA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="famotidine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="famotidine, combinations" type="fsn">famotidine, combinations</designation>
                    <desc language="en-US">famotidine, combinations</desc>
                </concept>
                <concept code="A02BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Prostaglandins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Prostaglandins" type="fsn">Prostaglandins</designation>
                    <desc language="en-US">Prostaglandins</desc>
                </concept>
                <concept code="A02BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="misoprostol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="misoprostol" type="fsn">misoprostol</designation>
                    <desc language="en-US">misoprostol</desc>
                </concept>
                <concept code="A02BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enprostil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enprostil" type="fsn">enprostil</designation>
                    <desc language="en-US">enprostil</desc>
                </concept>
                <concept code="A02BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Proton pump inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Proton pump inhibitors" type="fsn">Proton pump inhibitors</designation>
                    <desc language="en-US">Proton pump inhibitors</desc>
                </concept>
                <concept code="A02BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omeprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="omeprazole" type="fsn">omeprazole</designation>
                    <desc language="en-US">omeprazole</desc>
                </concept>
                <concept code="A02BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pantoprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pantoprazole" type="fsn">pantoprazole</designation>
                    <desc language="en-US">pantoprazole</desc>
                </concept>
                <concept code="A02BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lansoprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lansoprazole" type="fsn">lansoprazole</designation>
                    <desc language="en-US">lansoprazole</desc>
                </concept>
                <concept code="A02BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rabeprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rabeprazole" type="fsn">rabeprazole</designation>
                    <desc language="en-US">rabeprazole</desc>
                </concept>
                <concept code="A02BC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="esomeprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="esomeprazole" type="fsn">esomeprazole</designation>
                    <desc language="en-US">esomeprazole</desc>
                </concept>
                <concept code="A02BC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexlansoprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexlansoprazole" type="fsn">dexlansoprazole</designation>
                    <desc language="en-US">dexlansoprazole</desc>
                </concept>
                <concept code="A02BC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexrabeprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexrabeprazole" type="fsn">dexrabeprazole</designation>
                    <desc language="en-US">dexrabeprazole</desc>
                </concept>
                <concept code="A02BC53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lansoprazole, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lansoprazole, combinations"
                         type="fsn">lansoprazole, combinations</designation>
                    <desc language="en-US">lansoprazole, combinations</desc>
                </concept>
                <concept code="A02BC54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rabeprazole, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rabeprazole, combinations" type="fsn">rabeprazole, combinations</designation>
                    <desc language="en-US">rabeprazole, combinations</desc>
                </concept>
                <concept code="A02BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations for eradication of Helicobacter pylori"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations for eradication of Helicobacter pylori"
                         type="fsn">Combinations for eradication of Helicobacter pylori</designation>
                    <desc language="en-US">Combinations for eradication of Helicobacter pylori</desc>
                </concept>
                <concept code="A02BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omeprazole, amoxicillin and metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="omeprazole, amoxicillin and metronidazole"
                         type="fsn">omeprazole, amoxicillin and metronidazole</designation>
                    <desc language="en-US">omeprazole, amoxicillin and metronidazole</desc>
                </concept>
                <concept code="A02BD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lansoprazole, tetracycline and metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lansoprazole, tetracycline and metronidazole"
                         type="fsn">lansoprazole, tetracycline and metronidazole</designation>
                    <desc language="en-US">lansoprazole, tetracycline and metronidazole</desc>
                </concept>
                <concept code="A02BD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lansoprazole, amoxicillin and metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lansoprazole, amoxicillin and metronidazole"
                         type="fsn">lansoprazole, amoxicillin and metronidazole</designation>
                    <desc language="en-US">lansoprazole, amoxicillin and metronidazole</desc>
                </concept>
                <concept code="A02BD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pantoprazole, amoxicillin and clarithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pantoprazole, amoxicillin and clarithromycin"
                         type="fsn">pantoprazole, amoxicillin and clarithromycin</designation>
                    <desc language="en-US">pantoprazole, amoxicillin and clarithromycin</desc>
                </concept>
                <concept code="A02BD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omeprazole, amoxicillin and clarithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="omeprazole, amoxicillin and clarithromycin"
                         type="fsn">omeprazole, amoxicillin and clarithromycin</designation>
                    <desc language="en-US">omeprazole, amoxicillin and clarithromycin</desc>
                </concept>
                <concept code="A02BD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="esomeprazole, amoxicillin and clarithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="esomeprazole, amoxicillin and clarithromycin"
                         type="fsn">esomeprazole, amoxicillin and clarithromycin</designation>
                    <desc language="en-US">esomeprazole, amoxicillin and clarithromycin</desc>
                </concept>
                <concept code="A02BD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lansoprazole, amoxicillin and clarithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lansoprazole, amoxicillin and clarithromycin"
                         type="fsn">lansoprazole, amoxicillin and clarithromycin</designation>
                    <desc language="en-US">lansoprazole, amoxicillin and clarithromycin</desc>
                </concept>
                <concept code="A02BD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bismuth subcitrate, tetracycline and metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bismuth subcitrate, tetracycline and metronidazole"
                         type="fsn">bismuth subcitrate, tetracycline and metronidazole</designation>
                    <desc language="en-US">bismuth subcitrate, tetracycline and metronidazole</desc>
                </concept>
                <concept code="A02BD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lansoprazole, clarithromycin and tinidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lansoprazole, clarithromycin and tinidazole"
                         type="fsn">lansoprazole, clarithromycin and tinidazole</designation>
                    <desc language="en-US">lansoprazole, clarithromycin and tinidazole</desc>
                </concept>
                <concept code="A02BD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lansoprazole, amoxicillin and levofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lansoprazole, amoxicillin and levofloxacin"
                         type="fsn">lansoprazole, amoxicillin and levofloxacin</designation>
                    <desc language="en-US">lansoprazole, amoxicillin and levofloxacin</desc>
                </concept>
                <concept code="A02BD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pantoprazole, amoxicillin, clarithromycin and metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pantoprazole, amoxicillin, clarithromycin and metronidazole"
                         type="fsn">pantoprazole, amoxicillin, clarithromycin and metronidazole</designation>
                    <desc language="en-US">pantoprazole, amoxicillin, clarithromycin and metronidazole</desc>
                </concept>
                <concept code="A02BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)"
                         type="fsn">Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)</designation>
                    <desc language="en-US">Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)</desc>
                </concept>
                <concept code="A02BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbenoxolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbenoxolone" type="fsn">carbenoxolone</designation>
                    <desc language="en-US">carbenoxolone</desc>
                </concept>
                <concept code="A02BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sucralfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sucralfate" type="fsn">sucralfate</designation>
                    <desc language="en-US">sucralfate</desc>
                </concept>
                <concept code="A02BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pirenzepine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pirenzepine" type="fsn">pirenzepine</designation>
                    <desc language="en-US">pirenzepine</desc>
                </concept>
                <concept code="A02BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methiosulfonium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methiosulfonium chloride" type="fsn">methiosulfonium chloride</designation>
                    <desc language="en-US">methiosulfonium chloride</desc>
                </concept>
                <concept code="A02BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bismuth subcitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bismuth subcitrate" type="fsn">bismuth subcitrate</designation>
                    <desc language="en-US">bismuth subcitrate</desc>
                </concept>
                <concept code="A02BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proglumide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proglumide" type="fsn">proglumide</designation>
                    <desc language="en-US">proglumide</desc>
                </concept>
                <concept code="A02BX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gefarnate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gefarnate" type="fsn">gefarnate</designation>
                    <desc language="en-US">gefarnate</desc>
                </concept>
                <concept code="A02BX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulglicotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulglicotide" type="fsn">sulglicotide</designation>
                    <desc language="en-US">sulglicotide</desc>
                </concept>
                <concept code="A02BX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetoxolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetoxolone" type="fsn">acetoxolone</designation>
                    <desc language="en-US">acetoxolone</desc>
                </concept>
                <concept code="A02BX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zolimidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zolimidine" type="fsn">zolimidine</designation>
                    <desc language="en-US">zolimidine</desc>
                </concept>
                <concept code="A02BX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="troxipide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="troxipide" type="fsn">troxipide</designation>
                    <desc language="en-US">troxipide</desc>
                </concept>
                <concept code="A02BX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bismuth subnitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bismuth subnitrate" type="fsn">bismuth subnitrate</designation>
                    <desc language="en-US">bismuth subnitrate</desc>
                </concept>
                <concept code="A02BX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alginic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alginic acid" type="fsn">alginic acid</designation>
                    <desc language="en-US">alginic acid</desc>
                </concept>
                <concept code="A02BX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rebamipide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rebamipide" type="fsn">rebamipide</designation>
                    <desc language="en-US">rebamipide</desc>
                </concept>
                <concept code="A02BX51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbenoxolone, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="carbenoxolone, combinations excl. psycholeptics"
                         type="fsn">carbenoxolone, combinations excl. psycholeptics</designation>
                    <desc language="en-US">carbenoxolone, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="A02BX71"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbenoxolone, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="carbenoxolone, combinations with psycholeptics"
                         type="fsn">carbenoxolone, combinations with psycholeptics</designation>
                    <desc language="en-US">carbenoxolone, combinations with psycholeptics</desc>
                </concept>
                <concept code="A02BX77"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gefarnate, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="gefarnate, combinations with psycholeptics"
                         type="fsn">gefarnate, combinations with psycholeptics</designation>
                    <desc language="en-US">gefarnate, combinations with psycholeptics</desc>
                </concept>
                <concept code="A02X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DRUGS FOR ACID RELATED DISORDERS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER DRUGS FOR ACID RELATED DISORDERS"
                         type="fsn">OTHER DRUGS FOR ACID RELATED DISORDERS</designation>
                    <desc language="en-US">OTHER DRUGS FOR ACID RELATED DISORDERS</desc>
                </concept>
                <concept code="A03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS"
                         type="fsn">DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS</designation>
                    <desc language="en-US">DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS</desc>
                </concept>
                <concept code="A03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS"
                         type="fsn">DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS</designation>
                    <desc language="en-US">DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS</desc>
                </concept>
                <concept code="A03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Synthetic anticholinergics, esters with tertiary amino group"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Synthetic anticholinergics, esters with tertiary amino group"
                         type="fsn">Synthetic anticholinergics, esters with tertiary amino group</designation>
                    <desc language="en-US">Synthetic anticholinergics, esters with tertiary amino group</desc>
                </concept>
                <concept code="A03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyphencyclimine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyphencyclimine" type="fsn">oxyphencyclimine</designation>
                    <desc language="en-US">oxyphencyclimine</desc>
                </concept>
                <concept code="A03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="camylofin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="camylofin" type="fsn">camylofin</designation>
                    <desc language="en-US">camylofin</desc>
                </concept>
                <concept code="A03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mebeverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mebeverine" type="fsn">mebeverine</designation>
                    <desc language="en-US">mebeverine</desc>
                </concept>
                <concept code="A03AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimebutine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimebutine" type="fsn">trimebutine</designation>
                    <desc language="en-US">trimebutine</desc>
                </concept>
                <concept code="A03AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rociverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rociverine" type="fsn">rociverine</designation>
                    <desc language="en-US">rociverine</desc>
                </concept>
                <concept code="A03AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dicycloverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dicycloverine" type="fsn">dicycloverine</designation>
                    <desc language="en-US">dicycloverine</desc>
                </concept>
                <concept code="A03AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihexyverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dihexyverine" type="fsn">dihexyverine</designation>
                    <desc language="en-US">dihexyverine</desc>
                </concept>
                <concept code="A03AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="difemerine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="difemerine" type="fsn">difemerine</designation>
                    <desc language="en-US">difemerine</desc>
                </concept>
                <concept code="A03AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piperidolate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piperidolate" type="fsn">piperidolate</designation>
                    <desc language="en-US">piperidolate</desc>
                </concept>
                <concept code="A03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Synthetic anticholinergics, quaternary ammonium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Synthetic anticholinergics, quaternary ammonium compounds"
                         type="fsn">Synthetic anticholinergics, quaternary ammonium compounds</designation>
                    <desc language="en-US">Synthetic anticholinergics, quaternary ammonium compounds</desc>
                </concept>
                <concept code="A03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzilone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzilone" type="fsn">benzilone</designation>
                    <desc language="en-US">benzilone</desc>
                </concept>
                <concept code="A03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycopyrronium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glycopyrronium bromide" type="fsn">glycopyrronium bromide</designation>
                    <desc language="en-US">glycopyrronium bromide</desc>
                </concept>
                <concept code="A03AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyphenonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyphenonium" type="fsn">oxyphenonium</designation>
                    <desc language="en-US">oxyphenonium</desc>
                </concept>
                <concept code="A03AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penthienate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="penthienate" type="fsn">penthienate</designation>
                    <desc language="en-US">penthienate</desc>
                </concept>
                <concept code="A03AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propantheline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propantheline" type="fsn">propantheline</designation>
                    <desc language="en-US">propantheline</desc>
                </concept>
                <concept code="A03AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="otilonium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="otilonium bromide" type="fsn">otilonium bromide</designation>
                    <desc language="en-US">otilonium bromide</desc>
                </concept>
                <concept code="A03AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methantheline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methantheline" type="fsn">methantheline</designation>
                    <desc language="en-US">methantheline</desc>
                </concept>
                <concept code="A03AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tridihexethyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tridihexethyl" type="fsn">tridihexethyl</designation>
                    <desc language="en-US">tridihexethyl</desc>
                </concept>
                <concept code="A03AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isopropamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isopropamide" type="fsn">isopropamide</designation>
                    <desc language="en-US">isopropamide</desc>
                </concept>
                <concept code="A03AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexocyclium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexocyclium" type="fsn">hexocyclium</designation>
                    <desc language="en-US">hexocyclium</desc>
                </concept>
                <concept code="A03AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="poldine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="poldine" type="fsn">poldine</designation>
                    <desc language="en-US">poldine</desc>
                </concept>
                <concept code="A03AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepenzolate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepenzolate" type="fsn">mepenzolate</designation>
                    <desc language="en-US">mepenzolate</desc>
                </concept>
                <concept code="A03AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bevonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bevonium" type="fsn">bevonium</designation>
                    <desc language="en-US">bevonium</desc>
                </concept>
                <concept code="A03AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipenzolate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pipenzolate" type="fsn">pipenzolate</designation>
                    <desc language="en-US">pipenzolate</desc>
                </concept>
                <concept code="A03AB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphemanil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphemanil" type="fsn">diphemanil</designation>
                    <desc language="en-US">diphemanil</desc>
                </concept>
                <concept code="A03AB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="(2-benzhydryloxyethyl)diethyl-methylammonium iodide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="(2-benzhydryloxyethyl)diethyl-methylammonium iodide"
                         type="fsn">(2-benzhydryloxyethyl)diethyl-methylammonium iodide</designation>
                    <desc language="en-US">(2-benzhydryloxyethyl)diethyl-methylammonium iodide</desc>
                </concept>
                <concept code="A03AB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiemonium iodide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiemonium iodide" type="fsn">tiemonium iodide</designation>
                    <desc language="en-US">tiemonium iodide</desc>
                </concept>
                <concept code="A03AB18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prifinium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prifinium bromide" type="fsn">prifinium bromide</designation>
                    <desc language="en-US">prifinium bromide</desc>
                </concept>
                <concept code="A03AB19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="timepidium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="timepidium bromide" type="fsn">timepidium bromide</designation>
                    <desc language="en-US">timepidium bromide</desc>
                </concept>
                <concept code="A03AB21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenpiverinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenpiverinium" type="fsn">fenpiverinium</designation>
                    <desc language="en-US">fenpiverinium</desc>
                </concept>
                <concept code="A03AB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyphenonium, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="oxyphenonium, combinations"
                         type="fsn">oxyphenonium, combinations</designation>
                    <desc language="en-US">oxyphenonium, combinations</desc>
                </concept>
                <concept code="A03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Synthetic antispasmodics, amides with tertiary amines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Synthetic antispasmodics, amides with tertiary amines"
                         type="fsn">Synthetic antispasmodics, amides with tertiary amines</designation>
                    <desc language="en-US">Synthetic antispasmodics, amides with tertiary amines</desc>
                </concept>
                <concept code="A03AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimethylaminopropionylphenothiazine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dimethylaminopropionylphenothiazine"
                         type="fsn">dimethylaminopropionylphenothiazine</designation>
                    <desc language="en-US">dimethylaminopropionylphenothiazine</desc>
                </concept>
                <concept code="A03AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicofetamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicofetamide" type="fsn">nicofetamide</designation>
                    <desc language="en-US">nicofetamide</desc>
                </concept>
                <concept code="A03AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiropramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiropramide" type="fsn">tiropramide</designation>
                    <desc language="en-US">tiropramide</desc>
                </concept>
                <concept code="A03AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Papaverine and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Papaverine and derivatives"
                         type="fsn">Papaverine and derivatives</designation>
                    <desc language="en-US">Papaverine and derivatives</desc>
                </concept>
                <concept code="A03AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="papaverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="papaverine" type="fsn">papaverine</designation>
                    <desc language="en-US">papaverine</desc>
                </concept>
                <concept code="A03AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="drotaverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="drotaverine" type="fsn">drotaverine</designation>
                    <desc language="en-US">drotaverine</desc>
                </concept>
                <concept code="A03AD30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moxaverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moxaverine" type="fsn">moxaverine</designation>
                    <desc language="en-US">moxaverine</desc>
                </concept>
                <concept code="A03AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Serotonin receptor antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Serotonin receptor antagonists"
                         type="fsn">Serotonin receptor antagonists</designation>
                    <desc language="en-US">Serotonin receptor antagonists</desc>
                </concept>
                <concept code="A03AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alosetron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alosetron" type="fsn">alosetron</designation>
                    <desc language="en-US">alosetron</desc>
                </concept>
                <concept code="A03AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cilansetron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cilansetron" type="fsn">cilansetron</designation>
                    <desc language="en-US">cilansetron</desc>
                </concept>
                <concept code="A03AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs for functional gastrointestinal disorders"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs for functional gastrointestinal disorders"
                         type="fsn">Other drugs for functional gastrointestinal disorders</designation>
                    <desc language="en-US">Other drugs for functional gastrointestinal disorders</desc>
                </concept>
                <concept code="A03AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenpiprane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenpiprane" type="fsn">fenpiprane</designation>
                    <desc language="en-US">fenpiprane</desc>
                </concept>
                <concept code="A03AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diisopromine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diisopromine" type="fsn">diisopromine</designation>
                    <desc language="en-US">diisopromine</desc>
                </concept>
                <concept code="A03AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorbenzoxamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorbenzoxamine" type="fsn">chlorbenzoxamine</designation>
                    <desc language="en-US">chlorbenzoxamine</desc>
                </concept>
                <concept code="A03AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pinaverium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pinaverium" type="fsn">pinaverium</designation>
                    <desc language="en-US">pinaverium</desc>
                </concept>
                <concept code="A03AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenoverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenoverine" type="fsn">fenoverine</designation>
                    <desc language="en-US">fenoverine</desc>
                </concept>
                <concept code="A03AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idanpramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idanpramine" type="fsn">idanpramine</designation>
                    <desc language="en-US">idanpramine</desc>
                </concept>
                <concept code="A03AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proxazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proxazole" type="fsn">proxazole</designation>
                    <desc language="en-US">proxazole</desc>
                </concept>
                <concept code="A03AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alverine" type="fsn">alverine</designation>
                    <desc language="en-US">alverine</desc>
                </concept>
                <concept code="A03AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trepibutone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trepibutone" type="fsn">trepibutone</designation>
                    <desc language="en-US">trepibutone</desc>
                </concept>
                <concept code="A03AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isometheptene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isometheptene" type="fsn">isometheptene</designation>
                    <desc language="en-US">isometheptene</desc>
                </concept>
                <concept code="A03AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="caroverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="caroverine" type="fsn">caroverine</designation>
                    <desc language="en-US">caroverine</desc>
                </concept>
                <concept code="A03AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phloroglucinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phloroglucinol" type="fsn">phloroglucinol</designation>
                    <desc language="en-US">phloroglucinol</desc>
                </concept>
                <concept code="A03AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="silicones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="silicones" type="fsn">silicones</designation>
                    <desc language="en-US">silicones</desc>
                </concept>
                <concept code="A03AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valethamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valethamate" type="fsn">valethamate</designation>
                    <desc language="en-US">valethamate</desc>
                </concept>
                <concept code="A03AX30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimethyldiphenylpropylamine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="trimethyldiphenylpropylamine"
                         type="fsn">trimethyldiphenylpropylamine</designation>
                    <desc language="en-US">trimethyldiphenylpropylamine</desc>
                </concept>
                <concept code="A03AX58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alverine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alverine, combinations" type="fsn">alverine, combinations</designation>
                    <desc language="en-US">alverine, combinations</desc>
                </concept>
                <concept code="A03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BELLADONNA AND DERIVATIVES, PLAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BELLADONNA AND DERIVATIVES, PLAIN"
                         type="fsn">BELLADONNA AND DERIVATIVES, PLAIN</designation>
                    <desc language="en-US">BELLADONNA AND DERIVATIVES, PLAIN</desc>
                </concept>
                <concept code="A03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Belladonna alkaloids, tertiary amines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Belladonna alkaloids, tertiary amines"
                         type="fsn">Belladonna alkaloids, tertiary amines</designation>
                    <desc language="en-US">Belladonna alkaloids, tertiary amines</desc>
                </concept>
                <concept code="A03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atropine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atropine" type="fsn">atropine</designation>
                    <desc language="en-US">atropine</desc>
                </concept>
                <concept code="A03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hyoscyamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hyoscyamine" type="fsn">hyoscyamine</designation>
                    <desc language="en-US">hyoscyamine</desc>
                </concept>
                <concept code="A03BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="belladonna total alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="belladonna total alkaloids"
                         type="fsn">belladonna total alkaloids</designation>
                    <desc language="en-US">belladonna total alkaloids</desc>
                </concept>
                <concept code="A03BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Belladonna alkaloids, semisynthetic, quaternary ammonium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Belladonna alkaloids, semisynthetic, quaternary ammonium compounds"
                         type="fsn">Belladonna alkaloids, semisynthetic, quaternary ammonium compounds</designation>
                    <desc language="en-US">Belladonna alkaloids, semisynthetic, quaternary ammonium compounds</desc>
                </concept>
                <concept code="A03BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butylscopolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butylscopolamine" type="fsn">butylscopolamine</designation>
                    <desc language="en-US">butylscopolamine</desc>
                </concept>
                <concept code="A03BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylatropine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylatropine" type="fsn">methylatropine</designation>
                    <desc language="en-US">methylatropine</desc>
                </concept>
                <concept code="A03BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylscopolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylscopolamine" type="fsn">methylscopolamine</designation>
                    <desc language="en-US">methylscopolamine</desc>
                </concept>
                <concept code="A03BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fentonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fentonium" type="fsn">fentonium</designation>
                    <desc language="en-US">fentonium</desc>
                </concept>
                <concept code="A03BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cimetropium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cimetropium bromide" type="fsn">cimetropium bromide</designation>
                    <desc language="en-US">cimetropium bromide</desc>
                </concept>
                <concept code="A03C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS"
                         type="fsn">ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS</designation>
                    <desc language="en-US">ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS</desc>
                </concept>
                <concept code="A03CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Synthetic anticholinergic agents in combination with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Synthetic anticholinergic agents in combination with psycholeptics"
                         type="fsn">Synthetic anticholinergic agents in combination with psycholeptics</designation>
                    <desc language="en-US">Synthetic anticholinergic agents in combination with psycholeptics</desc>
                </concept>
                <concept code="A03CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isopropamide and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="isopropamide and psycholeptics"
                         type="fsn">isopropamide and psycholeptics</designation>
                    <desc language="en-US">isopropamide and psycholeptics</desc>
                </concept>
                <concept code="A03CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clidinium and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="clidinium and psycholeptics"
                         type="fsn">clidinium and psycholeptics</designation>
                    <desc language="en-US">clidinium and psycholeptics</desc>
                </concept>
                <concept code="A03CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyphencyclimine and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="oxyphencyclimine and psycholeptics"
                         type="fsn">oxyphencyclimine and psycholeptics</designation>
                    <desc language="en-US">oxyphencyclimine and psycholeptics</desc>
                </concept>
                <concept code="A03CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="otilonium bromide and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="otilonium bromide and psycholeptics"
                         type="fsn">otilonium bromide and psycholeptics</designation>
                    <desc language="en-US">otilonium bromide and psycholeptics</desc>
                </concept>
                <concept code="A03CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycopyrronium bromide and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="glycopyrronium bromide and psycholeptics"
                         type="fsn">glycopyrronium bromide and psycholeptics</designation>
                    <desc language="en-US">glycopyrronium bromide and psycholeptics</desc>
                </concept>
                <concept code="A03CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bevonium and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bevonium and psycholeptics"
                         type="fsn">bevonium and psycholeptics</designation>
                    <desc language="en-US">bevonium and psycholeptics</desc>
                </concept>
                <concept code="A03CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ambutonium and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ambutonium and psycholeptics"
                         type="fsn">ambutonium and psycholeptics</designation>
                    <desc language="en-US">ambutonium and psycholeptics</desc>
                </concept>
                <concept code="A03CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphemanil and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphemanil and psycholeptics"
                         type="fsn">diphemanil and psycholeptics</designation>
                    <desc language="en-US">diphemanil and psycholeptics</desc>
                </concept>
                <concept code="A03CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipenzolate and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pipenzolate and psycholeptics"
                         type="fsn">pipenzolate and psycholeptics</designation>
                    <desc language="en-US">pipenzolate and psycholeptics</desc>
                </concept>
                <concept code="A03CA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emepronium and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emepronium and psycholeptics"
                         type="fsn">emepronium and psycholeptics</designation>
                    <desc language="en-US">emepronium and psycholeptics</desc>
                </concept>
                <concept code="A03CA34"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propantheline and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="propantheline and psycholeptics"
                         type="fsn">propantheline and psycholeptics</designation>
                    <desc language="en-US">propantheline and psycholeptics</desc>
                </concept>
                <concept code="A03CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Belladonna and derivatives in combination with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Belladonna and derivatives in combination with psycholeptics"
                         type="fsn">Belladonna and derivatives in combination with psycholeptics</designation>
                    <desc language="en-US">Belladonna and derivatives in combination with psycholeptics</desc>
                </concept>
                <concept code="A03CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylscopolamine and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylscopolamine and psycholeptics"
                         type="fsn">methylscopolamine and psycholeptics</designation>
                    <desc language="en-US">methylscopolamine and psycholeptics</desc>
                </concept>
                <concept code="A03CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="belladonna total alkaloids and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="belladonna total alkaloids and psycholeptics"
                         type="fsn">belladonna total alkaloids and psycholeptics</designation>
                    <desc language="en-US">belladonna total alkaloids and psycholeptics</desc>
                </concept>
                <concept code="A03CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atropine and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atropine and psycholeptics"
                         type="fsn">atropine and psycholeptics</designation>
                    <desc language="en-US">atropine and psycholeptics</desc>
                </concept>
                <concept code="A03CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylhomatropine and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylhomatropine and psycholeptics"
                         type="fsn">methylhomatropine and psycholeptics</designation>
                    <desc language="en-US">methylhomatropine and psycholeptics</desc>
                </concept>
                <concept code="A03CB31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hyoscyamine and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hyoscyamine and psycholeptics"
                         type="fsn">hyoscyamine and psycholeptics</designation>
                    <desc language="en-US">hyoscyamine and psycholeptics</desc>
                </concept>
                <concept code="A03CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antispasmodics in combination with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antispasmodics in combination with psycholeptics"
                         type="fsn">Other antispasmodics in combination with psycholeptics</designation>
                    <desc language="en-US">Other antispasmodics in combination with psycholeptics</desc>
                </concept>
                <concept code="A03D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTISPASMODICS IN COMBINATION WITH ANALGESICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTISPASMODICS IN COMBINATION WITH ANALGESICS"
                         type="fsn">ANTISPASMODICS IN COMBINATION WITH ANALGESICS</designation>
                    <desc language="en-US">ANTISPASMODICS IN COMBINATION WITH ANALGESICS</desc>
                </concept>
                <concept code="A03DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Synthetic anticholinergic agents in combination with analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Synthetic anticholinergic agents in combination with analgesics"
                         type="fsn">Synthetic anticholinergic agents in combination with analgesics</designation>
                    <desc language="en-US">Synthetic anticholinergic agents in combination with analgesics</desc>
                </concept>
                <concept code="A03DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tropenzilone and analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tropenzilone and analgesics"
                         type="fsn">tropenzilone and analgesics</designation>
                    <desc language="en-US">tropenzilone and analgesics</desc>
                </concept>
                <concept code="A03DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pitofenone and analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pitofenone and analgesics" type="fsn">pitofenone and analgesics</designation>
                    <desc language="en-US">pitofenone and analgesics</desc>
                </concept>
                <concept code="A03DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bevonium and analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bevonium and analgesics" type="fsn">bevonium and analgesics</designation>
                    <desc language="en-US">bevonium and analgesics</desc>
                </concept>
                <concept code="A03DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclonium and analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclonium and analgesics" type="fsn">ciclonium and analgesics</designation>
                    <desc language="en-US">ciclonium and analgesics</desc>
                </concept>
                <concept code="A03DA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="camylofin and analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="camylofin and analgesics" type="fsn">camylofin and analgesics</designation>
                    <desc language="en-US">camylofin and analgesics</desc>
                </concept>
                <concept code="A03DA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trospium and analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trospium and analgesics" type="fsn">trospium and analgesics</designation>
                    <desc language="en-US">trospium and analgesics</desc>
                </concept>
                <concept code="A03DA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiemonium iodide and analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tiemonium iodide and analgesics"
                         type="fsn">tiemonium iodide and analgesics</designation>
                    <desc language="en-US">tiemonium iodide and analgesics</desc>
                </concept>
                <concept code="A03DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Belladonna and derivatives in combination with analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Belladonna and derivatives in combination with analgesics"
                         type="fsn">Belladonna and derivatives in combination with analgesics</designation>
                    <desc language="en-US">Belladonna and derivatives in combination with analgesics</desc>
                </concept>
                <concept code="A03DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butylscopolamine and analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="butylscopolamine and analgesics"
                         type="fsn">butylscopolamine and analgesics</designation>
                    <desc language="en-US">butylscopolamine and analgesics</desc>
                </concept>
                <concept code="A03DC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antispasmodics in combination with analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antispasmodics in combination with analgesics"
                         type="fsn">Other antispasmodics in combination with analgesics</designation>
                    <desc language="en-US">Other antispasmodics in combination with analgesics</desc>
                </concept>
                <concept code="A03E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS"
                         type="fsn">ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS</designation>
                    <desc language="en-US">ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS</desc>
                </concept>
                <concept code="A03EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antispasmodics, psycholeptics and analgesics in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antispasmodics, psycholeptics and analgesics in combination"
                         type="fsn">Antispasmodics, psycholeptics and analgesics in combination</designation>
                    <desc language="en-US">Antispasmodics, psycholeptics and analgesics in combination</desc>
                </concept>
                <concept code="A03ED"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antispasmodics in combination with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antispasmodics in combination with other drugs"
                         type="fsn">Antispasmodics in combination with other drugs</designation>
                    <desc language="en-US">Antispasmodics in combination with other drugs</desc>
                </concept>
                <concept code="A03F"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PROPULSIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PROPULSIVES" type="fsn">PROPULSIVES</designation>
                    <desc language="en-US">PROPULSIVES</desc>
                </concept>
                <concept code="A03FA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Propulsives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Propulsives" type="fsn">Propulsives</designation>
                    <desc language="en-US">Propulsives</desc>
                </concept>
                <concept code="A03FA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoclopramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metoclopramide" type="fsn">metoclopramide</designation>
                    <desc language="en-US">metoclopramide</desc>
                </concept>
                <concept code="A03FA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cisapride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cisapride" type="fsn">cisapride</designation>
                    <desc language="en-US">cisapride</desc>
                </concept>
                <concept code="A03FA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="domperidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="domperidone" type="fsn">domperidone</designation>
                    <desc language="en-US">domperidone</desc>
                </concept>
                <concept code="A03FA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromopride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromopride" type="fsn">bromopride</designation>
                    <desc language="en-US">bromopride</desc>
                </concept>
                <concept code="A03FA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alizapride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alizapride" type="fsn">alizapride</designation>
                    <desc language="en-US">alizapride</desc>
                </concept>
                <concept code="A03FA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clebopride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clebopride" type="fsn">clebopride</designation>
                    <desc language="en-US">clebopride</desc>
                </concept>
                <concept code="A03FA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="itopride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="itopride" type="fsn">itopride</designation>
                    <desc language="en-US">itopride</desc>
                </concept>
                <concept code="A03FA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinitapride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinitapride" type="fsn">cinitapride</designation>
                    <desc language="en-US">cinitapride</desc>
                </concept>
                <concept code="A04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIEMETICS AND ANTINAUSEANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIEMETICS AND ANTINAUSEANTS"
                         type="fsn">ANTIEMETICS AND ANTINAUSEANTS</designation>
                    <desc language="en-US">ANTIEMETICS AND ANTINAUSEANTS</desc>
                </concept>
                <concept code="A04A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIEMETICS AND ANTINAUSEANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIEMETICS AND ANTINAUSEANTS"
                         type="fsn">ANTIEMETICS AND ANTINAUSEANTS</designation>
                    <desc language="en-US">ANTIEMETICS AND ANTINAUSEANTS</desc>
                </concept>
                <concept code="A04AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Serotonin (5HT3) antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Serotonin (5HT3) antagonists"
                         type="fsn">Serotonin (5HT3) antagonists</designation>
                    <desc language="en-US">Serotonin (5HT3) antagonists</desc>
                </concept>
                <concept code="A04AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ondansetron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ondansetron" type="fsn">ondansetron</designation>
                    <desc language="en-US">ondansetron</desc>
                </concept>
                <concept code="A04AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="granisetron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="granisetron" type="fsn">granisetron</designation>
                    <desc language="en-US">granisetron</desc>
                </concept>
                <concept code="A04AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tropisetron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tropisetron" type="fsn">tropisetron</designation>
                    <desc language="en-US">tropisetron</desc>
                </concept>
                <concept code="A04AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dolasetron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dolasetron" type="fsn">dolasetron</designation>
                    <desc language="en-US">dolasetron</desc>
                </concept>
                <concept code="A04AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="palonosetron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="palonosetron" type="fsn">palonosetron</designation>
                    <desc language="en-US">palonosetron</desc>
                </concept>
                <concept code="A04AA55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="palonosetron, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="palonosetron, combinations"
                         type="fsn">palonosetron, combinations</designation>
                    <desc language="en-US">palonosetron, combinations</desc>
                </concept>
                <concept code="A04AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiemetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antiemetics" type="fsn">Other antiemetics</designation>
                    <desc language="en-US">Other antiemetics</desc>
                </concept>
                <concept code="A04AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="scopolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="scopolamine" type="fsn">scopolamine</designation>
                    <desc language="en-US">scopolamine</desc>
                </concept>
                <concept code="A04AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cerium oxalate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cerium oxalate" type="fsn">cerium oxalate</designation>
                    <desc language="en-US">cerium oxalate</desc>
                </concept>
                <concept code="A04AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorobutanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorobutanol" type="fsn">chlorobutanol</designation>
                    <desc language="en-US">chlorobutanol</desc>
                </concept>
                <concept code="A04AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metopimazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metopimazine" type="fsn">metopimazine</designation>
                    <desc language="en-US">metopimazine</desc>
                </concept>
                <concept code="A04AD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dronabinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dronabinol" type="fsn">dronabinol</designation>
                    <desc language="en-US">dronabinol</desc>
                </concept>
                <concept code="A04AD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nabilone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nabilone" type="fsn">nabilone</designation>
                    <desc language="en-US">nabilone</desc>
                </concept>
                <concept code="A04AD12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aprepitant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aprepitant" type="fsn">aprepitant</designation>
                    <desc language="en-US">aprepitant</desc>
                </concept>
                <concept code="A04AD13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="casopitant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="casopitant" type="fsn">casopitant</designation>
                    <desc language="en-US">casopitant</desc>
                </concept>
                <concept code="A04AD14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rolapitant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rolapitant" type="fsn">rolapitant</designation>
                    <desc language="en-US">rolapitant</desc>
                </concept>
                <concept code="A04AD51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="scopolamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="scopolamine, combinations" type="fsn">scopolamine, combinations</designation>
                    <desc language="en-US">scopolamine, combinations</desc>
                </concept>
                <concept code="A04AD54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorobutanol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlorobutanol, combinations"
                         type="fsn">chlorobutanol, combinations</designation>
                    <desc language="en-US">chlorobutanol, combinations</desc>
                </concept>
                <concept code="A05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BILE AND LIVER THERAPY"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="BILE AND LIVER THERAPY" type="fsn">BILE AND LIVER THERAPY</designation>
                    <desc language="en-US">BILE AND LIVER THERAPY</desc>
                </concept>
                <concept code="A05A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BILE THERAPY"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="BILE THERAPY" type="fsn">BILE THERAPY</designation>
                    <desc language="en-US">BILE THERAPY</desc>
                </concept>
                <concept code="A05AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bile acids and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Bile acids and derivatives"
                         type="fsn">Bile acids and derivatives</designation>
                    <desc language="en-US">Bile acids and derivatives</desc>
                </concept>
                <concept code="A05AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chenodeoxycholic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chenodeoxycholic acid" type="fsn">chenodeoxycholic acid</designation>
                    <desc language="en-US">chenodeoxycholic acid</desc>
                </concept>
                <concept code="A05AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ursodeoxycholic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ursodeoxycholic acid" type="fsn">ursodeoxycholic acid</designation>
                    <desc language="en-US">ursodeoxycholic acid</desc>
                </concept>
                <concept code="A05AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cholic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cholic acid" type="fsn">cholic acid</designation>
                    <desc language="en-US">cholic acid</desc>
                </concept>
                <concept code="A05AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="obeticholic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="obeticholic acid" type="fsn">obeticholic acid</designation>
                    <desc language="en-US">obeticholic acid</desc>
                </concept>
                <concept code="A05AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Preparations for biliary tract therapy"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Preparations for biliary tract therapy"
                         type="fsn">Preparations for biliary tract therapy</designation>
                    <desc language="en-US">Preparations for biliary tract therapy</desc>
                </concept>
                <concept code="A05AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicotinyl methylamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicotinyl methylamide" type="fsn">nicotinyl methylamide</designation>
                    <desc language="en-US">nicotinyl methylamide</desc>
                </concept>
                <concept code="A05AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs for bile therapy"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs for bile therapy"
                         type="fsn">Other drugs for bile therapy</designation>
                    <desc language="en-US">Other drugs for bile therapy</desc>
                </concept>
                <concept code="A05AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piprozolin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piprozolin" type="fsn">piprozolin</designation>
                    <desc language="en-US">piprozolin</desc>
                </concept>
                <concept code="A05AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hymecromone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hymecromone" type="fsn">hymecromone</designation>
                    <desc language="en-US">hymecromone</desc>
                </concept>
                <concept code="A05AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclobutyrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclobutyrol" type="fsn">cyclobutyrol</designation>
                    <desc language="en-US">cyclobutyrol</desc>
                </concept>
                <concept code="A05B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="LIVER THERAPY, LIPOTROPICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="LIVER THERAPY, LIPOTROPICS"
                         type="fsn">LIVER THERAPY, LIPOTROPICS</designation>
                    <desc language="en-US">LIVER THERAPY, LIPOTROPICS</desc>
                </concept>
                <concept code="A05BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Liver therapy"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Liver therapy" type="fsn">Liver therapy</designation>
                    <desc language="en-US">Liver therapy</desc>
                </concept>
                <concept code="A05BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="arginine glutamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="arginine glutamate" type="fsn">arginine glutamate</designation>
                    <desc language="en-US">arginine glutamate</desc>
                </concept>
                <concept code="A05BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="silymarin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="silymarin" type="fsn">silymarin</designation>
                    <desc language="en-US">silymarin</desc>
                </concept>
                <concept code="A05BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="citiolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="citiolone" type="fsn">citiolone</designation>
                    <desc language="en-US">citiolone</desc>
                </concept>
                <concept code="A05BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epomediol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epomediol" type="fsn">epomediol</designation>
                    <desc language="en-US">epomediol</desc>
                </concept>
                <concept code="A05BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ornithine oxoglurate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ornithine oxoglurate" type="fsn">ornithine oxoglurate</designation>
                    <desc language="en-US">ornithine oxoglurate</desc>
                </concept>
                <concept code="A05BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tidiacic arginine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tidiacic arginine" type="fsn">tidiacic arginine</designation>
                    <desc language="en-US">tidiacic arginine</desc>
                </concept>
                <concept code="A05BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycyrrhizic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glycyrrhizic acid" type="fsn">glycyrrhizic acid</designation>
                    <desc language="en-US">glycyrrhizic acid</desc>
                </concept>
                <concept code="A05C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION"
                         type="fsn">DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION</designation>
                    <desc language="en-US">DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION</desc>
                </concept>
                <concept code="A06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR CONSTIPATION"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DRUGS FOR CONSTIPATION" type="fsn">DRUGS FOR CONSTIPATION</designation>
                    <desc language="en-US">DRUGS FOR CONSTIPATION</desc>
                </concept>
                <concept code="A06A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR CONSTIPATION"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DRUGS FOR CONSTIPATION" type="fsn">DRUGS FOR CONSTIPATION</designation>
                    <desc language="en-US">DRUGS FOR CONSTIPATION</desc>
                </concept>
                <concept code="A06AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Softeners, emollients"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Softeners, emollients" type="fsn">Softeners, emollients</designation>
                    <desc language="en-US">Softeners, emollients</desc>
                </concept>
                <concept code="A06AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="liquid paraffin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="liquid paraffin" type="fsn">liquid paraffin</designation>
                    <desc language="en-US">liquid paraffin</desc>
                </concept>
                <concept code="A06AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="docusate sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="docusate sodium" type="fsn">docusate sodium</designation>
                    <desc language="en-US">docusate sodium</desc>
                </concept>
                <concept code="A06AA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="liquid paraffin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="liquid paraffin, combinations"
                         type="fsn">liquid paraffin, combinations</designation>
                    <desc language="en-US">liquid paraffin, combinations</desc>
                </concept>
                <concept code="A06AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Contact laxatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Contact laxatives" type="fsn">Contact laxatives</designation>
                    <desc language="en-US">Contact laxatives</desc>
                </concept>
                <concept code="A06AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyphenisatine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyphenisatine" type="fsn">oxyphenisatine</designation>
                    <desc language="en-US">oxyphenisatine</desc>
                </concept>
                <concept code="A06AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bisacodyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bisacodyl" type="fsn">bisacodyl</designation>
                    <desc language="en-US">bisacodyl</desc>
                </concept>
                <concept code="A06AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dantron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dantron" type="fsn">dantron</designation>
                    <desc language="en-US">dantron</desc>
                </concept>
                <concept code="A06AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenolphthalein"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenolphthalein" type="fsn">phenolphthalein</designation>
                    <desc language="en-US">phenolphthalein</desc>
                </concept>
                <concept code="A06AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="castor oil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="castor oil" type="fsn">castor oil</designation>
                    <desc language="en-US">castor oil</desc>
                </concept>
                <concept code="A06AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="senna glycosides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="senna glycosides" type="fsn">senna glycosides</designation>
                    <desc language="en-US">senna glycosides</desc>
                </concept>
                <concept code="A06AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cascara"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cascara" type="fsn">cascara</designation>
                    <desc language="en-US">cascara</desc>
                </concept>
                <concept code="A06AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium picosulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium picosulfate" type="fsn">sodium picosulfate</designation>
                    <desc language="en-US">sodium picosulfate</desc>
                </concept>
                <concept code="A06AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bisoxatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bisoxatin" type="fsn">bisoxatin</designation>
                    <desc language="en-US">bisoxatin</desc>
                </concept>
                <concept code="A06AB20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="contact laxatives in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="contact laxatives in combination"
                         type="fsn">contact laxatives in combination</designation>
                    <desc language="en-US">contact laxatives in combination</desc>
                </concept>
                <concept code="A06AB30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="contact laxatives in combination with belladonna alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="contact laxatives in combination with belladonna alkaloids"
                         type="fsn">contact laxatives in combination with belladonna alkaloids</designation>
                    <desc language="en-US">contact laxatives in combination with belladonna alkaloids</desc>
                </concept>
                <concept code="A06AB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bisacodyl, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bisacodyl, combinations" type="fsn">bisacodyl, combinations</designation>
                    <desc language="en-US">bisacodyl, combinations</desc>
                </concept>
                <concept code="A06AB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dantron, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dantron, combinations" type="fsn">dantron, combinations</designation>
                    <desc language="en-US">dantron, combinations</desc>
                </concept>
                <concept code="A06AB56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="senna glycosides, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="senna glycosides, combinations"
                         type="fsn">senna glycosides, combinations</designation>
                    <desc language="en-US">senna glycosides, combinations</desc>
                </concept>
                <concept code="A06AB57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cascara, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cascara, combinations" type="fsn">cascara, combinations</designation>
                    <desc language="en-US">cascara, combinations</desc>
                </concept>
                <concept code="A06AB58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium picosulfate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium picosulfate, combinations"
                         type="fsn">sodium picosulfate, combinations</designation>
                    <desc language="en-US">sodium picosulfate, combinations</desc>
                </concept>
                <concept code="A06AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bulk-forming laxatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Bulk-forming laxatives" type="fsn">Bulk-forming laxatives</designation>
                    <desc language="en-US">Bulk-forming laxatives</desc>
                </concept>
                <concept code="A06AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ispaghula (psylla seeds)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ispaghula (psylla seeds)" type="fsn">ispaghula (psylla seeds)</designation>
                    <desc language="en-US">ispaghula (psylla seeds)</desc>
                </concept>
                <concept code="A06AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethulose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethulose" type="fsn">ethulose</designation>
                    <desc language="en-US">ethulose</desc>
                </concept>
                <concept code="A06AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sterculia"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sterculia" type="fsn">sterculia</designation>
                    <desc language="en-US">sterculia</desc>
                </concept>
                <concept code="A06AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="linseed"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="linseed" type="fsn">linseed</designation>
                    <desc language="en-US">linseed</desc>
                </concept>
                <concept code="A06AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylcellulose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylcellulose" type="fsn">methylcellulose</designation>
                    <desc language="en-US">methylcellulose</desc>
                </concept>
                <concept code="A06AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triticum (wheat fibre)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triticum (wheat fibre)" type="fsn">triticum (wheat fibre)</designation>
                    <desc language="en-US">triticum (wheat fibre)</desc>
                </concept>
                <concept code="A06AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polycarbophil calcium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polycarbophil calcium" type="fsn">polycarbophil calcium</designation>
                    <desc language="en-US">polycarbophil calcium</desc>
                </concept>
                <concept code="A06AC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ispaghula, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ispaghula, combinations" type="fsn">ispaghula, combinations</designation>
                    <desc language="en-US">ispaghula, combinations</desc>
                </concept>
                <concept code="A06AC53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sterculia, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sterculia, combinations" type="fsn">sterculia, combinations</designation>
                    <desc language="en-US">sterculia, combinations</desc>
                </concept>
                <concept code="A06AC55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="linseed, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="linseed, combinations" type="fsn">linseed, combinations</designation>
                    <desc language="en-US">linseed, combinations</desc>
                </concept>
                <concept code="A06AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Osmotically acting laxatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Osmotically acting laxatives"
                         type="fsn">Osmotically acting laxatives</designation>
                    <desc language="en-US">Osmotically acting laxatives</desc>
                </concept>
                <concept code="A06AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium carbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium carbonate" type="fsn">magnesium carbonate</designation>
                    <desc language="en-US">magnesium carbonate</desc>
                </concept>
                <concept code="A06AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium oxide" type="fsn">magnesium oxide</designation>
                    <desc language="en-US">magnesium oxide</desc>
                </concept>
                <concept code="A06AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium peroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium peroxide" type="fsn">magnesium peroxide</designation>
                    <desc language="en-US">magnesium peroxide</desc>
                </concept>
                <concept code="A06AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium sulfate" type="fsn">magnesium sulfate</designation>
                    <desc language="en-US">magnesium sulfate</desc>
                </concept>
                <concept code="A06AD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mineral salts in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="mineral salts in combination"
                         type="fsn">mineral salts in combination</designation>
                    <desc language="en-US">mineral salts in combination</desc>
                </concept>
                <concept code="A06AD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lactulose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lactulose" type="fsn">lactulose</designation>
                    <desc language="en-US">lactulose</desc>
                </concept>
                <concept code="A06AD12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lactitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lactitol" type="fsn">lactitol</designation>
                    <desc language="en-US">lactitol</desc>
                </concept>
                <concept code="A06AD13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium sulfate" type="fsn">sodium sulfate</designation>
                    <desc language="en-US">sodium sulfate</desc>
                </concept>
                <concept code="A06AD14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentaerithrityl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentaerithrityl" type="fsn">pentaerithrityl</designation>
                    <desc language="en-US">pentaerithrityl</desc>
                </concept>
                <concept code="A06AD15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="macrogol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="macrogol" type="fsn">macrogol</designation>
                    <desc language="en-US">macrogol</desc>
                </concept>
                <concept code="A06AD16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mannitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mannitol" type="fsn">mannitol</designation>
                    <desc language="en-US">mannitol</desc>
                </concept>
                <concept code="A06AD17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium phosphate" type="fsn">sodium phosphate</designation>
                    <desc language="en-US">sodium phosphate</desc>
                </concept>
                <concept code="A06AD18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sorbitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sorbitol" type="fsn">sorbitol</designation>
                    <desc language="en-US">sorbitol</desc>
                </concept>
                <concept code="A06AD19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium citrate" type="fsn">magnesium citrate</designation>
                    <desc language="en-US">magnesium citrate</desc>
                </concept>
                <concept code="A06AD21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium tartrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium tartrate" type="fsn">sodium tartrate</designation>
                    <desc language="en-US">sodium tartrate</desc>
                </concept>
                <concept code="A06AD61"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lactulose, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lactulose, combinations" type="fsn">lactulose, combinations</designation>
                    <desc language="en-US">lactulose, combinations</desc>
                </concept>
                <concept code="A06AD65"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="macrogol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="macrogol, combinations" type="fsn">macrogol, combinations</designation>
                    <desc language="en-US">macrogol, combinations</desc>
                </concept>
                <concept code="A06AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Enemas"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Enemas" type="fsn">Enemas</designation>
                    <desc language="en-US">Enemas</desc>
                </concept>
                <concept code="A06AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium phosphate" type="fsn">sodium phosphate</designation>
                    <desc language="en-US">sodium phosphate</desc>
                </concept>
                <concept code="A06AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bisacodyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bisacodyl" type="fsn">bisacodyl</designation>
                    <desc language="en-US">bisacodyl</desc>
                </concept>
                <concept code="A06AG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dantron, incl. combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dantron, incl. combinations"
                         type="fsn">dantron, incl. combinations</designation>
                    <desc language="en-US">dantron, incl. combinations</desc>
                </concept>
                <concept code="A06AG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycerol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glycerol" type="fsn">glycerol</designation>
                    <desc language="en-US">glycerol</desc>
                </concept>
                <concept code="A06AG06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oil" type="fsn">oil</designation>
                    <desc language="en-US">oil</desc>
                </concept>
                <concept code="A06AG07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sorbitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sorbitol" type="fsn">sorbitol</designation>
                    <desc language="en-US">sorbitol</desc>
                </concept>
                <concept code="A06AG10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="docusate sodium, incl. combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="docusate sodium, incl. combinations"
                         type="fsn">docusate sodium, incl. combinations</designation>
                    <desc language="en-US">docusate sodium, incl. combinations</desc>
                </concept>
                <concept code="A06AG11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium lauryl sulfoacetate, incl. combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium lauryl sulfoacetate, incl. combinations"
                         type="fsn">sodium lauryl sulfoacetate, incl. combinations</designation>
                    <desc language="en-US">sodium lauryl sulfoacetate, incl. combinations</desc>
                </concept>
                <concept code="A06AG20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A06AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Peripheral opioid receptor antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Peripheral opioid receptor antagonists"
                         type="fsn">Peripheral opioid receptor antagonists</designation>
                    <desc language="en-US">Peripheral opioid receptor antagonists</desc>
                </concept>
                <concept code="A06AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylnaltrexone bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylnaltrexone bromide" type="fsn">methylnaltrexone bromide</designation>
                    <desc language="en-US">methylnaltrexone bromide</desc>
                </concept>
                <concept code="A06AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alvimopan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alvimopan" type="fsn">alvimopan</designation>
                    <desc language="en-US">alvimopan</desc>
                </concept>
                <concept code="A06AH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naloxegol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naloxegol" type="fsn">naloxegol</designation>
                    <desc language="en-US">naloxegol</desc>
                </concept>
                <concept code="A06AH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naloxone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naloxone" type="fsn">naloxone</designation>
                    <desc language="en-US">naloxone</desc>
                </concept>
                <concept code="A06AH05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naldemedine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naldemedine" type="fsn">naldemedine</designation>
                    <desc language="en-US">naldemedine</desc>
                </concept>
                <concept code="A06AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs for constipation"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs for constipation"
                         type="fsn">Other drugs for constipation</designation>
                    <desc language="en-US">Other drugs for constipation</desc>
                </concept>
                <concept code="A06AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycerol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glycerol" type="fsn">glycerol</designation>
                    <desc language="en-US">glycerol</desc>
                </concept>
                <concept code="A06AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbon dioxide producing drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="carbon dioxide producing drugs"
                         type="fsn">carbon dioxide producing drugs</designation>
                    <desc language="en-US">carbon dioxide producing drugs</desc>
                </concept>
                <concept code="A06AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lubiprostone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lubiprostone" type="fsn">lubiprostone</designation>
                    <desc language="en-US">lubiprostone</desc>
                </concept>
                <concept code="A06AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="linaclotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="linaclotide" type="fsn">linaclotide</designation>
                    <desc language="en-US">linaclotide</desc>
                </concept>
                <concept code="A06AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prucalopride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prucalopride" type="fsn">prucalopride</designation>
                    <desc language="en-US">prucalopride</desc>
                </concept>
                <concept code="A06AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tegaserod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tegaserod" type="fsn">tegaserod</designation>
                    <desc language="en-US">tegaserod</desc>
                </concept>
                <concept code="A06AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="plecanatide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="plecanatide" type="fsn">plecanatide</designation>
                    <desc language="en-US">plecanatide</desc>
                </concept>
                <concept code="A07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS"
                         type="fsn">ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS</designation>
                    <desc language="en-US">ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS</desc>
                </concept>
                <concept code="A07A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="INTESTINAL ANTIINFECTIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="INTESTINAL ANTIINFECTIVES" type="fsn">INTESTINAL ANTIINFECTIVES</designation>
                    <desc language="en-US">INTESTINAL ANTIINFECTIVES</desc>
                </concept>
                <concept code="A07AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antibiotics" type="fsn">Antibiotics</designation>
                    <desc language="en-US">Antibiotics</desc>
                </concept>
                <concept code="A07AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="A07AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nystatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nystatin" type="fsn">nystatin</designation>
                    <desc language="en-US">nystatin</desc>
                </concept>
                <concept code="A07AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="natamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="natamycin" type="fsn">natamycin</designation>
                    <desc language="en-US">natamycin</desc>
                </concept>
                <concept code="A07AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="streptomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="streptomycin" type="fsn">streptomycin</designation>
                    <desc language="en-US">streptomycin</desc>
                </concept>
                <concept code="A07AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polymyxin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polymyxin B" type="fsn">polymyxin B</designation>
                    <desc language="en-US">polymyxin B</desc>
                </concept>
                <concept code="A07AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paromomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paromomycin" type="fsn">paromomycin</designation>
                    <desc language="en-US">paromomycin</desc>
                </concept>
                <concept code="A07AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amphotericin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amphotericin B" type="fsn">amphotericin B</designation>
                    <desc language="en-US">amphotericin B</desc>
                </concept>
                <concept code="A07AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="kanamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="kanamycin" type="fsn">kanamycin</designation>
                    <desc language="en-US">kanamycin</desc>
                </concept>
                <concept code="A07AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vancomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vancomycin" type="fsn">vancomycin</designation>
                    <desc language="en-US">vancomycin</desc>
                </concept>
                <concept code="A07AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colistin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colistin" type="fsn">colistin</designation>
                    <desc language="en-US">colistin</desc>
                </concept>
                <concept code="A07AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifaximin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifaximin" type="fsn">rifaximin</designation>
                    <desc language="en-US">rifaximin</desc>
                </concept>
                <concept code="A07AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fidaxomicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fidaxomicin" type="fsn">fidaxomicin</designation>
                    <desc language="en-US">fidaxomicin</desc>
                </concept>
                <concept code="A07AA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin, combinations" type="fsn">neomycin, combinations</designation>
                    <desc language="en-US">neomycin, combinations</desc>
                </concept>
                <concept code="A07AA54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="streptomycin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="streptomycin, combinations"
                         type="fsn">streptomycin, combinations</designation>
                    <desc language="en-US">streptomycin, combinations</desc>
                </concept>
                <concept code="A07AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sulfonamides" type="fsn">Sulfonamides</designation>
                    <desc language="en-US">Sulfonamides</desc>
                </concept>
                <concept code="A07AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phthalylsulfathiazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phthalylsulfathiazole" type="fsn">phthalylsulfathiazole</designation>
                    <desc language="en-US">phthalylsulfathiazole</desc>
                </concept>
                <concept code="A07AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfaguanidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfaguanidine" type="fsn">sulfaguanidine</designation>
                    <desc language="en-US">sulfaguanidine</desc>
                </concept>
                <concept code="A07AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="succinylsulfathiazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="succinylsulfathiazole" type="fsn">succinylsulfathiazole</designation>
                    <desc language="en-US">succinylsulfathiazole</desc>
                </concept>
                <concept code="A07AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Imidazole derivatives" type="fsn">Imidazole derivatives</designation>
                    <desc language="en-US">Imidazole derivatives</desc>
                </concept>
                <concept code="A07AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miconazole" type="fsn">miconazole</designation>
                    <desc language="en-US">miconazole</desc>
                </concept>
                <concept code="A07AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other intestinal antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other intestinal antiinfectives"
                         type="fsn">Other intestinal antiinfectives</designation>
                    <desc language="en-US">Other intestinal antiinfectives</desc>
                </concept>
                <concept code="A07AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="broxyquinoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="broxyquinoline" type="fsn">broxyquinoline</designation>
                    <desc language="en-US">broxyquinoline</desc>
                </concept>
                <concept code="A07AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetarsol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetarsol" type="fsn">acetarsol</designation>
                    <desc language="en-US">acetarsol</desc>
                </concept>
                <concept code="A07AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifuroxazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifuroxazide" type="fsn">nifuroxazide</designation>
                    <desc language="en-US">nifuroxazide</desc>
                </concept>
                <concept code="A07AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifurzide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifurzide" type="fsn">nifurzide</designation>
                    <desc language="en-US">nifurzide</desc>
                </concept>
                <concept code="A07B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="INTESTINAL ADSORBENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="INTESTINAL ADSORBENTS" type="fsn">INTESTINAL ADSORBENTS</designation>
                    <desc language="en-US">INTESTINAL ADSORBENTS</desc>
                </concept>
                <concept code="A07BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Charcoal preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Charcoal preparations" type="fsn">Charcoal preparations</designation>
                    <desc language="en-US">Charcoal preparations</desc>
                </concept>
                <concept code="A07BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medicinal charcoal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medicinal charcoal" type="fsn">medicinal charcoal</designation>
                    <desc language="en-US">medicinal charcoal</desc>
                </concept>
                <concept code="A07BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medicinal charcoal, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="medicinal charcoal, combinations"
                         type="fsn">medicinal charcoal, combinations</designation>
                    <desc language="en-US">medicinal charcoal, combinations</desc>
                </concept>
                <concept code="A07BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bismuth preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Bismuth preparations" type="fsn">Bismuth preparations</designation>
                    <desc language="en-US">Bismuth preparations</desc>
                </concept>
                <concept code="A07BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other intestinal adsorbents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other intestinal adsorbents"
                         type="fsn">Other intestinal adsorbents</designation>
                    <desc language="en-US">Other intestinal adsorbents</desc>
                </concept>
                <concept code="A07BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pectin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pectin" type="fsn">pectin</designation>
                    <desc language="en-US">pectin</desc>
                </concept>
                <concept code="A07BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="kaolin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="kaolin" type="fsn">kaolin</designation>
                    <desc language="en-US">kaolin</desc>
                </concept>
                <concept code="A07BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="crospovidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="crospovidone" type="fsn">crospovidone</designation>
                    <desc language="en-US">crospovidone</desc>
                </concept>
                <concept code="A07BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="attapulgite"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="attapulgite" type="fsn">attapulgite</designation>
                    <desc language="en-US">attapulgite</desc>
                </concept>
                <concept code="A07BC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diosmectite"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diosmectite" type="fsn">diosmectite</designation>
                    <desc language="en-US">diosmectite</desc>
                </concept>
                <concept code="A07BC30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A07BC54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="attapulgite, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="attapulgite, combinations" type="fsn">attapulgite, combinations</designation>
                    <desc language="en-US">attapulgite, combinations</desc>
                </concept>
                <concept code="A07C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ELECTROLYTES WITH CARBOHYDRATES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ELECTROLYTES WITH CARBOHYDRATES"
                         type="fsn">ELECTROLYTES WITH CARBOHYDRATES</designation>
                    <desc language="en-US">ELECTROLYTES WITH CARBOHYDRATES</desc>
                </concept>
                <concept code="A07CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Oral rehydration salt formulations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Oral rehydration salt formulations"
                         type="fsn">Oral rehydration salt formulations</designation>
                    <desc language="en-US">Oral rehydration salt formulations</desc>
                </concept>
                <concept code="A07D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPROPULSIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIPROPULSIVES" type="fsn">ANTIPROPULSIVES</designation>
                    <desc language="en-US">ANTIPROPULSIVES</desc>
                </concept>
                <concept code="A07DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antipropulsives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antipropulsives" type="fsn">Antipropulsives</designation>
                    <desc language="en-US">Antipropulsives</desc>
                </concept>
                <concept code="A07DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphenoxylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphenoxylate" type="fsn">diphenoxylate</designation>
                    <desc language="en-US">diphenoxylate</desc>
                </concept>
                <concept code="A07DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="opium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="opium" type="fsn">opium</designation>
                    <desc language="en-US">opium</desc>
                </concept>
                <concept code="A07DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="loperamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="loperamide" type="fsn">loperamide</designation>
                    <desc language="en-US">loperamide</desc>
                </concept>
                <concept code="A07DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="difenoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="difenoxin" type="fsn">difenoxin</designation>
                    <desc language="en-US">difenoxin</desc>
                </concept>
                <concept code="A07DA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="loperamide oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="loperamide oxide" type="fsn">loperamide oxide</designation>
                    <desc language="en-US">loperamide oxide</desc>
                </concept>
                <concept code="A07DA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eluxadoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eluxadoline" type="fsn">eluxadoline</designation>
                    <desc language="en-US">eluxadoline</desc>
                </concept>
                <concept code="A07DA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="morphine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="morphine, combinations" type="fsn">morphine, combinations</designation>
                    <desc language="en-US">morphine, combinations</desc>
                </concept>
                <concept code="A07DA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="loperamide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="loperamide, combinations" type="fsn">loperamide, combinations</designation>
                    <desc language="en-US">loperamide, combinations</desc>
                </concept>
                <concept code="A07E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="INTESTINAL ANTIINFLAMMATORY AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="INTESTINAL ANTIINFLAMMATORY AGENTS"
                         type="fsn">INTESTINAL ANTIINFLAMMATORY AGENTS</designation>
                    <desc language="en-US">INTESTINAL ANTIINFLAMMATORY AGENTS</desc>
                </concept>
                <concept code="A07EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids acting locally"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids acting locally"
                         type="fsn">Corticosteroids acting locally</designation>
                    <desc language="en-US">Corticosteroids acting locally</desc>
                </concept>
                <concept code="A07EA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="A07EA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="A07EA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisone" type="fsn">prednisone</designation>
                    <desc language="en-US">prednisone</desc>
                </concept>
                <concept code="A07EA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="A07EA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tixocortol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tixocortol" type="fsn">tixocortol</designation>
                    <desc language="en-US">tixocortol</desc>
                </concept>
                <concept code="A07EA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="budesonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="budesonide" type="fsn">budesonide</designation>
                    <desc language="en-US">budesonide</desc>
                </concept>
                <concept code="A07EA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="beclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="beclometasone" type="fsn">beclometasone</designation>
                    <desc language="en-US">beclometasone</desc>
                </concept>
                <concept code="A07EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiallergic agents, excl. corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiallergic agents, excl. corticosteroids"
                         type="fsn">Antiallergic agents, excl. corticosteroids</designation>
                    <desc language="en-US">Antiallergic agents, excl. corticosteroids</desc>
                </concept>
                <concept code="A07EB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cromoglicic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cromoglicic acid" type="fsn">cromoglicic acid</designation>
                    <desc language="en-US">cromoglicic acid</desc>
                </concept>
                <concept code="A07EC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aminosalicylic acid and similar agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Aminosalicylic acid and similar agents"
                         type="fsn">Aminosalicylic acid and similar agents</designation>
                    <desc language="en-US">Aminosalicylic acid and similar agents</desc>
                </concept>
                <concept code="A07EC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfasalazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfasalazine" type="fsn">sulfasalazine</designation>
                    <desc language="en-US">sulfasalazine</desc>
                </concept>
                <concept code="A07EC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mesalazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mesalazine" type="fsn">mesalazine</designation>
                    <desc language="en-US">mesalazine</desc>
                </concept>
                <concept code="A07EC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olsalazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olsalazine" type="fsn">olsalazine</designation>
                    <desc language="en-US">olsalazine</desc>
                </concept>
                <concept code="A07EC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="balsalazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="balsalazide" type="fsn">balsalazide</designation>
                    <desc language="en-US">balsalazide</desc>
                </concept>
                <concept code="A07F"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIDIARRHEAL MICROORGANISMS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIDIARRHEAL MICROORGANISMS"
                         type="fsn">ANTIDIARRHEAL MICROORGANISMS</designation>
                    <desc language="en-US">ANTIDIARRHEAL MICROORGANISMS</desc>
                </concept>
                <concept code="A07FA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antidiarrheal microorganisms"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antidiarrheal microorganisms"
                         type="fsn">Antidiarrheal microorganisms</designation>
                    <desc language="en-US">Antidiarrheal microorganisms</desc>
                </concept>
                <concept code="A07FA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lactic acid producing organisms"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lactic acid producing organisms"
                         type="fsn">lactic acid producing organisms</designation>
                    <desc language="en-US">lactic acid producing organisms</desc>
                </concept>
                <concept code="A07FA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="saccharomyces boulardii"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="saccharomyces boulardii" type="fsn">saccharomyces boulardii</designation>
                    <desc language="en-US">saccharomyces boulardii</desc>
                </concept>
                <concept code="A07FA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lactic acid producing organisms, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lactic acid producing organisms, combinations"
                         type="fsn">lactic acid producing organisms, combinations</designation>
                    <desc language="en-US">lactic acid producing organisms, combinations</desc>
                </concept>
                <concept code="A07X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ANTIDIARRHEALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER ANTIDIARRHEALS" type="fsn">OTHER ANTIDIARRHEALS</designation>
                    <desc language="en-US">OTHER ANTIDIARRHEALS</desc>
                </concept>
                <concept code="A07XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antidiarrheals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antidiarrheals" type="fsn">Other antidiarrheals</designation>
                    <desc language="en-US">Other antidiarrheals</desc>
                </concept>
                <concept code="A07XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="albumin tannate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="albumin tannate" type="fsn">albumin tannate</designation>
                    <desc language="en-US">albumin tannate</desc>
                </concept>
                <concept code="A07XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceratonia"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceratonia" type="fsn">ceratonia</designation>
                    <desc language="en-US">ceratonia</desc>
                </concept>
                <concept code="A07XA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium compounds" type="fsn">calcium compounds</designation>
                    <desc language="en-US">calcium compounds</desc>
                </concept>
                <concept code="A07XA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="racecadotril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="racecadotril" type="fsn">racecadotril</designation>
                    <desc language="en-US">racecadotril</desc>
                </concept>
                <concept code="A07XA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="crofelemer"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="crofelemer" type="fsn">crofelemer</designation>
                    <desc language="en-US">crofelemer</desc>
                </concept>
                <concept code="A07XA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="albumin tannate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="albumin tannate, combinations"
                         type="fsn">albumin tannate, combinations</designation>
                    <desc language="en-US">albumin tannate, combinations</desc>
                </concept>
                <concept code="A08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS"
                         type="fsn">ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS</designation>
                    <desc language="en-US">ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS</desc>
                </concept>
                <concept code="A08A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS"
                         type="fsn">ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS</designation>
                    <desc language="en-US">ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS</desc>
                </concept>
                <concept code="A08AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Centrally acting antiobesity products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Centrally acting antiobesity products"
                         type="fsn">Centrally acting antiobesity products</designation>
                    <desc language="en-US">Centrally acting antiobesity products</desc>
                </concept>
                <concept code="A08AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phentermine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phentermine" type="fsn">phentermine</designation>
                    <desc language="en-US">phentermine</desc>
                </concept>
                <concept code="A08AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenfluramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenfluramine" type="fsn">fenfluramine</designation>
                    <desc language="en-US">fenfluramine</desc>
                </concept>
                <concept code="A08AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amfepramone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amfepramone" type="fsn">amfepramone</designation>
                    <desc language="en-US">amfepramone</desc>
                </concept>
                <concept code="A08AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexfenfluramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexfenfluramine" type="fsn">dexfenfluramine</designation>
                    <desc language="en-US">dexfenfluramine</desc>
                </concept>
                <concept code="A08AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mazindol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mazindol" type="fsn">mazindol</designation>
                    <desc language="en-US">mazindol</desc>
                </concept>
                <concept code="A08AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etilamfetamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etilamfetamine" type="fsn">etilamfetamine</designation>
                    <desc language="en-US">etilamfetamine</desc>
                </concept>
                <concept code="A08AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cathine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cathine" type="fsn">cathine</designation>
                    <desc language="en-US">cathine</desc>
                </concept>
                <concept code="A08AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clobenzorex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clobenzorex" type="fsn">clobenzorex</designation>
                    <desc language="en-US">clobenzorex</desc>
                </concept>
                <concept code="A08AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mefenorex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mefenorex" type="fsn">mefenorex</designation>
                    <desc language="en-US">mefenorex</desc>
                </concept>
                <concept code="A08AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sibutramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sibutramine" type="fsn">sibutramine</designation>
                    <desc language="en-US">sibutramine</desc>
                </concept>
                <concept code="A08AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lorcaserin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lorcaserin" type="fsn">lorcaserin</designation>
                    <desc language="en-US">lorcaserin</desc>
                </concept>
                <concept code="A08AA56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ephedrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ephedrine, combinations" type="fsn">ephedrine, combinations</designation>
                    <desc language="en-US">ephedrine, combinations</desc>
                </concept>
                <concept code="A08AA62"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bupropion and naltrexone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bupropion and naltrexone" type="fsn">bupropion and naltrexone</designation>
                    <desc language="en-US">bupropion and naltrexone</desc>
                </concept>
                <concept code="A08AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Peripherally acting antiobesity products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Peripherally acting antiobesity products"
                         type="fsn">Peripherally acting antiobesity products</designation>
                    <desc language="en-US">Peripherally acting antiobesity products</desc>
                </concept>
                <concept code="A08AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="orlistat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="orlistat" type="fsn">orlistat</designation>
                    <desc language="en-US">orlistat</desc>
                </concept>
                <concept code="A08AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiobesity drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antiobesity drugs" type="fsn">Other antiobesity drugs</designation>
                    <desc language="en-US">Other antiobesity drugs</desc>
                </concept>
                <concept code="A08AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rimonabant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rimonabant" type="fsn">rimonabant</designation>
                    <desc language="en-US">rimonabant</desc>
                </concept>
                <concept code="A09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIGESTIVES, INCL. ENZYMES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DIGESTIVES, INCL. ENZYMES" type="fsn">DIGESTIVES, INCL. ENZYMES</designation>
                    <desc language="en-US">DIGESTIVES, INCL. ENZYMES</desc>
                </concept>
                <concept code="A09A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIGESTIVES, INCL. ENZYMES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DIGESTIVES, INCL. ENZYMES" type="fsn">DIGESTIVES, INCL. ENZYMES</designation>
                    <desc language="en-US">DIGESTIVES, INCL. ENZYMES</desc>
                </concept>
                <concept code="A09AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Enzyme preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Enzyme preparations" type="fsn">Enzyme preparations</designation>
                    <desc language="en-US">Enzyme preparations</desc>
                </concept>
                <concept code="A09AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diastase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diastase" type="fsn">diastase</designation>
                    <desc language="en-US">diastase</desc>
                </concept>
                <concept code="A09AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="multienzymes (lipase, protease etc.)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="multienzymes (lipase, protease etc.)"
                         type="fsn">multienzymes (lipase, protease etc.)</designation>
                    <desc language="en-US">multienzymes (lipase, protease etc.)</desc>
                </concept>
                <concept code="A09AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pepsin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pepsin" type="fsn">pepsin</designation>
                    <desc language="en-US">pepsin</desc>
                </concept>
                <concept code="A09AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tilactase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tilactase" type="fsn">tilactase</designation>
                    <desc language="en-US">tilactase</desc>
                </concept>
                <concept code="A09AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Acid preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Acid preparations" type="fsn">Acid preparations</designation>
                    <desc language="en-US">Acid preparations</desc>
                </concept>
                <concept code="A09AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glutamic acid hydrochloride"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="glutamic acid hydrochloride"
                         type="fsn">glutamic acid hydrochloride</designation>
                    <desc language="en-US">glutamic acid hydrochloride</desc>
                </concept>
                <concept code="A09AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betaine hydrochloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betaine hydrochloride" type="fsn">betaine hydrochloride</designation>
                    <desc language="en-US">betaine hydrochloride</desc>
                </concept>
                <concept code="A09AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrochloric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrochloric acid" type="fsn">hydrochloric acid</designation>
                    <desc language="en-US">hydrochloric acid</desc>
                </concept>
                <concept code="A09AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="citric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="citric acid" type="fsn">citric acid</designation>
                    <desc language="en-US">citric acid</desc>
                </concept>
                <concept code="A09AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Enzyme and acid preparations, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Enzyme and acid preparations, combinations"
                         type="fsn">Enzyme and acid preparations, combinations</designation>
                    <desc language="en-US">Enzyme and acid preparations, combinations</desc>
                </concept>
                <concept code="A09AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pepsin and acid preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pepsin and acid preparations"
                         type="fsn">pepsin and acid preparations</designation>
                    <desc language="en-US">pepsin and acid preparations</desc>
                </concept>
                <concept code="A09AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="multienzymes and acid preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="multienzymes and acid preparations"
                         type="fsn">multienzymes and acid preparations</designation>
                    <desc language="en-US">multienzymes and acid preparations</desc>
                </concept>
                <concept code="A10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS USED IN DIABETES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DRUGS USED IN DIABETES" type="fsn">DRUGS USED IN DIABETES</designation>
                    <desc language="en-US">DRUGS USED IN DIABETES</desc>
                </concept>
                <concept code="A10A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="INSULINS AND ANALOGUES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="INSULINS AND ANALOGUES" type="fsn">INSULINS AND ANALOGUES</designation>
                    <desc language="en-US">INSULINS AND ANALOGUES</desc>
                </concept>
                <concept code="A10AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Insulins and analogues for injection, fast-acting"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Insulins and analogues for injection, fast-acting"
                         type="fsn">Insulins and analogues for injection, fast-acting</designation>
                    <desc language="en-US">Insulins and analogues for injection, fast-acting</desc>
                </concept>
                <concept code="A10AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (human)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (human)" type="fsn">insulin (human)</designation>
                    <desc language="en-US">insulin (human)</desc>
                </concept>
                <concept code="A10AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (beef)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (beef)" type="fsn">insulin (beef)</designation>
                    <desc language="en-US">insulin (beef)</desc>
                </concept>
                <concept code="A10AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (pork)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (pork)" type="fsn">insulin (pork)</designation>
                    <desc language="en-US">insulin (pork)</desc>
                </concept>
                <concept code="A10AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin lispro"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin lispro" type="fsn">insulin lispro</designation>
                    <desc language="en-US">insulin lispro</desc>
                </concept>
                <concept code="A10AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin aspart"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin aspart" type="fsn">insulin aspart</designation>
                    <desc language="en-US">insulin aspart</desc>
                </concept>
                <concept code="A10AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin glulisine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin glulisine" type="fsn">insulin glulisine</designation>
                    <desc language="en-US">insulin glulisine</desc>
                </concept>
                <concept code="A10AB30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A10AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Insulins and analogues for injection, intermediate-acting"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Insulins and analogues for injection, intermediate-acting"
                         type="fsn">Insulins and analogues for injection, intermediate-acting</designation>
                    <desc language="en-US">Insulins and analogues for injection, intermediate-acting</desc>
                </concept>
                <concept code="A10AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (human)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (human)" type="fsn">insulin (human)</designation>
                    <desc language="en-US">insulin (human)</desc>
                </concept>
                <concept code="A10AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (beef)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (beef)" type="fsn">insulin (beef)</designation>
                    <desc language="en-US">insulin (beef)</desc>
                </concept>
                <concept code="A10AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (pork)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (pork)" type="fsn">insulin (pork)</designation>
                    <desc language="en-US">insulin (pork)</desc>
                </concept>
                <concept code="A10AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin lispro"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin lispro" type="fsn">insulin lispro</designation>
                    <desc language="en-US">insulin lispro</desc>
                </concept>
                <concept code="A10AC30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A10AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting"
                         type="fsn">Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting</designation>
                    <desc language="en-US">Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting</desc>
                </concept>
                <concept code="A10AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (human)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (human)" type="fsn">insulin (human)</designation>
                    <desc language="en-US">insulin (human)</desc>
                </concept>
                <concept code="A10AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (beef)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (beef)" type="fsn">insulin (beef)</designation>
                    <desc language="en-US">insulin (beef)</desc>
                </concept>
                <concept code="A10AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (pork)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (pork)" type="fsn">insulin (pork)</designation>
                    <desc language="en-US">insulin (pork)</desc>
                </concept>
                <concept code="A10AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin lispro"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin lispro" type="fsn">insulin lispro</designation>
                    <desc language="en-US">insulin lispro</desc>
                </concept>
                <concept code="A10AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin aspart"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin aspart" type="fsn">insulin aspart</designation>
                    <desc language="en-US">insulin aspart</desc>
                </concept>
                <concept code="A10AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin degludec and insulin aspart"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="insulin degludec and insulin aspart"
                         type="fsn">insulin degludec and insulin aspart</designation>
                    <desc language="en-US">insulin degludec and insulin aspart</desc>
                </concept>
                <concept code="A10AD30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A10AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Insulins and analogues for injection, long-acting"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Insulins and analogues for injection, long-acting"
                         type="fsn">Insulins and analogues for injection, long-acting</designation>
                    <desc language="en-US">Insulins and analogues for injection, long-acting</desc>
                </concept>
                <concept code="A10AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (human)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (human)" type="fsn">insulin (human)</designation>
                    <desc language="en-US">insulin (human)</desc>
                </concept>
                <concept code="A10AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (beef)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (beef)" type="fsn">insulin (beef)</designation>
                    <desc language="en-US">insulin (beef)</desc>
                </concept>
                <concept code="A10AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (pork)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (pork)" type="fsn">insulin (pork)</designation>
                    <desc language="en-US">insulin (pork)</desc>
                </concept>
                <concept code="A10AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin glargine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin glargine" type="fsn">insulin glargine</designation>
                    <desc language="en-US">insulin glargine</desc>
                </concept>
                <concept code="A10AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin detemir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin detemir" type="fsn">insulin detemir</designation>
                    <desc language="en-US">insulin detemir</desc>
                </concept>
                <concept code="A10AE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin degludec"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin degludec" type="fsn">insulin degludec</designation>
                    <desc language="en-US">insulin degludec</desc>
                </concept>
                <concept code="A10AE30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A10AE54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin glargine and lixisenatide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="insulin glargine and lixisenatide"
                         type="fsn">insulin glargine and lixisenatide</designation>
                    <desc language="en-US">insulin glargine and lixisenatide</desc>
                </concept>
                <concept code="A10AE56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin degludec and liraglutide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="insulin degludec and liraglutide"
                         type="fsn">insulin degludec and liraglutide</designation>
                    <desc language="en-US">insulin degludec and liraglutide</desc>
                </concept>
                <concept code="A10AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Insulins and analogues for inhalation"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Insulins and analogues for inhalation"
                         type="fsn">Insulins and analogues for inhalation</designation>
                    <desc language="en-US">Insulins and analogues for inhalation</desc>
                </concept>
                <concept code="A10AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insulin (human)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insulin (human)" type="fsn">insulin (human)</designation>
                    <desc language="en-US">insulin (human)</desc>
                </concept>
                <concept code="A10B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS"
                         type="fsn">BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS</designation>
                    <desc language="en-US">BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS</desc>
                </concept>
                <concept code="A10BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Biguanides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Biguanides" type="fsn">Biguanides</designation>
                    <desc language="en-US">Biguanides</desc>
                </concept>
                <concept code="A10BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenformin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenformin" type="fsn">phenformin</designation>
                    <desc language="en-US">phenformin</desc>
                </concept>
                <concept code="A10BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin" type="fsn">metformin</designation>
                    <desc language="en-US">metformin</desc>
                </concept>
                <concept code="A10BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buformin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buformin" type="fsn">buformin</designation>
                    <desc language="en-US">buformin</desc>
                </concept>
                <concept code="A10BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonylureas"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sulfonylureas" type="fsn">Sulfonylureas</designation>
                    <desc language="en-US">Sulfonylureas</desc>
                </concept>
                <concept code="A10BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glibenclamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glibenclamide" type="fsn">glibenclamide</designation>
                    <desc language="en-US">glibenclamide</desc>
                </concept>
                <concept code="A10BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorpropamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorpropamide" type="fsn">chlorpropamide</designation>
                    <desc language="en-US">chlorpropamide</desc>
                </concept>
                <concept code="A10BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolbutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolbutamide" type="fsn">tolbutamide</designation>
                    <desc language="en-US">tolbutamide</desc>
                </concept>
                <concept code="A10BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glibornuride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glibornuride" type="fsn">glibornuride</designation>
                    <desc language="en-US">glibornuride</desc>
                </concept>
                <concept code="A10BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolazamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolazamide" type="fsn">tolazamide</designation>
                    <desc language="en-US">tolazamide</desc>
                </concept>
                <concept code="A10BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbutamide" type="fsn">carbutamide</designation>
                    <desc language="en-US">carbutamide</desc>
                </concept>
                <concept code="A10BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glipizide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glipizide" type="fsn">glipizide</designation>
                    <desc language="en-US">glipizide</desc>
                </concept>
                <concept code="A10BB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gliquidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gliquidone" type="fsn">gliquidone</designation>
                    <desc language="en-US">gliquidone</desc>
                </concept>
                <concept code="A10BB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gliclazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gliclazide" type="fsn">gliclazide</designation>
                    <desc language="en-US">gliclazide</desc>
                </concept>
                <concept code="A10BB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metahexamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metahexamide" type="fsn">metahexamide</designation>
                    <desc language="en-US">metahexamide</desc>
                </concept>
                <concept code="A10BB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glisoxepide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glisoxepide" type="fsn">glisoxepide</designation>
                    <desc language="en-US">glisoxepide</desc>
                </concept>
                <concept code="A10BB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glimepiride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glimepiride" type="fsn">glimepiride</designation>
                    <desc language="en-US">glimepiride</desc>
                </concept>
                <concept code="A10BB31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetohexamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetohexamide" type="fsn">acetohexamide</designation>
                    <desc language="en-US">acetohexamide</desc>
                </concept>
                <concept code="A10BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides (heterocyclic)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sulfonamides (heterocyclic)"
                         type="fsn">Sulfonamides (heterocyclic)</designation>
                    <desc language="en-US">Sulfonamides (heterocyclic)</desc>
                </concept>
                <concept code="A10BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glymidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glymidine" type="fsn">glymidine</designation>
                    <desc language="en-US">glymidine</desc>
                </concept>
                <concept code="A10BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of oral blood glucose lowering drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations of oral blood glucose lowering drugs"
                         type="fsn">Combinations of oral blood glucose lowering drugs</designation>
                    <desc language="en-US">Combinations of oral blood glucose lowering drugs</desc>
                </concept>
                <concept code="A10BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenformin and sulfonylureas"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenformin and sulfonylureas"
                         type="fsn">phenformin and sulfonylureas</designation>
                    <desc language="en-US">phenformin and sulfonylureas</desc>
                </concept>
                <concept code="A10BD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and sulfonylureas"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin and sulfonylureas"
                         type="fsn">metformin and sulfonylureas</designation>
                    <desc language="en-US">metformin and sulfonylureas</desc>
                </concept>
                <concept code="A10BD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and rosiglitazone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin and rosiglitazone"
                         type="fsn">metformin and rosiglitazone</designation>
                    <desc language="en-US">metformin and rosiglitazone</desc>
                </concept>
                <concept code="A10BD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glimepiride and rosiglitazone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="glimepiride and rosiglitazone"
                         type="fsn">glimepiride and rosiglitazone</designation>
                    <desc language="en-US">glimepiride and rosiglitazone</desc>
                </concept>
                <concept code="A10BD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and pioglitazone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin and pioglitazone"
                         type="fsn">metformin and pioglitazone</designation>
                    <desc language="en-US">metformin and pioglitazone</desc>
                </concept>
                <concept code="A10BD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glimepiride and pioglitazone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="glimepiride and pioglitazone"
                         type="fsn">glimepiride and pioglitazone</designation>
                    <desc language="en-US">glimepiride and pioglitazone</desc>
                </concept>
                <concept code="A10BD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and sitagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin and sitagliptin" type="fsn">metformin and sitagliptin</designation>
                    <desc language="en-US">metformin and sitagliptin</desc>
                </concept>
                <concept code="A10BD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and vildagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin and vildagliptin"
                         type="fsn">metformin and vildagliptin</designation>
                    <desc language="en-US">metformin and vildagliptin</desc>
                </concept>
                <concept code="A10BD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pioglitazone and alogliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pioglitazone and alogliptin"
                         type="fsn">pioglitazone and alogliptin</designation>
                    <desc language="en-US">pioglitazone and alogliptin</desc>
                </concept>
                <concept code="A10BD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and saxagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin and saxagliptin" type="fsn">metformin and saxagliptin</designation>
                    <desc language="en-US">metformin and saxagliptin</desc>
                </concept>
                <concept code="A10BD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and linagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin and linagliptin" type="fsn">metformin and linagliptin</designation>
                    <desc language="en-US">metformin and linagliptin</desc>
                </concept>
                <concept code="A10BD12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pioglitazone and sitagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pioglitazone and sitagliptin"
                         type="fsn">pioglitazone and sitagliptin</designation>
                    <desc language="en-US">pioglitazone and sitagliptin</desc>
                </concept>
                <concept code="A10BD13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and alogliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin and alogliptin" type="fsn">metformin and alogliptin</designation>
                    <desc language="en-US">metformin and alogliptin</desc>
                </concept>
                <concept code="A10BD14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and repaglinide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin and repaglinide" type="fsn">metformin and repaglinide</designation>
                    <desc language="en-US">metformin and repaglinide</desc>
                </concept>
                <concept code="A10BD15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and dapagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin and dapagliflozin"
                         type="fsn">metformin and dapagliflozin</designation>
                    <desc language="en-US">metformin and dapagliflozin</desc>
                </concept>
                <concept code="A10BD16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and canagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin and canagliflozin"
                         type="fsn">metformin and canagliflozin</designation>
                    <desc language="en-US">metformin and canagliflozin</desc>
                </concept>
                <concept code="A10BD17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and acarbose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin and acarbose" type="fsn">metformin and acarbose</designation>
                    <desc language="en-US">metformin and acarbose</desc>
                </concept>
                <concept code="A10BD18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and gemigliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin and gemigliptin" type="fsn">metformin and gemigliptin</designation>
                    <desc language="en-US">metformin and gemigliptin</desc>
                </concept>
                <concept code="A10BD19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="linagliptin and empagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="linagliptin and empagliflozin"
                         type="fsn">linagliptin and empagliflozin</designation>
                    <desc language="en-US">linagliptin and empagliflozin</desc>
                </concept>
                <concept code="A10BD20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and empagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin and empagliflozin"
                         type="fsn">metformin and empagliflozin</designation>
                    <desc language="en-US">metformin and empagliflozin</desc>
                </concept>
                <concept code="A10BD21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="saxagliptin and dapagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="saxagliptin and dapagliflozin"
                         type="fsn">saxagliptin and dapagliflozin</designation>
                    <desc language="en-US">saxagliptin and dapagliflozin</desc>
                </concept>
                <concept code="A10BD22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and evogliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metformin and evogliptin" type="fsn">metformin and evogliptin</designation>
                    <desc language="en-US">metformin and evogliptin</desc>
                </concept>
                <concept code="A10BD23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin and ertugliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin and ertugliflozin"
                         type="fsn">metformin and ertugliflozin</designation>
                    <desc language="en-US">metformin and ertugliflozin</desc>
                </concept>
                <concept code="A10BD24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sitagliptin and ertugliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sitagliptin and ertugliflozin"
                         type="fsn">sitagliptin and ertugliflozin</designation>
                    <desc language="en-US">sitagliptin and ertugliflozin</desc>
                </concept>
                <concept code="A10BD25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metformin, saxagliptin and dapagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metformin, saxagliptin and dapagliflozin"
                         type="fsn">metformin, saxagliptin and dapagliflozin</designation>
                    <desc language="en-US">metformin, saxagliptin and dapagliflozin</desc>
                </concept>
                <concept code="A10BF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha glucosidase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha glucosidase inhibitors"
                         type="fsn">Alpha glucosidase inhibitors</designation>
                    <desc language="en-US">Alpha glucosidase inhibitors</desc>
                </concept>
                <concept code="A10BF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acarbose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acarbose" type="fsn">acarbose</designation>
                    <desc language="en-US">acarbose</desc>
                </concept>
                <concept code="A10BF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miglitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miglitol" type="fsn">miglitol</designation>
                    <desc language="en-US">miglitol</desc>
                </concept>
                <concept code="A10BF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="voglibose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="voglibose" type="fsn">voglibose</designation>
                    <desc language="en-US">voglibose</desc>
                </concept>
                <concept code="A10BG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiazolidinediones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thiazolidinediones" type="fsn">Thiazolidinediones</designation>
                    <desc language="en-US">Thiazolidinediones</desc>
                </concept>
                <concept code="A10BG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="troglitazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="troglitazone" type="fsn">troglitazone</designation>
                    <desc language="en-US">troglitazone</desc>
                </concept>
                <concept code="A10BG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosiglitazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rosiglitazone" type="fsn">rosiglitazone</designation>
                    <desc language="en-US">rosiglitazone</desc>
                </concept>
                <concept code="A10BG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pioglitazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pioglitazone" type="fsn">pioglitazone</designation>
                    <desc language="en-US">pioglitazone</desc>
                </concept>
                <concept code="A10BH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Dipeptidyl peptidase 4 (DPP-4) inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Dipeptidyl peptidase 4 (DPP-4) inhibitors"
                         type="fsn">Dipeptidyl peptidase 4 (DPP-4) inhibitors</designation>
                    <desc language="en-US">Dipeptidyl peptidase 4 (DPP-4) inhibitors</desc>
                </concept>
                <concept code="A10BH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sitagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sitagliptin" type="fsn">sitagliptin</designation>
                    <desc language="en-US">sitagliptin</desc>
                </concept>
                <concept code="A10BH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vildagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vildagliptin" type="fsn">vildagliptin</designation>
                    <desc language="en-US">vildagliptin</desc>
                </concept>
                <concept code="A10BH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="saxagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="saxagliptin" type="fsn">saxagliptin</designation>
                    <desc language="en-US">saxagliptin</desc>
                </concept>
                <concept code="A10BH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alogliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alogliptin" type="fsn">alogliptin</designation>
                    <desc language="en-US">alogliptin</desc>
                </concept>
                <concept code="A10BH05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="linagliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="linagliptin" type="fsn">linagliptin</designation>
                    <desc language="en-US">linagliptin</desc>
                </concept>
                <concept code="A10BH06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gemigliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gemigliptin" type="fsn">gemigliptin</designation>
                    <desc language="en-US">gemigliptin</desc>
                </concept>
                <concept code="A10BH07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="evogliptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="evogliptin" type="fsn">evogliptin</designation>
                    <desc language="en-US">evogliptin</desc>
                </concept>
                <concept code="A10BH51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sitagliptin and simvastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sitagliptin and simvastatin"
                         type="fsn">sitagliptin and simvastatin</designation>
                    <desc language="en-US">sitagliptin and simvastatin</desc>
                </concept>
                <concept code="A10BH52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gemigliptin and rosuvastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="gemigliptin and rosuvastatin"
                         type="fsn">gemigliptin and rosuvastatin</designation>
                    <desc language="en-US">gemigliptin and rosuvastatin</desc>
                </concept>
                <concept code="A10BJ"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Glucagon-like peptide-1 (GLP-1) analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Glucagon-like peptide-1 (GLP-1) analogues"
                         type="fsn">Glucagon-like peptide-1 (GLP-1) analogues</designation>
                    <desc language="en-US">Glucagon-like peptide-1 (GLP-1) analogues</desc>
                </concept>
                <concept code="A10BJ01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="exenatide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="exenatide" type="fsn">exenatide</designation>
                    <desc language="en-US">exenatide</desc>
                </concept>
                <concept code="A10BJ02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="liraglutide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="liraglutide" type="fsn">liraglutide</designation>
                    <desc language="en-US">liraglutide</desc>
                </concept>
                <concept code="A10BJ03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lixisenatide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lixisenatide" type="fsn">lixisenatide</designation>
                    <desc language="en-US">lixisenatide</desc>
                </concept>
                <concept code="A10BJ04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="albiglutide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="albiglutide" type="fsn">albiglutide</designation>
                    <desc language="en-US">albiglutide</desc>
                </concept>
                <concept code="A10BJ05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dulaglutide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dulaglutide" type="fsn">dulaglutide</designation>
                    <desc language="en-US">dulaglutide</desc>
                </concept>
                <concept code="A10BJ06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="semaglutide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="semaglutide" type="fsn">semaglutide</designation>
                    <desc language="en-US">semaglutide</desc>
                </concept>
                <concept code="A10BK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sodium-glucose co-transporter 2 (SGLT2) inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sodium-glucose co-transporter 2 (SGLT2) inhibitors"
                         type="fsn">Sodium-glucose co-transporter 2 (SGLT2) inhibitors</designation>
                    <desc language="en-US">Sodium-glucose co-transporter 2 (SGLT2) inhibitors</desc>
                </concept>
                <concept code="A10BK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dapagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dapagliflozin" type="fsn">dapagliflozin</designation>
                    <desc language="en-US">dapagliflozin</desc>
                </concept>
                <concept code="A10BK02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="canagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="canagliflozin" type="fsn">canagliflozin</designation>
                    <desc language="en-US">canagliflozin</desc>
                </concept>
                <concept code="A10BK03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="empagliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="empagliflozin" type="fsn">empagliflozin</designation>
                    <desc language="en-US">empagliflozin</desc>
                </concept>
                <concept code="A10BK04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ertugliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ertugliflozin" type="fsn">ertugliflozin</designation>
                    <desc language="en-US">ertugliflozin</desc>
                </concept>
                <concept code="A10BK05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ipragliflozin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ipragliflozin" type="fsn">ipragliflozin</designation>
                    <desc language="en-US">ipragliflozin</desc>
                </concept>
                <concept code="A10BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other blood glucose lowering drugs, excl. insulins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other blood glucose lowering drugs, excl. insulins"
                         type="fsn">Other blood glucose lowering drugs, excl. insulins</designation>
                    <desc language="en-US">Other blood glucose lowering drugs, excl. insulins</desc>
                </concept>
                <concept code="A10BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guar gum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guar gum" type="fsn">guar gum</designation>
                    <desc language="en-US">guar gum</desc>
                </concept>
                <concept code="A10BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="repaglinide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="repaglinide" type="fsn">repaglinide</designation>
                    <desc language="en-US">repaglinide</desc>
                </concept>
                <concept code="A10BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nateglinide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nateglinide" type="fsn">nateglinide</designation>
                    <desc language="en-US">nateglinide</desc>
                </concept>
                <concept code="A10BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pramlintide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pramlintide" type="fsn">pramlintide</designation>
                    <desc language="en-US">pramlintide</desc>
                </concept>
                <concept code="A10BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benfluorex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benfluorex" type="fsn">benfluorex</designation>
                    <desc language="en-US">benfluorex</desc>
                </concept>
                <concept code="A10BX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mitiglinide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mitiglinide" type="fsn">mitiglinide</designation>
                    <desc language="en-US">mitiglinide</desc>
                </concept>
                <concept code="A10X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DRUGS USED IN DIABETES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER DRUGS USED IN DIABETES"
                         type="fsn">OTHER DRUGS USED IN DIABETES</designation>
                    <desc language="en-US">OTHER DRUGS USED IN DIABETES</desc>
                </concept>
                <concept code="A10XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aldose reductase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Aldose reductase inhibitors"
                         type="fsn">Aldose reductase inhibitors</designation>
                    <desc language="en-US">Aldose reductase inhibitors</desc>
                </concept>
                <concept code="A10XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolrestat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolrestat" type="fsn">tolrestat</designation>
                    <desc language="en-US">tolrestat</desc>
                </concept>
                <concept code="A11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VITAMINS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="VITAMINS" type="fsn">VITAMINS</designation>
                    <desc language="en-US">VITAMINS</desc>
                </concept>
                <concept code="A11A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MULTIVITAMINS, COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="MULTIVITAMINS, COMBINATIONS"
                         type="fsn">MULTIVITAMINS, COMBINATIONS</designation>
                    <desc language="en-US">MULTIVITAMINS, COMBINATIONS</desc>
                </concept>
                <concept code="A11AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Multivitamins with minerals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Multivitamins with minerals"
                         type="fsn">Multivitamins with minerals</designation>
                    <desc language="en-US">Multivitamins with minerals</desc>
                </concept>
                <concept code="A11AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="multivitamins and iron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="multivitamins and iron" type="fsn">multivitamins and iron</designation>
                    <desc language="en-US">multivitamins and iron</desc>
                </concept>
                <concept code="A11AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="multivitamins and calcium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="multivitamins and calcium" type="fsn">multivitamins and calcium</designation>
                    <desc language="en-US">multivitamins and calcium</desc>
                </concept>
                <concept code="A11AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="multivitamins and other minerals, incl. combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="multivitamins and other minerals, incl. combinations"
                         type="fsn">multivitamins and other minerals, incl. combinations</designation>
                    <desc language="en-US">multivitamins and other minerals, incl. combinations</desc>
                </concept>
                <concept code="A11AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="multivitamins and trace elements"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="multivitamins and trace elements"
                         type="fsn">multivitamins and trace elements</designation>
                    <desc language="en-US">multivitamins and trace elements</desc>
                </concept>
                <concept code="A11AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Multivitamins, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Multivitamins, other combinations"
                         type="fsn">Multivitamins, other combinations</designation>
                    <desc language="en-US">Multivitamins, other combinations</desc>
                </concept>
                <concept code="A11B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MULTIVITAMINS, PLAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="MULTIVITAMINS, PLAIN" type="fsn">MULTIVITAMINS, PLAIN</designation>
                    <desc language="en-US">MULTIVITAMINS, PLAIN</desc>
                </concept>
                <concept code="A11BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Multivitamins, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Multivitamins, plain" type="fsn">Multivitamins, plain</designation>
                    <desc language="en-US">Multivitamins, plain</desc>
                </concept>
                <concept code="A11C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO"
                         type="fsn">VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO</designation>
                    <desc language="en-US">VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO</desc>
                </concept>
                <concept code="A11CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin A, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vitamin A, plain" type="fsn">Vitamin A, plain</designation>
                    <desc language="en-US">Vitamin A, plain</desc>
                </concept>
                <concept code="A11CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="retinol (vit A)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="retinol (vit A)" type="fsn">retinol (vit A)</designation>
                    <desc language="en-US">retinol (vit A)</desc>
                </concept>
                <concept code="A11CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betacarotene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betacarotene" type="fsn">betacarotene</designation>
                    <desc language="en-US">betacarotene</desc>
                </concept>
                <concept code="A11CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin A and D in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vitamin A and D in combination"
                         type="fsn">Vitamin A and D in combination</designation>
                    <desc language="en-US">Vitamin A and D in combination</desc>
                </concept>
                <concept code="A11CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin D and analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vitamin D and analogues" type="fsn">Vitamin D and analogues</designation>
                    <desc language="en-US">Vitamin D and analogues</desc>
                </concept>
                <concept code="A11CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ergocalciferol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ergocalciferol" type="fsn">ergocalciferol</designation>
                    <desc language="en-US">ergocalciferol</desc>
                </concept>
                <concept code="A11CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydrotachysterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dihydrotachysterol" type="fsn">dihydrotachysterol</designation>
                    <desc language="en-US">dihydrotachysterol</desc>
                </concept>
                <concept code="A11CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alfacalcidol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alfacalcidol" type="fsn">alfacalcidol</designation>
                    <desc language="en-US">alfacalcidol</desc>
                </concept>
                <concept code="A11CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcitriol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcitriol" type="fsn">calcitriol</designation>
                    <desc language="en-US">calcitriol</desc>
                </concept>
                <concept code="A11CC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colecalciferol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colecalciferol" type="fsn">colecalciferol</designation>
                    <desc language="en-US">colecalciferol</desc>
                </concept>
                <concept code="A11CC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcifediol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcifediol" type="fsn">calcifediol</designation>
                    <desc language="en-US">calcifediol</desc>
                </concept>
                <concept code="A11CC20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="A11CC55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colecalciferol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="colecalciferol, combinations"
                         type="fsn">colecalciferol, combinations</designation>
                    <desc language="en-US">colecalciferol, combinations</desc>
                </concept>
                <concept code="A11D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12"
                         type="fsn">VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12</designation>
                    <desc language="en-US">VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12</desc>
                </concept>
                <concept code="A11DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin B1, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vitamin B1, plain" type="fsn">Vitamin B1, plain</designation>
                    <desc language="en-US">Vitamin B1, plain</desc>
                </concept>
                <concept code="A11DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiamine (vit B1)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiamine (vit B1)" type="fsn">thiamine (vit B1)</designation>
                    <desc language="en-US">thiamine (vit B1)</desc>
                </concept>
                <concept code="A11DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulbutiamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulbutiamine" type="fsn">sulbutiamine</designation>
                    <desc language="en-US">sulbutiamine</desc>
                </concept>
                <concept code="A11DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benfotiamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benfotiamine" type="fsn">benfotiamine</designation>
                    <desc language="en-US">benfotiamine</desc>
                </concept>
                <concept code="A11DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin B1 in combination with vitamin B6 and/or vitamin B12"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vitamin B1 in combination with vitamin B6 and/or vitamin B12"
                         type="fsn">Vitamin B1 in combination with vitamin B6 and/or vitamin B12</designation>
                    <desc language="en-US">Vitamin B1 in combination with vitamin B6 and/or vitamin B12</desc>
                </concept>
                <concept code="A11E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VITAMIN B-COMPLEX, INCL. COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="VITAMIN B-COMPLEX, INCL. COMBINATIONS"
                         type="fsn">VITAMIN B-COMPLEX, INCL. COMBINATIONS</designation>
                    <desc language="en-US">VITAMIN B-COMPLEX, INCL. COMBINATIONS</desc>
                </concept>
                <concept code="A11EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin B-complex, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vitamin B-complex, plain" type="fsn">Vitamin B-complex, plain</designation>
                    <desc language="en-US">Vitamin B-complex, plain</desc>
                </concept>
                <concept code="A11EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin B-complex with vitamin C"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vitamin B-complex with vitamin C"
                         type="fsn">Vitamin B-complex with vitamin C</designation>
                    <desc language="en-US">Vitamin B-complex with vitamin C</desc>
                </concept>
                <concept code="A11EC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin B-complex with minerals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vitamin B-complex with minerals"
                         type="fsn">Vitamin B-complex with minerals</designation>
                    <desc language="en-US">Vitamin B-complex with minerals</desc>
                </concept>
                <concept code="A11ED"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin B-complex with anabolic steroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vitamin B-complex with anabolic steroids"
                         type="fsn">Vitamin B-complex with anabolic steroids</designation>
                    <desc language="en-US">Vitamin B-complex with anabolic steroids</desc>
                </concept>
                <concept code="A11EX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin B-complex, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vitamin B-complex, other combinations"
                         type="fsn">Vitamin B-complex, other combinations</designation>
                    <desc language="en-US">Vitamin B-complex, other combinations</desc>
                </concept>
                <concept code="A11G"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS"
                         type="fsn">ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS</designation>
                    <desc language="en-US">ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS</desc>
                </concept>
                <concept code="A11GA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ascorbic acid (vitamin C), plain"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Ascorbic acid (vitamin C), plain"
                         type="fsn">Ascorbic acid (vitamin C), plain</designation>
                    <desc language="en-US">Ascorbic acid (vitamin C), plain</desc>
                </concept>
                <concept code="A11GA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ascorbic acid (vit C)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ascorbic acid (vit C)" type="fsn">ascorbic acid (vit C)</designation>
                    <desc language="en-US">ascorbic acid (vit C)</desc>
                </concept>
                <concept code="A11GB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ascorbic acid (vitamin C), combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Ascorbic acid (vitamin C), combinations"
                         type="fsn">Ascorbic acid (vitamin C), combinations</designation>
                    <desc language="en-US">Ascorbic acid (vitamin C), combinations</desc>
                </concept>
                <concept code="A11GB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ascorbic acid (vit C) and calcium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ascorbic acid (vit C) and calcium"
                         type="fsn">ascorbic acid (vit C) and calcium</designation>
                    <desc language="en-US">ascorbic acid (vit C) and calcium</desc>
                </concept>
                <concept code="A11H"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER PLAIN VITAMIN PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER PLAIN VITAMIN PREPARATIONS"
                         type="fsn">OTHER PLAIN VITAMIN PREPARATIONS</designation>
                    <desc language="en-US">OTHER PLAIN VITAMIN PREPARATIONS</desc>
                </concept>
                <concept code="A11HA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other plain vitamin preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other plain vitamin preparations"
                         type="fsn">Other plain vitamin preparations</designation>
                    <desc language="en-US">Other plain vitamin preparations</desc>
                </concept>
                <concept code="A11HA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicotinamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicotinamide" type="fsn">nicotinamide</designation>
                    <desc language="en-US">nicotinamide</desc>
                </concept>
                <concept code="A11HA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyridoxine (vit B6)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyridoxine (vit B6)" type="fsn">pyridoxine (vit B6)</designation>
                    <desc language="en-US">pyridoxine (vit B6)</desc>
                </concept>
                <concept code="A11HA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tocopherol (vit E)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tocopherol (vit E)" type="fsn">tocopherol (vit E)</designation>
                    <desc language="en-US">tocopherol (vit E)</desc>
                </concept>
                <concept code="A11HA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="riboflavin (vit B2)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="riboflavin (vit B2)" type="fsn">riboflavin (vit B2)</designation>
                    <desc language="en-US">riboflavin (vit B2)</desc>
                </concept>
                <concept code="A11HA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="biotin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="biotin" type="fsn">biotin</designation>
                    <desc language="en-US">biotin</desc>
                </concept>
                <concept code="A11HA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyridoxal phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyridoxal phosphate" type="fsn">pyridoxal phosphate</designation>
                    <desc language="en-US">pyridoxal phosphate</desc>
                </concept>
                <concept code="A11HA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="inositol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="inositol" type="fsn">inositol</designation>
                    <desc language="en-US">inositol</desc>
                </concept>
                <concept code="A11HA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tocofersolan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tocofersolan" type="fsn">tocofersolan</designation>
                    <desc language="en-US">tocofersolan</desc>
                </concept>
                <concept code="A11HA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexpanthenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexpanthenol" type="fsn">dexpanthenol</designation>
                    <desc language="en-US">dexpanthenol</desc>
                </concept>
                <concept code="A11HA31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium pantothenate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium pantothenate" type="fsn">calcium pantothenate</designation>
                    <desc language="en-US">calcium pantothenate</desc>
                </concept>
                <concept code="A11HA32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pantethine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pantethine" type="fsn">pantethine</designation>
                    <desc language="en-US">pantethine</desc>
                </concept>
                <concept code="A11J"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER VITAMIN PRODUCTS, COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER VITAMIN PRODUCTS, COMBINATIONS"
                         type="fsn">OTHER VITAMIN PRODUCTS, COMBINATIONS</designation>
                    <desc language="en-US">OTHER VITAMIN PRODUCTS, COMBINATIONS</desc>
                </concept>
                <concept code="A11JA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of vitamins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Combinations of vitamins" type="fsn">Combinations of vitamins</designation>
                    <desc language="en-US">Combinations of vitamins</desc>
                </concept>
                <concept code="A11JB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamins with minerals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vitamins with minerals" type="fsn">Vitamins with minerals</designation>
                    <desc language="en-US">Vitamins with minerals</desc>
                </concept>
                <concept code="A11JC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamins, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vitamins, other combinations"
                         type="fsn">Vitamins, other combinations</designation>
                    <desc language="en-US">Vitamins, other combinations</desc>
                </concept>
                <concept code="A12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MINERAL SUPPLEMENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="MINERAL SUPPLEMENTS" type="fsn">MINERAL SUPPLEMENTS</designation>
                    <desc language="en-US">MINERAL SUPPLEMENTS</desc>
                </concept>
                <concept code="A12A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CALCIUM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CALCIUM" type="fsn">CALCIUM</designation>
                    <desc language="en-US">CALCIUM</desc>
                </concept>
                <concept code="A12AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Calcium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Calcium" type="fsn">Calcium</designation>
                    <desc language="en-US">Calcium</desc>
                </concept>
                <concept code="A12AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium phosphate" type="fsn">calcium phosphate</designation>
                    <desc language="en-US">calcium phosphate</desc>
                </concept>
                <concept code="A12AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium glubionate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium glubionate" type="fsn">calcium glubionate</designation>
                    <desc language="en-US">calcium glubionate</desc>
                </concept>
                <concept code="A12AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium gluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium gluconate" type="fsn">calcium gluconate</designation>
                    <desc language="en-US">calcium gluconate</desc>
                </concept>
                <concept code="A12AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium carbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium carbonate" type="fsn">calcium carbonate</designation>
                    <desc language="en-US">calcium carbonate</desc>
                </concept>
                <concept code="A12AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium lactate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium lactate" type="fsn">calcium lactate</designation>
                    <desc language="en-US">calcium lactate</desc>
                </concept>
                <concept code="A12AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium lactate gluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium lactate gluconate" type="fsn">calcium lactate gluconate</designation>
                    <desc language="en-US">calcium lactate gluconate</desc>
                </concept>
                <concept code="A12AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium chloride" type="fsn">calcium chloride</designation>
                    <desc language="en-US">calcium chloride</desc>
                </concept>
                <concept code="A12AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium glycerylphosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium glycerylphosphate" type="fsn">calcium glycerylphosphate</designation>
                    <desc language="en-US">calcium glycerylphosphate</desc>
                </concept>
                <concept code="A12AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium citrate lysine complex"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="calcium citrate lysine complex"
                         type="fsn">calcium citrate lysine complex</designation>
                    <desc language="en-US">calcium citrate lysine complex</desc>
                </concept>
                <concept code="A12AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium glucoheptonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium glucoheptonate" type="fsn">calcium glucoheptonate</designation>
                    <desc language="en-US">calcium glucoheptonate</desc>
                </concept>
                <concept code="A12AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium pangamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium pangamate" type="fsn">calcium pangamate</designation>
                    <desc language="en-US">calcium pangamate</desc>
                </concept>
                <concept code="A12AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium citrate" type="fsn">calcium citrate</designation>
                    <desc language="en-US">calcium citrate</desc>
                </concept>
                <concept code="A12AA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium (different salts in combination)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="calcium (different salts in combination)"
                         type="fsn">calcium (different salts in combination)</designation>
                    <desc language="en-US">calcium (different salts in combination)</desc>
                </concept>
                <concept code="A12AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium laevulate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium laevulate" type="fsn">calcium laevulate</designation>
                    <desc language="en-US">calcium laevulate</desc>
                </concept>
                <concept code="A12AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Calcium, combinations with vitamin D and/or other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Calcium, combinations with vitamin D and/or other drugs"
                         type="fsn">Calcium, combinations with vitamin D and/or other drugs</designation>
                    <desc language="en-US">Calcium, combinations with vitamin D and/or other drugs</desc>
                </concept>
                <concept code="A12B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="POTASSIUM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="POTASSIUM" type="fsn">POTASSIUM</designation>
                    <desc language="en-US">POTASSIUM</desc>
                </concept>
                <concept code="A12BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Potassium" type="fsn">Potassium</designation>
                    <desc language="en-US">Potassium</desc>
                </concept>
                <concept code="A12BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium chloride" type="fsn">potassium chloride</designation>
                    <desc language="en-US">potassium chloride</desc>
                </concept>
                <concept code="A12BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium citrate" type="fsn">potassium citrate</designation>
                    <desc language="en-US">potassium citrate</desc>
                </concept>
                <concept code="A12BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium hydrogentartrate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="potassium hydrogentartrate"
                         type="fsn">potassium hydrogentartrate</designation>
                    <desc language="en-US">potassium hydrogentartrate</desc>
                </concept>
                <concept code="A12BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium hydrogencarbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="potassium hydrogencarbonate"
                         type="fsn">potassium hydrogencarbonate</designation>
                    <desc language="en-US">potassium hydrogencarbonate</desc>
                </concept>
                <concept code="A12BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium gluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium gluconate" type="fsn">potassium gluconate</designation>
                    <desc language="en-US">potassium gluconate</desc>
                </concept>
                <concept code="A12BA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium (different salts in combination)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="potassium (different salts in combination)"
                         type="fsn">potassium (different salts in combination)</designation>
                    <desc language="en-US">potassium (different salts in combination)</desc>
                </concept>
                <concept code="A12BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium chloride, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="potassium chloride, combinations"
                         type="fsn">potassium chloride, combinations</designation>
                    <desc language="en-US">potassium chloride, combinations</desc>
                </concept>
                <concept code="A12C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER MINERAL SUPPLEMENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER MINERAL SUPPLEMENTS" type="fsn">OTHER MINERAL SUPPLEMENTS</designation>
                    <desc language="en-US">OTHER MINERAL SUPPLEMENTS</desc>
                </concept>
                <concept code="A12CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sodium" type="fsn">Sodium</designation>
                    <desc language="en-US">Sodium</desc>
                </concept>
                <concept code="A12CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium chloride" type="fsn">sodium chloride</designation>
                    <desc language="en-US">sodium chloride</desc>
                </concept>
                <concept code="A12CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium sulfate" type="fsn">sodium sulfate</designation>
                    <desc language="en-US">sodium sulfate</desc>
                </concept>
                <concept code="A12CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Zinc"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Zinc" type="fsn">Zinc</designation>
                    <desc language="en-US">Zinc</desc>
                </concept>
                <concept code="A12CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zinc sulfate" type="fsn">zinc sulfate</designation>
                    <desc language="en-US">zinc sulfate</desc>
                </concept>
                <concept code="A12CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc gluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zinc gluconate" type="fsn">zinc gluconate</designation>
                    <desc language="en-US">zinc gluconate</desc>
                </concept>
                <concept code="A12CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc protein complex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zinc protein complex" type="fsn">zinc protein complex</designation>
                    <desc language="en-US">zinc protein complex</desc>
                </concept>
                <concept code="A12CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Magnesium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Magnesium" type="fsn">Magnesium</designation>
                    <desc language="en-US">Magnesium</desc>
                </concept>
                <concept code="A12CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium chloride" type="fsn">magnesium chloride</designation>
                    <desc language="en-US">magnesium chloride</desc>
                </concept>
                <concept code="A12CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium sulfate" type="fsn">magnesium sulfate</designation>
                    <desc language="en-US">magnesium sulfate</desc>
                </concept>
                <concept code="A12CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium gluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium gluconate" type="fsn">magnesium gluconate</designation>
                    <desc language="en-US">magnesium gluconate</desc>
                </concept>
                <concept code="A12CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium citrate" type="fsn">magnesium citrate</designation>
                    <desc language="en-US">magnesium citrate</desc>
                </concept>
                <concept code="A12CC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium aspartate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium aspartate" type="fsn">magnesium aspartate</designation>
                    <desc language="en-US">magnesium aspartate</desc>
                </concept>
                <concept code="A12CC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium lactate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium lactate" type="fsn">magnesium lactate</designation>
                    <desc language="en-US">magnesium lactate</desc>
                </concept>
                <concept code="A12CC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium levulinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium levulinate" type="fsn">magnesium levulinate</designation>
                    <desc language="en-US">magnesium levulinate</desc>
                </concept>
                <concept code="A12CC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium pidolate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium pidolate" type="fsn">magnesium pidolate</designation>
                    <desc language="en-US">magnesium pidolate</desc>
                </concept>
                <concept code="A12CC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium orotate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium orotate" type="fsn">magnesium orotate</designation>
                    <desc language="en-US">magnesium orotate</desc>
                </concept>
                <concept code="A12CC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium oxide" type="fsn">magnesium oxide</designation>
                    <desc language="en-US">magnesium oxide</desc>
                </concept>
                <concept code="A12CC30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium (different salts in combination)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="magnesium (different salts in combination)"
                         type="fsn">magnesium (different salts in combination)</designation>
                    <desc language="en-US">magnesium (different salts in combination)</desc>
                </concept>
                <concept code="A12CD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fluoride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Fluoride" type="fsn">Fluoride</designation>
                    <desc language="en-US">Fluoride</desc>
                </concept>
                <concept code="A12CD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium fluoride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium fluoride" type="fsn">sodium fluoride</designation>
                    <desc language="en-US">sodium fluoride</desc>
                </concept>
                <concept code="A12CD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium monofluorophosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium monofluorophosphate"
                         type="fsn">sodium monofluorophosphate</designation>
                    <desc language="en-US">sodium monofluorophosphate</desc>
                </concept>
                <concept code="A12CD51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluoride, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluoride, combinations" type="fsn">fluoride, combinations</designation>
                    <desc language="en-US">fluoride, combinations</desc>
                </concept>
                <concept code="A12CE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Selenium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Selenium" type="fsn">Selenium</designation>
                    <desc language="en-US">Selenium</desc>
                </concept>
                <concept code="A12CE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium selenate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium selenate" type="fsn">sodium selenate</designation>
                    <desc language="en-US">sodium selenate</desc>
                </concept>
                <concept code="A12CE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium selenite"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium selenite" type="fsn">sodium selenite</designation>
                    <desc language="en-US">sodium selenite</desc>
                </concept>
                <concept code="A12CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other mineral products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other mineral products" type="fsn">Other mineral products</designation>
                    <desc language="en-US">Other mineral products</desc>
                </concept>
                <concept code="A13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="TONICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="TONICS" type="fsn">TONICS</designation>
                    <desc language="en-US">TONICS</desc>
                </concept>
                <concept code="A13A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="TONICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="TONICS" type="fsn">TONICS</designation>
                    <desc language="en-US">TONICS</desc>
                </concept>
                <concept code="A14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANABOLIC AGENTS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANABOLIC AGENTS FOR SYSTEMIC USE"
                         type="fsn">ANABOLIC AGENTS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANABOLIC AGENTS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="A14A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANABOLIC STEROIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANABOLIC STEROIDS" type="fsn">ANABOLIC STEROIDS</designation>
                    <desc language="en-US">ANABOLIC STEROIDS</desc>
                </concept>
                <concept code="A14AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Androstan derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Androstan derivatives" type="fsn">Androstan derivatives</designation>
                    <desc language="en-US">Androstan derivatives</desc>
                </concept>
                <concept code="A14AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="androstanolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="androstanolone" type="fsn">androstanolone</designation>
                    <desc language="en-US">androstanolone</desc>
                </concept>
                <concept code="A14AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stanozolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="stanozolol" type="fsn">stanozolol</designation>
                    <desc language="en-US">stanozolol</desc>
                </concept>
                <concept code="A14AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metandienone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metandienone" type="fsn">metandienone</designation>
                    <desc language="en-US">metandienone</desc>
                </concept>
                <concept code="A14AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metenolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metenolone" type="fsn">metenolone</designation>
                    <desc language="en-US">metenolone</desc>
                </concept>
                <concept code="A14AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxymetholone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxymetholone" type="fsn">oxymetholone</designation>
                    <desc language="en-US">oxymetholone</desc>
                </concept>
                <concept code="A14AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinbolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinbolone" type="fsn">quinbolone</designation>
                    <desc language="en-US">quinbolone</desc>
                </concept>
                <concept code="A14AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prasterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prasterone" type="fsn">prasterone</designation>
                    <desc language="en-US">prasterone</desc>
                </concept>
                <concept code="A14AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxandrolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxandrolone" type="fsn">oxandrolone</designation>
                    <desc language="en-US">oxandrolone</desc>
                </concept>
                <concept code="A14AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norethandrolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norethandrolone" type="fsn">norethandrolone</designation>
                    <desc language="en-US">norethandrolone</desc>
                </concept>
                <concept code="A14AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Estren derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Estren derivatives" type="fsn">Estren derivatives</designation>
                    <desc language="en-US">Estren derivatives</desc>
                </concept>
                <concept code="A14AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nandrolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nandrolone" type="fsn">nandrolone</designation>
                    <desc language="en-US">nandrolone</desc>
                </concept>
                <concept code="A14AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethylestrenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethylestrenol" type="fsn">ethylestrenol</designation>
                    <desc language="en-US">ethylestrenol</desc>
                </concept>
                <concept code="A14AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxabolone cipionate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxabolone cipionate" type="fsn">oxabolone cipionate</designation>
                    <desc language="en-US">oxabolone cipionate</desc>
                </concept>
                <concept code="A14B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ANABOLIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER ANABOLIC AGENTS" type="fsn">OTHER ANABOLIC AGENTS</designation>
                    <desc language="en-US">OTHER ANABOLIC AGENTS</desc>
                </concept>
                <concept code="A15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="APPETITE STIMULANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="APPETITE STIMULANTS" type="fsn">APPETITE STIMULANTS</designation>
                    <desc language="en-US">APPETITE STIMULANTS</desc>
                </concept>
                <concept code="A16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS"
                         type="fsn">OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS</designation>
                    <desc language="en-US">OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS</desc>
                </concept>
                <concept code="A16A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS"
                         type="fsn">OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS</designation>
                    <desc language="en-US">OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS</desc>
                </concept>
                <concept code="A16AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Amino acids and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Amino acids and derivatives"
                         type="fsn">Amino acids and derivatives</designation>
                    <desc language="en-US">Amino acids and derivatives</desc>
                </concept>
                <concept code="A16AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levocarnitine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levocarnitine" type="fsn">levocarnitine</designation>
                    <desc language="en-US">levocarnitine</desc>
                </concept>
                <concept code="A16AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ademetionine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ademetionine" type="fsn">ademetionine</designation>
                    <desc language="en-US">ademetionine</desc>
                </concept>
                <concept code="A16AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glutamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glutamine" type="fsn">glutamine</designation>
                    <desc language="en-US">glutamine</desc>
                </concept>
                <concept code="A16AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mercaptamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mercaptamine" type="fsn">mercaptamine</designation>
                    <desc language="en-US">mercaptamine</desc>
                </concept>
                <concept code="A16AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carglumic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carglumic acid" type="fsn">carglumic acid</designation>
                    <desc language="en-US">carglumic acid</desc>
                </concept>
                <concept code="A16AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betaine" type="fsn">betaine</designation>
                    <desc language="en-US">betaine</desc>
                </concept>
                <concept code="A16AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metreleptin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metreleptin" type="fsn">metreleptin</designation>
                    <desc language="en-US">metreleptin</desc>
                </concept>
                <concept code="A16AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Enzymes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Enzymes" type="fsn">Enzymes</designation>
                    <desc language="en-US">Enzymes</desc>
                </concept>
                <concept code="A16AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alglucerase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alglucerase" type="fsn">alglucerase</designation>
                    <desc language="en-US">alglucerase</desc>
                </concept>
                <concept code="A16AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imiglucerase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imiglucerase" type="fsn">imiglucerase</designation>
                    <desc language="en-US">imiglucerase</desc>
                </concept>
                <concept code="A16AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="agalsidase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="agalsidase alfa" type="fsn">agalsidase alfa</designation>
                    <desc language="en-US">agalsidase alfa</desc>
                </concept>
                <concept code="A16AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="agalsidase beta"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="agalsidase beta" type="fsn">agalsidase beta</designation>
                    <desc language="en-US">agalsidase beta</desc>
                </concept>
                <concept code="A16AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="laronidase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="laronidase" type="fsn">laronidase</designation>
                    <desc language="en-US">laronidase</desc>
                </concept>
                <concept code="A16AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sacrosidase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sacrosidase" type="fsn">sacrosidase</designation>
                    <desc language="en-US">sacrosidase</desc>
                </concept>
                <concept code="A16AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alglucosidase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alglucosidase alfa" type="fsn">alglucosidase alfa</designation>
                    <desc language="en-US">alglucosidase alfa</desc>
                </concept>
                <concept code="A16AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="galsulfase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="galsulfase" type="fsn">galsulfase</designation>
                    <desc language="en-US">galsulfase</desc>
                </concept>
                <concept code="A16AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idursulfase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idursulfase" type="fsn">idursulfase</designation>
                    <desc language="en-US">idursulfase</desc>
                </concept>
                <concept code="A16AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="velaglucerase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="velaglucerase alfa" type="fsn">velaglucerase alfa</designation>
                    <desc language="en-US">velaglucerase alfa</desc>
                </concept>
                <concept code="A16AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="taliglucerase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="taliglucerase alfa" type="fsn">taliglucerase alfa</designation>
                    <desc language="en-US">taliglucerase alfa</desc>
                </concept>
                <concept code="A16AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="elosulfase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="elosulfase alfa" type="fsn">elosulfase alfa</designation>
                    <desc language="en-US">elosulfase alfa</desc>
                </concept>
                <concept code="A16AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="asfotase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="asfotase alfa" type="fsn">asfotase alfa</designation>
                    <desc language="en-US">asfotase alfa</desc>
                </concept>
                <concept code="A16AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sebelipase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sebelipase alfa" type="fsn">sebelipase alfa</designation>
                    <desc language="en-US">sebelipase alfa</desc>
                </concept>
                <concept code="A16AB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="velmanase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="velmanase alfa" type="fsn">velmanase alfa</designation>
                    <desc language="en-US">velmanase alfa</desc>
                </concept>
                <concept code="A16AB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idursulfase beta"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idursulfase beta" type="fsn">idursulfase beta</designation>
                    <desc language="en-US">idursulfase beta</desc>
                </concept>
                <concept code="A16AB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cerliponase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cerliponase alfa" type="fsn">cerliponase alfa</designation>
                    <desc language="en-US">cerliponase alfa</desc>
                </concept>
                <concept code="A16AB18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vestronidase alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vestronidase alfa" type="fsn">vestronidase alfa</designation>
                    <desc language="en-US">vestronidase alfa</desc>
                </concept>
                <concept code="A16AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Various alimentary tract and metabolism products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Various alimentary tract and metabolism products"
                         type="fsn">Various alimentary tract and metabolism products</designation>
                    <desc language="en-US">Various alimentary tract and metabolism products</desc>
                </concept>
                <concept code="A16AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thioctic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thioctic acid" type="fsn">thioctic acid</designation>
                    <desc language="en-US">thioctic acid</desc>
                </concept>
                <concept code="A16AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anethole trithione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anethole trithione" type="fsn">anethole trithione</designation>
                    <desc language="en-US">anethole trithione</desc>
                </concept>
                <concept code="A16AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium phenylbutyrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium phenylbutyrate" type="fsn">sodium phenylbutyrate</designation>
                    <desc language="en-US">sodium phenylbutyrate</desc>
                </concept>
                <concept code="A16AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitisinone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitisinone" type="fsn">nitisinone</designation>
                    <desc language="en-US">nitisinone</desc>
                </concept>
                <concept code="A16AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc acetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zinc acetate" type="fsn">zinc acetate</designation>
                    <desc language="en-US">zinc acetate</desc>
                </concept>
                <concept code="A16AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miglustat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miglustat" type="fsn">miglustat</designation>
                    <desc language="en-US">miglustat</desc>
                </concept>
                <concept code="A16AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sapropterin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sapropterin" type="fsn">sapropterin</designation>
                    <desc language="en-US">sapropterin</desc>
                </concept>
                <concept code="A16AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="teduglutide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="teduglutide" type="fsn">teduglutide</designation>
                    <desc language="en-US">teduglutide</desc>
                </concept>
                <concept code="A16AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycerol phenylbutyrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glycerol phenylbutyrate" type="fsn">glycerol phenylbutyrate</designation>
                    <desc language="en-US">glycerol phenylbutyrate</desc>
                </concept>
                <concept code="A16AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eliglustat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eliglustat" type="fsn">eliglustat</designation>
                    <desc language="en-US">eliglustat</desc>
                </concept>
                <concept code="A16AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium benzoate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium benzoate" type="fsn">sodium benzoate</designation>
                    <desc language="en-US">sodium benzoate</desc>
                </concept>
                <concept code="A16AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trientine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trientine" type="fsn">trientine</designation>
                    <desc language="en-US">trientine</desc>
                </concept>
                <concept code="A16AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="uridine triacetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="uridine triacetate" type="fsn">uridine triacetate</designation>
                    <desc language="en-US">uridine triacetate</desc>
                </concept>
                <concept code="A16AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="migalastat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="migalastat" type="fsn">migalastat</designation>
                    <desc language="en-US">migalastat</desc>
                </concept>
                <concept code="A16AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="telotristat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="telotristat" type="fsn">telotristat</designation>
                    <desc language="en-US">telotristat</desc>
                </concept>
                <concept code="B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BLOOD AND BLOOD FORMING ORGANS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BLOOD AND BLOOD FORMING ORGANS"
                         type="fsn">BLOOD AND BLOOD FORMING ORGANS</designation>
                    <desc language="en-US">BLOOD AND BLOOD FORMING ORGANS</desc>
                </concept>
                <concept code="B01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTITHROMBOTIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTITHROMBOTIC AGENTS" type="fsn">ANTITHROMBOTIC AGENTS</designation>
                    <desc language="en-US">ANTITHROMBOTIC AGENTS</desc>
                </concept>
                <concept code="B01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTITHROMBOTIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTITHROMBOTIC AGENTS" type="fsn">ANTITHROMBOTIC AGENTS</designation>
                    <desc language="en-US">ANTITHROMBOTIC AGENTS</desc>
                </concept>
                <concept code="B01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin K antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vitamin K antagonists" type="fsn">Vitamin K antagonists</designation>
                    <desc language="en-US">Vitamin K antagonists</desc>
                </concept>
                <concept code="B01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dicoumarol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dicoumarol" type="fsn">dicoumarol</designation>
                    <desc language="en-US">dicoumarol</desc>
                </concept>
                <concept code="B01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenindione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenindione" type="fsn">phenindione</designation>
                    <desc language="en-US">phenindione</desc>
                </concept>
                <concept code="B01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="warfarin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="warfarin" type="fsn">warfarin</designation>
                    <desc language="en-US">warfarin</desc>
                </concept>
                <concept code="B01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenprocoumon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenprocoumon" type="fsn">phenprocoumon</designation>
                    <desc language="en-US">phenprocoumon</desc>
                </concept>
                <concept code="B01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acenocoumarol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acenocoumarol" type="fsn">acenocoumarol</designation>
                    <desc language="en-US">acenocoumarol</desc>
                </concept>
                <concept code="B01AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethyl biscoumacetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethyl biscoumacetate" type="fsn">ethyl biscoumacetate</designation>
                    <desc language="en-US">ethyl biscoumacetate</desc>
                </concept>
                <concept code="B01AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clorindione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clorindione" type="fsn">clorindione</designation>
                    <desc language="en-US">clorindione</desc>
                </concept>
                <concept code="B01AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphenadione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphenadione" type="fsn">diphenadione</designation>
                    <desc language="en-US">diphenadione</desc>
                </concept>
                <concept code="B01AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tioclomarol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tioclomarol" type="fsn">tioclomarol</designation>
                    <desc language="en-US">tioclomarol</desc>
                </concept>
                <concept code="B01AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluindione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluindione" type="fsn">fluindione</designation>
                    <desc language="en-US">fluindione</desc>
                </concept>
                <concept code="B01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Heparin group"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Heparin group" type="fsn">Heparin group</designation>
                    <desc language="en-US">Heparin group</desc>
                </concept>
                <concept code="B01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="heparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="heparin" type="fsn">heparin</designation>
                    <desc language="en-US">heparin</desc>
                </concept>
                <concept code="B01AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antithrombin III"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="antithrombin III" type="fsn">antithrombin III</designation>
                    <desc language="en-US">antithrombin III</desc>
                </concept>
                <concept code="B01AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dalteparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dalteparin" type="fsn">dalteparin</designation>
                    <desc language="en-US">dalteparin</desc>
                </concept>
                <concept code="B01AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enoxaparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enoxaparin" type="fsn">enoxaparin</designation>
                    <desc language="en-US">enoxaparin</desc>
                </concept>
                <concept code="B01AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nadroparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nadroparin" type="fsn">nadroparin</designation>
                    <desc language="en-US">nadroparin</desc>
                </concept>
                <concept code="B01AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="parnaparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="parnaparin" type="fsn">parnaparin</designation>
                    <desc language="en-US">parnaparin</desc>
                </concept>
                <concept code="B01AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reviparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reviparin" type="fsn">reviparin</designation>
                    <desc language="en-US">reviparin</desc>
                </concept>
                <concept code="B01AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="danaparoid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="danaparoid" type="fsn">danaparoid</designation>
                    <desc language="en-US">danaparoid</desc>
                </concept>
                <concept code="B01AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tinzaparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tinzaparin" type="fsn">tinzaparin</designation>
                    <desc language="en-US">tinzaparin</desc>
                </concept>
                <concept code="B01AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulodexide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulodexide" type="fsn">sulodexide</designation>
                    <desc language="en-US">sulodexide</desc>
                </concept>
                <concept code="B01AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bemiparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bemiparin" type="fsn">bemiparin</designation>
                    <desc language="en-US">bemiparin</desc>
                </concept>
                <concept code="B01AB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="heparin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="heparin, combinations" type="fsn">heparin, combinations</designation>
                    <desc language="en-US">heparin, combinations</desc>
                </concept>
                <concept code="B01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Platelet aggregation inhibitors excl. heparin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Platelet aggregation inhibitors excl. heparin"
                         type="fsn">Platelet aggregation inhibitors excl. heparin</designation>
                    <desc language="en-US">Platelet aggregation inhibitors excl. heparin</desc>
                </concept>
                <concept code="B01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ditazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ditazole" type="fsn">ditazole</designation>
                    <desc language="en-US">ditazole</desc>
                </concept>
                <concept code="B01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cloricromen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cloricromen" type="fsn">cloricromen</designation>
                    <desc language="en-US">cloricromen</desc>
                </concept>
                <concept code="B01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="picotamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="picotamide" type="fsn">picotamide</designation>
                    <desc language="en-US">picotamide</desc>
                </concept>
                <concept code="B01AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clopidogrel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clopidogrel" type="fsn">clopidogrel</designation>
                    <desc language="en-US">clopidogrel</desc>
                </concept>
                <concept code="B01AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ticlopidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ticlopidine" type="fsn">ticlopidine</designation>
                    <desc language="en-US">ticlopidine</desc>
                </concept>
                <concept code="B01AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylsalicylic acid" type="fsn">acetylsalicylic acid</designation>
                    <desc language="en-US">acetylsalicylic acid</desc>
                </concept>
                <concept code="B01AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dipyridamole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dipyridamole" type="fsn">dipyridamole</designation>
                    <desc language="en-US">dipyridamole</desc>
                </concept>
                <concept code="B01AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbasalate calcium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbasalate calcium" type="fsn">carbasalate calcium</designation>
                    <desc language="en-US">carbasalate calcium</desc>
                </concept>
                <concept code="B01AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epoprostenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epoprostenol" type="fsn">epoprostenol</designation>
                    <desc language="en-US">epoprostenol</desc>
                </concept>
                <concept code="B01AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indobufen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indobufen" type="fsn">indobufen</designation>
                    <desc language="en-US">indobufen</desc>
                </concept>
                <concept code="B01AC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iloprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iloprost" type="fsn">iloprost</designation>
                    <desc language="en-US">iloprost</desc>
                </concept>
                <concept code="B01AC13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="abciximab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="abciximab" type="fsn">abciximab</designation>
                    <desc language="en-US">abciximab</desc>
                </concept>
                <concept code="B01AC15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aloxiprin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aloxiprin" type="fsn">aloxiprin</designation>
                    <desc language="en-US">aloxiprin</desc>
                </concept>
                <concept code="B01AC16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eptifibatide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eptifibatide" type="fsn">eptifibatide</designation>
                    <desc language="en-US">eptifibatide</desc>
                </concept>
                <concept code="B01AC17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tirofiban"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tirofiban" type="fsn">tirofiban</designation>
                    <desc language="en-US">tirofiban</desc>
                </concept>
                <concept code="B01AC18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triflusal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triflusal" type="fsn">triflusal</designation>
                    <desc language="en-US">triflusal</desc>
                </concept>
                <concept code="B01AC19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="beraprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="beraprost" type="fsn">beraprost</designation>
                    <desc language="en-US">beraprost</desc>
                </concept>
                <concept code="B01AC21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="treprostinil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="treprostinil" type="fsn">treprostinil</designation>
                    <desc language="en-US">treprostinil</desc>
                </concept>
                <concept code="B01AC22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prasugrel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prasugrel" type="fsn">prasugrel</designation>
                    <desc language="en-US">prasugrel</desc>
                </concept>
                <concept code="B01AC23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cilostazol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cilostazol" type="fsn">cilostazol</designation>
                    <desc language="en-US">cilostazol</desc>
                </concept>
                <concept code="B01AC24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ticagrelor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ticagrelor" type="fsn">ticagrelor</designation>
                    <desc language="en-US">ticagrelor</desc>
                </concept>
                <concept code="B01AC25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cangrelor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cangrelor" type="fsn">cangrelor</designation>
                    <desc language="en-US">cangrelor</desc>
                </concept>
                <concept code="B01AC26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vorapaxar"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vorapaxar" type="fsn">vorapaxar</designation>
                    <desc language="en-US">vorapaxar</desc>
                </concept>
                <concept code="B01AC27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="selexipag"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="selexipag" type="fsn">selexipag</designation>
                    <desc language="en-US">selexipag</desc>
                </concept>
                <concept code="B01AC30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="B01AC56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylsalicylic acid, combinations with proton pump inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="acetylsalicylic acid, combinations with proton pump inhibitors"
                         type="fsn">acetylsalicylic acid, combinations with proton pump inhibitors</designation>
                    <desc language="en-US">acetylsalicylic acid, combinations with proton pump inhibitors</desc>
                </concept>
                <concept code="B01AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Enzymes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Enzymes" type="fsn">Enzymes</designation>
                    <desc language="en-US">Enzymes</desc>
                </concept>
                <concept code="B01AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="streptokinase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="streptokinase" type="fsn">streptokinase</designation>
                    <desc language="en-US">streptokinase</desc>
                </concept>
                <concept code="B01AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alteplase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alteplase" type="fsn">alteplase</designation>
                    <desc language="en-US">alteplase</desc>
                </concept>
                <concept code="B01AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anistreplase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anistreplase" type="fsn">anistreplase</designation>
                    <desc language="en-US">anistreplase</desc>
                </concept>
                <concept code="B01AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="urokinase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="urokinase" type="fsn">urokinase</designation>
                    <desc language="en-US">urokinase</desc>
                </concept>
                <concept code="B01AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fibrinolysin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fibrinolysin" type="fsn">fibrinolysin</designation>
                    <desc language="en-US">fibrinolysin</desc>
                </concept>
                <concept code="B01AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brinase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brinase" type="fsn">brinase</designation>
                    <desc language="en-US">brinase</desc>
                </concept>
                <concept code="B01AD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reteplase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reteplase" type="fsn">reteplase</designation>
                    <desc language="en-US">reteplase</desc>
                </concept>
                <concept code="B01AD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="saruplase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="saruplase" type="fsn">saruplase</designation>
                    <desc language="en-US">saruplase</desc>
                </concept>
                <concept code="B01AD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ancrod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ancrod" type="fsn">ancrod</designation>
                    <desc language="en-US">ancrod</desc>
                </concept>
                <concept code="B01AD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="drotrecogin alfa (activated)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="drotrecogin alfa (activated)"
                         type="fsn">drotrecogin alfa (activated)</designation>
                    <desc language="en-US">drotrecogin alfa (activated)</desc>
                </concept>
                <concept code="B01AD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tenecteplase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tenecteplase" type="fsn">tenecteplase</designation>
                    <desc language="en-US">tenecteplase</desc>
                </concept>
                <concept code="B01AD12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="protein C"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="protein C" type="fsn">protein C</designation>
                    <desc language="en-US">protein C</desc>
                </concept>
                <concept code="B01AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Direct thrombin inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Direct thrombin inhibitors"
                         type="fsn">Direct thrombin inhibitors</designation>
                    <desc language="en-US">Direct thrombin inhibitors</desc>
                </concept>
                <concept code="B01AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desirudin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desirudin" type="fsn">desirudin</designation>
                    <desc language="en-US">desirudin</desc>
                </concept>
                <concept code="B01AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lepirudin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lepirudin" type="fsn">lepirudin</designation>
                    <desc language="en-US">lepirudin</desc>
                </concept>
                <concept code="B01AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="argatroban"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="argatroban" type="fsn">argatroban</designation>
                    <desc language="en-US">argatroban</desc>
                </concept>
                <concept code="B01AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melagatran"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="melagatran" type="fsn">melagatran</designation>
                    <desc language="en-US">melagatran</desc>
                </concept>
                <concept code="B01AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ximelagatran"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ximelagatran" type="fsn">ximelagatran</designation>
                    <desc language="en-US">ximelagatran</desc>
                </concept>
                <concept code="B01AE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bivalirudin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bivalirudin" type="fsn">bivalirudin</designation>
                    <desc language="en-US">bivalirudin</desc>
                </concept>
                <concept code="B01AE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dabigatran etexilate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dabigatran etexilate" type="fsn">dabigatran etexilate</designation>
                    <desc language="en-US">dabigatran etexilate</desc>
                </concept>
                <concept code="B01AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Direct factor Xa inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Direct factor Xa inhibitors"
                         type="fsn">Direct factor Xa inhibitors</designation>
                    <desc language="en-US">Direct factor Xa inhibitors</desc>
                </concept>
                <concept code="B01AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rivaroxaban"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rivaroxaban" type="fsn">rivaroxaban</designation>
                    <desc language="en-US">rivaroxaban</desc>
                </concept>
                <concept code="B01AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="apixaban"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="apixaban" type="fsn">apixaban</designation>
                    <desc language="en-US">apixaban</desc>
                </concept>
                <concept code="B01AF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="edoxaban"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="edoxaban" type="fsn">edoxaban</designation>
                    <desc language="en-US">edoxaban</desc>
                </concept>
                <concept code="B01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antithrombotic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antithrombotic agents"
                         type="fsn">Other antithrombotic agents</designation>
                    <desc language="en-US">Other antithrombotic agents</desc>
                </concept>
                <concept code="B01AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="defibrotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="defibrotide" type="fsn">defibrotide</designation>
                    <desc language="en-US">defibrotide</desc>
                </concept>
                <concept code="B01AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dermatan sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dermatan sulfate" type="fsn">dermatan sulfate</designation>
                    <desc language="en-US">dermatan sulfate</desc>
                </concept>
                <concept code="B01AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fondaparinux"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fondaparinux" type="fsn">fondaparinux</designation>
                    <desc language="en-US">fondaparinux</desc>
                </concept>
                <concept code="B01AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="caplacizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="caplacizumab" type="fsn">caplacizumab</designation>
                    <desc language="en-US">caplacizumab</desc>
                </concept>
                <concept code="B02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIHEMORRHAGICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIHEMORRHAGICS" type="fsn">ANTIHEMORRHAGICS</designation>
                    <desc language="en-US">ANTIHEMORRHAGICS</desc>
                </concept>
                <concept code="B02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIFIBRINOLYTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIFIBRINOLYTICS" type="fsn">ANTIFIBRINOLYTICS</designation>
                    <desc language="en-US">ANTIFIBRINOLYTICS</desc>
                </concept>
                <concept code="B02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Amino acids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Amino acids" type="fsn">Amino acids</designation>
                    <desc language="en-US">Amino acids</desc>
                </concept>
                <concept code="B02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminocaproic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminocaproic acid" type="fsn">aminocaproic acid</designation>
                    <desc language="en-US">aminocaproic acid</desc>
                </concept>
                <concept code="B02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tranexamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tranexamic acid" type="fsn">tranexamic acid</designation>
                    <desc language="en-US">tranexamic acid</desc>
                </concept>
                <concept code="B02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminomethylbenzoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminomethylbenzoic acid" type="fsn">aminomethylbenzoic acid</designation>
                    <desc language="en-US">aminomethylbenzoic acid</desc>
                </concept>
                <concept code="B02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Proteinase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Proteinase inhibitors" type="fsn">Proteinase inhibitors</designation>
                    <desc language="en-US">Proteinase inhibitors</desc>
                </concept>
                <concept code="B02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aprotinin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aprotinin" type="fsn">aprotinin</designation>
                    <desc language="en-US">aprotinin</desc>
                </concept>
                <concept code="B02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alfa1 antitrypsin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alfa1 antitrypsin" type="fsn">alfa1 antitrypsin</designation>
                    <desc language="en-US">alfa1 antitrypsin</desc>
                </concept>
                <concept code="B02AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="camostat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="camostat" type="fsn">camostat</designation>
                    <desc language="en-US">camostat</desc>
                </concept>
                <concept code="B02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VITAMIN K AND OTHER HEMOSTATICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="VITAMIN K AND OTHER HEMOSTATICS"
                         type="fsn">VITAMIN K AND OTHER HEMOSTATICS</designation>
                    <desc language="en-US">VITAMIN K AND OTHER HEMOSTATICS</desc>
                </concept>
                <concept code="B02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin K"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vitamin K" type="fsn">Vitamin K</designation>
                    <desc language="en-US">Vitamin K</desc>
                </concept>
                <concept code="B02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phytomenadione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phytomenadione" type="fsn">phytomenadione</designation>
                    <desc language="en-US">phytomenadione</desc>
                </concept>
                <concept code="B02BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="menadione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="menadione" type="fsn">menadione</designation>
                    <desc language="en-US">menadione</desc>
                </concept>
                <concept code="B02BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fibrinogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Fibrinogen" type="fsn">Fibrinogen</designation>
                    <desc language="en-US">Fibrinogen</desc>
                </concept>
                <concept code="B02BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fibrinogen, human"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fibrinogen, human" type="fsn">fibrinogen, human</designation>
                    <desc language="en-US">fibrinogen, human</desc>
                </concept>
                <concept code="B02BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Local hemostatics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Local hemostatics" type="fsn">Local hemostatics</designation>
                    <desc language="en-US">Local hemostatics</desc>
                </concept>
                <concept code="B02BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="absorbable gelatin sponge"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="absorbable gelatin sponge" type="fsn">absorbable gelatin sponge</designation>
                    <desc language="en-US">absorbable gelatin sponge</desc>
                </concept>
                <concept code="B02BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxidized cellulose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxidized cellulose" type="fsn">oxidized cellulose</designation>
                    <desc language="en-US">oxidized cellulose</desc>
                </concept>
                <concept code="B02BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetragalacturonic acid hydroxymethylester"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tetragalacturonic acid hydroxymethylester"
                         type="fsn">tetragalacturonic acid hydroxymethylester</designation>
                    <desc language="en-US">tetragalacturonic acid hydroxymethylester</desc>
                </concept>
                <concept code="B02BC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adrenalone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adrenalone" type="fsn">adrenalone</designation>
                    <desc language="en-US">adrenalone</desc>
                </concept>
                <concept code="B02BC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thrombin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thrombin" type="fsn">thrombin</designation>
                    <desc language="en-US">thrombin</desc>
                </concept>
                <concept code="B02BC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="collagen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="collagen" type="fsn">collagen</designation>
                    <desc language="en-US">collagen</desc>
                </concept>
                <concept code="B02BC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium alginate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium alginate" type="fsn">calcium alginate</designation>
                    <desc language="en-US">calcium alginate</desc>
                </concept>
                <concept code="B02BC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinephrine" type="fsn">epinephrine</designation>
                    <desc language="en-US">epinephrine</desc>
                </concept>
                <concept code="B02BC30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="B02BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Blood coagulation factors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Blood coagulation factors" type="fsn">Blood coagulation factors</designation>
                    <desc language="en-US">Blood coagulation factors</desc>
                </concept>
                <concept code="B02BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="coagulation factor IX, II, VII and X in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="coagulation factor IX, II, VII and X in combination"
                         type="fsn">coagulation factor IX, II, VII and X in combination</designation>
                    <desc language="en-US">coagulation factor IX, II, VII and X in combination</desc>
                </concept>
                <concept code="B02BD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="coagulation factor VIII"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="coagulation factor VIII" type="fsn">coagulation factor VIII</designation>
                    <desc language="en-US">coagulation factor VIII</desc>
                </concept>
                <concept code="B02BD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="factor VIII inhibitor bypassing activity"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="factor VIII inhibitor bypassing activity"
                         type="fsn">factor VIII inhibitor bypassing activity</designation>
                    <desc language="en-US">factor VIII inhibitor bypassing activity</desc>
                </concept>
                <concept code="B02BD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="coagulation factor IX"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="coagulation factor IX" type="fsn">coagulation factor IX</designation>
                    <desc language="en-US">coagulation factor IX</desc>
                </concept>
                <concept code="B02BD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="coagulation factor VII"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="coagulation factor VII" type="fsn">coagulation factor VII</designation>
                    <desc language="en-US">coagulation factor VII</desc>
                </concept>
                <concept code="B02BD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="von Willebrand factor and coagulation factor VIII in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="von Willebrand factor and coagulation factor VIII in combination"
                         type="fsn">von Willebrand factor and coagulation factor VIII in combination</designation>
                    <desc language="en-US">von Willebrand factor and coagulation factor VIII in combination</desc>
                </concept>
                <concept code="B02BD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="coagulation factor XIII"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="coagulation factor XIII" type="fsn">coagulation factor XIII</designation>
                    <desc language="en-US">coagulation factor XIII</desc>
                </concept>
                <concept code="B02BD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="coagulation factor VIIa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="coagulation factor VIIa" type="fsn">coagulation factor VIIa</designation>
                    <desc language="en-US">coagulation factor VIIa</desc>
                </concept>
                <concept code="B02BD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="von Willebrand factor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="von Willebrand factor" type="fsn">von Willebrand factor</designation>
                    <desc language="en-US">von Willebrand factor</desc>
                </concept>
                <concept code="B02BD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="catridecacog"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="catridecacog" type="fsn">catridecacog</designation>
                    <desc language="en-US">catridecacog</desc>
                </concept>
                <concept code="B02BD13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="coagulation factor X"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="coagulation factor X" type="fsn">coagulation factor X</designation>
                    <desc language="en-US">coagulation factor X</desc>
                </concept>
                <concept code="B02BD14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="susoctocog alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="susoctocog alfa" type="fsn">susoctocog alfa</designation>
                    <desc language="en-US">susoctocog alfa</desc>
                </concept>
                <concept code="B02BD30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thrombin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thrombin" type="fsn">thrombin</designation>
                    <desc language="en-US">thrombin</desc>
                </concept>
                <concept code="B02BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other systemic hemostatics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other systemic hemostatics"
                         type="fsn">Other systemic hemostatics</designation>
                    <desc language="en-US">Other systemic hemostatics</desc>
                </concept>
                <concept code="B02BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etamsylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etamsylate" type="fsn">etamsylate</designation>
                    <desc language="en-US">etamsylate</desc>
                </concept>
                <concept code="B02BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbazochrome"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbazochrome" type="fsn">carbazochrome</designation>
                    <desc language="en-US">carbazochrome</desc>
                </concept>
                <concept code="B02BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="batroxobin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="batroxobin" type="fsn">batroxobin</designation>
                    <desc language="en-US">batroxobin</desc>
                </concept>
                <concept code="B02BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="romiplostim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="romiplostim" type="fsn">romiplostim</designation>
                    <desc language="en-US">romiplostim</desc>
                </concept>
                <concept code="B02BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eltrombopag"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eltrombopag" type="fsn">eltrombopag</designation>
                    <desc language="en-US">eltrombopag</desc>
                </concept>
                <concept code="B02BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emicizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emicizumab" type="fsn">emicizumab</designation>
                    <desc language="en-US">emicizumab</desc>
                </concept>
                <concept code="B02BX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lusutrombopag"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lusutrombopag" type="fsn">lusutrombopag</designation>
                    <desc language="en-US">lusutrombopag</desc>
                </concept>
                <concept code="B02BX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="avatrombopag"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="avatrombopag" type="fsn">avatrombopag</designation>
                    <desc language="en-US">avatrombopag</desc>
                </concept>
                <concept code="B02BX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fostamatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fostamatinib" type="fsn">fostamatinib</designation>
                    <desc language="en-US">fostamatinib</desc>
                </concept>
                <concept code="B03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIANEMIC PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIANEMIC PREPARATIONS" type="fsn">ANTIANEMIC PREPARATIONS</designation>
                    <desc language="en-US">ANTIANEMIC PREPARATIONS</desc>
                </concept>
                <concept code="B03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IRON PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IRON PREPARATIONS" type="fsn">IRON PREPARATIONS</designation>
                    <desc language="en-US">IRON PREPARATIONS</desc>
                </concept>
                <concept code="B03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iron bivalent, oral preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Iron bivalent, oral preparations"
                         type="fsn">Iron bivalent, oral preparations</designation>
                    <desc language="en-US">Iron bivalent, oral preparations</desc>
                </concept>
                <concept code="B03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous glycine sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous glycine sulfate" type="fsn">ferrous glycine sulfate</designation>
                    <desc language="en-US">ferrous glycine sulfate</desc>
                </concept>
                <concept code="B03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous fumarate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous fumarate" type="fsn">ferrous fumarate</designation>
                    <desc language="en-US">ferrous fumarate</desc>
                </concept>
                <concept code="B03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous gluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous gluconate" type="fsn">ferrous gluconate</designation>
                    <desc language="en-US">ferrous gluconate</desc>
                </concept>
                <concept code="B03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous carbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous carbonate" type="fsn">ferrous carbonate</designation>
                    <desc language="en-US">ferrous carbonate</desc>
                </concept>
                <concept code="B03AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous chloride" type="fsn">ferrous chloride</designation>
                    <desc language="en-US">ferrous chloride</desc>
                </concept>
                <concept code="B03AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous succinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous succinate" type="fsn">ferrous succinate</designation>
                    <desc language="en-US">ferrous succinate</desc>
                </concept>
                <concept code="B03AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous sulfate" type="fsn">ferrous sulfate</designation>
                    <desc language="en-US">ferrous sulfate</desc>
                </concept>
                <concept code="B03AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous tartrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous tartrate" type="fsn">ferrous tartrate</designation>
                    <desc language="en-US">ferrous tartrate</desc>
                </concept>
                <concept code="B03AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous aspartate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous aspartate" type="fsn">ferrous aspartate</designation>
                    <desc language="en-US">ferrous aspartate</desc>
                </concept>
                <concept code="B03AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous ascorbate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous ascorbate" type="fsn">ferrous ascorbate</designation>
                    <desc language="en-US">ferrous ascorbate</desc>
                </concept>
                <concept code="B03AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous iodine" type="fsn">ferrous iodine</designation>
                    <desc language="en-US">ferrous iodine</desc>
                </concept>
                <concept code="B03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iron trivalent, oral preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Iron trivalent, oral preparations"
                         type="fsn">Iron trivalent, oral preparations</designation>
                    <desc language="en-US">Iron trivalent, oral preparations</desc>
                </concept>
                <concept code="B03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric sodium citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferric sodium citrate" type="fsn">ferric sodium citrate</designation>
                    <desc language="en-US">ferric sodium citrate</desc>
                </concept>
                <concept code="B03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="saccharated iron oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="saccharated iron oxide" type="fsn">saccharated iron oxide</designation>
                    <desc language="en-US">saccharated iron oxide</desc>
                </concept>
                <concept code="B03AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium feredetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium feredetate" type="fsn">sodium feredetate</designation>
                    <desc language="en-US">sodium feredetate</desc>
                </concept>
                <concept code="B03AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric hydroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferric hydroxide" type="fsn">ferric hydroxide</designation>
                    <desc language="en-US">ferric hydroxide</desc>
                </concept>
                <concept code="B03AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric oxide polymaltose complexes"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ferric oxide polymaltose complexes"
                         type="fsn">ferric oxide polymaltose complexes</designation>
                    <desc language="en-US">ferric oxide polymaltose complexes</desc>
                </concept>
                <concept code="B03AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chondroitin sulfate-iron complex"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chondroitin sulfate-iron complex"
                         type="fsn">chondroitin sulfate-iron complex</designation>
                    <desc language="en-US">chondroitin sulfate-iron complex</desc>
                </concept>
                <concept code="B03AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric acetyl transferrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferric acetyl transferrin" type="fsn">ferric acetyl transferrin</designation>
                    <desc language="en-US">ferric acetyl transferrin</desc>
                </concept>
                <concept code="B03AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric proteinsuccinylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferric proteinsuccinylate" type="fsn">ferric proteinsuccinylate</designation>
                    <desc language="en-US">ferric proteinsuccinylate</desc>
                </concept>
                <concept code="B03AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric maltol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferric maltol" type="fsn">ferric maltol</designation>
                    <desc language="en-US">ferric maltol</desc>
                </concept>
                <concept code="B03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iron, parenteral preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Iron, parenteral preparations"
                         type="fsn">Iron, parenteral preparations</designation>
                    <desc language="en-US">Iron, parenteral preparations</desc>
                </concept>
                <concept code="B03AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iron in combination with folic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Iron in combination with folic acid"
                         type="fsn">Iron in combination with folic acid</designation>
                    <desc language="en-US">Iron in combination with folic acid</desc>
                </concept>
                <concept code="B03AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous amino acid complex"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ferrous amino acid complex"
                         type="fsn">ferrous amino acid complex</designation>
                    <desc language="en-US">ferrous amino acid complex</desc>
                </concept>
                <concept code="B03AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous fumarate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous fumarate" type="fsn">ferrous fumarate</designation>
                    <desc language="en-US">ferrous fumarate</desc>
                </concept>
                <concept code="B03AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferrous sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferrous sulfate" type="fsn">ferrous sulfate</designation>
                    <desc language="en-US">ferrous sulfate</desc>
                </concept>
                <concept code="B03AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric oxide polymaltose complexes"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ferric oxide polymaltose complexes"
                         type="fsn">ferric oxide polymaltose complexes</designation>
                    <desc language="en-US">ferric oxide polymaltose complexes</desc>
                </concept>
                <concept code="B03AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iron in other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Iron in other combinations"
                         type="fsn">Iron in other combinations</designation>
                    <desc language="en-US">Iron in other combinations</desc>
                </concept>
                <concept code="B03AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iron, vitamin B12 and folic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iron, vitamin B12 and folic acid"
                         type="fsn">iron, vitamin B12 and folic acid</designation>
                    <desc language="en-US">iron, vitamin B12 and folic acid</desc>
                </concept>
                <concept code="B03AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iron, multivitamins and folic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iron, multivitamins and folic acid"
                         type="fsn">iron, multivitamins and folic acid</designation>
                    <desc language="en-US">iron, multivitamins and folic acid</desc>
                </concept>
                <concept code="B03AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iron and multivitamins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iron and multivitamins" type="fsn">iron and multivitamins</designation>
                    <desc language="en-US">iron and multivitamins</desc>
                </concept>
                <concept code="B03AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iron, multivitamins and minerals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iron, multivitamins and minerals"
                         type="fsn">iron, multivitamins and minerals</designation>
                    <desc language="en-US">iron, multivitamins and minerals</desc>
                </concept>
                <concept code="B03AE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="various combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="various combinations" type="fsn">various combinations</designation>
                    <desc language="en-US">various combinations</desc>
                </concept>
                <concept code="B03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VITAMIN B12 AND FOLIC ACID"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="VITAMIN B12 AND FOLIC ACID"
                         type="fsn">VITAMIN B12 AND FOLIC ACID</designation>
                    <desc language="en-US">VITAMIN B12 AND FOLIC ACID</desc>
                </concept>
                <concept code="B03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamin B12 (cyanocobalamin and analogues)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vitamin B12 (cyanocobalamin and analogues)"
                         type="fsn">Vitamin B12 (cyanocobalamin and analogues)</designation>
                    <desc language="en-US">Vitamin B12 (cyanocobalamin and analogues)</desc>
                </concept>
                <concept code="B03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyanocobalamin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyanocobalamin" type="fsn">cyanocobalamin</designation>
                    <desc language="en-US">cyanocobalamin</desc>
                </concept>
                <concept code="B03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyanocobalamin tannin complex"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cyanocobalamin tannin complex"
                         type="fsn">cyanocobalamin tannin complex</designation>
                    <desc language="en-US">cyanocobalamin tannin complex</desc>
                </concept>
                <concept code="B03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxocobalamin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxocobalamin" type="fsn">hydroxocobalamin</designation>
                    <desc language="en-US">hydroxocobalamin</desc>
                </concept>
                <concept code="B03BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cobamamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cobamamide" type="fsn">cobamamide</designation>
                    <desc language="en-US">cobamamide</desc>
                </concept>
                <concept code="B03BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mecobalamin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mecobalamin" type="fsn">mecobalamin</designation>
                    <desc language="en-US">mecobalamin</desc>
                </concept>
                <concept code="B03BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyanocobalamin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cyanocobalamin, combinations"
                         type="fsn">cyanocobalamin, combinations</designation>
                    <desc language="en-US">cyanocobalamin, combinations</desc>
                </concept>
                <concept code="B03BA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxocobalamin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydroxocobalamin, combinations"
                         type="fsn">hydroxocobalamin, combinations</designation>
                    <desc language="en-US">hydroxocobalamin, combinations</desc>
                </concept>
                <concept code="B03BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Folic acid and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Folic acid and derivatives"
                         type="fsn">Folic acid and derivatives</designation>
                    <desc language="en-US">Folic acid and derivatives</desc>
                </concept>
                <concept code="B03BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="folic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="folic acid" type="fsn">folic acid</designation>
                    <desc language="en-US">folic acid</desc>
                </concept>
                <concept code="B03BB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="folic acid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="folic acid, combinations" type="fsn">folic acid, combinations</designation>
                    <desc language="en-US">folic acid, combinations</desc>
                </concept>
                <concept code="B03X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ANTIANEMIC PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER ANTIANEMIC PREPARATIONS"
                         type="fsn">OTHER ANTIANEMIC PREPARATIONS</designation>
                    <desc language="en-US">OTHER ANTIANEMIC PREPARATIONS</desc>
                </concept>
                <concept code="B03XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antianemic preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antianemic preparations"
                         type="fsn">Other antianemic preparations</designation>
                    <desc language="en-US">Other antianemic preparations</desc>
                </concept>
                <concept code="B03XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erythropoietin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="erythropoietin" type="fsn">erythropoietin</designation>
                    <desc language="en-US">erythropoietin</desc>
                </concept>
                <concept code="B03XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="darbepoetin alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="darbepoetin alfa" type="fsn">darbepoetin alfa</designation>
                    <desc language="en-US">darbepoetin alfa</desc>
                </concept>
                <concept code="B03XA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methoxy polyethylene glycol-epoetin beta"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methoxy polyethylene glycol-epoetin beta"
                         type="fsn">methoxy polyethylene glycol-epoetin beta</designation>
                    <desc language="en-US">methoxy polyethylene glycol-epoetin beta</desc>
                </concept>
                <concept code="B03XA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="peginesatide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="peginesatide" type="fsn">peginesatide</designation>
                    <desc language="en-US">peginesatide</desc>
                </concept>
                <concept code="B03XA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="roxadustat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="roxadustat" type="fsn">roxadustat</designation>
                    <desc language="en-US">roxadustat</desc>
                </concept>
                <concept code="B05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS"
                         type="fsn">BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS</designation>
                    <desc language="en-US">BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS</desc>
                </concept>
                <concept code="B05A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BLOOD AND RELATED PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BLOOD AND RELATED PRODUCTS"
                         type="fsn">BLOOD AND RELATED PRODUCTS</designation>
                    <desc language="en-US">BLOOD AND RELATED PRODUCTS</desc>
                </concept>
                <concept code="B05AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Blood substitutes and plasma protein fractions"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Blood substitutes and plasma protein fractions"
                         type="fsn">Blood substitutes and plasma protein fractions</designation>
                    <desc language="en-US">Blood substitutes and plasma protein fractions</desc>
                </concept>
                <concept code="B05AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="albumin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="albumin" type="fsn">albumin</designation>
                    <desc language="en-US">albumin</desc>
                </concept>
                <concept code="B05AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="other plasma protein fractions"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="other plasma protein fractions"
                         type="fsn">other plasma protein fractions</designation>
                    <desc language="en-US">other plasma protein fractions</desc>
                </concept>
                <concept code="B05AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorocarbon blood substitutes"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluorocarbon blood substitutes"
                         type="fsn">fluorocarbon blood substitutes</designation>
                    <desc language="en-US">fluorocarbon blood substitutes</desc>
                </concept>
                <concept code="B05AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextran"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dextran" type="fsn">dextran</designation>
                    <desc language="en-US">dextran</desc>
                </concept>
                <concept code="B05AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gelatin agents"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gelatin agents" type="fsn">gelatin agents</designation>
                    <desc language="en-US">gelatin agents</desc>
                </concept>
                <concept code="B05AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxyethylstarch"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxyethylstarch" type="fsn">hydroxyethylstarch</designation>
                    <desc language="en-US">hydroxyethylstarch</desc>
                </concept>
                <concept code="B05AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemoglobin crosfumaril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hemoglobin crosfumaril" type="fsn">hemoglobin crosfumaril</designation>
                    <desc language="en-US">hemoglobin crosfumaril</desc>
                </concept>
                <concept code="B05AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemoglobin raffimer"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hemoglobin raffimer" type="fsn">hemoglobin raffimer</designation>
                    <desc language="en-US">hemoglobin raffimer</desc>
                </concept>
                <concept code="B05AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemoglobin glutamer (bovine)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hemoglobin glutamer (bovine)"
                         type="fsn">hemoglobin glutamer (bovine)</designation>
                    <desc language="en-US">hemoglobin glutamer (bovine)</desc>
                </concept>
                <concept code="B05AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other blood products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other blood products" type="fsn">Other blood products</designation>
                    <desc language="en-US">Other blood products</desc>
                </concept>
                <concept code="B05AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erythrocytes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="erythrocytes" type="fsn">erythrocytes</designation>
                    <desc language="en-US">erythrocytes</desc>
                </concept>
                <concept code="B05AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thrombocytes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thrombocytes" type="fsn">thrombocytes</designation>
                    <desc language="en-US">thrombocytes</desc>
                </concept>
                <concept code="B05AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="blood plasma"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="blood plasma" type="fsn">blood plasma</designation>
                    <desc language="en-US">blood plasma</desc>
                </concept>
                <concept code="B05AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stem cells from umbilical cord blood"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="stem cells from umbilical cord blood"
                         type="fsn">stem cells from umbilical cord blood</designation>
                    <desc language="en-US">stem cells from umbilical cord blood</desc>
                </concept>
                <concept code="B05B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="I.V. SOLUTIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="I.V. SOLUTIONS" type="fsn">I.V. SOLUTIONS</designation>
                    <desc language="en-US">I.V. SOLUTIONS</desc>
                </concept>
                <concept code="B05BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Solutions for parenteral nutrition"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Solutions for parenteral nutrition"
                         type="fsn">Solutions for parenteral nutrition</designation>
                    <desc language="en-US">Solutions for parenteral nutrition</desc>
                </concept>
                <concept code="B05BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amino acids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amino acids" type="fsn">amino acids</designation>
                    <desc language="en-US">amino acids</desc>
                </concept>
                <concept code="B05BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fat emulsions"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fat emulsions" type="fsn">fat emulsions</designation>
                    <desc language="en-US">fat emulsions</desc>
                </concept>
                <concept code="B05BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbohydrates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbohydrates" type="fsn">carbohydrates</designation>
                    <desc language="en-US">carbohydrates</desc>
                </concept>
                <concept code="B05BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="protein hydrolysates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="protein hydrolysates" type="fsn">protein hydrolysates</designation>
                    <desc language="en-US">protein hydrolysates</desc>
                </concept>
                <concept code="B05BA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="B05BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Solutions affecting the electrolyte balance"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Solutions affecting the electrolyte balance"
                         type="fsn">Solutions affecting the electrolyte balance</designation>
                    <desc language="en-US">Solutions affecting the electrolyte balance</desc>
                </concept>
                <concept code="B05BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="electrolytes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="electrolytes" type="fsn">electrolytes</designation>
                    <desc language="en-US">electrolytes</desc>
                </concept>
                <concept code="B05BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="electrolytes with carbohydrates"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="electrolytes with carbohydrates"
                         type="fsn">electrolytes with carbohydrates</designation>
                    <desc language="en-US">electrolytes with carbohydrates</desc>
                </concept>
                <concept code="B05BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trometamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trometamol" type="fsn">trometamol</designation>
                    <desc language="en-US">trometamol</desc>
                </concept>
                <concept code="B05BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="electrolytes in combination with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="electrolytes in combination with other drugs"
                         type="fsn">electrolytes in combination with other drugs</designation>
                    <desc language="en-US">electrolytes in combination with other drugs</desc>
                </concept>
                <concept code="B05BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Solutions producing osmotic diuresis"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Solutions producing osmotic diuresis"
                         type="fsn">Solutions producing osmotic diuresis</designation>
                    <desc language="en-US">Solutions producing osmotic diuresis</desc>
                </concept>
                <concept code="B05BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mannitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mannitol" type="fsn">mannitol</designation>
                    <desc language="en-US">mannitol</desc>
                </concept>
                <concept code="B05BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbamide" type="fsn">carbamide</designation>
                    <desc language="en-US">carbamide</desc>
                </concept>
                <concept code="B05C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IRRIGATING SOLUTIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IRRIGATING SOLUTIONS" type="fsn">IRRIGATING SOLUTIONS</designation>
                    <desc language="en-US">IRRIGATING SOLUTIONS</desc>
                </concept>
                <concept code="B05CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antiinfectives" type="fsn">Antiinfectives</designation>
                    <desc language="en-US">Antiinfectives</desc>
                </concept>
                <concept code="B05CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetylpyridinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetylpyridinium" type="fsn">cetylpyridinium</designation>
                    <desc language="en-US">cetylpyridinium</desc>
                </concept>
                <concept code="B05CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorhexidine" type="fsn">chlorhexidine</designation>
                    <desc language="en-US">chlorhexidine</desc>
                </concept>
                <concept code="B05CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrofural"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrofural" type="fsn">nitrofural</designation>
                    <desc language="en-US">nitrofural</desc>
                </concept>
                <concept code="B05CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamethizole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamethizole" type="fsn">sulfamethizole</designation>
                    <desc language="en-US">sulfamethizole</desc>
                </concept>
                <concept code="B05CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="taurolidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="taurolidine" type="fsn">taurolidine</designation>
                    <desc language="en-US">taurolidine</desc>
                </concept>
                <concept code="B05CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mandelic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mandelic acid" type="fsn">mandelic acid</designation>
                    <desc language="en-US">mandelic acid</desc>
                </concept>
                <concept code="B05CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="noxytiolin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="noxytiolin" type="fsn">noxytiolin</designation>
                    <desc language="en-US">noxytiolin</desc>
                </concept>
                <concept code="B05CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethacridine lactate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethacridine lactate" type="fsn">ethacridine lactate</designation>
                    <desc language="en-US">ethacridine lactate</desc>
                </concept>
                <concept code="B05CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="B05CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="B05CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Salt solutions"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Salt solutions" type="fsn">Salt solutions</designation>
                    <desc language="en-US">Salt solutions</desc>
                </concept>
                <concept code="B05CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium chloride" type="fsn">sodium chloride</designation>
                    <desc language="en-US">sodium chloride</desc>
                </concept>
                <concept code="B05CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium citrate" type="fsn">sodium citrate</designation>
                    <desc language="en-US">sodium citrate</desc>
                </concept>
                <concept code="B05CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium citrate" type="fsn">magnesium citrate</designation>
                    <desc language="en-US">magnesium citrate</desc>
                </concept>
                <concept code="B05CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium bicarbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium bicarbonate" type="fsn">sodium bicarbonate</designation>
                    <desc language="en-US">sodium bicarbonate</desc>
                </concept>
                <concept code="B05CB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="B05CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other irrigating solutions"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other irrigating solutions"
                         type="fsn">Other irrigating solutions</designation>
                    <desc language="en-US">Other irrigating solutions</desc>
                </concept>
                <concept code="B05CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glucose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glucose" type="fsn">glucose</designation>
                    <desc language="en-US">glucose</desc>
                </concept>
                <concept code="B05CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sorbitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sorbitol" type="fsn">sorbitol</designation>
                    <desc language="en-US">sorbitol</desc>
                </concept>
                <concept code="B05CX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glycine" type="fsn">glycine</designation>
                    <desc language="en-US">glycine</desc>
                </concept>
                <concept code="B05CX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mannitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mannitol" type="fsn">mannitol</designation>
                    <desc language="en-US">mannitol</desc>
                </concept>
                <concept code="B05CX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="B05D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PERITONEAL DIALYTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PERITONEAL DIALYTICS" type="fsn">PERITONEAL DIALYTICS</designation>
                    <desc language="en-US">PERITONEAL DIALYTICS</desc>
                </concept>
                <concept code="B05DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Isotonic solutions"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Isotonic solutions" type="fsn">Isotonic solutions</designation>
                    <desc language="en-US">Isotonic solutions</desc>
                </concept>
                <concept code="B05DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hypertonic solutions"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Hypertonic solutions" type="fsn">Hypertonic solutions</designation>
                    <desc language="en-US">Hypertonic solutions</desc>
                </concept>
                <concept code="B05X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="I.V. SOLUTION ADDITIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="I.V. SOLUTION ADDITIVES" type="fsn">I.V. SOLUTION ADDITIVES</designation>
                    <desc language="en-US">I.V. SOLUTION ADDITIVES</desc>
                </concept>
                <concept code="B05XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Electrolyte solutions"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Electrolyte solutions" type="fsn">Electrolyte solutions</designation>
                    <desc language="en-US">Electrolyte solutions</desc>
                </concept>
                <concept code="B05XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium chloride" type="fsn">potassium chloride</designation>
                    <desc language="en-US">potassium chloride</desc>
                </concept>
                <concept code="B05XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium bicarbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium bicarbonate" type="fsn">sodium bicarbonate</designation>
                    <desc language="en-US">sodium bicarbonate</desc>
                </concept>
                <concept code="B05XA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium chloride" type="fsn">sodium chloride</designation>
                    <desc language="en-US">sodium chloride</desc>
                </concept>
                <concept code="B05XA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ammonium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ammonium chloride" type="fsn">ammonium chloride</designation>
                    <desc language="en-US">ammonium chloride</desc>
                </concept>
                <concept code="B05XA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium sulfate" type="fsn">magnesium sulfate</designation>
                    <desc language="en-US">magnesium sulfate</desc>
                </concept>
                <concept code="B05XA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium phosphate, incl. combinations with other potassium salts"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="potassium phosphate, incl. combinations with other potassium salts"
                         type="fsn">potassium phosphate, incl. combinations with other potassium salts</designation>
                    <desc language="en-US">potassium phosphate, incl. combinations with other potassium salts</desc>
                </concept>
                <concept code="B05XA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium chloride" type="fsn">calcium chloride</designation>
                    <desc language="en-US">calcium chloride</desc>
                </concept>
                <concept code="B05XA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium acetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium acetate" type="fsn">sodium acetate</designation>
                    <desc language="en-US">sodium acetate</desc>
                </concept>
                <concept code="B05XA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium phosphate" type="fsn">sodium phosphate</designation>
                    <desc language="en-US">sodium phosphate</desc>
                </concept>
                <concept code="B05XA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium phosphate" type="fsn">magnesium phosphate</designation>
                    <desc language="en-US">magnesium phosphate</desc>
                </concept>
                <concept code="B05XA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium chloride" type="fsn">magnesium chloride</designation>
                    <desc language="en-US">magnesium chloride</desc>
                </concept>
                <concept code="B05XA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zinc chloride" type="fsn">zinc chloride</designation>
                    <desc language="en-US">zinc chloride</desc>
                </concept>
                <concept code="B05XA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrochloric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrochloric acid" type="fsn">hydrochloric acid</designation>
                    <desc language="en-US">hydrochloric acid</desc>
                </concept>
                <concept code="B05XA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium glycerophosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium glycerophosphate" type="fsn">sodium glycerophosphate</designation>
                    <desc language="en-US">sodium glycerophosphate</desc>
                </concept>
                <concept code="B05XA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium lactate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium lactate" type="fsn">potassium lactate</designation>
                    <desc language="en-US">potassium lactate</desc>
                </concept>
                <concept code="B05XA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cardioplegia solutions"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cardioplegia solutions" type="fsn">cardioplegia solutions</designation>
                    <desc language="en-US">cardioplegia solutions</desc>
                </concept>
                <concept code="B05XA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium acetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium acetate" type="fsn">potassium acetate</designation>
                    <desc language="en-US">potassium acetate</desc>
                </concept>
                <concept code="B05XA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of electrolytes"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of electrolytes"
                         type="fsn">combinations of electrolytes</designation>
                    <desc language="en-US">combinations of electrolytes</desc>
                </concept>
                <concept code="B05XA31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="electrolytes in combination with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="electrolytes in combination with other drugs"
                         type="fsn">electrolytes in combination with other drugs</designation>
                    <desc language="en-US">electrolytes in combination with other drugs</desc>
                </concept>
                <concept code="B05XB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Amino acids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Amino acids" type="fsn">Amino acids</designation>
                    <desc language="en-US">Amino acids</desc>
                </concept>
                <concept code="B05XB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="arginine hydrochloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="arginine hydrochloride" type="fsn">arginine hydrochloride</designation>
                    <desc language="en-US">arginine hydrochloride</desc>
                </concept>
                <concept code="B05XB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alanyl glutamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alanyl glutamine" type="fsn">alanyl glutamine</designation>
                    <desc language="en-US">alanyl glutamine</desc>
                </concept>
                <concept code="B05XB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lysine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lysine" type="fsn">lysine</designation>
                    <desc language="en-US">lysine</desc>
                </concept>
                <concept code="B05XC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vitamins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vitamins" type="fsn">Vitamins</designation>
                    <desc language="en-US">Vitamins</desc>
                </concept>
                <concept code="B05XX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other i.v. solution additives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other i.v. solution additives"
                         type="fsn">Other i.v. solution additives</designation>
                    <desc language="en-US">Other i.v. solution additives</desc>
                </concept>
                <concept code="B05XX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trometamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trometamol" type="fsn">trometamol</designation>
                    <desc language="en-US">trometamol</desc>
                </concept>
                <concept code="B05Z"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HEMODIALYTICS AND HEMOFILTRATES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="HEMODIALYTICS AND HEMOFILTRATES"
                         type="fsn">HEMODIALYTICS AND HEMOFILTRATES</designation>
                    <desc language="en-US">HEMODIALYTICS AND HEMOFILTRATES</desc>
                </concept>
                <concept code="B05ZA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hemodialytics, concentrates"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Hemodialytics, concentrates"
                         type="fsn">Hemodialytics, concentrates</designation>
                    <desc language="en-US">Hemodialytics, concentrates</desc>
                </concept>
                <concept code="B05ZB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hemofiltrates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Hemofiltrates" type="fsn">Hemofiltrates</designation>
                    <desc language="en-US">Hemofiltrates</desc>
                </concept>
                <concept code="B06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER HEMATOLOGICAL AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER HEMATOLOGICAL AGENTS"
                         type="fsn">OTHER HEMATOLOGICAL AGENTS</designation>
                    <desc language="en-US">OTHER HEMATOLOGICAL AGENTS</desc>
                </concept>
                <concept code="B06A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER HEMATOLOGICAL AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER HEMATOLOGICAL AGENTS"
                         type="fsn">OTHER HEMATOLOGICAL AGENTS</designation>
                    <desc language="en-US">OTHER HEMATOLOGICAL AGENTS</desc>
                </concept>
                <concept code="B06AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Enzymes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Enzymes" type="fsn">Enzymes</designation>
                    <desc language="en-US">Enzymes</desc>
                </concept>
                <concept code="B06AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fibrinolysin and desoxyribonuclease"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fibrinolysin and desoxyribonuclease"
                         type="fsn">fibrinolysin and desoxyribonuclease</designation>
                    <desc language="en-US">fibrinolysin and desoxyribonuclease</desc>
                </concept>
                <concept code="B06AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hyaluronidase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hyaluronidase" type="fsn">hyaluronidase</designation>
                    <desc language="en-US">hyaluronidase</desc>
                </concept>
                <concept code="B06AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chymotrypsin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chymotrypsin" type="fsn">chymotrypsin</designation>
                    <desc language="en-US">chymotrypsin</desc>
                </concept>
                <concept code="B06AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trypsin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trypsin" type="fsn">trypsin</designation>
                    <desc language="en-US">trypsin</desc>
                </concept>
                <concept code="B06AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desoxyribonuclease"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desoxyribonuclease" type="fsn">desoxyribonuclease</designation>
                    <desc language="en-US">desoxyribonuclease</desc>
                </concept>
                <concept code="B06AA55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="streptokinase, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="streptokinase, combinations"
                         type="fsn">streptokinase, combinations</designation>
                    <desc language="en-US">streptokinase, combinations</desc>
                </concept>
                <concept code="B06AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other hem products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other hem products" type="fsn">Other hem products</designation>
                    <desc language="en-US">Other hem products</desc>
                </concept>
                <concept code="B06AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hematin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hematin" type="fsn">hematin</designation>
                    <desc language="en-US">hematin</desc>
                </concept>
                <concept code="B06AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs used in hereditary angioedema"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs used in hereditary angioedema"
                         type="fsn">Drugs used in hereditary angioedema</designation>
                    <desc language="en-US">Drugs used in hereditary angioedema</desc>
                </concept>
                <concept code="B06AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="c1-inhibitor, plasma derived"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="c1-inhibitor, plasma derived"
                         type="fsn">c1-inhibitor, plasma derived</designation>
                    <desc language="en-US">c1-inhibitor, plasma derived</desc>
                </concept>
                <concept code="B06AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="icatibant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="icatibant" type="fsn">icatibant</designation>
                    <desc language="en-US">icatibant</desc>
                </concept>
                <concept code="B06AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ecallantide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ecallantide" type="fsn">ecallantide</designation>
                    <desc language="en-US">ecallantide</desc>
                </concept>
                <concept code="B06AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="conestat alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="conestat alfa" type="fsn">conestat alfa</designation>
                    <desc language="en-US">conestat alfa</desc>
                </concept>
                <concept code="B06AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lanadelumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lanadelumab" type="fsn">lanadelumab</designation>
                    <desc language="en-US">lanadelumab</desc>
                </concept>
                <concept code="C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CARDIOVASCULAR SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CARDIOVASCULAR SYSTEM" type="fsn">CARDIOVASCULAR SYSTEM</designation>
                    <desc language="en-US">CARDIOVASCULAR SYSTEM</desc>
                </concept>
                <concept code="C01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CARDIAC THERAPY"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CARDIAC THERAPY" type="fsn">CARDIAC THERAPY</designation>
                    <desc language="en-US">CARDIAC THERAPY</desc>
                </concept>
                <concept code="C01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CARDIAC GLYCOSIDES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CARDIAC GLYCOSIDES" type="fsn">CARDIAC GLYCOSIDES</designation>
                    <desc language="en-US">CARDIAC GLYCOSIDES</desc>
                </concept>
                <concept code="C01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Digitalis glycosides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Digitalis glycosides" type="fsn">Digitalis glycosides</designation>
                    <desc language="en-US">Digitalis glycosides</desc>
                </concept>
                <concept code="C01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetyldigitoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetyldigitoxin" type="fsn">acetyldigitoxin</designation>
                    <desc language="en-US">acetyldigitoxin</desc>
                </concept>
                <concept code="C01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetyldigoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetyldigoxin" type="fsn">acetyldigoxin</designation>
                    <desc language="en-US">acetyldigoxin</desc>
                </concept>
                <concept code="C01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="digitalis leaves"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="digitalis leaves" type="fsn">digitalis leaves</designation>
                    <desc language="en-US">digitalis leaves</desc>
                </concept>
                <concept code="C01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="digitoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="digitoxin" type="fsn">digitoxin</designation>
                    <desc language="en-US">digitoxin</desc>
                </concept>
                <concept code="C01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="digoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="digoxin" type="fsn">digoxin</designation>
                    <desc language="en-US">digoxin</desc>
                </concept>
                <concept code="C01AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lanatoside C"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lanatoside C" type="fsn">lanatoside C</designation>
                    <desc language="en-US">lanatoside C</desc>
                </concept>
                <concept code="C01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deslanoside"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deslanoside" type="fsn">deslanoside</designation>
                    <desc language="en-US">deslanoside</desc>
                </concept>
                <concept code="C01AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metildigoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metildigoxin" type="fsn">metildigoxin</designation>
                    <desc language="en-US">metildigoxin</desc>
                </concept>
                <concept code="C01AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gitoformate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gitoformate" type="fsn">gitoformate</designation>
                    <desc language="en-US">gitoformate</desc>
                </concept>
                <concept code="C01AA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetyldigoxin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="acetyldigoxin, combinations"
                         type="fsn">acetyldigoxin, combinations</designation>
                    <desc language="en-US">acetyldigoxin, combinations</desc>
                </concept>
                <concept code="C01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Scilla glycosides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Scilla glycosides" type="fsn">Scilla glycosides</designation>
                    <desc language="en-US">Scilla glycosides</desc>
                </concept>
                <concept code="C01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proscillaridin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proscillaridin" type="fsn">proscillaridin</designation>
                    <desc language="en-US">proscillaridin</desc>
                </concept>
                <concept code="C01AB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proscillaridin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="proscillaridin, combinations"
                         type="fsn">proscillaridin, combinations</designation>
                    <desc language="en-US">proscillaridin, combinations</desc>
                </concept>
                <concept code="C01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Strophanthus glycosides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Strophanthus glycosides" type="fsn">Strophanthus glycosides</designation>
                    <desc language="en-US">Strophanthus glycosides</desc>
                </concept>
                <concept code="C01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="g-strophanthin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="g-strophanthin" type="fsn">g-strophanthin</designation>
                    <desc language="en-US">g-strophanthin</desc>
                </concept>
                <concept code="C01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cymarin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cymarin" type="fsn">cymarin</designation>
                    <desc language="en-US">cymarin</desc>
                </concept>
                <concept code="C01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cardiac glycosides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other cardiac glycosides" type="fsn">Other cardiac glycosides</designation>
                    <desc language="en-US">Other cardiac glycosides</desc>
                </concept>
                <concept code="C01AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="peruvoside"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="peruvoside" type="fsn">peruvoside</designation>
                    <desc language="en-US">peruvoside</desc>
                </concept>
                <concept code="C01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIARRHYTHMICS, CLASS I AND III"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIARRHYTHMICS, CLASS I AND III"
                         type="fsn">ANTIARRHYTHMICS, CLASS I AND III</designation>
                    <desc language="en-US">ANTIARRHYTHMICS, CLASS I AND III</desc>
                </concept>
                <concept code="C01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiarrhythmics, class Ia"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antiarrhythmics, class Ia" type="fsn">Antiarrhythmics, class Ia</designation>
                    <desc language="en-US">Antiarrhythmics, class Ia</desc>
                </concept>
                <concept code="C01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinidine" type="fsn">quinidine</designation>
                    <desc language="en-US">quinidine</desc>
                </concept>
                <concept code="C01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procainamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procainamide" type="fsn">procainamide</designation>
                    <desc language="en-US">procainamide</desc>
                </concept>
                <concept code="C01BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="disopyramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="disopyramide" type="fsn">disopyramide</designation>
                    <desc language="en-US">disopyramide</desc>
                </concept>
                <concept code="C01BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sparteine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sparteine" type="fsn">sparteine</designation>
                    <desc language="en-US">sparteine</desc>
                </concept>
                <concept code="C01BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ajmaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ajmaline" type="fsn">ajmaline</designation>
                    <desc language="en-US">ajmaline</desc>
                </concept>
                <concept code="C01BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prajmaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prajmaline" type="fsn">prajmaline</designation>
                    <desc language="en-US">prajmaline</desc>
                </concept>
                <concept code="C01BA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lorajmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lorajmine" type="fsn">lorajmine</designation>
                    <desc language="en-US">lorajmine</desc>
                </concept>
                <concept code="C01BA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroquinidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroquinidine" type="fsn">hydroquinidine</designation>
                    <desc language="en-US">hydroquinidine</desc>
                </concept>
                <concept code="C01BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinidine, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="quinidine, combinations excl. psycholeptics"
                         type="fsn">quinidine, combinations excl. psycholeptics</designation>
                    <desc language="en-US">quinidine, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="C01BA71"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinidine, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="quinidine, combinations with psycholeptics"
                         type="fsn">quinidine, combinations with psycholeptics</designation>
                    <desc language="en-US">quinidine, combinations with psycholeptics</desc>
                </concept>
                <concept code="C01BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiarrhythmics, class Ib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antiarrhythmics, class Ib" type="fsn">Antiarrhythmics, class Ib</designation>
                    <desc language="en-US">Antiarrhythmics, class Ib</desc>
                </concept>
                <concept code="C01BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidocaine" type="fsn">lidocaine</designation>
                    <desc language="en-US">lidocaine</desc>
                </concept>
                <concept code="C01BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mexiletine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mexiletine" type="fsn">mexiletine</designation>
                    <desc language="en-US">mexiletine</desc>
                </concept>
                <concept code="C01BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tocainide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tocainide" type="fsn">tocainide</designation>
                    <desc language="en-US">tocainide</desc>
                </concept>
                <concept code="C01BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aprindine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aprindine" type="fsn">aprindine</designation>
                    <desc language="en-US">aprindine</desc>
                </concept>
                <concept code="C01BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiarrhythmics, class Ic"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antiarrhythmics, class Ic" type="fsn">Antiarrhythmics, class Ic</designation>
                    <desc language="en-US">Antiarrhythmics, class Ic</desc>
                </concept>
                <concept code="C01BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propafenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propafenone" type="fsn">propafenone</designation>
                    <desc language="en-US">propafenone</desc>
                </concept>
                <concept code="C01BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flecainide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flecainide" type="fsn">flecainide</designation>
                    <desc language="en-US">flecainide</desc>
                </concept>
                <concept code="C01BC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lorcainide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lorcainide" type="fsn">lorcainide</designation>
                    <desc language="en-US">lorcainide</desc>
                </concept>
                <concept code="C01BC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="encainide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="encainide" type="fsn">encainide</designation>
                    <desc language="en-US">encainide</desc>
                </concept>
                <concept code="C01BC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethacizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethacizine" type="fsn">ethacizine</designation>
                    <desc language="en-US">ethacizine</desc>
                </concept>
                <concept code="C01BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiarrhythmics, class III"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiarrhythmics, class III"
                         type="fsn">Antiarrhythmics, class III</designation>
                    <desc language="en-US">Antiarrhythmics, class III</desc>
                </concept>
                <concept code="C01BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amiodarone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amiodarone" type="fsn">amiodarone</designation>
                    <desc language="en-US">amiodarone</desc>
                </concept>
                <concept code="C01BD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bretylium tosilate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bretylium tosilate" type="fsn">bretylium tosilate</designation>
                    <desc language="en-US">bretylium tosilate</desc>
                </concept>
                <concept code="C01BD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bunaftine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bunaftine" type="fsn">bunaftine</designation>
                    <desc language="en-US">bunaftine</desc>
                </concept>
                <concept code="C01BD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dofetilide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dofetilide" type="fsn">dofetilide</designation>
                    <desc language="en-US">dofetilide</desc>
                </concept>
                <concept code="C01BD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibutilide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibutilide" type="fsn">ibutilide</designation>
                    <desc language="en-US">ibutilide</desc>
                </concept>
                <concept code="C01BD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tedisamil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tedisamil" type="fsn">tedisamil</designation>
                    <desc language="en-US">tedisamil</desc>
                </concept>
                <concept code="C01BD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dronedarone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dronedarone" type="fsn">dronedarone</designation>
                    <desc language="en-US">dronedarone</desc>
                </concept>
                <concept code="C01BG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiarrhythmics, class I and III"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antiarrhythmics, class I and III"
                         type="fsn">Other antiarrhythmics, class I and III</designation>
                    <desc language="en-US">Other antiarrhythmics, class I and III</desc>
                </concept>
                <concept code="C01BG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moracizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moracizine" type="fsn">moracizine</designation>
                    <desc language="en-US">moracizine</desc>
                </concept>
                <concept code="C01BG07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cibenzoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cibenzoline" type="fsn">cibenzoline</designation>
                    <desc language="en-US">cibenzoline</desc>
                </concept>
                <concept code="C01BG11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vernakalant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vernakalant" type="fsn">vernakalant</designation>
                    <desc language="en-US">vernakalant</desc>
                </concept>
                <concept code="C01C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES"
                         type="fsn">CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES</designation>
                    <desc language="en-US">CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES</desc>
                </concept>
                <concept code="C01CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Adrenergic and dopaminergic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Adrenergic and dopaminergic agents"
                         type="fsn">Adrenergic and dopaminergic agents</designation>
                    <desc language="en-US">Adrenergic and dopaminergic agents</desc>
                </concept>
                <concept code="C01CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etilefrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etilefrine" type="fsn">etilefrine</designation>
                    <desc language="en-US">etilefrine</desc>
                </concept>
                <concept code="C01CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoprenaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoprenaline" type="fsn">isoprenaline</designation>
                    <desc language="en-US">isoprenaline</desc>
                </concept>
                <concept code="C01CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norepinephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norepinephrine" type="fsn">norepinephrine</designation>
                    <desc language="en-US">norepinephrine</desc>
                </concept>
                <concept code="C01CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dopamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dopamine" type="fsn">dopamine</designation>
                    <desc language="en-US">dopamine</desc>
                </concept>
                <concept code="C01CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norfenefrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norfenefrine" type="fsn">norfenefrine</designation>
                    <desc language="en-US">norfenefrine</desc>
                </concept>
                <concept code="C01CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylephrine" type="fsn">phenylephrine</designation>
                    <desc language="en-US">phenylephrine</desc>
                </concept>
                <concept code="C01CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dobutamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dobutamine" type="fsn">dobutamine</designation>
                    <desc language="en-US">dobutamine</desc>
                </concept>
                <concept code="C01CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxedrine" type="fsn">oxedrine</designation>
                    <desc language="en-US">oxedrine</desc>
                </concept>
                <concept code="C01CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metaraminol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metaraminol" type="fsn">metaraminol</designation>
                    <desc language="en-US">metaraminol</desc>
                </concept>
                <concept code="C01CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methoxamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methoxamine" type="fsn">methoxamine</designation>
                    <desc language="en-US">methoxamine</desc>
                </concept>
                <concept code="C01CA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mephentermine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mephentermine" type="fsn">mephentermine</designation>
                    <desc language="en-US">mephentermine</desc>
                </concept>
                <concept code="C01CA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimetofrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimetofrine" type="fsn">dimetofrine</designation>
                    <desc language="en-US">dimetofrine</desc>
                </concept>
                <concept code="C01CA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prenalterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prenalterol" type="fsn">prenalterol</designation>
                    <desc language="en-US">prenalterol</desc>
                </concept>
                <concept code="C01CA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dopexamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dopexamine" type="fsn">dopexamine</designation>
                    <desc language="en-US">dopexamine</desc>
                </concept>
                <concept code="C01CA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gepefrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gepefrine" type="fsn">gepefrine</designation>
                    <desc language="en-US">gepefrine</desc>
                </concept>
                <concept code="C01CA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibopamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibopamine" type="fsn">ibopamine</designation>
                    <desc language="en-US">ibopamine</desc>
                </concept>
                <concept code="C01CA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="midodrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="midodrine" type="fsn">midodrine</designation>
                    <desc language="en-US">midodrine</desc>
                </concept>
                <concept code="C01CA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="octopamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="octopamine" type="fsn">octopamine</designation>
                    <desc language="en-US">octopamine</desc>
                </concept>
                <concept code="C01CA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenoldopam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenoldopam" type="fsn">fenoldopam</designation>
                    <desc language="en-US">fenoldopam</desc>
                </concept>
                <concept code="C01CA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cafedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cafedrine" type="fsn">cafedrine</designation>
                    <desc language="en-US">cafedrine</desc>
                </concept>
                <concept code="C01CA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="arbutamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="arbutamine" type="fsn">arbutamine</designation>
                    <desc language="en-US">arbutamine</desc>
                </concept>
                <concept code="C01CA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="theodrenaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="theodrenaline" type="fsn">theodrenaline</designation>
                    <desc language="en-US">theodrenaline</desc>
                </concept>
                <concept code="C01CA24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinephrine" type="fsn">epinephrine</designation>
                    <desc language="en-US">epinephrine</desc>
                </concept>
                <concept code="C01CA25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amezinium metilsulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amezinium metilsulfate" type="fsn">amezinium metilsulfate</designation>
                    <desc language="en-US">amezinium metilsulfate</desc>
                </concept>
                <concept code="C01CA26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ephedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ephedrine" type="fsn">ephedrine</designation>
                    <desc language="en-US">ephedrine</desc>
                </concept>
                <concept code="C01CA27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="droxidopa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="droxidopa" type="fsn">droxidopa</designation>
                    <desc language="en-US">droxidopa</desc>
                </concept>
                <concept code="C01CA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="C01CA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etilefrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etilefrine, combinations" type="fsn">etilefrine, combinations</designation>
                    <desc language="en-US">etilefrine, combinations</desc>
                </concept>
                <concept code="C01CE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phosphodiesterase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Phosphodiesterase inhibitors"
                         type="fsn">Phosphodiesterase inhibitors</designation>
                    <desc language="en-US">Phosphodiesterase inhibitors</desc>
                </concept>
                <concept code="C01CE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amrinone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amrinone" type="fsn">amrinone</designation>
                    <desc language="en-US">amrinone</desc>
                </concept>
                <concept code="C01CE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="milrinone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="milrinone" type="fsn">milrinone</designation>
                    <desc language="en-US">milrinone</desc>
                </concept>
                <concept code="C01CE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enoximone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enoximone" type="fsn">enoximone</designation>
                    <desc language="en-US">enoximone</desc>
                </concept>
                <concept code="C01CE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bucladesine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bucladesine" type="fsn">bucladesine</designation>
                    <desc language="en-US">bucladesine</desc>
                </concept>
                <concept code="C01CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cardiac stimulants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other cardiac stimulants" type="fsn">Other cardiac stimulants</designation>
                    <desc language="en-US">Other cardiac stimulants</desc>
                </concept>
                <concept code="C01CX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="angiotensinamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="angiotensinamide" type="fsn">angiotensinamide</designation>
                    <desc language="en-US">angiotensinamide</desc>
                </concept>
                <concept code="C01CX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xamoterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xamoterol" type="fsn">xamoterol</designation>
                    <desc language="en-US">xamoterol</desc>
                </concept>
                <concept code="C01CX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levosimendan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levosimendan" type="fsn">levosimendan</designation>
                    <desc language="en-US">levosimendan</desc>
                </concept>
                <concept code="C01CX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="angiotensin II"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="angiotensin II" type="fsn">angiotensin II</designation>
                    <desc language="en-US">angiotensin II</desc>
                </concept>
                <concept code="C01D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VASODILATORS USED IN CARDIAC DISEASES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="VASODILATORS USED IN CARDIAC DISEASES"
                         type="fsn">VASODILATORS USED IN CARDIAC DISEASES</designation>
                    <desc language="en-US">VASODILATORS USED IN CARDIAC DISEASES</desc>
                </concept>
                <concept code="C01DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Organic nitrates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Organic nitrates" type="fsn">Organic nitrates</designation>
                    <desc language="en-US">Organic nitrates</desc>
                </concept>
                <concept code="C01DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glyceryl trinitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glyceryl trinitrate" type="fsn">glyceryl trinitrate</designation>
                    <desc language="en-US">glyceryl trinitrate</desc>
                </concept>
                <concept code="C01DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylpropylpropanediol dinitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylpropylpropanediol dinitrate"
                         type="fsn">methylpropylpropanediol dinitrate</designation>
                    <desc language="en-US">methylpropylpropanediol dinitrate</desc>
                </concept>
                <concept code="C01DA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentaerithrityl tetranitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pentaerithrityl tetranitrate"
                         type="fsn">pentaerithrityl tetranitrate</designation>
                    <desc language="en-US">pentaerithrityl tetranitrate</desc>
                </concept>
                <concept code="C01DA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propatylnitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propatylnitrate" type="fsn">propatylnitrate</designation>
                    <desc language="en-US">propatylnitrate</desc>
                </concept>
                <concept code="C01DA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isosorbide dinitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isosorbide dinitrate" type="fsn">isosorbide dinitrate</designation>
                    <desc language="en-US">isosorbide dinitrate</desc>
                </concept>
                <concept code="C01DA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trolnitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trolnitrate" type="fsn">trolnitrate</designation>
                    <desc language="en-US">trolnitrate</desc>
                </concept>
                <concept code="C01DA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eritrityl tetranitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eritrityl tetranitrate" type="fsn">eritrityl tetranitrate</designation>
                    <desc language="en-US">eritrityl tetranitrate</desc>
                </concept>
                <concept code="C01DA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isosorbide mononitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isosorbide mononitrate" type="fsn">isosorbide mononitrate</designation>
                    <desc language="en-US">isosorbide mononitrate</desc>
                </concept>
                <concept code="C01DA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="organic nitrates in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="organic nitrates in combination"
                         type="fsn">organic nitrates in combination</designation>
                    <desc language="en-US">organic nitrates in combination</desc>
                </concept>
                <concept code="C01DA38"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tenitramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tenitramine" type="fsn">tenitramine</designation>
                    <desc language="en-US">tenitramine</desc>
                </concept>
                <concept code="C01DA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glyceryl trinitrate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="glyceryl trinitrate, combinations"
                         type="fsn">glyceryl trinitrate, combinations</designation>
                    <desc language="en-US">glyceryl trinitrate, combinations</desc>
                </concept>
                <concept code="C01DA54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylpropylpropanediol dinitrate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylpropylpropanediol dinitrate, combinations"
                         type="fsn">methylpropylpropanediol dinitrate, combinations</designation>
                    <desc language="en-US">methylpropylpropanediol dinitrate, combinations</desc>
                </concept>
                <concept code="C01DA55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentaerithrityl tetranitrate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pentaerithrityl tetranitrate, combinations"
                         type="fsn">pentaerithrityl tetranitrate, combinations</designation>
                    <desc language="en-US">pentaerithrityl tetranitrate, combinations</desc>
                </concept>
                <concept code="C01DA57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propatylnitrate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="propatylnitrate, combinations"
                         type="fsn">propatylnitrate, combinations</designation>
                    <desc language="en-US">propatylnitrate, combinations</desc>
                </concept>
                <concept code="C01DA58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isosorbide dinitrate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="isosorbide dinitrate, combinations"
                         type="fsn">isosorbide dinitrate, combinations</designation>
                    <desc language="en-US">isosorbide dinitrate, combinations</desc>
                </concept>
                <concept code="C01DA59"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trolnitrate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trolnitrate, combinations" type="fsn">trolnitrate, combinations</designation>
                    <desc language="en-US">trolnitrate, combinations</desc>
                </concept>
                <concept code="C01DA63"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eritrityl tetranitrate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="eritrityl tetranitrate, combinations"
                         type="fsn">eritrityl tetranitrate, combinations</designation>
                    <desc language="en-US">eritrityl tetranitrate, combinations</desc>
                </concept>
                <concept code="C01DA70"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="organic nitrates in combination with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="organic nitrates in combination with psycholeptics"
                         type="fsn">organic nitrates in combination with psycholeptics</designation>
                    <desc language="en-US">organic nitrates in combination with psycholeptics</desc>
                </concept>
                <concept code="C01DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Quinolone vasodilators"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Quinolone vasodilators" type="fsn">Quinolone vasodilators</designation>
                    <desc language="en-US">Quinolone vasodilators</desc>
                </concept>
                <concept code="C01DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flosequinan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flosequinan" type="fsn">flosequinan</designation>
                    <desc language="en-US">flosequinan</desc>
                </concept>
                <concept code="C01DX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other vasodilators used in cardiac diseases"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other vasodilators used in cardiac diseases"
                         type="fsn">Other vasodilators used in cardiac diseases</designation>
                    <desc language="en-US">Other vasodilators used in cardiac diseases</desc>
                </concept>
                <concept code="C01DX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="itramin tosilate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="itramin tosilate" type="fsn">itramin tosilate</designation>
                    <desc language="en-US">itramin tosilate</desc>
                </concept>
                <concept code="C01DX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prenylamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prenylamine" type="fsn">prenylamine</designation>
                    <desc language="en-US">prenylamine</desc>
                </concept>
                <concept code="C01DX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyfedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyfedrine" type="fsn">oxyfedrine</designation>
                    <desc language="en-US">oxyfedrine</desc>
                </concept>
                <concept code="C01DX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benziodarone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benziodarone" type="fsn">benziodarone</designation>
                    <desc language="en-US">benziodarone</desc>
                </concept>
                <concept code="C01DX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbocromen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbocromen" type="fsn">carbocromen</designation>
                    <desc language="en-US">carbocromen</desc>
                </concept>
                <concept code="C01DX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexobendine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexobendine" type="fsn">hexobendine</designation>
                    <desc language="en-US">hexobendine</desc>
                </concept>
                <concept code="C01DX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etafenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etafenone" type="fsn">etafenone</designation>
                    <desc language="en-US">etafenone</desc>
                </concept>
                <concept code="C01DX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="heptaminol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="heptaminol" type="fsn">heptaminol</designation>
                    <desc language="en-US">heptaminol</desc>
                </concept>
                <concept code="C01DX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imolamine" type="fsn">imolamine</designation>
                    <desc language="en-US">imolamine</desc>
                </concept>
                <concept code="C01DX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dilazep"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dilazep" type="fsn">dilazep</designation>
                    <desc language="en-US">dilazep</desc>
                </concept>
                <concept code="C01DX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trapidil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trapidil" type="fsn">trapidil</designation>
                    <desc language="en-US">trapidil</desc>
                </concept>
                <concept code="C01DX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="molsidomine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="molsidomine" type="fsn">molsidomine</designation>
                    <desc language="en-US">molsidomine</desc>
                </concept>
                <concept code="C01DX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="efloxate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="efloxate" type="fsn">efloxate</designation>
                    <desc language="en-US">efloxate</desc>
                </concept>
                <concept code="C01DX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinepazet"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinepazet" type="fsn">cinepazet</designation>
                    <desc language="en-US">cinepazet</desc>
                </concept>
                <concept code="C01DX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cloridarol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cloridarol" type="fsn">cloridarol</designation>
                    <desc language="en-US">cloridarol</desc>
                </concept>
                <concept code="C01DX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicorandil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicorandil" type="fsn">nicorandil</designation>
                    <desc language="en-US">nicorandil</desc>
                </concept>
                <concept code="C01DX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="linsidomine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="linsidomine" type="fsn">linsidomine</designation>
                    <desc language="en-US">linsidomine</desc>
                </concept>
                <concept code="C01DX19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nesiritide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nesiritide" type="fsn">nesiritide</designation>
                    <desc language="en-US">nesiritide</desc>
                </concept>
                <concept code="C01DX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="serelaxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="serelaxin" type="fsn">serelaxin</designation>
                    <desc language="en-US">serelaxin</desc>
                </concept>
                <concept code="C01DX51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="itramin tosilate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="itramin tosilate, combinations"
                         type="fsn">itramin tosilate, combinations</designation>
                    <desc language="en-US">itramin tosilate, combinations</desc>
                </concept>
                <concept code="C01DX52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prenylamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prenylamine, combinations" type="fsn">prenylamine, combinations</designation>
                    <desc language="en-US">prenylamine, combinations</desc>
                </concept>
                <concept code="C01DX53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyfedrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyfedrine, combinations" type="fsn">oxyfedrine, combinations</designation>
                    <desc language="en-US">oxyfedrine, combinations</desc>
                </concept>
                <concept code="C01DX54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benziodarone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="benziodarone, combinations"
                         type="fsn">benziodarone, combinations</designation>
                    <desc language="en-US">benziodarone, combinations</desc>
                </concept>
                <concept code="C01E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER CARDIAC PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER CARDIAC PREPARATIONS"
                         type="fsn">OTHER CARDIAC PREPARATIONS</designation>
                    <desc language="en-US">OTHER CARDIAC PREPARATIONS</desc>
                </concept>
                <concept code="C01EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Prostaglandins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Prostaglandins" type="fsn">Prostaglandins</designation>
                    <desc language="en-US">Prostaglandins</desc>
                </concept>
                <concept code="C01EA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alprostadil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alprostadil" type="fsn">alprostadil</designation>
                    <desc language="en-US">alprostadil</desc>
                </concept>
                <concept code="C01EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cardiac preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other cardiac preparations"
                         type="fsn">Other cardiac preparations</designation>
                    <desc language="en-US">Other cardiac preparations</desc>
                </concept>
                <concept code="C01EB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="camphora"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="camphora" type="fsn">camphora</designation>
                    <desc language="en-US">camphora</desc>
                </concept>
                <concept code="C01EB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indometacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indometacin" type="fsn">indometacin</designation>
                    <desc language="en-US">indometacin</desc>
                </concept>
                <concept code="C01EB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="crataegus glycosides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="crataegus glycosides" type="fsn">crataegus glycosides</designation>
                    <desc language="en-US">crataegus glycosides</desc>
                </concept>
                <concept code="C01EB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="creatinolfosfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="creatinolfosfate" type="fsn">creatinolfosfate</designation>
                    <desc language="en-US">creatinolfosfate</desc>
                </concept>
                <concept code="C01EB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fosfocreatine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fosfocreatine" type="fsn">fosfocreatine</designation>
                    <desc language="en-US">fosfocreatine</desc>
                </concept>
                <concept code="C01EB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fructose 1,6-diphosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fructose 1,6-diphosphate" type="fsn">fructose 1,6-diphosphate</designation>
                    <desc language="en-US">fructose 1,6-diphosphate</desc>
                </concept>
                <concept code="C01EB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ubidecarenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ubidecarenone" type="fsn">ubidecarenone</designation>
                    <desc language="en-US">ubidecarenone</desc>
                </concept>
                <concept code="C01EB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adenosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adenosine" type="fsn">adenosine</designation>
                    <desc language="en-US">adenosine</desc>
                </concept>
                <concept code="C01EB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiracizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiracizine" type="fsn">tiracizine</designation>
                    <desc language="en-US">tiracizine</desc>
                </concept>
                <concept code="C01EB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acadesine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acadesine" type="fsn">acadesine</designation>
                    <desc language="en-US">acadesine</desc>
                </concept>
                <concept code="C01EB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimetazidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimetazidine" type="fsn">trimetazidine</designation>
                    <desc language="en-US">trimetazidine</desc>
                </concept>
                <concept code="C01EB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibuprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibuprofen" type="fsn">ibuprofen</designation>
                    <desc language="en-US">ibuprofen</desc>
                </concept>
                <concept code="C01EB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ivabradine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ivabradine" type="fsn">ivabradine</designation>
                    <desc language="en-US">ivabradine</desc>
                </concept>
                <concept code="C01EB18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ranolazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ranolazine" type="fsn">ranolazine</designation>
                    <desc language="en-US">ranolazine</desc>
                </concept>
                <concept code="C01EB21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="regadenoson"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="regadenoson" type="fsn">regadenoson</designation>
                    <desc language="en-US">regadenoson</desc>
                </concept>
                <concept code="C01EB22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meldonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meldonium" type="fsn">meldonium</designation>
                    <desc language="en-US">meldonium</desc>
                </concept>
                <concept code="C01EB23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiazotic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiazotic acid" type="fsn">tiazotic acid</designation>
                    <desc language="en-US">tiazotic acid</desc>
                </concept>
                <concept code="C01EX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cardiac combination products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other cardiac combination products"
                         type="fsn">Other cardiac combination products</designation>
                    <desc language="en-US">Other cardiac combination products</desc>
                </concept>
                <concept code="C02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIHYPERTENSIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIHYPERTENSIVES" type="fsn">ANTIHYPERTENSIVES</designation>
                    <desc language="en-US">ANTIHYPERTENSIVES</desc>
                </concept>
                <concept code="C02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIADRENERGIC AGENTS, CENTRALLY ACTING"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIADRENERGIC AGENTS, CENTRALLY ACTING"
                         type="fsn">ANTIADRENERGIC AGENTS, CENTRALLY ACTING</designation>
                    <desc language="en-US">ANTIADRENERGIC AGENTS, CENTRALLY ACTING</desc>
                </concept>
                <concept code="C02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Rauwolfia alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Rauwolfia alkaloids" type="fsn">Rauwolfia alkaloids</designation>
                    <desc language="en-US">Rauwolfia alkaloids</desc>
                </concept>
                <concept code="C02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rescinnamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rescinnamine" type="fsn">rescinnamine</designation>
                    <desc language="en-US">rescinnamine</desc>
                </concept>
                <concept code="C02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reserpine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reserpine" type="fsn">reserpine</designation>
                    <desc language="en-US">reserpine</desc>
                </concept>
                <concept code="C02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of rauwolfia alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of rauwolfia alkaloids"
                         type="fsn">combinations of rauwolfia alkaloids</designation>
                    <desc language="en-US">combinations of rauwolfia alkaloids</desc>
                </concept>
                <concept code="C02AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rauwolfia alkaloids, whole root"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rauwolfia alkaloids, whole root"
                         type="fsn">rauwolfia alkaloids, whole root</designation>
                    <desc language="en-US">rauwolfia alkaloids, whole root</desc>
                </concept>
                <concept code="C02AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deserpidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deserpidine" type="fsn">deserpidine</designation>
                    <desc language="en-US">deserpidine</desc>
                </concept>
                <concept code="C02AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methoserpidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methoserpidine" type="fsn">methoserpidine</designation>
                    <desc language="en-US">methoserpidine</desc>
                </concept>
                <concept code="C02AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bietaserpine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bietaserpine" type="fsn">bietaserpine</designation>
                    <desc language="en-US">bietaserpine</desc>
                </concept>
                <concept code="C02AA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reserpine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reserpine, combinations" type="fsn">reserpine, combinations</designation>
                    <desc language="en-US">reserpine, combinations</desc>
                </concept>
                <concept code="C02AA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of rauwolfia alkoloids, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of rauwolfia alkoloids, combinations"
                         type="fsn">combinations of rauwolfia alkoloids, combinations</designation>
                    <desc language="en-US">combinations of rauwolfia alkoloids, combinations</desc>
                </concept>
                <concept code="C02AA57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bietaserpine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bietaserpine, combinations"
                         type="fsn">bietaserpine, combinations</designation>
                    <desc language="en-US">bietaserpine, combinations</desc>
                </concept>
                <concept code="C02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Methyldopa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Methyldopa" type="fsn">Methyldopa</designation>
                    <desc language="en-US">Methyldopa</desc>
                </concept>
                <concept code="C02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyldopa (levorotatory)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methyldopa (levorotatory)" type="fsn">methyldopa (levorotatory)</designation>
                    <desc language="en-US">methyldopa (levorotatory)</desc>
                </concept>
                <concept code="C02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyldopa (racemic)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methyldopa (racemic)" type="fsn">methyldopa (racemic)</designation>
                    <desc language="en-US">methyldopa (racemic)</desc>
                </concept>
                <concept code="C02AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazoline receptor agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Imidazoline receptor agonists"
                         type="fsn">Imidazoline receptor agonists</designation>
                    <desc language="en-US">Imidazoline receptor agonists</desc>
                </concept>
                <concept code="C02AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clonidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clonidine" type="fsn">clonidine</designation>
                    <desc language="en-US">clonidine</desc>
                </concept>
                <concept code="C02AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guanfacine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guanfacine" type="fsn">guanfacine</designation>
                    <desc language="en-US">guanfacine</desc>
                </concept>
                <concept code="C02AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolonidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolonidine" type="fsn">tolonidine</designation>
                    <desc language="en-US">tolonidine</desc>
                </concept>
                <concept code="C02AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moxonidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moxonidine" type="fsn">moxonidine</designation>
                    <desc language="en-US">moxonidine</desc>
                </concept>
                <concept code="C02AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rilmenidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rilmenidine" type="fsn">rilmenidine</designation>
                    <desc language="en-US">rilmenidine</desc>
                </concept>
                <concept code="C02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIADRENERGIC AGENTS, GANGLION-BLOCKING"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIADRENERGIC AGENTS, GANGLION-BLOCKING"
                         type="fsn">ANTIADRENERGIC AGENTS, GANGLION-BLOCKING</designation>
                    <desc language="en-US">ANTIADRENERGIC AGENTS, GANGLION-BLOCKING</desc>
                </concept>
                <concept code="C02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonium derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sulfonium derivatives" type="fsn">Sulfonium derivatives</designation>
                    <desc language="en-US">Sulfonium derivatives</desc>
                </concept>
                <concept code="C02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimetaphan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimetaphan" type="fsn">trimetaphan</designation>
                    <desc language="en-US">trimetaphan</desc>
                </concept>
                <concept code="C02BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Secondary and tertiary amines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Secondary and tertiary amines"
                         type="fsn">Secondary and tertiary amines</designation>
                    <desc language="en-US">Secondary and tertiary amines</desc>
                </concept>
                <concept code="C02BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mecamylamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mecamylamine" type="fsn">mecamylamine</designation>
                    <desc language="en-US">mecamylamine</desc>
                </concept>
                <concept code="C02BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bisquaternary ammonium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Bisquaternary ammonium compounds"
                         type="fsn">Bisquaternary ammonium compounds</designation>
                    <desc language="en-US">Bisquaternary ammonium compounds</desc>
                </concept>
                <concept code="C02C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING"
                         type="fsn">ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING</designation>
                    <desc language="en-US">ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING</desc>
                </concept>
                <concept code="C02CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha-adrenoreceptor antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha-adrenoreceptor antagonists"
                         type="fsn">Alpha-adrenoreceptor antagonists</designation>
                    <desc language="en-US">Alpha-adrenoreceptor antagonists</desc>
                </concept>
                <concept code="C02CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prazosin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prazosin" type="fsn">prazosin</designation>
                    <desc language="en-US">prazosin</desc>
                </concept>
                <concept code="C02CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indoramin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indoramin" type="fsn">indoramin</designation>
                    <desc language="en-US">indoramin</desc>
                </concept>
                <concept code="C02CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimazosin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimazosin" type="fsn">trimazosin</designation>
                    <desc language="en-US">trimazosin</desc>
                </concept>
                <concept code="C02CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxazosin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxazosin" type="fsn">doxazosin</designation>
                    <desc language="en-US">doxazosin</desc>
                </concept>
                <concept code="C02CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="urapidil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="urapidil" type="fsn">urapidil</designation>
                    <desc language="en-US">urapidil</desc>
                </concept>
                <concept code="C02CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Guanidine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Guanidine derivatives" type="fsn">Guanidine derivatives</designation>
                    <desc language="en-US">Guanidine derivatives</desc>
                </concept>
                <concept code="C02CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betanidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betanidine" type="fsn">betanidine</designation>
                    <desc language="en-US">betanidine</desc>
                </concept>
                <concept code="C02CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guanethidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guanethidine" type="fsn">guanethidine</designation>
                    <desc language="en-US">guanethidine</desc>
                </concept>
                <concept code="C02CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guanoxan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guanoxan" type="fsn">guanoxan</designation>
                    <desc language="en-US">guanoxan</desc>
                </concept>
                <concept code="C02CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="debrisoquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="debrisoquine" type="fsn">debrisoquine</designation>
                    <desc language="en-US">debrisoquine</desc>
                </concept>
                <concept code="C02CC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guanoclor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guanoclor" type="fsn">guanoclor</designation>
                    <desc language="en-US">guanoclor</desc>
                </concept>
                <concept code="C02CC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guanazodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guanazodine" type="fsn">guanazodine</designation>
                    <desc language="en-US">guanazodine</desc>
                </concept>
                <concept code="C02CC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guanoxabenz"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guanoxabenz" type="fsn">guanoxabenz</designation>
                    <desc language="en-US">guanoxabenz</desc>
                </concept>
                <concept code="C02D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON"
                         type="fsn">ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON</designation>
                    <desc language="en-US">ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON</desc>
                </concept>
                <concept code="C02DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiazide derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thiazide derivatives" type="fsn">Thiazide derivatives</designation>
                    <desc language="en-US">Thiazide derivatives</desc>
                </concept>
                <concept code="C02DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diazoxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diazoxide" type="fsn">diazoxide</designation>
                    <desc language="en-US">diazoxide</desc>
                </concept>
                <concept code="C02DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hydrazinophthalazine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Hydrazinophthalazine derivatives"
                         type="fsn">Hydrazinophthalazine derivatives</designation>
                    <desc language="en-US">Hydrazinophthalazine derivatives</desc>
                </concept>
                <concept code="C02DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydralazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dihydralazine" type="fsn">dihydralazine</designation>
                    <desc language="en-US">dihydralazine</desc>
                </concept>
                <concept code="C02DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydralazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydralazine" type="fsn">hydralazine</designation>
                    <desc language="en-US">hydralazine</desc>
                </concept>
                <concept code="C02DB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="endralazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="endralazine" type="fsn">endralazine</designation>
                    <desc language="en-US">endralazine</desc>
                </concept>
                <concept code="C02DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cadralazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cadralazine" type="fsn">cadralazine</designation>
                    <desc language="en-US">cadralazine</desc>
                </concept>
                <concept code="C02DC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pyrimidine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pyrimidine derivatives" type="fsn">Pyrimidine derivatives</designation>
                    <desc language="en-US">Pyrimidine derivatives</desc>
                </concept>
                <concept code="C02DC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="minoxidil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="minoxidil" type="fsn">minoxidil</designation>
                    <desc language="en-US">minoxidil</desc>
                </concept>
                <concept code="C02DD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nitroferricyanide derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nitroferricyanide derivatives"
                         type="fsn">Nitroferricyanide derivatives</designation>
                    <desc language="en-US">Nitroferricyanide derivatives</desc>
                </concept>
                <concept code="C02DD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitroprusside"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitroprusside" type="fsn">nitroprusside</designation>
                    <desc language="en-US">nitroprusside</desc>
                </concept>
                <concept code="C02DG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Guanidine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Guanidine derivatives" type="fsn">Guanidine derivatives</designation>
                    <desc language="en-US">Guanidine derivatives</desc>
                </concept>
                <concept code="C02DG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pinacidil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pinacidil" type="fsn">pinacidil</designation>
                    <desc language="en-US">pinacidil</desc>
                </concept>
                <concept code="C02K"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ANTIHYPERTENSIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER ANTIHYPERTENSIVES" type="fsn">OTHER ANTIHYPERTENSIVES</designation>
                    <desc language="en-US">OTHER ANTIHYPERTENSIVES</desc>
                </concept>
                <concept code="C02KA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alkaloids, excl. rauwolfia"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alkaloids, excl. rauwolfia"
                         type="fsn">Alkaloids, excl. rauwolfia</designation>
                    <desc language="en-US">Alkaloids, excl. rauwolfia</desc>
                </concept>
                <concept code="C02KA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="veratrum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="veratrum" type="fsn">veratrum</designation>
                    <desc language="en-US">veratrum</desc>
                </concept>
                <concept code="C02KB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tyrosine hydroxylase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tyrosine hydroxylase inhibitors"
                         type="fsn">Tyrosine hydroxylase inhibitors</designation>
                    <desc language="en-US">Tyrosine hydroxylase inhibitors</desc>
                </concept>
                <concept code="C02KB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metirosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metirosine" type="fsn">metirosine</designation>
                    <desc language="en-US">metirosine</desc>
                </concept>
                <concept code="C02KC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MAO inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="MAO inhibitors" type="fsn">MAO inhibitors</designation>
                    <desc language="en-US">MAO inhibitors</desc>
                </concept>
                <concept code="C02KC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pargyline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pargyline" type="fsn">pargyline</designation>
                    <desc language="en-US">pargyline</desc>
                </concept>
                <concept code="C02KD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Serotonin antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Serotonin antagonists" type="fsn">Serotonin antagonists</designation>
                    <desc language="en-US">Serotonin antagonists</desc>
                </concept>
                <concept code="C02KD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketanserin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketanserin" type="fsn">ketanserin</designation>
                    <desc language="en-US">ketanserin</desc>
                </concept>
                <concept code="C02KX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antihypertensives for pulmonary arterial hypertension"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antihypertensives for pulmonary arterial hypertension"
                         type="fsn">Antihypertensives for pulmonary arterial hypertension</designation>
                    <desc language="en-US">Antihypertensives for pulmonary arterial hypertension</desc>
                </concept>
                <concept code="C02KX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bosentan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bosentan" type="fsn">bosentan</designation>
                    <desc language="en-US">bosentan</desc>
                </concept>
                <concept code="C02KX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ambrisentan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ambrisentan" type="fsn">ambrisentan</designation>
                    <desc language="en-US">ambrisentan</desc>
                </concept>
                <concept code="C02KX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sitaxentan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sitaxentan" type="fsn">sitaxentan</designation>
                    <desc language="en-US">sitaxentan</desc>
                </concept>
                <concept code="C02KX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="macitentan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="macitentan" type="fsn">macitentan</designation>
                    <desc language="en-US">macitentan</desc>
                </concept>
                <concept code="C02KX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="riociguat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="riociguat" type="fsn">riociguat</designation>
                    <desc language="en-US">riociguat</desc>
                </concept>
                <concept code="C02KX52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ambrisentan and tadalafil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ambrisentan and tadalafil" type="fsn">ambrisentan and tadalafil</designation>
                    <desc language="en-US">ambrisentan and tadalafil</desc>
                </concept>
                <concept code="C02L"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION"
                         type="fsn">ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION</designation>
                    <desc language="en-US">ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION</desc>
                </concept>
                <concept code="C02LA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Rauwolfia alkaloids and diuretics in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Rauwolfia alkaloids and diuretics in combination"
                         type="fsn">Rauwolfia alkaloids and diuretics in combination</designation>
                    <desc language="en-US">Rauwolfia alkaloids and diuretics in combination</desc>
                </concept>
                <concept code="C02LA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reserpine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reserpine and diuretics" type="fsn">reserpine and diuretics</designation>
                    <desc language="en-US">reserpine and diuretics</desc>
                </concept>
                <concept code="C02LA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rescinnamine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rescinnamine and diuretics"
                         type="fsn">rescinnamine and diuretics</designation>
                    <desc language="en-US">rescinnamine and diuretics</desc>
                </concept>
                <concept code="C02LA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deserpidine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deserpidine and diuretics" type="fsn">deserpidine and diuretics</designation>
                    <desc language="en-US">deserpidine and diuretics</desc>
                </concept>
                <concept code="C02LA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methoserpidine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methoserpidine and diuretics"
                         type="fsn">methoserpidine and diuretics</designation>
                    <desc language="en-US">methoserpidine and diuretics</desc>
                </concept>
                <concept code="C02LA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bietaserpine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bietaserpine and diuretics"
                         type="fsn">bietaserpine and diuretics</designation>
                    <desc language="en-US">bietaserpine and diuretics</desc>
                </concept>
                <concept code="C02LA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rauwolfia alkaloids, whole root and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rauwolfia alkaloids, whole root and diuretics"
                         type="fsn">rauwolfia alkaloids, whole root and diuretics</designation>
                    <desc language="en-US">rauwolfia alkaloids, whole root and diuretics</desc>
                </concept>
                <concept code="C02LA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="syrosingopine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="syrosingopine and diuretics"
                         type="fsn">syrosingopine and diuretics</designation>
                    <desc language="en-US">syrosingopine and diuretics</desc>
                </concept>
                <concept code="C02LA50"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combination of rauwolfia alkaloids and diuretics incl. other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combination of rauwolfia alkaloids and diuretics incl. other combinations"
                         type="fsn">combination of rauwolfia alkaloids and diuretics incl. other combinations</designation>
                    <desc language="en-US">combination of rauwolfia alkaloids and diuretics incl. other combinations</desc>
                </concept>
                <concept code="C02LA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reserpine and diuretics, combinations with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="reserpine and diuretics, combinations with other drugs"
                         type="fsn">reserpine and diuretics, combinations with other drugs</designation>
                    <desc language="en-US">reserpine and diuretics, combinations with other drugs</desc>
                </concept>
                <concept code="C02LA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rescinnamine and diuretics, combinations with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rescinnamine and diuretics, combinations with other drugs"
                         type="fsn">rescinnamine and diuretics, combinations with other drugs</designation>
                    <desc language="en-US">rescinnamine and diuretics, combinations with other drugs</desc>
                </concept>
                <concept code="C02LA71"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reserpine and diuretics, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="reserpine and diuretics, combinations with psycholeptics"
                         type="fsn">reserpine and diuretics, combinations with psycholeptics</designation>
                    <desc language="en-US">reserpine and diuretics, combinations with psycholeptics</desc>
                </concept>
                <concept code="C02LB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Methyldopa and diuretics in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Methyldopa and diuretics in combination"
                         type="fsn">Methyldopa and diuretics in combination</designation>
                    <desc language="en-US">Methyldopa and diuretics in combination</desc>
                </concept>
                <concept code="C02LB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyldopa (levorotatory) and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methyldopa (levorotatory) and diuretics"
                         type="fsn">methyldopa (levorotatory) and diuretics</designation>
                    <desc language="en-US">methyldopa (levorotatory) and diuretics</desc>
                </concept>
                <concept code="C02LC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazoline receptor agonists in combination with diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Imidazoline receptor agonists in combination with diuretics"
                         type="fsn">Imidazoline receptor agonists in combination with diuretics</designation>
                    <desc language="en-US">Imidazoline receptor agonists in combination with diuretics</desc>
                </concept>
                <concept code="C02LC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clonidine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clonidine and diuretics" type="fsn">clonidine and diuretics</designation>
                    <desc language="en-US">clonidine and diuretics</desc>
                </concept>
                <concept code="C02LC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moxonidine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moxonidine and diuretics" type="fsn">moxonidine and diuretics</designation>
                    <desc language="en-US">moxonidine and diuretics</desc>
                </concept>
                <concept code="C02LC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clonidine and diuretics, combinations with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="clonidine and diuretics, combinations with other drugs"
                         type="fsn">clonidine and diuretics, combinations with other drugs</designation>
                    <desc language="en-US">clonidine and diuretics, combinations with other drugs</desc>
                </concept>
                <concept code="C02LE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha-adrenoreceptor antagonists and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha-adrenoreceptor antagonists and diuretics"
                         type="fsn">Alpha-adrenoreceptor antagonists and diuretics</designation>
                    <desc language="en-US">Alpha-adrenoreceptor antagonists and diuretics</desc>
                </concept>
                <concept code="C02LE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prazosin and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prazosin and diuretics" type="fsn">prazosin and diuretics</designation>
                    <desc language="en-US">prazosin and diuretics</desc>
                </concept>
                <concept code="C02LF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Guanidine derivatives and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Guanidine derivatives and diuretics"
                         type="fsn">Guanidine derivatives and diuretics</designation>
                    <desc language="en-US">Guanidine derivatives and diuretics</desc>
                </concept>
                <concept code="C02LF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guanethidine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="guanethidine and diuretics"
                         type="fsn">guanethidine and diuretics</designation>
                    <desc language="en-US">guanethidine and diuretics</desc>
                </concept>
                <concept code="C02LG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hydrazinophthalazine derivatives and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Hydrazinophthalazine derivatives and diuretics"
                         type="fsn">Hydrazinophthalazine derivatives and diuretics</designation>
                    <desc language="en-US">Hydrazinophthalazine derivatives and diuretics</desc>
                </concept>
                <concept code="C02LG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydralazine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydralazine and diuretics"
                         type="fsn">dihydralazine and diuretics</designation>
                    <desc language="en-US">dihydralazine and diuretics</desc>
                </concept>
                <concept code="C02LG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydralazine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydralazine and diuretics" type="fsn">hydralazine and diuretics</designation>
                    <desc language="en-US">hydralazine and diuretics</desc>
                </concept>
                <concept code="C02LG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="picodralazine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="picodralazine and diuretics"
                         type="fsn">picodralazine and diuretics</designation>
                    <desc language="en-US">picodralazine and diuretics</desc>
                </concept>
                <concept code="C02LG51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydralazine and diuretics, combinations with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydralazine and diuretics, combinations with other drugs"
                         type="fsn">dihydralazine and diuretics, combinations with other drugs</designation>
                    <desc language="en-US">dihydralazine and diuretics, combinations with other drugs</desc>
                </concept>
                <concept code="C02LG73"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="picodralazine and diuretics, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="picodralazine and diuretics, combinations with psycholeptics"
                         type="fsn">picodralazine and diuretics, combinations with psycholeptics</designation>
                    <desc language="en-US">picodralazine and diuretics, combinations with psycholeptics</desc>
                </concept>
                <concept code="C02LK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alkaloids, excl. rauwolfia, in combination with diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alkaloids, excl. rauwolfia, in combination with diuretics"
                         type="fsn">Alkaloids, excl. rauwolfia, in combination with diuretics</designation>
                    <desc language="en-US">Alkaloids, excl. rauwolfia, in combination with diuretics</desc>
                </concept>
                <concept code="C02LK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="veratrum and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="veratrum and diuretics" type="fsn">veratrum and diuretics</designation>
                    <desc language="en-US">veratrum and diuretics</desc>
                </concept>
                <concept code="C02LL"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MAO inhibitors and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="MAO inhibitors and diuretics"
                         type="fsn">MAO inhibitors and diuretics</designation>
                    <desc language="en-US">MAO inhibitors and diuretics</desc>
                </concept>
                <concept code="C02LL01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pargyline and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pargyline and diuretics" type="fsn">pargyline and diuretics</designation>
                    <desc language="en-US">pargyline and diuretics</desc>
                </concept>
                <concept code="C02LN"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Serotonin antagonists and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Serotonin antagonists and diuretics"
                         type="fsn">Serotonin antagonists and diuretics</designation>
                    <desc language="en-US">Serotonin antagonists and diuretics</desc>
                </concept>
                <concept code="C02LX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antihypertensives and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antihypertensives and diuretics"
                         type="fsn">Other antihypertensives and diuretics</designation>
                    <desc language="en-US">Other antihypertensives and diuretics</desc>
                </concept>
                <concept code="C02LX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pinacidil and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pinacidil and diuretics" type="fsn">pinacidil and diuretics</designation>
                    <desc language="en-US">pinacidil and diuretics</desc>
                </concept>
                <concept code="C02N"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02"
                         type="fsn">COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02</designation>
                    <desc language="en-US">COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02</desc>
                </concept>
                <concept code="C03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIURETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DIURETICS" type="fsn">DIURETICS</designation>
                    <desc language="en-US">DIURETICS</desc>
                </concept>
                <concept code="C03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="LOW-CEILING DIURETICS, THIAZIDES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="LOW-CEILING DIURETICS, THIAZIDES"
                         type="fsn">LOW-CEILING DIURETICS, THIAZIDES</designation>
                    <desc language="en-US">LOW-CEILING DIURETICS, THIAZIDES</desc>
                </concept>
                <concept code="C03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiazides, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thiazides, plain" type="fsn">Thiazides, plain</designation>
                    <desc language="en-US">Thiazides, plain</desc>
                </concept>
                <concept code="C03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bendroflumethiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bendroflumethiazide" type="fsn">bendroflumethiazide</designation>
                    <desc language="en-US">bendroflumethiazide</desc>
                </concept>
                <concept code="C03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroflumethiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroflumethiazide" type="fsn">hydroflumethiazide</designation>
                    <desc language="en-US">hydroflumethiazide</desc>
                </concept>
                <concept code="C03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrochlorothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrochlorothiazide" type="fsn">hydrochlorothiazide</designation>
                    <desc language="en-US">hydrochlorothiazide</desc>
                </concept>
                <concept code="C03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorothiazide" type="fsn">chlorothiazide</designation>
                    <desc language="en-US">chlorothiazide</desc>
                </concept>
                <concept code="C03AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polythiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polythiazide" type="fsn">polythiazide</designation>
                    <desc language="en-US">polythiazide</desc>
                </concept>
                <concept code="C03AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trichlormethiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trichlormethiazide" type="fsn">trichlormethiazide</designation>
                    <desc language="en-US">trichlormethiazide</desc>
                </concept>
                <concept code="C03AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclopenthiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclopenthiazide" type="fsn">cyclopenthiazide</designation>
                    <desc language="en-US">cyclopenthiazide</desc>
                </concept>
                <concept code="C03AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyclothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methyclothiazide" type="fsn">methyclothiazide</designation>
                    <desc language="en-US">methyclothiazide</desc>
                </concept>
                <concept code="C03AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclothiazide" type="fsn">cyclothiazide</designation>
                    <desc language="en-US">cyclothiazide</desc>
                </concept>
                <concept code="C03AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mebutizide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mebutizide" type="fsn">mebutizide</designation>
                    <desc language="en-US">mebutizide</desc>
                </concept>
                <concept code="C03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiazides and potassium in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Thiazides and potassium in combination"
                         type="fsn">Thiazides and potassium in combination</designation>
                    <desc language="en-US">Thiazides and potassium in combination</desc>
                </concept>
                <concept code="C03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bendroflumethiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bendroflumethiazide and potassium"
                         type="fsn">bendroflumethiazide and potassium</designation>
                    <desc language="en-US">bendroflumethiazide and potassium</desc>
                </concept>
                <concept code="C03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroflumethiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydroflumethiazide and potassium"
                         type="fsn">hydroflumethiazide and potassium</designation>
                    <desc language="en-US">hydroflumethiazide and potassium</desc>
                </concept>
                <concept code="C03AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrochlorothiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrochlorothiazide and potassium"
                         type="fsn">hydrochlorothiazide and potassium</designation>
                    <desc language="en-US">hydrochlorothiazide and potassium</desc>
                </concept>
                <concept code="C03AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorothiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlorothiazide and potassium"
                         type="fsn">chlorothiazide and potassium</designation>
                    <desc language="en-US">chlorothiazide and potassium</desc>
                </concept>
                <concept code="C03AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polythiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="polythiazide and potassium"
                         type="fsn">polythiazide and potassium</designation>
                    <desc language="en-US">polythiazide and potassium</desc>
                </concept>
                <concept code="C03AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trichlormethiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="trichlormethiazide and potassium"
                         type="fsn">trichlormethiazide and potassium</designation>
                    <desc language="en-US">trichlormethiazide and potassium</desc>
                </concept>
                <concept code="C03AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclopenthiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cyclopenthiazide and potassium"
                         type="fsn">cyclopenthiazide and potassium</designation>
                    <desc language="en-US">cyclopenthiazide and potassium</desc>
                </concept>
                <concept code="C03AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyclothiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methyclothiazide and potassium"
                         type="fsn">methyclothiazide and potassium</designation>
                    <desc language="en-US">methyclothiazide and potassium</desc>
                </concept>
                <concept code="C03AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclothiazide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cyclothiazide and potassium"
                         type="fsn">cyclothiazide and potassium</designation>
                    <desc language="en-US">cyclothiazide and potassium</desc>
                </concept>
                <concept code="C03AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiazides, combinations with psycholeptics and/or analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Thiazides, combinations with psycholeptics and/or analgesics"
                         type="fsn">Thiazides, combinations with psycholeptics and/or analgesics</designation>
                    <desc language="en-US">Thiazides, combinations with psycholeptics and/or analgesics</desc>
                </concept>
                <concept code="C03AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorothiazide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlorothiazide, combinations"
                         type="fsn">chlorothiazide, combinations</designation>
                    <desc language="en-US">chlorothiazide, combinations</desc>
                </concept>
                <concept code="C03AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroflumethiazide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydroflumethiazide, combinations"
                         type="fsn">hydroflumethiazide, combinations</designation>
                    <desc language="en-US">hydroflumethiazide, combinations</desc>
                </concept>
                <concept code="C03AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiazides, combinations with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Thiazides, combinations with other drugs"
                         type="fsn">Thiazides, combinations with other drugs</designation>
                    <desc language="en-US">Thiazides, combinations with other drugs</desc>
                </concept>
                <concept code="C03AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrochlorothiazide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrochlorothiazide, combinations"
                         type="fsn">hydrochlorothiazide, combinations</designation>
                    <desc language="en-US">hydrochlorothiazide, combinations</desc>
                </concept>
                <concept code="C03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="LOW-CEILING DIURETICS, EXCL. THIAZIDES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="LOW-CEILING DIURETICS, EXCL. THIAZIDES"
                         type="fsn">LOW-CEILING DIURETICS, EXCL. THIAZIDES</designation>
                    <desc language="en-US">LOW-CEILING DIURETICS, EXCL. THIAZIDES</desc>
                </concept>
                <concept code="C03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sulfonamides, plain" type="fsn">Sulfonamides, plain</designation>
                    <desc language="en-US">Sulfonamides, plain</desc>
                </concept>
                <concept code="C03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinethazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinethazone" type="fsn">quinethazone</designation>
                    <desc language="en-US">quinethazone</desc>
                </concept>
                <concept code="C03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clopamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clopamide" type="fsn">clopamide</designation>
                    <desc language="en-US">clopamide</desc>
                </concept>
                <concept code="C03BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlortalidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlortalidone" type="fsn">chlortalidone</designation>
                    <desc language="en-US">chlortalidone</desc>
                </concept>
                <concept code="C03BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mefruside"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mefruside" type="fsn">mefruside</designation>
                    <desc language="en-US">mefruside</desc>
                </concept>
                <concept code="C03BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofenamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofenamide" type="fsn">clofenamide</designation>
                    <desc language="en-US">clofenamide</desc>
                </concept>
                <concept code="C03BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metolazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metolazone" type="fsn">metolazone</designation>
                    <desc language="en-US">metolazone</desc>
                </concept>
                <concept code="C03BA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meticrane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meticrane" type="fsn">meticrane</designation>
                    <desc language="en-US">meticrane</desc>
                </concept>
                <concept code="C03BA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xipamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xipamide" type="fsn">xipamide</designation>
                    <desc language="en-US">xipamide</desc>
                </concept>
                <concept code="C03BA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indapamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indapamide" type="fsn">indapamide</designation>
                    <desc language="en-US">indapamide</desc>
                </concept>
                <concept code="C03BA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clorexolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clorexolone" type="fsn">clorexolone</designation>
                    <desc language="en-US">clorexolone</desc>
                </concept>
                <concept code="C03BA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenquizone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenquizone" type="fsn">fenquizone</designation>
                    <desc language="en-US">fenquizone</desc>
                </concept>
                <concept code="C03BA82"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clorexolone, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="clorexolone, combinations with psycholeptics"
                         type="fsn">clorexolone, combinations with psycholeptics</designation>
                    <desc language="en-US">clorexolone, combinations with psycholeptics</desc>
                </concept>
                <concept code="C03BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides and potassium in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sulfonamides and potassium in combination"
                         type="fsn">Sulfonamides and potassium in combination</designation>
                    <desc language="en-US">Sulfonamides and potassium in combination</desc>
                </concept>
                <concept code="C03BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinethazone and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="quinethazone and potassium"
                         type="fsn">quinethazone and potassium</designation>
                    <desc language="en-US">quinethazone and potassium</desc>
                </concept>
                <concept code="C03BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clopamide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clopamide and potassium" type="fsn">clopamide and potassium</designation>
                    <desc language="en-US">clopamide and potassium</desc>
                </concept>
                <concept code="C03BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlortalidone and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlortalidone and potassium"
                         type="fsn">chlortalidone and potassium</designation>
                    <desc language="en-US">chlortalidone and potassium</desc>
                </concept>
                <concept code="C03BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mefruside and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mefruside and potassium" type="fsn">mefruside and potassium</designation>
                    <desc language="en-US">mefruside and potassium</desc>
                </concept>
                <concept code="C03BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofenamide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofenamide and potassium" type="fsn">clofenamide and potassium</designation>
                    <desc language="en-US">clofenamide and potassium</desc>
                </concept>
                <concept code="C03BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Mercurial diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Mercurial diuretics" type="fsn">Mercurial diuretics</designation>
                    <desc language="en-US">Mercurial diuretics</desc>
                </concept>
                <concept code="C03BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mersalyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mersalyl" type="fsn">mersalyl</designation>
                    <desc language="en-US">mersalyl</desc>
                </concept>
                <concept code="C03BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Xanthine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Xanthine derivatives" type="fsn">Xanthine derivatives</designation>
                    <desc language="en-US">Xanthine derivatives</desc>
                </concept>
                <concept code="C03BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="theobromine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="theobromine" type="fsn">theobromine</designation>
                    <desc language="en-US">theobromine</desc>
                </concept>
                <concept code="C03BK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides, combinations with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sulfonamides, combinations with other drugs"
                         type="fsn">Sulfonamides, combinations with other drugs</designation>
                    <desc language="en-US">Sulfonamides, combinations with other drugs</desc>
                </concept>
                <concept code="C03BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other low-ceiling diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other low-ceiling diuretics"
                         type="fsn">Other low-ceiling diuretics</designation>
                    <desc language="en-US">Other low-ceiling diuretics</desc>
                </concept>
                <concept code="C03BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cicletanine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cicletanine" type="fsn">cicletanine</designation>
                    <desc language="en-US">cicletanine</desc>
                </concept>
                <concept code="C03C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HIGH-CEILING DIURETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="HIGH-CEILING DIURETICS" type="fsn">HIGH-CEILING DIURETICS</designation>
                    <desc language="en-US">HIGH-CEILING DIURETICS</desc>
                </concept>
                <concept code="C03CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sulfonamides, plain" type="fsn">Sulfonamides, plain</designation>
                    <desc language="en-US">Sulfonamides, plain</desc>
                </concept>
                <concept code="C03CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="furosemide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="furosemide" type="fsn">furosemide</designation>
                    <desc language="en-US">furosemide</desc>
                </concept>
                <concept code="C03CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bumetanide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bumetanide" type="fsn">bumetanide</designation>
                    <desc language="en-US">bumetanide</desc>
                </concept>
                <concept code="C03CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piretanide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piretanide" type="fsn">piretanide</designation>
                    <desc language="en-US">piretanide</desc>
                </concept>
                <concept code="C03CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="torasemide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="torasemide" type="fsn">torasemide</designation>
                    <desc language="en-US">torasemide</desc>
                </concept>
                <concept code="C03CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides and potassium in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sulfonamides and potassium in combination"
                         type="fsn">Sulfonamides and potassium in combination</designation>
                    <desc language="en-US">Sulfonamides and potassium in combination</desc>
                </concept>
                <concept code="C03CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="furosemide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="furosemide and potassium" type="fsn">furosemide and potassium</designation>
                    <desc language="en-US">furosemide and potassium</desc>
                </concept>
                <concept code="C03CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bumetanide and potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bumetanide and potassium" type="fsn">bumetanide and potassium</designation>
                    <desc language="en-US">bumetanide and potassium</desc>
                </concept>
                <concept code="C03CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aryloxyacetic acid derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Aryloxyacetic acid derivatives"
                         type="fsn">Aryloxyacetic acid derivatives</designation>
                    <desc language="en-US">Aryloxyacetic acid derivatives</desc>
                </concept>
                <concept code="C03CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etacrynic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etacrynic acid" type="fsn">etacrynic acid</designation>
                    <desc language="en-US">etacrynic acid</desc>
                </concept>
                <concept code="C03CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tienilic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tienilic acid" type="fsn">tienilic acid</designation>
                    <desc language="en-US">tienilic acid</desc>
                </concept>
                <concept code="C03CD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pyrazolone derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pyrazolone derivatives" type="fsn">Pyrazolone derivatives</designation>
                    <desc language="en-US">Pyrazolone derivatives</desc>
                </concept>
                <concept code="C03CD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="muzolimine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="muzolimine" type="fsn">muzolimine</designation>
                    <desc language="en-US">muzolimine</desc>
                </concept>
                <concept code="C03CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other high-ceiling diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other high-ceiling diuretics"
                         type="fsn">Other high-ceiling diuretics</designation>
                    <desc language="en-US">Other high-ceiling diuretics</desc>
                </concept>
                <concept code="C03CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etozolin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etozolin" type="fsn">etozolin</designation>
                    <desc language="en-US">etozolin</desc>
                </concept>
                <concept code="C03D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="POTASSIUM-SPARING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="POTASSIUM-SPARING AGENTS" type="fsn">POTASSIUM-SPARING AGENTS</designation>
                    <desc language="en-US">POTASSIUM-SPARING AGENTS</desc>
                </concept>
                <concept code="C03DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aldosterone antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Aldosterone antagonists" type="fsn">Aldosterone antagonists</designation>
                    <desc language="en-US">Aldosterone antagonists</desc>
                </concept>
                <concept code="C03DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="spironolactone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="spironolactone" type="fsn">spironolactone</designation>
                    <desc language="en-US">spironolactone</desc>
                </concept>
                <concept code="C03DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium canrenoate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium canrenoate" type="fsn">potassium canrenoate</designation>
                    <desc language="en-US">potassium canrenoate</desc>
                </concept>
                <concept code="C03DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="canrenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="canrenone" type="fsn">canrenone</designation>
                    <desc language="en-US">canrenone</desc>
                </concept>
                <concept code="C03DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eplerenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eplerenone" type="fsn">eplerenone</designation>
                    <desc language="en-US">eplerenone</desc>
                </concept>
                <concept code="C03DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other potassium-sparing agents"
                         type="fsn">Other potassium-sparing agents</designation>
                    <desc language="en-US">Other potassium-sparing agents</desc>
                </concept>
                <concept code="C03DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amiloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amiloride" type="fsn">amiloride</designation>
                    <desc language="en-US">amiloride</desc>
                </concept>
                <concept code="C03DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamterene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamterene" type="fsn">triamterene</designation>
                    <desc language="en-US">triamterene</desc>
                </concept>
                <concept code="C03E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION"
                         type="fsn">DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION</designation>
                    <desc language="en-US">DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION</desc>
                </concept>
                <concept code="C03EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Low-ceiling diuretics and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Low-ceiling diuretics and potassium-sparing agents"
                         type="fsn">Low-ceiling diuretics and potassium-sparing agents</designation>
                    <desc language="en-US">Low-ceiling diuretics and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrochlorothiazide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrochlorothiazide and potassium-sparing agents"
                         type="fsn">hydrochlorothiazide and potassium-sparing agents</designation>
                    <desc language="en-US">hydrochlorothiazide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trichlormethiazide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="trichlormethiazide and potassium-sparing agents"
                         type="fsn">trichlormethiazide and potassium-sparing agents</designation>
                    <desc language="en-US">trichlormethiazide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epitizide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="epitizide and potassium-sparing agents"
                         type="fsn">epitizide and potassium-sparing agents</designation>
                    <desc language="en-US">epitizide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="altizide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="altizide and potassium-sparing agents"
                         type="fsn">altizide and potassium-sparing agents</designation>
                    <desc language="en-US">altizide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mebutizide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="mebutizide and potassium-sparing agents"
                         type="fsn">mebutizide and potassium-sparing agents</designation>
                    <desc language="en-US">mebutizide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlortalidone and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlortalidone and potassium-sparing agents"
                         type="fsn">chlortalidone and potassium-sparing agents</designation>
                    <desc language="en-US">chlortalidone and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclopenthiazide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cyclopenthiazide and potassium-sparing agents"
                         type="fsn">cyclopenthiazide and potassium-sparing agents</designation>
                    <desc language="en-US">cyclopenthiazide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metolazone and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metolazone and potassium-sparing agents"
                         type="fsn">metolazone and potassium-sparing agents</designation>
                    <desc language="en-US">metolazone and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bendroflumethiazide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bendroflumethiazide and potassium-sparing agents"
                         type="fsn">bendroflumethiazide and potassium-sparing agents</designation>
                    <desc language="en-US">bendroflumethiazide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butizide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="butizide and potassium-sparing agents"
                         type="fsn">butizide and potassium-sparing agents</designation>
                    <desc language="en-US">butizide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="High-ceiling diuretics and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="High-ceiling diuretics and potassium-sparing agents"
                         type="fsn">High-ceiling diuretics and potassium-sparing agents</designation>
                    <desc language="en-US">High-ceiling diuretics and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="furosemide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="furosemide and potassium-sparing agents"
                         type="fsn">furosemide and potassium-sparing agents</designation>
                    <desc language="en-US">furosemide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03EB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bumetanide and potassium-sparing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bumetanide and potassium-sparing agents"
                         type="fsn">bumetanide and potassium-sparing agents</designation>
                    <desc language="en-US">bumetanide and potassium-sparing agents</desc>
                </concept>
                <concept code="C03X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DIURETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER DIURETICS" type="fsn">OTHER DIURETICS</designation>
                    <desc language="en-US">OTHER DIURETICS</desc>
                </concept>
                <concept code="C03XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vasopressin antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vasopressin antagonists" type="fsn">Vasopressin antagonists</designation>
                    <desc language="en-US">Vasopressin antagonists</desc>
                </concept>
                <concept code="C03XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolvaptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolvaptan" type="fsn">tolvaptan</designation>
                    <desc language="en-US">tolvaptan</desc>
                </concept>
                <concept code="C03XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="conivaptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="conivaptan" type="fsn">conivaptan</designation>
                    <desc language="en-US">conivaptan</desc>
                </concept>
                <concept code="C04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PERIPHERAL VASODILATORS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PERIPHERAL VASODILATORS" type="fsn">PERIPHERAL VASODILATORS</designation>
                    <desc language="en-US">PERIPHERAL VASODILATORS</desc>
                </concept>
                <concept code="C04A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PERIPHERAL VASODILATORS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PERIPHERAL VASODILATORS" type="fsn">PERIPHERAL VASODILATORS</designation>
                    <desc language="en-US">PERIPHERAL VASODILATORS</desc>
                </concept>
                <concept code="C04AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="2-amino-1-phenylethanol derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="2-amino-1-phenylethanol derivatives"
                         type="fsn">2-amino-1-phenylethanol derivatives</designation>
                    <desc language="en-US">2-amino-1-phenylethanol derivatives</desc>
                </concept>
                <concept code="C04AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoxsuprine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoxsuprine" type="fsn">isoxsuprine</designation>
                    <desc language="en-US">isoxsuprine</desc>
                </concept>
                <concept code="C04AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buphenine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buphenine" type="fsn">buphenine</designation>
                    <desc language="en-US">buphenine</desc>
                </concept>
                <concept code="C04AA31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bamethan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bamethan" type="fsn">bamethan</designation>
                    <desc language="en-US">bamethan</desc>
                </concept>
                <concept code="C04AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazoline derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Imidazoline derivatives" type="fsn">Imidazoline derivatives</designation>
                    <desc language="en-US">Imidazoline derivatives</desc>
                </concept>
                <concept code="C04AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phentolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phentolamine" type="fsn">phentolamine</designation>
                    <desc language="en-US">phentolamine</desc>
                </concept>
                <concept code="C04AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolazoline" type="fsn">tolazoline</designation>
                    <desc language="en-US">tolazoline</desc>
                </concept>
                <concept code="C04AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nicotinic acid and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nicotinic acid and derivatives"
                         type="fsn">Nicotinic acid and derivatives</designation>
                    <desc language="en-US">Nicotinic acid and derivatives</desc>
                </concept>
                <concept code="C04AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicotinic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicotinic acid" type="fsn">nicotinic acid</designation>
                    <desc language="en-US">nicotinic acid</desc>
                </concept>
                <concept code="C04AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicotinyl alcohol (pyridylcarbinol)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="nicotinyl alcohol (pyridylcarbinol)"
                         type="fsn">nicotinyl alcohol (pyridylcarbinol)</designation>
                    <desc language="en-US">nicotinyl alcohol (pyridylcarbinol)</desc>
                </concept>
                <concept code="C04AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="inositol nicotinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="inositol nicotinate" type="fsn">inositol nicotinate</designation>
                    <desc language="en-US">inositol nicotinate</desc>
                </concept>
                <concept code="C04AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclonicate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclonicate" type="fsn">ciclonicate</designation>
                    <desc language="en-US">ciclonicate</desc>
                </concept>
                <concept code="C04AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Purine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Purine derivatives" type="fsn">Purine derivatives</designation>
                    <desc language="en-US">Purine derivatives</desc>
                </concept>
                <concept code="C04AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentifylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentifylline" type="fsn">pentifylline</designation>
                    <desc language="en-US">pentifylline</desc>
                </concept>
                <concept code="C04AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xantinol nicotinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xantinol nicotinate" type="fsn">xantinol nicotinate</designation>
                    <desc language="en-US">xantinol nicotinate</desc>
                </concept>
                <concept code="C04AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentoxifylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentoxifylline" type="fsn">pentoxifylline</designation>
                    <desc language="en-US">pentoxifylline</desc>
                </concept>
                <concept code="C04AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etofylline nicotinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etofylline nicotinate" type="fsn">etofylline nicotinate</designation>
                    <desc language="en-US">etofylline nicotinate</desc>
                </concept>
                <concept code="C04AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ergot alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Ergot alkaloids" type="fsn">Ergot alkaloids</designation>
                    <desc language="en-US">Ergot alkaloids</desc>
                </concept>
                <concept code="C04AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ergoloid mesylates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ergoloid mesylates" type="fsn">ergoloid mesylates</designation>
                    <desc language="en-US">ergoloid mesylates</desc>
                </concept>
                <concept code="C04AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicergoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicergoline" type="fsn">nicergoline</designation>
                    <desc language="en-US">nicergoline</desc>
                </concept>
                <concept code="C04AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydroergocristine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dihydroergocristine" type="fsn">dihydroergocristine</designation>
                    <desc language="en-US">dihydroergocristine</desc>
                </concept>
                <concept code="C04AE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ergoloid mesylates, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ergoloid mesylates, combinations"
                         type="fsn">ergoloid mesylates, combinations</designation>
                    <desc language="en-US">ergoloid mesylates, combinations</desc>
                </concept>
                <concept code="C04AE54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydroergocristine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydroergocristine, combinations"
                         type="fsn">dihydroergocristine, combinations</designation>
                    <desc language="en-US">dihydroergocristine, combinations</desc>
                </concept>
                <concept code="C04AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Enzymes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Enzymes" type="fsn">Enzymes</designation>
                    <desc language="en-US">Enzymes</desc>
                </concept>
                <concept code="C04AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="kallidinogenase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="kallidinogenase" type="fsn">kallidinogenase</designation>
                    <desc language="en-US">kallidinogenase</desc>
                </concept>
                <concept code="C04AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other peripheral vasodilators"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other peripheral vasodilators"
                         type="fsn">Other peripheral vasodilators</designation>
                    <desc language="en-US">Other peripheral vasodilators</desc>
                </concept>
                <concept code="C04AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclandelate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclandelate" type="fsn">cyclandelate</designation>
                    <desc language="en-US">cyclandelate</desc>
                </concept>
                <concept code="C04AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenoxybenzamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenoxybenzamine" type="fsn">phenoxybenzamine</designation>
                    <desc language="en-US">phenoxybenzamine</desc>
                </concept>
                <concept code="C04AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vincamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vincamine" type="fsn">vincamine</designation>
                    <desc language="en-US">vincamine</desc>
                </concept>
                <concept code="C04AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moxisylyte"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moxisylyte" type="fsn">moxisylyte</designation>
                    <desc language="en-US">moxisylyte</desc>
                </concept>
                <concept code="C04AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bencyclane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bencyclane" type="fsn">bencyclane</designation>
                    <desc language="en-US">bencyclane</desc>
                </concept>
                <concept code="C04AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vinburnine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vinburnine" type="fsn">vinburnine</designation>
                    <desc language="en-US">vinburnine</desc>
                </concept>
                <concept code="C04AX19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="suloctidil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="suloctidil" type="fsn">suloctidil</designation>
                    <desc language="en-US">suloctidil</desc>
                </concept>
                <concept code="C04AX20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buflomedil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buflomedil" type="fsn">buflomedil</designation>
                    <desc language="en-US">buflomedil</desc>
                </concept>
                <concept code="C04AX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naftidrofuryl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naftidrofuryl" type="fsn">naftidrofuryl</designation>
                    <desc language="en-US">naftidrofuryl</desc>
                </concept>
                <concept code="C04AX23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butalamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butalamine" type="fsn">butalamine</designation>
                    <desc language="en-US">butalamine</desc>
                </concept>
                <concept code="C04AX24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="visnadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="visnadine" type="fsn">visnadine</designation>
                    <desc language="en-US">visnadine</desc>
                </concept>
                <concept code="C04AX26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetiedil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetiedil" type="fsn">cetiedil</designation>
                    <desc language="en-US">cetiedil</desc>
                </concept>
                <concept code="C04AX27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinepazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinepazide" type="fsn">cinepazide</designation>
                    <desc language="en-US">cinepazide</desc>
                </concept>
                <concept code="C04AX28"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ifenprodil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ifenprodil" type="fsn">ifenprodil</designation>
                    <desc language="en-US">ifenprodil</desc>
                </concept>
                <concept code="C04AX30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azapetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azapetine" type="fsn">azapetine</designation>
                    <desc language="en-US">azapetine</desc>
                </concept>
                <concept code="C04AX32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fasudil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fasudil" type="fsn">fasudil</designation>
                    <desc language="en-US">fasudil</desc>
                </concept>
                <concept code="C05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VASOPROTECTIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="VASOPROTECTIVES" type="fsn">VASOPROTECTIVES</designation>
                    <desc language="en-US">VASOPROTECTIVES</desc>
                </concept>
                <concept code="C05A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE"
                         type="fsn">AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE</designation>
                    <desc language="en-US">AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE</desc>
                </concept>
                <concept code="C05AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Corticosteroids" type="fsn">Corticosteroids</designation>
                    <desc language="en-US">Corticosteroids</desc>
                </concept>
                <concept code="C05AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="C05AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="C05AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="C05AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorometholone" type="fsn">fluorometholone</designation>
                    <desc language="en-US">fluorometholone</desc>
                </concept>
                <concept code="C05AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocortolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocortolone" type="fsn">fluocortolone</designation>
                    <desc language="en-US">fluocortolone</desc>
                </concept>
                <concept code="C05AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="C05AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinolone acetonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocinolone acetonide" type="fsn">fluocinolone acetonide</designation>
                    <desc language="en-US">fluocinolone acetonide</desc>
                </concept>
                <concept code="C05AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocinonide" type="fsn">fluocinonide</designation>
                    <desc language="en-US">fluocinonide</desc>
                </concept>
                <concept code="C05AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamcinolone" type="fsn">triamcinolone</designation>
                    <desc language="en-US">triamcinolone</desc>
                </concept>
                <concept code="C05AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antibiotics" type="fsn">Antibiotics</designation>
                    <desc language="en-US">Antibiotics</desc>
                </concept>
                <concept code="C05AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Local anesthetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Local anesthetics" type="fsn">Local anesthetics</designation>
                    <desc language="en-US">Local anesthetics</desc>
                </concept>
                <concept code="C05AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidocaine" type="fsn">lidocaine</designation>
                    <desc language="en-US">lidocaine</desc>
                </concept>
                <concept code="C05AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracaine" type="fsn">tetracaine</designation>
                    <desc language="en-US">tetracaine</desc>
                </concept>
                <concept code="C05AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzocaine" type="fsn">benzocaine</designation>
                    <desc language="en-US">benzocaine</desc>
                </concept>
                <concept code="C05AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinchocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinchocaine" type="fsn">cinchocaine</designation>
                    <desc language="en-US">cinchocaine</desc>
                </concept>
                <concept code="C05AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procaine" type="fsn">procaine</designation>
                    <desc language="en-US">procaine</desc>
                </concept>
                <concept code="C05AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxetacaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxetacaine" type="fsn">oxetacaine</designation>
                    <desc language="en-US">oxetacaine</desc>
                </concept>
                <concept code="C05AD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pramocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pramocaine" type="fsn">pramocaine</designation>
                    <desc language="en-US">pramocaine</desc>
                </concept>
                <concept code="C05AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Muscle relaxants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Muscle relaxants" type="fsn">Muscle relaxants</designation>
                    <desc language="en-US">Muscle relaxants</desc>
                </concept>
                <concept code="C05AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glyceryl trinitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glyceryl trinitrate" type="fsn">glyceryl trinitrate</designation>
                    <desc language="en-US">glyceryl trinitrate</desc>
                </concept>
                <concept code="C05AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isosorbide dinitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isosorbide dinitrate" type="fsn">isosorbide dinitrate</designation>
                    <desc language="en-US">isosorbide dinitrate</desc>
                </concept>
                <concept code="C05AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diltiazem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diltiazem" type="fsn">diltiazem</designation>
                    <desc language="en-US">diltiazem</desc>
                </concept>
                <concept code="C05AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other agents for treatment of hemorrhoids and anal fissures for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other agents for treatment of hemorrhoids and anal fissures for topical use"
                         type="fsn">Other agents for treatment of hemorrhoids and anal fissures for topical use</designation>
                    <desc language="en-US">Other agents for treatment of hemorrhoids and anal fissures for topical use</desc>
                </concept>
                <concept code="C05AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium preparations" type="fsn">aluminium preparations</designation>
                    <desc language="en-US">aluminium preparations</desc>
                </concept>
                <concept code="C05AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bismuth preparations, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bismuth preparations, combinations"
                         type="fsn">bismuth preparations, combinations</designation>
                    <desc language="en-US">bismuth preparations, combinations</desc>
                </concept>
                <concept code="C05AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="other preparations, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="other preparations, combinations"
                         type="fsn">other preparations, combinations</designation>
                    <desc language="en-US">other preparations, combinations</desc>
                </concept>
                <concept code="C05AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zinc preparations" type="fsn">zinc preparations</designation>
                    <desc language="en-US">zinc preparations</desc>
                </concept>
                <concept code="C05AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tribenoside"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tribenoside" type="fsn">tribenoside</designation>
                    <desc language="en-US">tribenoside</desc>
                </concept>
                <concept code="C05B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIVARICOSE THERAPY"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIVARICOSE THERAPY" type="fsn">ANTIVARICOSE THERAPY</designation>
                    <desc language="en-US">ANTIVARICOSE THERAPY</desc>
                </concept>
                <concept code="C05BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Heparins or heparinoids for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Heparins or heparinoids for topical use"
                         type="fsn">Heparins or heparinoids for topical use</designation>
                    <desc language="en-US">Heparins or heparinoids for topical use</desc>
                </concept>
                <concept code="C05BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="organo-heparinoid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="organo-heparinoid" type="fsn">organo-heparinoid</designation>
                    <desc language="en-US">organo-heparinoid</desc>
                </concept>
                <concept code="C05BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium apolate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium apolate" type="fsn">sodium apolate</designation>
                    <desc language="en-US">sodium apolate</desc>
                </concept>
                <concept code="C05BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="heparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="heparin" type="fsn">heparin</designation>
                    <desc language="en-US">heparin</desc>
                </concept>
                <concept code="C05BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentosan polysulfate sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pentosan polysulfate sodium"
                         type="fsn">pentosan polysulfate sodium</designation>
                    <desc language="en-US">pentosan polysulfate sodium</desc>
                </concept>
                <concept code="C05BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="heparinoid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="heparinoid, combinations" type="fsn">heparinoid, combinations</designation>
                    <desc language="en-US">heparinoid, combinations</desc>
                </concept>
                <concept code="C05BA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="heparin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="heparin, combinations" type="fsn">heparin, combinations</designation>
                    <desc language="en-US">heparin, combinations</desc>
                </concept>
                <concept code="C05BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sclerosing agents for local injection"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sclerosing agents for local injection"
                         type="fsn">Sclerosing agents for local injection</designation>
                    <desc language="en-US">Sclerosing agents for local injection</desc>
                </concept>
                <concept code="C05BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="monoethanolamine oleate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="monoethanolamine oleate" type="fsn">monoethanolamine oleate</designation>
                    <desc language="en-US">monoethanolamine oleate</desc>
                </concept>
                <concept code="C05BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polidocanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polidocanol" type="fsn">polidocanol</designation>
                    <desc language="en-US">polidocanol</desc>
                </concept>
                <concept code="C05BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="invert sugar"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="invert sugar" type="fsn">invert sugar</designation>
                    <desc language="en-US">invert sugar</desc>
                </concept>
                <concept code="C05BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium tetradecyl sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium tetradecyl sulfate" type="fsn">sodium tetradecyl sulfate</designation>
                    <desc language="en-US">sodium tetradecyl sulfate</desc>
                </concept>
                <concept code="C05BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenol" type="fsn">phenol</designation>
                    <desc language="en-US">phenol</desc>
                </concept>
                <concept code="C05BB56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glucose, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glucose, combinations" type="fsn">glucose, combinations</designation>
                    <desc language="en-US">glucose, combinations</desc>
                </concept>
                <concept code="C05BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other sclerosing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other sclerosing agents" type="fsn">Other sclerosing agents</designation>
                    <desc language="en-US">Other sclerosing agents</desc>
                </concept>
                <concept code="C05BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium dobesilate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium dobesilate" type="fsn">calcium dobesilate</designation>
                    <desc language="en-US">calcium dobesilate</desc>
                </concept>
                <concept code="C05BX51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium dobesilate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="calcium dobesilate, combinations"
                         type="fsn">calcium dobesilate, combinations</designation>
                    <desc language="en-US">calcium dobesilate, combinations</desc>
                </concept>
                <concept code="C05C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CAPILLARY STABILIZING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CAPILLARY STABILIZING AGENTS"
                         type="fsn">CAPILLARY STABILIZING AGENTS</designation>
                    <desc language="en-US">CAPILLARY STABILIZING AGENTS</desc>
                </concept>
                <concept code="C05CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bioflavonoids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Bioflavonoids" type="fsn">Bioflavonoids</designation>
                    <desc language="en-US">Bioflavonoids</desc>
                </concept>
                <concept code="C05CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rutoside"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rutoside" type="fsn">rutoside</designation>
                    <desc language="en-US">rutoside</desc>
                </concept>
                <concept code="C05CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="monoxerutin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="monoxerutin" type="fsn">monoxerutin</designation>
                    <desc language="en-US">monoxerutin</desc>
                </concept>
                <concept code="C05CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diosmin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diosmin" type="fsn">diosmin</designation>
                    <desc language="en-US">diosmin</desc>
                </concept>
                <concept code="C05CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="troxerutin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="troxerutin" type="fsn">troxerutin</designation>
                    <desc language="en-US">troxerutin</desc>
                </concept>
                <concept code="C05CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hidrosmin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hidrosmin" type="fsn">hidrosmin</designation>
                    <desc language="en-US">hidrosmin</desc>
                </concept>
                <concept code="C05CA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rutoside, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rutoside, combinations" type="fsn">rutoside, combinations</designation>
                    <desc language="en-US">rutoside, combinations</desc>
                </concept>
                <concept code="C05CA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diosmin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diosmin, combinations" type="fsn">diosmin, combinations</designation>
                    <desc language="en-US">diosmin, combinations</desc>
                </concept>
                <concept code="C05CA54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="troxerutin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="troxerutin, combinations" type="fsn">troxerutin, combinations</designation>
                    <desc language="en-US">troxerutin, combinations</desc>
                </concept>
                <concept code="C05CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other capillary stabilizing agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other capillary stabilizing agents"
                         type="fsn">Other capillary stabilizing agents</designation>
                    <desc language="en-US">Other capillary stabilizing agents</desc>
                </concept>
                <concept code="C05CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tribenoside"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tribenoside" type="fsn">tribenoside</designation>
                    <desc language="en-US">tribenoside</desc>
                </concept>
                <concept code="C05CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naftazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naftazone" type="fsn">naftazone</designation>
                    <desc language="en-US">naftazone</desc>
                </concept>
                <concept code="C05CX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hippocastani semen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Hippocastani semen" type="fsn">Hippocastani semen</designation>
                    <desc language="en-US">Hippocastani semen</desc>
                </concept>
                <concept code="C07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BETA BLOCKING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="BETA BLOCKING AGENTS" type="fsn">BETA BLOCKING AGENTS</designation>
                    <desc language="en-US">BETA BLOCKING AGENTS</desc>
                </concept>
                <concept code="C07A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BETA BLOCKING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="BETA BLOCKING AGENTS" type="fsn">BETA BLOCKING AGENTS</designation>
                    <desc language="en-US">BETA BLOCKING AGENTS</desc>
                </concept>
                <concept code="C07AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, non-selective"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, non-selective"
                         type="fsn">Beta blocking agents, non-selective</designation>
                    <desc language="en-US">Beta blocking agents, non-selective</desc>
                </concept>
                <concept code="C07AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alprenolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alprenolol" type="fsn">alprenolol</designation>
                    <desc language="en-US">alprenolol</desc>
                </concept>
                <concept code="C07AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxprenolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxprenolol" type="fsn">oxprenolol</designation>
                    <desc language="en-US">oxprenolol</desc>
                </concept>
                <concept code="C07AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pindolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pindolol" type="fsn">pindolol</designation>
                    <desc language="en-US">pindolol</desc>
                </concept>
                <concept code="C07AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propranolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propranolol" type="fsn">propranolol</designation>
                    <desc language="en-US">propranolol</desc>
                </concept>
                <concept code="C07AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="timolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="timolol" type="fsn">timolol</designation>
                    <desc language="en-US">timolol</desc>
                </concept>
                <concept code="C07AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sotalol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sotalol" type="fsn">sotalol</designation>
                    <desc language="en-US">sotalol</desc>
                </concept>
                <concept code="C07AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nadolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nadolol" type="fsn">nadolol</designation>
                    <desc language="en-US">nadolol</desc>
                </concept>
                <concept code="C07AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepindolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepindolol" type="fsn">mepindolol</designation>
                    <desc language="en-US">mepindolol</desc>
                </concept>
                <concept code="C07AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carteolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carteolol" type="fsn">carteolol</designation>
                    <desc language="en-US">carteolol</desc>
                </concept>
                <concept code="C07AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tertatolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tertatolol" type="fsn">tertatolol</designation>
                    <desc language="en-US">tertatolol</desc>
                </concept>
                <concept code="C07AA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bopindolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bopindolol" type="fsn">bopindolol</designation>
                    <desc language="en-US">bopindolol</desc>
                </concept>
                <concept code="C07AA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bupranolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bupranolol" type="fsn">bupranolol</designation>
                    <desc language="en-US">bupranolol</desc>
                </concept>
                <concept code="C07AA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penbutolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="penbutolol" type="fsn">penbutolol</designation>
                    <desc language="en-US">penbutolol</desc>
                </concept>
                <concept code="C07AA27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cloranolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cloranolol" type="fsn">cloranolol</designation>
                    <desc language="en-US">cloranolol</desc>
                </concept>
                <concept code="C07AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, selective"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, selective"
                         type="fsn">Beta blocking agents, selective</designation>
                    <desc language="en-US">Beta blocking agents, selective</desc>
                </concept>
                <concept code="C07AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="practolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="practolol" type="fsn">practolol</designation>
                    <desc language="en-US">practolol</desc>
                </concept>
                <concept code="C07AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoprolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metoprolol" type="fsn">metoprolol</designation>
                    <desc language="en-US">metoprolol</desc>
                </concept>
                <concept code="C07AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atenolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atenolol" type="fsn">atenolol</designation>
                    <desc language="en-US">atenolol</desc>
                </concept>
                <concept code="C07AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acebutolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acebutolol" type="fsn">acebutolol</designation>
                    <desc language="en-US">acebutolol</desc>
                </concept>
                <concept code="C07AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betaxolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betaxolol" type="fsn">betaxolol</designation>
                    <desc language="en-US">betaxolol</desc>
                </concept>
                <concept code="C07AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bevantolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bevantolol" type="fsn">bevantolol</designation>
                    <desc language="en-US">bevantolol</desc>
                </concept>
                <concept code="C07AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bisoprolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bisoprolol" type="fsn">bisoprolol</designation>
                    <desc language="en-US">bisoprolol</desc>
                </concept>
                <concept code="C07AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="celiprolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="celiprolol" type="fsn">celiprolol</designation>
                    <desc language="en-US">celiprolol</desc>
                </concept>
                <concept code="C07AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="esmolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="esmolol" type="fsn">esmolol</designation>
                    <desc language="en-US">esmolol</desc>
                </concept>
                <concept code="C07AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epanolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epanolol" type="fsn">epanolol</designation>
                    <desc language="en-US">epanolol</desc>
                </concept>
                <concept code="C07AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="s-atenolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="s-atenolol" type="fsn">s-atenolol</designation>
                    <desc language="en-US">s-atenolol</desc>
                </concept>
                <concept code="C07AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nebivolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nebivolol" type="fsn">nebivolol</designation>
                    <desc language="en-US">nebivolol</desc>
                </concept>
                <concept code="C07AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="talinolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="talinolol" type="fsn">talinolol</designation>
                    <desc language="en-US">talinolol</desc>
                </concept>
                <concept code="C07AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="landiolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="landiolol" type="fsn">landiolol</designation>
                    <desc language="en-US">landiolol</desc>
                </concept>
                <concept code="C07AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha and beta blocking agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha and beta blocking agents"
                         type="fsn">Alpha and beta blocking agents</designation>
                    <desc language="en-US">Alpha and beta blocking agents</desc>
                </concept>
                <concept code="C07AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="labetalol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="labetalol" type="fsn">labetalol</designation>
                    <desc language="en-US">labetalol</desc>
                </concept>
                <concept code="C07AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carvedilol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carvedilol" type="fsn">carvedilol</designation>
                    <desc language="en-US">carvedilol</desc>
                </concept>
                <concept code="C07B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BETA BLOCKING AGENTS AND THIAZIDES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BETA BLOCKING AGENTS AND THIAZIDES"
                         type="fsn">BETA BLOCKING AGENTS AND THIAZIDES</designation>
                    <desc language="en-US">BETA BLOCKING AGENTS AND THIAZIDES</desc>
                </concept>
                <concept code="C07BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, non-selective, and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, non-selective, and thiazides"
                         type="fsn">Beta blocking agents, non-selective, and thiazides</designation>
                    <desc language="en-US">Beta blocking agents, non-selective, and thiazides</desc>
                </concept>
                <concept code="C07BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxprenolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxprenolol and thiazides" type="fsn">oxprenolol and thiazides</designation>
                    <desc language="en-US">oxprenolol and thiazides</desc>
                </concept>
                <concept code="C07BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propranolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propranolol and thiazides" type="fsn">propranolol and thiazides</designation>
                    <desc language="en-US">propranolol and thiazides</desc>
                </concept>
                <concept code="C07BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="timolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="timolol and thiazides" type="fsn">timolol and thiazides</designation>
                    <desc language="en-US">timolol and thiazides</desc>
                </concept>
                <concept code="C07BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sotalol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sotalol and thiazides" type="fsn">sotalol and thiazides</designation>
                    <desc language="en-US">sotalol and thiazides</desc>
                </concept>
                <concept code="C07BA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nadolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nadolol and thiazides" type="fsn">nadolol and thiazides</designation>
                    <desc language="en-US">nadolol and thiazides</desc>
                </concept>
                <concept code="C07BA68"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metipranolol and thiazides, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metipranolol and thiazides, combinations"
                         type="fsn">metipranolol and thiazides, combinations</designation>
                    <desc language="en-US">metipranolol and thiazides, combinations</desc>
                </concept>
                <concept code="C07BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, selective, and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, selective, and thiazides"
                         type="fsn">Beta blocking agents, selective, and thiazides</designation>
                    <desc language="en-US">Beta blocking agents, selective, and thiazides</desc>
                </concept>
                <concept code="C07BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoprolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metoprolol and thiazides" type="fsn">metoprolol and thiazides</designation>
                    <desc language="en-US">metoprolol and thiazides</desc>
                </concept>
                <concept code="C07BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atenolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atenolol and thiazides" type="fsn">atenolol and thiazides</designation>
                    <desc language="en-US">atenolol and thiazides</desc>
                </concept>
                <concept code="C07BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acebutolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acebutolol and thiazides" type="fsn">acebutolol and thiazides</designation>
                    <desc language="en-US">acebutolol and thiazides</desc>
                </concept>
                <concept code="C07BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bevantolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bevantolol and thiazides" type="fsn">bevantolol and thiazides</designation>
                    <desc language="en-US">bevantolol and thiazides</desc>
                </concept>
                <concept code="C07BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bisoprolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bisoprolol and thiazides" type="fsn">bisoprolol and thiazides</designation>
                    <desc language="en-US">bisoprolol and thiazides</desc>
                </concept>
                <concept code="C07BB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nebivolol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nebivolol and thiazides" type="fsn">nebivolol and thiazides</designation>
                    <desc language="en-US">nebivolol and thiazides</desc>
                </concept>
                <concept code="C07BB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoprolol and thiazides, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metoprolol and thiazides, combinations"
                         type="fsn">metoprolol and thiazides, combinations</designation>
                    <desc language="en-US">metoprolol and thiazides, combinations</desc>
                </concept>
                <concept code="C07BG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha and beta blocking agents and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha and beta blocking agents and thiazides"
                         type="fsn">Alpha and beta blocking agents and thiazides</designation>
                    <desc language="en-US">Alpha and beta blocking agents and thiazides</desc>
                </concept>
                <concept code="C07BG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="labetalol and thiazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="labetalol and thiazides" type="fsn">labetalol and thiazides</designation>
                    <desc language="en-US">labetalol and thiazides</desc>
                </concept>
                <concept code="C07C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BETA BLOCKING AGENTS AND OTHER DIURETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BETA BLOCKING AGENTS AND OTHER DIURETICS"
                         type="fsn">BETA BLOCKING AGENTS AND OTHER DIURETICS</designation>
                    <desc language="en-US">BETA BLOCKING AGENTS AND OTHER DIURETICS</desc>
                </concept>
                <concept code="C07CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, non-selective, and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, non-selective, and other diuretics"
                         type="fsn">Beta blocking agents, non-selective, and other diuretics</designation>
                    <desc language="en-US">Beta blocking agents, non-selective, and other diuretics</desc>
                </concept>
                <concept code="C07CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxprenolol and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="oxprenolol and other diuretics"
                         type="fsn">oxprenolol and other diuretics</designation>
                    <desc language="en-US">oxprenolol and other diuretics</desc>
                </concept>
                <concept code="C07CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pindolol and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pindolol and other diuretics"
                         type="fsn">pindolol and other diuretics</designation>
                    <desc language="en-US">pindolol and other diuretics</desc>
                </concept>
                <concept code="C07CA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bopindolol and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bopindolol and other diuretics"
                         type="fsn">bopindolol and other diuretics</designation>
                    <desc language="en-US">bopindolol and other diuretics</desc>
                </concept>
                <concept code="C07CA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penbutolol and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="penbutolol and other diuretics"
                         type="fsn">penbutolol and other diuretics</designation>
                    <desc language="en-US">penbutolol and other diuretics</desc>
                </concept>
                <concept code="C07CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, selective, and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, selective, and other diuretics"
                         type="fsn">Beta blocking agents, selective, and other diuretics</designation>
                    <desc language="en-US">Beta blocking agents, selective, and other diuretics</desc>
                </concept>
                <concept code="C07CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoprolol and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metoprolol and other diuretics"
                         type="fsn">metoprolol and other diuretics</designation>
                    <desc language="en-US">metoprolol and other diuretics</desc>
                </concept>
                <concept code="C07CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atenolol and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atenolol and other diuretics"
                         type="fsn">atenolol and other diuretics</designation>
                    <desc language="en-US">atenolol and other diuretics</desc>
                </concept>
                <concept code="C07CB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atenolol and other diuretics, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atenolol and other diuretics, combinations"
                         type="fsn">atenolol and other diuretics, combinations</designation>
                    <desc language="en-US">atenolol and other diuretics, combinations</desc>
                </concept>
                <concept code="C07CG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha and beta blocking agents and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha and beta blocking agents and other diuretics"
                         type="fsn">Alpha and beta blocking agents and other diuretics</designation>
                    <desc language="en-US">Alpha and beta blocking agents and other diuretics</desc>
                </concept>
                <concept code="C07CG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="labetalol and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="labetalol and other diuretics"
                         type="fsn">labetalol and other diuretics</designation>
                    <desc language="en-US">labetalol and other diuretics</desc>
                </concept>
                <concept code="C07D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS"
                         type="fsn">BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS</designation>
                    <desc language="en-US">BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS</desc>
                </concept>
                <concept code="C07DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, non-selective, thiazides and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, non-selective, thiazides and other diuretics"
                         type="fsn">Beta blocking agents, non-selective, thiazides and other diuretics</designation>
                    <desc language="en-US">Beta blocking agents, non-selective, thiazides and other diuretics</desc>
                </concept>
                <concept code="C07DA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="timolol, thiazides and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="timolol, thiazides and other diuretics"
                         type="fsn">timolol, thiazides and other diuretics</designation>
                    <desc language="en-US">timolol, thiazides and other diuretics</desc>
                </concept>
                <concept code="C07DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, selective, thiazides and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, selective, thiazides and other diuretics"
                         type="fsn">Beta blocking agents, selective, thiazides and other diuretics</designation>
                    <desc language="en-US">Beta blocking agents, selective, thiazides and other diuretics</desc>
                </concept>
                <concept code="C07DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atenolol, thiazides and other diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atenolol, thiazides and other diuretics"
                         type="fsn">atenolol, thiazides and other diuretics</designation>
                    <desc language="en-US">atenolol, thiazides and other diuretics</desc>
                </concept>
                <concept code="C07E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BETA BLOCKING AGENTS AND VASODILATORS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BETA BLOCKING AGENTS AND VASODILATORS"
                         type="fsn">BETA BLOCKING AGENTS AND VASODILATORS</designation>
                    <desc language="en-US">BETA BLOCKING AGENTS AND VASODILATORS</desc>
                </concept>
                <concept code="C07EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, non-selective, and vasodilators"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, non-selective, and vasodilators"
                         type="fsn">Beta blocking agents, non-selective, and vasodilators</designation>
                    <desc language="en-US">Beta blocking agents, non-selective, and vasodilators</desc>
                </concept>
                <concept code="C07EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, selective, and vasodilators"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, selective, and vasodilators"
                         type="fsn">Beta blocking agents, selective, and vasodilators</designation>
                    <desc language="en-US">Beta blocking agents, selective, and vasodilators</desc>
                </concept>
                <concept code="C07F"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BETA BLOCKING AGENTS, OTHER COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BETA BLOCKING AGENTS, OTHER COMBINATIONS"
                         type="fsn">BETA BLOCKING AGENTS, OTHER COMBINATIONS</designation>
                    <desc language="en-US">BETA BLOCKING AGENTS, OTHER COMBINATIONS</desc>
                </concept>
                <concept code="C07FB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents and calcium channel blockers"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents and calcium channel blockers"
                         type="fsn">Beta blocking agents and calcium channel blockers</designation>
                    <desc language="en-US">Beta blocking agents and calcium channel blockers</desc>
                </concept>
                <concept code="C07FB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoprolol and felodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metoprolol and felodipine" type="fsn">metoprolol and felodipine</designation>
                    <desc language="en-US">metoprolol and felodipine</desc>
                </concept>
                <concept code="C07FB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atenolol and nifedipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atenolol and nifedipine" type="fsn">atenolol and nifedipine</designation>
                    <desc language="en-US">atenolol and nifedipine</desc>
                </concept>
                <concept code="C07FB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bisoprolol and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bisoprolol and amlodipine" type="fsn">bisoprolol and amlodipine</designation>
                    <desc language="en-US">bisoprolol and amlodipine</desc>
                </concept>
                <concept code="C07FB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nebivolol and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nebivolol and amlodipine" type="fsn">nebivolol and amlodipine</designation>
                    <desc language="en-US">nebivolol and amlodipine</desc>
                </concept>
                <concept code="C07FB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoprolol and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metoprolol and amlodipine" type="fsn">metoprolol and amlodipine</designation>
                    <desc language="en-US">metoprolol and amlodipine</desc>
                </concept>
                <concept code="C07FX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta blocking agents, other combinations"
                         type="fsn">Beta blocking agents, other combinations</designation>
                    <desc language="en-US">Beta blocking agents, other combinations</desc>
                </concept>
                <concept code="C07FX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propranolol and other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="propranolol and other combinations"
                         type="fsn">propranolol and other combinations</designation>
                    <desc language="en-US">propranolol and other combinations</desc>
                </concept>
                <concept code="C07FX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sotalol and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sotalol and acetylsalicylic acid"
                         type="fsn">sotalol and acetylsalicylic acid</designation>
                    <desc language="en-US">sotalol and acetylsalicylic acid</desc>
                </concept>
                <concept code="C07FX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoprolol and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metoprolol and acetylsalicylic acid"
                         type="fsn">metoprolol and acetylsalicylic acid</designation>
                    <desc language="en-US">metoprolol and acetylsalicylic acid</desc>
                </concept>
                <concept code="C07FX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bisoprolol and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bisoprolol and acetylsalicylic acid"
                         type="fsn">bisoprolol and acetylsalicylic acid</designation>
                    <desc language="en-US">bisoprolol and acetylsalicylic acid</desc>
                </concept>
                <concept code="C07FX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metoprolol and ivabradine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metoprolol and ivabradine" type="fsn">metoprolol and ivabradine</designation>
                    <desc language="en-US">metoprolol and ivabradine</desc>
                </concept>
                <concept code="C07FX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carvedilol and ivabradine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carvedilol and ivabradine" type="fsn">carvedilol and ivabradine</designation>
                    <desc language="en-US">carvedilol and ivabradine</desc>
                </concept>
                <concept code="C08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CALCIUM CHANNEL BLOCKERS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CALCIUM CHANNEL BLOCKERS" type="fsn">CALCIUM CHANNEL BLOCKERS</designation>
                    <desc language="en-US">CALCIUM CHANNEL BLOCKERS</desc>
                </concept>
                <concept code="C08C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS"
                         type="fsn">SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS</designation>
                    <desc language="en-US">SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS</desc>
                </concept>
                <concept code="C08CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Dihydropyridine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Dihydropyridine derivatives"
                         type="fsn">Dihydropyridine derivatives</designation>
                    <desc language="en-US">Dihydropyridine derivatives</desc>
                </concept>
                <concept code="C08CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amlodipine" type="fsn">amlodipine</designation>
                    <desc language="en-US">amlodipine</desc>
                </concept>
                <concept code="C08CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="felodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="felodipine" type="fsn">felodipine</designation>
                    <desc language="en-US">felodipine</desc>
                </concept>
                <concept code="C08CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isradipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isradipine" type="fsn">isradipine</designation>
                    <desc language="en-US">isradipine</desc>
                </concept>
                <concept code="C08CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicardipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicardipine" type="fsn">nicardipine</designation>
                    <desc language="en-US">nicardipine</desc>
                </concept>
                <concept code="C08CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifedipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifedipine" type="fsn">nifedipine</designation>
                    <desc language="en-US">nifedipine</desc>
                </concept>
                <concept code="C08CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nimodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nimodipine" type="fsn">nimodipine</designation>
                    <desc language="en-US">nimodipine</desc>
                </concept>
                <concept code="C08CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nisoldipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nisoldipine" type="fsn">nisoldipine</designation>
                    <desc language="en-US">nisoldipine</desc>
                </concept>
                <concept code="C08CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrendipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrendipine" type="fsn">nitrendipine</designation>
                    <desc language="en-US">nitrendipine</desc>
                </concept>
                <concept code="C08CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lacidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lacidipine" type="fsn">lacidipine</designation>
                    <desc language="en-US">lacidipine</desc>
                </concept>
                <concept code="C08CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nilvadipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nilvadipine" type="fsn">nilvadipine</designation>
                    <desc language="en-US">nilvadipine</desc>
                </concept>
                <concept code="C08CA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="manidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="manidipine" type="fsn">manidipine</designation>
                    <desc language="en-US">manidipine</desc>
                </concept>
                <concept code="C08CA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="barnidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="barnidipine" type="fsn">barnidipine</designation>
                    <desc language="en-US">barnidipine</desc>
                </concept>
                <concept code="C08CA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lercanidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lercanidipine" type="fsn">lercanidipine</designation>
                    <desc language="en-US">lercanidipine</desc>
                </concept>
                <concept code="C08CA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cilnidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cilnidipine" type="fsn">cilnidipine</designation>
                    <desc language="en-US">cilnidipine</desc>
                </concept>
                <concept code="C08CA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benidipine" type="fsn">benidipine</designation>
                    <desc language="en-US">benidipine</desc>
                </concept>
                <concept code="C08CA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clevidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clevidipine" type="fsn">clevidipine</designation>
                    <desc language="en-US">clevidipine</desc>
                </concept>
                <concept code="C08CA55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifedipine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifedipine, combinations" type="fsn">nifedipine, combinations</designation>
                    <desc language="en-US">nifedipine, combinations</desc>
                </concept>
                <concept code="C08CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other selective calcium channel blockers with mainly vascular effects"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other selective calcium channel blockers with mainly vascular effects"
                         type="fsn">Other selective calcium channel blockers with mainly vascular effects</designation>
                    <desc language="en-US">Other selective calcium channel blockers with mainly vascular effects</desc>
                </concept>
                <concept code="C08CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mibefradil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mibefradil" type="fsn">mibefradil</designation>
                    <desc language="en-US">mibefradil</desc>
                </concept>
                <concept code="C08D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS"
                         type="fsn">SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS</designation>
                    <desc language="en-US">SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS</desc>
                </concept>
                <concept code="C08DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phenylalkylamine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Phenylalkylamine derivatives"
                         type="fsn">Phenylalkylamine derivatives</designation>
                    <desc language="en-US">Phenylalkylamine derivatives</desc>
                </concept>
                <concept code="C08DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="verapamil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="verapamil" type="fsn">verapamil</designation>
                    <desc language="en-US">verapamil</desc>
                </concept>
                <concept code="C08DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gallopamil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gallopamil" type="fsn">gallopamil</designation>
                    <desc language="en-US">gallopamil</desc>
                </concept>
                <concept code="C08DA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="verapamil, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="verapamil, combinations" type="fsn">verapamil, combinations</designation>
                    <desc language="en-US">verapamil, combinations</desc>
                </concept>
                <concept code="C08DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Benzothiazepine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Benzothiazepine derivatives"
                         type="fsn">Benzothiazepine derivatives</designation>
                    <desc language="en-US">Benzothiazepine derivatives</desc>
                </concept>
                <concept code="C08DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diltiazem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diltiazem" type="fsn">diltiazem</designation>
                    <desc language="en-US">diltiazem</desc>
                </concept>
                <concept code="C08E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="NON-SELECTIVE CALCIUM CHANNEL BLOCKERS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="NON-SELECTIVE CALCIUM CHANNEL BLOCKERS"
                         type="fsn">NON-SELECTIVE CALCIUM CHANNEL BLOCKERS</designation>
                    <desc language="en-US">NON-SELECTIVE CALCIUM CHANNEL BLOCKERS</desc>
                </concept>
                <concept code="C08EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phenylalkylamine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Phenylalkylamine derivatives"
                         type="fsn">Phenylalkylamine derivatives</designation>
                    <desc language="en-US">Phenylalkylamine derivatives</desc>
                </concept>
                <concept code="C08EA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fendiline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fendiline" type="fsn">fendiline</designation>
                    <desc language="en-US">fendiline</desc>
                </concept>
                <concept code="C08EA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bepridil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bepridil" type="fsn">bepridil</designation>
                    <desc language="en-US">bepridil</desc>
                </concept>
                <concept code="C08EX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other non-selective calcium channel blockers"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other non-selective calcium channel blockers"
                         type="fsn">Other non-selective calcium channel blockers</designation>
                    <desc language="en-US">Other non-selective calcium channel blockers</desc>
                </concept>
                <concept code="C08EX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidoflazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidoflazine" type="fsn">lidoflazine</designation>
                    <desc language="en-US">lidoflazine</desc>
                </concept>
                <concept code="C08EX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perhexiline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="perhexiline" type="fsn">perhexiline</designation>
                    <desc language="en-US">perhexiline</desc>
                </concept>
                <concept code="C08G"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CALCIUM CHANNEL BLOCKERS AND DIURETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CALCIUM CHANNEL BLOCKERS AND DIURETICS"
                         type="fsn">CALCIUM CHANNEL BLOCKERS AND DIURETICS</designation>
                    <desc language="en-US">CALCIUM CHANNEL BLOCKERS AND DIURETICS</desc>
                </concept>
                <concept code="C08GA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Calcium channel blockers and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Calcium channel blockers and diuretics"
                         type="fsn">Calcium channel blockers and diuretics</designation>
                    <desc language="en-US">Calcium channel blockers and diuretics</desc>
                </concept>
                <concept code="C08GA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifedipine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifedipine and diuretics" type="fsn">nifedipine and diuretics</designation>
                    <desc language="en-US">nifedipine and diuretics</desc>
                </concept>
                <concept code="C08GA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amlodipine and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amlodipine and diuretics" type="fsn">amlodipine and diuretics</designation>
                    <desc language="en-US">amlodipine and diuretics</desc>
                </concept>
                <concept code="C09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM"
                         type="fsn">AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM</designation>
                    <desc language="en-US">AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM</desc>
                </concept>
                <concept code="C09A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ACE INHIBITORS, PLAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ACE INHIBITORS, PLAIN" type="fsn">ACE INHIBITORS, PLAIN</designation>
                    <desc language="en-US">ACE INHIBITORS, PLAIN</desc>
                </concept>
                <concept code="C09AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ACE inhibitors, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ACE inhibitors, plain" type="fsn">ACE inhibitors, plain</designation>
                    <desc language="en-US">ACE inhibitors, plain</desc>
                </concept>
                <concept code="C09AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="captopril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="captopril" type="fsn">captopril</designation>
                    <desc language="en-US">captopril</desc>
                </concept>
                <concept code="C09AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enalapril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enalapril" type="fsn">enalapril</designation>
                    <desc language="en-US">enalapril</desc>
                </concept>
                <concept code="C09AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lisinopril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lisinopril" type="fsn">lisinopril</designation>
                    <desc language="en-US">lisinopril</desc>
                </concept>
                <concept code="C09AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perindopril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="perindopril" type="fsn">perindopril</designation>
                    <desc language="en-US">perindopril</desc>
                </concept>
                <concept code="C09AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ramipril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ramipril" type="fsn">ramipril</designation>
                    <desc language="en-US">ramipril</desc>
                </concept>
                <concept code="C09AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinapril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinapril" type="fsn">quinapril</designation>
                    <desc language="en-US">quinapril</desc>
                </concept>
                <concept code="C09AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benazepril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benazepril" type="fsn">benazepril</designation>
                    <desc language="en-US">benazepril</desc>
                </concept>
                <concept code="C09AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cilazapril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cilazapril" type="fsn">cilazapril</designation>
                    <desc language="en-US">cilazapril</desc>
                </concept>
                <concept code="C09AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fosinopril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fosinopril" type="fsn">fosinopril</designation>
                    <desc language="en-US">fosinopril</desc>
                </concept>
                <concept code="C09AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trandolapril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trandolapril" type="fsn">trandolapril</designation>
                    <desc language="en-US">trandolapril</desc>
                </concept>
                <concept code="C09AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="spirapril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="spirapril" type="fsn">spirapril</designation>
                    <desc language="en-US">spirapril</desc>
                </concept>
                <concept code="C09AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="delapril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="delapril" type="fsn">delapril</designation>
                    <desc language="en-US">delapril</desc>
                </concept>
                <concept code="C09AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moexipril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moexipril" type="fsn">moexipril</designation>
                    <desc language="en-US">moexipril</desc>
                </concept>
                <concept code="C09AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="temocapril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="temocapril" type="fsn">temocapril</designation>
                    <desc language="en-US">temocapril</desc>
                </concept>
                <concept code="C09AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zofenopril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zofenopril" type="fsn">zofenopril</designation>
                    <desc language="en-US">zofenopril</desc>
                </concept>
                <concept code="C09AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imidapril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imidapril" type="fsn">imidapril</designation>
                    <desc language="en-US">imidapril</desc>
                </concept>
                <concept code="C09B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ACE INHIBITORS, COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ACE INHIBITORS, COMBINATIONS"
                         type="fsn">ACE INHIBITORS, COMBINATIONS</designation>
                    <desc language="en-US">ACE INHIBITORS, COMBINATIONS</desc>
                </concept>
                <concept code="C09BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ACE inhibitors and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ACE inhibitors and diuretics"
                         type="fsn">ACE inhibitors and diuretics</designation>
                    <desc language="en-US">ACE inhibitors and diuretics</desc>
                </concept>
                <concept code="C09BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="captopril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="captopril and diuretics" type="fsn">captopril and diuretics</designation>
                    <desc language="en-US">captopril and diuretics</desc>
                </concept>
                <concept code="C09BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enalapril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enalapril and diuretics" type="fsn">enalapril and diuretics</designation>
                    <desc language="en-US">enalapril and diuretics</desc>
                </concept>
                <concept code="C09BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lisinopril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lisinopril and diuretics" type="fsn">lisinopril and diuretics</designation>
                    <desc language="en-US">lisinopril and diuretics</desc>
                </concept>
                <concept code="C09BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perindopril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="perindopril and diuretics" type="fsn">perindopril and diuretics</designation>
                    <desc language="en-US">perindopril and diuretics</desc>
                </concept>
                <concept code="C09BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ramipril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ramipril and diuretics" type="fsn">ramipril and diuretics</designation>
                    <desc language="en-US">ramipril and diuretics</desc>
                </concept>
                <concept code="C09BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinapril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinapril and diuretics" type="fsn">quinapril and diuretics</designation>
                    <desc language="en-US">quinapril and diuretics</desc>
                </concept>
                <concept code="C09BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benazepril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benazepril and diuretics" type="fsn">benazepril and diuretics</designation>
                    <desc language="en-US">benazepril and diuretics</desc>
                </concept>
                <concept code="C09BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cilazapril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cilazapril and diuretics" type="fsn">cilazapril and diuretics</designation>
                    <desc language="en-US">cilazapril and diuretics</desc>
                </concept>
                <concept code="C09BA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fosinopril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fosinopril and diuretics" type="fsn">fosinopril and diuretics</designation>
                    <desc language="en-US">fosinopril and diuretics</desc>
                </concept>
                <concept code="C09BA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="delapril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="delapril and diuretics" type="fsn">delapril and diuretics</designation>
                    <desc language="en-US">delapril and diuretics</desc>
                </concept>
                <concept code="C09BA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moexipril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moexipril and diuretics" type="fsn">moexipril and diuretics</designation>
                    <desc language="en-US">moexipril and diuretics</desc>
                </concept>
                <concept code="C09BA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zofenopril and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zofenopril and diuretics" type="fsn">zofenopril and diuretics</designation>
                    <desc language="en-US">zofenopril and diuretics</desc>
                </concept>
                <concept code="C09BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ACE inhibitors and calcium channel blockers"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ACE inhibitors and calcium channel blockers"
                         type="fsn">ACE inhibitors and calcium channel blockers</designation>
                    <desc language="en-US">ACE inhibitors and calcium channel blockers</desc>
                </concept>
                <concept code="C09BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enalapril and lercanidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="enalapril and lercanidipine"
                         type="fsn">enalapril and lercanidipine</designation>
                    <desc language="en-US">enalapril and lercanidipine</desc>
                </concept>
                <concept code="C09BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lisinopril and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lisinopril and amlodipine" type="fsn">lisinopril and amlodipine</designation>
                    <desc language="en-US">lisinopril and amlodipine</desc>
                </concept>
                <concept code="C09BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perindopril and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="perindopril and amlodipine"
                         type="fsn">perindopril and amlodipine</designation>
                    <desc language="en-US">perindopril and amlodipine</desc>
                </concept>
                <concept code="C09BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ramipril and felodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ramipril and felodipine" type="fsn">ramipril and felodipine</designation>
                    <desc language="en-US">ramipril and felodipine</desc>
                </concept>
                <concept code="C09BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enalapril and nitrendipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="enalapril and nitrendipine"
                         type="fsn">enalapril and nitrendipine</designation>
                    <desc language="en-US">enalapril and nitrendipine</desc>
                </concept>
                <concept code="C09BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ramipril and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ramipril and amlodipine" type="fsn">ramipril and amlodipine</designation>
                    <desc language="en-US">ramipril and amlodipine</desc>
                </concept>
                <concept code="C09BB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trandolapril and verapamil"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="trandolapril and verapamil"
                         type="fsn">trandolapril and verapamil</designation>
                    <desc language="en-US">trandolapril and verapamil</desc>
                </concept>
                <concept code="C09BB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="delapril and manidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="delapril and manidipine" type="fsn">delapril and manidipine</designation>
                    <desc language="en-US">delapril and manidipine</desc>
                </concept>
                <concept code="C09BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ACE inhibitors, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ACE inhibitors, other combinations"
                         type="fsn">ACE inhibitors, other combinations</designation>
                    <desc language="en-US">ACE inhibitors, other combinations</desc>
                </concept>
                <concept code="C09BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perindopril, amlodipine and indapamide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="perindopril, amlodipine and indapamide"
                         type="fsn">perindopril, amlodipine and indapamide</designation>
                    <desc language="en-US">perindopril, amlodipine and indapamide</desc>
                </concept>
                <concept code="C09BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perindopril and bisoprolol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="perindopril and bisoprolol"
                         type="fsn">perindopril and bisoprolol</designation>
                    <desc language="en-US">perindopril and bisoprolol</desc>
                </concept>
                <concept code="C09BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ramipril, amlodipine and hydrochlorothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ramipril, amlodipine and hydrochlorothiazide"
                         type="fsn">ramipril, amlodipine and hydrochlorothiazide</designation>
                    <desc language="en-US">ramipril, amlodipine and hydrochlorothiazide</desc>
                </concept>
                <concept code="C09C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN"
                         type="fsn">ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN</designation>
                    <desc language="en-US">ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN</desc>
                </concept>
                <concept code="C09CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Angiotensin II receptor blockers (ARBs), plain"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Angiotensin II receptor blockers (ARBs), plain"
                         type="fsn">Angiotensin II receptor blockers (ARBs), plain</designation>
                    <desc language="en-US">Angiotensin II receptor blockers (ARBs), plain</desc>
                </concept>
                <concept code="C09CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="losartan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="losartan" type="fsn">losartan</designation>
                    <desc language="en-US">losartan</desc>
                </concept>
                <concept code="C09CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eprosartan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eprosartan" type="fsn">eprosartan</designation>
                    <desc language="en-US">eprosartan</desc>
                </concept>
                <concept code="C09CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valsartan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valsartan" type="fsn">valsartan</designation>
                    <desc language="en-US">valsartan</desc>
                </concept>
                <concept code="C09CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="irbesartan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="irbesartan" type="fsn">irbesartan</designation>
                    <desc language="en-US">irbesartan</desc>
                </concept>
                <concept code="C09CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tasosartan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tasosartan" type="fsn">tasosartan</designation>
                    <desc language="en-US">tasosartan</desc>
                </concept>
                <concept code="C09CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="candesartan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="candesartan" type="fsn">candesartan</designation>
                    <desc language="en-US">candesartan</desc>
                </concept>
                <concept code="C09CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="telmisartan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="telmisartan" type="fsn">telmisartan</designation>
                    <desc language="en-US">telmisartan</desc>
                </concept>
                <concept code="C09CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olmesartan medoxomil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olmesartan medoxomil" type="fsn">olmesartan medoxomil</designation>
                    <desc language="en-US">olmesartan medoxomil</desc>
                </concept>
                <concept code="C09CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azilsartan medoxomil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azilsartan medoxomil" type="fsn">azilsartan medoxomil</designation>
                    <desc language="en-US">azilsartan medoxomil</desc>
                </concept>
                <concept code="C09CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fimasartan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fimasartan" type="fsn">fimasartan</designation>
                    <desc language="en-US">fimasartan</desc>
                </concept>
                <concept code="C09D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS"
                         type="fsn">ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS</designation>
                    <desc language="en-US">ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS</desc>
                </concept>
                <concept code="C09DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Angiotensin II receptor blockers (ARBs) and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Angiotensin II receptor blockers (ARBs) and diuretics"
                         type="fsn">Angiotensin II receptor blockers (ARBs) and diuretics</designation>
                    <desc language="en-US">Angiotensin II receptor blockers (ARBs) and diuretics</desc>
                </concept>
                <concept code="C09DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="losartan and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="losartan and diuretics" type="fsn">losartan and diuretics</designation>
                    <desc language="en-US">losartan and diuretics</desc>
                </concept>
                <concept code="C09DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eprosartan and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eprosartan and diuretics" type="fsn">eprosartan and diuretics</designation>
                    <desc language="en-US">eprosartan and diuretics</desc>
                </concept>
                <concept code="C09DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valsartan and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valsartan and diuretics" type="fsn">valsartan and diuretics</designation>
                    <desc language="en-US">valsartan and diuretics</desc>
                </concept>
                <concept code="C09DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="irbesartan and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="irbesartan and diuretics" type="fsn">irbesartan and diuretics</designation>
                    <desc language="en-US">irbesartan and diuretics</desc>
                </concept>
                <concept code="C09DA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="candesartan and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="candesartan and diuretics" type="fsn">candesartan and diuretics</designation>
                    <desc language="en-US">candesartan and diuretics</desc>
                </concept>
                <concept code="C09DA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="telmisartan and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="telmisartan and diuretics" type="fsn">telmisartan and diuretics</designation>
                    <desc language="en-US">telmisartan and diuretics</desc>
                </concept>
                <concept code="C09DA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olmesartan medoxomil and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="olmesartan medoxomil and diuretics"
                         type="fsn">olmesartan medoxomil and diuretics</designation>
                    <desc language="en-US">olmesartan medoxomil and diuretics</desc>
                </concept>
                <concept code="C09DA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azilsartan medoxomil and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="azilsartan medoxomil and diuretics"
                         type="fsn">azilsartan medoxomil and diuretics</designation>
                    <desc language="en-US">azilsartan medoxomil and diuretics</desc>
                </concept>
                <concept code="C09DA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fimasartan and diuretics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fimasartan and diuretics" type="fsn">fimasartan and diuretics</designation>
                    <desc language="en-US">fimasartan and diuretics</desc>
                </concept>
                <concept code="C09DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
                         type="fsn">Angiotensin II receptor blockers (ARBs) and calcium channel blockers</designation>
                    <desc language="en-US">Angiotensin II receptor blockers (ARBs) and calcium channel blockers</desc>
                </concept>
                <concept code="C09DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valsartan and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valsartan and amlodipine" type="fsn">valsartan and amlodipine</designation>
                    <desc language="en-US">valsartan and amlodipine</desc>
                </concept>
                <concept code="C09DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olmesartan medoxomil and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="olmesartan medoxomil and amlodipine"
                         type="fsn">olmesartan medoxomil and amlodipine</designation>
                    <desc language="en-US">olmesartan medoxomil and amlodipine</desc>
                </concept>
                <concept code="C09DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="telmisartan and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="telmisartan and amlodipine"
                         type="fsn">telmisartan and amlodipine</designation>
                    <desc language="en-US">telmisartan and amlodipine</desc>
                </concept>
                <concept code="C09DB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="irbesartan and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="irbesartan and amlodipine" type="fsn">irbesartan and amlodipine</designation>
                    <desc language="en-US">irbesartan and amlodipine</desc>
                </concept>
                <concept code="C09DB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="losartan and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="losartan and amlodipine" type="fsn">losartan and amlodipine</designation>
                    <desc language="en-US">losartan and amlodipine</desc>
                </concept>
                <concept code="C09DB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="candesartan and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="candesartan and amlodipine"
                         type="fsn">candesartan and amlodipine</designation>
                    <desc language="en-US">candesartan and amlodipine</desc>
                </concept>
                <concept code="C09DB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valsartan and lercanidipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="valsartan and lercanidipine"
                         type="fsn">valsartan and lercanidipine</designation>
                    <desc language="en-US">valsartan and lercanidipine</desc>
                </concept>
                <concept code="C09DX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Angiotensin II receptor blockers (ARBs), other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Angiotensin II receptor blockers (ARBs), other combinations"
                         type="fsn">Angiotensin II receptor blockers (ARBs), other combinations</designation>
                    <desc language="en-US">Angiotensin II receptor blockers (ARBs), other combinations</desc>
                </concept>
                <concept code="C09DX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valsartan, amlodipine and hydrochlorothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="valsartan, amlodipine and hydrochlorothiazide"
                         type="fsn">valsartan, amlodipine and hydrochlorothiazide</designation>
                    <desc language="en-US">valsartan, amlodipine and hydrochlorothiazide</desc>
                </concept>
                <concept code="C09DX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valsartan and aliskiren"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valsartan and aliskiren" type="fsn">valsartan and aliskiren</designation>
                    <desc language="en-US">valsartan and aliskiren</desc>
                </concept>
                <concept code="C09DX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olmesartan medoxomil, amlodipine and hydrochlorothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="olmesartan medoxomil, amlodipine and hydrochlorothiazide"
                         type="fsn">olmesartan medoxomil, amlodipine and hydrochlorothiazide</designation>
                    <desc language="en-US">olmesartan medoxomil, amlodipine and hydrochlorothiazide</desc>
                </concept>
                <concept code="C09DX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valsartan and sacubitril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valsartan and sacubitril" type="fsn">valsartan and sacubitril</designation>
                    <desc language="en-US">valsartan and sacubitril</desc>
                </concept>
                <concept code="C09DX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valsartan and nebivolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valsartan and nebivolol" type="fsn">valsartan and nebivolol</designation>
                    <desc language="en-US">valsartan and nebivolol</desc>
                </concept>
                <concept code="C09DX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="candesartan, amlodipine and hydrochlorothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="candesartan, amlodipine and hydrochlorothiazide"
                         type="fsn">candesartan, amlodipine and hydrochlorothiazide</designation>
                    <desc language="en-US">candesartan, amlodipine and hydrochlorothiazide</desc>
                </concept>
                <concept code="C09X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM"
                         type="fsn">OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM</designation>
                    <desc language="en-US">OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM</desc>
                </concept>
                <concept code="C09XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Renin-inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Renin-inhibitors" type="fsn">Renin-inhibitors</designation>
                    <desc language="en-US">Renin-inhibitors</desc>
                </concept>
                <concept code="C09XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="remikiren"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="remikiren" type="fsn">remikiren</designation>
                    <desc language="en-US">remikiren</desc>
                </concept>
                <concept code="C09X             A02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aliskiren"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aliskiren" type="fsn">aliskiren</designation>
                    <desc language="en-US">aliskiren</desc>
                </concept>
                <concept code="C09XA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aliskiren and hydrochlorothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="aliskiren and hydrochlorothiazide"
                         type="fsn">aliskiren and hydrochlorothiazide</designation>
                    <desc language="en-US">aliskiren and hydrochlorothiazide</desc>
                </concept>
                <concept code="C09XA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aliskiren and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aliskiren and amlodipine" type="fsn">aliskiren and amlodipine</designation>
                    <desc language="en-US">aliskiren and amlodipine</desc>
                </concept>
                <concept code="C09XA54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aliskiren, amlodipine and hydrochlorothiazide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="aliskiren, amlodipine and hydrochlorothiazide"
                         type="fsn">aliskiren, amlodipine and hydrochlorothiazide</designation>
                    <desc language="en-US">aliskiren, amlodipine and hydrochlorothiazide</desc>
                </concept>
                <concept code="C10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="LIPID MODIFYING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="LIPID MODIFYING AGENTS" type="fsn">LIPID MODIFYING AGENTS</designation>
                    <desc language="en-US">LIPID MODIFYING AGENTS</desc>
                </concept>
                <concept code="C10A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="LIPID MODIFYING AGENTS, PLAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="LIPID MODIFYING AGENTS, PLAIN"
                         type="fsn">LIPID MODIFYING AGENTS, PLAIN</designation>
                    <desc language="en-US">LIPID MODIFYING AGENTS, PLAIN</desc>
                </concept>
                <concept code="C10AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HMG CoA reductase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="HMG CoA reductase inhibitors"
                         type="fsn">HMG CoA reductase inhibitors</designation>
                    <desc language="en-US">HMG CoA reductase inhibitors</desc>
                </concept>
                <concept code="C10AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="simvastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="simvastatin" type="fsn">simvastatin</designation>
                    <desc language="en-US">simvastatin</desc>
                </concept>
                <concept code="C10AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lovastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lovastatin" type="fsn">lovastatin</designation>
                    <desc language="en-US">lovastatin</desc>
                </concept>
                <concept code="C10AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pravastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pravastatin" type="fsn">pravastatin</designation>
                    <desc language="en-US">pravastatin</desc>
                </concept>
                <concept code="C10AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluvastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluvastatin" type="fsn">fluvastatin</designation>
                    <desc language="en-US">fluvastatin</desc>
                </concept>
                <concept code="C10AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atorvastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atorvastatin" type="fsn">atorvastatin</designation>
                    <desc language="en-US">atorvastatin</desc>
                </concept>
                <concept code="C10AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cerivastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cerivastatin" type="fsn">cerivastatin</designation>
                    <desc language="en-US">cerivastatin</desc>
                </concept>
                <concept code="C10AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosuvastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rosuvastatin" type="fsn">rosuvastatin</designation>
                    <desc language="en-US">rosuvastatin</desc>
                </concept>
                <concept code="C10AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pitavastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pitavastatin" type="fsn">pitavastatin</designation>
                    <desc language="en-US">pitavastatin</desc>
                </concept>
                <concept code="C10AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fibrates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Fibrates" type="fsn">Fibrates</designation>
                    <desc language="en-US">Fibrates</desc>
                </concept>
                <concept code="C10AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofibrate" type="fsn">clofibrate</designation>
                    <desc language="en-US">clofibrate</desc>
                </concept>
                <concept code="C10AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bezafibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bezafibrate" type="fsn">bezafibrate</designation>
                    <desc language="en-US">bezafibrate</desc>
                </concept>
                <concept code="C10AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium clofibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium clofibrate" type="fsn">aluminium clofibrate</designation>
                    <desc language="en-US">aluminium clofibrate</desc>
                </concept>
                <concept code="C10AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gemfibrozil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gemfibrozil" type="fsn">gemfibrozil</designation>
                    <desc language="en-US">gemfibrozil</desc>
                </concept>
                <concept code="C10AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenofibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenofibrate" type="fsn">fenofibrate</designation>
                    <desc language="en-US">fenofibrate</desc>
                </concept>
                <concept code="C10AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="simfibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="simfibrate" type="fsn">simfibrate</designation>
                    <desc language="en-US">simfibrate</desc>
                </concept>
                <concept code="C10AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ronifibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ronifibrate" type="fsn">ronifibrate</designation>
                    <desc language="en-US">ronifibrate</desc>
                </concept>
                <concept code="C10AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciprofibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciprofibrate" type="fsn">ciprofibrate</designation>
                    <desc language="en-US">ciprofibrate</desc>
                </concept>
                <concept code="C10AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etofibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etofibrate" type="fsn">etofibrate</designation>
                    <desc language="en-US">etofibrate</desc>
                </concept>
                <concept code="C10AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofibride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofibride" type="fsn">clofibride</designation>
                    <desc language="en-US">clofibride</desc>
                </concept>
                <concept code="C10AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="choline fenofibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="choline fenofibrate" type="fsn">choline fenofibrate</designation>
                    <desc language="en-US">choline fenofibrate</desc>
                </concept>
                <concept code="C10AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bile acid sequestrants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Bile acid sequestrants" type="fsn">Bile acid sequestrants</designation>
                    <desc language="en-US">Bile acid sequestrants</desc>
                </concept>
                <concept code="C10AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colestyramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colestyramine" type="fsn">colestyramine</designation>
                    <desc language="en-US">colestyramine</desc>
                </concept>
                <concept code="C10AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colestipol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colestipol" type="fsn">colestipol</designation>
                    <desc language="en-US">colestipol</desc>
                </concept>
                <concept code="C10AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colextran"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colextran" type="fsn">colextran</designation>
                    <desc language="en-US">colextran</desc>
                </concept>
                <concept code="C10AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colesevelam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colesevelam" type="fsn">colesevelam</designation>
                    <desc language="en-US">colesevelam</desc>
                </concept>
                <concept code="C10AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nicotinic acid and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nicotinic acid and derivatives"
                         type="fsn">Nicotinic acid and derivatives</designation>
                    <desc language="en-US">Nicotinic acid and derivatives</desc>
                </concept>
                <concept code="C10AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="niceritrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="niceritrol" type="fsn">niceritrol</designation>
                    <desc language="en-US">niceritrol</desc>
                </concept>
                <concept code="C10AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicotinic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicotinic acid" type="fsn">nicotinic acid</designation>
                    <desc language="en-US">nicotinic acid</desc>
                </concept>
                <concept code="C10AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicofuranose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicofuranose" type="fsn">nicofuranose</designation>
                    <desc language="en-US">nicofuranose</desc>
                </concept>
                <concept code="C10AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium nicotinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium nicotinate" type="fsn">aluminium nicotinate</designation>
                    <desc language="en-US">aluminium nicotinate</desc>
                </concept>
                <concept code="C10AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicotinyl alcohol (pyridylcarbinol)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="nicotinyl alcohol (pyridylcarbinol)"
                         type="fsn">nicotinyl alcohol (pyridylcarbinol)</designation>
                    <desc language="en-US">nicotinyl alcohol (pyridylcarbinol)</desc>
                </concept>
                <concept code="C10AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acipimox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acipimox" type="fsn">acipimox</designation>
                    <desc language="en-US">acipimox</desc>
                </concept>
                <concept code="C10AD52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicotinic acid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="nicotinic acid, combinations"
                         type="fsn">nicotinic acid, combinations</designation>
                    <desc language="en-US">nicotinic acid, combinations</desc>
                </concept>
                <concept code="C10AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other lipid modifying agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other lipid modifying agents"
                         type="fsn">Other lipid modifying agents</designation>
                    <desc language="en-US">Other lipid modifying agents</desc>
                </concept>
                <concept code="C10AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextrothyroxine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dextrothyroxine" type="fsn">dextrothyroxine</designation>
                    <desc language="en-US">dextrothyroxine</desc>
                </concept>
                <concept code="C10AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="probucol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="probucol" type="fsn">probucol</designation>
                    <desc language="en-US">probucol</desc>
                </concept>
                <concept code="C10AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiadenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiadenol" type="fsn">tiadenol</designation>
                    <desc language="en-US">tiadenol</desc>
                </concept>
                <concept code="C10AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meglutol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meglutol" type="fsn">meglutol</designation>
                    <desc language="en-US">meglutol</desc>
                </concept>
                <concept code="C10AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omega-3-triglycerides incl. other esters and acids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="omega-3-triglycerides incl. other esters and acids"
                         type="fsn">omega-3-triglycerides incl. other esters and acids</designation>
                    <desc language="en-US">omega-3-triglycerides incl. other esters and acids</desc>
                </concept>
                <concept code="C10AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium pyridoxal 5-phosphate glutamate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="magnesium pyridoxal 5-phosphate glutamate"
                         type="fsn">magnesium pyridoxal 5-phosphate glutamate</designation>
                    <desc language="en-US">magnesium pyridoxal 5-phosphate glutamate</desc>
                </concept>
                <concept code="C10AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="policosanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="policosanol" type="fsn">policosanol</designation>
                    <desc language="en-US">policosanol</desc>
                </concept>
                <concept code="C10AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ezetimibe"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ezetimibe" type="fsn">ezetimibe</designation>
                    <desc language="en-US">ezetimibe</desc>
                </concept>
                <concept code="C10AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alipogene tiparvovec"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alipogene tiparvovec" type="fsn">alipogene tiparvovec</designation>
                    <desc language="en-US">alipogene tiparvovec</desc>
                </concept>
                <concept code="C10AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mipomersen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mipomersen" type="fsn">mipomersen</designation>
                    <desc language="en-US">mipomersen</desc>
                </concept>
                <concept code="C10AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lomitapide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lomitapide" type="fsn">lomitapide</designation>
                    <desc language="en-US">lomitapide</desc>
                </concept>
                <concept code="C10AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="evolocumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="evolocumab" type="fsn">evolocumab</designation>
                    <desc language="en-US">evolocumab</desc>
                </concept>
                <concept code="C10AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alirocumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alirocumab" type="fsn">alirocumab</designation>
                    <desc language="en-US">alirocumab</desc>
                </concept>
                <concept code="C10B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="LIPID MODIFYING AGENTS, COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="LIPID MODIFYING AGENTS, COMBINATIONS"
                         type="fsn">LIPID MODIFYING AGENTS, COMBINATIONS</designation>
                    <desc language="en-US">LIPID MODIFYING AGENTS, COMBINATIONS</desc>
                </concept>
                <concept code="C10BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HMG CoA reductase inhibitors in combination with other lipid modifying agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="HMG CoA reductase inhibitors in combination with other lipid modifying agents"
                         type="fsn">HMG CoA reductase inhibitors in combination with other lipid modifying agents</designation>
                    <desc language="en-US">HMG CoA reductase inhibitors in combination with other lipid modifying agents</desc>
                </concept>
                <concept code="C10BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lovastatin and nicotinic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lovastatin and nicotinic acid"
                         type="fsn">lovastatin and nicotinic acid</designation>
                    <desc language="en-US">lovastatin and nicotinic acid</desc>
                </concept>
                <concept code="C10BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="simvastatin and ezetimibe"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="simvastatin and ezetimibe" type="fsn">simvastatin and ezetimibe</designation>
                    <desc language="en-US">simvastatin and ezetimibe</desc>
                </concept>
                <concept code="C10BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pravastatin and fenofibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pravastatin and fenofibrate"
                         type="fsn">pravastatin and fenofibrate</designation>
                    <desc language="en-US">pravastatin and fenofibrate</desc>
                </concept>
                <concept code="C10BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="simvastatin and fenofibrate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="simvastatin and fenofibrate"
                         type="fsn">simvastatin and fenofibrate</designation>
                    <desc language="en-US">simvastatin and fenofibrate</desc>
                </concept>
                <concept code="C10BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atorvastatin and ezetimibe"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atorvastatin and ezetimibe"
                         type="fsn">atorvastatin and ezetimibe</designation>
                    <desc language="en-US">atorvastatin and ezetimibe</desc>
                </concept>
                <concept code="C10BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosuvastatin and ezetimibe"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rosuvastatin and ezetimibe"
                         type="fsn">rosuvastatin and ezetimibe</designation>
                    <desc language="en-US">rosuvastatin and ezetimibe</desc>
                </concept>
                <concept code="C10BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HMG CoA reductase inhibitors, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="HMG CoA reductase inhibitors, other combinations"
                         type="fsn">HMG CoA reductase inhibitors, other combinations</designation>
                    <desc language="en-US">HMG CoA reductase inhibitors, other combinations</desc>
                </concept>
                <concept code="C10BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="simvastatin and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="simvastatin and acetylsalicylic acid"
                         type="fsn">simvastatin and acetylsalicylic acid</designation>
                    <desc language="en-US">simvastatin and acetylsalicylic acid</desc>
                </concept>
                <concept code="C10BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pravastatin and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pravastatin and acetylsalicylic acid"
                         type="fsn">pravastatin and acetylsalicylic acid</designation>
                    <desc language="en-US">pravastatin and acetylsalicylic acid</desc>
                </concept>
                <concept code="C10BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atorvastatin and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atorvastatin and amlodipine"
                         type="fsn">atorvastatin and amlodipine</designation>
                    <desc language="en-US">atorvastatin and amlodipine</desc>
                </concept>
                <concept code="C10BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="simvastatin, acetylsalicylic acid and ramipril"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="simvastatin, acetylsalicylic acid and ramipril"
                         type="fsn">simvastatin, acetylsalicylic acid and ramipril</designation>
                    <desc language="en-US">simvastatin, acetylsalicylic acid and ramipril</desc>
                </concept>
                <concept code="C10BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosuvastatin and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rosuvastatin and acetylsalicylic acid"
                         type="fsn">rosuvastatin and acetylsalicylic acid</designation>
                    <desc language="en-US">rosuvastatin and acetylsalicylic acid</desc>
                </concept>
                <concept code="C10BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atorvastatin, acetylsalicylic acid and ramipril"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atorvastatin, acetylsalicylic acid and ramipril"
                         type="fsn">atorvastatin, acetylsalicylic acid and ramipril</designation>
                    <desc language="en-US">atorvastatin, acetylsalicylic acid and ramipril</desc>
                </concept>
                <concept code="C10BX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosuvastatin, amlodipine and lisinopril"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rosuvastatin, amlodipine and lisinopril"
                         type="fsn">rosuvastatin, amlodipine and lisinopril</designation>
                    <desc language="en-US">rosuvastatin, amlodipine and lisinopril</desc>
                </concept>
                <concept code="C10BX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atorvastatin and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atorvastatin and acetylsalicylic acid"
                         type="fsn">atorvastatin and acetylsalicylic acid</designation>
                    <desc language="en-US">atorvastatin and acetylsalicylic acid</desc>
                </concept>
                <concept code="C10BX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosuvastatin and amlodipine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rosuvastatin and amlodipine"
                         type="fsn">rosuvastatin and amlodipine</designation>
                    <desc language="en-US">rosuvastatin and amlodipine</desc>
                </concept>
                <concept code="C10BX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosuvastatin and valsartan"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rosuvastatin and valsartan"
                         type="fsn">rosuvastatin and valsartan</designation>
                    <desc language="en-US">rosuvastatin and valsartan</desc>
                </concept>
                <concept code="C10BX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atorvastatin, amlodipine and perindopril"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atorvastatin, amlodipine and perindopril"
                         type="fsn">atorvastatin, amlodipine and perindopril</designation>
                    <desc language="en-US">atorvastatin, amlodipine and perindopril</desc>
                </concept>
                <concept code="C10BX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atorvastatin, acetylsalicylic acid and perindopril"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atorvastatin, acetylsalicylic acid and perindopril"
                         type="fsn">atorvastatin, acetylsalicylic acid and perindopril</designation>
                    <desc language="en-US">atorvastatin, acetylsalicylic acid and perindopril</desc>
                </concept>
                <concept code="C10BX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosuvastatin, perindopril and indapamide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rosuvastatin, perindopril and indapamide"
                         type="fsn">rosuvastatin, perindopril and indapamide</designation>
                    <desc language="en-US">rosuvastatin, perindopril and indapamide</desc>
                </concept>
                <concept code="C10BX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosuvastatin, amlodipine and perindopril"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rosuvastatin, amlodipine and perindopril"
                         type="fsn">rosuvastatin, amlodipine and perindopril</designation>
                    <desc language="en-US">rosuvastatin, amlodipine and perindopril</desc>
                </concept>
                <concept code="C10BX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atorvastatin and perindopril"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="atorvastatin and perindopril"
                         type="fsn">atorvastatin and perindopril</designation>
                    <desc language="en-US">atorvastatin and perindopril</desc>
                </concept>
                <concept code="D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DERMATOLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DERMATOLOGICALS" type="fsn">DERMATOLOGICALS</designation>
                    <desc language="en-US">DERMATOLOGICALS</desc>
                </concept>
                <concept code="D01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIFUNGALS FOR DERMATOLOGICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIFUNGALS FOR DERMATOLOGICAL USE"
                         type="fsn">ANTIFUNGALS FOR DERMATOLOGICAL USE</designation>
                    <desc language="en-US">ANTIFUNGALS FOR DERMATOLOGICAL USE</desc>
                </concept>
                <concept code="D01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIFUNGALS FOR TOPICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIFUNGALS FOR TOPICAL USE"
                         type="fsn">ANTIFUNGALS FOR TOPICAL USE</designation>
                    <desc language="en-US">ANTIFUNGALS FOR TOPICAL USE</desc>
                </concept>
                <concept code="D01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antibiotics" type="fsn">Antibiotics</designation>
                    <desc language="en-US">Antibiotics</desc>
                </concept>
                <concept code="D01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nystatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nystatin" type="fsn">nystatin</designation>
                    <desc language="en-US">nystatin</desc>
                </concept>
                <concept code="D01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="natamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="natamycin" type="fsn">natamycin</designation>
                    <desc language="en-US">natamycin</desc>
                </concept>
                <concept code="D01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hachimycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hachimycin" type="fsn">hachimycin</designation>
                    <desc language="en-US">hachimycin</desc>
                </concept>
                <concept code="D01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pecilocin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pecilocin" type="fsn">pecilocin</designation>
                    <desc language="en-US">pecilocin</desc>
                </concept>
                <concept code="D01AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepartricin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepartricin" type="fsn">mepartricin</designation>
                    <desc language="en-US">mepartricin</desc>
                </concept>
                <concept code="D01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrrolnitrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrrolnitrin" type="fsn">pyrrolnitrin</designation>
                    <desc language="en-US">pyrrolnitrin</desc>
                </concept>
                <concept code="D01AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="griseofulvin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="griseofulvin" type="fsn">griseofulvin</designation>
                    <desc language="en-US">griseofulvin</desc>
                </concept>
                <concept code="D01AA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="D01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazole and triazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Imidazole and triazole derivatives"
                         type="fsn">Imidazole and triazole derivatives</designation>
                    <desc language="en-US">Imidazole and triazole derivatives</desc>
                </concept>
                <concept code="D01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clotrimazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clotrimazole" type="fsn">clotrimazole</designation>
                    <desc language="en-US">clotrimazole</desc>
                </concept>
                <concept code="D01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miconazole" type="fsn">miconazole</designation>
                    <desc language="en-US">miconazole</desc>
                </concept>
                <concept code="D01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="econazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="econazole" type="fsn">econazole</designation>
                    <desc language="en-US">econazole</desc>
                </concept>
                <concept code="D01AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlormidazole" type="fsn">chlormidazole</designation>
                    <desc language="en-US">chlormidazole</desc>
                </concept>
                <concept code="D01AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoconazole" type="fsn">isoconazole</designation>
                    <desc language="en-US">isoconazole</desc>
                </concept>
                <concept code="D01AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiabendazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiabendazole" type="fsn">tiabendazole</designation>
                    <desc language="en-US">tiabendazole</desc>
                </concept>
                <concept code="D01AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tioconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tioconazole" type="fsn">tioconazole</designation>
                    <desc language="en-US">tioconazole</desc>
                </concept>
                <concept code="D01AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketoconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketoconazole" type="fsn">ketoconazole</designation>
                    <desc language="en-US">ketoconazole</desc>
                </concept>
                <concept code="D01AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulconazole" type="fsn">sulconazole</designation>
                    <desc language="en-US">sulconazole</desc>
                </concept>
                <concept code="D01AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bifonazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bifonazole" type="fsn">bifonazole</designation>
                    <desc language="en-US">bifonazole</desc>
                </concept>
                <concept code="D01AC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxiconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxiconazole" type="fsn">oxiconazole</designation>
                    <desc language="en-US">oxiconazole</desc>
                </concept>
                <concept code="D01AC12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenticonazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenticonazole" type="fsn">fenticonazole</designation>
                    <desc language="en-US">fenticonazole</desc>
                </concept>
                <concept code="D01AC13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omoconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="omoconazole" type="fsn">omoconazole</designation>
                    <desc language="en-US">omoconazole</desc>
                </concept>
                <concept code="D01AC14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sertaconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sertaconazole" type="fsn">sertaconazole</designation>
                    <desc language="en-US">sertaconazole</desc>
                </concept>
                <concept code="D01AC15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluconazole" type="fsn">fluconazole</designation>
                    <desc language="en-US">fluconazole</desc>
                </concept>
                <concept code="D01AC16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flutrimazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flutrimazole" type="fsn">flutrimazole</designation>
                    <desc language="en-US">flutrimazole</desc>
                </concept>
                <concept code="D01AC17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eberconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eberconazole" type="fsn">eberconazole</designation>
                    <desc language="en-US">eberconazole</desc>
                </concept>
                <concept code="D01AC18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="luliconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="luliconazole" type="fsn">luliconazole</designation>
                    <desc language="en-US">luliconazole</desc>
                </concept>
                <concept code="D01AC19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="efinaconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="efinaconazole" type="fsn">efinaconazole</designation>
                    <desc language="en-US">efinaconazole</desc>
                </concept>
                <concept code="D01AC20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imidazoles/triazoles in combination with corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="imidazoles/triazoles in combination with corticosteroids"
                         type="fsn">imidazoles/triazoles in combination with corticosteroids</designation>
                    <desc language="en-US">imidazoles/triazoles in combination with corticosteroids</desc>
                </concept>
                <concept code="D01AC52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miconazole, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miconazole, combinations" type="fsn">miconazole, combinations</designation>
                    <desc language="en-US">miconazole, combinations</desc>
                </concept>
                <concept code="D01AC60"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bifonazole, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bifonazole, combinations" type="fsn">bifonazole, combinations</designation>
                    <desc language="en-US">bifonazole, combinations</desc>
                </concept>
                <concept code="D01AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antifungals for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antifungals for topical use"
                         type="fsn">Other antifungals for topical use</designation>
                    <desc language="en-US">Other antifungals for topical use</desc>
                </concept>
                <concept code="D01AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromochlorosalicylanilide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromochlorosalicylanilide" type="fsn">bromochlorosalicylanilide</designation>
                    <desc language="en-US">bromochlorosalicylanilide</desc>
                </concept>
                <concept code="D01AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylrosaniline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylrosaniline" type="fsn">methylrosaniline</designation>
                    <desc language="en-US">methylrosaniline</desc>
                </concept>
                <concept code="D01AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tribromometacresol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tribromometacresol" type="fsn">tribromometacresol</designation>
                    <desc language="en-US">tribromometacresol</desc>
                </concept>
                <concept code="D01AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="undecylenic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="undecylenic acid" type="fsn">undecylenic acid</designation>
                    <desc language="en-US">undecylenic acid</desc>
                </concept>
                <concept code="D01AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polynoxylin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polynoxylin" type="fsn">polynoxylin</designation>
                    <desc language="en-US">polynoxylin</desc>
                </concept>
                <concept code="D01AE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="2-(4-chlorphenoxy)-ethanol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="2-(4-chlorphenoxy)-ethanol"
                         type="fsn">2-(4-chlorphenoxy)-ethanol</designation>
                    <desc language="en-US">2-(4-chlorphenoxy)-ethanol</desc>
                </concept>
                <concept code="D01AE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorphenesin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorphenesin" type="fsn">chlorphenesin</designation>
                    <desc language="en-US">chlorphenesin</desc>
                </concept>
                <concept code="D01AE08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ticlatone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ticlatone" type="fsn">ticlatone</designation>
                    <desc language="en-US">ticlatone</desc>
                </concept>
                <concept code="D01AE09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulbentine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulbentine" type="fsn">sulbentine</designation>
                    <desc language="en-US">sulbentine</desc>
                </concept>
                <concept code="D01AE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethyl hydroxybenzoate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethyl hydroxybenzoate" type="fsn">ethyl hydroxybenzoate</designation>
                    <desc language="en-US">ethyl hydroxybenzoate</desc>
                </concept>
                <concept code="D01AE11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="haloprogin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="haloprogin" type="fsn">haloprogin</designation>
                    <desc language="en-US">haloprogin</desc>
                </concept>
                <concept code="D01AE12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="salicylic acid" type="fsn">salicylic acid</designation>
                    <desc language="en-US">salicylic acid</desc>
                </concept>
                <concept code="D01AE13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="selenium sulfide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="selenium sulfide" type="fsn">selenium sulfide</designation>
                    <desc language="en-US">selenium sulfide</desc>
                </concept>
                <concept code="D01AE14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclopirox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclopirox" type="fsn">ciclopirox</designation>
                    <desc language="en-US">ciclopirox</desc>
                </concept>
                <concept code="D01AE15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terbinafine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terbinafine" type="fsn">terbinafine</designation>
                    <desc language="en-US">terbinafine</desc>
                </concept>
                <concept code="D01AE16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amorolfine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amorolfine" type="fsn">amorolfine</designation>
                    <desc language="en-US">amorolfine</desc>
                </concept>
                <concept code="D01AE17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimazole" type="fsn">dimazole</designation>
                    <desc language="en-US">dimazole</desc>
                </concept>
                <concept code="D01AE18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolnaftate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolnaftate" type="fsn">tolnaftate</designation>
                    <desc language="en-US">tolnaftate</desc>
                </concept>
                <concept code="D01AE19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolciclate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolciclate" type="fsn">tolciclate</designation>
                    <desc language="en-US">tolciclate</desc>
                </concept>
                <concept code="D01AE20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="D01AE21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flucytosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flucytosine" type="fsn">flucytosine</designation>
                    <desc language="en-US">flucytosine</desc>
                </concept>
                <concept code="D01AE22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naftifine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naftifine" type="fsn">naftifine</designation>
                    <desc language="en-US">naftifine</desc>
                </concept>
                <concept code="D01AE23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butenafine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butenafine" type="fsn">butenafine</designation>
                    <desc language="en-US">butenafine</desc>
                </concept>
                <concept code="D01AE24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tavaborole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tavaborole" type="fsn">tavaborole</designation>
                    <desc language="en-US">tavaborole</desc>
                </concept>
                <concept code="D01AE54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="undecylenic acid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="undecylenic acid, combinations"
                         type="fsn">undecylenic acid, combinations</designation>
                    <desc language="en-US">undecylenic acid, combinations</desc>
                </concept>
                <concept code="D01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIFUNGALS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIFUNGALS FOR SYSTEMIC USE"
                         type="fsn">ANTIFUNGALS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIFUNGALS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="D01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antifungals for systemic use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antifungals for systemic use"
                         type="fsn">Antifungals for systemic use</designation>
                    <desc language="en-US">Antifungals for systemic use</desc>
                </concept>
                <concept code="D01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="griseofulvin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="griseofulvin" type="fsn">griseofulvin</designation>
                    <desc language="en-US">griseofulvin</desc>
                </concept>
                <concept code="D01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terbinafine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terbinafine" type="fsn">terbinafine</designation>
                    <desc language="en-US">terbinafine</desc>
                </concept>
                <concept code="D02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="EMOLLIENTS AND PROTECTIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="EMOLLIENTS AND PROTECTIVES"
                         type="fsn">EMOLLIENTS AND PROTECTIVES</designation>
                    <desc language="en-US">EMOLLIENTS AND PROTECTIVES</desc>
                </concept>
                <concept code="D02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="EMOLLIENTS AND PROTECTIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="EMOLLIENTS AND PROTECTIVES"
                         type="fsn">EMOLLIENTS AND PROTECTIVES</designation>
                    <desc language="en-US">EMOLLIENTS AND PROTECTIVES</desc>
                </concept>
                <concept code="D02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Silicone products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Silicone products" type="fsn">Silicone products</designation>
                    <desc language="en-US">Silicone products</desc>
                </concept>
                <concept code="D02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Zinc products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Zinc products" type="fsn">Zinc products</designation>
                    <desc language="en-US">Zinc products</desc>
                </concept>
                <concept code="D02AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Soft paraffin and fat products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Soft paraffin and fat products"
                         type="fsn">Soft paraffin and fat products</designation>
                    <desc language="en-US">Soft paraffin and fat products</desc>
                </concept>
                <concept code="D02AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Liquid plasters"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Liquid plasters" type="fsn">Liquid plasters</designation>
                    <desc language="en-US">Liquid plasters</desc>
                </concept>
                <concept code="D02AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Carbamide products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Carbamide products" type="fsn">Carbamide products</designation>
                    <desc language="en-US">Carbamide products</desc>
                </concept>
                <concept code="D02AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbamide" type="fsn">carbamide</designation>
                    <desc language="en-US">carbamide</desc>
                </concept>
                <concept code="D02AE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbamide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbamide, combinations" type="fsn">carbamide, combinations</designation>
                    <desc language="en-US">carbamide, combinations</desc>
                </concept>
                <concept code="D02AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Salicylic acid preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Salicylic acid preparations"
                         type="fsn">Salicylic acid preparations</designation>
                    <desc language="en-US">Salicylic acid preparations</desc>
                </concept>
                <concept code="D02AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other emollients and protectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other emollients and protectives"
                         type="fsn">Other emollients and protectives</designation>
                    <desc language="en-US">Other emollients and protectives</desc>
                </concept>
                <concept code="D02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PROTECTIVES AGAINST UV-RADIATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PROTECTIVES AGAINST UV-RADIATION"
                         type="fsn">PROTECTIVES AGAINST UV-RADIATION</designation>
                    <desc language="en-US">PROTECTIVES AGAINST UV-RADIATION</desc>
                </concept>
                <concept code="D02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Protectives against UV-radiation for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Protectives against UV-radiation for topical use"
                         type="fsn">Protectives against UV-radiation for topical use</designation>
                    <desc language="en-US">Protectives against UV-radiation for topical use</desc>
                </concept>
                <concept code="D02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminobenzoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminobenzoic acid" type="fsn">aminobenzoic acid</designation>
                    <desc language="en-US">aminobenzoic acid</desc>
                </concept>
                <concept code="D02BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="octinoxate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="octinoxate" type="fsn">octinoxate</designation>
                    <desc language="en-US">octinoxate</desc>
                </concept>
                <concept code="D02BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Protectives against UV-radiation for systemic use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Protectives against UV-radiation for systemic use"
                         type="fsn">Protectives against UV-radiation for systemic use</designation>
                    <desc language="en-US">Protectives against UV-radiation for systemic use</desc>
                </concept>
                <concept code="D02BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betacarotene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betacarotene" type="fsn">betacarotene</designation>
                    <desc language="en-US">betacarotene</desc>
                </concept>
                <concept code="D02BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="afamelanotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="afamelanotide" type="fsn">afamelanotide</designation>
                    <desc language="en-US">afamelanotide</desc>
                </concept>
                <concept code="D03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS"
                         type="fsn">PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS</designation>
                    <desc language="en-US">PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS</desc>
                </concept>
                <concept code="D03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CICATRIZANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CICATRIZANTS" type="fsn">CICATRIZANTS</designation>
                    <desc language="en-US">CICATRIZANTS</desc>
                </concept>
                <concept code="D03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Cod-liver oil ointments"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Cod-liver oil ointments" type="fsn">Cod-liver oil ointments</designation>
                    <desc language="en-US">Cod-liver oil ointments</desc>
                </concept>
                <concept code="D03AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cicatrizants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other cicatrizants" type="fsn">Other cicatrizants</designation>
                    <desc language="en-US">Other cicatrizants</desc>
                </concept>
                <concept code="D03AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cadexomer iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cadexomer iodine" type="fsn">cadexomer iodine</designation>
                    <desc language="en-US">cadexomer iodine</desc>
                </concept>
                <concept code="D03AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextranomer"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dextranomer" type="fsn">dextranomer</designation>
                    <desc language="en-US">dextranomer</desc>
                </concept>
                <concept code="D03AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexpanthenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexpanthenol" type="fsn">dexpanthenol</designation>
                    <desc language="en-US">dexpanthenol</desc>
                </concept>
                <concept code="D03AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium pantothenate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium pantothenate" type="fsn">calcium pantothenate</designation>
                    <desc language="en-US">calcium pantothenate</desc>
                </concept>
                <concept code="D03AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hyaluronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hyaluronic acid" type="fsn">hyaluronic acid</designation>
                    <desc language="en-US">hyaluronic acid</desc>
                </concept>
                <concept code="D03AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="becaplermin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="becaplermin" type="fsn">becaplermin</designation>
                    <desc language="en-US">becaplermin</desc>
                </concept>
                <concept code="D03AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="crilanomer"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="crilanomer" type="fsn">crilanomer</designation>
                    <desc language="en-US">crilanomer</desc>
                </concept>
                <concept code="D03AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enoxolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enoxolone" type="fsn">enoxolone</designation>
                    <desc language="en-US">enoxolone</desc>
                </concept>
                <concept code="D03AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium chlorite"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium chlorite" type="fsn">sodium chlorite</designation>
                    <desc language="en-US">sodium chlorite</desc>
                </concept>
                <concept code="D03AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trolamine" type="fsn">trolamine</designation>
                    <desc language="en-US">trolamine</desc>
                </concept>
                <concept code="D03AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Betulae cortex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Betulae cortex" type="fsn">Betulae cortex</designation>
                    <desc language="en-US">Betulae cortex</desc>
                </concept>
                <concept code="D03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ENZYMES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ENZYMES" type="fsn">ENZYMES</designation>
                    <desc language="en-US">ENZYMES</desc>
                </concept>
                <concept code="D03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Proteolytic enzymes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Proteolytic enzymes" type="fsn">Proteolytic enzymes</designation>
                    <desc language="en-US">Proteolytic enzymes</desc>
                </concept>
                <concept code="D03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trypsin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trypsin" type="fsn">trypsin</designation>
                    <desc language="en-US">trypsin</desc>
                </concept>
                <concept code="D03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="collagenase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="collagenase" type="fsn">collagenase</designation>
                    <desc language="en-US">collagenase</desc>
                </concept>
                <concept code="D03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromelains"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromelains" type="fsn">bromelains</designation>
                    <desc language="en-US">bromelains</desc>
                </concept>
                <concept code="D03BA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="collagenase, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="collagenase, combinations" type="fsn">collagenase, combinations</designation>
                    <desc language="en-US">collagenase, combinations</desc>
                </concept>
                <concept code="D04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC."
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC."
                         type="fsn">ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.</designation>
                    <desc language="en-US">ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.</desc>
                </concept>
                <concept code="D04A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC."
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC."
                         type="fsn">ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.</designation>
                    <desc language="en-US">ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.</desc>
                </concept>
                <concept code="D04AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antihistamines for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antihistamines for topical use"
                         type="fsn">Antihistamines for topical use</designation>
                    <desc language="en-US">Antihistamines for topical use</desc>
                </concept>
                <concept code="D04AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thonzylamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thonzylamine" type="fsn">thonzylamine</designation>
                    <desc language="en-US">thonzylamine</desc>
                </concept>
                <concept code="D04AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepyramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepyramine" type="fsn">mepyramine</designation>
                    <desc language="en-US">mepyramine</desc>
                </concept>
                <concept code="D04AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thenalidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thenalidine" type="fsn">thenalidine</designation>
                    <desc language="en-US">thenalidine</desc>
                </concept>
                <concept code="D04AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tripelennamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tripelennamine" type="fsn">tripelennamine</designation>
                    <desc language="en-US">tripelennamine</desc>
                </concept>
                <concept code="D04AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloropyramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloropyramine" type="fsn">chloropyramine</designation>
                    <desc language="en-US">chloropyramine</desc>
                </concept>
                <concept code="D04AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="promethazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="promethazine" type="fsn">promethazine</designation>
                    <desc language="en-US">promethazine</desc>
                </concept>
                <concept code="D04AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolpropamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolpropamine" type="fsn">tolpropamine</designation>
                    <desc language="en-US">tolpropamine</desc>
                </concept>
                <concept code="D04AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimetindene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimetindene" type="fsn">dimetindene</designation>
                    <desc language="en-US">dimetindene</desc>
                </concept>
                <concept code="D04AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clemastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clemastine" type="fsn">clemastine</designation>
                    <desc language="en-US">clemastine</desc>
                </concept>
                <concept code="D04AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bamipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bamipine" type="fsn">bamipine</designation>
                    <desc language="en-US">bamipine</desc>
                </concept>
                <concept code="D04AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pheniramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pheniramine" type="fsn">pheniramine</designation>
                    <desc language="en-US">pheniramine</desc>
                </concept>
                <concept code="D04AA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isothipendyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isothipendyl" type="fsn">isothipendyl</designation>
                    <desc language="en-US">isothipendyl</desc>
                </concept>
                <concept code="D04AA32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphenhydramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphenhydramine" type="fsn">diphenhydramine</designation>
                    <desc language="en-US">diphenhydramine</desc>
                </concept>
                <concept code="D04AA33"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphenhydramine methylbromide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphenhydramine methylbromide"
                         type="fsn">diphenhydramine methylbromide</designation>
                    <desc language="en-US">diphenhydramine methylbromide</desc>
                </concept>
                <concept code="D04AA34"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorphenoxamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorphenoxamine" type="fsn">chlorphenoxamine</designation>
                    <desc language="en-US">chlorphenoxamine</desc>
                </concept>
                <concept code="D04AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anesthetics for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Anesthetics for topical use"
                         type="fsn">Anesthetics for topical use</designation>
                    <desc language="en-US">Anesthetics for topical use</desc>
                </concept>
                <concept code="D04AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidocaine" type="fsn">lidocaine</designation>
                    <desc language="en-US">lidocaine</desc>
                </concept>
                <concept code="D04AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinchocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinchocaine" type="fsn">cinchocaine</designation>
                    <desc language="en-US">cinchocaine</desc>
                </concept>
                <concept code="D04AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxybuprocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxybuprocaine" type="fsn">oxybuprocaine</designation>
                    <desc language="en-US">oxybuprocaine</desc>
                </concept>
                <concept code="D04AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzocaine" type="fsn">benzocaine</designation>
                    <desc language="en-US">benzocaine</desc>
                </concept>
                <concept code="D04AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinisocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinisocaine" type="fsn">quinisocaine</designation>
                    <desc language="en-US">quinisocaine</desc>
                </concept>
                <concept code="D04AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracaine" type="fsn">tetracaine</designation>
                    <desc language="en-US">tetracaine</desc>
                </concept>
                <concept code="D04AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pramocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pramocaine" type="fsn">pramocaine</designation>
                    <desc language="en-US">pramocaine</desc>
                </concept>
                <concept code="D04AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antipruritics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antipruritics" type="fsn">Other antipruritics</designation>
                    <desc language="en-US">Other antipruritics</desc>
                </concept>
                <concept code="D04AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxepin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxepin" type="fsn">doxepin</designation>
                    <desc language="en-US">doxepin</desc>
                </concept>
                <concept code="D05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPSORIATICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIPSORIATICS" type="fsn">ANTIPSORIATICS</designation>
                    <desc language="en-US">ANTIPSORIATICS</desc>
                </concept>
                <concept code="D05A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPSORIATICS FOR TOPICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIPSORIATICS FOR TOPICAL USE"
                         type="fsn">ANTIPSORIATICS FOR TOPICAL USE</designation>
                    <desc language="en-US">ANTIPSORIATICS FOR TOPICAL USE</desc>
                </concept>
                <concept code="D05AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tars"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tars" type="fsn">Tars</designation>
                    <desc language="en-US">Tars</desc>
                </concept>
                <concept code="D05AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antracen derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antracen derivatives" type="fsn">Antracen derivatives</designation>
                    <desc language="en-US">Antracen derivatives</desc>
                </concept>
                <concept code="D05AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dithranol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dithranol" type="fsn">dithranol</designation>
                    <desc language="en-US">dithranol</desc>
                </concept>
                <concept code="D05AC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dithranol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dithranol, combinations" type="fsn">dithranol, combinations</designation>
                    <desc language="en-US">dithranol, combinations</desc>
                </concept>
                <concept code="D05AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Psoralens for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Psoralens for topical use" type="fsn">Psoralens for topical use</designation>
                    <desc language="en-US">Psoralens for topical use</desc>
                </concept>
                <concept code="D05AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trioxysalen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trioxysalen" type="fsn">trioxysalen</designation>
                    <desc language="en-US">trioxysalen</desc>
                </concept>
                <concept code="D05AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methoxsalen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methoxsalen" type="fsn">methoxsalen</designation>
                    <desc language="en-US">methoxsalen</desc>
                </concept>
                <concept code="D05AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antipsoriatics for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antipsoriatics for topical use"
                         type="fsn">Other antipsoriatics for topical use</designation>
                    <desc language="en-US">Other antipsoriatics for topical use</desc>
                </concept>
                <concept code="D05AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fumaric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fumaric acid" type="fsn">fumaric acid</designation>
                    <desc language="en-US">fumaric acid</desc>
                </concept>
                <concept code="D05AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcipotriol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcipotriol" type="fsn">calcipotriol</designation>
                    <desc language="en-US">calcipotriol</desc>
                </concept>
                <concept code="D05AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcitriol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcitriol" type="fsn">calcitriol</designation>
                    <desc language="en-US">calcitriol</desc>
                </concept>
                <concept code="D05AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tacalcitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tacalcitol" type="fsn">tacalcitol</designation>
                    <desc language="en-US">tacalcitol</desc>
                </concept>
                <concept code="D05AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tazarotene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tazarotene" type="fsn">tazarotene</designation>
                    <desc language="en-US">tazarotene</desc>
                </concept>
                <concept code="D05AX52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcipotriol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="calcipotriol, combinations"
                         type="fsn">calcipotriol, combinations</designation>
                    <desc language="en-US">calcipotriol, combinations</desc>
                </concept>
                <concept code="D05B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPSORIATICS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIPSORIATICS FOR SYSTEMIC USE"
                         type="fsn">ANTIPSORIATICS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIPSORIATICS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="D05BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Psoralens for systemic use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Psoralens for systemic use"
                         type="fsn">Psoralens for systemic use</designation>
                    <desc language="en-US">Psoralens for systemic use</desc>
                </concept>
                <concept code="D05BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trioxysalen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trioxysalen" type="fsn">trioxysalen</designation>
                    <desc language="en-US">trioxysalen</desc>
                </concept>
                <concept code="D05BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methoxsalen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methoxsalen" type="fsn">methoxsalen</designation>
                    <desc language="en-US">methoxsalen</desc>
                </concept>
                <concept code="D05BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bergapten"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bergapten" type="fsn">bergapten</designation>
                    <desc language="en-US">bergapten</desc>
                </concept>
                <concept code="D05BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Retinoids for treatment of psoriasis"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Retinoids for treatment of psoriasis"
                         type="fsn">Retinoids for treatment of psoriasis</designation>
                    <desc language="en-US">Retinoids for treatment of psoriasis</desc>
                </concept>
                <concept code="D05BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etretinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etretinate" type="fsn">etretinate</designation>
                    <desc language="en-US">etretinate</desc>
                </concept>
                <concept code="D05BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acitretin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acitretin" type="fsn">acitretin</designation>
                    <desc language="en-US">acitretin</desc>
                </concept>
                <concept code="D05BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antipsoriatics for systemic use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antipsoriatics for systemic use"
                         type="fsn">Other antipsoriatics for systemic use</designation>
                    <desc language="en-US">Other antipsoriatics for systemic use</desc>
                </concept>
                <concept code="D05BX51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fumaric acid derivatives, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fumaric acid derivatives, combinations"
                         type="fsn">fumaric acid derivatives, combinations</designation>
                    <desc language="en-US">fumaric acid derivatives, combinations</desc>
                </concept>
                <concept code="D06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE"
                         type="fsn">ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE</designation>
                    <desc language="en-US">ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE</desc>
                </concept>
                <concept code="D06A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIBIOTICS FOR TOPICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIBIOTICS FOR TOPICAL USE"
                         type="fsn">ANTIBIOTICS FOR TOPICAL USE</designation>
                    <desc language="en-US">ANTIBIOTICS FOR TOPICAL USE</desc>
                </concept>
                <concept code="D06AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tetracycline and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tetracycline and derivatives"
                         type="fsn">Tetracycline and derivatives</designation>
                    <desc language="en-US">Tetracycline and derivatives</desc>
                </concept>
                <concept code="D06AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="demeclocycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="demeclocycline" type="fsn">demeclocycline</designation>
                    <desc language="en-US">demeclocycline</desc>
                </concept>
                <concept code="D06AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlortetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlortetracycline" type="fsn">chlortetracycline</designation>
                    <desc language="en-US">chlortetracycline</desc>
                </concept>
                <concept code="D06AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxytetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxytetracycline" type="fsn">oxytetracycline</designation>
                    <desc language="en-US">oxytetracycline</desc>
                </concept>
                <concept code="D06AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracycline" type="fsn">tetracycline</designation>
                    <desc language="en-US">tetracycline</desc>
                </concept>
                <concept code="D06AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antibiotics for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antibiotics for topical use"
                         type="fsn">Other antibiotics for topical use</designation>
                    <desc language="en-US">Other antibiotics for topical use</desc>
                </concept>
                <concept code="D06AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fusidic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fusidic acid" type="fsn">fusidic acid</designation>
                    <desc language="en-US">fusidic acid</desc>
                </concept>
                <concept code="D06AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloramphenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloramphenicol" type="fsn">chloramphenicol</designation>
                    <desc language="en-US">chloramphenicol</desc>
                </concept>
                <concept code="D06AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="D06AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bacitracin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bacitracin" type="fsn">bacitracin</designation>
                    <desc language="en-US">bacitracin</desc>
                </concept>
                <concept code="D06AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gentamicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gentamicin" type="fsn">gentamicin</designation>
                    <desc language="en-US">gentamicin</desc>
                </concept>
                <concept code="D06AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tyrothricin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tyrothricin" type="fsn">tyrothricin</designation>
                    <desc language="en-US">tyrothricin</desc>
                </concept>
                <concept code="D06AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mupirocin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mupirocin" type="fsn">mupirocin</designation>
                    <desc language="en-US">mupirocin</desc>
                </concept>
                <concept code="D06AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="virginiamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="virginiamycin" type="fsn">virginiamycin</designation>
                    <desc language="en-US">virginiamycin</desc>
                </concept>
                <concept code="D06AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifaximin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifaximin" type="fsn">rifaximin</designation>
                    <desc language="en-US">rifaximin</desc>
                </concept>
                <concept code="D06AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amikacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amikacin" type="fsn">amikacin</designation>
                    <desc language="en-US">amikacin</desc>
                </concept>
                <concept code="D06AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="retapamulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="retapamulin" type="fsn">retapamulin</designation>
                    <desc language="en-US">retapamulin</desc>
                </concept>
                <concept code="D06AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ozenoxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ozenoxacin" type="fsn">ozenoxacin</designation>
                    <desc language="en-US">ozenoxacin</desc>
                </concept>
                <concept code="D06B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CHEMOTHERAPEUTICS FOR TOPICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CHEMOTHERAPEUTICS FOR TOPICAL USE"
                         type="fsn">CHEMOTHERAPEUTICS FOR TOPICAL USE</designation>
                    <desc language="en-US">CHEMOTHERAPEUTICS FOR TOPICAL USE</desc>
                </concept>
                <concept code="D06BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sulfonamides" type="fsn">Sulfonamides</designation>
                    <desc language="en-US">Sulfonamides</desc>
                </concept>
                <concept code="D06BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="silver sulfadiazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="silver sulfadiazine" type="fsn">silver sulfadiazine</designation>
                    <desc language="en-US">silver sulfadiazine</desc>
                </concept>
                <concept code="D06BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfathiazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfathiazole" type="fsn">sulfathiazole</designation>
                    <desc language="en-US">sulfathiazole</desc>
                </concept>
                <concept code="D06BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mafenide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mafenide" type="fsn">mafenide</designation>
                    <desc language="en-US">mafenide</desc>
                </concept>
                <concept code="D06BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamethizole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamethizole" type="fsn">sulfamethizole</designation>
                    <desc language="en-US">sulfamethizole</desc>
                </concept>
                <concept code="D06BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfanilamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfanilamide" type="fsn">sulfanilamide</designation>
                    <desc language="en-US">sulfanilamide</desc>
                </concept>
                <concept code="D06BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamerazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamerazine" type="fsn">sulfamerazine</designation>
                    <desc language="en-US">sulfamerazine</desc>
                </concept>
                <concept code="D06BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="silver sulfadiazine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="silver sulfadiazine, combinations"
                         type="fsn">silver sulfadiazine, combinations</designation>
                    <desc language="en-US">silver sulfadiazine, combinations</desc>
                </concept>
                <concept code="D06BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antivirals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antivirals" type="fsn">Antivirals</designation>
                    <desc language="en-US">Antivirals</desc>
                </concept>
                <concept code="D06BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idoxuridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idoxuridine" type="fsn">idoxuridine</designation>
                    <desc language="en-US">idoxuridine</desc>
                </concept>
                <concept code="D06BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tromantadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tromantadine" type="fsn">tromantadine</designation>
                    <desc language="en-US">tromantadine</desc>
                </concept>
                <concept code="D06BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aciclovir" type="fsn">aciclovir</designation>
                    <desc language="en-US">aciclovir</desc>
                </concept>
                <concept code="D06BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="podophyllotoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="podophyllotoxin" type="fsn">podophyllotoxin</designation>
                    <desc language="en-US">podophyllotoxin</desc>
                </concept>
                <concept code="D06BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="inosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="inosine" type="fsn">inosine</designation>
                    <desc language="en-US">inosine</desc>
                </concept>
                <concept code="D06BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="penciclovir" type="fsn">penciclovir</designation>
                    <desc language="en-US">penciclovir</desc>
                </concept>
                <concept code="D06BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lysozyme"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lysozyme" type="fsn">lysozyme</designation>
                    <desc language="en-US">lysozyme</desc>
                </concept>
                <concept code="D06BB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibacitabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibacitabine" type="fsn">ibacitabine</designation>
                    <desc language="en-US">ibacitabine</desc>
                </concept>
                <concept code="D06BB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="edoxudine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="edoxudine" type="fsn">edoxudine</designation>
                    <desc language="en-US">edoxudine</desc>
                </concept>
                <concept code="D06BB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imiquimod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imiquimod" type="fsn">imiquimod</designation>
                    <desc language="en-US">imiquimod</desc>
                </concept>
                <concept code="D06BB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="docosanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="docosanol" type="fsn">docosanol</designation>
                    <desc language="en-US">docosanol</desc>
                </concept>
                <concept code="D06BB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sinecatechins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sinecatechins" type="fsn">sinecatechins</designation>
                    <desc language="en-US">sinecatechins</desc>
                </concept>
                <concept code="D06BB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aciclovir, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aciclovir, combinations" type="fsn">aciclovir, combinations</designation>
                    <desc language="en-US">aciclovir, combinations</desc>
                </concept>
                <concept code="D06BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other chemotherapeutics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other chemotherapeutics" type="fsn">Other chemotherapeutics</designation>
                    <desc language="en-US">Other chemotherapeutics</desc>
                </concept>
                <concept code="D06BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metronidazole" type="fsn">metronidazole</designation>
                    <desc language="en-US">metronidazole</desc>
                </concept>
                <concept code="D06BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ingenol mebutate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ingenol mebutate" type="fsn">ingenol mebutate</designation>
                    <desc language="en-US">ingenol mebutate</desc>
                </concept>
                <concept code="D06C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS"
                         type="fsn">ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS</designation>
                    <desc language="en-US">ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS</desc>
                </concept>
                <concept code="D07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS"
                         type="fsn">CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS</designation>
                    <desc language="en-US">CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS</desc>
                </concept>
                <concept code="D07A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS, PLAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CORTICOSTEROIDS, PLAIN" type="fsn">CORTICOSTEROIDS, PLAIN</designation>
                    <desc language="en-US">CORTICOSTEROIDS, PLAIN</desc>
                </concept>
                <concept code="D07AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, weak (group I)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, weak (group I)"
                         type="fsn">Corticosteroids, weak (group I)</designation>
                    <desc language="en-US">Corticosteroids, weak (group I)</desc>
                </concept>
                <concept code="D07AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylprednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylprednisolone" type="fsn">methylprednisolone</designation>
                    <desc language="en-US">methylprednisolone</desc>
                </concept>
                <concept code="D07AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="D07AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="D07AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, moderately potent (group II)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, moderately potent (group II)"
                         type="fsn">Corticosteroids, moderately potent (group II)</designation>
                    <desc language="en-US">Corticosteroids, moderately potent (group II)</desc>
                </concept>
                <concept code="D07AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clobetasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clobetasone" type="fsn">clobetasone</designation>
                    <desc language="en-US">clobetasone</desc>
                </concept>
                <concept code="D07AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone butyrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone butyrate" type="fsn">hydrocortisone butyrate</designation>
                    <desc language="en-US">hydrocortisone butyrate</desc>
                </concept>
                <concept code="D07AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flumetasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flumetasone" type="fsn">flumetasone</designation>
                    <desc language="en-US">flumetasone</desc>
                </concept>
                <concept code="D07AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocortin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocortin" type="fsn">fluocortin</designation>
                    <desc language="en-US">fluocortin</desc>
                </concept>
                <concept code="D07AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluperolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluperolone" type="fsn">fluperolone</designation>
                    <desc language="en-US">fluperolone</desc>
                </concept>
                <concept code="D07AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorometholone" type="fsn">fluorometholone</designation>
                    <desc language="en-US">fluorometholone</desc>
                </concept>
                <concept code="D07AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluprednidene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluprednidene" type="fsn">fluprednidene</designation>
                    <desc language="en-US">fluprednidene</desc>
                </concept>
                <concept code="D07AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desonide" type="fsn">desonide</designation>
                    <desc language="en-US">desonide</desc>
                </concept>
                <concept code="D07AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamcinolone" type="fsn">triamcinolone</designation>
                    <desc language="en-US">triamcinolone</desc>
                </concept>
                <concept code="D07AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alclometasone" type="fsn">alclometasone</designation>
                    <desc language="en-US">alclometasone</desc>
                </concept>
                <concept code="D07AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone buteprate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone buteprate" type="fsn">hydrocortisone buteprate</designation>
                    <desc language="en-US">hydrocortisone buteprate</desc>
                </concept>
                <concept code="D07AB19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="D07AB21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clocortolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clocortolone" type="fsn">clocortolone</designation>
                    <desc language="en-US">clocortolone</desc>
                </concept>
                <concept code="D07AB30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of corticosteroids"
                         type="fsn">combinations of corticosteroids</designation>
                    <desc language="en-US">combinations of corticosteroids</desc>
                </concept>
                <concept code="D07AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, potent (group III)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, potent (group III)"
                         type="fsn">Corticosteroids, potent (group III)</designation>
                    <desc language="en-US">Corticosteroids, potent (group III)</desc>
                </concept>
                <concept code="D07AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="D07AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluclorolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluclorolone" type="fsn">fluclorolone</designation>
                    <desc language="en-US">fluclorolone</desc>
                </concept>
                <concept code="D07AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desoximetasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desoximetasone" type="fsn">desoximetasone</designation>
                    <desc language="en-US">desoximetasone</desc>
                </concept>
                <concept code="D07AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinolone acetonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocinolone acetonide" type="fsn">fluocinolone acetonide</designation>
                    <desc language="en-US">fluocinolone acetonide</desc>
                </concept>
                <concept code="D07AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocortolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocortolone" type="fsn">fluocortolone</designation>
                    <desc language="en-US">fluocortolone</desc>
                </concept>
                <concept code="D07AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diflucortolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diflucortolone" type="fsn">diflucortolone</designation>
                    <desc language="en-US">diflucortolone</desc>
                </concept>
                <concept code="D07AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludroxycortide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fludroxycortide" type="fsn">fludroxycortide</designation>
                    <desc language="en-US">fludroxycortide</desc>
                </concept>
                <concept code="D07AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocinonide" type="fsn">fluocinonide</designation>
                    <desc language="en-US">fluocinonide</desc>
                </concept>
                <concept code="D07AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="budesonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="budesonide" type="fsn">budesonide</designation>
                    <desc language="en-US">budesonide</desc>
                </concept>
                <concept code="D07AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diflorasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diflorasone" type="fsn">diflorasone</designation>
                    <desc language="en-US">diflorasone</desc>
                </concept>
                <concept code="D07AC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amcinonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amcinonide" type="fsn">amcinonide</designation>
                    <desc language="en-US">amcinonide</desc>
                </concept>
                <concept code="D07AC12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="halometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="halometasone" type="fsn">halometasone</designation>
                    <desc language="en-US">halometasone</desc>
                </concept>
                <concept code="D07AC13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mometasone" type="fsn">mometasone</designation>
                    <desc language="en-US">mometasone</desc>
                </concept>
                <concept code="D07AC14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylprednisolone aceponate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylprednisolone aceponate"
                         type="fsn">methylprednisolone aceponate</designation>
                    <desc language="en-US">methylprednisolone aceponate</desc>
                </concept>
                <concept code="D07AC15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="beclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="beclometasone" type="fsn">beclometasone</designation>
                    <desc language="en-US">beclometasone</desc>
                </concept>
                <concept code="D07AC16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone aceponate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone aceponate" type="fsn">hydrocortisone aceponate</designation>
                    <desc language="en-US">hydrocortisone aceponate</desc>
                </concept>
                <concept code="D07AC17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluticasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluticasone" type="fsn">fluticasone</designation>
                    <desc language="en-US">fluticasone</desc>
                </concept>
                <concept code="D07AC18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednicarbate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednicarbate" type="fsn">prednicarbate</designation>
                    <desc language="en-US">prednicarbate</desc>
                </concept>
                <concept code="D07AC19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="difluprednate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="difluprednate" type="fsn">difluprednate</designation>
                    <desc language="en-US">difluprednate</desc>
                </concept>
                <concept code="D07AC21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ulobetasol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ulobetasol" type="fsn">ulobetasol</designation>
                    <desc language="en-US">ulobetasol</desc>
                </concept>
                <concept code="D07AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, very potent (group IV)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, very potent (group IV)"
                         type="fsn">Corticosteroids, very potent (group IV)</designation>
                    <desc language="en-US">Corticosteroids, very potent (group IV)</desc>
                </concept>
                <concept code="D07AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clobetasol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clobetasol" type="fsn">clobetasol</designation>
                    <desc language="en-US">clobetasol</desc>
                </concept>
                <concept code="D07AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="halcinonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="halcinonide" type="fsn">halcinonide</designation>
                    <desc language="en-US">halcinonide</desc>
                </concept>
                <concept code="D07B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS"
                         type="fsn">CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS</designation>
                    <desc language="en-US">CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS</desc>
                </concept>
                <concept code="D07BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, weak, combinations with antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, weak, combinations with antiseptics"
                         type="fsn">Corticosteroids, weak, combinations with antiseptics</designation>
                    <desc language="en-US">Corticosteroids, weak, combinations with antiseptics</desc>
                </concept>
                <concept code="D07BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone and antiseptics"
                         type="fsn">prednisolone and antiseptics</designation>
                    <desc language="en-US">prednisolone and antiseptics</desc>
                </concept>
                <concept code="D07BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrocortisone and antiseptics"
                         type="fsn">hydrocortisone and antiseptics</designation>
                    <desc language="en-US">hydrocortisone and antiseptics</desc>
                </concept>
                <concept code="D07BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, moderately potent, combinations with antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, moderately potent, combinations with antiseptics"
                         type="fsn">Corticosteroids, moderately potent, combinations with antiseptics</designation>
                    <desc language="en-US">Corticosteroids, moderately potent, combinations with antiseptics</desc>
                </concept>
                <concept code="D07BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flumetasone and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="flumetasone and antiseptics"
                         type="fsn">flumetasone and antiseptics</designation>
                    <desc language="en-US">flumetasone and antiseptics</desc>
                </concept>
                <concept code="D07BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desonide and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desonide and antiseptics" type="fsn">desonide and antiseptics</designation>
                    <desc language="en-US">desonide and antiseptics</desc>
                </concept>
                <concept code="D07BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="triamcinolone and antiseptics"
                         type="fsn">triamcinolone and antiseptics</designation>
                    <desc language="en-US">triamcinolone and antiseptics</desc>
                </concept>
                <concept code="D07BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone butyrate and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrocortisone butyrate and antiseptics"
                         type="fsn">hydrocortisone butyrate and antiseptics</designation>
                    <desc language="en-US">hydrocortisone butyrate and antiseptics</desc>
                </concept>
                <concept code="D07BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, potent, combinations with antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, potent, combinations with antiseptics"
                         type="fsn">Corticosteroids, potent, combinations with antiseptics</designation>
                    <desc language="en-US">Corticosteroids, potent, combinations with antiseptics</desc>
                </concept>
                <concept code="D07BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="betamethasone and antiseptics"
                         type="fsn">betamethasone and antiseptics</designation>
                    <desc language="en-US">betamethasone and antiseptics</desc>
                </concept>
                <concept code="D07BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinolone acetonide and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluocinolone acetonide and antiseptics"
                         type="fsn">fluocinolone acetonide and antiseptics</designation>
                    <desc language="en-US">fluocinolone acetonide and antiseptics</desc>
                </concept>
                <concept code="D07BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocortolone and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluocortolone and antiseptics"
                         type="fsn">fluocortolone and antiseptics</designation>
                    <desc language="en-US">fluocortolone and antiseptics</desc>
                </concept>
                <concept code="D07BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diflucortolone and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diflucortolone and antiseptics"
                         type="fsn">diflucortolone and antiseptics</designation>
                    <desc language="en-US">diflucortolone and antiseptics</desc>
                </concept>
                <concept code="D07BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, very potent, combinations with antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, very potent, combinations with antiseptics"
                         type="fsn">Corticosteroids, very potent, combinations with antiseptics</designation>
                    <desc language="en-US">Corticosteroids, very potent, combinations with antiseptics</desc>
                </concept>
                <concept code="D07C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS"
                         type="fsn">CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS</designation>
                    <desc language="en-US">CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS</desc>
                </concept>
                <concept code="D07CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, weak, combinations with antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, weak, combinations with antibiotics"
                         type="fsn">Corticosteroids, weak, combinations with antibiotics</designation>
                    <desc language="en-US">Corticosteroids, weak, combinations with antibiotics</desc>
                </concept>
                <concept code="D07CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrocortisone and antibiotics"
                         type="fsn">hydrocortisone and antibiotics</designation>
                    <desc language="en-US">hydrocortisone and antibiotics</desc>
                </concept>
                <concept code="D07CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylprednisolone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylprednisolone and antibiotics"
                         type="fsn">methylprednisolone and antibiotics</designation>
                    <desc language="en-US">methylprednisolone and antibiotics</desc>
                </concept>
                <concept code="D07CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone and antibiotics"
                         type="fsn">prednisolone and antibiotics</designation>
                    <desc language="en-US">prednisolone and antibiotics</desc>
                </concept>
                <concept code="D07CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, moderately potent, combinations with antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, moderately potent, combinations with antibiotics"
                         type="fsn">Corticosteroids, moderately potent, combinations with antibiotics</designation>
                    <desc language="en-US">Corticosteroids, moderately potent, combinations with antibiotics</desc>
                </concept>
                <concept code="D07CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="triamcinolone and antibiotics"
                         type="fsn">triamcinolone and antibiotics</designation>
                    <desc language="en-US">triamcinolone and antibiotics</desc>
                </concept>
                <concept code="D07CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluprednidene and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluprednidene and antibiotics"
                         type="fsn">fluprednidene and antibiotics</designation>
                    <desc language="en-US">fluprednidene and antibiotics</desc>
                </concept>
                <concept code="D07CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluorometholone and antibiotics"
                         type="fsn">fluorometholone and antibiotics</designation>
                    <desc language="en-US">fluorometholone and antibiotics</desc>
                </concept>
                <concept code="D07CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dexamethasone and antibiotics"
                         type="fsn">dexamethasone and antibiotics</designation>
                    <desc language="en-US">dexamethasone and antibiotics</desc>
                </concept>
                <concept code="D07CB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flumetasone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="flumetasone and antibiotics"
                         type="fsn">flumetasone and antibiotics</designation>
                    <desc language="en-US">flumetasone and antibiotics</desc>
                </concept>
                <concept code="D07CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, potent, combinations with antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, potent, combinations with antibiotics"
                         type="fsn">Corticosteroids, potent, combinations with antibiotics</designation>
                    <desc language="en-US">Corticosteroids, potent, combinations with antibiotics</desc>
                </concept>
                <concept code="D07CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="betamethasone and antibiotics"
                         type="fsn">betamethasone and antibiotics</designation>
                    <desc language="en-US">betamethasone and antibiotics</desc>
                </concept>
                <concept code="D07CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinolone acetonide and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluocinolone acetonide and antibiotics"
                         type="fsn">fluocinolone acetonide and antibiotics</designation>
                    <desc language="en-US">fluocinolone acetonide and antibiotics</desc>
                </concept>
                <concept code="D07CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludroxycortide and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fludroxycortide and antibiotics"
                         type="fsn">fludroxycortide and antibiotics</designation>
                    <desc language="en-US">fludroxycortide and antibiotics</desc>
                </concept>
                <concept code="D07CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="beclometasone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="beclometasone and antibiotics"
                         type="fsn">beclometasone and antibiotics</designation>
                    <desc language="en-US">beclometasone and antibiotics</desc>
                </concept>
                <concept code="D07CC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinonide and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluocinonide and antibiotics"
                         type="fsn">fluocinonide and antibiotics</designation>
                    <desc language="en-US">fluocinonide and antibiotics</desc>
                </concept>
                <concept code="D07CC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocortolone and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluocortolone and antibiotics"
                         type="fsn">fluocortolone and antibiotics</designation>
                    <desc language="en-US">fluocortolone and antibiotics</desc>
                </concept>
                <concept code="D07CD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, very potent, combinations with antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, very potent, combinations with antibiotics"
                         type="fsn">Corticosteroids, very potent, combinations with antibiotics</designation>
                    <desc language="en-US">Corticosteroids, very potent, combinations with antibiotics</desc>
                </concept>
                <concept code="D07CD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clobetasol and antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="clobetasol and antibiotics"
                         type="fsn">clobetasol and antibiotics</designation>
                    <desc language="en-US">clobetasol and antibiotics</desc>
                </concept>
                <concept code="D07X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS, OTHER COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS, OTHER COMBINATIONS"
                         type="fsn">CORTICOSTEROIDS, OTHER COMBINATIONS</designation>
                    <desc language="en-US">CORTICOSTEROIDS, OTHER COMBINATIONS</desc>
                </concept>
                <concept code="D07XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, weak, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, weak, other combinations"
                         type="fsn">Corticosteroids, weak, other combinations</designation>
                    <desc language="en-US">Corticosteroids, weak, other combinations</desc>
                </concept>
                <concept code="D07XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="D07XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="D07XB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, moderately potent, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, moderately potent, other combinations"
                         type="fsn">Corticosteroids, moderately potent, other combinations</designation>
                    <desc language="en-US">Corticosteroids, moderately potent, other combinations</desc>
                </concept>
                <concept code="D07XB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flumetasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flumetasone" type="fsn">flumetasone</designation>
                    <desc language="en-US">flumetasone</desc>
                </concept>
                <concept code="D07XB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamcinolone" type="fsn">triamcinolone</designation>
                    <desc language="en-US">triamcinolone</desc>
                </concept>
                <concept code="D07XB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluprednidene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluprednidene" type="fsn">fluprednidene</designation>
                    <desc language="en-US">fluprednidene</desc>
                </concept>
                <concept code="D07XB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorometholone" type="fsn">fluorometholone</designation>
                    <desc language="en-US">fluorometholone</desc>
                </concept>
                <concept code="D07XB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="D07XB30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of corticosteroids"
                         type="fsn">combinations of corticosteroids</designation>
                    <desc language="en-US">combinations of corticosteroids</desc>
                </concept>
                <concept code="D07XC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, potent, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, potent, other combinations"
                         type="fsn">Corticosteroids, potent, other combinations</designation>
                    <desc language="en-US">Corticosteroids, potent, other combinations</desc>
                </concept>
                <concept code="D07XC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="D07XC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desoximetasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desoximetasone" type="fsn">desoximetasone</designation>
                    <desc language="en-US">desoximetasone</desc>
                </concept>
                <concept code="D07XC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mometasone" type="fsn">mometasone</designation>
                    <desc language="en-US">mometasone</desc>
                </concept>
                <concept code="D07XC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diflucortolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diflucortolone" type="fsn">diflucortolone</designation>
                    <desc language="en-US">diflucortolone</desc>
                </concept>
                <concept code="D07XC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocortolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocortolone" type="fsn">fluocortolone</designation>
                    <desc language="en-US">fluocortolone</desc>
                </concept>
                <concept code="D07XD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, very potent, other combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, very potent, other combinations"
                         type="fsn">Corticosteroids, very potent, other combinations</designation>
                    <desc language="en-US">Corticosteroids, very potent, other combinations</desc>
                </concept>
                <concept code="D08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTISEPTICS AND DISINFECTANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTISEPTICS AND DISINFECTANTS"
                         type="fsn">ANTISEPTICS AND DISINFECTANTS</designation>
                    <desc language="en-US">ANTISEPTICS AND DISINFECTANTS</desc>
                </concept>
                <concept code="D08A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTISEPTICS AND DISINFECTANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTISEPTICS AND DISINFECTANTS"
                         type="fsn">ANTISEPTICS AND DISINFECTANTS</designation>
                    <desc language="en-US">ANTISEPTICS AND DISINFECTANTS</desc>
                </concept>
                <concept code="D08AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Acridine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Acridine derivatives" type="fsn">Acridine derivatives</designation>
                    <desc language="en-US">Acridine derivatives</desc>
                </concept>
                <concept code="D08AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethacridine lactate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethacridine lactate" type="fsn">ethacridine lactate</designation>
                    <desc language="en-US">ethacridine lactate</desc>
                </concept>
                <concept code="D08AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminoacridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminoacridine" type="fsn">aminoacridine</designation>
                    <desc language="en-US">aminoacridine</desc>
                </concept>
                <concept code="D08AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="euflavine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="euflavine" type="fsn">euflavine</designation>
                    <desc language="en-US">euflavine</desc>
                </concept>
                <concept code="D08AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aluminium agents"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Aluminium agents" type="fsn">Aluminium agents</designation>
                    <desc language="en-US">Aluminium agents</desc>
                </concept>
                <concept code="D08AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Biguanides and amidines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Biguanides and amidines" type="fsn">Biguanides and amidines</designation>
                    <desc language="en-US">Biguanides and amidines</desc>
                </concept>
                <concept code="D08AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibrompropamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibrompropamidine" type="fsn">dibrompropamidine</designation>
                    <desc language="en-US">dibrompropamidine</desc>
                </concept>
                <concept code="D08AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorhexidine" type="fsn">chlorhexidine</designation>
                    <desc language="en-US">chlorhexidine</desc>
                </concept>
                <concept code="D08AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propamidine" type="fsn">propamidine</designation>
                    <desc language="en-US">propamidine</desc>
                </concept>
                <concept code="D08AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexamidine" type="fsn">hexamidine</designation>
                    <desc language="en-US">hexamidine</desc>
                </concept>
                <concept code="D08AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polihexanide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polihexanide" type="fsn">polihexanide</designation>
                    <desc language="en-US">polihexanide</desc>
                </concept>
                <concept code="D08AC52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlorhexidine, combinations"
                         type="fsn">chlorhexidine, combinations</designation>
                    <desc language="en-US">chlorhexidine, combinations</desc>
                </concept>
                <concept code="D08AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Boric acid products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Boric acid products" type="fsn">Boric acid products</designation>
                    <desc language="en-US">Boric acid products</desc>
                </concept>
                <concept code="D08AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phenol and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Phenol and derivatives" type="fsn">Phenol and derivatives</designation>
                    <desc language="en-US">Phenol and derivatives</desc>
                </concept>
                <concept code="D08AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexachlorophene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexachlorophene" type="fsn">hexachlorophene</designation>
                    <desc language="en-US">hexachlorophene</desc>
                </concept>
                <concept code="D08AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="policresulen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="policresulen" type="fsn">policresulen</designation>
                    <desc language="en-US">policresulen</desc>
                </concept>
                <concept code="D08AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenol" type="fsn">phenol</designation>
                    <desc language="en-US">phenol</desc>
                </concept>
                <concept code="D08AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triclosan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triclosan" type="fsn">triclosan</designation>
                    <desc language="en-US">triclosan</desc>
                </concept>
                <concept code="D08AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloroxylenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloroxylenol" type="fsn">chloroxylenol</designation>
                    <desc language="en-US">chloroxylenol</desc>
                </concept>
                <concept code="D08AE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="biphenylol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="biphenylol" type="fsn">biphenylol</designation>
                    <desc language="en-US">biphenylol</desc>
                </concept>
                <concept code="D08AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nitrofuran derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Nitrofuran derivatives" type="fsn">Nitrofuran derivatives</designation>
                    <desc language="en-US">Nitrofuran derivatives</desc>
                </concept>
                <concept code="D08AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrofural"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrofural" type="fsn">nitrofural</designation>
                    <desc language="en-US">nitrofural</desc>
                </concept>
                <concept code="D08AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iodine products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Iodine products" type="fsn">Iodine products</designation>
                    <desc language="en-US">Iodine products</desc>
                </concept>
                <concept code="D08AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine/octylphenoxypolyglycolether"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iodine/octylphenoxypolyglycolether"
                         type="fsn">iodine/octylphenoxypolyglycolether</designation>
                    <desc language="en-US">iodine/octylphenoxypolyglycolether</desc>
                </concept>
                <concept code="D08AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="povidone-iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="povidone-iodine" type="fsn">povidone-iodine</designation>
                    <desc language="en-US">povidone-iodine</desc>
                </concept>
                <concept code="D08AG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodine" type="fsn">iodine</designation>
                    <desc language="en-US">iodine</desc>
                </concept>
                <concept code="D08AG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diiodohydroxypropane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diiodohydroxypropane" type="fsn">diiodohydroxypropane</designation>
                    <desc language="en-US">diiodohydroxypropane</desc>
                </concept>
                <concept code="D08AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Quinoline derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Quinoline derivatives" type="fsn">Quinoline derivatives</designation>
                    <desc language="en-US">Quinoline derivatives</desc>
                </concept>
                <concept code="D08AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dequalinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dequalinium" type="fsn">dequalinium</designation>
                    <desc language="en-US">dequalinium</desc>
                </concept>
                <concept code="D08AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorquinaldol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorquinaldol" type="fsn">chlorquinaldol</designation>
                    <desc language="en-US">chlorquinaldol</desc>
                </concept>
                <concept code="D08AH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyquinoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyquinoline" type="fsn">oxyquinoline</designation>
                    <desc language="en-US">oxyquinoline</desc>
                </concept>
                <concept code="D08AH30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clioquinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clioquinol" type="fsn">clioquinol</designation>
                    <desc language="en-US">clioquinol</desc>
                </concept>
                <concept code="D08AJ"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Quaternary ammonium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Quaternary ammonium compounds"
                         type="fsn">Quaternary ammonium compounds</designation>
                    <desc language="en-US">Quaternary ammonium compounds</desc>
                </concept>
                <concept code="D08AJ01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzalkonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzalkonium" type="fsn">benzalkonium</designation>
                    <desc language="en-US">benzalkonium</desc>
                </concept>
                <concept code="D08AJ02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetrimonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetrimonium" type="fsn">cetrimonium</designation>
                    <desc language="en-US">cetrimonium</desc>
                </concept>
                <concept code="D08AJ03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetylpyridinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetylpyridinium" type="fsn">cetylpyridinium</designation>
                    <desc language="en-US">cetylpyridinium</desc>
                </concept>
                <concept code="D08AJ04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetrimide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetrimide" type="fsn">cetrimide</designation>
                    <desc language="en-US">cetrimide</desc>
                </concept>
                <concept code="D08AJ05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzoxonium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzoxonium chloride" type="fsn">benzoxonium chloride</designation>
                    <desc language="en-US">benzoxonium chloride</desc>
                </concept>
                <concept code="D08AJ06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="didecyldimethylammonium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="didecyldimethylammonium chloride"
                         type="fsn">didecyldimethylammonium chloride</designation>
                    <desc language="en-US">didecyldimethylammonium chloride</desc>
                </concept>
                <concept code="D08AJ08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzethonium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzethonium chloride" type="fsn">benzethonium chloride</designation>
                    <desc language="en-US">benzethonium chloride</desc>
                </concept>
                <concept code="D08AJ10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="decamethoxine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="decamethoxine" type="fsn">decamethoxine</designation>
                    <desc language="en-US">decamethoxine</desc>
                </concept>
                <concept code="D08AJ57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="octenidine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="octenidine, combinations" type="fsn">octenidine, combinations</designation>
                    <desc language="en-US">octenidine, combinations</desc>
                </concept>
                <concept code="D08AJ58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzethonium chloride, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="benzethonium chloride, combinations"
                         type="fsn">benzethonium chloride, combinations</designation>
                    <desc language="en-US">benzethonium chloride, combinations</desc>
                </concept>
                <concept code="D08AJ59"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dodeclonium bromide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dodeclonium bromide, combinations"
                         type="fsn">dodeclonium bromide, combinations</designation>
                    <desc language="en-US">dodeclonium bromide, combinations</desc>
                </concept>
                <concept code="D08AK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Mercurial products"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Mercurial products" type="fsn">Mercurial products</designation>
                    <desc language="en-US">Mercurial products</desc>
                </concept>
                <concept code="D08AK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mercuric amidochloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mercuric amidochloride" type="fsn">mercuric amidochloride</designation>
                    <desc language="en-US">mercuric amidochloride</desc>
                </concept>
                <concept code="D08AK02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylmercuric borate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylmercuric borate" type="fsn">phenylmercuric borate</designation>
                    <desc language="en-US">phenylmercuric borate</desc>
                </concept>
                <concept code="D08AK03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mercuric chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mercuric chloride" type="fsn">mercuric chloride</designation>
                    <desc language="en-US">mercuric chloride</desc>
                </concept>
                <concept code="D08AK04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="merbromin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="merbromin" type="fsn">merbromin</designation>
                    <desc language="en-US">merbromin</desc>
                </concept>
                <concept code="D08AK05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mercury, metallic"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mercury, metallic" type="fsn">mercury, metallic</designation>
                    <desc language="en-US">mercury, metallic</desc>
                </concept>
                <concept code="D08AK06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiomersal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiomersal" type="fsn">thiomersal</designation>
                    <desc language="en-US">thiomersal</desc>
                </concept>
                <concept code="D08AK30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mercuric iodide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mercuric iodide" type="fsn">mercuric iodide</designation>
                    <desc language="en-US">mercuric iodide</desc>
                </concept>
                <concept code="D08AL"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Silver compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Silver compounds" type="fsn">Silver compounds</designation>
                    <desc language="en-US">Silver compounds</desc>
                </concept>
                <concept code="D08AL01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="silver nitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="silver nitrate" type="fsn">silver nitrate</designation>
                    <desc language="en-US">silver nitrate</desc>
                </concept>
                <concept code="D08AL30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="silver"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="silver" type="fsn">silver</designation>
                    <desc language="en-US">silver</desc>
                </concept>
                <concept code="D08AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiseptics and disinfectants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antiseptics and disinfectants"
                         type="fsn">Other antiseptics and disinfectants</designation>
                    <desc language="en-US">Other antiseptics and disinfectants</desc>
                </concept>
                <concept code="D08AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrogen peroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrogen peroxide" type="fsn">hydrogen peroxide</designation>
                    <desc language="en-US">hydrogen peroxide</desc>
                </concept>
                <concept code="D08AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eosin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eosin" type="fsn">eosin</designation>
                    <desc language="en-US">eosin</desc>
                </concept>
                <concept code="D08AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propanol" type="fsn">propanol</designation>
                    <desc language="en-US">propanol</desc>
                </concept>
                <concept code="D08AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tosylchloramide sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tosylchloramide sodium" type="fsn">tosylchloramide sodium</designation>
                    <desc language="en-US">tosylchloramide sodium</desc>
                </concept>
                <concept code="D08AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isopropanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isopropanol" type="fsn">isopropanol</designation>
                    <desc language="en-US">isopropanol</desc>
                </concept>
                <concept code="D08AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium permanganate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium permanganate" type="fsn">potassium permanganate</designation>
                    <desc language="en-US">potassium permanganate</desc>
                </concept>
                <concept code="D08AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium hypochlorite"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium hypochlorite" type="fsn">sodium hypochlorite</designation>
                    <desc language="en-US">sodium hypochlorite</desc>
                </concept>
                <concept code="D08AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethanol" type="fsn">ethanol</designation>
                    <desc language="en-US">ethanol</desc>
                </concept>
                <concept code="D08AX53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propanol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propanol, combinations" type="fsn">propanol, combinations</designation>
                    <desc language="en-US">propanol, combinations</desc>
                </concept>
                <concept code="D09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MEDICATED DRESSINGS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="MEDICATED DRESSINGS" type="fsn">MEDICATED DRESSINGS</designation>
                    <desc language="en-US">MEDICATED DRESSINGS</desc>
                </concept>
                <concept code="D09A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MEDICATED DRESSINGS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="MEDICATED DRESSINGS" type="fsn">MEDICATED DRESSINGS</designation>
                    <desc language="en-US">MEDICATED DRESSINGS</desc>
                </concept>
                <concept code="D09AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Medicated dressings with antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Medicated dressings with antiinfectives"
                         type="fsn">Medicated dressings with antiinfectives</designation>
                    <desc language="en-US">Medicated dressings with antiinfectives</desc>
                </concept>
                <concept code="D09AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="framycetin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="framycetin" type="fsn">framycetin</designation>
                    <desc language="en-US">framycetin</desc>
                </concept>
                <concept code="D09AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fusidic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fusidic acid" type="fsn">fusidic acid</designation>
                    <desc language="en-US">fusidic acid</desc>
                </concept>
                <concept code="D09AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrofural"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrofural" type="fsn">nitrofural</designation>
                    <desc language="en-US">nitrofural</desc>
                </concept>
                <concept code="D09AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylmercuric nitrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylmercuric nitrate" type="fsn">phenylmercuric nitrate</designation>
                    <desc language="en-US">phenylmercuric nitrate</desc>
                </concept>
                <concept code="D09AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzododecinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzododecinium" type="fsn">benzododecinium</designation>
                    <desc language="en-US">benzododecinium</desc>
                </concept>
                <concept code="D09AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triclosan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triclosan" type="fsn">triclosan</designation>
                    <desc language="en-US">triclosan</desc>
                </concept>
                <concept code="D09AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetylpyridinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetylpyridinium" type="fsn">cetylpyridinium</designation>
                    <desc language="en-US">cetylpyridinium</desc>
                </concept>
                <concept code="D09AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium chlorohydrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium chlorohydrate" type="fsn">aluminium chlorohydrate</designation>
                    <desc language="en-US">aluminium chlorohydrate</desc>
                </concept>
                <concept code="D09AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="povidone-iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="povidone-iodine" type="fsn">povidone-iodine</designation>
                    <desc language="en-US">povidone-iodine</desc>
                </concept>
                <concept code="D09AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clioquinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clioquinol" type="fsn">clioquinol</designation>
                    <desc language="en-US">clioquinol</desc>
                </concept>
                <concept code="D09AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzalkonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzalkonium" type="fsn">benzalkonium</designation>
                    <desc language="en-US">benzalkonium</desc>
                </concept>
                <concept code="D09AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorhexidine" type="fsn">chlorhexidine</designation>
                    <desc language="en-US">chlorhexidine</desc>
                </concept>
                <concept code="D09AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodoform"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodoform" type="fsn">iodoform</designation>
                    <desc language="en-US">iodoform</desc>
                </concept>
                <concept code="D09AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Zinc bandages"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Zinc bandages" type="fsn">Zinc bandages</designation>
                    <desc language="en-US">Zinc bandages</desc>
                </concept>
                <concept code="D09AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc bandage without supplements"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="zinc bandage without supplements"
                         type="fsn">zinc bandage without supplements</designation>
                    <desc language="en-US">zinc bandage without supplements</desc>
                </concept>
                <concept code="D09AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc bandage with supplements"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="zinc bandage with supplements"
                         type="fsn">zinc bandage with supplements</designation>
                    <desc language="en-US">zinc bandage with supplements</desc>
                </concept>
                <concept code="D09AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Soft paraffin dressings"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Soft paraffin dressings" type="fsn">Soft paraffin dressings</designation>
                    <desc language="en-US">Soft paraffin dressings</desc>
                </concept>
                <concept code="D10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTI-ACNE PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTI-ACNE PREPARATIONS" type="fsn">ANTI-ACNE PREPARATIONS</designation>
                    <desc language="en-US">ANTI-ACNE PREPARATIONS</desc>
                </concept>
                <concept code="D10A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTI-ACNE PREPARATIONS FOR TOPICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTI-ACNE PREPARATIONS FOR TOPICAL USE"
                         type="fsn">ANTI-ACNE PREPARATIONS FOR TOPICAL USE</designation>
                    <desc language="en-US">ANTI-ACNE PREPARATIONS FOR TOPICAL USE</desc>
                </concept>
                <concept code="D10AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, combinations for treatment of acne"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids, combinations for treatment of acne"
                         type="fsn">Corticosteroids, combinations for treatment of acne</designation>
                    <desc language="en-US">Corticosteroids, combinations for treatment of acne</desc>
                </concept>
                <concept code="D10AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorometholone" type="fsn">fluorometholone</designation>
                    <desc language="en-US">fluorometholone</desc>
                </concept>
                <concept code="D10AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylprednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylprednisolone" type="fsn">methylprednisolone</designation>
                    <desc language="en-US">methylprednisolone</desc>
                </concept>
                <concept code="D10AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="D10AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Preparations containing sulfur"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Preparations containing sulfur"
                         type="fsn">Preparations containing sulfur</designation>
                    <desc language="en-US">Preparations containing sulfur</desc>
                </concept>
                <concept code="D10AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bithionol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bithionol" type="fsn">bithionol</designation>
                    <desc language="en-US">bithionol</desc>
                </concept>
                <concept code="D10AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfur"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfur" type="fsn">sulfur</designation>
                    <desc language="en-US">sulfur</desc>
                </concept>
                <concept code="D10AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tioxolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tioxolone" type="fsn">tioxolone</designation>
                    <desc language="en-US">tioxolone</desc>
                </concept>
                <concept code="D10AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mesulfen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mesulfen" type="fsn">mesulfen</designation>
                    <desc language="en-US">mesulfen</desc>
                </concept>
                <concept code="D10AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Retinoids for topical use in acne"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Retinoids for topical use in acne"
                         type="fsn">Retinoids for topical use in acne</designation>
                    <desc language="en-US">Retinoids for topical use in acne</desc>
                </concept>
                <concept code="D10AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tretinoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tretinoin" type="fsn">tretinoin</designation>
                    <desc language="en-US">tretinoin</desc>
                </concept>
                <concept code="D10AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="retinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="retinol" type="fsn">retinol</designation>
                    <desc language="en-US">retinol</desc>
                </concept>
                <concept code="D10AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adapalene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adapalene" type="fsn">adapalene</designation>
                    <desc language="en-US">adapalene</desc>
                </concept>
                <concept code="D10AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isotretinoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isotretinoin" type="fsn">isotretinoin</designation>
                    <desc language="en-US">isotretinoin</desc>
                </concept>
                <concept code="D10AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="motretinide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="motretinide" type="fsn">motretinide</designation>
                    <desc language="en-US">motretinide</desc>
                </concept>
                <concept code="D10AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trifarotene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trifarotene" type="fsn">trifarotene</designation>
                    <desc language="en-US">trifarotene</desc>
                </concept>
                <concept code="D10AD51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tretinoin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tretinoin, combinations" type="fsn">tretinoin, combinations</designation>
                    <desc language="en-US">tretinoin, combinations</desc>
                </concept>
                <concept code="D10AD53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adapalene, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adapalene, combinations" type="fsn">adapalene, combinations</designation>
                    <desc language="en-US">adapalene, combinations</desc>
                </concept>
                <concept code="D10AD54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isotretinoin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="isotretinoin, combinations"
                         type="fsn">isotretinoin, combinations</designation>
                    <desc language="en-US">isotretinoin, combinations</desc>
                </concept>
                <concept code="D10AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Peroxides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Peroxides" type="fsn">Peroxides</designation>
                    <desc language="en-US">Peroxides</desc>
                </concept>
                <concept code="D10AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzoyl peroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzoyl peroxide" type="fsn">benzoyl peroxide</designation>
                    <desc language="en-US">benzoyl peroxide</desc>
                </concept>
                <concept code="D10AE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzoyl peroxide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="benzoyl peroxide, combinations"
                         type="fsn">benzoyl peroxide, combinations</designation>
                    <desc language="en-US">benzoyl peroxide, combinations</desc>
                </concept>
                <concept code="D10AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinfectives for treatment of acne"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiinfectives for treatment of acne"
                         type="fsn">Antiinfectives for treatment of acne</designation>
                    <desc language="en-US">Antiinfectives for treatment of acne</desc>
                </concept>
                <concept code="D10AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clindamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clindamycin" type="fsn">clindamycin</designation>
                    <desc language="en-US">clindamycin</desc>
                </concept>
                <concept code="D10AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erythromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="erythromycin" type="fsn">erythromycin</designation>
                    <desc language="en-US">erythromycin</desc>
                </concept>
                <concept code="D10AF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloramphenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloramphenicol" type="fsn">chloramphenicol</designation>
                    <desc language="en-US">chloramphenicol</desc>
                </concept>
                <concept code="D10AF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meclocycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meclocycline" type="fsn">meclocycline</designation>
                    <desc language="en-US">meclocycline</desc>
                </concept>
                <concept code="D10AF05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nadifloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nadifloxacin" type="fsn">nadifloxacin</designation>
                    <desc language="en-US">nadifloxacin</desc>
                </concept>
                <concept code="D10AF06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfacetamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfacetamide" type="fsn">sulfacetamide</designation>
                    <desc language="en-US">sulfacetamide</desc>
                </concept>
                <concept code="D10AF51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clindamycin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clindamycin, combinations" type="fsn">clindamycin, combinations</designation>
                    <desc language="en-US">clindamycin, combinations</desc>
                </concept>
                <concept code="D10AF52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erythromycin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="erythromycin, combinations"
                         type="fsn">erythromycin, combinations</designation>
                    <desc language="en-US">erythromycin, combinations</desc>
                </concept>
                <concept code="D10AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other anti-acne preparations for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other anti-acne preparations for topical use"
                         type="fsn">Other anti-acne preparations for topical use</designation>
                    <desc language="en-US">Other anti-acne preparations for topical use</desc>
                </concept>
                <concept code="D10AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium chloride" type="fsn">aluminium chloride</designation>
                    <desc language="en-US">aluminium chloride</desc>
                </concept>
                <concept code="D10AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="resorcinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="resorcinol" type="fsn">resorcinol</designation>
                    <desc language="en-US">resorcinol</desc>
                </concept>
                <concept code="D10AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azelaic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azelaic acid" type="fsn">azelaic acid</designation>
                    <desc language="en-US">azelaic acid</desc>
                </concept>
                <concept code="D10AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium oxide" type="fsn">aluminium oxide</designation>
                    <desc language="en-US">aluminium oxide</desc>
                </concept>
                <concept code="D10AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dapsone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dapsone" type="fsn">dapsone</designation>
                    <desc language="en-US">dapsone</desc>
                </concept>
                <concept code="D10AX30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="various combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="various combinations" type="fsn">various combinations</designation>
                    <desc language="en-US">various combinations</desc>
                </concept>
                <concept code="D10B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE"
                         type="fsn">ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="D10BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Retinoids for treatment of acne"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Retinoids for treatment of acne"
                         type="fsn">Retinoids for treatment of acne</designation>
                    <desc language="en-US">Retinoids for treatment of acne</desc>
                </concept>
                <concept code="D10BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isotretinoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isotretinoin" type="fsn">isotretinoin</designation>
                    <desc language="en-US">isotretinoin</desc>
                </concept>
                <concept code="D10BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other anti-acne preparations for systemic use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other anti-acne preparations for systemic use"
                         type="fsn">Other anti-acne preparations for systemic use</designation>
                    <desc language="en-US">Other anti-acne preparations for systemic use</desc>
                </concept>
                <concept code="D10BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ichtasol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ichtasol" type="fsn">ichtasol</designation>
                    <desc language="en-US">ichtasol</desc>
                </concept>
                <concept code="D11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DERMATOLOGICAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER DERMATOLOGICAL PREPARATIONS"
                         type="fsn">OTHER DERMATOLOGICAL PREPARATIONS</designation>
                    <desc language="en-US">OTHER DERMATOLOGICAL PREPARATIONS</desc>
                </concept>
                <concept code="D11A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DERMATOLOGICAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER DERMATOLOGICAL PREPARATIONS"
                         type="fsn">OTHER DERMATOLOGICAL PREPARATIONS</designation>
                    <desc language="en-US">OTHER DERMATOLOGICAL PREPARATIONS</desc>
                </concept>
                <concept code="D11AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antihidrotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antihidrotics" type="fsn">Antihidrotics</designation>
                    <desc language="en-US">Antihidrotics</desc>
                </concept>
                <concept code="D11AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Medicated shampoos"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Medicated shampoos" type="fsn">Medicated shampoos</designation>
                    <desc language="en-US">Medicated shampoos</desc>
                </concept>
                <concept code="D11AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetrimide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetrimide" type="fsn">cetrimide</designation>
                    <desc language="en-US">cetrimide</desc>
                </concept>
                <concept code="D11AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cadmium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cadmium compounds" type="fsn">cadmium compounds</designation>
                    <desc language="en-US">cadmium compounds</desc>
                </concept>
                <concept code="D11AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="selenium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="selenium compounds" type="fsn">selenium compounds</designation>
                    <desc language="en-US">selenium compounds</desc>
                </concept>
                <concept code="D11AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="povidone-iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="povidone-iodine" type="fsn">povidone-iodine</designation>
                    <desc language="en-US">povidone-iodine</desc>
                </concept>
                <concept code="D11AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfur compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfur compounds" type="fsn">sulfur compounds</designation>
                    <desc language="en-US">sulfur compounds</desc>
                </concept>
                <concept code="D11AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xenysalate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xenysalate" type="fsn">xenysalate</designation>
                    <desc language="en-US">xenysalate</desc>
                </concept>
                <concept code="D11AC30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="others"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="others" type="fsn">others</designation>
                    <desc language="en-US">others</desc>
                </concept>
                <concept code="D11AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Androgens for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Androgens for topical use" type="fsn">Androgens for topical use</designation>
                    <desc language="en-US">Androgens for topical use</desc>
                </concept>
                <concept code="D11AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metandienone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metandienone" type="fsn">metandienone</designation>
                    <desc language="en-US">metandienone</desc>
                </concept>
                <concept code="D11AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Wart and anti-corn preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Wart and anti-corn preparations"
                         type="fsn">Wart and anti-corn preparations</designation>
                    <desc language="en-US">Wart and anti-corn preparations</desc>
                </concept>
                <concept code="D11AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Agents for dermatitis, excluding corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Agents for dermatitis, excluding corticosteroids"
                         type="fsn">Agents for dermatitis, excluding corticosteroids</designation>
                    <desc language="en-US">Agents for dermatitis, excluding corticosteroids</desc>
                </concept>
                <concept code="D11AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tacrolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tacrolimus" type="fsn">tacrolimus</designation>
                    <desc language="en-US">tacrolimus</desc>
                </concept>
                <concept code="D11AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pimecrolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pimecrolimus" type="fsn">pimecrolimus</designation>
                    <desc language="en-US">pimecrolimus</desc>
                </concept>
                <concept code="D11AH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cromoglicic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cromoglicic acid" type="fsn">cromoglicic acid</designation>
                    <desc language="en-US">cromoglicic acid</desc>
                </concept>
                <concept code="D11AH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alitretinoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alitretinoin" type="fsn">alitretinoin</designation>
                    <desc language="en-US">alitretinoin</desc>
                </concept>
                <concept code="D11AH05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dupilumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dupilumab" type="fsn">dupilumab</designation>
                    <desc language="en-US">dupilumab</desc>
                </concept>
                <concept code="D11AH06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="crisaborole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="crisaborole" type="fsn">crisaborole</designation>
                    <desc language="en-US">crisaborole</desc>
                </concept>
                <concept code="D11AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other dermatologicals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other dermatologicals" type="fsn">Other dermatologicals</designation>
                    <desc language="en-US">Other dermatologicals</desc>
                </concept>
                <concept code="D11AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="minoxidil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="minoxidil" type="fsn">minoxidil</designation>
                    <desc language="en-US">minoxidil</desc>
                </concept>
                <concept code="D11AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gamolenic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gamolenic acid" type="fsn">gamolenic acid</designation>
                    <desc language="en-US">gamolenic acid</desc>
                </concept>
                <concept code="D11AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium gluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium gluconate" type="fsn">calcium gluconate</designation>
                    <desc language="en-US">calcium gluconate</desc>
                </concept>
                <concept code="D11AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lithium succinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lithium succinate" type="fsn">lithium succinate</designation>
                    <desc language="en-US">lithium succinate</desc>
                </concept>
                <concept code="D11AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium sulfate" type="fsn">magnesium sulfate</designation>
                    <desc language="en-US">magnesium sulfate</desc>
                </concept>
                <concept code="D11AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mequinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mequinol" type="fsn">mequinol</designation>
                    <desc language="en-US">mequinol</desc>
                </concept>
                <concept code="D11AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiratricol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiratricol" type="fsn">tiratricol</designation>
                    <desc language="en-US">tiratricol</desc>
                </concept>
                <concept code="D11AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxaceprol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxaceprol" type="fsn">oxaceprol</designation>
                    <desc language="en-US">oxaceprol</desc>
                </concept>
                <concept code="D11AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="finasteride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="finasteride" type="fsn">finasteride</designation>
                    <desc language="en-US">finasteride</desc>
                </concept>
                <concept code="D11AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroquinone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroquinone" type="fsn">hydroquinone</designation>
                    <desc language="en-US">hydroquinone</desc>
                </concept>
                <concept code="D11AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrithione zinc"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrithione zinc" type="fsn">pyrithione zinc</designation>
                    <desc language="en-US">pyrithione zinc</desc>
                </concept>
                <concept code="D11AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="monobenzone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="monobenzone" type="fsn">monobenzone</designation>
                    <desc language="en-US">monobenzone</desc>
                </concept>
                <concept code="D11AX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eflornithine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eflornithine" type="fsn">eflornithine</designation>
                    <desc language="en-US">eflornithine</desc>
                </concept>
                <concept code="D11AX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diclofenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diclofenac" type="fsn">diclofenac</designation>
                    <desc language="en-US">diclofenac</desc>
                </concept>
                <concept code="D11AX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brimonidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brimonidine" type="fsn">brimonidine</designation>
                    <desc language="en-US">brimonidine</desc>
                </concept>
                <concept code="D11AX22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ivermectin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ivermectin" type="fsn">ivermectin</designation>
                    <desc language="en-US">ivermectin</desc>
                </concept>
                <concept code="D11AX23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminobenzoate potassium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminobenzoate potassium" type="fsn">aminobenzoate potassium</designation>
                    <desc language="en-US">aminobenzoate potassium</desc>
                </concept>
                <concept code="D11AX24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deoxycholic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deoxycholic acid" type="fsn">deoxycholic acid</designation>
                    <desc language="en-US">deoxycholic acid</desc>
                </concept>
                <concept code="D11AX25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrogen peroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrogen peroxide" type="fsn">hydrogen peroxide</designation>
                    <desc language="en-US">hydrogen peroxide</desc>
                </concept>
                <concept code="D11AX52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gamolenic acid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="gamolenic acid, combinations"
                         type="fsn">gamolenic acid, combinations</designation>
                    <desc language="en-US">gamolenic acid, combinations</desc>
                </concept>
                <concept code="D11AX57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="collagen, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="collagen, combinations" type="fsn">collagen, combinations</designation>
                    <desc language="en-US">collagen, combinations</desc>
                </concept>
                <concept code="G"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="GENITO URINARY SYSTEM AND SEX HORMONES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="GENITO URINARY SYSTEM AND SEX HORMONES"
                         type="fsn">GENITO URINARY SYSTEM AND SEX HORMONES</designation>
                    <desc language="en-US">GENITO URINARY SYSTEM AND SEX HORMONES</desc>
                </concept>
                <concept code="G01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS"
                         type="fsn">GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS</designation>
                    <desc language="en-US">GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS</desc>
                </concept>
                <concept code="G01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS"
                         type="fsn">ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS</designation>
                    <desc language="en-US">ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS</desc>
                </concept>
                <concept code="G01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antibiotics" type="fsn">Antibiotics</designation>
                    <desc language="en-US">Antibiotics</desc>
                </concept>
                <concept code="G01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nystatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nystatin" type="fsn">nystatin</designation>
                    <desc language="en-US">nystatin</desc>
                </concept>
                <concept code="G01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="natamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="natamycin" type="fsn">natamycin</designation>
                    <desc language="en-US">natamycin</desc>
                </concept>
                <concept code="G01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amphotericin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amphotericin B" type="fsn">amphotericin B</designation>
                    <desc language="en-US">amphotericin B</desc>
                </concept>
                <concept code="G01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="candicidin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="candicidin" type="fsn">candicidin</designation>
                    <desc language="en-US">candicidin</desc>
                </concept>
                <concept code="G01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloramphenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloramphenicol" type="fsn">chloramphenicol</designation>
                    <desc language="en-US">chloramphenicol</desc>
                </concept>
                <concept code="G01AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hachimycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hachimycin" type="fsn">hachimycin</designation>
                    <desc language="en-US">hachimycin</desc>
                </concept>
                <concept code="G01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxytetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxytetracycline" type="fsn">oxytetracycline</designation>
                    <desc language="en-US">oxytetracycline</desc>
                </concept>
                <concept code="G01AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carfecillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carfecillin" type="fsn">carfecillin</designation>
                    <desc language="en-US">carfecillin</desc>
                </concept>
                <concept code="G01AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepartricin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepartricin" type="fsn">mepartricin</designation>
                    <desc language="en-US">mepartricin</desc>
                </concept>
                <concept code="G01AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clindamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clindamycin" type="fsn">clindamycin</designation>
                    <desc language="en-US">clindamycin</desc>
                </concept>
                <concept code="G01AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentamycin" type="fsn">pentamycin</designation>
                    <desc language="en-US">pentamycin</desc>
                </concept>
                <concept code="G01AA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nystatin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nystatin, combinations" type="fsn">nystatin, combinations</designation>
                    <desc language="en-US">nystatin, combinations</desc>
                </concept>
                <concept code="G01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Arsenic compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Arsenic compounds" type="fsn">Arsenic compounds</designation>
                    <desc language="en-US">Arsenic compounds</desc>
                </concept>
                <concept code="G01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetarsol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetarsol" type="fsn">acetarsol</designation>
                    <desc language="en-US">acetarsol</desc>
                </concept>
                <concept code="G01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Quinoline derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Quinoline derivatives" type="fsn">Quinoline derivatives</designation>
                    <desc language="en-US">Quinoline derivatives</desc>
                </concept>
                <concept code="G01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diiodohydroxyquinoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diiodohydroxyquinoline" type="fsn">diiodohydroxyquinoline</designation>
                    <desc language="en-US">diiodohydroxyquinoline</desc>
                </concept>
                <concept code="G01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clioquinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clioquinol" type="fsn">clioquinol</designation>
                    <desc language="en-US">clioquinol</desc>
                </concept>
                <concept code="G01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorquinaldol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorquinaldol" type="fsn">chlorquinaldol</designation>
                    <desc language="en-US">chlorquinaldol</desc>
                </concept>
                <concept code="G01AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dequalinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dequalinium" type="fsn">dequalinium</designation>
                    <desc language="en-US">dequalinium</desc>
                </concept>
                <concept code="G01AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="broxyquinoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="broxyquinoline" type="fsn">broxyquinoline</designation>
                    <desc language="en-US">broxyquinoline</desc>
                </concept>
                <concept code="G01AC30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyquinoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyquinoline" type="fsn">oxyquinoline</designation>
                    <desc language="en-US">oxyquinoline</desc>
                </concept>
                <concept code="G01AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Organic acids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Organic acids" type="fsn">Organic acids</designation>
                    <desc language="en-US">Organic acids</desc>
                </concept>
                <concept code="G01AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lactic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lactic acid" type="fsn">lactic acid</designation>
                    <desc language="en-US">lactic acid</desc>
                </concept>
                <concept code="G01AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetic acid" type="fsn">acetic acid</designation>
                    <desc language="en-US">acetic acid</desc>
                </concept>
                <concept code="G01AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ascorbic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ascorbic acid" type="fsn">ascorbic acid</designation>
                    <desc language="en-US">ascorbic acid</desc>
                </concept>
                <concept code="G01AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sulfonamides" type="fsn">Sulfonamides</designation>
                    <desc language="en-US">Sulfonamides</desc>
                </concept>
                <concept code="G01AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfatolamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfatolamide" type="fsn">sulfatolamide</designation>
                    <desc language="en-US">sulfatolamide</desc>
                </concept>
                <concept code="G01AE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of sulfonamides"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of sulfonamides"
                         type="fsn">combinations of sulfonamides</designation>
                    <desc language="en-US">combinations of sulfonamides</desc>
                </concept>
                <concept code="G01AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Imidazole derivatives" type="fsn">Imidazole derivatives</designation>
                    <desc language="en-US">Imidazole derivatives</desc>
                </concept>
                <concept code="G01AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metronidazole" type="fsn">metronidazole</designation>
                    <desc language="en-US">metronidazole</desc>
                </concept>
                <concept code="G01AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clotrimazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clotrimazole" type="fsn">clotrimazole</designation>
                    <desc language="en-US">clotrimazole</desc>
                </concept>
                <concept code="G01AF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miconazole" type="fsn">miconazole</designation>
                    <desc language="en-US">miconazole</desc>
                </concept>
                <concept code="G01AF05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="econazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="econazole" type="fsn">econazole</designation>
                    <desc language="en-US">econazole</desc>
                </concept>
                <concept code="G01AF06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ornidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ornidazole" type="fsn">ornidazole</designation>
                    <desc language="en-US">ornidazole</desc>
                </concept>
                <concept code="G01AF07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoconazole" type="fsn">isoconazole</designation>
                    <desc language="en-US">isoconazole</desc>
                </concept>
                <concept code="G01AF08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tioconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tioconazole" type="fsn">tioconazole</designation>
                    <desc language="en-US">tioconazole</desc>
                </concept>
                <concept code="G01AF11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketoconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketoconazole" type="fsn">ketoconazole</designation>
                    <desc language="en-US">ketoconazole</desc>
                </concept>
                <concept code="G01AF12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenticonazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenticonazole" type="fsn">fenticonazole</designation>
                    <desc language="en-US">fenticonazole</desc>
                </concept>
                <concept code="G01AF13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azanidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azanidazole" type="fsn">azanidazole</designation>
                    <desc language="en-US">azanidazole</desc>
                </concept>
                <concept code="G01AF14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propenidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propenidazole" type="fsn">propenidazole</designation>
                    <desc language="en-US">propenidazole</desc>
                </concept>
                <concept code="G01AF15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butoconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butoconazole" type="fsn">butoconazole</designation>
                    <desc language="en-US">butoconazole</desc>
                </concept>
                <concept code="G01AF16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omoconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="omoconazole" type="fsn">omoconazole</designation>
                    <desc language="en-US">omoconazole</desc>
                </concept>
                <concept code="G01AF17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxiconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxiconazole" type="fsn">oxiconazole</designation>
                    <desc language="en-US">oxiconazole</desc>
                </concept>
                <concept code="G01AF18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flutrimazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flutrimazole" type="fsn">flutrimazole</designation>
                    <desc language="en-US">flutrimazole</desc>
                </concept>
                <concept code="G01AF19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sertaconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sertaconazole" type="fsn">sertaconazole</designation>
                    <desc language="en-US">sertaconazole</desc>
                </concept>
                <concept code="G01AF20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of imidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of imidazole derivatives"
                         type="fsn">combinations of imidazole derivatives</designation>
                    <desc language="en-US">combinations of imidazole derivatives</desc>
                </concept>
                <concept code="G01AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Triazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Triazole derivatives" type="fsn">Triazole derivatives</designation>
                    <desc language="en-US">Triazole derivatives</desc>
                </concept>
                <concept code="G01AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terconazole" type="fsn">terconazole</designation>
                    <desc language="en-US">terconazole</desc>
                </concept>
                <concept code="G01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiinfectives and antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antiinfectives and antiseptics"
                         type="fsn">Other antiinfectives and antiseptics</designation>
                    <desc language="en-US">Other antiinfectives and antiseptics</desc>
                </concept>
                <concept code="G01AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clodantoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clodantoin" type="fsn">clodantoin</designation>
                    <desc language="en-US">clodantoin</desc>
                </concept>
                <concept code="G01AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="inosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="inosine" type="fsn">inosine</designation>
                    <desc language="en-US">inosine</desc>
                </concept>
                <concept code="G01AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="policresulen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="policresulen" type="fsn">policresulen</designation>
                    <desc language="en-US">policresulen</desc>
                </concept>
                <concept code="G01AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifuratel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifuratel" type="fsn">nifuratel</designation>
                    <desc language="en-US">nifuratel</desc>
                </concept>
                <concept code="G01AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="furazolidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="furazolidone" type="fsn">furazolidone</designation>
                    <desc language="en-US">furazolidone</desc>
                </concept>
                <concept code="G01AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylrosaniline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylrosaniline" type="fsn">methylrosaniline</designation>
                    <desc language="en-US">methylrosaniline</desc>
                </concept>
                <concept code="G01AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="povidone-iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="povidone-iodine" type="fsn">povidone-iodine</designation>
                    <desc language="en-US">povidone-iodine</desc>
                </concept>
                <concept code="G01AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclopirox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclopirox" type="fsn">ciclopirox</designation>
                    <desc language="en-US">ciclopirox</desc>
                </concept>
                <concept code="G01AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="protiofate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="protiofate" type="fsn">protiofate</designation>
                    <desc language="en-US">protiofate</desc>
                </concept>
                <concept code="G01AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lactobacillus fermentum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lactobacillus fermentum" type="fsn">lactobacillus fermentum</designation>
                    <desc language="en-US">lactobacillus fermentum</desc>
                </concept>
                <concept code="G01AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="copper usnate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="copper usnate" type="fsn">copper usnate</designation>
                    <desc language="en-US">copper usnate</desc>
                </concept>
                <concept code="G01AX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexetidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexetidine" type="fsn">hexetidine</designation>
                    <desc language="en-US">hexetidine</desc>
                </concept>
                <concept code="G01AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dapivirine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dapivirine" type="fsn">dapivirine</designation>
                    <desc language="en-US">dapivirine</desc>
                </concept>
                <concept code="G01AX66"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="octenidine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="octenidine, combinations" type="fsn">octenidine, combinations</designation>
                    <desc language="en-US">octenidine, combinations</desc>
                </concept>
                <concept code="G01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS"
                         type="fsn">ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS</designation>
                    <desc language="en-US">ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS</desc>
                </concept>
                <concept code="G01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics and corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antibiotics and corticosteroids"
                         type="fsn">Antibiotics and corticosteroids</designation>
                    <desc language="en-US">Antibiotics and corticosteroids</desc>
                </concept>
                <concept code="G01BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Quinoline derivatives and corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Quinoline derivatives and corticosteroids"
                         type="fsn">Quinoline derivatives and corticosteroids</designation>
                    <desc language="en-US">Quinoline derivatives and corticosteroids</desc>
                </concept>
                <concept code="G01BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiseptics and corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiseptics and corticosteroids"
                         type="fsn">Antiseptics and corticosteroids</designation>
                    <desc language="en-US">Antiseptics and corticosteroids</desc>
                </concept>
                <concept code="G01BE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides and corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sulfonamides and corticosteroids"
                         type="fsn">Sulfonamides and corticosteroids</designation>
                    <desc language="en-US">Sulfonamides and corticosteroids</desc>
                </concept>
                <concept code="G01BF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazole derivatives and corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Imidazole derivatives and corticosteroids"
                         type="fsn">Imidazole derivatives and corticosteroids</designation>
                    <desc language="en-US">Imidazole derivatives and corticosteroids</desc>
                </concept>
                <concept code="G02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER GYNECOLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER GYNECOLOGICALS" type="fsn">OTHER GYNECOLOGICALS</designation>
                    <desc language="en-US">OTHER GYNECOLOGICALS</desc>
                </concept>
                <concept code="G02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="UTEROTONICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="UTEROTONICS" type="fsn">UTEROTONICS</designation>
                    <desc language="en-US">UTEROTONICS</desc>
                </concept>
                <concept code="G02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ergot alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Ergot alkaloids" type="fsn">Ergot alkaloids</designation>
                    <desc language="en-US">Ergot alkaloids</desc>
                </concept>
                <concept code="G02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylergometrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylergometrine" type="fsn">methylergometrine</designation>
                    <desc language="en-US">methylergometrine</desc>
                </concept>
                <concept code="G02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ergot alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ergot alkaloids" type="fsn">ergot alkaloids</designation>
                    <desc language="en-US">ergot alkaloids</desc>
                </concept>
                <concept code="G02AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ergometrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ergometrine" type="fsn">ergometrine</designation>
                    <desc language="en-US">ergometrine</desc>
                </concept>
                <concept code="G02AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ergot alkaloids and oxytocin incl. analogues, in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Ergot alkaloids and oxytocin incl. analogues, in combination"
                         type="fsn">Ergot alkaloids and oxytocin incl. analogues, in combination</designation>
                    <desc language="en-US">Ergot alkaloids and oxytocin incl. analogues, in combination</desc>
                </concept>
                <concept code="G02AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylergometrine and oxytocin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylergometrine and oxytocin"
                         type="fsn">methylergometrine and oxytocin</designation>
                    <desc language="en-US">methylergometrine and oxytocin</desc>
                </concept>
                <concept code="G02AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Prostaglandins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Prostaglandins" type="fsn">Prostaglandins</designation>
                    <desc language="en-US">Prostaglandins</desc>
                </concept>
                <concept code="G02AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dinoprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dinoprost" type="fsn">dinoprost</designation>
                    <desc language="en-US">dinoprost</desc>
                </concept>
                <concept code="G02AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dinoprostone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dinoprostone" type="fsn">dinoprostone</designation>
                    <desc language="en-US">dinoprostone</desc>
                </concept>
                <concept code="G02AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gemeprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gemeprost" type="fsn">gemeprost</designation>
                    <desc language="en-US">gemeprost</desc>
                </concept>
                <concept code="G02AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carboprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carboprost" type="fsn">carboprost</designation>
                    <desc language="en-US">carboprost</desc>
                </concept>
                <concept code="G02AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulprostone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulprostone" type="fsn">sulprostone</designation>
                    <desc language="en-US">sulprostone</desc>
                </concept>
                <concept code="G02AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="misoprostol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="misoprostol" type="fsn">misoprostol</designation>
                    <desc language="en-US">misoprostol</desc>
                </concept>
                <concept code="G02AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other uterotonics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other uterotonics" type="fsn">Other uterotonics</designation>
                    <desc language="en-US">Other uterotonics</desc>
                </concept>
                <concept code="G02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CONTRACEPTIVES FOR TOPICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CONTRACEPTIVES FOR TOPICAL USE"
                         type="fsn">CONTRACEPTIVES FOR TOPICAL USE</designation>
                    <desc language="en-US">CONTRACEPTIVES FOR TOPICAL USE</desc>
                </concept>
                <concept code="G02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Intrauterine contraceptives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Intrauterine contraceptives"
                         type="fsn">Intrauterine contraceptives</designation>
                    <desc language="en-US">Intrauterine contraceptives</desc>
                </concept>
                <concept code="G02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="plastic IUD"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="plastic IUD" type="fsn">plastic IUD</designation>
                    <desc language="en-US">plastic IUD</desc>
                </concept>
                <concept code="G02BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="plastic IUD with copper"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="plastic IUD with copper" type="fsn">plastic IUD with copper</designation>
                    <desc language="en-US">plastic IUD with copper</desc>
                </concept>
                <concept code="G02BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="plastic IUD with progestogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="plastic IUD with progestogen"
                         type="fsn">plastic IUD with progestogen</designation>
                    <desc language="en-US">plastic IUD with progestogen</desc>
                </concept>
                <concept code="G02BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Intravaginal contraceptives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Intravaginal contraceptives"
                         type="fsn">Intravaginal contraceptives</designation>
                    <desc language="en-US">Intravaginal contraceptives</desc>
                </concept>
                <concept code="G02BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vaginal ring with progestogen and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="vaginal ring with progestogen and estrogen"
                         type="fsn">vaginal ring with progestogen and estrogen</designation>
                    <desc language="en-US">vaginal ring with progestogen and estrogen</desc>
                </concept>
                <concept code="G02BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vaginal ring with progestogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="vaginal ring with progestogen"
                         type="fsn">vaginal ring with progestogen</designation>
                    <desc language="en-US">vaginal ring with progestogen</desc>
                </concept>
                <concept code="G02C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER GYNECOLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER GYNECOLOGICALS" type="fsn">OTHER GYNECOLOGICALS</designation>
                    <desc language="en-US">OTHER GYNECOLOGICALS</desc>
                </concept>
                <concept code="G02CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sympathomimetics, labour repressants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sympathomimetics, labour repressants"
                         type="fsn">Sympathomimetics, labour repressants</designation>
                    <desc language="en-US">Sympathomimetics, labour repressants</desc>
                </concept>
                <concept code="G02CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ritodrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ritodrine" type="fsn">ritodrine</designation>
                    <desc language="en-US">ritodrine</desc>
                </concept>
                <concept code="G02CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buphenine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buphenine" type="fsn">buphenine</designation>
                    <desc language="en-US">buphenine</desc>
                </concept>
                <concept code="G02CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenoterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenoterol" type="fsn">fenoterol</designation>
                    <desc language="en-US">fenoterol</desc>
                </concept>
                <concept code="G02CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Prolactine inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Prolactine inhibitors" type="fsn">Prolactine inhibitors</designation>
                    <desc language="en-US">Prolactine inhibitors</desc>
                </concept>
                <concept code="G02CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromocriptine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromocriptine" type="fsn">bromocriptine</designation>
                    <desc language="en-US">bromocriptine</desc>
                </concept>
                <concept code="G02CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lisuride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lisuride" type="fsn">lisuride</designation>
                    <desc language="en-US">lisuride</desc>
                </concept>
                <concept code="G02CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cabergoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cabergoline" type="fsn">cabergoline</designation>
                    <desc language="en-US">cabergoline</desc>
                </concept>
                <concept code="G02CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinagolide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinagolide" type="fsn">quinagolide</designation>
                    <desc language="en-US">quinagolide</desc>
                </concept>
                <concept code="G02CB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metergoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metergoline" type="fsn">metergoline</designation>
                    <desc language="en-US">metergoline</desc>
                </concept>
                <concept code="G02CB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terguride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terguride" type="fsn">terguride</designation>
                    <desc language="en-US">terguride</desc>
                </concept>
                <concept code="G02CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinflammatory products for vaginal administration"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiinflammatory products for vaginal administration"
                         type="fsn">Antiinflammatory products for vaginal administration</designation>
                    <desc language="en-US">Antiinflammatory products for vaginal administration</desc>
                </concept>
                <concept code="G02CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibuprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibuprofen" type="fsn">ibuprofen</designation>
                    <desc language="en-US">ibuprofen</desc>
                </concept>
                <concept code="G02CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naproxen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naproxen" type="fsn">naproxen</designation>
                    <desc language="en-US">naproxen</desc>
                </concept>
                <concept code="G02CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzydamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzydamine" type="fsn">benzydamine</designation>
                    <desc language="en-US">benzydamine</desc>
                </concept>
                <concept code="G02CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flunoxaprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flunoxaprofen" type="fsn">flunoxaprofen</designation>
                    <desc language="en-US">flunoxaprofen</desc>
                </concept>
                <concept code="G02CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other gynecologicals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other gynecologicals" type="fsn">Other gynecologicals</designation>
                    <desc language="en-US">Other gynecologicals</desc>
                </concept>
                <concept code="G02CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atosiban"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atosiban" type="fsn">atosiban</designation>
                    <desc language="en-US">atosiban</desc>
                </concept>
                <concept code="G02CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flibanserin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flibanserin" type="fsn">flibanserin</designation>
                    <desc language="en-US">flibanserin</desc>
                </concept>
                <concept code="G02CX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Agni casti fructus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Agni casti fructus" type="fsn">Agni casti fructus</designation>
                    <desc language="en-US">Agni casti fructus</desc>
                </concept>
                <concept code="G02CX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Cimicifugae rhizoma"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Cimicifugae rhizoma" type="fsn">Cimicifugae rhizoma</designation>
                    <desc language="en-US">Cimicifugae rhizoma</desc>
                </concept>
                <concept code="G03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM"
                         type="fsn">SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM</designation>
                    <desc language="en-US">SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM</desc>
                </concept>
                <concept code="G03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE"
                         type="fsn">HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE</designation>
                    <desc language="en-US">HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="G03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Progestogens and estrogens, fixed combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Progestogens and estrogens, fixed combinations"
                         type="fsn">Progestogens and estrogens, fixed combinations</designation>
                    <desc language="en-US">Progestogens and estrogens, fixed combinations</desc>
                </concept>
                <concept code="G03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etynodiol and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="etynodiol and ethinylestradiol"
                         type="fsn">etynodiol and ethinylestradiol</designation>
                    <desc language="en-US">etynodiol and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quingestanol and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="quingestanol and ethinylestradiol"
                         type="fsn">quingestanol and ethinylestradiol</designation>
                    <desc language="en-US">quingestanol and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lynestrenol and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lynestrenol and ethinylestradiol"
                         type="fsn">lynestrenol and ethinylestradiol</designation>
                    <desc language="en-US">lynestrenol and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="megestrol and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="megestrol and ethinylestradiol"
                         type="fsn">megestrol and ethinylestradiol</designation>
                    <desc language="en-US">megestrol and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norethisterone and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norethisterone and ethinylestradiol"
                         type="fsn">norethisterone and ethinylestradiol</designation>
                    <desc language="en-US">norethisterone and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norgestrel and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norgestrel and ethinylestradiol"
                         type="fsn">norgestrel and ethinylestradiol</designation>
                    <desc language="en-US">norgestrel and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levonorgestrel and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="levonorgestrel and ethinylestradiol"
                         type="fsn">levonorgestrel and ethinylestradiol</designation>
                    <desc language="en-US">levonorgestrel and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medroxyprogesterone and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="medroxyprogesterone and ethinylestradiol"
                         type="fsn">medroxyprogesterone and ethinylestradiol</designation>
                    <desc language="en-US">medroxyprogesterone and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desogestrel and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="desogestrel and ethinylestradiol"
                         type="fsn">desogestrel and ethinylestradiol</designation>
                    <desc language="en-US">desogestrel and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gestodene and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="gestodene and ethinylestradiol"
                         type="fsn">gestodene and ethinylestradiol</designation>
                    <desc language="en-US">gestodene and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norgestimate and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norgestimate and ethinylestradiol"
                         type="fsn">norgestimate and ethinylestradiol</designation>
                    <desc language="en-US">norgestimate and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="drospirenone and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="drospirenone and ethinylestradiol"
                         type="fsn">drospirenone and ethinylestradiol</designation>
                    <desc language="en-US">drospirenone and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norelgestromin and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norelgestromin and ethinylestradiol"
                         type="fsn">norelgestromin and ethinylestradiol</designation>
                    <desc language="en-US">norelgestromin and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nomegestrol and estradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nomegestrol and estradiol" type="fsn">nomegestrol and estradiol</designation>
                    <desc language="en-US">nomegestrol and estradiol</desc>
                </concept>
                <concept code="G03AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormadinone and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlormadinone and ethinylestradiol"
                         type="fsn">chlormadinone and ethinylestradiol</designation>
                    <desc language="en-US">chlormadinone and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dienogest and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dienogest and ethinylestradiol"
                         type="fsn">dienogest and ethinylestradiol</designation>
                    <desc language="en-US">dienogest and ethinylestradiol</desc>
                </concept>
                <concept code="G03AA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medroxyprogesterone and estradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="medroxyprogesterone and estradiol"
                         type="fsn">medroxyprogesterone and estradiol</designation>
                    <desc language="en-US">medroxyprogesterone and estradiol</desc>
                </concept>
                <concept code="G03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Progestogens and estrogens, sequential preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Progestogens and estrogens, sequential preparations"
                         type="fsn">Progestogens and estrogens, sequential preparations</designation>
                    <desc language="en-US">Progestogens and estrogens, sequential preparations</desc>
                </concept>
                <concept code="G03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="megestrol and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="megestrol and ethinylestradiol"
                         type="fsn">megestrol and ethinylestradiol</designation>
                    <desc language="en-US">megestrol and ethinylestradiol</desc>
                </concept>
                <concept code="G03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lynestrenol and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lynestrenol and ethinylestradiol"
                         type="fsn">lynestrenol and ethinylestradiol</designation>
                    <desc language="en-US">lynestrenol and ethinylestradiol</desc>
                </concept>
                <concept code="G03AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levonorgestrel and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="levonorgestrel and ethinylestradiol"
                         type="fsn">levonorgestrel and ethinylestradiol</designation>
                    <desc language="en-US">levonorgestrel and ethinylestradiol</desc>
                </concept>
                <concept code="G03AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norethisterone and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norethisterone and ethinylestradiol"
                         type="fsn">norethisterone and ethinylestradiol</designation>
                    <desc language="en-US">norethisterone and ethinylestradiol</desc>
                </concept>
                <concept code="G03AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desogestrel and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="desogestrel and ethinylestradiol"
                         type="fsn">desogestrel and ethinylestradiol</designation>
                    <desc language="en-US">desogestrel and ethinylestradiol</desc>
                </concept>
                <concept code="G03AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gestodene and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="gestodene and ethinylestradiol"
                         type="fsn">gestodene and ethinylestradiol</designation>
                    <desc language="en-US">gestodene and ethinylestradiol</desc>
                </concept>
                <concept code="G03AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormadinone and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlormadinone and ethinylestradiol"
                         type="fsn">chlormadinone and ethinylestradiol</designation>
                    <desc language="en-US">chlormadinone and ethinylestradiol</desc>
                </concept>
                <concept code="G03AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dienogest and estradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dienogest and estradiol" type="fsn">dienogest and estradiol</designation>
                    <desc language="en-US">dienogest and estradiol</desc>
                </concept>
                <concept code="G03AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norgestimate and ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norgestimate and ethinylestradiol"
                         type="fsn">norgestimate and ethinylestradiol</designation>
                    <desc language="en-US">norgestimate and ethinylestradiol</desc>
                </concept>
                <concept code="G03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Progestogens"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Progestogens" type="fsn">Progestogens</designation>
                    <desc language="en-US">Progestogens</desc>
                </concept>
                <concept code="G03AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norethisterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norethisterone" type="fsn">norethisterone</designation>
                    <desc language="en-US">norethisterone</desc>
                </concept>
                <concept code="G03AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lynestrenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lynestrenol" type="fsn">lynestrenol</designation>
                    <desc language="en-US">lynestrenol</desc>
                </concept>
                <concept code="G03AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levonorgestrel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levonorgestrel" type="fsn">levonorgestrel</designation>
                    <desc language="en-US">levonorgestrel</desc>
                </concept>
                <concept code="G03AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quingestanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quingestanol" type="fsn">quingestanol</designation>
                    <desc language="en-US">quingestanol</desc>
                </concept>
                <concept code="G03AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="megestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="megestrol" type="fsn">megestrol</designation>
                    <desc language="en-US">megestrol</desc>
                </concept>
                <concept code="G03AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medroxyprogesterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medroxyprogesterone" type="fsn">medroxyprogesterone</designation>
                    <desc language="en-US">medroxyprogesterone</desc>
                </concept>
                <concept code="G03AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norgestrienone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norgestrienone" type="fsn">norgestrienone</designation>
                    <desc language="en-US">norgestrienone</desc>
                </concept>
                <concept code="G03AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etonogestrel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etonogestrel" type="fsn">etonogestrel</designation>
                    <desc language="en-US">etonogestrel</desc>
                </concept>
                <concept code="G03AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desogestrel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desogestrel" type="fsn">desogestrel</designation>
                    <desc language="en-US">desogestrel</desc>
                </concept>
                <concept code="G03AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="drospirenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="drospirenone" type="fsn">drospirenone</designation>
                    <desc language="en-US">drospirenone</desc>
                </concept>
                <concept code="G03AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Emergency contraceptives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Emergency contraceptives" type="fsn">Emergency contraceptives</designation>
                    <desc language="en-US">Emergency contraceptives</desc>
                </concept>
                <concept code="G03AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levonorgestrel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levonorgestrel" type="fsn">levonorgestrel</designation>
                    <desc language="en-US">levonorgestrel</desc>
                </concept>
                <concept code="G03AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ulipristal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ulipristal" type="fsn">ulipristal</designation>
                    <desc language="en-US">ulipristal</desc>
                </concept>
                <concept code="G03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANDROGENS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANDROGENS" type="fsn">ANDROGENS</designation>
                    <desc language="en-US">ANDROGENS</desc>
                </concept>
                <concept code="G03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="3-oxoandrosten (4) derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="3-oxoandrosten (4) derivatives"
                         type="fsn">3-oxoandrosten (4) derivatives</designation>
                    <desc language="en-US">3-oxoandrosten (4) derivatives</desc>
                </concept>
                <concept code="G03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluoxymesterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluoxymesterone" type="fsn">fluoxymesterone</designation>
                    <desc language="en-US">fluoxymesterone</desc>
                </concept>
                <concept code="G03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyltestosterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methyltestosterone" type="fsn">methyltestosterone</designation>
                    <desc language="en-US">methyltestosterone</desc>
                </concept>
                <concept code="G03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="testosterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="testosterone" type="fsn">testosterone</designation>
                    <desc language="en-US">testosterone</desc>
                </concept>
                <concept code="G03BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="5-androstanon (3) derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="5-androstanon (3) derivatives"
                         type="fsn">5-androstanon (3) derivatives</designation>
                    <desc language="en-US">5-androstanon (3) derivatives</desc>
                </concept>
                <concept code="G03BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mesterolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mesterolone" type="fsn">mesterolone</designation>
                    <desc language="en-US">mesterolone</desc>
                </concept>
                <concept code="G03BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="androstanolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="androstanolone" type="fsn">androstanolone</designation>
                    <desc language="en-US">androstanolone</desc>
                </concept>
                <concept code="G03C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ESTROGENS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ESTROGENS" type="fsn">ESTROGENS</designation>
                    <desc language="en-US">ESTROGENS</desc>
                </concept>
                <concept code="G03CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Natural and semisynthetic estrogens, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Natural and semisynthetic estrogens, plain"
                         type="fsn">Natural and semisynthetic estrogens, plain</designation>
                    <desc language="en-US">Natural and semisynthetic estrogens, plain</desc>
                </concept>
                <concept code="G03CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethinylestradiol" type="fsn">ethinylestradiol</designation>
                    <desc language="en-US">ethinylestradiol</desc>
                </concept>
                <concept code="G03CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="estradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="estradiol" type="fsn">estradiol</designation>
                    <desc language="en-US">estradiol</desc>
                </concept>
                <concept code="G03CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="estriol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="estriol" type="fsn">estriol</designation>
                    <desc language="en-US">estriol</desc>
                </concept>
                <concept code="G03CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorotrianisene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorotrianisene" type="fsn">chlorotrianisene</designation>
                    <desc language="en-US">chlorotrianisene</desc>
                </concept>
                <concept code="G03CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="estrone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="estrone" type="fsn">estrone</designation>
                    <desc language="en-US">estrone</desc>
                </concept>
                <concept code="G03CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="promestriene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="promestriene" type="fsn">promestriene</designation>
                    <desc language="en-US">promestriene</desc>
                </concept>
                <concept code="G03CA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="estradiol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="estradiol, combinations" type="fsn">estradiol, combinations</designation>
                    <desc language="en-US">estradiol, combinations</desc>
                </concept>
                <concept code="G03CA57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="conjugated estrogens"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="conjugated estrogens" type="fsn">conjugated estrogens</designation>
                    <desc language="en-US">conjugated estrogens</desc>
                </concept>
                <concept code="G03CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Synthetic estrogens, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Synthetic estrogens, plain"
                         type="fsn">Synthetic estrogens, plain</designation>
                    <desc language="en-US">Synthetic estrogens, plain</desc>
                </concept>
                <concept code="G03CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dienestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dienestrol" type="fsn">dienestrol</designation>
                    <desc language="en-US">dienestrol</desc>
                </concept>
                <concept code="G03CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diethylstilbestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diethylstilbestrol" type="fsn">diethylstilbestrol</designation>
                    <desc language="en-US">diethylstilbestrol</desc>
                </concept>
                <concept code="G03CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methallenestril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methallenestril" type="fsn">methallenestril</designation>
                    <desc language="en-US">methallenestril</desc>
                </concept>
                <concept code="G03CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moxestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moxestrol" type="fsn">moxestrol</designation>
                    <desc language="en-US">moxestrol</desc>
                </concept>
                <concept code="G03CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Estrogens, combinations with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Estrogens, combinations with other drugs"
                         type="fsn">Estrogens, combinations with other drugs</designation>
                    <desc language="en-US">Estrogens, combinations with other drugs</desc>
                </concept>
                <concept code="G03CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dienestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dienestrol" type="fsn">dienestrol</designation>
                    <desc language="en-US">dienestrol</desc>
                </concept>
                <concept code="G03CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methallenestril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methallenestril" type="fsn">methallenestril</designation>
                    <desc language="en-US">methallenestril</desc>
                </concept>
                <concept code="G03CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="estrone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="estrone" type="fsn">estrone</designation>
                    <desc language="en-US">estrone</desc>
                </concept>
                <concept code="G03CC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diethylstilbestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diethylstilbestrol" type="fsn">diethylstilbestrol</designation>
                    <desc language="en-US">diethylstilbestrol</desc>
                </concept>
                <concept code="G03CC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="estriol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="estriol" type="fsn">estriol</designation>
                    <desc language="en-US">estriol</desc>
                </concept>
                <concept code="G03CC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="conjugated estrogens and bazedoxifene"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="conjugated estrogens and bazedoxifene"
                         type="fsn">conjugated estrogens and bazedoxifene</designation>
                    <desc language="en-US">conjugated estrogens and bazedoxifene</desc>
                </concept>
                <concept code="G03CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other estrogens"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other estrogens" type="fsn">Other estrogens</designation>
                    <desc language="en-US">Other estrogens</desc>
                </concept>
                <concept code="G03CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tibolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tibolone" type="fsn">tibolone</designation>
                    <desc language="en-US">tibolone</desc>
                </concept>
                <concept code="G03D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PROGESTOGENS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PROGESTOGENS" type="fsn">PROGESTOGENS</designation>
                    <desc language="en-US">PROGESTOGENS</desc>
                </concept>
                <concept code="G03DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pregnen (4) derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pregnen (4) derivatives" type="fsn">Pregnen (4) derivatives</designation>
                    <desc language="en-US">Pregnen (4) derivatives</desc>
                </concept>
                <concept code="G03DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gestonorone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gestonorone" type="fsn">gestonorone</designation>
                    <desc language="en-US">gestonorone</desc>
                </concept>
                <concept code="G03DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medroxyprogesterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medroxyprogesterone" type="fsn">medroxyprogesterone</designation>
                    <desc language="en-US">medroxyprogesterone</desc>
                </concept>
                <concept code="G03DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxyprogesterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxyprogesterone" type="fsn">hydroxyprogesterone</designation>
                    <desc language="en-US">hydroxyprogesterone</desc>
                </concept>
                <concept code="G03DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="progesterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="progesterone" type="fsn">progesterone</designation>
                    <desc language="en-US">progesterone</desc>
                </concept>
                <concept code="G03DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pregnadien derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pregnadien derivatives" type="fsn">Pregnadien derivatives</designation>
                    <desc language="en-US">Pregnadien derivatives</desc>
                </concept>
                <concept code="G03DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dydrogesterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dydrogesterone" type="fsn">dydrogesterone</designation>
                    <desc language="en-US">dydrogesterone</desc>
                </concept>
                <concept code="G03DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="megestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="megestrol" type="fsn">megestrol</designation>
                    <desc language="en-US">megestrol</desc>
                </concept>
                <concept code="G03DB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medrogestone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medrogestone" type="fsn">medrogestone</designation>
                    <desc language="en-US">medrogestone</desc>
                </concept>
                <concept code="G03DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nomegestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nomegestrol" type="fsn">nomegestrol</designation>
                    <desc language="en-US">nomegestrol</desc>
                </concept>
                <concept code="G03DB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="demegestone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="demegestone" type="fsn">demegestone</designation>
                    <desc language="en-US">demegestone</desc>
                </concept>
                <concept code="G03DB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormadinone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlormadinone" type="fsn">chlormadinone</designation>
                    <desc language="en-US">chlormadinone</desc>
                </concept>
                <concept code="G03DB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="promegestone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="promegestone" type="fsn">promegestone</designation>
                    <desc language="en-US">promegestone</desc>
                </concept>
                <concept code="G03DB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dienogest"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dienogest" type="fsn">dienogest</designation>
                    <desc language="en-US">dienogest</desc>
                </concept>
                <concept code="G03DC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Estren derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Estren derivatives" type="fsn">Estren derivatives</designation>
                    <desc language="en-US">Estren derivatives</desc>
                </concept>
                <concept code="G03DC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="allylestrenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="allylestrenol" type="fsn">allylestrenol</designation>
                    <desc language="en-US">allylestrenol</desc>
                </concept>
                <concept code="G03DC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norethisterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norethisterone" type="fsn">norethisterone</designation>
                    <desc language="en-US">norethisterone</desc>
                </concept>
                <concept code="G03DC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lynestrenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lynestrenol" type="fsn">lynestrenol</designation>
                    <desc language="en-US">lynestrenol</desc>
                </concept>
                <concept code="G03DC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethisterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethisterone" type="fsn">ethisterone</designation>
                    <desc language="en-US">ethisterone</desc>
                </concept>
                <concept code="G03DC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etynodiol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etynodiol" type="fsn">etynodiol</designation>
                    <desc language="en-US">etynodiol</desc>
                </concept>
                <concept code="G03DC31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylestrenolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylestrenolone" type="fsn">methylestrenolone</designation>
                    <desc language="en-US">methylestrenolone</desc>
                </concept>
                <concept code="G03E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION"
                         type="fsn">ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION</designation>
                    <desc language="en-US">ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION</desc>
                </concept>
                <concept code="G03EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Androgens and estrogens"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Androgens and estrogens" type="fsn">Androgens and estrogens</designation>
                    <desc language="en-US">Androgens and estrogens</desc>
                </concept>
                <concept code="G03EA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyltestosterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methyltestosterone and estrogen"
                         type="fsn">methyltestosterone and estrogen</designation>
                    <desc language="en-US">methyltestosterone and estrogen</desc>
                </concept>
                <concept code="G03EA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="testosterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="testosterone and estrogen" type="fsn">testosterone and estrogen</designation>
                    <desc language="en-US">testosterone and estrogen</desc>
                </concept>
                <concept code="G03EA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prasterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prasterone and estrogen" type="fsn">prasterone and estrogen</designation>
                    <desc language="en-US">prasterone and estrogen</desc>
                </concept>
                <concept code="G03EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Androgen, progestogen and estrogen in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Androgen, progestogen and estrogen in combination"
                         type="fsn">Androgen, progestogen and estrogen in combination</designation>
                    <desc language="en-US">Androgen, progestogen and estrogen in combination</desc>
                </concept>
                <concept code="G03EK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Androgens and female sex hormones in combination with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Androgens and female sex hormones in combination with other drugs"
                         type="fsn">Androgens and female sex hormones in combination with other drugs</designation>
                    <desc language="en-US">Androgens and female sex hormones in combination with other drugs</desc>
                </concept>
                <concept code="G03EK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyltestosterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methyltestosterone" type="fsn">methyltestosterone</designation>
                    <desc language="en-US">methyltestosterone</desc>
                </concept>
                <concept code="G03F"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PROGESTOGENS AND ESTROGENS IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PROGESTOGENS AND ESTROGENS IN COMBINATION"
                         type="fsn">PROGESTOGENS AND ESTROGENS IN COMBINATION</designation>
                    <desc language="en-US">PROGESTOGENS AND ESTROGENS IN COMBINATION</desc>
                </concept>
                <concept code="G03FA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Progestogens and estrogens, fixed combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Progestogens and estrogens, fixed combinations"
                         type="fsn">Progestogens and estrogens, fixed combinations</designation>
                    <desc language="en-US">Progestogens and estrogens, fixed combinations</desc>
                </concept>
                <concept code="G03FA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norethisterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norethisterone and estrogen"
                         type="fsn">norethisterone and estrogen</designation>
                    <desc language="en-US">norethisterone and estrogen</desc>
                </concept>
                <concept code="G03FA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxyprogesterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydroxyprogesterone and estrogen"
                         type="fsn">hydroxyprogesterone and estrogen</designation>
                    <desc language="en-US">hydroxyprogesterone and estrogen</desc>
                </concept>
                <concept code="G03FA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethisterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethisterone and estrogen" type="fsn">ethisterone and estrogen</designation>
                    <desc language="en-US">ethisterone and estrogen</desc>
                </concept>
                <concept code="G03FA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="progesterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="progesterone and estrogen" type="fsn">progesterone and estrogen</designation>
                    <desc language="en-US">progesterone and estrogen</desc>
                </concept>
                <concept code="G03FA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylnortestosterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylnortestosterone and estrogen"
                         type="fsn">methylnortestosterone and estrogen</designation>
                    <desc language="en-US">methylnortestosterone and estrogen</desc>
                </concept>
                <concept code="G03FA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etynodiol and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etynodiol and estrogen" type="fsn">etynodiol and estrogen</designation>
                    <desc language="en-US">etynodiol and estrogen</desc>
                </concept>
                <concept code="G03FA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lynestrenol and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lynestrenol and estrogen" type="fsn">lynestrenol and estrogen</designation>
                    <desc language="en-US">lynestrenol and estrogen</desc>
                </concept>
                <concept code="G03FA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="megestrol and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="megestrol and estrogen" type="fsn">megestrol and estrogen</designation>
                    <desc language="en-US">megestrol and estrogen</desc>
                </concept>
                <concept code="G03FA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="noretynodrel and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="noretynodrel and estrogen" type="fsn">noretynodrel and estrogen</designation>
                    <desc language="en-US">noretynodrel and estrogen</desc>
                </concept>
                <concept code="G03FA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norgestrel and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norgestrel and estrogen" type="fsn">norgestrel and estrogen</designation>
                    <desc language="en-US">norgestrel and estrogen</desc>
                </concept>
                <concept code="G03FA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levonorgestrel and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="levonorgestrel and estrogen"
                         type="fsn">levonorgestrel and estrogen</designation>
                    <desc language="en-US">levonorgestrel and estrogen</desc>
                </concept>
                <concept code="G03FA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medroxyprogesterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="medroxyprogesterone and estrogen"
                         type="fsn">medroxyprogesterone and estrogen</designation>
                    <desc language="en-US">medroxyprogesterone and estrogen</desc>
                </concept>
                <concept code="G03FA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norgestimate and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norgestimate and estrogen" type="fsn">norgestimate and estrogen</designation>
                    <desc language="en-US">norgestimate and estrogen</desc>
                </concept>
                <concept code="G03FA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dydrogesterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dydrogesterone and estrogen"
                         type="fsn">dydrogesterone and estrogen</designation>
                    <desc language="en-US">dydrogesterone and estrogen</desc>
                </concept>
                <concept code="G03FA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dienogest and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dienogest and estrogen" type="fsn">dienogest and estrogen</designation>
                    <desc language="en-US">dienogest and estrogen</desc>
                </concept>
                <concept code="G03FA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimegestone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimegestone and estrogen" type="fsn">trimegestone and estrogen</designation>
                    <desc language="en-US">trimegestone and estrogen</desc>
                </concept>
                <concept code="G03FA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="drospirenone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="drospirenone and estrogen" type="fsn">drospirenone and estrogen</designation>
                    <desc language="en-US">drospirenone and estrogen</desc>
                </concept>
                <concept code="G03FB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Progestogens and estrogens, sequential preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Progestogens and estrogens, sequential preparations"
                         type="fsn">Progestogens and estrogens, sequential preparations</designation>
                    <desc language="en-US">Progestogens and estrogens, sequential preparations</desc>
                </concept>
                <concept code="G03FB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norgestrel and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norgestrel and estrogen" type="fsn">norgestrel and estrogen</designation>
                    <desc language="en-US">norgestrel and estrogen</desc>
                </concept>
                <concept code="G03FB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lynestrenol and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lynestrenol and estrogen" type="fsn">lynestrenol and estrogen</designation>
                    <desc language="en-US">lynestrenol and estrogen</desc>
                </concept>
                <concept code="G03FB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormadinone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlormadinone and estrogen"
                         type="fsn">chlormadinone and estrogen</designation>
                    <desc language="en-US">chlormadinone and estrogen</desc>
                </concept>
                <concept code="G03FB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="megestrol and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="megestrol and estrogen" type="fsn">megestrol and estrogen</designation>
                    <desc language="en-US">megestrol and estrogen</desc>
                </concept>
                <concept code="G03FB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norethisterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norethisterone and estrogen"
                         type="fsn">norethisterone and estrogen</designation>
                    <desc language="en-US">norethisterone and estrogen</desc>
                </concept>
                <concept code="G03FB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medroxyprogesterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="medroxyprogesterone and estrogen"
                         type="fsn">medroxyprogesterone and estrogen</designation>
                    <desc language="en-US">medroxyprogesterone and estrogen</desc>
                </concept>
                <concept code="G03FB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medrogestone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medrogestone and estrogen" type="fsn">medrogestone and estrogen</designation>
                    <desc language="en-US">medrogestone and estrogen</desc>
                </concept>
                <concept code="G03FB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dydrogesterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dydrogesterone and estrogen"
                         type="fsn">dydrogesterone and estrogen</designation>
                    <desc language="en-US">dydrogesterone and estrogen</desc>
                </concept>
                <concept code="G03FB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levonorgestrel and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="levonorgestrel and estrogen"
                         type="fsn">levonorgestrel and estrogen</designation>
                    <desc language="en-US">levonorgestrel and estrogen</desc>
                </concept>
                <concept code="G03FB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desogestrel and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desogestrel and estrogen" type="fsn">desogestrel and estrogen</designation>
                    <desc language="en-US">desogestrel and estrogen</desc>
                </concept>
                <concept code="G03FB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimegestone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimegestone and estrogen" type="fsn">trimegestone and estrogen</designation>
                    <desc language="en-US">trimegestone and estrogen</desc>
                </concept>
                <concept code="G03FB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nomegestrol and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nomegestrol and estrogen" type="fsn">nomegestrol and estrogen</designation>
                    <desc language="en-US">nomegestrol and estrogen</desc>
                </concept>
                <concept code="G03G"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="GONADOTROPINS AND OTHER OVULATION STIMULANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="GONADOTROPINS AND OTHER OVULATION STIMULANTS"
                         type="fsn">GONADOTROPINS AND OTHER OVULATION STIMULANTS</designation>
                    <desc language="en-US">GONADOTROPINS AND OTHER OVULATION STIMULANTS</desc>
                </concept>
                <concept code="G03GA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Gonadotropins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Gonadotropins" type="fsn">Gonadotropins</designation>
                    <desc language="en-US">Gonadotropins</desc>
                </concept>
                <concept code="G03GA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chorionic gonadotrophin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chorionic gonadotrophin" type="fsn">chorionic gonadotrophin</designation>
                    <desc language="en-US">chorionic gonadotrophin</desc>
                </concept>
                <concept code="G03GA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="human menopausal gonadotrophin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="human menopausal gonadotrophin"
                         type="fsn">human menopausal gonadotrophin</designation>
                    <desc language="en-US">human menopausal gonadotrophin</desc>
                </concept>
                <concept code="G03GA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="serum gonadotrophin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="serum gonadotrophin" type="fsn">serum gonadotrophin</designation>
                    <desc language="en-US">serum gonadotrophin</desc>
                </concept>
                <concept code="G03GA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="urofollitropin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="urofollitropin" type="fsn">urofollitropin</designation>
                    <desc language="en-US">urofollitropin</desc>
                </concept>
                <concept code="G03GA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="follitropin alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="follitropin alfa" type="fsn">follitropin alfa</designation>
                    <desc language="en-US">follitropin alfa</desc>
                </concept>
                <concept code="G03GA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="follitropin beta"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="follitropin beta" type="fsn">follitropin beta</designation>
                    <desc language="en-US">follitropin beta</desc>
                </concept>
                <concept code="G03GA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lutropin alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lutropin alfa" type="fsn">lutropin alfa</designation>
                    <desc language="en-US">lutropin alfa</desc>
                </concept>
                <concept code="G03GA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="choriogonadotropin alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="choriogonadotropin alfa" type="fsn">choriogonadotropin alfa</designation>
                    <desc language="en-US">choriogonadotropin alfa</desc>
                </concept>
                <concept code="G03GA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="corifollitropin alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="corifollitropin alfa" type="fsn">corifollitropin alfa</designation>
                    <desc language="en-US">corifollitropin alfa</desc>
                </concept>
                <concept code="G03GA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="follitropin delta"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="follitropin delta" type="fsn">follitropin delta</designation>
                    <desc language="en-US">follitropin delta</desc>
                </concept>
                <concept code="G03GA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="G03GB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ovulation stimulants, synthetic"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Ovulation stimulants, synthetic"
                         type="fsn">Ovulation stimulants, synthetic</designation>
                    <desc language="en-US">Ovulation stimulants, synthetic</desc>
                </concept>
                <concept code="G03GB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclofenil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclofenil" type="fsn">cyclofenil</designation>
                    <desc language="en-US">cyclofenil</desc>
                </concept>
                <concept code="G03GB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clomifene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clomifene" type="fsn">clomifene</designation>
                    <desc language="en-US">clomifene</desc>
                </concept>
                <concept code="G03GB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epimestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epimestrol" type="fsn">epimestrol</designation>
                    <desc language="en-US">epimestrol</desc>
                </concept>
                <concept code="G03H"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIANDROGENS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIANDROGENS" type="fsn">ANTIANDROGENS</designation>
                    <desc language="en-US">ANTIANDROGENS</desc>
                </concept>
                <concept code="G03HA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiandrogens, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antiandrogens, plain" type="fsn">Antiandrogens, plain</designation>
                    <desc language="en-US">Antiandrogens, plain</desc>
                </concept>
                <concept code="G03HA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyproterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyproterone" type="fsn">cyproterone</designation>
                    <desc language="en-US">cyproterone</desc>
                </concept>
                <concept code="G03HB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiandrogens and estrogens"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiandrogens and estrogens"
                         type="fsn">Antiandrogens and estrogens</designation>
                    <desc language="en-US">Antiandrogens and estrogens</desc>
                </concept>
                <concept code="G03HB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyproterone and estrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyproterone and estrogen" type="fsn">cyproterone and estrogen</designation>
                    <desc language="en-US">cyproterone and estrogen</desc>
                </concept>
                <concept code="G03X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM"
                         type="fsn">OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM</designation>
                    <desc language="en-US">OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM</desc>
                </concept>
                <concept code="G03XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antigonadotropins and similar agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antigonadotropins and similar agents"
                         type="fsn">Antigonadotropins and similar agents</designation>
                    <desc language="en-US">Antigonadotropins and similar agents</desc>
                </concept>
                <concept code="G03XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="danazol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="danazol" type="fsn">danazol</designation>
                    <desc language="en-US">danazol</desc>
                </concept>
                <concept code="G03XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gestrinone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gestrinone" type="fsn">gestrinone</designation>
                    <desc language="en-US">gestrinone</desc>
                </concept>
                <concept code="G03XB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Progesterone receptor modulators"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Progesterone receptor modulators"
                         type="fsn">Progesterone receptor modulators</designation>
                    <desc language="en-US">Progesterone receptor modulators</desc>
                </concept>
                <concept code="G03XB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mifepristone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mifepristone" type="fsn">mifepristone</designation>
                    <desc language="en-US">mifepristone</desc>
                </concept>
                <concept code="G03XB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ulipristal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ulipristal" type="fsn">ulipristal</designation>
                    <desc language="en-US">ulipristal</desc>
                </concept>
                <concept code="G03XB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mifepristone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="mifepristone, combinations"
                         type="fsn">mifepristone, combinations</designation>
                    <desc language="en-US">mifepristone, combinations</desc>
                </concept>
                <concept code="G03XC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Selective estrogen receptor modulators"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Selective estrogen receptor modulators"
                         type="fsn">Selective estrogen receptor modulators</designation>
                    <desc language="en-US">Selective estrogen receptor modulators</desc>
                </concept>
                <concept code="G03XC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="raloxifene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="raloxifene" type="fsn">raloxifene</designation>
                    <desc language="en-US">raloxifene</desc>
                </concept>
                <concept code="G03XC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bazedoxifene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bazedoxifene" type="fsn">bazedoxifene</designation>
                    <desc language="en-US">bazedoxifene</desc>
                </concept>
                <concept code="G03XC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lasofoxifene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lasofoxifene" type="fsn">lasofoxifene</designation>
                    <desc language="en-US">lasofoxifene</desc>
                </concept>
                <concept code="G03XC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ormeloxifene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ormeloxifene" type="fsn">ormeloxifene</designation>
                    <desc language="en-US">ormeloxifene</desc>
                </concept>
                <concept code="G03XC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ospemifene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ospemifene" type="fsn">ospemifene</designation>
                    <desc language="en-US">ospemifene</desc>
                </concept>
                <concept code="G03XX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other sex hormones and modulators of the genital system"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other sex hormones and modulators of the genital system"
                         type="fsn">Other sex hormones and modulators of the genital system</designation>
                    <desc language="en-US">Other sex hormones and modulators of the genital system</desc>
                </concept>
                <concept code="G03XX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prasterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prasterone" type="fsn">prasterone</designation>
                    <desc language="en-US">prasterone</desc>
                </concept>
                <concept code="G04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="UROLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="UROLOGICALS" type="fsn">UROLOGICALS</designation>
                    <desc language="en-US">UROLOGICALS</desc>
                </concept>
                <concept code="G04B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="UROLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="UROLOGICALS" type="fsn">UROLOGICALS</designation>
                    <desc language="en-US">UROLOGICALS</desc>
                </concept>
                <concept code="G04BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Acidifiers"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Acidifiers" type="fsn">Acidifiers</designation>
                    <desc language="en-US">Acidifiers</desc>
                </concept>
                <concept code="G04BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ammonium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ammonium chloride" type="fsn">ammonium chloride</designation>
                    <desc language="en-US">ammonium chloride</desc>
                </concept>
                <concept code="G04BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium chloride" type="fsn">calcium chloride</designation>
                    <desc language="en-US">calcium chloride</desc>
                </concept>
                <concept code="G04BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Urinary concrement solvents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Urinary concrement solvents"
                         type="fsn">Urinary concrement solvents</designation>
                    <desc language="en-US">Urinary concrement solvents</desc>
                </concept>
                <concept code="G04BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs for urinary frequency and incontinence"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs for urinary frequency and incontinence"
                         type="fsn">Drugs for urinary frequency and incontinence</designation>
                    <desc language="en-US">Drugs for urinary frequency and incontinence</desc>
                </concept>
                <concept code="G04BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emepronium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emepronium" type="fsn">emepronium</designation>
                    <desc language="en-US">emepronium</desc>
                </concept>
                <concept code="G04BD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flavoxate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flavoxate" type="fsn">flavoxate</designation>
                    <desc language="en-US">flavoxate</desc>
                </concept>
                <concept code="G04BD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meladrazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meladrazine" type="fsn">meladrazine</designation>
                    <desc language="en-US">meladrazine</desc>
                </concept>
                <concept code="G04BD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxybutynin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxybutynin" type="fsn">oxybutynin</designation>
                    <desc language="en-US">oxybutynin</desc>
                </concept>
                <concept code="G04BD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terodiline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terodiline" type="fsn">terodiline</designation>
                    <desc language="en-US">terodiline</desc>
                </concept>
                <concept code="G04BD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propiverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propiverine" type="fsn">propiverine</designation>
                    <desc language="en-US">propiverine</desc>
                </concept>
                <concept code="G04BD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolterodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolterodine" type="fsn">tolterodine</designation>
                    <desc language="en-US">tolterodine</desc>
                </concept>
                <concept code="G04BD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="solifenacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="solifenacin" type="fsn">solifenacin</designation>
                    <desc language="en-US">solifenacin</desc>
                </concept>
                <concept code="G04BD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trospium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trospium" type="fsn">trospium</designation>
                    <desc language="en-US">trospium</desc>
                </concept>
                <concept code="G04BD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="darifenacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="darifenacin" type="fsn">darifenacin</designation>
                    <desc language="en-US">darifenacin</desc>
                </concept>
                <concept code="G04BD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fesoterodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fesoterodine" type="fsn">fesoterodine</designation>
                    <desc language="en-US">fesoterodine</desc>
                </concept>
                <concept code="G04BD12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mirabegron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mirabegron" type="fsn">mirabegron</designation>
                    <desc language="en-US">mirabegron</desc>
                </concept>
                <concept code="G04BD13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desfesoterodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desfesoterodine" type="fsn">desfesoterodine</designation>
                    <desc language="en-US">desfesoterodine</desc>
                </concept>
                <concept code="G04BE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs used in erectile dysfunction"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs used in erectile dysfunction"
                         type="fsn">Drugs used in erectile dysfunction</designation>
                    <desc language="en-US">Drugs used in erectile dysfunction</desc>
                </concept>
                <concept code="G04BE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alprostadil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alprostadil" type="fsn">alprostadil</designation>
                    <desc language="en-US">alprostadil</desc>
                </concept>
                <concept code="G04BE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="papaverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="papaverine" type="fsn">papaverine</designation>
                    <desc language="en-US">papaverine</desc>
                </concept>
                <concept code="G04BE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sildenafil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sildenafil" type="fsn">sildenafil</designation>
                    <desc language="en-US">sildenafil</desc>
                </concept>
                <concept code="G04BE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="yohimbine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="yohimbine" type="fsn">yohimbine</designation>
                    <desc language="en-US">yohimbine</desc>
                </concept>
                <concept code="G04BE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moxisylyte"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moxisylyte" type="fsn">moxisylyte</designation>
                    <desc language="en-US">moxisylyte</desc>
                </concept>
                <concept code="G04BE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="apomorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="apomorphine" type="fsn">apomorphine</designation>
                    <desc language="en-US">apomorphine</desc>
                </concept>
                <concept code="G04BE08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tadalafil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tadalafil" type="fsn">tadalafil</designation>
                    <desc language="en-US">tadalafil</desc>
                </concept>
                <concept code="G04BE09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vardenafil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vardenafil" type="fsn">vardenafil</designation>
                    <desc language="en-US">vardenafil</desc>
                </concept>
                <concept code="G04BE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="avanafil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="avanafil" type="fsn">avanafil</designation>
                    <desc language="en-US">avanafil</desc>
                </concept>
                <concept code="G04BE11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="udenafil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="udenafil" type="fsn">udenafil</designation>
                    <desc language="en-US">udenafil</desc>
                </concept>
                <concept code="G04BE30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="G04BE52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="papaverine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="papaverine, combinations" type="fsn">papaverine, combinations</designation>
                    <desc language="en-US">papaverine, combinations</desc>
                </concept>
                <concept code="G04BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other urologicals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other urologicals" type="fsn">Other urologicals</designation>
                    <desc language="en-US">Other urologicals</desc>
                </concept>
                <concept code="G04BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium hydroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium hydroxide" type="fsn">magnesium hydroxide</designation>
                    <desc language="en-US">magnesium hydroxide</desc>
                </concept>
                <concept code="G04BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetohydroxamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetohydroxamic acid" type="fsn">acetohydroxamic acid</designation>
                    <desc language="en-US">acetohydroxamic acid</desc>
                </concept>
                <concept code="G04BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenazopyridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenazopyridine" type="fsn">phenazopyridine</designation>
                    <desc language="en-US">phenazopyridine</desc>
                </concept>
                <concept code="G04BX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="succinimide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="succinimide" type="fsn">succinimide</designation>
                    <desc language="en-US">succinimide</desc>
                </concept>
                <concept code="G04BX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="collagen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="collagen" type="fsn">collagen</designation>
                    <desc language="en-US">collagen</desc>
                </concept>
                <concept code="G04BX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenyl salicylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenyl salicylate" type="fsn">phenyl salicylate</designation>
                    <desc language="en-US">phenyl salicylate</desc>
                </concept>
                <concept code="G04BX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimethyl sulfoxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimethyl sulfoxide" type="fsn">dimethyl sulfoxide</designation>
                    <desc language="en-US">dimethyl sulfoxide</desc>
                </concept>
                <concept code="G04BX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dapoxetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dapoxetine" type="fsn">dapoxetine</designation>
                    <desc language="en-US">dapoxetine</desc>
                </concept>
                <concept code="G04BX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentosan polysulfate sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pentosan polysulfate sodium"
                         type="fsn">pentosan polysulfate sodium</designation>
                    <desc language="en-US">pentosan polysulfate sodium</desc>
                </concept>
                <concept code="G04BX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiopronin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiopronin" type="fsn">tiopronin</designation>
                    <desc language="en-US">tiopronin</desc>
                </concept>
                <concept code="G04C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY"
                         type="fsn">DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY</designation>
                    <desc language="en-US">DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY</desc>
                </concept>
                <concept code="G04CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha-adrenoreceptor antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha-adrenoreceptor antagonists"
                         type="fsn">Alpha-adrenoreceptor antagonists</designation>
                    <desc language="en-US">Alpha-adrenoreceptor antagonists</desc>
                </concept>
                <concept code="G04CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alfuzosin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alfuzosin" type="fsn">alfuzosin</designation>
                    <desc language="en-US">alfuzosin</desc>
                </concept>
                <concept code="G04CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tamsulosin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tamsulosin" type="fsn">tamsulosin</designation>
                    <desc language="en-US">tamsulosin</desc>
                </concept>
                <concept code="G04CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terazosin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terazosin" type="fsn">terazosin</designation>
                    <desc language="en-US">terazosin</desc>
                </concept>
                <concept code="G04CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="silodosin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="silodosin" type="fsn">silod
            osin</designation>
                    <desc language="en-US">silodosin</desc>
                </concept>
                <concept code="G04CA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alfuzosin and finasteride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alfuzosin and finasteride" type="fsn">alfuzosin and finasteride</designation>
                    <desc language="en-US">alfuzosin and finasteride</desc>
                </concept>
                <concept code="G04CA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tamsulosin and dutasteride"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tamsulosin and dutasteride"
                         type="fsn">tamsulosin and dutasteride</designation>
                    <desc language="en-US">tamsulosin and dutasteride</desc>
                </concept>
                <concept code="G04CA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tamsulosin and solifenacin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tamsulosin and solifenacin"
                         type="fsn">tamsulosin and solifenacin</designation>
                    <desc language="en-US">tamsulosin and solifenacin</desc>
                </concept>
                <concept code="G04CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Testosterone-5-alpha reductase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Testosterone-5-alpha reductase inhibitors"
                         type="fsn">Testosterone-5-alpha reductase inhibitors</designation>
                    <desc language="en-US">Testosterone-5-alpha reductase inhibitors</desc>
                </concept>
                <concept code="G04CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="finasteride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="finasteride" type="fsn">finasteride</designation>
                    <desc language="en-US">finasteride</desc>
                </concept>
                <concept code="G04CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dutasteride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dutasteride" type="fsn">dutasteride</designation>
                    <desc language="en-US">dutasteride</desc>
                </concept>
                <concept code="G04CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs used in benign prostatic hypertrophy"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs used in benign prostatic hypertrophy"
                         type="fsn">Other drugs used in benign prostatic hypertrophy</designation>
                    <desc language="en-US">Other drugs used in benign prostatic hypertrophy</desc>
                </concept>
                <concept code="G04CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Prunus africanae cortex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Prunus africanae cortex" type="fsn">Prunus africanae cortex</designation>
                    <desc language="en-US">Prunus africanae cortex</desc>
                </concept>
                <concept code="G04CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sabalis serrulatae fructus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sabalis serrulatae fructus"
                         type="fsn">Sabalis serrulatae fructus</designation>
                    <desc language="en-US">Sabalis serrulatae fructus</desc>
                </concept>
                <concept code="G04CX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepartricin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepartricin" type="fsn">mepartricin</designation>
                    <desc language="en-US">mepartricin</desc>
                </concept>
                <concept code="G04CX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fexapotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fexapotide" type="fsn">fexapotide</designation>
                    <desc language="en-US">fexapotide</desc>
                </concept>
                <concept code="H"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
                         type="fsn">SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS</designation>
                    <desc language="en-US">SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS</desc>
                </concept>
                <concept code="H01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES"
                         type="fsn">PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES</designation>
                    <desc language="en-US">PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES</desc>
                </concept>
                <concept code="H01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES"
                         type="fsn">ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES</designation>
                    <desc language="en-US">ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES</desc>
                </concept>
                <concept code="H01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ACTH"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ACTH" type="fsn">ACTH</designation>
                    <desc language="en-US">ACTH</desc>
                </concept>
                <concept code="H01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="corticotropin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="corticotropin" type="fsn">corticotropin</designation>
                    <desc language="en-US">corticotropin</desc>
                </concept>
                <concept code="H01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracosactide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracosactide" type="fsn">tetracosactide</designation>
                    <desc language="en-US">tetracosactide</desc>
                </concept>
                <concept code="H01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thyrotropin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thyrotropin" type="fsn">Thyrotropin</designation>
                    <desc language="en-US">Thyrotropin</desc>
                </concept>
                <concept code="H01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thyrotropin alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thyrotropin alfa" type="fsn">thyrotropin alfa</designation>
                    <desc language="en-US">thyrotropin alfa</desc>
                </concept>
                <concept code="H01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Somatropin and somatropin agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Somatropin and somatropin agonists"
                         type="fsn">Somatropin and somatropin agonists</designation>
                    <desc language="en-US">Somatropin and somatropin agonists</desc>
                </concept>
                <concept code="H01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="somatropin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="somatropin" type="fsn">somatropin</designation>
                    <desc language="en-US">somatropin</desc>
                </concept>
                <concept code="H01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="somatrem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="somatrem" type="fsn">somatrem</designation>
                    <desc language="en-US">somatrem</desc>
                </concept>
                <concept code="H01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mecasermin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mecasermin" type="fsn">mecasermin</designation>
                    <desc language="en-US">mecasermin</desc>
                </concept>
                <concept code="H01AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sermorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sermorelin" type="fsn">sermorelin</designation>
                    <desc language="en-US">sermorelin</desc>
                </concept>
                <concept code="H01AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mecasermin rinfabate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mecasermin rinfabate" type="fsn">mecasermin rinfabate</designation>
                    <desc language="en-US">mecasermin rinfabate</desc>
                </concept>
                <concept code="H01AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tesamorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tesamorelin" type="fsn">tesamorelin</designation>
                    <desc language="en-US">tesamorelin</desc>
                </concept>
                <concept code="H01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other anterior pituitary lobe hormones and analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other anterior pituitary lobe hormones and analogues"
                         type="fsn">Other anterior pituitary lobe hormones and analogues</designation>
                    <desc language="en-US">Other anterior pituitary lobe hormones and analogues</desc>
                </concept>
                <concept code="H01AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pegvisomant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pegvisomant" type="fsn">pegvisomant</designation>
                    <desc language="en-US">pegvisomant</desc>
                </concept>
                <concept code="H01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="POSTERIOR PITUITARY LOBE HORMONES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="POSTERIOR PITUITARY LOBE HORMONES"
                         type="fsn">POSTERIOR PITUITARY LOBE HORMONES</designation>
                    <desc language="en-US">POSTERIOR PITUITARY LOBE HORMONES</desc>
                </concept>
                <concept code="H01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vasopressin and analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Vasopressin and analogues" type="fsn">Vasopressin and analogues</designation>
                    <desc language="en-US">Vasopressin and analogues</desc>
                </concept>
                <concept code="H01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vasopressin (argipressin)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vasopressin (argipressin)" type="fsn">vasopressin (argipressin)</designation>
                    <desc language="en-US">vasopressin (argipressin)</desc>
                </concept>
                <concept code="H01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desmopressin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desmopressin" type="fsn">desmopressin</designation>
                    <desc language="en-US">desmopressin</desc>
                </concept>
                <concept code="H01BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lypressin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lypressin" type="fsn">lypressin</designation>
                    <desc language="en-US">lypressin</desc>
                </concept>
                <concept code="H01BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terlipressin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terlipressin" type="fsn">terlipressin</designation>
                    <desc language="en-US">terlipressin</desc>
                </concept>
                <concept code="H01BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ornipressin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ornipressin" type="fsn">ornipressin</designation>
                    <desc language="en-US">ornipressin</desc>
                </concept>
                <concept code="H01BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Oxytocin and analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Oxytocin and analogues" type="fsn">Oxytocin and analogues</designation>
                    <desc language="en-US">Oxytocin and analogues</desc>
                </concept>
                <concept code="H01BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="demoxytocin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="demoxytocin" type="fsn">demoxytocin</designation>
                    <desc language="en-US">demoxytocin</desc>
                </concept>
                <concept code="H01BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxytocin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxytocin" type="fsn">oxytocin</designation>
                    <desc language="en-US">oxytocin</desc>
                </concept>
                <concept code="H01BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbetocin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbetocin" type="fsn">carbetocin</designation>
                    <desc language="en-US">carbetocin</desc>
                </concept>
                <concept code="H01C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HYPOTHALAMIC HORMONES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="HYPOTHALAMIC HORMONES" type="fsn">HYPOTHALAMIC HORMONES</designation>
                    <desc language="en-US">HYPOTHALAMIC HORMONES</desc>
                </concept>
                <concept code="H01CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Gonadotropin-releasing hormones"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Gonadotropin-releasing hormones"
                         type="fsn">Gonadotropin-releasing hormones</designation>
                    <desc language="en-US">Gonadotropin-releasing hormones</desc>
                </concept>
                <concept code="H01CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gonadorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gonadorelin" type="fsn">gonadorelin</designation>
                    <desc language="en-US">gonadorelin</desc>
                </concept>
                <concept code="H01CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nafarelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nafarelin" type="fsn">nafarelin</designation>
                    <desc language="en-US">nafarelin</desc>
                </concept>
                <concept code="H01CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Somatostatin and analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Somatostatin and analogues"
                         type="fsn">Somatostatin and analogues</designation>
                    <desc language="en-US">Somatostatin and analogues</desc>
                </concept>
                <concept code="H01CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="somatostatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="somatostatin" type="fsn">somatostatin</designation>
                    <desc language="en-US">somatostatin</desc>
                </concept>
                <concept code="H01CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="octreotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="octreotide" type="fsn">octreotide</designation>
                    <desc language="en-US">octreotide</desc>
                </concept>
                <concept code="H01CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lanreotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lanreotide" type="fsn">lanreotide</designation>
                    <desc language="en-US">lanreotide</desc>
                </concept>
                <concept code="H01CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vapreotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vapreotide" type="fsn">vapreotide</designation>
                    <desc language="en-US">vapreotide</desc>
                </concept>
                <concept code="H01CB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pasireotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pasireotide" type="fsn">pasireotide</designation>
                    <desc language="en-US">pasireotide</desc>
                </concept>
                <concept code="H01CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anti-gonadotropin-releasing hormones"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Anti-gonadotropin-releasing hormones"
                         type="fsn">Anti-gonadotropin-releasing hormones</designation>
                    <desc language="en-US">Anti-gonadotropin-releasing hormones</desc>
                </concept>
                <concept code="H01CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ganirelix"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ganirelix" type="fsn">ganirelix</designation>
                    <desc language="en-US">ganirelix</desc>
                </concept>
                <concept code="H01CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetrorelix"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetrorelix" type="fsn">cetrorelix</designation>
                    <desc language="en-US">cetrorelix</desc>
                </concept>
                <concept code="H02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS FOR SYSTEMIC USE"
                         type="fsn">CORTICOSTEROIDS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">CORTICOSTEROIDS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="H02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN"
                         type="fsn">CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN</designation>
                    <desc language="en-US">CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN</desc>
                </concept>
                <concept code="H02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Mineralocorticoids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Mineralocorticoids" type="fsn">Mineralocorticoids</designation>
                    <desc language="en-US">Mineralocorticoids</desc>
                </concept>
                <concept code="H02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aldosterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aldosterone" type="fsn">aldosterone</designation>
                    <desc language="en-US">aldosterone</desc>
                </concept>
                <concept code="H02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fludrocortisone" type="fsn">fludrocortisone</designation>
                    <desc language="en-US">fludrocortisone</desc>
                </concept>
                <concept code="H02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desoxycortone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desoxycortone" type="fsn">desoxycortone</designation>
                    <desc language="en-US">desoxycortone</desc>
                </concept>
                <concept code="H02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Glucocorticoids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Glucocorticoids" type="fsn">Glucocorticoids</designation>
                    <desc language="en-US">Glucocorticoids</desc>
                </concept>
                <concept code="H02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="H02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="H02AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocortolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocortolone" type="fsn">fluocortolone</designation>
                    <desc language="en-US">fluocortolone</desc>
                </concept>
                <concept code="H02AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylprednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylprednisolone" type="fsn">methylprednisolone</designation>
                    <desc language="en-US">methylprednisolone</desc>
                </concept>
                <concept code="H02AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paramethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paramethasone" type="fsn">paramethasone</designation>
                    <desc language="en-US">paramethasone</desc>
                </concept>
                <concept code="H02AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="H02AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisone" type="fsn">prednisone</designation>
                    <desc language="en-US">prednisone</desc>
                </concept>
                <concept code="H02AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamcinolone" type="fsn">triamcinolone</designation>
                    <desc language="en-US">triamcinolone</desc>
                </concept>
                <concept code="H02AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="H02AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cortisone" type="fsn">cortisone</designation>
                    <desc language="en-US">cortisone</desc>
                </concept>
                <concept code="H02AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednylidene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednylidene" type="fsn">prednylidene</designation>
                    <desc language="en-US">prednylidene</desc>
                </concept>
                <concept code="H02AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rimexolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rimexolone" type="fsn">rimexolone</designation>
                    <desc language="en-US">rimexolone</desc>
                </concept>
                <concept code="H02AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deflazacort"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deflazacort" type="fsn">deflazacort</designation>
                    <desc language="en-US">deflazacort</desc>
                </concept>
                <concept code="H02AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cloprednol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cloprednol" type="fsn">cloprednol</designation>
                    <desc language="en-US">cloprednol</desc>
                </concept>
                <concept code="H02AB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meprednisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meprednisone" type="fsn">meprednisone</designation>
                    <desc language="en-US">meprednisone</desc>
                </concept>
                <concept code="H02AB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cortivazol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cortivazol" type="fsn">cortivazol</designation>
                    <desc language="en-US">cortivazol</desc>
                </concept>
                <concept code="H02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS"
                         type="fsn">CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS</designation>
                    <desc language="en-US">CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS</desc>
                </concept>
                <concept code="H02BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids for systemic use, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids for systemic use, combinations"
                         type="fsn">Corticosteroids for systemic use, combinations</designation>
                    <desc language="en-US">Corticosteroids for systemic use, combinations</desc>
                </concept>
                <concept code="H02BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylprednisolone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylprednisolone, combinations"
                         type="fsn">methylprednisolone, combinations</designation>
                    <desc language="en-US">methylprednisolone, combinations</desc>
                </concept>
                <concept code="H02C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIADRENAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIADRENAL PREPARATIONS" type="fsn">ANTIADRENAL PREPARATIONS</designation>
                    <desc language="en-US">ANTIADRENAL PREPARATIONS</desc>
                </concept>
                <concept code="H02CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anticorticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anticorticosteroids" type="fsn">Anticorticosteroids</designation>
                    <desc language="en-US">Anticorticosteroids</desc>
                </concept>
                <concept code="H02CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trilostane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trilostane" type="fsn">trilostane</designation>
                    <desc language="en-US">trilostane</desc>
                </concept>
                <concept code="H03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="THYROID THERAPY"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="THYROID THERAPY" type="fsn">THYROID THERAPY</designation>
                    <desc language="en-US">THYROID THERAPY</desc>
                </concept>
                <concept code="H03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="THYROID PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="THYROID PREPARATIONS" type="fsn">THYROID PREPARATIONS</designation>
                    <desc language="en-US">THYROID PREPARATIONS</desc>
                </concept>
                <concept code="H03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thyroid hormones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thyroid hormones" type="fsn">Thyroid hormones</designation>
                    <desc language="en-US">Thyroid hormones</desc>
                </concept>
                <concept code="H03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levothyroxine sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levothyroxine sodium" type="fsn">levothyroxine sodium</designation>
                    <desc language="en-US">levothyroxine sodium</desc>
                </concept>
                <concept code="H03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="liothyronine sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="liothyronine sodium" type="fsn">liothyronine sodium</designation>
                    <desc language="en-US">liothyronine sodium</desc>
                </concept>
                <concept code="H03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of levothyroxine and liothyronine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of levothyroxine and liothyronine"
                         type="fsn">combinations of levothyroxine and liothyronine</designation>
                    <desc language="en-US">combinations of levothyroxine and liothyronine</desc>
                </concept>
                <concept code="H03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiratricol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiratricol" type="fsn">tiratricol</designation>
                    <desc language="en-US">tiratricol</desc>
                </concept>
                <concept code="H03AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thyroid gland preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="thyroid gland preparations"
                         type="fsn">thyroid gland preparations</designation>
                    <desc language="en-US">thyroid gland preparations</desc>
                </concept>
                <concept code="H03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTITHYROID PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTITHYROID PREPARATIONS" type="fsn">ANTITHYROID PREPARATIONS</designation>
                    <desc language="en-US">ANTITHYROID PREPARATIONS</desc>
                </concept>
                <concept code="H03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiouracils"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thiouracils" type="fsn">Thiouracils</designation>
                    <desc language="en-US">Thiouracils</desc>
                </concept>
                <concept code="H03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylthiouracil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylthiouracil" type="fsn">methylthiouracil</designation>
                    <desc language="en-US">methylthiouracil</desc>
                </concept>
                <concept code="H03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propylthiouracil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propylthiouracil" type="fsn">propylthiouracil</designation>
                    <desc language="en-US">propylthiouracil</desc>
                </concept>
                <concept code="H03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzylthiouracil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzylthiouracil" type="fsn">benzylthiouracil</designation>
                    <desc language="en-US">benzylthiouracil</desc>
                </concept>
                <concept code="H03BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfur-containing imidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sulfur-containing imidazole derivatives"
                         type="fsn">Sulfur-containing imidazole derivatives</designation>
                    <desc language="en-US">Sulfur-containing imidazole derivatives</desc>
                </concept>
                <concept code="H03BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbimazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbimazole" type="fsn">carbimazole</designation>
                    <desc language="en-US">carbimazole</desc>
                </concept>
                <concept code="H03BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiamazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiamazole" type="fsn">thiamazole</designation>
                    <desc language="en-US">thiamazole</desc>
                </concept>
                <concept code="H03BB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiamazole, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiamazole, combinations" type="fsn">thiamazole, combinations</designation>
                    <desc language="en-US">thiamazole, combinations</desc>
                </concept>
                <concept code="H03BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Perchlorates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Perchlorates" type="fsn">Perchlorates</designation>
                    <desc language="en-US">Perchlorates</desc>
                </concept>
                <concept code="H03BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium perchlorate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium perchlorate" type="fsn">potassium perchlorate</designation>
                    <desc language="en-US">potassium perchlorate</desc>
                </concept>
                <concept code="H03BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antithyroid preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antithyroid preparations"
                         type="fsn">Other antithyroid preparations</designation>
                    <desc language="en-US">Other antithyroid preparations</desc>
                </concept>
                <concept code="H03BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diiodotyrosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diiodotyrosine" type="fsn">diiodotyrosine</designation>
                    <desc language="en-US">diiodotyrosine</desc>
                </concept>
                <concept code="H03BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibromotyrosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibromotyrosine" type="fsn">dibromotyrosine</designation>
                    <desc language="en-US">dibromotyrosine</desc>
                </concept>
                <concept code="H03C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IODINE THERAPY"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IODINE THERAPY" type="fsn">IODINE THERAPY</designation>
                    <desc language="en-US">IODINE THERAPY</desc>
                </concept>
                <concept code="H03CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iodine therapy"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Iodine therapy" type="fsn">Iodine therapy</designation>
                    <desc language="en-US">Iodine therapy</desc>
                </concept>
                <concept code="H04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PANCREATIC HORMONES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PANCREATIC HORMONES" type="fsn">PANCREATIC HORMONES</designation>
                    <desc language="en-US">PANCREATIC HORMONES</desc>
                </concept>
                <concept code="H04A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="GLYCOGENOLYTIC HORMONES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="GLYCOGENOLYTIC HORMONES" type="fsn">GLYCOGENOLYTIC HORMONES</designation>
                    <desc language="en-US">GLYCOGENOLYTIC HORMONES</desc>
                </concept>
                <concept code="H04AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Glycogenolytic hormones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Glycogenolytic hormones" type="fsn">Glycogenolytic hormones</designation>
                    <desc language="en-US">Glycogenolytic hormones</desc>
                </concept>
                <concept code="H04AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glucagon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glucagon" type="fsn">glucagon</designation>
                    <desc language="en-US">glucagon</desc>
                </concept>
                <concept code="H05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CALCIUM HOMEOSTASIS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CALCIUM HOMEOSTASIS" type="fsn">CALCIUM HOMEOSTASIS</designation>
                    <desc language="en-US">CALCIUM HOMEOSTASIS</desc>
                </concept>
                <concept code="H05A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PARATHYROID HORMONES AND ANALOGUES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PARATHYROID HORMONES AND ANALOGUES"
                         type="fsn">PARATHYROID HORMONES AND ANALOGUES</designation>
                    <desc language="en-US">PARATHYROID HORMONES AND ANALOGUES</desc>
                </concept>
                <concept code="H05AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Parathyroid hormones and analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Parathyroid hormones and analogues"
                         type="fsn">Parathyroid hormones and analogues</designation>
                    <desc language="en-US">Parathyroid hormones and analogues</desc>
                </concept>
                <concept code="H05AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="parathyroid gland extract"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="parathyroid gland extract" type="fsn">parathyroid gland extract</designation>
                    <desc language="en-US">parathyroid gland extract</desc>
                </concept>
                <concept code="H05AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="teriparatide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="teriparatide" type="fsn">teriparatide</designation>
                    <desc language="en-US">teriparatide</desc>
                </concept>
                <concept code="H05AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="parathyroid hormone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="parathyroid hormone" type="fsn">parathyroid hormone</designation>
                    <desc language="en-US">parathyroid hormone</desc>
                </concept>
                <concept code="H05B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTI-PARATHYROID AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTI-PARATHYROID AGENTS" type="fsn">ANTI-PARATHYROID AGENTS</designation>
                    <desc language="en-US">ANTI-PARATHYROID AGENTS</desc>
                </concept>
                <concept code="H05BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Calcitonin preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Calcitonin preparations" type="fsn">Calcitonin preparations</designation>
                    <desc language="en-US">Calcitonin preparations</desc>
                </concept>
                <concept code="H05BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcitonin (salmon synthetic)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="calcitonin (salmon synthetic)"
                         type="fsn">calcitonin (salmon synthetic)</designation>
                    <desc language="en-US">calcitonin (salmon synthetic)</desc>
                </concept>
                <concept code="H05BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcitonin (pork natural)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcitonin (pork natural)" type="fsn">calcitonin (pork natural)</designation>
                    <desc language="en-US">calcitonin (pork natural)</desc>
                </concept>
                <concept code="H05BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcitonin (human synthetic)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="calcitonin (human synthetic)"
                         type="fsn">calcitonin (human synthetic)</designation>
                    <desc language="en-US">calcitonin (human synthetic)</desc>
                </concept>
                <concept code="H05BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="elcatonin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="elcatonin" type="fsn">elcatonin</designation>
                    <desc language="en-US">elcatonin</desc>
                </concept>
                <concept code="H05BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other anti-parathyroid agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other anti-parathyroid agents"
                         type="fsn">Other anti-parathyroid agents</designation>
                    <desc language="en-US">Other anti-parathyroid agents</desc>
                </concept>
                <concept code="H05BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinacalcet"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinacalcet" type="fsn">cinacalcet</designation>
                    <desc language="en-US">cinacalcet</desc>
                </concept>
                <concept code="H05BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paricalcitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paricalcitol" type="fsn">paricalcitol</designation>
                    <desc language="en-US">paricalcitol</desc>
                </concept>
                <concept code="H05BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxercalciferol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxercalciferol" type="fsn">doxercalciferol</designation>
                    <desc language="en-US">doxercalciferol</desc>
                </concept>
                <concept code="H05BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etelcalcetide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etelcalcetide" type="fsn">etelcalcetide</designation>
                    <desc language="en-US">etelcalcetide</desc>
                </concept>
                <concept code="J"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFECTIVES FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIINFECTIVES FOR SYSTEMIC USE"
                         type="fsn">ANTIINFECTIVES FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIINFECTIVES FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="J01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIBACTERIALS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIBACTERIALS FOR SYSTEMIC USE"
                         type="fsn">ANTIBACTERIALS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIBACTERIALS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="J01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="TETRACYCLINES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="TETRACYCLINES" type="fsn">TETRACYCLINES</designation>
                    <desc language="en-US">TETRACYCLINES</desc>
                </concept>
                <concept code="J01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tetracyclines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tetracyclines" type="fsn">Tetracyclines</designation>
                    <desc language="en-US">Tetracyclines</desc>
                </concept>
                <concept code="J01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="demeclocycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="demeclocycline" type="fsn">demeclocycline</designation>
                    <desc language="en-US">demeclocycline</desc>
                </concept>
                <concept code="J01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxycycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxycycline" type="fsn">doxycycline</designation>
                    <desc language="en-US">doxycycline</desc>
                </concept>
                <concept code="J01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlortetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlortetracycline" type="fsn">chlortetracycline</designation>
                    <desc language="en-US">chlortetracycline</desc>
                </concept>
                <concept code="J01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lymecycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lymecycline" type="fsn">lymecycline</designation>
                    <desc language="en-US">lymecycline</desc>
                </concept>
                <concept code="J01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metacycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metacycline" type="fsn">metacycline</designation>
                    <desc language="en-US">metacycline</desc>
                </concept>
                <concept code="J01AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxytetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxytetracycline" type="fsn">oxytetracycline</designation>
                    <desc language="en-US">oxytetracycline</desc>
                </concept>
                <concept code="J01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracycline" type="fsn">tetracycline</designation>
                    <desc language="en-US">tetracycline</desc>
                </concept>
                <concept code="J01AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="minocycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="minocycline" type="fsn">minocycline</designation>
                    <desc language="en-US">minocycline</desc>
                </concept>
                <concept code="J01AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rolitetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rolitetracycline" type="fsn">rolitetracycline</designation>
                    <desc language="en-US">rolitetracycline</desc>
                </concept>
                <concept code="J01AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penimepicycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="penimepicycline" type="fsn">penimepicycline</designation>
                    <desc language="en-US">penimepicycline</desc>
                </concept>
                <concept code="J01AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clomocycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clomocycline" type="fsn">clomocycline</designation>
                    <desc language="en-US">clomocycline</desc>
                </concept>
                <concept code="J01AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tigecycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tigecycline" type="fsn">tigecycline</designation>
                    <desc language="en-US">tigecycline</desc>
                </concept>
                <concept code="J01AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eravacycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eravacycline" type="fsn">eravacycline</designation>
                    <desc language="en-US">eravacycline</desc>
                </concept>
                <concept code="J01AA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of tetracyclines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of tetracyclines"
                         type="fsn">combinations of tetracyclines</designation>
                    <desc language="en-US">combinations of tetracyclines</desc>
                </concept>
                <concept code="J01AA56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxytetracycline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="oxytetracycline, combinations"
                         type="fsn">oxytetracycline, combinations</designation>
                    <desc language="en-US">oxytetracycline, combinations</desc>
                </concept>
                <concept code="J01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="AMPHENICOLS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="AMPHENICOLS" type="fsn">AMPHENICOLS</designation>
                    <desc language="en-US">AMPHENICOLS</desc>
                </concept>
                <concept code="J01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Amphenicols"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Amphenicols" type="fsn">Amphenicols</designation>
                    <desc language="en-US">Amphenicols</desc>
                </concept>
                <concept code="J01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloramphenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloramphenicol" type="fsn">chloramphenicol</designation>
                    <desc language="en-US">chloramphenicol</desc>
                </concept>
                <concept code="J01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiamphenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiamphenicol" type="fsn">thiamphenicol</designation>
                    <desc language="en-US">thiamphenicol</desc>
                </concept>
                <concept code="J01BA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiamphenicol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="thiamphenicol, combinations"
                         type="fsn">thiamphenicol, combinations</designation>
                    <desc language="en-US">thiamphenicol, combinations</desc>
                </concept>
                <concept code="J01C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BETA-LACTAM ANTIBACTERIALS, PENICILLINS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BETA-LACTAM ANTIBACTERIALS, PENICILLINS"
                         type="fsn">BETA-LACTAM ANTIBACTERIALS, PENICILLINS</designation>
                    <desc language="en-US">BETA-LACTAM ANTIBACTERIALS, PENICILLINS</desc>
                </concept>
                <concept code="J01CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Penicillins with extended spectrum"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Penicillins with extended spectrum"
                         type="fsn">Penicillins with extended spectrum</designation>
                    <desc language="en-US">Penicillins with extended spectrum</desc>
                </concept>
                <concept code="J01CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ampicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ampicillin" type="fsn">ampicillin</designation>
                    <desc language="en-US">ampicillin</desc>
                </concept>
                <concept code="J01CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pivampicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pivampicillin" type="fsn">pivampicillin</designation>
                    <desc language="en-US">pivampicillin</desc>
                </concept>
                <concept code="J01CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbenicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbenicillin" type="fsn">carbenicillin</designation>
                    <desc language="en-US">carbenicillin</desc>
                </concept>
                <concept code="J01CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amoxicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amoxicillin" type="fsn">amoxicillin</designation>
                    <desc language="en-US">amoxicillin</desc>
                </concept>
                <concept code="J01CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carindacillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carindacillin" type="fsn">carindacillin</designation>
                    <desc language="en-US">carindacillin</desc>
                </concept>
                <concept code="J01CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bacampicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bacampicillin" type="fsn">bacampicillin</designation>
                    <desc language="en-US">bacampicillin</desc>
                </concept>
                <concept code="J01CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epicillin" type="fsn">epicillin</designation>
                    <desc language="en-US">epicillin</desc>
                </concept>
                <concept code="J01CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pivmecillinam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pivmecillinam" type="fsn">pivmecillinam</designation>
                    <desc language="en-US">pivmecillinam</desc>
                </concept>
                <concept code="J01CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azlocillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azlocillin" type="fsn">azlocillin</designation>
                    <desc language="en-US">azlocillin</desc>
                </concept>
                <concept code="J01CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mezlocillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mezlocillin" type="fsn">mezlocillin</designation>
                    <desc language="en-US">mezlocillin</desc>
                </concept>
                <concept code="J01CA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mecillinam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mecillinam" type="fsn">mecillinam</designation>
                    <desc language="en-US">mecillinam</desc>
                </concept>
                <concept code="J01CA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piperacillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piperacillin" type="fsn">piperacillin</designation>
                    <desc language="en-US">piperacillin</desc>
                </concept>
                <concept code="J01CA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ticarcillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ticarcillin" type="fsn">ticarcillin</designation>
                    <desc language="en-US">ticarcillin</desc>
                </concept>
                <concept code="J01CA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metampicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metampicillin" type="fsn">metampicillin</designation>
                    <desc language="en-US">metampicillin</desc>
                </concept>
                <concept code="J01CA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="talampicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="talampicillin" type="fsn">talampicillin</designation>
                    <desc language="en-US">talampicillin</desc>
                </concept>
                <concept code="J01CA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulbenicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulbenicillin" type="fsn">sulbenicillin</designation>
                    <desc language="en-US">sulbenicillin</desc>
                </concept>
                <concept code="J01CA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="temocillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="temocillin" type="fsn">temocillin</designation>
                    <desc language="en-US">temocillin</desc>
                </concept>
                <concept code="J01CA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hetacillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hetacillin" type="fsn">hetacillin</designation>
                    <desc language="en-US">hetacillin</desc>
                </concept>
                <concept code="J01CA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aspoxicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aspoxicillin" type="fsn">aspoxicillin</designation>
                    <desc language="en-US">aspoxicillin</desc>
                </concept>
                <concept code="J01CA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="J01CA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ampicillin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ampicillin, combinations" type="fsn">ampicillin, combinations</designation>
                    <desc language="en-US">ampicillin, combinations</desc>
                </concept>
                <concept code="J01CE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta-lactamase sensitive penicillins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta-lactamase sensitive penicillins"
                         type="fsn">Beta-lactamase sensitive penicillins</designation>
                    <desc language="en-US">Beta-lactamase sensitive penicillins</desc>
                </concept>
                <concept code="J01CE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzylpenicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzylpenicillin" type="fsn">benzylpenicillin</designation>
                    <desc language="en-US">benzylpenicillin</desc>
                </concept>
                <concept code="J01CE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenoxymethylpenicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenoxymethylpenicillin" type="fsn">phenoxymethylpenicillin</designation>
                    <desc language="en-US">phenoxymethylpenicillin</desc>
                </concept>
                <concept code="J01CE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propicillin" type="fsn">propicillin</designation>
                    <desc language="en-US">propicillin</desc>
                </concept>
                <concept code="J01CE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azidocillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azidocillin" type="fsn">azidocillin</designation>
                    <desc language="en-US">azidocillin</desc>
                </concept>
                <concept code="J01CE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pheneticillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pheneticillin" type="fsn">pheneticillin</designation>
                    <desc language="en-US">pheneticillin</desc>
                </concept>
                <concept code="J01CE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penamecillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="penamecillin" type="fsn">penamecillin</designation>
                    <desc language="en-US">penamecillin</desc>
                </concept>
                <concept code="J01CE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clometocillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clometocillin" type="fsn">clometocillin</designation>
                    <desc language="en-US">clometocillin</desc>
                </concept>
                <concept code="J01CE08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzathine benzylpenicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="benzathine benzylpenicillin"
                         type="fsn">benzathine benzylpenicillin</designation>
                    <desc language="en-US">benzathine benzylpenicillin</desc>
                </concept>
                <concept code="J01CE09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procaine benzylpenicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procaine benzylpenicillin" type="fsn">procaine benzylpenicillin</designation>
                    <desc language="en-US">procaine benzylpenicillin</desc>
                </concept>
                <concept code="J01CE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzathine phenoxymethylpenicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="benzathine phenoxymethylpenicillin"
                         type="fsn">benzathine phenoxymethylpenicillin</designation>
                    <desc language="en-US">benzathine phenoxymethylpenicillin</desc>
                </concept>
                <concept code="J01CE30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="J01CF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta-lactamase resistant penicillins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Beta-lactamase resistant penicillins"
                         type="fsn">Beta-lactamase resistant penicillins</designation>
                    <desc language="en-US">Beta-lactamase resistant penicillins</desc>
                </concept>
                <concept code="J01CF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dicloxacillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dicloxacillin" type="fsn">dicloxacillin</designation>
                    <desc language="en-US">dicloxacillin</desc>
                </concept>
                <concept code="J01CF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cloxacillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cloxacillin" type="fsn">cloxacillin</designation>
                    <desc language="en-US">cloxacillin</desc>
                </concept>
                <concept code="J01CF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meticillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meticillin" type="fsn">meticillin</designation>
                    <desc language="en-US">meticillin</desc>
                </concept>
                <concept code="J01CF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxacillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxacillin" type="fsn">oxacillin</designation>
                    <desc language="en-US">oxacillin</desc>
                </concept>
                <concept code="J01CF05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flucloxacillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flucloxacillin" type="fsn">flucloxacillin</designation>
                    <desc language="en-US">flucloxacillin</desc>
                </concept>
                <concept code="J01CF06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nafcillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nafcillin" type="fsn">nafcillin</designation>
                    <desc language="en-US">nafcillin</desc>
                </concept>
                <concept code="J01CG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta-lactamase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Beta-lactamase inhibitors" type="fsn">Beta-lactamase inhibitors</designation>
                    <desc language="en-US">Beta-lactamase inhibitors</desc>
                </concept>
                <concept code="J01CG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulbactam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulbactam" type="fsn">sulbactam</designation>
                    <desc language="en-US">sulbactam</desc>
                </concept>
                <concept code="J01CG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tazobactam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tazobactam" type="fsn">tazobactam</designation>
                    <desc language="en-US">tazobactam</desc>
                </concept>
                <concept code="J01CR"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of penicillins, incl. beta-lactamase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations of penicillins, incl. beta-lactamase inhibitors"
                         type="fsn">Combinations of penicillins, incl. beta-lactamase inhibitors</designation>
                    <desc language="en-US">Combinations of penicillins, incl. beta-lactamase inhibitors</desc>
                </concept>
                <concept code="J01CR01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ampicillin and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ampicillin and beta-lactamase inhibitor"
                         type="fsn">ampicillin and beta-lactamase inhibitor</designation>
                    <desc language="en-US">ampicillin and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01CR02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amoxicillin and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="amoxicillin and beta-lactamase inhibitor"
                         type="fsn">amoxicillin and beta-lactamase inhibitor</designation>
                    <desc language="en-US">amoxicillin and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01CR03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ticarcillin and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ticarcillin and beta-lactamase inhibitor"
                         type="fsn">ticarcillin and beta-lactamase inhibitor</designation>
                    <desc language="en-US">ticarcillin and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01CR04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sultamicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sultamicillin" type="fsn">sultamicillin</designation>
                    <desc language="en-US">sultamicillin</desc>
                </concept>
                <concept code="J01CR05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piperacillin and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="piperacillin and beta-lactamase inhibitor"
                         type="fsn">piperacillin and beta-lactamase inhibitor</designation>
                    <desc language="en-US">piperacillin and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01CR50"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of penicillins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of penicillins"
                         type="fsn">combinations of penicillins</designation>
                    <desc language="en-US">combinations of penicillins</desc>
                </concept>
                <concept code="J01D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER BETA-LACTAM ANTIBACTERIALS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER BETA-LACTAM ANTIBACTERIALS"
                         type="fsn">OTHER BETA-LACTAM ANTIBACTERIALS</designation>
                    <desc language="en-US">OTHER BETA-LACTAM ANTIBACTERIALS</desc>
                </concept>
                <concept code="J01DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="First-generation cephalosporins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="First-generation cephalosporins"
                         type="fsn">First-generation cephalosporins</designation>
                    <desc language="en-US">First-generation cephalosporins</desc>
                </concept>
                <concept code="J01DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefalexin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefalexin" type="fsn">cefalexin</designation>
                    <desc language="en-US">cefalexin</desc>
                </concept>
                <concept code="J01DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefaloridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefaloridine" type="fsn">cefaloridine</designation>
                    <desc language="en-US">cefaloridine</desc>
                </concept>
                <concept code="J01DB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefalotin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefalotin" type="fsn">cefalotin</designation>
                    <desc language="en-US">cefalotin</desc>
                </concept>
                <concept code="J01DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefazolin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefazolin" type="fsn">cefazolin</designation>
                    <desc language="en-US">cefazolin</desc>
                </concept>
                <concept code="J01DB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefadroxil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefadroxil" type="fsn">cefadroxil</designation>
                    <desc language="en-US">cefadroxil</desc>
                </concept>
                <concept code="J01DB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefazedone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefazedone" type="fsn">cefazedone</designation>
                    <desc language="en-US">cefazedone</desc>
                </concept>
                <concept code="J01DB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefatrizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefatrizine" type="fsn">cefatrizine</designation>
                    <desc language="en-US">cefatrizine</desc>
                </concept>
                <concept code="J01DB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefapirin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefapirin" type="fsn">cefapirin</designation>
                    <desc language="en-US">cefapirin</desc>
                </concept>
                <concept code="J01DB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefradine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefradine" type="fsn">cefradine</designation>
                    <desc language="en-US">cefradine</desc>
                </concept>
                <concept code="J01DB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefacetrile"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefacetrile" type="fsn">cefacetrile</designation>
                    <desc language="en-US">cefacetrile</desc>
                </concept>
                <concept code="J01DB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefroxadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefroxadine" type="fsn">cefroxadine</designation>
                    <desc language="en-US">cefroxadine</desc>
                </concept>
                <concept code="J01DB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftezole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceftezole" type="fsn">ceftezole</designation>
                    <desc language="en-US">ceftezole</desc>
                </concept>
                <concept code="J01DC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Second-generation cephalosporins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Second-generation cephalosporins"
                         type="fsn">Second-generation cephalosporins</designation>
                    <desc language="en-US">Second-generation cephalosporins</desc>
                </concept>
                <concept code="J01DC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefoxitin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefoxitin" type="fsn">cefoxitin</designation>
                    <desc language="en-US">cefoxitin</desc>
                </concept>
                <concept code="J01DC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefuroxime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefuroxime" type="fsn">cefuroxime</designation>
                    <desc language="en-US">cefuroxime</desc>
                </concept>
                <concept code="J01DC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefamandole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefamandole" type="fsn">cefamandole</designation>
                    <desc language="en-US">cefamandole</desc>
                </concept>
                <concept code="J01DC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefaclor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefaclor" type="fsn">cefaclor</designation>
                    <desc language="en-US">cefaclor</desc>
                </concept>
                <concept code="J01DC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefotetan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefotetan" type="fsn">cefotetan</designation>
                    <desc language="en-US">cefotetan</desc>
                </concept>
                <concept code="J01DC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefonicid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefonicid" type="fsn">cefonicid</designation>
                    <desc language="en-US">cefonicid</desc>
                </concept>
                <concept code="J01DC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefotiam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefotiam" type="fsn">cefotiam</designation>
                    <desc language="en-US">cefotiam</desc>
                </concept>
                <concept code="J01DC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="loracarbef"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="loracarbef" type="fsn">loracarbef</designation>
                    <desc language="en-US">loracarbef</desc>
                </concept>
                <concept code="J01DC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefmetazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefmetazole" type="fsn">cefmetazole</designation>
                    <desc language="en-US">cefmetazole</desc>
                </concept>
                <concept code="J01DC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefprozil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefprozil" type="fsn">cefprozil</designation>
                    <desc language="en-US">cefprozil</desc>
                </concept>
                <concept code="J01DC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceforanide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceforanide" type="fsn">ceforanide</designation>
                    <desc language="en-US">ceforanide</desc>
                </concept>
                <concept code="J01DC12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefminox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefminox" type="fsn">cefminox</designation>
                    <desc language="en-US">cefminox</desc>
                </concept>
                <concept code="J01DC13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefbuperazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefbuperazone" type="fsn">cefbuperazone</designation>
                    <desc language="en-US">cefbuperazone</desc>
                </concept>
                <concept code="J01DC14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flomoxef"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flomoxef" type="fsn">flomoxef</designation>
                    <desc language="en-US">flomoxef</desc>
                </concept>
                <concept code="J01DD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Third-generation cephalosporins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Third-generation cephalosporins"
                         type="fsn">Third-generation cephalosporins</designation>
                    <desc language="en-US">Third-generation cephalosporins</desc>
                </concept>
                <concept code="J01DD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefotaxime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefotaxime" type="fsn">cefotaxime</designation>
                    <desc language="en-US">cefotaxime</desc>
                </concept>
                <concept code="J01DD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftazidime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceftazidime" type="fsn">ceftazidime</designation>
                    <desc language="en-US">ceftazidime</desc>
                </concept>
                <concept code="J01DD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefsulodin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefsulodin" type="fsn">cefsulodin</designation>
                    <desc language="en-US">cefsulodin</desc>
                </concept>
                <concept code="J01DD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftriaxone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceftriaxone" type="fsn">ceftriaxone</designation>
                    <desc language="en-US">ceftriaxone</desc>
                </concept>
                <concept code="J01DD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefmenoxime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefmenoxime" type="fsn">cefmenoxime</designation>
                    <desc language="en-US">cefmenoxime</desc>
                </concept>
                <concept code="J01DD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="latamoxef"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="latamoxef" type="fsn">latamoxef</designation>
                    <desc language="en-US">latamoxef</desc>
                </concept>
                <concept code="J01DD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftizoxime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceftizoxime" type="fsn">ceftizoxime</designation>
                    <desc language="en-US">ceftizoxime</desc>
                </concept>
                <concept code="J01DD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefixime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefixime" type="fsn">cefixime</designation>
                    <desc language="en-US">cefixime</desc>
                </concept>
                <concept code="J01DD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefodizime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefodizime" type="fsn">cefodizime</designation>
                    <desc language="en-US">cefodizime</desc>
                </concept>
                <concept code="J01DD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefetamet"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefetamet" type="fsn">cefetamet</designation>
                    <desc language="en-US">cefetamet</desc>
                </concept>
                <concept code="J01DD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefpiramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefpiramide" type="fsn">cefpiramide</designation>
                    <desc language="en-US">cefpiramide</desc>
                </concept>
                <concept code="J01DD12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefoperazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefoperazone" type="fsn">cefoperazone</designation>
                    <desc language="en-US">cefoperazone</desc>
                </concept>
                <concept code="J01DD13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefpodoxime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefpodoxime" type="fsn">cefpodoxime</designation>
                    <desc language="en-US">cefpodoxime</desc>
                </concept>
                <concept code="J01DD14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftibuten"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceftibuten" type="fsn">ceftibuten</designation>
                    <desc language="en-US">ceftibuten</desc>
                </concept>
                <concept code="J01DD15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefdinir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefdinir" type="fsn">cefdinir</designation>
                    <desc language="en-US">cefdinir</desc>
                </concept>
                <concept code="J01DD16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefditoren"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefditoren" type="fsn">cefditoren</designation>
                    <desc language="en-US">cefditoren</desc>
                </concept>
                <concept code="J01DD17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefcapene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefcapene" type="fsn">cefcapene</designation>
                    <desc language="en-US">cefcapene</desc>
                </concept>
                <concept code="J01DD18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefteram"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefteram" type="fsn">cefteram</designation>
                    <desc language="en-US">cefteram</desc>
                </concept>
                <concept code="J01DD51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefotaxime and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cefotaxime and beta-lactamase inhibitor"
                         type="fsn">cefotaxime and beta-lactamase inhibitor</designation>
                    <desc language="en-US">cefotaxime and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01DD52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftazidime and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ceftazidime and beta-lactamase inhibitor"
                         type="fsn">ceftazidime and beta-lactamase inhibitor</designation>
                    <desc language="en-US">ceftazidime and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01DD54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftriaxone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceftriaxone, combinations" type="fsn">ceftriaxone, combinations</designation>
                    <desc language="en-US">ceftriaxone, combinations</desc>
                </concept>
                <concept code="J01DD62"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefoperazone and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cefoperazone and beta-lactamase inhibitor"
                         type="fsn">cefoperazone and beta-lactamase inhibitor</designation>
                    <desc language="en-US">cefoperazone and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01DD63"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftriaxone and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ceftriaxone and beta-lactamase inhibitor"
                         type="fsn">ceftriaxone and beta-lactamase inhibitor</designation>
                    <desc language="en-US">ceftriaxone and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01DD64"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefpodoxime and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cefpodoxime and beta-lactamase inhibitor"
                         type="fsn">cefpodoxime and beta-lactamase inhibitor</designation>
                    <desc language="en-US">cefpodoxime and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01DE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fourth-generation cephalosporins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Fourth-generation cephalosporins"
                         type="fsn">Fourth-generation cephalosporins</designation>
                    <desc language="en-US">Fourth-generation cephalosporins</desc>
                </concept>
                <concept code="J01DE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefepime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefepime" type="fsn">cefepime</designation>
                    <desc language="en-US">cefepime</desc>
                </concept>
                <concept code="J01DE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefpirome"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefpirome" type="fsn">cefpirome</designation>
                    <desc language="en-US">cefpirome</desc>
                </concept>
                <concept code="J01DE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefozopran"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefozopran" type="fsn">cefozopran</designation>
                    <desc language="en-US">cefozopran</desc>
                </concept>
                <concept code="J01DF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Monobactams"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Monobactams" type="fsn">Monobactams</designation>
                    <desc language="en-US">Monobactams</desc>
                </concept>
                <concept code="J01DF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aztreonam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aztreonam" type="fsn">aztreonam</designation>
                    <desc language="en-US">aztreonam</desc>
                </concept>
                <concept code="J01DF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carumonam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carumonam" type="fsn">carumonam</designation>
                    <desc language="en-US">carumonam</desc>
                </concept>
                <concept code="J01DH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Carbapenems"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Carbapenems" type="fsn">Carbapenems</designation>
                    <desc language="en-US">Carbapenems</desc>
                </concept>
                <concept code="J01DH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meropenem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meropenem" type="fsn">meropenem</designation>
                    <desc language="en-US">meropenem</desc>
                </concept>
                <concept code="J01DH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ertapenem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ertapenem" type="fsn">ertapenem</designation>
                    <desc language="en-US">ertapenem</desc>
                </concept>
                <concept code="J01DH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doripenem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doripenem" type="fsn">doripenem</designation>
                    <desc language="en-US">doripenem</desc>
                </concept>
                <concept code="J01DH05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="biapenem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="biapenem" type="fsn">biapenem</designation>
                    <desc language="en-US">biapenem</desc>
                </concept>
                <concept code="J01DH06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tebipenem pivoxil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tebipenem pivoxil" type="fsn">tebipenem pivoxil</designation>
                    <desc language="en-US">tebipenem pivoxil</desc>
                </concept>
                <concept code="J01DH51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imipenem and cilastatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imipenem and cilastatin" type="fsn">imipenem and cilastatin</designation>
                    <desc language="en-US">imipenem and cilastatin</desc>
                </concept>
                <concept code="J01DH52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meropenem and vaborbactam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meropenem and vaborbactam" type="fsn">meropenem and vaborbactam</designation>
                    <desc language="en-US">meropenem and vaborbactam</desc>
                </concept>
                <concept code="J01DH55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="panipenem and betamipron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="panipenem and betamipron" type="fsn">panipenem and betamipron</designation>
                    <desc language="en-US">panipenem and betamipron</desc>
                </concept>
                <concept code="J01DI"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cephalosporins and penems"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other cephalosporins and penems"
                         type="fsn">Other cephalosporins and penems</designation>
                    <desc language="en-US">Other cephalosporins and penems</desc>
                </concept>
                <concept code="J01DI01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftobiprole medocaril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceftobiprole medocaril" type="fsn">ceftobiprole medocaril</designation>
                    <desc language="en-US">ceftobiprole medocaril</desc>
                </concept>
                <concept code="J01DI02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftaroline fosamil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceftaroline fosamil" type="fsn">ceftaroline fosamil</designation>
                    <desc language="en-US">ceftaroline fosamil</desc>
                </concept>
                <concept code="J01DI03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="faropenem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="faropenem" type="fsn">faropenem</designation>
                    <desc language="en-US">faropenem</desc>
                </concept>
                <concept code="J01DI54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceftolozane and beta-lactamase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ceftolozane and beta-lactamase inhibitor"
                         type="fsn">ceftolozane and beta-lactamase inhibitor</designation>
                    <desc language="en-US">ceftolozane and beta-lactamase inhibitor</desc>
                </concept>
                <concept code="J01E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SULFONAMIDES AND TRIMETHOPRIM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="SULFONAMIDES AND TRIMETHOPRIM"
                         type="fsn">SULFONAMIDES AND TRIMETHOPRIM</designation>
                    <desc language="en-US">SULFONAMIDES AND TRIMETHOPRIM</desc>
                </concept>
                <concept code="J01EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Trimethoprim and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Trimethoprim and derivatives"
                         type="fsn">Trimethoprim and derivatives</designation>
                    <desc language="en-US">Trimethoprim and derivatives</desc>
                </concept>
                <concept code="J01EA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimethoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimethoprim" type="fsn">trimethoprim</designation>
                    <desc language="en-US">trimethoprim</desc>
                </concept>
                <concept code="J01EA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brodimoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brodimoprim" type="fsn">brodimoprim</designation>
                    <desc language="en-US">brodimoprim</desc>
                </concept>
                <concept code="J01EA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iclaprim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iclaprim" type="fsn">iclaprim</designation>
                    <desc language="en-US">iclaprim</desc>
                </concept>
                <concept code="J01EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Short-acting sulfonamides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Short-acting sulfonamides" type="fsn">Short-acting sulfonamides</designation>
                    <desc language="en-US">Short-acting sulfonamides</desc>
                </concept>
                <concept code="J01EB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfaisodimidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfaisodimidine" type="fsn">sulfaisodimidine</designation>
                    <desc language="en-US">sulfaisodimidine</desc>
                </concept>
                <concept code="J01EB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamethizole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamethizole" type="fsn">sulfamethizole</designation>
                    <desc language="en-US">sulfamethizole</desc>
                </concept>
                <concept code="J01EB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfadimidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfadimidine" type="fsn">sulfadimidine</designation>
                    <desc language="en-US">sulfadimidine</desc>
                </concept>
                <concept code="J01EB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfapyridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfapyridine" type="fsn">sulfapyridine</designation>
                    <desc language="en-US">sulfapyridine</desc>
                </concept>
                <concept code="J01EB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfafurazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfafurazole" type="fsn">sulfafurazole</designation>
                    <desc language="en-US">sulfafurazole</desc>
                </concept>
                <concept code="J01EB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfanilamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfanilamide" type="fsn">sulfanilamide</designation>
                    <desc language="en-US">sulfanilamide</desc>
                </concept>
                <concept code="J01EB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfathiazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfathiazole" type="fsn">sulfathiazole</designation>
                    <desc language="en-US">sulfathiazole</desc>
                </concept>
                <concept code="J01EB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfathiourea"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfathiourea" type="fsn">sulfathiourea</designation>
                    <desc language="en-US">sulfathiourea</desc>
                </concept>
                <concept code="J01EB20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="J01EC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Intermediate-acting sulfonamides"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Intermediate-acting sulfonamides"
                         type="fsn">Intermediate-acting sulfonamides</designation>
                    <desc language="en-US">Intermediate-acting sulfonamides</desc>
                </concept>
                <concept code="J01EC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamethoxazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamethoxazole" type="fsn">sulfamethoxazole</designation>
                    <desc language="en-US">sulfamethoxazole</desc>
                </concept>
                <concept code="J01EC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfadiazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfadiazine" type="fsn">sulfadiazine</designation>
                    <desc language="en-US">sulfadiazine</desc>
                </concept>
                <concept code="J01EC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamoxole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamoxole" type="fsn">sulfamoxole</designation>
                    <desc language="en-US">sulfamoxole</desc>
                </concept>
                <concept code="J01EC20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="J01ED"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Long-acting sulfonamides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Long-acting sulfonamides" type="fsn">Long-acting sulfonamides</designation>
                    <desc language="en-US">Long-acting sulfonamides</desc>
                </concept>
                <concept code="J01ED01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfadimethoxine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfadimethoxine" type="fsn">sulfadimethoxine</designation>
                    <desc language="en-US">sulfadimethoxine</desc>
                </concept>
                <concept code="J01ED02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfalene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfalene" type="fsn">sulfalene</designation>
                    <desc language="en-US">sulfalene</desc>
                </concept>
                <concept code="J01ED03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfametomidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfametomidine" type="fsn">sulfametomidine</designation>
                    <desc language="en-US">sulfametomidine</desc>
                </concept>
                <concept code="J01ED04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfametoxydiazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfametoxydiazine" type="fsn">sulfametoxydiazine</designation>
                    <desc language="en-US">sulfametoxydiazine</desc>
                </concept>
                <concept code="J01ED05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamethoxypyridazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamethoxypyridazine" type="fsn">sulfamethoxypyridazine</designation>
                    <desc language="en-US">sulfamethoxypyridazine</desc>
                </concept>
                <concept code="J01ED06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfaperin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfaperin" type="fsn">sulfaperin</designation>
                    <desc language="en-US">sulfaperin</desc>
                </concept>
                <concept code="J01ED07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamerazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamerazine" type="fsn">sulfamerazine</designation>
                    <desc language="en-US">sulfamerazine</desc>
                </concept>
                <concept code="J01ED08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfaphenazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfaphenazole" type="fsn">sulfaphenazole</designation>
                    <desc language="en-US">sulfaphenazole</desc>
                </concept>
                <concept code="J01ED09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamazone" type="fsn">sulfamazone</designation>
                    <desc language="en-US">sulfamazone</desc>
                </concept>
                <concept code="J01ED20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="J01EE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of sulfonamides and trimethoprim, incl. derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations of sulfonamides and trimethoprim, incl. derivatives"
                         type="fsn">Combinations of sulfonamides and trimethoprim, incl. derivatives</designation>
                    <desc language="en-US">Combinations of sulfonamides and trimethoprim, incl. derivatives</desc>
                </concept>
                <concept code="J01EE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamethoxazole and trimethoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sulfamethoxazole and trimethoprim"
                         type="fsn">sulfamethoxazole and trimethoprim</designation>
                    <desc language="en-US">sulfamethoxazole and trimethoprim</desc>
                </concept>
                <concept code="J01EE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfadiazine and trimethoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sulfadiazine and trimethoprim"
                         type="fsn">sulfadiazine and trimethoprim</designation>
                    <desc language="en-US">sulfadiazine and trimethoprim</desc>
                </concept>
                <concept code="J01EE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfametrole and trimethoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sulfametrole and trimethoprim"
                         type="fsn">sulfametrole and trimethoprim</designation>
                    <desc language="en-US">sulfametrole and trimethoprim</desc>
                </concept>
                <concept code="J01EE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamoxole and trimethoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sulfamoxole and trimethoprim"
                         type="fsn">sulfamoxole and trimethoprim</designation>
                    <desc language="en-US">sulfamoxole and trimethoprim</desc>
                </concept>
                <concept code="J01EE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfadimidine and trimethoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sulfadimidine and trimethoprim"
                         type="fsn">sulfadimidine and trimethoprim</designation>
                    <desc language="en-US">sulfadimidine and trimethoprim</desc>
                </concept>
                <concept code="J01EE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfadiazine and tetroxoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sulfadiazine and tetroxoprim"
                         type="fsn">sulfadiazine and tetroxoprim</designation>
                    <desc language="en-US">sulfadiazine and tetroxoprim</desc>
                </concept>
                <concept code="J01EE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamerazine and trimethoprim"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sulfamerazine and trimethoprim"
                         type="fsn">sulfamerazine and trimethoprim</designation>
                    <desc language="en-US">sulfamerazine and trimethoprim</desc>
                </concept>
                <concept code="J01F"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS"
                         type="fsn">MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS</designation>
                    <desc language="en-US">MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS</desc>
                </concept>
                <concept code="J01FA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Macrolides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Macrolides" type="fsn">Macrolides</designation>
                    <desc language="en-US">Macrolides</desc>
                </concept>
                <concept code="J01FA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erythromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="erythromycin" type="fsn">erythromycin</designation>
                    <desc language="en-US">erythromycin</desc>
                </concept>
                <concept code="J01FA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="spiramycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="spiramycin" type="fsn">spiramycin</designation>
                    <desc language="en-US">spiramycin</desc>
                </concept>
                <concept code="J01FA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="midecamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="midecamycin" type="fsn">midecamycin</designation>
                    <desc language="en-US">midecamycin</desc>
                </concept>
                <concept code="J01FA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oleandomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oleandomycin" type="fsn">oleandomycin</designation>
                    <desc language="en-US">oleandomycin</desc>
                </concept>
                <concept code="J01FA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="roxithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="roxithromycin" type="fsn">roxithromycin</designation>
                    <desc language="en-US">roxithromycin</desc>
                </concept>
                <concept code="J01FA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="josamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="josamycin" type="fsn">josamycin</designation>
                    <desc language="en-US">josamycin</desc>
                </concept>
                <concept code="J01FA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="troleandomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="troleandomycin" type="fsn">troleandomycin</designation>
                    <desc language="en-US">troleandomycin</desc>
                </concept>
                <concept code="J01FA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clarithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clarithromycin" type="fsn">clarithromycin</designation>
                    <desc language="en-US">clarithromycin</desc>
                </concept>
                <concept code="J01FA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azithromycin" type="fsn">azithromycin</designation>
                    <desc language="en-US">azithromycin</desc>
                </concept>
                <concept code="J01FA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miocamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miocamycin" type="fsn">miocamycin</designation>
                    <desc language="en-US">miocamycin</desc>
                </concept>
                <concept code="J01FA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rokitamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rokitamycin" type="fsn">rokitamycin</designation>
                    <desc language="en-US">rokitamycin</desc>
                </concept>
                <concept code="J01FA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dirithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dirithromycin" type="fsn">dirithromycin</designation>
                    <desc language="en-US">dirithromycin</desc>
                </concept>
                <concept code="J01FA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flurithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flurithromycin" type="fsn">flurithromycin</designation>
                    <desc language="en-US">flurithromycin</desc>
                </concept>
                <concept code="J01FA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="telithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="telithromycin" type="fsn">telithromycin</designation>
                    <desc language="en-US">telithromycin</desc>
                </concept>
                <concept code="J01FA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="solithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="solithromycin" type="fsn">solithromycin</designation>
                    <desc language="en-US">solithromycin</desc>
                </concept>
                <concept code="J01FF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Lincosamides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Lincosamides" type="fsn">Lincosamides</designation>
                    <desc language="en-US">Lincosamides</desc>
                </concept>
                <concept code="J01FF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clindamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clindamycin" type="fsn">clindamycin</designation>
                    <desc language="en-US">clindamycin</desc>
                </concept>
                <concept code="J01FF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lincomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lincomycin" type="fsn">lincomycin</designation>
                    <desc language="en-US">lincomycin</desc>
                </concept>
                <concept code="J01FG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Streptogramins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Streptogramins" type="fsn">Streptogramins</designation>
                    <desc language="en-US">Streptogramins</desc>
                </concept>
                <concept code="J01FG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pristinamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pristinamycin" type="fsn">pristinamycin</designation>
                    <desc language="en-US">pristinamycin</desc>
                </concept>
                <concept code="J01FG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinupristin/dalfopristin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinupristin/dalfopristin" type="fsn">quinupristin/dalfopristin</designation>
                    <desc language="en-US">quinupristin/dalfopristin</desc>
                </concept>
                <concept code="J01G"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="AMINOGLYCOSIDE ANTIBACTERIALS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="AMINOGLYCOSIDE ANTIBACTERIALS"
                         type="fsn">AMINOGLYCOSIDE ANTIBACTERIALS</designation>
                    <desc language="en-US">AMINOGLYCOSIDE ANTIBACTERIALS</desc>
                </concept>
                <concept code="J01GA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Streptomycins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Streptomycins" type="fsn">Streptomycins</designation>
                    <desc language="en-US">Streptomycins</desc>
                </concept>
                <concept code="J01GA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="streptomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="streptomycin" type="fsn">streptomycin</designation>
                    <desc language="en-US">streptomycin</desc>
                </concept>
                <concept code="J01GA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="streptoduocin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="streptoduocin" type="fsn">streptoduocin</designation>
                    <desc language="en-US">streptoduocin</desc>
                </concept>
                <concept code="J01GB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other aminoglycosides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other aminoglycosides" type="fsn">Other aminoglycosides</designation>
                    <desc language="en-US">Other aminoglycosides</desc>
                </concept>
                <concept code="J01GB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tobramycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tobramycin" type="fsn">tobramycin</designation>
                    <desc language="en-US">tobramycin</desc>
                </concept>
                <concept code="J01GB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gentamicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gentamicin" type="fsn">gentamicin</designation>
                    <desc language="en-US">gentamicin</desc>
                </concept>
                <concept code="J01GB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="kanamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="kanamycin" type="fsn">kanamycin</designation>
                    <desc language="en-US">kanamycin</desc>
                </concept>
                <concept code="J01GB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="J01GB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amikacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amikacin" type="fsn">amikacin</designation>
                    <desc language="en-US">amikacin</desc>
                </concept>
                <concept code="J01GB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="netilmicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="netilmicin" type="fsn">netilmicin</designation>
                    <desc language="en-US">netilmicin</desc>
                </concept>
                <concept code="J01GB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sisomicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sisomicin" type="fsn">sisomicin</designation>
                    <desc language="en-US">sisomicin</desc>
                </concept>
                <concept code="J01GB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibekacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibekacin" type="fsn">dibekacin</designation>
                    <desc language="en-US">dibekacin</desc>
                </concept>
                <concept code="J01GB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ribostamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ribostamycin" type="fsn">ribostamycin</designation>
                    <desc language="en-US">ribostamycin</desc>
                </concept>
                <concept code="J01GB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isepamicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isepamicin" type="fsn">isepamicin</designation>
                    <desc language="en-US">isepamicin</desc>
                </concept>
                <concept code="J01GB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="arbekacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="arbekacin" type="fsn">arbekacin</designation>
                    <desc language="en-US">arbekacin</desc>
                </concept>
                <concept code="J01GB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bekanamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bekanamycin" type="fsn">bekanamycin</designation>
                    <desc language="en-US">bekanamycin</desc>
                </concept>
                <concept code="J01M"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="QUINOLONE ANTIBACTERIALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="QUINOLONE ANTIBACTERIALS" type="fsn">QUINOLONE ANTIBACTERIALS</designation>
                    <desc language="en-US">QUINOLONE ANTIBACTERIALS</desc>
                </concept>
                <concept code="J01MA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fluoroquinolones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Fluoroquinolones" type="fsn">Fluoroquinolones</designation>
                    <desc language="en-US">Fluoroquinolones</desc>
                </concept>
                <concept code="J01MA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ofloxacin" type="fsn">ofloxacin</designation>
                    <desc language="en-US">ofloxacin</desc>
                </concept>
                <concept code="J01MA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciprofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciprofloxacin" type="fsn">ciprofloxacin</designation>
                    <desc language="en-US">ciprofloxacin</desc>
                </concept>
                <concept code="J01MA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pefloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pefloxacin" type="fsn">pefloxacin</designation>
                    <desc language="en-US">pefloxacin</desc>
                </concept>
                <concept code="J01MA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enoxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enoxacin" type="fsn">enoxacin</designation>
                    <desc language="en-US">enoxacin</desc>
                </concept>
                <concept code="J01MA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="temafloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="temafloxacin" type="fsn">temafloxacin</designation>
                    <desc language="en-US">temafloxacin</desc>
                </concept>
                <concept code="J01MA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norfloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norfloxacin" type="fsn">norfloxacin</designation>
                    <desc language="en-US">norfloxacin</desc>
                </concept>
                <concept code="J01MA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lomefloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lomefloxacin" type="fsn">lomefloxacin</designation>
                    <desc language="en-US">lomefloxacin</desc>
                </concept>
                <concept code="J01MA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fleroxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fleroxacin" type="fsn">fleroxacin</designation>
                    <desc language="en-US">fleroxacin</desc>
                </concept>
                <concept code="J01MA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sparfloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sparfloxacin" type="fsn">sparfloxacin</designation>
                    <desc language="en-US">sparfloxacin</desc>
                </concept>
                <concept code="J01MA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rufloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rufloxacin" type="fsn">rufloxacin</designation>
                    <desc language="en-US">rufloxacin</desc>
                </concept>
                <concept code="J01MA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="grepafloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="grepafloxacin" type="fsn">grepafloxacin</designation>
                    <desc language="en-US">grepafloxacin</desc>
                </concept>
                <concept code="J01MA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levofloxacin" type="fsn">levofloxacin</designation>
                    <desc language="en-US">levofloxacin</desc>
                </concept>
                <concept code="J01MA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trovafloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trovafloxacin" type="fsn">trovafloxacin</designation>
                    <desc language="en-US">trovafloxacin</desc>
                </concept>
                <concept code="J01MA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moxifloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moxifloxacin" type="fsn">moxifloxacin</designation>
                    <desc language="en-US">moxifloxacin</desc>
                </concept>
                <concept code="J01MA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gemifloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gemifloxacin" type="fsn">gemifloxacin</designation>
                    <desc language="en-US">gemifloxacin</desc>
                </concept>
                <concept code="J01MA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gatifloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gatifloxacin" type="fsn">gatifloxacin</designation>
                    <desc language="en-US">gatifloxacin</desc>
                </concept>
                <concept code="J01MA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prulifloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prulifloxacin" type="fsn">prulifloxacin</designation>
                    <desc language="en-US">prulifloxacin</desc>
                </concept>
                <concept code="J01MA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pazufloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pazufloxacin" type="fsn">pazufloxacin</designation>
                    <desc language="en-US">pazufloxacin</desc>
                </concept>
                <concept code="J01MA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="garenoxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="garenoxacin" type="fsn">garenoxacin</designation>
                    <desc language="en-US">garenoxacin</desc>
                </concept>
                <concept code="J01MA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sitafloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sitafloxacin" type="fsn">sitafloxacin</designation>
                    <desc language="en-US">sitafloxacin</desc>
                </concept>
                <concept code="J01MA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tosufloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tosufloxacin" type="fsn">tosufloxacin</designation>
                    <desc language="en-US">tosufloxacin</desc>
                </concept>
                <concept code="J01MA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="delafloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="delafloxacin" type="fsn">delafloxacin</designation>
                    <desc language="en-US">delafloxacin</desc>
                </concept>
                <concept code="J01MB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other quinolones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other quinolones" type="fsn">Other quinolones</designation>
                    <desc language="en-US">Other quinolones</desc>
                </concept>
                <concept code="J01MB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rosoxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rosoxacin" type="fsn">rosoxacin</designation>
                    <desc language="en-US">rosoxacin</desc>
                </concept>
                <concept code="J01MB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nalidixic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nalidixic acid" type="fsn">nalidixic acid</designation>
                    <desc language="en-US">nalidixic acid</desc>
                </concept>
                <concept code="J01MB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piromidic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piromidic acid" type="fsn">piromidic acid</designation>
                    <desc language="en-US">piromidic acid</desc>
                </concept>
                <concept code="J01MB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipemidic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pipemidic acid" type="fsn">pipemidic acid</designation>
                    <desc language="en-US">pipemidic acid</desc>
                </concept>
                <concept code="J01MB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxolinic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxolinic acid" type="fsn">oxolinic acid</designation>
                    <desc language="en-US">oxolinic acid</desc>
                </concept>
                <concept code="J01MB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinoxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinoxacin" type="fsn">cinoxacin</designation>
                    <desc language="en-US">cinoxacin</desc>
                </concept>
                <concept code="J01MB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flumequine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flumequine" type="fsn">flumequine</designation>
                    <desc language="en-US">flumequine</desc>
                </concept>
                <concept code="J01MB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nemonoxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nemonoxacin" type="fsn">nemonoxacin</designation>
                    <desc language="en-US">nemonoxacin</desc>
                </concept>
                <concept code="J01R"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="COMBINATIONS OF ANTIBACTERIALS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="COMBINATIONS OF ANTIBACTERIALS"
                         type="fsn">COMBINATIONS OF ANTIBACTERIALS</designation>
                    <desc language="en-US">COMBINATIONS OF ANTIBACTERIALS</desc>
                </concept>
                <concept code="J01RA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of antibacterials"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations of antibacterials"
                         type="fsn">Combinations of antibacterials</designation>
                    <desc language="en-US">Combinations of antibacterials</desc>
                </concept>
                <concept code="J01RA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penicillins, combinations with other antibacterials"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="penicillins, combinations with other antibacterials"
                         type="fsn">penicillins, combinations with other antibacterials</designation>
                    <desc language="en-US">penicillins, combinations with other antibacterials</desc>
                </concept>
                <concept code="J01RA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfonamides, combinations with other antibacterials (excl. trimethoprim)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sulfonamides, combinations with other antibacterials (excl. trimethoprim)"
                         type="fsn">sulfonamides, combinations with other antibacterials (excl. trimethoprim)</designation>
                    <desc language="en-US">sulfonamides, combinations with other antibacterials (excl. trimethoprim)</desc>
                </concept>
                <concept code="J01RA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefuroxime and metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cefuroxime and metronidazole"
                         type="fsn">cefuroxime and metronidazole</designation>
                    <desc language="en-US">cefuroxime and metronidazole</desc>
                </concept>
                <concept code="J01RA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="spiramycin and metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="spiramycin and metronidazole"
                         type="fsn">spiramycin and metronidazole</designation>
                    <desc language="en-US">spiramycin and metronidazole</desc>
                </concept>
                <concept code="J01RA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levofloxacin and ornidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="levofloxacin and ornidazole"
                         type="fsn">levofloxacin and ornidazole</designation>
                    <desc language="en-US">levofloxacin and ornidazole</desc>
                </concept>
                <concept code="J01RA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefepime and amikacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefepime and amikacin" type="fsn">cefepime and amikacin</designation>
                    <desc language="en-US">cefepime and amikacin</desc>
                </concept>
                <concept code="J01RA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azithromycin, fluconazole and secnidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="azithromycin, fluconazole and secnidazole"
                         type="fsn">azithromycin, fluconazole and secnidazole</designation>
                    <desc language="en-US">azithromycin, fluconazole and secnidazole</desc>
                </concept>
                <concept code="J01RA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracycline and oleandomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tetracycline and oleandomycin"
                         type="fsn">tetracycline and oleandomycin</designation>
                    <desc language="en-US">tetracycline and oleandomycin</desc>
                </concept>
                <concept code="J01RA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ofloxacin and ornidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ofloxacin and ornidazole" type="fsn">ofloxacin and ornidazole</designation>
                    <desc language="en-US">ofloxacin and ornidazole</desc>
                </concept>
                <concept code="J01RA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciprofloxacin and metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ciprofloxacin and metronidazole"
                         type="fsn">ciprofloxacin and metronidazole</designation>
                    <desc language="en-US">ciprofloxacin and metronidazole</desc>
                </concept>
                <concept code="J01RA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciprofloxacin and tinidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ciprofloxacin and tinidazole"
                         type="fsn">ciprofloxacin and tinidazole</designation>
                    <desc language="en-US">ciprofloxacin and tinidazole</desc>
                </concept>
                <concept code="J01RA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciprofloxacin and ornidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ciprofloxacin and ornidazole"
                         type="fsn">ciprofloxacin and ornidazole</designation>
                    <desc language="en-US">ciprofloxacin and ornidazole</desc>
                </concept>
                <concept code="J01RA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norfloxacin and tinidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="norfloxacin and tinidazole"
                         type="fsn">norfloxacin and tinidazole</designation>
                    <desc language="en-US">norfloxacin and tinidazole</desc>
                </concept>
                <concept code="J01X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ANTIBACTERIALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER ANTIBACTERIALS" type="fsn">OTHER ANTIBACTERIALS</designation>
                    <desc language="en-US">OTHER ANTIBACTERIALS</desc>
                </concept>
                <concept code="J01XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Glycopeptide antibacterials"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Glycopeptide antibacterials"
                         type="fsn">Glycopeptide antibacterials</designation>
                    <desc language="en-US">Glycopeptide antibacterials</desc>
                </concept>
                <concept code="J01XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vancomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vancomycin" type="fsn">vancomycin</designation>
                    <desc language="en-US">vancomycin</desc>
                </concept>
                <concept code="J01XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="teicoplanin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="teicoplanin" type="fsn">teicoplanin</designation>
                    <desc language="en-US">teicoplanin</desc>
                </concept>
                <concept code="J01XA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="telavancin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="telavancin" type="fsn">telavancin</designation>
                    <desc language="en-US">telavancin</desc>
                </concept>
                <concept code="J01XA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dalbavancin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dalbavancin" type="fsn">dalbavancin</designation>
                    <desc language="en-US">dalbavancin</desc>
                </concept>
                <concept code="J01XA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oritavancin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oritavancin" type="fsn">oritavancin</designation>
                    <desc language="en-US">oritavancin</desc>
                </concept>
                <concept code="J01XB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Polymyxins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Polymyxins" type="fsn">Polymyxins</designation>
                    <desc language="en-US">Polymyxins</desc>
                </concept>
                <concept code="J01XB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colistin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colistin" type="fsn">colistin</designation>
                    <desc language="en-US">colistin</desc>
                </concept>
                <concept code="J01XB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polymyxin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polymyxin B" type="fsn">polymyxin B</designation>
                    <desc language="en-US">polymyxin B</desc>
                </concept>
                <concept code="J01XC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Steroid antibacterials"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Steroid antibacterials" type="fsn">Steroid antibacterials</designation>
                    <desc language="en-US">Steroid antibacterials</desc>
                </concept>
                <concept code="J01XC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fusidic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fusidic acid" type="fsn">fusidic acid</designation>
                    <desc language="en-US">fusidic acid</desc>
                </concept>
                <concept code="J01XD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Imidazole derivatives" type="fsn">Imidazole derivatives</designation>
                    <desc language="en-US">Imidazole derivatives</desc>
                </concept>
                <concept code="J01XD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metronidazole" type="fsn">metronidazole</designation>
                    <desc language="en-US">metronidazole</desc>
                </concept>
                <concept code="J01XD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tinidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tinidazole" type="fsn">tinidazole</designation>
                    <desc language="en-US">tinidazole</desc>
                </concept>
                <concept code="J01XD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ornidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ornidazole" type="fsn">ornidazole</designation>
                    <desc language="en-US">ornidazole</desc>
                </concept>
                <concept code="J01XE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nitrofuran derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Nitrofuran derivatives" type="fsn">Nitrofuran derivatives</designation>
                    <desc language="en-US">Nitrofuran derivatives</desc>
                </concept>
                <concept code="J01XE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrofurantoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrofurantoin" type="fsn">nitrofurantoin</designation>
                    <desc language="en-US">nitrofurantoin</desc>
                </concept>
                <concept code="J01XE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifurtoinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifurtoinol" type="fsn">nifurtoinol</designation>
                    <desc language="en-US">nifurtoinol</desc>
                </concept>
                <concept code="J01XE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="furazidin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="furazidin" type="fsn">furazidin</designation>
                    <desc language="en-US">furazidin</desc>
                </concept>
                <concept code="J01XE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrofurantoin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="nitrofurantoin, combinations"
                         type="fsn">nitrofurantoin, combinations</designation>
                    <desc language="en-US">nitrofurantoin, combinations</desc>
                </concept>
                <concept code="J01XX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antibacterials"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antibacterials" type="fsn">Other antibacterials</designation>
                    <desc language="en-US">Other antibacterials</desc>
                </concept>
                <concept code="J01XX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fosfomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fosfomycin" type="fsn">fosfomycin</designation>
                    <desc language="en-US">fosfomycin</desc>
                </concept>
                <concept code="J01XX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xibornol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xibornol" type="fsn">xibornol</designation>
                    <desc language="en-US">xibornol</desc>
                </concept>
                <concept code="J01XX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofoctol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofoctol" type="fsn">clofoctol</designation>
                    <desc language="en-US">clofoctol</desc>
                </concept>
                <concept code="J01XX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="spectinomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="spectinomycin" type="fsn">spectinomycin</designation>
                    <desc language="en-US">spectinomycin</desc>
                </concept>
                <concept code="J01XX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methenamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methenamine" type="fsn">methenamine</designation>
                    <desc language="en-US">methenamine</desc>
                </concept>
                <concept code="J01XX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mandelic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mandelic acid" type="fsn">mandelic acid</designation>
                    <desc language="en-US">mandelic acid</desc>
                </concept>
                <concept code="J01XX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitroxoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitroxoline" type="fsn">nitroxoline</designation>
                    <desc language="en-US">nitroxoline</desc>
                </concept>
                <concept code="J01XX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="linezolid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="linezolid" type="fsn">linezolid</designation>
                    <desc language="en-US">linezolid</desc>
                </concept>
                <concept code="J01XX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="daptomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="daptomycin" type="fsn">daptomycin</designation>
                    <desc language="en-US">daptomycin</desc>
                </concept>
                <concept code="J01XX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bacitracin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bacitracin" type="fsn">bacitracin</designation>
                    <desc language="en-US">bacitracin</desc>
                </concept>
                <concept code="J01XX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tedizolid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tedizolid" type="fsn">tedizolid</designation>
                    <desc language="en-US">tedizolid</desc>
                </concept>
                <concept code="J02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIMYCOTICS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIMYCOTICS FOR SYSTEMIC USE"
                         type="fsn">ANTIMYCOTICS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIMYCOTICS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="J02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIMYCOTICS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIMYCOTICS FOR SYSTEMIC USE"
                         type="fsn">ANTIMYCOTICS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIMYCOTICS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="J02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antibiotics" type="fsn">Antibiotics</designation>
                    <desc language="en-US">Antibiotics</desc>
                </concept>
                <concept code="J02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amphotericin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amphotericin B" type="fsn">amphotericin B</designation>
                    <desc language="en-US">amphotericin B</desc>
                </concept>
                <concept code="J02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hachimycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hachimycin" type="fsn">hachimycin</designation>
                    <desc language="en-US">hachimycin</desc>
                </concept>
                <concept code="J02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Imidazole derivatives" type="fsn">Imidazole derivatives</designation>
                    <desc language="en-US">Imidazole derivatives</desc>
                </concept>
                <concept code="J02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miconazole" type="fsn">miconazole</designation>
                    <desc language="en-US">miconazole</desc>
                </concept>
                <concept code="J02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketoconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketoconazole" type="fsn">ketoconazole</designation>
                    <desc language="en-US">ketoconazole</desc>
                </concept>
                <concept code="J02AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Triazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Triazole derivatives" type="fsn">Triazole derivatives</designation>
                    <desc language="en-US">Triazole derivatives</desc>
                </concept>
                <concept code="J02AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluconazole" type="fsn">fluconazole</designation>
                    <desc language="en-US">fluconazole</desc>
                </concept>
                <concept code="J02AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="itraconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="itraconazole" type="fsn">itraconazole</designation>
                    <desc language="en-US">itraconazole</desc>
                </concept>
                <concept code="J02AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="voriconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="voriconazole" type="fsn">voriconazole</designation>
                    <desc language="en-US">voriconazole</desc>
                </concept>
                <concept code="J02AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="posaconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="posaconazole" type="fsn">posaconazole</designation>
                    <desc language="en-US">posaconazole</desc>
                </concept>
                <concept code="J02AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isavuconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isavuconazole" type="fsn">isavuconazole</designation>
                    <desc language="en-US">isavuconazole</desc>
                </concept>
                <concept code="J02AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antimycotics for systemic use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antimycotics for systemic use"
                         type="fsn">Other antimycotics for systemic use</designation>
                    <desc language="en-US">Other antimycotics for systemic use</desc>
                </concept>
                <concept code="J02AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flucytosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flucytosine" type="fsn">flucytosine</designation>
                    <desc language="en-US">flucytosine</desc>
                </concept>
                <concept code="J02AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="caspofungin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="caspofungin" type="fsn">caspofungin</designation>
                    <desc language="en-US">caspofungin</desc>
                </concept>
                <concept code="J02AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="micafungin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="micafungin" type="fsn">micafungin</designation>
                    <desc language="en-US">micafungin</desc>
                </concept>
                <concept code="J02AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anidulafungin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anidulafungin" type="fsn">anidulafungin</designation>
                    <desc language="en-US">anidulafungin</desc>
                </concept>
                <concept code="J04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIMYCOBACTERIALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIMYCOBACTERIALS" type="fsn">ANTIMYCOBACTERIALS</designation>
                    <desc language="en-US">ANTIMYCOBACTERIALS</desc>
                </concept>
                <concept code="J04A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR TREATMENT OF TUBERCULOSIS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR TREATMENT OF TUBERCULOSIS"
                         type="fsn">DRUGS FOR TREATMENT OF TUBERCULOSIS</designation>
                    <desc language="en-US">DRUGS FOR TREATMENT OF TUBERCULOSIS</desc>
                </concept>
                <concept code="J04AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aminosalicylic acid and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Aminosalicylic acid and derivatives"
                         type="fsn">Aminosalicylic acid and derivatives</designation>
                    <desc language="en-US">Aminosalicylic acid and derivatives</desc>
                </concept>
                <concept code="J04AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="4-aminosalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="4-aminosalicylic acid" type="fsn">4-aminosalicylic acid</designation>
                    <desc language="en-US">4-aminosalicylic acid</desc>
                </concept>
                <concept code="J04AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium aminosalicylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium aminosalicylate" type="fsn">sodium aminosalicylate</designation>
                    <desc language="en-US">sodium aminosalicylate</desc>
                </concept>
                <concept code="J04AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium aminosalicylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium aminosalicylate" type="fsn">calcium aminosalicylate</designation>
                    <desc language="en-US">calcium aminosalicylate</desc>
                </concept>
                <concept code="J04AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antibiotics" type="fsn">Antibiotics</designation>
                    <desc language="en-US">Antibiotics</desc>
                </concept>
                <concept code="J04AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cycloserine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cycloserine" type="fsn">cycloserine</designation>
                    <desc language="en-US">cycloserine</desc>
                </concept>
                <concept code="J04AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifampicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifampicin" type="fsn">rifampicin</designation>
                    <desc language="en-US">rifampicin</desc>
                </concept>
                <concept code="J04AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifamycin" type="fsn">rifamycin</designation>
                    <desc language="en-US">rifamycin</desc>
                </concept>
                <concept code="J04AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifabutin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifabutin" type="fsn">rifabutin</designation>
                    <desc language="en-US">rifabutin</desc>
                </concept>
                <concept code="J04AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifapentine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifapentine" type="fsn">rifapentine</designation>
                    <desc language="en-US">rifapentine</desc>
                </concept>
                <concept code="J04AB30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="capreomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="capreomycin" type="fsn">capreomycin</designation>
                    <desc language="en-US">capreomycin</desc>
                </concept>
                <concept code="J04AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hydrazides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Hydrazides" type="fsn">Hydrazides</designation>
                    <desc language="en-US">Hydrazides</desc>
                </concept>
                <concept code="J04AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoniazid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoniazid" type="fsn">isoniazid</designation>
                    <desc language="en-US">isoniazid</desc>
                </concept>
                <concept code="J04AC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoniazid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoniazid, combinations" type="fsn">isoniazid, combinations</designation>
                    <desc language="en-US">isoniazid, combinations</desc>
                </concept>
                <concept code="J04AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiocarbamide derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thiocarbamide derivatives" type="fsn">Thiocarbamide derivatives</designation>
                    <desc language="en-US">Thiocarbamide derivatives</desc>
                </concept>
                <concept code="J04AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="protionamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="protionamide" type="fsn">protionamide</designation>
                    <desc language="en-US">protionamide</desc>
                </concept>
                <concept code="J04AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiocarlide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiocarlide" type="fsn">tiocarlide</designation>
                    <desc language="en-US">tiocarlide</desc>
                </concept>
                <concept code="J04AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethionamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethionamide" type="fsn">ethionamide</designation>
                    <desc language="en-US">ethionamide</desc>
                </concept>
                <concept code="J04AK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs for treatment of tuberculosis"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs for treatment of tuberculosis"
                         type="fsn">Other drugs for treatment of tuberculosis</designation>
                    <desc language="en-US">Other drugs for treatment of tuberculosis</desc>
                </concept>
                <concept code="J04AK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrazinamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrazinamide" type="fsn">pyrazinamide</designation>
                    <desc language="en-US">pyrazinamide</desc>
                </concept>
                <concept code="J04AK02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethambutol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethambutol" type="fsn">ethambutol</designation>
                    <desc language="en-US">ethambutol</desc>
                </concept>
                <concept code="J04AK03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terizidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terizidone" type="fsn">terizidone</designation>
                    <desc language="en-US">terizidone</desc>
                </concept>
                <concept code="J04AK04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="morinamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="morinamide" type="fsn">morinamide</designation>
                    <desc language="en-US">morinamide</desc>
                </concept>
                <concept code="J04AK05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bedaquiline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bedaquiline" type="fsn">bedaquiline</designation>
                    <desc language="en-US">bedaquiline</desc>
                </concept>
                <concept code="J04AK06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="delamanid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="delamanid" type="fsn">delamanid</designation>
                    <desc language="en-US">delamanid</desc>
                </concept>
                <concept code="J04AK07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thioacetazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thioacetazone" type="fsn">thioacetazone</designation>
                    <desc language="en-US">thioacetazone</desc>
                </concept>
                <concept code="J04AM"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of drugs for treatment of tuberculosis"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations of drugs for treatment of tuberculosis"
                         type="fsn">Combinations of drugs for treatment of tuberculosis</designation>
                    <desc language="en-US">Combinations of drugs for treatment of tuberculosis</desc>
                </concept>
                <concept code="J04AM01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="streptomycin and isoniazid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="streptomycin and isoniazid"
                         type="fsn">streptomycin and isoniazid</designation>
                    <desc language="en-US">streptomycin and isoniazid</desc>
                </concept>
                <concept code="J04AM02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifampicin and isoniazid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifampicin and isoniazid" type="fsn">rifampicin and isoniazid</designation>
                    <desc language="en-US">rifampicin and isoniazid</desc>
                </concept>
                <concept code="J04AM03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethambutol and isoniazid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethambutol and isoniazid" type="fsn">ethambutol and isoniazid</designation>
                    <desc language="en-US">ethambutol and isoniazid</desc>
                </concept>
                <concept code="J04AM04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thioacetazone and isoniazid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="thioacetazone and isoniazid"
                         type="fsn">thioacetazone and isoniazid</designation>
                    <desc language="en-US">thioacetazone and isoniazid</desc>
                </concept>
                <concept code="J04AM05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifampicin, pyrazinamide and isoniazid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rifampicin, pyrazinamide and isoniazid"
                         type="fsn">rifampicin, pyrazinamide and isoniazid</designation>
                    <desc language="en-US">rifampicin, pyrazinamide and isoniazid</desc>
                </concept>
                <concept code="J04AM06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifampicin, pyrazinamide, ethambutol and isoniazid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rifampicin, pyrazinamide, ethambutol and isoniazid"
                         type="fsn">rifampicin, pyrazinamide, ethambutol and isoniazid</designation>
                    <desc language="en-US">rifampicin, pyrazinamide, ethambutol and isoniazid</desc>
                </concept>
                <concept code="J04AM07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifampicin, ethambutol and isoniazid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rifampicin, ethambutol and isoniazid"
                         type="fsn">rifampicin, ethambutol and isoniazid</designation>
                    <desc language="en-US">rifampicin, ethambutol and isoniazid</desc>
                </concept>
                <concept code="J04AM08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoniazid, sulfamethoxazole, trimethoprim and pyridoxine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="isoniazid, sulfamethoxazole, trimethoprim and pyridoxine"
                         type="fsn">isoniazid, sulfamethoxazole, trimethoprim and pyridoxine</designation>
                    <desc language="en-US">isoniazid, sulfamethoxazole, trimethoprim and pyridoxine</desc>
                </concept>
                <concept code="J04B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR TREATMENT OF LEPRA"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR TREATMENT OF LEPRA"
                         type="fsn">DRUGS FOR TREATMENT OF LEPRA</designation>
                    <desc language="en-US">DRUGS FOR TREATMENT OF LEPRA</desc>
                </concept>
                <concept code="J04BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs for treatment of lepra"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs for treatment of lepra"
                         type="fsn">Drugs for treatment of lepra</designation>
                    <desc language="en-US">Drugs for treatment of lepra</desc>
                </concept>
                <concept code="J04BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofazimine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofazimine" type="fsn">clofazimine</designation>
                    <desc language="en-US">clofazimine</desc>
                </concept>
                <concept code="J04BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dapsone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dapsone" type="fsn">dapsone</designation>
                    <desc language="en-US">dapsone</desc>
                </concept>
                <concept code="J04BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aldesulfone sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aldesulfone sodium" type="fsn">aldesulfone sodium</designation>
                    <desc language="en-US">aldesulfone sodium</desc>
                </concept>
                <concept code="J05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIVIRALS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIVIRALS FOR SYSTEMIC USE"
                         type="fsn">ANTIVIRALS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIVIRALS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="J05A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIRECT ACTING ANTIVIRALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DIRECT ACTING ANTIVIRALS" type="fsn">DIRECT ACTING ANTIVIRALS</designation>
                    <desc language="en-US">DIRECT ACTING ANTIVIRALS</desc>
                </concept>
                <concept code="J05AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thiosemicarbazones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thiosemicarbazones" type="fsn">Thiosemicarbazones</designation>
                    <desc language="en-US">Thiosemicarbazones</desc>
                </concept>
                <concept code="J05AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metisazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metisazone" type="fsn">metisazone</designation>
                    <desc language="en-US">metisazone</desc>
                </concept>
                <concept code="J05AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
                         type="fsn">Nucleosides and nucleotides excl. reverse transcriptase inhibitors</designation>
                    <desc language="en-US">Nucleosides and nucleotides excl. reverse transcriptase inhibitors</desc>
                </concept>
                <concept code="J05AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aciclovir" type="fsn">aciclovir</designation>
                    <desc language="en-US">aciclovir</desc>
                </concept>
                <concept code="J05AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idoxuridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idoxuridine" type="fsn">idoxuridine</designation>
                    <desc language="en-US">idoxuridine</desc>
                </concept>
                <concept code="J05AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vidarabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vidarabine" type="fsn">vidarabine</designation>
                    <desc language="en-US">vidarabine</desc>
                </concept>
                <concept code="J05AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ganciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ganciclovir" type="fsn">ganciclovir</designation>
                    <desc language="en-US">ganciclovir</desc>
                </concept>
                <concept code="J05AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="famciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="famciclovir" type="fsn">famciclovir</designation>
                    <desc language="en-US">famciclovir</desc>
                </concept>
                <concept code="J05AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valaciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valaciclovir" type="fsn">valaciclovir</designation>
                    <desc language="en-US">valaciclovir</desc>
                </concept>
                <concept code="J05AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cidofovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cidofovir" type="fsn">cidofovir</designation>
                    <desc language="en-US">cidofovir</desc>
                </concept>
                <concept code="J05AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="penciclovir" type="fsn">penciclovir</designation>
                    <desc language="en-US">penciclovir</desc>
                </concept>
                <concept code="J05AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valganciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valganciclovir" type="fsn">valganciclovir</designation>
                    <desc language="en-US">valganciclovir</desc>
                </concept>
                <concept code="J05AB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brivudine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brivudine" type="fsn">brivudine</designation>
                    <desc language="en-US">brivudine</desc>
                </concept>
                <concept code="J05AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Cyclic amines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Cyclic amines" type="fsn">Cyclic amines</designation>
                    <desc language="en-US">Cyclic amines</desc>
                </concept>
                <concept code="J05AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rimantadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rimantadine" type="fsn">rimantadine</designation>
                    <desc language="en-US">rimantadine</desc>
                </concept>
                <concept code="J05AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tromantadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tromantadine" type="fsn">tromantadine</designation>
                    <desc language="en-US">tromantadine</desc>
                </concept>
                <concept code="J05AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phosphonic acid derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Phosphonic acid derivatives"
                         type="fsn">Phosphonic acid derivatives</designation>
                    <desc language="en-US">Phosphonic acid derivatives</desc>
                </concept>
                <concept code="J05AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="foscarnet"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="foscarnet" type="fsn">foscarnet</designation>
                    <desc language="en-US">foscarnet</desc>
                </concept>
                <concept code="J05AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fosfonet"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fosfonet" type="fsn">fosfonet</designation>
                    <desc language="en-US">fosfonet</desc>
                </concept>
                <concept code="J05AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Protease inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Protease inhibitors" type="fsn">Protease inhibitors</designation>
                    <desc language="en-US">Protease inhibitors</desc>
                </concept>
                <concept code="J05AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="saquinavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="saquinavir" type="fsn">saquinavir</designation>
                    <desc language="en-US">saquinavir</desc>
                </concept>
                <concept code="J05AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indinavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indinavir" type="fsn">indinavir</designation>
                    <desc language="en-US">indinavir</desc>
                </concept>
                <concept code="J05AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ritonavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ritonavir" type="fsn">ritonavir</designation>
                    <desc language="en-US">ritonavir</desc>
                </concept>
                <concept code="J05AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nelfinavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nelfinavir" type="fsn">nelfinavir</designation>
                    <desc language="en-US">nelfinavir</desc>
                </concept>
                <concept code="J05AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amprenavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amprenavir" type="fsn">amprenavir</designation>
                    <desc language="en-US">amprenavir</desc>
                </concept>
                <concept code="J05AE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fosamprenavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fosamprenavir" type="fsn">fosamprenavir</designation>
                    <desc language="en-US">fosamprenavir</desc>
                </concept>
                <concept code="J05AE08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atazanavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atazanavir" type="fsn">atazanavir</designation>
                    <desc language="en-US">atazanavir</desc>
                </concept>
                <concept code="J05AE09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tipranavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tipranavir" type="fsn">tipranavir</designation>
                    <desc language="en-US">tipranavir</desc>
                </concept>
                <concept code="J05AE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="darunavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="darunavir" type="fsn">darunavir</designation>
                    <desc language="en-US">darunavir</desc>
                </concept>
                <concept code="J05AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nucleoside and nucleotide reverse transcriptase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nucleoside and nucleotide reverse transcriptase inhibitors"
                         type="fsn">Nucleoside and nucleotide reverse transcriptase inhibitors</designation>
                    <desc language="en-US">Nucleoside and nucleotide reverse transcriptase inhibitors</desc>
                </concept>
                <concept code="J05AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zidovudine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zidovudine" type="fsn">zidovudine</designation>
                    <desc language="en-US">zidovudine</desc>
                </concept>
                <concept code="J05AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="didanosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="didanosine" type="fsn">didanosine</designation>
                    <desc language="en-US">didanosine</desc>
                </concept>
                <concept code="J05AF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zalcitabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zalcitabine" type="fsn">zalcitabine</designation>
                    <desc language="en-US">zalcitabine</desc>
                </concept>
                <concept code="J05AF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stavudine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="stavudine" type="fsn">stavudine</designation>
                    <desc language="en-US">stavudine</desc>
                </concept>
                <concept code="J05AF05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lamivudine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lamivudine" type="fsn">lamivudine</designation>
                    <desc language="en-US">lamivudine</desc>
                </concept>
                <concept code="J05AF06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="abacavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="abacavir" type="fsn">abacavir</designation>
                    <desc language="en-US">abacavir</desc>
                </concept>
                <concept code="J05AF07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tenofovir disoproxil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tenofovir disoproxil" type="fsn">tenofovir disoproxil</designation>
                    <desc language="en-US">tenofovir disoproxil</desc>
                </concept>
                <concept code="J05AF08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adefovir dipivoxil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adefovir dipivoxil" type="fsn">adefovir dipivoxil</designation>
                    <desc language="en-US">adefovir dipivoxil</desc>
                </concept>
                <concept code="J05AF09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emtricitabine" type="fsn">emtricitabine</designation>
                    <desc language="en-US">emtricitabine</desc>
                </concept>
                <concept code="J05AF10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="entecavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="entecavir" type="fsn">entecavir</designation>
                    <desc language="en-US">entecavir</desc>
                </concept>
                <concept code="J05AF11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="telbivudine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="telbivudine" type="fsn">telbivudine</designation>
                    <desc language="en-US">telbivudine</desc>
                </concept>
                <concept code="J05AF12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clevudine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clevudine" type="fsn">clevudine</designation>
                    <desc language="en-US">clevudine</desc>
                </concept>
                <concept code="J05AF13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tenofovir alafenamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tenofovir alafenamide" type="fsn">tenofovir alafenamide</designation>
                    <desc language="en-US">tenofovir alafenamide</desc>
                </concept>
                <concept code="J05AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Non-nucleoside reverse transcriptase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Non-nucleoside reverse transcriptase inhibitors"
                         type="fsn">Non-nucleoside reverse transcriptase inhibitors</designation>
                    <desc language="en-US">Non-nucleoside reverse transcriptase inhibitors</desc>
                </concept>
                <concept code="J05AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nevirapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nevirapine" type="fsn">nevirapine</designation>
                    <desc language="en-US">nevirapine</desc>
                </concept>
                <concept code="J05AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="delavirdine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="delavirdine" type="fsn">delavirdine</designation>
                    <desc language="en-US">delavirdine</desc>
                </concept>
                <concept code="J05AG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="efavirenz"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="efavirenz" type="fsn">efavirenz</designation>
                    <desc language="en-US">efavirenz</desc>
                </concept>
                <concept code="J05AG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etravirine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etravirine" type="fsn">etravirine</designation>
                    <desc language="en-US">etravirine</desc>
                </concept>
                <concept code="J05AG05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rilpivirine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rilpivirine" type="fsn">rilpivirine</designation>
                    <desc language="en-US">rilpivirine</desc>
                </concept>
                <concept code="J05AG06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doravirine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doravirine" type="fsn">doravirine</designation>
                    <desc language="en-US">doravirine</desc>
                </concept>
                <concept code="J05AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Neuraminidase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Neuraminidase inhibitors" type="fsn">Neuraminidase inhibitors</designation>
                    <desc language="en-US">Neuraminidase inhibitors</desc>
                </concept>
                <concept code="J05AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zanamivir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zanamivir" type="fsn">zanamivir</designation>
                    <desc language="en-US">zanamivir</desc>
                </concept>
                <concept code="J05AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oseltamivir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oseltamivir" type="fsn">oseltamivir</designation>
                    <desc language="en-US">oseltamivir</desc>
                </concept>
                <concept code="J05AH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="peramivir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="peramivir" type="fsn">peramivir</designation>
                    <desc language="en-US">peramivir</desc>
                </concept>
                <concept code="J05AP"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antivirals for treatment of HCV infections"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antivirals for treatment of HCV infections"
                         type="fsn">Antivirals for treatment of HCV infections</designation>
                    <desc language="en-US">Antivirals for treatment of HCV infections</desc>
                </concept>
                <concept code="J05AP01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ribavirin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ribavirin" type="fsn">ribavirin</designation>
                    <desc language="en-US">ribavirin</desc>
                </concept>
                <concept code="J05AP02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="telaprevir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="telaprevir" type="fsn">telaprevir</designation>
                    <desc language="en-US">telaprevir</desc>
                </concept>
                <concept code="J05AP03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="boceprevir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="boceprevir" type="fsn">boceprevir</designation>
                    <desc language="en-US">boceprevir</desc>
                </concept>
                <concept code="J05AP04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="faldaprevir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="faldaprevir" type="fsn">faldaprevir</designation>
                    <desc language="en-US">faldaprevir</desc>
                </concept>
                <concept code="J05AP05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="simeprevir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="simeprevir" type="fsn">simeprevir</designation>
                    <desc language="en-US">simeprevir</desc>
                </concept>
                <concept code="J05AP06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="asunaprevir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="asunaprevir" type="fsn">asunaprevir</designation>
                    <desc language="en-US">asunaprevir</desc>
                </concept>
                <concept code="J05AP07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="daclatasvir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="daclatasvir" type="fsn">daclatasvir</designation>
                    <desc language="en-US">daclatasvir</desc>
                </concept>
                <concept code="J05AP08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sofosbuvir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sofosbuvir" type="fsn">sofosbuvir</designation>
                    <desc language="en-US">sofosbuvir</desc>
                </concept>
                <concept code="J05AP09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dasabuvir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dasabuvir" type="fsn">dasabuvir</designation>
                    <desc language="en-US">dasabuvir</desc>
                </concept>
                <concept code="J05AP51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sofosbuvir and ledipasvir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sofosbuvir and ledipasvir" type="fsn">sofosbuvir and ledipasvir</designation>
                    <desc language="en-US">sofosbuvir and ledipasvir</desc>
                </concept>
                <concept code="J05AP52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dasabuvir, ombitasvir, paritaprevir and ritonavir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dasabuvir, ombitasvir, paritaprevir and ritonavir"
                         type="fsn">dasabuvir, ombitasvir, paritaprevir and ritonavir</designation>
                    <desc language="en-US">dasabuvir, ombitasvir, paritaprevir and ritonavir</desc>
                </concept>
                <concept code="J05AP53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ombitasvir, paritaprevir and ritonavir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ombitasvir, paritaprevir and ritonavir"
                         type="fsn">ombitasvir, paritaprevir and ritonavir</designation>
                    <desc language="en-US">ombitasvir, paritaprevir and ritonavir</desc>
                </concept>
                <concept code="J05AP54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="elbasvir and grazoprevir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="elbasvir and grazoprevir" type="fsn">elbasvir and grazoprevir</designation>
                    <desc language="en-US">elbasvir and grazoprevir</desc>
                </concept>
                <concept code="J05AP55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sofosbuvir and velpatasvir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sofosbuvir and velpatasvir"
                         type="fsn">sofosbuvir and velpatasvir</designation>
                    <desc language="en-US">sofosbuvir and velpatasvir</desc>
                </concept>
                <concept code="J05AP56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sofosbuvir, velpatasvir and voxilaprevir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sofosbuvir, velpatasvir and voxilaprevir"
                         type="fsn">sofosbuvir, velpatasvir and voxilaprevir</designation>
                    <desc language="en-US">sofosbuvir, velpatasvir and voxilaprevir</desc>
                </concept>
                <concept code="J05AP57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glecaprevir and pibrentasvir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="glecaprevir and pibrentasvir"
                         type="fsn">glecaprevir and pibrentasvir</designation>
                    <desc language="en-US">glecaprevir and pibrentasvir</desc>
                </concept>
                <concept code="J05AR"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antivirals for treatment of HIV infections, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antivirals for treatment of HIV infections, combinations"
                         type="fsn">Antivirals for treatment of HIV infections, combinations</designation>
                    <desc language="en-US">Antivirals for treatment of HIV infections, combinations</desc>
                </concept>
                <concept code="J05AR01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zidovudine and lamivudine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zidovudine and lamivudine" type="fsn">zidovudine and lamivudine</designation>
                    <desc language="en-US">zidovudine and lamivudine</desc>
                </concept>
                <concept code="J05AR02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lamivudine and abacavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lamivudine and abacavir" type="fsn">lamivudine and abacavir</designation>
                    <desc language="en-US">lamivudine and abacavir</desc>
                </concept>
                <concept code="J05AR03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tenofovir disoproxil and emtricitabine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tenofovir disoproxil and emtricitabine"
                         type="fsn">tenofovir disoproxil and emtricitabine</designation>
                    <desc language="en-US">tenofovir disoproxil and emtricitabine</desc>
                </concept>
                <concept code="J05AR04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zidovudine, lamivudine and abacavir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="zidovudine, lamivudine and abacavir"
                         type="fsn">zidovudine, lamivudine and abacavir</designation>
                    <desc language="en-US">zidovudine, lamivudine and abacavir</desc>
                </concept>
                <concept code="J05AR05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zidovudine, lamivudine and nevirapine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="zidovudine, lamivudine and nevirapine"
                         type="fsn">zidovudine, lamivudine and nevirapine</designation>
                    <desc language="en-US">zidovudine, lamivudine and nevirapine</desc>
                </concept>
                <concept code="J05AR06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine, tenofovir disoproxil and efavirenz"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emtricitabine, tenofovir disoproxil and efavirenz"
                         type="fsn">emtricitabine, tenofovir disoproxil and efavirenz</designation>
                    <desc language="en-US">emtricitabine, tenofovir disoproxil and efavirenz</desc>
                </concept>
                <concept code="J05AR07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stavudine, lamivudine and nevirapine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="stavudine, lamivudine and nevirapine"
                         type="fsn">stavudine, lamivudine and nevirapine</designation>
                    <desc language="en-US">stavudine, lamivudine and nevirapine</desc>
                </concept>
                <concept code="J05AR08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine, tenofovir disoproxil and rilpivirine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emtricitabine, tenofovir disoproxil and rilpivirine"
                         type="fsn">emtricitabine, tenofovir disoproxil and rilpivirine</designation>
                    <desc language="en-US">emtricitabine, tenofovir disoproxil and rilpivirine</desc>
                </concept>
                <concept code="J05AR09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat"
                         type="fsn">emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat</designation>
                    <desc language="en-US">emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat</desc>
                </concept>
                <concept code="J05AR10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lopinavir and ritonavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lopinavir and ritonavir" type="fsn">lopinavir and ritonavir</designation>
                    <desc language="en-US">lopinavir and ritonavir</desc>
                </concept>
                <concept code="J05AR11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lamivudine, tenofovir disoproxil and efavirenz"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lamivudine, tenofovir disoproxil and efavirenz"
                         type="fsn">lamivudine, tenofovir disoproxil and efavirenz</designation>
                    <desc language="en-US">lamivudine, tenofovir disoproxil and efavirenz</desc>
                </concept>
                <concept code="J05AR12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lamivudine and tenofovir disoproxil"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lamivudine and tenofovir disoproxil"
                         type="fsn">lamivudine and tenofovir disoproxil</designation>
                    <desc language="en-US">lamivudine and tenofovir disoproxil</desc>
                </concept>
                <concept code="J05AR13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lamivudine, abacavir and dolutegravir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lamivudine, abacavir and dolutegravir"
                         type="fsn">lamivudine, abacavir and dolutegravir</designation>
                    <desc language="en-US">lamivudine, abacavir and dolutegravir</desc>
                </concept>
                <concept code="J05AR14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="darunavir and cobicistat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="darunavir and cobicistat" type="fsn">darunavir and cobicistat</designation>
                    <desc language="en-US">darunavir and cobicistat</desc>
                </concept>
                <concept code="J05AR15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atazanavir and cobicistat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atazanavir and cobicistat" type="fsn">atazanavir and cobicistat</designation>
                    <desc language="en-US">atazanavir and cobicistat</desc>
                </concept>
                <concept code="J05AR16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lamivudine and raltegravir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lamivudine and raltegravir"
                         type="fsn">lamivudine and raltegravir</designation>
                    <desc language="en-US">lamivudine and raltegravir</desc>
                </concept>
                <concept code="J05AR17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine and tenofovir alafenamide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emtricitabine and tenofovir alafenamide"
                         type="fsn">emtricitabine and tenofovir alafenamide</designation>
                    <desc language="en-US">emtricitabine and tenofovir alafenamide</desc>
                </concept>
                <concept code="J05AR18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat"
                         type="fsn">emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat</designation>
                    <desc language="en-US">emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat</desc>
                </concept>
                <concept code="J05AR19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine, tenofovir alafenamide and rilpivirine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emtricitabine, tenofovir alafenamide and rilpivirine"
                         type="fsn">emtricitabine, tenofovir alafenamide and rilpivirine</designation>
                    <desc language="en-US">emtricitabine, tenofovir alafenamide and rilpivirine</desc>
                </concept>
                <concept code="J05AR20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine, tenofovir alafenamide and bictegravir"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emtricitabine, tenofovir alafenamide and bictegravir"
                         type="fsn">emtricitabine, tenofovir alafenamide and bictegravir</designation>
                    <desc language="en-US">emtricitabine, tenofovir alafenamide and bictegravir</desc>
                </concept>
                <concept code="J05AR21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dolutegravir and rilpivirine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dolutegravir and rilpivirine"
                         type="fsn">dolutegravir and rilpivirine</designation>
                    <desc language="en-US">dolutegravir and rilpivirine</desc>
                </concept>
                <concept code="J05AR22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emtricitabine, tenofovir alafenamide, darunavir and cobicistat"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="emtricitabine, tenofovir alafenamide, darunavir and cobicistat"
                         type="fsn">emtricitabine, tenofovir alafenamide, darunavir and cobicistat</designation>
                    <desc language="en-US">emtricitabine, tenofovir alafenamide, darunavir and cobicistat</desc>
                </concept>
                <concept code="J05AR23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atazanavir and ritonavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atazanavir and ritonavir" type="fsn">atazanavir and ritonavir</designation>
                    <desc language="en-US">atazanavir and ritonavir</desc>
                </concept>
                <concept code="J05AR24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lamivudine, tenofovir disoproxil and doravirine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lamivudine, tenofovir disoproxil and doravirine"
                         type="fsn">lamivudine, tenofovir disoproxil and doravirine</designation>
                    <desc language="en-US">lamivudine, tenofovir disoproxil and doravirine</desc>
                </concept>
                <concept code="J05AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antivirals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antivirals" type="fsn">Other antivirals</designation>
                    <desc language="en-US">Other antivirals</desc>
                </concept>
                <concept code="J05AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moroxydine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moroxydine" type="fsn">moroxydine</designation>
                    <desc language="en-US">moroxydine</desc>
                </concept>
                <concept code="J05AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lysozyme"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lysozyme" type="fsn">lysozyme</designation>
                    <desc language="en-US">lysozyme</desc>
                </concept>
                <concept code="J05AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="inosine pranobex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="inosine pranobex" type="fsn">inosine pranobex</designation>
                    <desc language="en-US">inosine pranobex</desc>
                </concept>
                <concept code="J05AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pleconaril"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pleconaril" type="fsn">pleconaril</designation>
                    <desc language="en-US">pleconaril</desc>
                </concept>
                <concept code="J05AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enfuvirtide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enfuvirtide" type="fsn">enfuvirtide</designation>
                    <desc language="en-US">enfuvirtide</desc>
                </concept>
                <concept code="J05AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="raltegravir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="raltegravir" type="fsn">raltegravir</designation>
                    <desc language="en-US">raltegravir</desc>
                </concept>
                <concept code="J05AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="maraviroc"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="maraviroc" type="fsn">maraviroc</designation>
                    <desc language="en-US">maraviroc</desc>
                </concept>
                <concept code="J05AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="maribavir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="maribavir" type="fsn">maribavir</designation>
                    <desc language="en-US">maribavir</desc>
                </concept>
                <concept code="J05AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="elvitegravir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="elvitegravir" type="fsn">elvitegravir</designation>
                    <desc language="en-US">elvitegravir</desc>
                </concept>
                <concept code="J05AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dolutegravir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dolutegravir" type="fsn">dolutegravir</designation>
                    <desc language="en-US">dolutegravir</desc>
                </concept>
                <concept code="J05AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="umifenovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="umifenovir" type="fsn">umifenovir</designation>
                    <desc language="en-US">umifenovir</desc>
                </concept>
                <concept code="J05AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enisamium iodide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enisamium iodide" type="fsn">enisamium iodide</designation>
                    <desc language="en-US">enisamium iodide</desc>
                </concept>
                <concept code="J05AX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="letermovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="letermovir" type="fsn">letermovir</designation>
                    <desc language="en-US">letermovir</desc>
                </concept>
                <concept code="J05AX19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tilorone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tilorone" type="fsn">tilorone</designation>
                    <desc language="en-US">tilorone</desc>
                </concept>
                <concept code="J05AX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentanedioic acid imidazolyl ethanamide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pentanedioic acid imidazolyl ethanamide"
                         type="fsn">pentanedioic acid imidazolyl ethanamide</designation>
                    <desc language="en-US">pentanedioic acid imidazolyl ethanamide</desc>
                </concept>
                <concept code="J05AX23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibalizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibalizumab" type="fsn">ibalizumab</designation>
                    <desc language="en-US">ibalizumab</desc>
                </concept>
                <concept code="J06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IMMUNE SERA AND IMMUNOGLOBULINS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="IMMUNE SERA AND IMMUNOGLOBULINS"
                         type="fsn">IMMUNE SERA AND IMMUNOGLOBULINS</designation>
                    <desc language="en-US">IMMUNE SERA AND IMMUNOGLOBULINS</desc>
                </concept>
                <concept code="J06A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IMMUNE SERA"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IMMUNE SERA" type="fsn">IMMUNE SERA</designation>
                    <desc language="en-US">IMMUNE SERA</desc>
                </concept>
                <concept code="J06AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Immune sera"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Immune sera" type="fsn">Immune sera</designation>
                    <desc language="en-US">Immune sera</desc>
                </concept>
                <concept code="J06AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria antitoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphtheria antitoxin" type="fsn">diphtheria antitoxin</designation>
                    <desc language="en-US">diphtheria antitoxin</desc>
                </concept>
                <concept code="J06AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetanus antitoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetanus antitoxin" type="fsn">tetanus antitoxin</designation>
                    <desc language="en-US">tetanus antitoxin</desc>
                </concept>
                <concept code="J06AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="snake venom antiserum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="snake venom antiserum" type="fsn">snake venom antiserum</designation>
                    <desc language="en-US">snake venom antiserum</desc>
                </concept>
                <concept code="J06AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="botulinum antitoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="botulinum antitoxin" type="fsn">botulinum antitoxin</designation>
                    <desc language="en-US">botulinum antitoxin</desc>
                </concept>
                <concept code="J06AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gas-gangrene sera"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gas-gangrene sera" type="fsn">gas-gangrene sera</designation>
                    <desc language="en-US">gas-gangrene sera</desc>
                </concept>
                <concept code="J06AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rabies serum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rabies serum" type="fsn">rabies serum</designation>
                    <desc language="en-US">rabies serum</desc>
                </concept>
                <concept code="J06B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IMMUNOGLOBULINS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IMMUNOGLOBULINS" type="fsn">IMMUNOGLOBULINS</designation>
                    <desc language="en-US">IMMUNOGLOBULINS</desc>
                </concept>
                <concept code="J06BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Immunoglobulins, normal human"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Immunoglobulins, normal human"
                         type="fsn">Immunoglobulins, normal human</designation>
                    <desc language="en-US">Immunoglobulins, normal human</desc>
                </concept>
                <concept code="J06BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="immunoglobulins, normal human, for extravascular adm."
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="immunoglobulins, normal human, for extravascular adm."
                         type="fsn">immunoglobulins, normal human, for extravascular adm.</designation>
                    <desc language="en-US">immunoglobulins, normal human, for extravascular adm.</desc>
                </concept>
                <concept code="J06BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="immunoglobulins, normal human, for intravascular adm."
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="immunoglobulins, normal human, for intravascular adm."
                         type="fsn">immunoglobulins, normal human, for intravascular adm.</designation>
                    <desc language="en-US">immunoglobulins, normal human, for intravascular adm.</desc>
                </concept>
                <concept code="J06BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Specific immunoglobulins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Specific immunoglobulins" type="fsn">Specific immunoglobulins</designation>
                    <desc language="en-US">Specific immunoglobulins</desc>
                </concept>
                <concept code="J06BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anti-D (rh) immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="anti-D (rh) immunoglobulin"
                         type="fsn">anti-D (rh) immunoglobulin</designation>
                    <desc language="en-US">anti-D (rh) immunoglobulin</desc>
                </concept>
                <concept code="J06BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetanus immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetanus immunoglobulin" type="fsn">tetanus immunoglobulin</designation>
                    <desc language="en-US">tetanus immunoglobulin</desc>
                </concept>
                <concept code="J06BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="varicella/zoster immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="varicella/zoster immunoglobulin"
                         type="fsn">varicella/zoster immunoglobulin</designation>
                    <desc language="en-US">varicella/zoster immunoglobulin</desc>
                </concept>
                <concept code="J06BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hepatitis B immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hepatitis B immunoglobulin"
                         type="fsn">hepatitis B immunoglobulin</designation>
                    <desc language="en-US">hepatitis B immunoglobulin</desc>
                </concept>
                <concept code="J06BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rabies immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rabies immunoglobulin" type="fsn">rabies immunoglobulin</designation>
                    <desc language="en-US">rabies immunoglobulin</desc>
                </concept>
                <concept code="J06BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rubella immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rubella immunoglobulin" type="fsn">rubella immunoglobulin</designation>
                    <desc language="en-US">rubella immunoglobulin</desc>
                </concept>
                <concept code="J06BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vaccinia immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vaccinia immunoglobulin" type="fsn">vaccinia immunoglobulin</designation>
                    <desc language="en-US">vaccinia immunoglobulin</desc>
                </concept>
                <concept code="J06BB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="staphylococcus immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="staphylococcus immunoglobulin"
                         type="fsn">staphylococcus immunoglobulin</designation>
                    <desc language="en-US">staphylococcus immunoglobulin</desc>
                </concept>
                <concept code="J06BB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cytomegalovirus immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cytomegalovirus immunoglobulin"
                         type="fsn">cytomegalovirus immunoglobulin</designation>
                    <desc language="en-US">cytomegalovirus immunoglobulin</desc>
                </concept>
                <concept code="J06BB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphtheria immunoglobulin" type="fsn">diphtheria immunoglobulin</designation>
                    <desc language="en-US">diphtheria immunoglobulin</desc>
                </concept>
                <concept code="J06BB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hepatitis A immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hepatitis A immunoglobulin"
                         type="fsn">hepatitis A immunoglobulin</designation>
                    <desc language="en-US">hepatitis A immunoglobulin</desc>
                </concept>
                <concept code="J06BB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="encephalitis, tick borne immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="encephalitis, tick borne immunoglobulin"
                         type="fsn">encephalitis, tick borne immunoglobulin</designation>
                    <desc language="en-US">encephalitis, tick borne immunoglobulin</desc>
                </concept>
                <concept code="J06BB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pertussis immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pertussis immunoglobulin" type="fsn">pertussis immunoglobulin</designation>
                    <desc language="en-US">pertussis immunoglobulin</desc>
                </concept>
                <concept code="J06BB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="measles immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="measles immunoglobulin" type="fsn">measles immunoglobulin</designation>
                    <desc language="en-US">measles immunoglobulin</desc>
                </concept>
                <concept code="J06BB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mumps immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mumps immunoglobulin" type="fsn">mumps immunoglobulin</designation>
                    <desc language="en-US">mumps immunoglobulin</desc>
                </concept>
                <concept code="J06BB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="palivizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="palivizumab" type="fsn">palivizumab</designation>
                    <desc language="en-US">palivizumab</desc>
                </concept>
                <concept code="J06BB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="motavizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="motavizumab" type="fsn">motavizumab</designation>
                    <desc language="en-US">motavizumab</desc>
                </concept>
                <concept code="J06BB18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="raxibacumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="raxibacumab" type="fsn">raxibacumab</designation>
                    <desc language="en-US">raxibacumab</desc>
                </concept>
                <concept code="J06BB19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anthrax immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anthrax immunoglobulin" type="fsn">anthrax immunoglobulin</designation>
                    <desc language="en-US">anthrax immunoglobulin</desc>
                </concept>
                <concept code="J06BB21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bezlotoxumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bezlotoxumab" type="fsn">bezlotoxumab</designation>
                    <desc language="en-US">bezlotoxumab</desc>
                </concept>
                <concept code="J06BB22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="obiltoxaximab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="obiltoxaximab" type="fsn">obiltoxaximab</designation>
                    <desc language="en-US">obiltoxaximab</desc>
                </concept>
                <concept code="J06BB30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="J06BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other immunoglobulins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other immunoglobulins" type="fsn">Other immunoglobulins</designation>
                    <desc language="en-US">Other immunoglobulins</desc>
                </concept>
                <concept code="J06BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nebacumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nebacumab" type="fsn">nebacumab</designation>
                    <desc language="en-US">nebacumab</desc>
                </concept>
                <concept code="J07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VACCINES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="VACCINES" type="fsn">VACCINES</designation>
                    <desc language="en-US">VACCINES</desc>
                </concept>
                <concept code="J07A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BACTERIAL VACCINES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="BACTERIAL VACCINES" type="fsn">BACTERIAL VACCINES</designation>
                    <desc language="en-US">BACTERIAL VACCINES</desc>
                </concept>
                <concept code="J07AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anthrax vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anthrax vaccines" type="fsn">Anthrax vaccines</designation>
                    <desc language="en-US">Anthrax vaccines</desc>
                </concept>
                <concept code="J07AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anthrax antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anthrax antigen" type="fsn">anthrax antigen</designation>
                    <desc language="en-US">anthrax antigen</desc>
                </concept>
                <concept code="J07AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Brucellosis vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Brucellosis vaccines" type="fsn">Brucellosis vaccines</designation>
                    <desc language="en-US">Brucellosis vaccines</desc>
                </concept>
                <concept code="J07AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brucella antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brucella antigen" type="fsn">brucella antigen</designation>
                    <desc language="en-US">brucella antigen</desc>
                </concept>
                <concept code="J07AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Cholera vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Cholera vaccines" type="fsn">Cholera vaccines</designation>
                    <desc language="en-US">Cholera vaccines</desc>
                </concept>
                <concept code="J07AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cholera, inactivated, whole cell"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cholera, inactivated, whole cell"
                         type="fsn">cholera, inactivated, whole cell</designation>
                    <desc language="en-US">cholera, inactivated, whole cell</desc>
                </concept>
                <concept code="J07AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cholera, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cholera, live attenuated" type="fsn">cholera, live attenuated</designation>
                    <desc language="en-US">cholera, live attenuated</desc>
                </concept>
                <concept code="J07AE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cholera, combinations with typhoid vaccine, inactivated, whole cell"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cholera, combinations with typhoid vaccine, inactivated, whole cell"
                         type="fsn">cholera, combinations with typhoid vaccine, inactivated, whole cell</designation>
                    <desc language="en-US">cholera, combinations with typhoid vaccine, inactivated, whole cell</desc>
                </concept>
                <concept code="J07AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Diphtheria vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Diphtheria vaccines" type="fsn">Diphtheria vaccines</designation>
                    <desc language="en-US">Diphtheria vaccines</desc>
                </concept>
                <concept code="J07AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria toxoid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphtheria toxoid" type="fsn">diphtheria toxoid</designation>
                    <desc language="en-US">diphtheria toxoid</desc>
                </concept>
                <concept code="J07AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hemophilus influenzae B vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Hemophilus influenzae B vaccines"
                         type="fsn">Hemophilus influenzae B vaccines</designation>
                    <desc language="en-US">Hemophilus influenzae B vaccines</desc>
                </concept>
                <concept code="J07AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemophilus influenzae B, purified antigen conjugated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hemophilus influenzae B, purified antigen conjugated"
                         type="fsn">hemophilus influenzae B, purified antigen conjugated</designation>
                    <desc language="en-US">hemophilus influenzae B, purified antigen conjugated</desc>
                </concept>
                <concept code="J07AG51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemophilus influenzae B, combinations with toxoids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hemophilus influenzae B, combinations with toxoids"
                         type="fsn">hemophilus influenzae B, combinations with toxoids</designation>
                    <desc language="en-US">hemophilus influenzae B, combinations with toxoids</desc>
                </concept>
                <concept code="J07AG52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemophilus influenzae B, combinations with pertussis and toxoids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hemophilus influenzae B, combinations with pertussis and toxoids"
                         type="fsn">hemophilus influenzae B, combinations with pertussis and toxoids</designation>
                    <desc language="en-US">hemophilus influenzae B, combinations with pertussis and toxoids</desc>
                </concept>
                <concept code="J07AG53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemophilus influenzae B, combinations with meningococcus C, conjugated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hemophilus influenzae B, combinations with meningococcus C, conjugated"
                         type="fsn">hemophilus influenzae B, combinations with meningococcus C, conjugated</designation>
                    <desc language="en-US">hemophilus influenzae B, combinations with meningococcus C, conjugated</desc>
                </concept>
                <concept code="J07AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Meningococcal vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Meningococcal vaccines" type="fsn">Meningococcal vaccines</designation>
                    <desc language="en-US">Meningococcal vaccines</desc>
                </concept>
                <concept code="J07AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meningococcus A, purified polysaccharides antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="meningococcus A, purified polysaccharides antigen"
                         type="fsn">meningococcus A, purified polysaccharides antigen</designation>
                    <desc language="en-US">meningococcus A, purified polysaccharides antigen</desc>
                </concept>
                <concept code="J07AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="other meningococcal monovalent purified polysaccharides antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="other meningococcal monovalent purified polysaccharides antigen"
                         type="fsn">other meningococcal monovalent purified polysaccharides antigen</designation>
                    <desc language="en-US">other meningococcal monovalent purified polysaccharides antigen</desc>
                </concept>
                <concept code="J07AH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meningococcus A,C, bivalent purified polysaccharides antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="meningococcus A,C, bivalent purified polysaccharides antigen"
                         type="fsn">meningococcus A,C, bivalent purified polysaccharides antigen</designation>
                    <desc language="en-US">meningococcus A,C, bivalent purified polysaccharides antigen</desc>
                </concept>
                <concept code="J07AH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen"
                         type="fsn">meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen</designation>
                    <desc language="en-US">meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen</desc>
                </concept>
                <concept code="J07AH05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="other meningococcal polyvalent purified polysaccharides antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="other meningococcal polyvalent purified polysaccharides antigen"
                         type="fsn">other meningococcal polyvalent purified polysaccharides antigen</designation>
                    <desc language="en-US">other meningococcal polyvalent purified polysaccharides antigen</desc>
                </concept>
                <concept code="J07AH06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meningococcus B, outer membrane vesicle vaccine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="meningococcus B, outer membrane vesicle vaccine"
                         type="fsn">meningococcus B, outer membrane vesicle vaccine</designation>
                    <desc language="en-US">meningococcus B, outer membrane vesicle vaccine</desc>
                </concept>
                <concept code="J07AH07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meningococcus C, purified polysaccharides antigen conjugated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="meningococcus C, purified polysaccharides antigen conjugated"
                         type="fsn">meningococcus C, purified polysaccharides antigen conjugated</designation>
                    <desc language="en-US">meningococcus C, purified polysaccharides antigen conjugated</desc>
                </concept>
                <concept code="J07AH08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated"
                         type="fsn">meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated</designation>
                    <desc language="en-US">meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated</desc>
                </concept>
                <concept code="J07AH09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meningococcus B, multicomponent vaccine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="meningococcus B, multicomponent vaccine"
                         type="fsn">meningococcus B, multicomponent vaccine</designation>
                    <desc language="en-US">meningococcus B, multicomponent vaccine</desc>
                </concept>
                <concept code="J07AH10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meningococcus A, purified polysaccharides antigen conjugated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="meningococcus A, purified polysaccharides antigen conjugated"
                         type="fsn">meningococcus A, purified polysaccharides antigen conjugated</designation>
                    <desc language="en-US">meningococcus A, purified polysaccharides antigen conjugated</desc>
                </concept>
                <concept code="J07AJ"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pertussis vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pertussis vaccines" type="fsn">Pertussis vaccines</designation>
                    <desc language="en-US">Pertussis vaccines</desc>
                </concept>
                <concept code="J07AJ01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pertussis, inactivated, whole cell"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pertussis, inactivated, whole cell"
                         type="fsn">pertussis, inactivated, whole cell</designation>
                    <desc language="en-US">pertussis, inactivated, whole cell</desc>
                </concept>
                <concept code="J07AJ02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pertussis, purified antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pertussis, purified antigen"
                         type="fsn">pertussis, purified antigen</designation>
                    <desc language="en-US">pertussis, purified antigen</desc>
                </concept>
                <concept code="J07AJ51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pertussis, inactivated, whole cell, combinations with toxoids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pertussis, inactivated, whole cell, combinations with toxoids"
                         type="fsn">pertussis, inactivated, whole cell, combinations with toxoids</designation>
                    <desc language="en-US">pertussis, inactivated, whole cell, combinations with toxoids</desc>
                </concept>
                <concept code="J07AJ52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pertussis, purified antigen, combinations with toxoids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pertussis, purified antigen, combinations with toxoids"
                         type="fsn">pertussis, purified antigen, combinations with toxoids</designation>
                    <desc language="en-US">pertussis, purified antigen, combinations with toxoids</desc>
                </concept>
                <concept code="J07AK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Plague vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Plague vaccines" type="fsn">Plague vaccines</designation>
                    <desc language="en-US">Plague vaccines</desc>
                </concept>
                <concept code="J07AK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="plague, inactivated, whole cell"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="plague, inactivated, whole cell"
                         type="fsn">plague, inactivated, whole cell</designation>
                    <desc language="en-US">plague, inactivated, whole cell</desc>
                </concept>
                <concept code="J07AL"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pneumococcal vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pneumococcal vaccines" type="fsn">Pneumococcal vaccines</designation>
                    <desc language="en-US">Pneumococcal vaccines</desc>
                </concept>
                <concept code="J07AL01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pneumococcus, purified polysaccharides antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pneumococcus, purified polysaccharides antigen"
                         type="fsn">pneumococcus, purified polysaccharides antigen</designation>
                    <desc language="en-US">pneumococcus, purified polysaccharides antigen</desc>
                </concept>
                <concept code="J07AL02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pneumococcus, purified polysaccharides antigen conjugated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pneumococcus, purified polysaccharides antigen conjugated"
                         type="fsn">pneumococcus, purified polysaccharides antigen conjugated</designation>
                    <desc language="en-US">pneumococcus, purified polysaccharides antigen conjugated</desc>
                </concept>
                <concept code="J07AL52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated"
                         type="fsn">pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated</designation>
                    <desc language="en-US">pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated</desc>
                </concept>
                <concept code="J07AM"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tetanus vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tetanus vaccines" type="fsn">Tetanus vaccines</designation>
                    <desc language="en-US">Tetanus vaccines</desc>
                </concept>
                <concept code="J07AM01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetanus toxoid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetanus toxoid" type="fsn">tetanus toxoid</designation>
                    <desc language="en-US">tetanus toxoid</desc>
                </concept>
                <concept code="J07AM51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetanus toxoid, combinations with diphtheria toxoid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tetanus toxoid, combinations with diphtheria toxoid"
                         type="fsn">tetanus toxoid, combinations with diphtheria toxoid</designation>
                    <desc language="en-US">tetanus toxoid, combinations with diphtheria toxoid</desc>
                </concept>
                <concept code="J07AM52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetanus toxoid, combinations with tetanus immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tetanus toxoid, combinations with tetanus immunoglobulin"
                         type="fsn">tetanus toxoid, combinations with tetanus immunoglobulin</designation>
                    <desc language="en-US">tetanus toxoid, combinations with tetanus immunoglobulin</desc>
                </concept>
                <concept code="J07AN"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tuberculosis vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tuberculosis vaccines" type="fsn">Tuberculosis vaccines</designation>
                    <desc language="en-US">Tuberculosis vaccines</desc>
                </concept>
                <concept code="J07AN01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tuberculosis, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tuberculosis, live attenuated"
                         type="fsn">tuberculosis, live attenuated</designation>
                    <desc language="en-US">tuberculosis, live attenuated</desc>
                </concept>
                <concept code="J07AP"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Typhoid vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Typhoid vaccines" type="fsn">Typhoid vaccines</designation>
                    <desc language="en-US">Typhoid vaccines</desc>
                </concept>
                <concept code="J07AP01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="typhoid, oral, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="typhoid, oral, live attenuated"
                         type="fsn">typhoid, oral, live attenuated</designation>
                    <desc language="en-US">typhoid, oral, live attenuated</desc>
                </concept>
                <concept code="J07AP02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="typhoid, inactivated, whole cell"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="typhoid, inactivated, whole cell"
                         type="fsn">typhoid, inactivated, whole cell</designation>
                    <desc language="en-US">typhoid, inactivated, whole cell</desc>
                </concept>
                <concept code="J07AP03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="typhoid, purified polysaccharide antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="typhoid, purified polysaccharide antigen"
                         type="fsn">typhoid, purified polysaccharide antigen</designation>
                    <desc language="en-US">typhoid, purified polysaccharide antigen</desc>
                </concept>
                <concept code="J07AP10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="typhoid, combinations with paratyphi types"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="typhoid, combinations with paratyphi types"
                         type="fsn">typhoid, combinations with paratyphi types</designation>
                    <desc language="en-US">typhoid, combinations with paratyphi types</desc>
                </concept>
                <concept code="J07AR"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Typhus (exanthematicus) vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Typhus (exanthematicus) vaccines"
                         type="fsn">Typhus (exanthematicus) vaccines</designation>
                    <desc language="en-US">Typhus (exanthematicus) vaccines</desc>
                </concept>
                <concept code="J07AR01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="typhus exanthematicus, inactivated, whole cell"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="typhus exanthematicus, inactivated, whole cell"
                         type="fsn">typhus exanthematicus, inactivated, whole cell</designation>
                    <desc language="en-US">typhus exanthematicus, inactivated, whole cell</desc>
                </concept>
                <concept code="J07AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other bacterial vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other bacterial vaccines" type="fsn">Other bacterial vaccines</designation>
                    <desc language="en-US">Other bacterial vaccines</desc>
                </concept>
                <concept code="J07B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VIRAL VACCINES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="VIRAL VACCINES" type="fsn">VIRAL VACCINES</designation>
                    <desc language="en-US">VIRAL VACCINES</desc>
                </concept>
                <concept code="J07BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Encephalitis vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Encephalitis vaccines" type="fsn">Encephalitis vaccines</designation>
                    <desc language="en-US">Encephalitis vaccines</desc>
                </concept>
                <concept code="J07BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="encephalitis, tick borne, inactivated, whole virus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="encephalitis, tick borne, inactivated, whole virus"
                         type="fsn">encephalitis, tick borne, inactivated, whole virus</designation>
                    <desc language="en-US">encephalitis, tick borne, inactivated, whole virus</desc>
                </concept>
                <concept code="J07BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="encephalitis, Japanese, inactivated, whole virus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="encephalitis, Japanese, inactivated, whole virus"
                         type="fsn">encephalitis, Japanese, inactivated, whole virus</designation>
                    <desc language="en-US">encephalitis, Japanese, inactivated, whole virus</desc>
                </concept>
                <concept code="J07BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="encephalitis, Japanese, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="encephalitis, Japanese, live attenuated"
                         type="fsn">encephalitis, Japanese, live attenuated</designation>
                    <desc language="en-US">encephalitis, Japanese, live attenuated</desc>
                </concept>
                <concept code="J07BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Influenza vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Influenza vaccines" type="fsn">Influenza vaccines</designation>
                    <desc language="en-US">Influenza vaccines</desc>
                </concept>
                <concept code="J07BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="influenza, inactivated, whole virus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="influenza, inactivated, whole virus"
                         type="fsn">influenza, inactivated, whole virus</designation>
                    <desc language="en-US">influenza, inactivated, whole virus</desc>
                </concept>
                <concept code="J07BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="influenza, inactivated, split virus or surface antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="influenza, inactivated, split virus or surface antigen"
                         type="fsn">influenza, inactivated, split virus or surface antigen</designation>
                    <desc language="en-US">influenza, inactivated, split virus or surface antigen</desc>
                </concept>
                <concept code="J07BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="influenza, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="influenza, live attenuated"
                         type="fsn">influenza, live attenuated</designation>
                    <desc language="en-US">influenza, live attenuated</desc>
                </concept>
                <concept code="J07BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hepatitis vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Hepatitis vaccines" type="fsn">Hepatitis vaccines</designation>
                    <desc language="en-US">Hepatitis vaccines</desc>
                </concept>
                <concept code="J07BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hepatitis B, purified antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hepatitis B, purified antigen"
                         type="fsn">hepatitis B, purified antigen</designation>
                    <desc language="en-US">hepatitis B, purified antigen</desc>
                </concept>
                <concept code="J07BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hepatitis A, inactivated, whole virus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hepatitis A, inactivated, whole virus"
                         type="fsn">hepatitis A, inactivated, whole virus</designation>
                    <desc language="en-US">hepatitis A, inactivated, whole virus</desc>
                </concept>
                <concept code="J07BC20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="J07BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Measles vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Measles vaccines" type="fsn">Measles vaccines</designation>
                    <desc language="en-US">Measles vaccines</desc>
                </concept>
                <concept code="J07BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="measles, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="measles, live attenuated" type="fsn">measles, live attenuated</designation>
                    <desc language="en-US">measles, live attenuated</desc>
                </concept>
                <concept code="J07BD51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="measles, combinations with mumps, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="measles, combinations with mumps, live attenuated"
                         type="fsn">measles, combinations with mumps, live attenuated</designation>
                    <desc language="en-US">measles, combinations with mumps, live attenuated</desc>
                </concept>
                <concept code="J07BD52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="measles, combinations with mumps and rubella, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="measles, combinations with mumps and rubella, live attenuated"
                         type="fsn">measles, combinations with mumps and rubella, live attenuated</designation>
                    <desc language="en-US">measles, combinations with mumps and rubella, live attenuated</desc>
                </concept>
                <concept code="J07BD53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="measles, combinations with rubella, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="measles, combinations with rubella, live attenuated"
                         type="fsn">measles, combinations with rubella, live attenuated</designation>
                    <desc language="en-US">measles, combinations with rubella, live attenuated</desc>
                </concept>
                <concept code="J07BD54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="measles, combinations with mumps, rubella and varicella, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="measles, combinations with mumps, rubella and varicella, live attenuated"
                         type="fsn">measles, combinations with mumps, rubella and varicella, live attenuated</designation>
                    <desc language="en-US">measles, combinations with mumps, rubella and varicella, live attenuated</desc>
                </concept>
                <concept code="J07BE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Mumps vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Mumps vaccines" type="fsn">Mumps vaccines</designation>
                    <desc language="en-US">Mumps vaccines</desc>
                </concept>
                <concept code="J07BE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mumps, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mumps, live attenuated" type="fsn">mumps, live attenuated</designation>
                    <desc language="en-US">mumps, live attenuated</desc>
                </concept>
                <concept code="J07BF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Poliomyelitis vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Poliomyelitis vaccines" type="fsn">Poliomyelitis vaccines</designation>
                    <desc language="en-US">Poliomyelitis vaccines</desc>
                </concept>
                <concept code="J07BF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="poliomyelitis oral, monovalent, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="poliomyelitis oral, monovalent, live attenuated"
                         type="fsn">poliomyelitis oral, monovalent, live attenuated</designation>
                    <desc language="en-US">poliomyelitis oral, monovalent, live attenuated</desc>
                </concept>
                <concept code="J07BF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="poliomyelitis oral, trivalent, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="poliomyelitis oral, trivalent, live attenuated"
                         type="fsn">poliomyelitis oral, trivalent, live attenuated</designation>
                    <desc language="en-US">poliomyelitis oral, trivalent, live attenuated</desc>
                </concept>
                <concept code="J07BF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="poliomyelitis, trivalent, inactivated, whole virus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="poliomyelitis, trivalent, inactivated, whole virus"
                         type="fsn">poliomyelitis, trivalent, inactivated, whole virus</designation>
                    <desc language="en-US">poliomyelitis, trivalent, inactivated, whole virus</desc>
                </concept>
                <concept code="J07BF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="poliomyelitis oral, bivalent, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="poliomyelitis oral, bivalent, live attenuated"
                         type="fsn">poliomyelitis oral, bivalent, live attenuated</designation>
                    <desc language="en-US">poliomyelitis oral, bivalent, live attenuated</desc>
                </concept>
                <concept code="J07BG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Rabies vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Rabies vaccines" type="fsn">Rabies vaccines</designation>
                    <desc language="en-US">Rabies vaccines</desc>
                </concept>
                <concept code="J07BG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rabies, inactivated, whole virus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rabies, inactivated, whole virus"
                         type="fsn">rabies, inactivated, whole virus</designation>
                    <desc language="en-US">rabies, inactivated, whole virus</desc>
                </concept>
                <concept code="J07BH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Rota virus diarrhea vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Rota virus diarrhea vaccines"
                         type="fsn">Rota virus diarrhea vaccines</designation>
                    <desc language="en-US">Rota virus diarrhea vaccines</desc>
                </concept>
                <concept code="J07BH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rota virus, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rota virus, live attenuated"
                         type="fsn">rota virus, live attenuated</designation>
                    <desc language="en-US">rota virus, live attenuated</desc>
                </concept>
                <concept code="J07BH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rota virus, pentavalent, live, reassorted"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rota virus, pentavalent, live, reassorted"
                         type="fsn">rota virus, pentavalent, live, reassorted</designation>
                    <desc language="en-US">rota virus, pentavalent, live, reassorted</desc>
                </concept>
                <concept code="J07BJ"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Rubella vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Rubella vaccines" type="fsn">Rubella vaccines</designation>
                    <desc language="en-US">Rubella vaccines</desc>
                </concept>
                <concept code="J07BJ01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rubella, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rubella, live attenuated" type="fsn">rubella, live attenuated</designation>
                    <desc language="en-US">rubella, live attenuated</desc>
                </concept>
                <concept code="J07BJ51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rubella, combinations with mumps, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rubella, combinations with mumps, live attenuated"
                         type="fsn">rubella, combinations with mumps, live attenuated</designation>
                    <desc language="en-US">rubella, combinations with mumps, live attenuated</desc>
                </concept>
                <concept code="J07BK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Varicella zoster vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Varicella zoster vaccines" type="fsn">Varicella zoster vaccines</designation>
                    <desc language="en-US">Varicella zoster vaccines</desc>
                </concept>
                <concept code="J07BK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="varicella, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="varicella, live attenuated"
                         type="fsn">varicella, live attenuated</designation>
                    <desc language="en-US">varicella, live attenuated</desc>
                </concept>
                <concept code="J07BK02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zoster, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zoster, live attenuated" type="fsn">zoster, live attenuated</designation>
                    <desc language="en-US">zoster, live attenuated</desc>
                </concept>
                <concept code="J07BK03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zoster, purified antigen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zoster, purified antigen" type="fsn">zoster, purified antigen</designation>
                    <desc language="en-US">zoster, purified antigen</desc>
                </concept>
                <concept code="J07BL"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Yellow fever vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Yellow fever vaccines" type="fsn">Yellow fever vaccines</designation>
                    <desc language="en-US">Yellow fever vaccines</desc>
                </concept>
                <concept code="J07BL01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="yellow fever, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="yellow fever, live attenuated"
                         type="fsn">yellow fever, live attenuated</designation>
                    <desc language="en-US">yellow fever, live attenuated</desc>
                </concept>
                <concept code="J07BM"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Papillomavirus vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Papillomavirus vaccines" type="fsn">Papillomavirus vaccines</designation>
                    <desc language="en-US">Papillomavirus vaccines</desc>
                </concept>
                <concept code="J07BM01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="papillomavirus (human types 6, 11, 16, 18)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="papillomavirus (human types 6, 11, 16, 18)"
                         type="fsn">papillomavirus (human types 6, 11, 16, 18)</designation>
                    <desc language="en-US">papillomavirus (human types 6, 11, 16, 18)</desc>
                </concept>
                <concept code="J07BM02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="papillomavirus (human types 16, 18)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="papillomavirus (human types 16, 18)"
                         type="fsn">papillomavirus (human types 16, 18)</designation>
                    <desc language="en-US">papillomavirus (human types 16, 18)</desc>
                </concept>
                <concept code="J07BM03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)"
                         type="fsn">papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)</designation>
                    <desc language="en-US">papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)</desc>
                </concept>
                <concept code="J07BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other viral vaccines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other viral vaccines" type="fsn">Other viral vaccines</designation>
                    <desc language="en-US">Other viral vaccines</desc>
                </concept>
                <concept code="J07BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="smallpox, live attenuated"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="smallpox, live attenuated" type="fsn">smallpox, live attenuated</designation>
                    <desc language="en-US">smallpox, live attenuated</desc>
                </concept>
                <concept code="J07C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BACTERIAL AND VIRAL VACCINES, COMBINED"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="BACTERIAL AND VIRAL VACCINES, COMBINED"
                         type="fsn">BACTERIAL AND VIRAL VACCINES, COMBINED</designation>
                    <desc language="en-US">BACTERIAL AND VIRAL VACCINES, COMBINED</desc>
                </concept>
                <concept code="J07CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bacterial and viral vaccines, combined"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Bacterial and viral vaccines, combined"
                         type="fsn">Bacterial and viral vaccines, combined</designation>
                    <desc language="en-US">Bacterial and viral vaccines, combined</desc>
                </concept>
                <concept code="J07CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-poliomyelitis-tetanus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-poliomyelitis-tetanus"
                         type="fsn">diphtheria-poliomyelitis-tetanus</designation>
                    <desc language="en-US">diphtheria-poliomyelitis-tetanus</desc>
                </concept>
                <concept code="J07CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-pertussis-poliomyelitis-tetanus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-pertussis-poliomyelitis-tetanus"
                         type="fsn">diphtheria-pertussis-poliomyelitis-tetanus</designation>
                    <desc language="en-US">diphtheria-pertussis-poliomyelitis-tetanus</desc>
                </concept>
                <concept code="J07CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-rubella-tetanus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-rubella-tetanus"
                         type="fsn">diphtheria-rubella-tetanus</designation>
                    <desc language="en-US">diphtheria-rubella-tetanus</desc>
                </concept>
                <concept code="J07CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemophilus influenzae B and poliomyelitis"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hemophilus influenzae B and poliomyelitis"
                         type="fsn">hemophilus influenzae B and poliomyelitis</designation>
                    <desc language="en-US">hemophilus influenzae B and poliomyelitis</desc>
                </concept>
                <concept code="J07CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-hepatitis B-pertussis-tetanus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-hepatitis B-pertussis-tetanus"
                         type="fsn">diphtheria-hepatitis B-pertussis-tetanus</designation>
                    <desc language="en-US">diphtheria-hepatitis B-pertussis-tetanus</desc>
                </concept>
                <concept code="J07CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus"
                         type="fsn">diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus</designation>
                    <desc language="en-US">diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus</desc>
                </concept>
                <concept code="J07CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-hepatitis B-tetanus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-hepatitis B-tetanus"
                         type="fsn">diphtheria-hepatitis B-tetanus</designation>
                    <desc language="en-US">diphtheria-hepatitis B-tetanus</desc>
                </concept>
                <concept code="J07CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hemophilus influenzae B and hepatitis B"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hemophilus influenzae B and hepatitis B"
                         type="fsn">hemophilus influenzae B and hepatitis B</designation>
                    <desc language="en-US">hemophilus influenzae B and hepatitis B</desc>
                </concept>
                <concept code="J07CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B"
                         type="fsn">diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B</designation>
                    <desc language="en-US">diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B</desc>
                </concept>
                <concept code="J07CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="typhoid-hepatitis A"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="typhoid-hepatitis A" type="fsn">typhoid-hepatitis A</designation>
                    <desc language="en-US">typhoid-hepatitis A</desc>
                </concept>
                <concept code="J07CA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B"
                         type="fsn">diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B</designation>
                    <desc language="en-US">diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B</desc>
                </concept>
                <concept code="J07CA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B"
                         type="fsn">diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B</designation>
                    <desc language="en-US">diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B</desc>
                </concept>
                <concept code="J07CA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C"
                         type="fsn">diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C</designation>
                    <desc language="en-US">diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C</desc>
                </concept>
                <concept code="J07X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER VACCINES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER VACCINES" type="fsn">OTHER VACCINES</designation>
                    <desc language="en-US">OTHER VACCINES</desc>
                </concept>
                <concept code="L"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS"
                         type="fsn">ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS</designation>
                    <desc language="en-US">ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS</desc>
                </concept>
                <concept code="L01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTINEOPLASTIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTINEOPLASTIC AGENTS" type="fsn">ANTINEOPLASTIC AGENTS</designation>
                    <desc language="en-US">ANTINEOPLASTIC AGENTS</desc>
                </concept>
                <concept code="L01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ALKYLATING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ALKYLATING AGENTS" type="fsn">ALKYLATING AGENTS</designation>
                    <desc language="en-US">ALKYLATING AGENTS</desc>
                </concept>
                <concept code="L01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nitrogen mustard analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nitrogen mustard analogues"
                         type="fsn">Nitrogen mustard analogues</designation>
                    <desc language="en-US">Nitrogen mustard analogues</desc>
                </concept>
                <concept code="L01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclophosphamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclophosphamide" type="fsn">cyclophosphamide</designation>
                    <desc language="en-US">cyclophosphamide</desc>
                </concept>
                <concept code="L01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorambucil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorambucil" type="fsn">chlorambucil</designation>
                    <desc language="en-US">chlorambucil</desc>
                </concept>
                <concept code="L01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melphalan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="melphalan" type="fsn">melphalan</designation>
                    <desc language="en-US">melphalan</desc>
                </concept>
                <concept code="L01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormethine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlormethine" type="fsn">chlormethine</designation>
                    <desc language="en-US">chlormethine</desc>
                </concept>
                <concept code="L01AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ifosfamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ifosfamide" type="fsn">ifosfamide</designation>
                    <desc language="en-US">ifosfamide</desc>
                </concept>
                <concept code="L01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trofosfamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trofosfamide" type="fsn">trofosfamide</designation>
                    <desc language="en-US">trofosfamide</desc>
                </concept>
                <concept code="L01AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednimustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednimustine" type="fsn">prednimustine</designation>
                    <desc language="en-US">prednimustine</desc>
                </concept>
                <concept code="L01AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bendamustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bendamustine" type="fsn">bendamustine</designation>
                    <desc language="en-US">bendamustine</desc>
                </concept>
                <concept code="L01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alkyl sulfonates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Alkyl sulfonates" type="fsn">Alkyl sulfonates</designation>
                    <desc language="en-US">Alkyl sulfonates</desc>
                </concept>
                <concept code="L01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="busulfan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="busulfan" type="fsn">busulfan</designation>
                    <desc language="en-US">busulfan</desc>
                </concept>
                <concept code="L01AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="treosulfan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="treosulfan" type="fsn">treosulfan</designation>
                    <desc language="en-US">treosulfan</desc>
                </concept>
                <concept code="L01AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mannosulfan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mannosulfan" type="fsn">mannosulfan</designation>
                    <desc language="en-US">mannosulfan</desc>
                </concept>
                <concept code="L01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ethylene imines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Ethylene imines" type="fsn">Ethylene imines</designation>
                    <desc language="en-US">Ethylene imines</desc>
                </concept>
                <concept code="L01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiotepa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiotepa" type="fsn">thiotepa</designation>
                    <desc language="en-US">thiotepa</desc>
                </concept>
                <concept code="L01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triaziquone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triaziquone" type="fsn">triaziquone</designation>
                    <desc language="en-US">triaziquone</desc>
                </concept>
                <concept code="L01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carboquone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carboquone" type="fsn">carboquone</designation>
                    <desc language="en-US">carboquone</desc>
                </concept>
                <concept code="L01AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nitrosoureas"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Nitrosoureas" type="fsn">Nitrosoureas</designation>
                    <desc language="en-US">Nitrosoureas</desc>
                </concept>
                <concept code="L01AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carmustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carmustine" type="fsn">carmustine</designation>
                    <desc language="en-US">carmustine</desc>
                </concept>
                <concept code="L01AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lomustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lomustine" type="fsn">lomustine</designation>
                    <desc language="en-US">lomustine</desc>
                </concept>
                <concept code="L01AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="semustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="semustine" type="fsn">semustine</designation>
                    <desc language="en-US">semustine</desc>
                </concept>
                <concept code="L01AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="streptozocin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="streptozocin" type="fsn">streptozocin</designation>
                    <desc language="en-US">streptozocin</desc>
                </concept>
                <concept code="L01AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fotemustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fotemustine" type="fsn">fotemustine</designation>
                    <desc language="en-US">fotemustine</desc>
                </concept>
                <concept code="L01AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nimustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nimustine" type="fsn">nimustine</designation>
                    <desc language="en-US">nimustine</desc>
                </concept>
                <concept code="L01AD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ranimustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ranimustine" type="fsn">ranimustine</designation>
                    <desc language="en-US">ranimustine</desc>
                </concept>
                <concept code="L01AD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="uramustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="uramustine" type="fsn">uramustine</designation>
                    <desc language="en-US">uramustine</desc>
                </concept>
                <concept code="L01AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Epoxides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Epoxides" type="fsn">Epoxides</designation>
                    <desc language="en-US">Epoxides</desc>
                </concept>
                <concept code="L01AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etoglucid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etoglucid" type="fsn">etoglucid</designation>
                    <desc language="en-US">etoglucid</desc>
                </concept>
                <concept code="L01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other alkylating agents"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other alkylating agents" type="fsn">Other alkylating agents</designation>
                    <desc language="en-US">Other alkylating agents</desc>
                </concept>
                <concept code="L01AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mitobronitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mitobronitol" type="fsn">mitobronitol</designation>
                    <desc language="en-US">mitobronitol</desc>
                </concept>
                <concept code="L01AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipobroman"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pipobroman" type="fsn">pipobroman</designation>
                    <desc language="en-US">pipobroman</desc>
                </concept>
                <concept code="L01AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="temozolomide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="temozolomide" type="fsn">temozolomide</designation>
                    <desc language="en-US">temozolomide</desc>
                </concept>
                <concept code="L01AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dacarbazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dacarbazine" type="fsn">dacarbazine</designation>
                    <desc language="en-US">dacarbazine</desc>
                </concept>
                <concept code="L01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIMETABOLITES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIMETABOLITES" type="fsn">ANTIMETABOLITES</designation>
                    <desc language="en-US">ANTIMETABOLITES</desc>
                </concept>
                <concept code="L01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Folic acid analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Folic acid analogues" type="fsn">Folic acid analogues</designation>
                    <desc language="en-US">Folic acid analogues</desc>
                </concept>
                <concept code="L01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methotrexate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methotrexate" type="fsn">methotrexate</designation>
                    <desc language="en-US">methotrexate</desc>
                </concept>
                <concept code="L01BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="raltitrexed"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="raltitrexed" type="fsn">raltitrexed</designation>
                    <desc language="en-US">raltitrexed</desc>
                </concept>
                <concept code="L01BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pemetrexed"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pemetrexed" type="fsn">pemetrexed</designation>
                    <desc language="en-US">pemetrexed</desc>
                </concept>
                <concept code="L01BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pralatrexate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pralatrexate" type="fsn">pralatrexate</designation>
                    <desc language="en-US">pralatrexate</desc>
                </concept>
                <concept code="L01BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Purine analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Purine analogues" type="fsn">Purine analogues</designation>
                    <desc language="en-US">Purine analogues</desc>
                </concept>
                <concept code="L01BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mercaptopurine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mercaptopurine" type="fsn">mercaptopurine</designation>
                    <desc language="en-US">mercaptopurine</desc>
                </concept>
                <concept code="L01BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tioguanine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tioguanine" type="fsn">tioguanine</designation>
                    <desc language="en-US">tioguanine</desc>
                </concept>
                <concept code="L01BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cladribine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cladribine" type="fsn">cladribine</designation>
                    <desc language="en-US">cladribine</desc>
                </concept>
                <concept code="L01BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludarabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fludarabine" type="fsn">fludarabine</designation>
                    <desc language="en-US">fludarabine</desc>
                </concept>
                <concept code="L01BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofarabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofarabine" type="fsn">clofarabine</designation>
                    <desc language="en-US">clofarabine</desc>
                </concept>
                <concept code="L01BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nelarabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nelarabine" type="fsn">nelarabine</designation>
                    <desc language="en-US">nelarabine</desc>
                </concept>
                <concept code="L01BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pyrimidine analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pyrimidine analogues" type="fsn">Pyrimidine analogues</designation>
                    <desc language="en-US">Pyrimidine analogues</desc>
                </concept>
                <concept code="L01BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cytarabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cytarabine" type="fsn">cytarabine</designation>
                    <desc language="en-US">cytarabine</desc>
                </concept>
                <concept code="L01BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorouracil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorouracil" type="fsn">fluorouracil</designation>
                    <desc language="en-US">fluorouracil</desc>
                </concept>
                <concept code="L01BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tegafur"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tegafur" type="fsn">tegafur</designation>
                    <desc language="en-US">tegafur</desc>
                </concept>
                <concept code="L01BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carmofur"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carmofur" type="fsn">carmofur</designation>
                    <desc language="en-US">carmofur</desc>
                </concept>
                <concept code="L01BC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gemcitabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gemcitabine" type="fsn">gemcitabine</designation>
                    <desc language="en-US">gemcitabine</desc>
                </concept>
                <concept code="L01BC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="capecitabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="capecitabine" type="fsn">capecitabine</designation>
                    <desc language="en-US">capecitabine</desc>
                </concept>
                <concept code="L01BC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azacitidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azacitidine" type="fsn">azacitidine</designation>
                    <desc language="en-US">azacitidine</desc>
                </concept>
                <concept code="L01BC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="decitabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="decitabine" type="fsn">decitabine</designation>
                    <desc language="en-US">decitabine</desc>
                </concept>
                <concept code="L01BC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="floxuridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="floxuridine" type="fsn">floxuridine</designation>
                    <desc language="en-US">floxuridine</desc>
                </concept>
                <concept code="L01BC52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorouracil, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluorouracil, combinations"
                         type="fsn">fluorouracil, combinations</designation>
                    <desc language="en-US">fluorouracil, combinations</desc>
                </concept>
                <concept code="L01BC53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tegafur, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tegafur, combinations" type="fsn">tegafur, combinations</designation>
                    <desc language="en-US">tegafur, combinations</desc>
                </concept>
                <concept code="L01BC59"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trifluridine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="trifluridine, combinations"
                         type="fsn">trifluridine, combinations</designation>
                    <desc language="en-US">trifluridine, combinations</desc>
                </concept>
                <concept code="L01C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS"
                         type="fsn">PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS</designation>
                    <desc language="en-US">PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS</desc>
                </concept>
                <concept code="L01CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Vinca alkaloids and analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Vinca alkaloids and analogues"
                         type="fsn">Vinca alkaloids and analogues</designation>
                    <desc language="en-US">Vinca alkaloids and analogues</desc>
                </concept>
                <concept code="L01CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vinblastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vinblastine" type="fsn">vinblastine</designation>
                    <desc language="en-US">vinblastine</desc>
                </concept>
                <concept code="L01CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vincristine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vincristine" type="fsn">vincristine</designation>
                    <desc language="en-US">vincristine</desc>
                </concept>
                <concept code="L01CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vindesine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vindesine" type="fsn">vindesine</designation>
                    <desc language="en-US">vindesine</desc>
                </concept>
                <concept code="L01CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vinorelbine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vinorelbine" type="fsn">vinorelbine</designation>
                    <desc language="en-US">vinorelbine</desc>
                </concept>
                <concept code="L01CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vinflunine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vinflunine" type="fsn">vinflunine</designation>
                    <desc language="en-US">vinflunine</desc>
                </concept>
                <concept code="L01CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vintafolide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vintafolide" type="fsn">vintafolide</designation>
                    <desc language="en-US">vintafolide</desc>
                </concept>
                <concept code="L01CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Podophyllotoxin derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Podophyllotoxin derivatives"
                         type="fsn">Podophyllotoxin derivatives</designation>
                    <desc language="en-US">Podophyllotoxin derivatives</desc>
                </concept>
                <concept code="L01CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etoposide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etoposide" type="fsn">etoposide</designation>
                    <desc language="en-US">etoposide</desc>
                </concept>
                <concept code="L01CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="teniposide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="teniposide" type="fsn">teniposide</designation>
                    <desc language="en-US">teniposide</desc>
                </concept>
                <concept code="L01CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Colchicine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Colchicine derivatives" type="fsn">Colchicine derivatives</designation>
                    <desc language="en-US">Colchicine derivatives</desc>
                </concept>
                <concept code="L01CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="demecolcine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="demecolcine" type="fsn">demecolcine</designation>
                    <desc language="en-US">demecolcine</desc>
                </concept>
                <concept code="L01CD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Taxanes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Taxanes" type="fsn">Taxanes</designation>
                    <desc language="en-US">Taxanes</desc>
                </concept>
                <concept code="L01CD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paclitaxel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paclitaxel" type="fsn">paclitaxel</designation>
                    <desc language="en-US">paclitaxel</desc>
                </concept>
                <concept code="L01CD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="docetaxel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="docetaxel" type="fsn">docetaxel</designation>
                    <desc language="en-US">docetaxel</desc>
                </concept>
                <concept code="L01CD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paclitaxel poliglumex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paclitaxel poliglumex" type="fsn">paclitaxel poliglumex</designation>
                    <desc language="en-US">paclitaxel poliglumex</desc>
                </concept>
                <concept code="L01CD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cabazitaxel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cabazitaxel" type="fsn">cabazitaxel</designation>
                    <desc language="en-US">cabazitaxel</desc>
                </concept>
                <concept code="L01CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other plant alkaloids and natural products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other plant alkaloids and natural products"
                         type="fsn">Other plant alkaloids and natural products</designation>
                    <desc language="en-US">Other plant alkaloids and natural products</desc>
                </concept>
                <concept code="L01CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trabectedin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trabectedin" type="fsn">trabectedin</designation>
                    <desc language="en-US">trabectedin</desc>
                </concept>
                <concept code="L01D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES"
                         type="fsn">CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES</designation>
                    <desc language="en-US">CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES</desc>
                </concept>
                <concept code="L01DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Actinomycines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Actinomycines" type="fsn">Actinomycines</designation>
                    <desc language="en-US">Actinomycines</desc>
                </concept>
                <concept code="L01DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dactinomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dactinomycin" type="fsn">dactinomycin</designation>
                    <desc language="en-US">dactinomycin</desc>
                </concept>
                <concept code="L01DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anthracyclines and related substances"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Anthracyclines and related substances"
                         type="fsn">Anthracyclines and related substances</designation>
                    <desc language="en-US">Anthracyclines and related substances</desc>
                </concept>
                <concept code="L01DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxorubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxorubicin" type="fsn">doxorubicin</designation>
                    <desc language="en-US">doxorubicin</desc>
                </concept>
                <concept code="L01DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="daunorubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="daunorubicin" type="fsn">daunorubicin</designation>
                    <desc language="en-US">daunorubicin</desc>
                </concept>
                <concept code="L01DB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epirubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epirubicin" type="fsn">epirubicin</designation>
                    <desc language="en-US">epirubicin</desc>
                </concept>
                <concept code="L01DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aclarubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aclarubicin" type="fsn">aclarubicin</designation>
                    <desc language="en-US">aclarubicin</desc>
                </concept>
                <concept code="L01DB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zorubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zorubicin" type="fsn">zorubicin</designation>
                    <desc language="en-US">zorubicin</desc>
                </concept>
                <concept code="L01DB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idarubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idarubicin" type="fsn">idarubicin</designation>
                    <desc language="en-US">idarubicin</desc>
                </concept>
                <concept code="L01DB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mitoxantrone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mitoxantrone" type="fsn">mitoxantrone</designation>
                    <desc language="en-US">mitoxantrone</desc>
                </concept>
                <concept code="L01DB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pirarubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pirarubicin" type="fsn">pirarubicin</designation>
                    <desc language="en-US">pirarubicin</desc>
                </concept>
                <concept code="L01DB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valrubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valrubicin" type="fsn">valrubicin</designation>
                    <desc language="en-US">valrubicin</desc>
                </concept>
                <concept code="L01DB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amrubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amrubicin" type="fsn">amrubicin</designation>
                    <desc language="en-US">amrubicin</desc>
                </concept>
                <concept code="L01DB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pixantrone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pixantrone" type="fsn">pixantrone</designation>
                    <desc language="en-US">pixantrone</desc>
                </concept>
                <concept code="L01DC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cytotoxic antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other cytotoxic antibiotics"
                         type="fsn">Other cytotoxic antibiotics</designation>
                    <desc language="en-US">Other cytotoxic antibiotics</desc>
                </concept>
                <concept code="L01DC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bleomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bleomycin" type="fsn">bleomycin</designation>
                    <desc language="en-US">bleomycin</desc>
                </concept>
                <concept code="L01DC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="plicamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="plicamycin" type="fsn">plicamycin</designation>
                    <desc language="en-US">plicamycin</desc>
                </concept>
                <concept code="L01DC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mitomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mitomycin" type="fsn">mitomycin</designation>
                    <desc language="en-US">mitomycin</desc>
                </concept>
                <concept code="L01DC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ixabepilone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ixabepilone" type="fsn">ixabepilone</designation>
                    <desc language="en-US">ixabepilone</desc>
                </concept>
                <concept code="L01X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ANTINEOPLASTIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER ANTINEOPLASTIC AGENTS"
                         type="fsn">OTHER ANTINEOPLASTIC AGENTS</designation>
                    <desc language="en-US">OTHER ANTINEOPLASTIC AGENTS</desc>
                </concept>
                <concept code="L01XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Platinum compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Platinum compounds" type="fsn">Platinum compounds</designation>
                    <desc language="en-US">Platinum compounds</desc>
                </concept>
                <concept code="L01XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cisplatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cisplatin" type="fsn">cisplatin</designation>
                    <desc language="en-US">cisplatin</desc>
                </concept>
                <concept code="L01XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carboplatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carboplatin" type="fsn">carboplatin</designation>
                    <desc language="en-US">carboplatin</desc>
                </concept>
                <concept code="L01XA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxaliplatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxaliplatin" type="fsn">oxaliplatin</designation>
                    <desc language="en-US">oxaliplatin</desc>
                </concept>
                <concept code="L01XA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="satraplatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="satraplatin" type="fsn">satraplatin</designation>
                    <desc language="en-US">satraplatin</desc>
                </concept>
                <concept code="L01XA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polyplatillen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polyplatillen" type="fsn">polyplatillen</designation>
                    <desc language="en-US">polyplatillen</desc>
                </concept>
                <concept code="L01XB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Methylhydrazines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Methylhydrazines" type="fsn">Methylhydrazines</designation>
                    <desc language="en-US">Methylhydrazines</desc>
                </concept>
                <concept code="L01XB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procarbazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procarbazine" type="fsn">procarbazine</designation>
                    <desc language="en-US">procarbazine</desc>
                </concept>
                <concept code="L01XC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Monoclonal antibodies"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Monoclonal antibodies" type="fsn">Monoclonal antibodies</designation>
                    <desc language="en-US">Monoclonal antibodies</desc>
                </concept>
                <concept code="L01XC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="edrecolomab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="edrecolomab" type="fsn">edrecolomab</designation>
                    <desc language="en-US">edrecolomab</desc>
                </concept>
                <concept code="L01XC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rituximab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rituximab" type="fsn">rituximab</designation>
                    <desc language="en-US">rituximab</desc>
                </concept>
                <concept code="L01XC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trastuzumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trastuzumab" type="fsn">trastuzumab</designation>
                    <desc language="en-US">trastuzumab</desc>
                </concept>
                <concept code="L01XC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gemtuzumab ozogamicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gemtuzumab ozogamicin" type="fsn">gemtuzumab ozogamicin</designation>
                    <desc language="en-US">gemtuzumab ozogamicin</desc>
                </concept>
                <concept code="L01XC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetuximab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetuximab" type="fsn">cetuximab</designation>
                    <desc language="en-US">cetuximab</desc>
                </concept>
                <concept code="L01XC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bevacizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bevacizumab" type="fsn">bevacizumab</designation>
                    <desc language="en-US">bevacizumab</desc>
                </concept>
                <concept code="L01XC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="panitumumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="panitumumab" type="fsn">panitumumab</designation>
                    <desc language="en-US">panitumumab</desc>
                </concept>
                <concept code="L01XC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="catumaxomab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="catumaxomab" type="fsn">catumaxomab</designation>
                    <desc language="en-US">catumaxomab</desc>
                </concept>
                <concept code="L01XC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ofatumumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ofatumumab" type="fsn">ofatumumab</designation>
                    <desc language="en-US">ofatumumab</desc>
                </concept>
                <concept code="L01XC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ipilimumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ipilimumab" type="fsn">ipilimumab</designation>
                    <desc language="en-US">ipilimumab</desc>
                </concept>
                <concept code="L01XC12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brentuximab vedotin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brentuximab vedotin" type="fsn">brentuximab vedotin</designation>
                    <desc language="en-US">brentuximab vedotin</desc>
                </concept>
                <concept code="L01XC13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pertuzumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pertuzumab" type="fsn">pertuzumab</designation>
                    <desc language="en-US">pertuzumab</desc>
                </concept>
                <concept code="L01XC14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trastuzumab emtansine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trastuzumab emtansine" type="fsn">trastuzumab emtansine</designation>
                    <desc language="en-US">trastuzumab emtansine</desc>
                </concept>
                <concept code="L01XC15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="obinutuzumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="obinu             tuzumab" type="fsn">obinutuzumab</designation>
                    <desc language="en-US">obinutuzumab</desc>
                </concept>
                <concept code="L01XC16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dinutuximab beta"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dinutuximab beta" type="fsn">dinutuximab beta</designation>
                    <desc language="en-US">dinutuximab beta</desc>
                </concept>
                <concept code="L01XC17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nivolumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nivolumab" type="fsn">nivolumab</designation>
                    <desc language="en-US">nivolumab</desc>
                </concept>
                <concept code="L01XC18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pembrolizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pembrolizumab" type="fsn">pembrolizumab</designation>
                    <desc language="en-US">pembrolizumab</desc>
                </concept>
                <concept code="L01XC19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="blinatumomab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="blinatumomab" type="fsn">blinatumomab</designation>
                    <desc language="en-US">blinatumomab</desc>
                </concept>
                <concept code="L01XC21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ramucirumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ramucirumab" type="fsn">ramucirumab</designation>
                    <desc language="en-US">ramucirumab</desc>
                </concept>
                <concept code="L01XC22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="necitumumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="necitumumab" type="fsn">necitumumab</designation>
                    <desc language="en-US">necitumumab</desc>
                </concept>
                <concept code="L01XC23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="elotuzumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="elotuzumab" type="fsn">elotuzumab</designation>
                    <desc language="en-US">elotuzumab</desc>
                </concept>
                <concept code="L01XC24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="daratumumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="daratumumab" type="fsn">daratumumab</designation>
                    <desc language="en-US">daratumumab</desc>
                </concept>
                <concept code="L01XC25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mogamulizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mogamulizumab" type="fsn">mogamulizumab</designation>
                    <desc language="en-US">mogamulizumab</desc>
                </concept>
                <concept code="L01XC26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="inotuzumab ozogamicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="inotuzumab ozogamicin" type="fsn">inotuzumab ozogamicin</designation>
                    <desc language="en-US">inotuzumab ozogamicin</desc>
                </concept>
                <concept code="L01XC27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olaratumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olaratumab" type="fsn">olaratumab</designation>
                    <desc language="en-US">olaratumab</desc>
                </concept>
                <concept code="L01XC28"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="durvalumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="durvalumab" type="fsn">durvalumab</designation>
                    <desc language="en-US">durvalumab</desc>
                </concept>
                <concept code="L01XC29"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bermekimab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bermekimab" type="fsn">bermekimab</designation>
                    <desc language="en-US">bermekimab</desc>
                </concept>
                <concept code="L01XC31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="avelumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="avelumab" type="fsn">avelumab</designation>
                    <desc language="en-US">avelumab</desc>
                </concept>
                <concept code="L01XC32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atezolizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atezolizumab" type="fsn">atezolizumab</designation>
                    <desc language="en-US">atezolizumab</desc>
                </concept>
                <concept code="L01XD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sensitizers used in photodynamic/radiation therapy"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sensitizers used in photodynamic/radiation therapy"
                         type="fsn">Sensitizers used in photodynamic/radiation therapy</designation>
                    <desc language="en-US">Sensitizers used in photodynamic/radiation therapy</desc>
                </concept>
                <concept code="L01XD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="porfimer sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="porfimer sodium" type="fsn">porfimer sodium</designation>
                    <desc language="en-US">porfimer sodium</desc>
                </concept>
                <concept code="L01XD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyl aminolevulinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methyl aminolevulinate" type="fsn">methyl aminolevulinate</designation>
                    <desc language="en-US">methyl aminolevulinate</desc>
                </concept>
                <concept code="L01XD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminolevulinic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminolevulinic acid" type="fsn">aminolevulinic acid</designation>
                    <desc language="en-US">aminolevulinic acid</desc>
                </concept>
                <concept code="L01XD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="temoporfin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="temoporfin" type="fsn">temoporfin</designation>
                    <desc language="en-US">temoporfin</desc>
                </concept>
                <concept code="L01XD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="efaproxiral"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="efaproxiral" type="fsn">efaproxiral</designation>
                    <desc language="en-US">efaproxiral</desc>
                </concept>
                <concept code="L01XD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="padeliporfin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="padeliporfin" type="fsn">padeliporfin</designation>
                    <desc language="en-US">padeliporfin</desc>
                </concept>
                <concept code="L01XE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Protein kinase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Protein kinase inhibitors" type="fsn">Protein kinase inhibitors</designation>
                    <desc language="en-US">Protein kinase inhibitors</desc>
                </concept>
                <concept code="L01XE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imatinib" type="fsn">imatinib</designation>
                    <desc language="en-US">imatinib</desc>
                </concept>
                <concept code="L01XE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gefitinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gefitinib" type="fsn">gefitinib</designation>
                    <desc language="en-US">gefitinib</desc>
                </concept>
                <concept code="L01XE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erlotinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="erlotinib" type="fsn">erlotinib</designation>
                    <desc language="en-US">erlotinib</desc>
                </concept>
                <concept code="L01XE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sunitinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sunitinib" type="fsn">sunitinib</designation>
                    <desc language="en-US">sunitinib</desc>
                </concept>
                <concept code="L01XE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sorafenib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sorafenib" type="fsn">sorafenib</designation>
                    <desc language="en-US">sorafenib</desc>
                </concept>
                <concept code="L01XE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dasatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dasatinib" type="fsn">dasatinib</designation>
                    <desc language="en-US">dasatinib</desc>
                </concept>
                <concept code="L01XE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lapatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lapatinib" type="fsn">lapatinib</designation>
                    <desc language="en-US">lapatinib</desc>
                </concept>
                <concept code="L01XE08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nilotinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nilotinib" type="fsn">nilotinib</designation>
                    <desc language="en-US">nilotinib</desc>
                </concept>
                <concept code="L01XE09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="temsirolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="temsirolimus" type="fsn">temsirolimus</designation>
                    <desc language="en-US">temsirolimus</desc>
                </concept>
                <concept code="L01XE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="everolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="everolimus" type="fsn">everolimus</designation>
                    <desc language="en-US">everolimus</desc>
                </concept>
                <concept code="L01XE11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pazopanib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pazopanib" type="fsn">pazopanib</designation>
                    <desc language="en-US">pazopanib</desc>
                </concept>
                <concept code="L01XE12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vandetanib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vandetanib" type="fsn">vandetanib</designation>
                    <desc language="en-US">vandetanib</desc>
                </concept>
                <concept code="L01XE13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="afatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="afatinib" type="fsn">afatinib</designation>
                    <desc language="en-US">afatinib</desc>
                </concept>
                <concept code="L01XE14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bosutinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bosutinib" type="fsn">bosutinib</designation>
                    <desc language="en-US">bosutinib</desc>
                </concept>
                <concept code="L01XE15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vemurafenib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vemurafenib" type="fsn">vemurafenib</designation>
                    <desc language="en-US">vemurafenib</desc>
                </concept>
                <concept code="L01XE16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="crizotinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="crizotinib" type="fsn">crizotinib</designation>
                    <desc language="en-US">crizotinib</desc>
                </concept>
                <concept code="L01XE17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="axitinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="axitinib" type="fsn">axitinib</designation>
                    <desc language="en-US">axitinib</desc>
                </concept>
                <concept code="L01XE18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ruxolitinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ruxolitinib" type="fsn">ruxolitinib</designation>
                    <desc language="en-US">ruxolitinib</desc>
                </concept>
                <concept code="L01XE19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ridaforolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ridaforolimus" type="fsn">ridaforolimus</designation>
                    <desc language="en-US">ridaforolimus</desc>
                </concept>
                <concept code="L01XE21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="regorafenib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="regorafenib" type="fsn">regorafenib</designation>
                    <desc language="en-US">regorafenib</desc>
                </concept>
                <concept code="L01XE22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="masitinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="masitinib" type="fsn">masitinib</designation>
                    <desc language="en-US">masitinib</desc>
                </concept>
                <concept code="L01XE23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dabrafenib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dabrafenib" type="fsn">dabrafenib</designation>
                    <desc language="en-US">dabrafenib</desc>
                </concept>
                <concept code="L01XE24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ponatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ponatinib" type="fsn">ponatinib</designation>
                    <desc language="en-US">ponatinib</desc>
                </concept>
                <concept code="L01XE25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trametinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trametinib" type="fsn">trametinib</designation>
                    <desc language="en-US">trametinib</desc>
                </concept>
                <concept code="L01XE26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cabozantinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cabozantinib" type="fsn">cabozantinib</designation>
                    <desc language="en-US">cabozantinib</desc>
                </concept>
                <concept code="L01XE27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibrutinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibrutinib" type="fsn">ibrutinib</designation>
                    <desc language="en-US">ibrutinib</desc>
                </concept>
                <concept code="L01XE28"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceritinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceritinib" type="fsn">ceritinib</designation>
                    <desc language="en-US">ceritinib</desc>
                </concept>
                <concept code="L01XE29"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lenvatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lenvatinib" type="fsn">lenvatinib</designation>
                    <desc language="en-US">lenvatinib</desc>
                </concept>
                <concept code="L01XE31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nintedanib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nintedanib" type="fsn">nintedanib</designation>
                    <desc language="en-US">nintedanib</desc>
                </concept>
                <concept code="L01XE32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cediranib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cediranib" type="fsn">cediranib</designation>
                    <desc language="en-US">cediranib</desc>
                </concept>
                <concept code="L01XE33"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="palbociclib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="palbociclib" type="fsn">palbociclib</designation>
                    <desc language="en-US">palbociclib</desc>
                </concept>
                <concept code="L01XE34"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tivozanib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tivozanib" type="fsn">tivozanib</designation>
                    <desc language="en-US">tivozanib</desc>
                </concept>
                <concept code="L01XE35"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="osimertinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="osimertinib" type="fsn">osimertinib</designation>
                    <desc language="en-US">osimertinib</desc>
                </concept>
                <concept code="L01XE36"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alectinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alectinib" type="fsn">alectinib</designation>
                    <desc language="en-US">alectinib</desc>
                </concept>
                <concept code="L01XE37"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rociletinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rociletinib" type="fsn">rociletinib</designation>
                    <desc language="en-US">rociletinib</desc>
                </concept>
                <concept code="L01XE38"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cobimetinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cobimetinib" type="fsn">cobimetinib</designation>
                    <desc language="en-US">cobimetinib</desc>
                </concept>
                <concept code="L01XE39"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="midostaurin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="midostaurin" type="fsn">midostaurin</designation>
                    <desc language="en-US">midostaurin</desc>
                </concept>
                <concept code="L01XE40"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olmutinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olmutinib" type="fsn">olmutinib</designation>
                    <desc language="en-US">olmutinib</desc>
                </concept>
                <concept code="L01XE41"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="binimetinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="binimetinib" type="fsn">binimetinib</designation>
                    <desc language="en-US">binimetinib</desc>
                </concept>
                <concept code="L01XE42"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ribociclib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ribociclib" type="fsn">ribociclib</designation>
                    <desc language="en-US">ribociclib</desc>
                </concept>
                <concept code="L01XE43"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brigatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brigatinib" type="fsn">brigatinib</designation>
                    <desc language="en-US">brigatinib</desc>
                </concept>
                <concept code="L01XE44"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lorlatinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lorlatinib" type="fsn">lorlatinib</designation>
                    <desc language="en-US">lorlatinib</desc>
                </concept>
                <concept code="L01XE45"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neratinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neratinib" type="fsn">neratinib</designation>
                    <desc language="en-US">neratinib</desc>
                </concept>
                <concept code="L01XE46"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="encorafenib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="encorafenib" type="fsn">encorafenib</designation>
                    <desc language="en-US">encorafenib</desc>
                </concept>
                <concept code="L01XE47"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dacomitinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dacomitinib" type="fsn">dacomitinib</designation>
                    <desc language="en-US">dacomitinib</desc>
                </concept>
                <concept code="L01XE48"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="icotinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="icotinib" type="fsn">icotinib</designation>
                    <desc language="en-US">icotinib</desc>
                </concept>
                <concept code="L01XE50"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="abemaciclib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="abemaciclib" type="fsn">abemaciclib</designation>
                    <desc language="en-US">abemaciclib</desc>
                </concept>
                <concept code="L01XX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antineoplastic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antineoplastic agents"
                         type="fsn">Other antineoplastic agents</designation>
                    <desc language="en-US">Other antineoplastic agents</desc>
                </concept>
                <concept code="L01XX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amsacrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amsacrine" type="fsn">amsacrine</designation>
                    <desc language="en-US">amsacrine</desc>
                </concept>
                <concept code="L01XX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="asparaginase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="asparaginase" type="fsn">asparaginase</designation>
                    <desc language="en-US">asparaginase</desc>
                </concept>
                <concept code="L01XX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="altretamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="altretamine" type="fsn">altretamine</designation>
                    <desc language="en-US">altretamine</desc>
                </concept>
                <concept code="L01XX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxycarbamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxycarbamide" type="fsn">hydroxycarbamide</designation>
                    <desc language="en-US">hydroxycarbamide</desc>
                </concept>
                <concept code="L01XX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lonidamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lonidamine" type="fsn">lonidamine</designation>
                    <desc language="en-US">lonidamine</desc>
                </concept>
                <concept code="L01XX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentostatin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentostatin" type="fsn">pentostatin</designation>
                    <desc language="en-US">pentostatin</desc>
                </concept>
                <concept code="L01XX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miltefosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miltefosine" type="fsn">miltefosine</designation>
                    <desc language="en-US">miltefosine</desc>
                </concept>
                <concept code="L01XX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="masoprocol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="masoprocol" type="fsn">masoprocol</designation>
                    <desc language="en-US">masoprocol</desc>
                </concept>
                <concept code="L01XX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="estramustine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="estramustine" type="fsn">estramustine</designation>
                    <desc language="en-US">estramustine</desc>
                </concept>
                <concept code="L01XX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tretinoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tretinoin" type="fsn">tretinoin</designation>
                    <desc language="en-US">tretinoin</desc>
                </concept>
                <concept code="L01XX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mitoguazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mitoguazone" type="fsn">mitoguazone</designation>
                    <desc language="en-US">mitoguazone</desc>
                </concept>
                <concept code="L01XX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="topotecan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="topotecan" type="fsn">topotecan</designation>
                    <desc language="en-US">topotecan</desc>
                </concept>
                <concept code="L01XX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiazofurine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiazofurine" type="fsn">tiazofurine</designation>
                    <desc language="en-US">tiazofurine</desc>
                </concept>
                <concept code="L01XX19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="irinotecan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="irinotecan" type="fsn">irinotecan</designation>
                    <desc language="en-US">irinotecan</desc>
                </concept>
                <concept code="L01XX22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alitretinoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alitretinoin" type="fsn">alitretinoin</designation>
                    <desc language="en-US">alitretinoin</desc>
                </concept>
                <concept code="L01XX23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mitotane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mitotane" type="fsn">mitotane</designation>
                    <desc language="en-US">mitotane</desc>
                </concept>
                <concept code="L01XX24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pegaspargase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pegaspargase" type="fsn">pegaspargase</designation>
                    <desc language="en-US">pegaspargase</desc>
                </concept>
                <concept code="L01XX25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bexarotene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bexarotene" type="fsn">bexarotene</designation>
                    <desc language="en-US">bexarotene</desc>
                </concept>
                <concept code="L01XX27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="arsenic trioxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="arsenic trioxide" type="fsn">arsenic trioxide</designation>
                    <desc language="en-US">arsenic trioxide</desc>
                </concept>
                <concept code="L01XX29"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="denileukin diftitox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="denileukin diftitox" type="fsn">denileukin diftitox</designation>
                    <desc language="en-US">denileukin diftitox</desc>
                </concept>
                <concept code="L01XX32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bortezomib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bortezomib" type="fsn">bortezomib</designation>
                    <desc language="en-US">bortezomib</desc>
                </concept>
                <concept code="L01XX33"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="celecoxib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="celecoxib" type="fsn">celecoxib</designation>
                    <desc language="en-US">celecoxib</desc>
                </concept>
                <concept code="L01XX35"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anagrelide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anagrelide" type="fsn">anagrelide</designation>
                    <desc language="en-US">anagrelide</desc>
                </concept>
                <concept code="L01XX36"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oblimersen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oblimersen" type="fsn">oblimersen</designation>
                    <desc language="en-US">oblimersen</desc>
                </concept>
                <concept code="L01XX37"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sitimagene ceradenovec"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sitimagene ceradenovec" type="fsn">sitimagene ceradenovec</designation>
                    <desc language="en-US">sitimagene ceradenovec</desc>
                </concept>
                <concept code="L01XX38"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vorinostat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vorinostat" type="fsn">vorinostat</designation>
                    <desc language="en-US">vorinostat</desc>
                </concept>
                <concept code="L01XX39"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="romidepsin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="romidepsin" type="fsn">romidepsin</designation>
                    <desc language="en-US">romidepsin</desc>
                </concept>
                <concept code="L01XX40"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omacetaxine mepesuccinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="omacetaxine mepesuccinate" type="fsn">omacetaxine mepesuccinate</designation>
                    <desc language="en-US">omacetaxine mepesuccinate</desc>
                </concept>
                <concept code="L01XX41"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eribulin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eribulin" type="fsn">eribulin</designation>
                    <desc language="en-US">eribulin</desc>
                </concept>
                <concept code="L01XX42"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="panobinostat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="panobinostat" type="fsn">panobinostat</designation>
                    <desc language="en-US">panobinostat</desc>
                </concept>
                <concept code="L01XX43"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vismodegib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vismodegib" type="fsn">vismodegib</designation>
                    <desc language="en-US">vismodegib</desc>
                </concept>
                <concept code="L01XX44"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aflibercept"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aflibercept" type="fsn">aflibercept</designation>
                    <desc language="en-US">aflibercept</desc>
                </concept>
                <concept code="L01XX45"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carfilzomib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carfilzomib" type="fsn">carfilzomib</designation>
                    <desc language="en-US">carfilzomib</desc>
                </concept>
                <concept code="L01XX46"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olaparib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olaparib" type="fsn">olaparib</designation>
                    <desc language="en-US">olaparib</desc>
                </concept>
                <concept code="L01XX47"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idelalisib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idelalisib" type="fsn">idelalisib</designation>
                    <desc language="en-US">idelalisib</desc>
                </concept>
                <concept code="L01XX48"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sonidegib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sonidegib" type="fsn">sonidegib</designation>
                    <desc language="en-US">sonidegib</desc>
                </concept>
                <concept code="L01XX49"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="belinostat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="belinostat" type="fsn">belinostat</designation>
                    <desc language="en-US">belinostat</desc>
                </concept>
                <concept code="L01XX50"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ixazomib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ixazomib" type="fsn">ixazomib</designation>
                    <desc language="en-US">ixazomib</desc>
                </concept>
                <concept code="L01XX51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="talimogene laherparepvec"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="talimogene laherparepvec" type="fsn">talimogene laherparepvec</designation>
                    <desc language="en-US">talimogene laherparepvec</desc>
                </concept>
                <concept code="L01XX52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="venetoclax"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="venetoclax" type="fsn">venetoclax</designation>
                    <desc language="en-US">venetoclax</desc>
                </concept>
                <concept code="L01XX53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vosaroxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vosaroxin" type="fsn">vosaroxin</designation>
                    <desc language="en-US">vosaroxin</desc>
                </concept>
                <concept code="L01XX54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="niraparib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="niraparib" type="fsn">niraparib</designation>
                    <desc language="en-US">niraparib</desc>
                </concept>
                <concept code="L01XX55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rucaparib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rucaparib" type="fsn">rucaparib</designation>
                    <desc language="en-US">rucaparib</desc>
                </concept>
                <concept code="L01XX56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etirinotecan pegol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etirinotecan pegol" type="fsn">etirinotecan pegol</designation>
                    <desc language="en-US">etirinotecan pegol</desc>
                </concept>
                <concept code="L01XX57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="plitidepsin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="plitidepsin" type="fsn">plitidepsin</designation>
                    <desc language="en-US">plitidepsin</desc>
                </concept>
                <concept code="L01XX58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epacadostat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epacadostat" type="fsn">epacadostat</designation>
                    <desc language="en-US">epacadostat</desc>
                </concept>
                <concept code="L01XX59"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enasidenib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enasidenib" type="fsn">enasidenib</designation>
                    <desc language="en-US">enasidenib</desc>
                </concept>
                <concept code="L01XX60"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="talazoparib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="talazoparib" type="fsn">talazoparib</designation>
                    <desc language="en-US">talazoparib</desc>
                </concept>
                <concept code="L01XX61"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="copanlisib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="copanlisib" type="fsn">copanlisib</designation>
                    <desc language="en-US">copanlisib</desc>
                </concept>
                <concept code="L01XY"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of antineoplastic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations of antineoplastic agents"
                         type="fsn">Combinations of antineoplastic agents</designation>
                    <desc language="en-US">Combinations of antineoplastic agents</desc>
                </concept>
                <concept code="L01XY01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cytarabine and daunorubicin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cytarabine and daunorubicin"
                         type="fsn">cytarabine and daunorubicin</designation>
                    <desc language="en-US">cytarabine and daunorubicin</desc>
                </concept>
                <concept code="L02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ENDOCRINE THERAPY"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ENDOCRINE THERAPY" type="fsn">ENDOCRINE THERAPY</designation>
                    <desc language="en-US">ENDOCRINE THERAPY</desc>
                </concept>
                <concept code="L02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HORMONES AND RELATED AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="HORMONES AND RELATED AGENTS"
                         type="fsn">HORMONES AND RELATED AGENTS</designation>
                    <desc language="en-US">HORMONES AND RELATED AGENTS</desc>
                </concept>
                <concept code="L02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Estrogens"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Estrogens" type="fsn">Estrogens</designation>
                    <desc language="en-US">Estrogens</desc>
                </concept>
                <concept code="L02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diethylstilbestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diethylstilbestrol" type="fsn">diethylstilbestrol</designation>
                    <desc language="en-US">diethylstilbestrol</desc>
                </concept>
                <concept code="L02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polyestradiol phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polyestradiol phosphate" type="fsn">polyestradiol phosphate</designation>
                    <desc language="en-US">polyestradiol phosphate</desc>
                </concept>
                <concept code="L02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethinylestradiol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethinylestradiol" type="fsn">ethinylestradiol</designation>
                    <desc language="en-US">ethinylestradiol</desc>
                </concept>
                <concept code="L02AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fosfestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fosfestrol" type="fsn">fosfestrol</designation>
                    <desc language="en-US">fosfestrol</desc>
                </concept>
                <concept code="L02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Progestogens"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Progestogens" type="fsn">Progestogens</designation>
                    <desc language="en-US">Progestogens</desc>
                </concept>
                <concept code="L02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="megestrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="megestrol" type="fsn">megestrol</designation>
                    <desc language="en-US">megestrol</desc>
                </concept>
                <concept code="L02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medroxyprogesterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medroxyprogesterone" type="fsn">medroxyprogesterone</designation>
                    <desc language="en-US">medroxyprogesterone</desc>
                </concept>
                <concept code="L02AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gestonorone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gestonorone" type="fsn">gestonorone</designation>
                    <desc language="en-US">gestonorone</desc>
                </concept>
                <concept code="L02AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Gonadotropin releasing hormone analogues"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Gonadotropin releasing hormone analogues"
                         type="fsn">Gonadotropin releasing hormone analogues</designation>
                    <desc language="en-US">Gonadotropin releasing hormone analogues</desc>
                </concept>
                <concept code="L02AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buserelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buserelin" type="fsn">buserelin</designation>
                    <desc language="en-US">buserelin</desc>
                </concept>
                <concept code="L02AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="leuprorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="leuprorelin" type="fsn">leuprorelin</designation>
                    <desc language="en-US">leuprorelin</desc>
                </concept>
                <concept code="L02AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="goserelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="goserelin" type="fsn">goserelin</designation>
                    <desc language="en-US">goserelin</desc>
                </concept>
                <concept code="L02AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triptorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triptorelin" type="fsn">triptorelin</designation>
                    <desc language="en-US">triptorelin</desc>
                </concept>
                <concept code="L02AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="histrelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="histrelin" type="fsn">histrelin</designation>
                    <desc language="en-US">histrelin</desc>
                </concept>
                <concept code="L02AE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="leuprorelin and bicalutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="leuprorelin and bicalutamide"
                         type="fsn">leuprorelin and bicalutamide</designation>
                    <desc language="en-US">leuprorelin and bicalutamide</desc>
                </concept>
                <concept code="L02AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other hormones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other hormones" type="fsn">Other hormones</designation>
                    <desc language="en-US">Other hormones</desc>
                </concept>
                <concept code="L02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HORMONE ANTAGONISTS AND RELATED AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="HORMONE ANTAGONISTS AND RELATED AGENTS"
                         type="fsn">HORMONE ANTAGONISTS AND RELATED AGENTS</designation>
                    <desc language="en-US">HORMONE ANTAGONISTS AND RELATED AGENTS</desc>
                </concept>
                <concept code="L02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anti-estrogens"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anti-estrogens" type="fsn">Anti-estrogens</designation>
                    <desc language="en-US">Anti-estrogens</desc>
                </concept>
                <concept code="L02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tamoxifen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tamoxifen" type="fsn">tamoxifen</designation>
                    <desc language="en-US">tamoxifen</desc>
                </concept>
                <concept code="L02BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="toremifene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="toremifene" type="fsn">toremifene</designation>
                    <desc language="en-US">toremifene</desc>
                </concept>
                <concept code="L02BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fulvestrant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fulvestrant" type="fsn">fulvestrant</designation>
                    <desc language="en-US">fulvestrant</desc>
                </concept>
                <concept code="L02BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anti-androgens"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anti-androgens" type="fsn">Anti-androgens</designation>
                    <desc language="en-US">Anti-androgens</desc>
                </concept>
                <concept code="L02BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flutamide" type="fsn">flutamide</designation>
                    <desc language="en-US">flutamide</desc>
                </concept>
                <concept code="L02BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nilutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nilutamide" type="fsn">nilutamide</designation>
                    <desc language="en-US">nilutamide</desc>
                </concept>
                <concept code="L02BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bicalutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bicalutamide" type="fsn">bicalutamide</designation>
                    <desc language="en-US">bicalutamide</desc>
                </concept>
                <concept code="L02BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enzalutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enzalutamide" type="fsn">enzalutamide</designation>
                    <desc language="en-US">enzalutamide</desc>
                </concept>
                <concept code="L02BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="apalutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="apalutamide" type="fsn">apalutamide</designation>
                    <desc language="en-US">apalutamide</desc>
                </concept>
                <concept code="L02BG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aromatase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Aromatase inhibitors" type="fsn">Aromatase inhibitors</designation>
                    <desc language="en-US">Aromatase inhibitors</desc>
                </concept>
                <concept code="L02BG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminoglutethimide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminoglutethimide" type="fsn">aminoglutethimide</designation>
                    <desc language="en-US">aminoglutethimide</desc>
                </concept>
                <concept code="L02BG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formestane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="formestane" type="fsn">formestane</designation>
                    <desc language="en-US">formestane</desc>
                </concept>
                <concept code="L02BG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anastrozole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anastrozole" type="fsn">anastrozole</designation>
                    <desc language="en-US">anastrozole</desc>
                </concept>
                <concept code="L02BG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="letrozole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="letrozole" type="fsn">letrozole</designation>
                    <desc language="en-US">letrozole</desc>
                </concept>
                <concept code="L02BG05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vorozole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vorozole" type="fsn">vorozole</designation>
                    <desc language="en-US">vorozole</desc>
                </concept>
                <concept code="L02BG06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="exemestane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="exemestane" type="fsn">exemestane</designation>
                    <desc language="en-US">exemestane</desc>
                </concept>
                <concept code="L02BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other hormone antagonists and related agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other hormone antagonists and related agents"
                         type="fsn">Other hormone antagonists and related agents</designation>
                    <desc language="en-US">Other hormone antagonists and related agents</desc>
                </concept>
                <concept code="L02BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="abarelix"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="abarelix" type="fsn">abarelix</designation>
                    <desc language="en-US">abarelix</desc>
                </concept>
                <concept code="L02BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="degarelix"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="degarelix" type="fsn">degarelix</designation>
                    <desc language="en-US">degarelix</desc>
                </concept>
                <concept code="L02BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="abiraterone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="abiraterone" type="fsn">abiraterone</designation>
                    <desc language="en-US">abiraterone</desc>
                </concept>
                <concept code="L03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IMMUNOSTIMULANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IMMUNOSTIMULANTS" type="fsn">IMMUNOSTIMULANTS</designation>
                    <desc language="en-US">IMMUNOSTIMULANTS</desc>
                </concept>
                <concept code="L03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IMMUNOSTIMULANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IMMUNOSTIMULANTS" type="fsn">IMMUNOSTIMULANTS</designation>
                    <desc language="en-US">IMMUNOSTIMULANTS</desc>
                </concept>
                <concept code="L03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Colony stimulating factors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Colony stimulating factors"
                         type="fsn">Colony stimulating factors</designation>
                    <desc language="en-US">Colony stimulating factors</desc>
                </concept>
                <concept code="L03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="filgrastim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="filgrastim" type="fsn">filgrastim</designation>
                    <desc language="en-US">filgrastim</desc>
                </concept>
                <concept code="L03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="molgramostim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="molgramostim" type="fsn">molgramostim</designation>
                    <desc language="en-US">molgramostim</desc>
                </concept>
                <concept code="L03AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sargramostim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sargramostim" type="fsn">sargramostim</designation>
                    <desc language="en-US">sargramostim</desc>
                </concept>
                <concept code="L03AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lenograstim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lenograstim" type="fsn">lenograstim</designation>
                    <desc language="en-US">lenograstim</desc>
                </concept>
                <concept code="L03AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ancestim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ancestim" type="fsn">ancestim</designation>
                    <desc language="en-US">ancestim</desc>
                </concept>
                <concept code="L03AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pegfilgrastim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pegfilgrastim" type="fsn">pegfilgrastim</designation>
                    <desc language="en-US">pegfilgrastim</desc>
                </concept>
                <concept code="L03AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lipegfilgrastim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lipegfilgrastim" type="fsn">lipegfilgrastim</designation>
                    <desc language="en-US">lipegfilgrastim</desc>
                </concept>
                <concept code="L03AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="balugrastim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="balugrastim" type="fsn">balugrastim</designation>
                    <desc language="en-US">balugrastim</desc>
                </concept>
                <concept code="L03AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="empegfilgrastim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="empegfilgrastim" type="fsn">empegfilgrastim</designation>
                    <desc language="en-US">empegfilgrastim</desc>
                </concept>
                <concept code="L03AA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pegteograstim"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pegteograstim" type="fsn">pegteograstim</designation>
                    <desc language="en-US">pegteograstim</desc>
                </concept>
                <concept code="L03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Interferons"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Interferons" type="fsn">Interferons</designation>
                    <desc language="en-US">Interferons</desc>
                </concept>
                <concept code="L03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon alfa natural"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon alfa natural" type="fsn">interferon alfa natural</designation>
                    <desc language="en-US">interferon alfa natural</desc>
                </concept>
                <concept code="L03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon beta natural"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon beta natural" type="fsn">interferon beta natural</designation>
                    <desc language="en-US">interferon beta natural</desc>
                </concept>
                <concept code="L03AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon gamma"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon gamma" type="fsn">interferon gamma</designation>
                    <desc language="en-US">interferon gamma</desc>
                </concept>
                <concept code="L03AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon alfa-2a"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon alfa-2a" type="fsn">interferon alfa-2a</designation>
                    <desc language="en-US">interferon alfa-2a</desc>
                </concept>
                <concept code="L03AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon alfa-2b"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon alfa-2b" type="fsn">interferon alfa-2b</designation>
                    <desc language="en-US">interferon alfa-2b</desc>
                </concept>
                <concept code="L03AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon alfa-n1"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon alfa-n1" type="fsn">interferon alfa-n1</designation>
                    <desc language="en-US">interferon alfa-n1</desc>
                </concept>
                <concept code="L03AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon beta-1a"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon beta-1a" type="fsn">interferon beta-1a</designation>
                    <desc language="en-US">interferon beta-1a</desc>
                </concept>
                <concept code="L03AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon beta-1b"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon beta-1b" type="fsn">interferon beta-1b</designation>
                    <desc language="en-US">interferon beta-1b</desc>
                </concept>
                <concept code="L03AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon alfacon-1"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon alfacon-1" type="fsn">interferon alfacon-1</designation>
                    <desc language="en-US">interferon alfacon-1</desc>
                </concept>
                <concept code="L03AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="peginterferon alfa-2b"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="peginterferon alfa-2b" type="fsn">peginterferon alfa-2b</designation>
                    <desc language="en-US">peginterferon alfa-2b</desc>
                </concept>
                <concept code="L03AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="peginterferon alfa-2a"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="peginterferon alfa-2a" type="fsn">peginterferon alfa-2a</designation>
                    <desc language="en-US">peginterferon alfa-2a</desc>
                </concept>
                <concept code="L03AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="albinterferon alfa-2b"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="albinterferon alfa-2b" type="fsn">albinterferon alfa-2b</designation>
                    <desc language="en-US">albinterferon alfa-2b</desc>
                </concept>
                <concept code="L03AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="peginterferon beta-1a"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="peginterferon beta-1a" type="fsn">peginterferon beta-1a</designation>
                    <desc language="en-US">peginterferon beta-1a</desc>
                </concept>
                <concept code="L03AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cepeginterferon alfa-2b"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cepeginterferon alfa-2b" type="fsn">cepeginterferon alfa-2b</designation>
                    <desc language="en-US">cepeginterferon alfa-2b</desc>
                </concept>
                <concept code="L03AB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ropeginterferon alfa-2b"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ropeginterferon alfa-2b" type="fsn">ropeginterferon alfa-2b</designation>
                    <desc language="en-US">ropeginterferon alfa-2b</desc>
                </concept>
                <concept code="L03AB60"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="peginterferon alfa-2b, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="peginterferon alfa-2b, combinations"
                         type="fsn">peginterferon alfa-2b, combinations</designation>
                    <desc language="en-US">peginterferon alfa-2b, combinations</desc>
                </concept>
                <concept code="L03AB61"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="peginterferon alfa-2a, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="peginterferon alfa-2a, combinations"
                         type="fsn">peginterferon alfa-2a, combinations</designation>
                    <desc language="en-US">peginterferon alfa-2a, combinations</desc>
                </concept>
                <concept code="L03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Interleukins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Interleukins" type="fsn">Interleukins</designation>
                    <desc language="en-US">Interleukins</desc>
                </concept>
                <concept code="L03AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aldesleukin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aldesleukin" type="fsn">aldesleukin</designation>
                    <desc language="en-US">aldesleukin</desc>
                </concept>
                <concept code="L03AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oprelvekin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oprelvekin" type="fsn">oprelvekin</designation>
                    <desc language="en-US">oprelvekin</desc>
                </concept>
                <concept code="L03AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other immunostimulants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other immunostimulants" type="fsn">Other immunostimulants</designation>
                    <desc language="en-US">Other immunostimulants</desc>
                </concept>
                <concept code="L03AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lentinan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lentinan" type="fsn">lentinan</designation>
                    <desc language="en-US">lentinan</desc>
                </concept>
                <concept code="L03AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="roquinimex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="roquinimex" type="fsn">roquinimex</designation>
                    <desc language="en-US">roquinimex</desc>
                </concept>
                <concept code="L03AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="BCG vaccine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="BCG vaccine" type="fsn">BCG vaccine</designation>
                    <desc language="en-US">BCG vaccine</desc>
                </concept>
                <concept code="L03AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pegademase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pegademase" type="fsn">pegademase</designation>
                    <desc language="en-US">pegademase</desc>
                </concept>
                <concept code="L03AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pidotimod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pidotimod" type="fsn">pidotimod</designation>
                    <desc language="en-US">pidotimod</desc>
                </concept>
                <concept code="L03AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="poly I:C"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="poly I:C" type="fsn">poly I:C</designation>
                    <desc language="en-US">poly I:C</desc>
                </concept>
                <concept code="L03AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="poly ICLC"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="poly ICLC" type="fsn">poly ICLC</designation>
                    <desc language="en-US">poly ICLC</desc>
                </concept>
                <concept code="L03AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thymopentin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thymopentin" type="fsn">thymopentin</designation>
                    <desc language="en-US">thymopentin</desc>
                </concept>
                <concept code="L03AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="immunocyanin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="immunocyanin" type="fsn">immunocyanin</designation>
                    <desc language="en-US">immunocyanin</desc>
                </concept>
                <concept code="L03AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tasonermin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tasonermin" type="fsn">tasonermin</designation>
                    <desc language="en-US">tasonermin</desc>
                </concept>
                <concept code="L03AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melanoma vaccine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="melanoma vaccine" type="fsn">melanoma vaccine</designation>
                    <desc language="en-US">melanoma vaccine</desc>
                </concept>
                <concept code="L03AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glatiramer acetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glatiramer acetate" type="fsn">glatiramer acetate</designation>
                    <desc language="en-US">glatiramer acetate</desc>
                </concept>
                <concept code="L03AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="histamine dihydrochloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="histamine dihydrochloride" type="fsn">histamine dihydrochloride</designation>
                    <desc language="en-US">histamine dihydrochloride</desc>
                </concept>
                <concept code="L03AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mifamurtide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mifamurtide" type="fsn">mifamurtide</designation>
                    <desc language="en-US">mifamurtide</desc>
                </concept>
                <concept code="L03AX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="plerixafor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="plerixafor" type="fsn">plerixafor</designation>
                    <desc language="en-US">plerixafor</desc>
                </concept>
                <concept code="L03AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sipuleucel-T"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sipuleucel-T" type="fsn">sipuleucel-T</designation>
                    <desc language="en-US">sipuleucel-T</desc>
                </concept>
                <concept code="L03AX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cridanimod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cridanimod" type="fsn">cridanimod</designation>
                    <desc language="en-US">cridanimod</desc>
                </concept>
                <concept code="L03AX19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dasiprotimut-T"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dasiprotimut-T" type="fsn">dasiprotimut-T</designation>
                    <desc language="en-US">dasiprotimut-T</desc>
                </concept>
                <concept code="L04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IMMUNOSUPPRESSANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IMMUNOSUPPRESSANTS" type="fsn">IMMUNOSUPPRESSANTS</designation>
                    <desc language="en-US">IMMUNOSUPPRESSANTS</desc>
                </concept>
                <concept code="L04A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="IMMUNOSUPPRESSANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="IMMUNOSUPPRESSANTS" type="fsn">IMMUNOSUPPRESSANTS</designation>
                    <desc language="en-US">IMMUNOSUPPRESSANTS</desc>
                </concept>
                <concept code="L04AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Selective immunosuppressants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Selective immunosuppressants"
                         type="fsn">Selective immunosuppressants</designation>
                    <desc language="en-US">Selective immunosuppressants</desc>
                </concept>
                <concept code="L04AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="muromonab-CD3"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="muromonab-CD3" type="fsn">muromonab-CD3</designation>
                    <desc language="en-US">muromonab-CD3</desc>
                </concept>
                <concept code="L04AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antilymphocyte immunoglobulin (horse)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="antilymphocyte immunoglobulin (horse)"
                         type="fsn">antilymphocyte immunoglobulin (horse)</designation>
                    <desc language="en-US">antilymphocyte immunoglobulin (horse)</desc>
                </concept>
                <concept code="L04AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antithymocyte immunoglobulin (rabbit)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="antithymocyte immunoglobulin (rabbit)"
                         type="fsn">antithymocyte immunoglobulin (rabbit)</designation>
                    <desc language="en-US">antithymocyte immunoglobulin (rabbit)</desc>
                </concept>
                <concept code="L04AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mycophenolic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mycophenolic acid" type="fsn">mycophenolic acid</designation>
                    <desc language="en-US">mycophenolic acid</desc>
                </concept>
                <concept code="L04AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sirolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sirolimus" type="fsn">sirolimus</designation>
                    <desc language="en-US">sirolimus</desc>
                </concept>
                <concept code="L04AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="leflunomide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="leflunomide" type="fsn">leflunomide</designation>
                    <desc language="en-US">leflunomide</desc>
                </concept>
                <concept code="L04AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alefacept"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alefacept" type="fsn">alefacept</designation>
                    <desc language="en-US">alefacept</desc>
                </concept>
                <concept code="L04AA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="everolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="everolimus" type="fsn">everolimus</designation>
                    <desc language="en-US">everolimus</desc>
                </concept>
                <concept code="L04AA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gusperimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gusperimus" type="fsn">gusperimus</designation>
                    <desc language="en-US">gusperimus</desc>
                </concept>
                <concept code="L04AA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="efalizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="efalizumab" type="fsn">efalizumab</designation>
                    <desc language="en-US">efalizumab</desc>
                </concept>
                <concept code="L04AA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="abetimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="abetimus" type="fsn">abetimus</designation>
                    <desc language="en-US">abetimus</desc>
                </concept>
                <concept code="L04AA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="natalizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="natalizumab" type="fsn">natalizumab</designation>
                    <desc language="en-US">natalizumab</desc>
                </concept>
                <concept code="L04AA24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="abatacept"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="abatacept" type="fsn">abatacept</designation>
                    <desc language="en-US">abatacept</desc>
                </concept>
                <concept code="L04AA25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eculizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eculizumab" type="fsn">eculizumab</designation>
                    <desc language="en-US">eculizumab</desc>
                </concept>
                <concept code="L04AA26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="belimumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="belimumab" type="fsn">belimumab</designation>
                    <desc language="en-US">belimumab</desc>
                </concept>
                <concept code="L04AA27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fingolimod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fingolimod" type="fsn">fingolimod</designation>
                    <desc language="en-US">fingolimod</desc>
                </concept>
                <concept code="L04AA28"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="belatacept"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="belatacept" type="fsn">belatacept</designation>
                    <desc language="en-US">belatacept</desc>
                </concept>
                <concept code="L04AA29"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tofacitinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tofacitinib" type="fsn">tofacitinib</designation>
                    <desc language="en-US">tofacitinib</desc>
                </concept>
                <concept code="L04AA31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="teriflunomide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="teriflunomide" type="fsn">teriflunomide</designation>
                    <desc language="en-US">teriflunomide</desc>
                </concept>
                <concept code="L04AA32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="apremilast"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="apremilast" type="fsn">apremilast</designation>
                    <desc language="en-US">apremilast</desc>
                </concept>
                <concept code="L04AA33"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vedolizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vedolizumab" type="fsn">vedolizumab</designation>
                    <desc language="en-US">vedolizumab</desc>
                </concept>
                <concept code="L04AA34"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alemtuzumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alemtuzumab" type="fsn">alemtuzumab</designation>
                    <desc language="en-US">alemtuzumab</desc>
                </concept>
                <concept code="L04AA35"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="begelomab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="begelomab" type="fsn">begelomab</designation>
                    <desc language="en-US">begelomab</desc>
                </concept>
                <concept code="L04AA36"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ocrelizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ocrelizumab" type="fsn">ocrelizumab</designation>
                    <desc language="en-US">ocrelizumab</desc>
                </concept>
                <concept code="L04AA37"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="baricitinib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="baricitinib" type="fsn">baricitinib</designation>
                    <desc language="en-US">baricitinib</desc>
                </concept>
                <concept code="L04AA38"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ozanimod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ozanimod" type="fsn">ozanimod</designation>
                    <desc language="en-US">ozanimod</desc>
                </concept>
                <concept code="L04AA39"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emapalumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emapalumab" type="fsn">emapalumab</designation>
                    <desc language="en-US">emapalumab</desc>
                </concept>
                <concept code="L04AA40"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cladribine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cladribine" type="fsn">cladribine</designation>
                    <desc language="en-US">cladribine</desc>
                </concept>
                <concept code="L04AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tumor necrosis factor alpha (TNF-) inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tumor necrosis factor alpha (TNF-) inhibitors"
                         type="fsn">Tumor necrosis factor alpha (TNF-) inhibitors</designation>
                    <desc language="en-US">Tumor necrosis factor alpha (TNF-) inhibitors</desc>
                </concept>
                <concept code="L04AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etanercept"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etanercept" type="fsn">etanercept</designation>
                    <desc language="en-US">etanercept</desc>
                </concept>
                <concept code="L04AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="infliximab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="infliximab" type="fsn">infliximab</designation>
                    <desc language="en-US">infliximab</desc>
                </concept>
                <concept code="L04AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="afelimomab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="afelimomab" type="fsn">afelimomab</designation>
                    <desc language="en-US">afelimomab</desc>
                </concept>
                <concept code="L04AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adalimumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adalimumab" type="fsn">adalimumab</designation>
                    <desc language="en-US">adalimumab</desc>
                </concept>
                <concept code="L04AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="certolizumab pegol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="certolizumab pegol" type="fsn">certolizumab pegol</designation>
                    <desc language="en-US">certolizumab pegol</desc>
                </concept>
                <concept code="L04AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="golimumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="golimumab" type="fsn">golimumab</designation>
                    <desc language="en-US">golimumab</desc>
                </concept>
                <concept code="L04AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Interleukin inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Interleukin inhibitors" type="fsn">Interleukin inhibitors</designation>
                    <desc language="en-US">Interleukin inhibitors</desc>
                </concept>
                <concept code="L04AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="daclizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="daclizumab" type="fsn">daclizumab</designation>
                    <desc language="en-US">daclizumab</desc>
                </concept>
                <concept code="L04AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="basiliximab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="basiliximab" type="fsn">basiliximab</designation>
                    <desc language="en-US">basiliximab</desc>
                </concept>
                <concept code="L04AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anakinra"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anakinra" type="fsn">anakinra</designation>
                    <desc language="en-US">anakinra</desc>
                </concept>
                <concept code="L04AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rilonacept"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rilonacept" type="fsn">rilonacept</designation>
                    <desc language="en-US">rilonacept</desc>
                </concept>
                <concept code="L04AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ustekinumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ustekinumab" type="fsn">ustekinumab</designation>
                    <desc language="en-US">ustekinumab</desc>
                </concept>
                <concept code="L04AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tocilizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tocilizumab" type="fsn">tocilizumab</designation>
                    <desc language="en-US">tocilizumab</desc>
                </concept>
                <concept code="L04AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="canakinumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="canakinumab" type="fsn">canakinumab</designation>
                    <desc language="en-US">canakinumab</desc>
                </concept>
                <concept code="L04AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="briakinumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="briakinumab" type="fsn">briakinumab</designation>
                    <desc language="en-US">briakinumab</desc>
                </concept>
                <concept code="L04AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="secukinumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="secukinumab" type="fsn">secukinumab</designation>
                    <desc language="en-US">secukinumab</desc>
                </concept>
                <concept code="L04AC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="siltuximab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="siltuximab" type="fsn">siltuximab</designation>
                    <desc language="en-US">siltuximab</desc>
                </concept>
                <concept code="L04AC12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brodalumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brodalumab" type="fsn">brodalumab</designation>
                    <desc language="en-US">brodalumab</desc>
                </concept>
                <concept code="L04AC13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ixekizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ixekizumab" type="fsn">ixekizumab</designation>
                    <desc language="en-US">ixekizumab</desc>
                </concept>
                <concept code="L04AC14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sarilumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sarilumab" type="fsn">sarilumab</designation>
                    <desc language="en-US">sarilumab</desc>
                </concept>
                <concept code="L04AC15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sirukumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sirukumab" type="fsn">sirukumab</designation>
                    <desc language="en-US">sirukumab</desc>
                </concept>
                <concept code="L04AC16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guselkumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guselkumab" type="fsn">guselkumab</designation>
                    <desc language="en-US">guselkumab</desc>
                </concept>
                <concept code="L04AC17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tildrakizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tildrakizumab" type="fsn">tildrakizumab</designation>
                    <desc language="en-US">tildrakizumab</desc>
                </concept>
                <concept code="L04AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Calcineurin inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Calcineurin inhibitors" type="fsn">Calcineurin inhibitors</designation>
                    <desc language="en-US">Calcineurin inhibitors</desc>
                </concept>
                <concept code="L04AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclosporin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclosporin" type="fsn">ciclosporin</designation>
                    <desc language="en-US">ciclosporin</desc>
                </concept>
                <concept code="L04AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tacrolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tacrolimus" type="fsn">tacrolimus</designation>
                    <desc language="en-US">tacrolimus</desc>
                </concept>
                <concept code="L04AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="voclosporin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="voclosporin" type="fsn">voclosporin</designation>
                    <desc language="en-US">voclosporin</desc>
                </concept>
                <concept code="L04AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other immunosuppressants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other immunosuppressants" type="fsn">Other immunosuppressants</designation>
                    <desc language="en-US">Other immunosuppressants</desc>
                </concept>
                <concept code="L04AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azathioprine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azathioprine" type="fsn">azathioprine</designation>
                    <desc language="en-US">azathioprine</desc>
                </concept>
                <concept code="L04AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thalidomide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thalidomide" type="fsn">thalidomide</designation>
                    <desc language="en-US">thalidomide</desc>
                </concept>
                <concept code="L04AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methotrexate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methotrexate" type="fsn">methotrexate</designation>
                    <desc language="en-US">methotrexate</desc>
                </concept>
                <concept code="L04AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lenalidomide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lenalidomide" type="fsn">lenalidomide</designation>
                    <desc language="en-US">lenalidomide</desc>
                </concept>
                <concept code="L04AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pirfenidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pirfenidone" type="fsn">pirfenidone</designation>
                    <desc language="en-US">pirfenidone</desc>
                </concept>
                <concept code="L04AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pomalidomide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pomalidomide" type="fsn">pomalidomide</designation>
                    <desc language="en-US">pomalidomide</desc>
                </concept>
                <concept code="L04AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimethyl fumarate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimethyl fumarate" type="fsn">dimethyl fumarate</designation>
                    <desc language="en-US">dimethyl fumarate</desc>
                </concept>
                <concept code="M"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MUSCULO-SKELETAL SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="MUSCULO-SKELETAL SYSTEM" type="fsn">MUSCULO-SKELETAL SYSTEM</designation>
                    <desc language="en-US">MUSCULO-SKELETAL SYSTEM</desc>
                </concept>
                <concept code="M01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS"
                         type="fsn">ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS</designation>
                    <desc language="en-US">ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS</desc>
                </concept>
                <concept code="M01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS"
                         type="fsn">ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS</designation>
                    <desc language="en-US">ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS</desc>
                </concept>
                <concept code="M01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Butylpyrazolidines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Butylpyrazolidines" type="fsn">Butylpyrazolidines</designation>
                    <desc language="en-US">Butylpyrazolidines</desc>
                </concept>
                <concept code="M01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylbutazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylbutazone" type="fsn">phenylbutazone</designation>
                    <desc language="en-US">phenylbutazone</desc>
                </concept>
                <concept code="M01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mofebutazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mofebutazone" type="fsn">mofebutazone</designation>
                    <desc language="en-US">mofebutazone</desc>
                </concept>
                <concept code="M01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyphenbutazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyphenbutazone" type="fsn">oxyphenbutazone</designation>
                    <desc language="en-US">oxyphenbutazone</desc>
                </concept>
                <concept code="M01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofezone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofezone" type="fsn">clofezone</designation>
                    <desc language="en-US">clofezone</desc>
                </concept>
                <concept code="M01AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="kebuzone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="kebuzone" type="fsn">kebuzone</designation>
                    <desc language="en-US">kebuzone</desc>
                </concept>
                <concept code="M01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Acetic acid derivatives and related substances"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Acetic acid derivatives and related substances"
                         type="fsn">Acetic acid derivatives and related substances</designation>
                    <desc language="en-US">Acetic acid derivatives and related substances</desc>
                </concept>
                <concept code="M01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indometacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indometacin" type="fsn">indometacin</designation>
                    <desc language="en-US">indometacin</desc>
                </concept>
                <concept code="M01AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulindac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulindac" type="fsn">sulindac</designation>
                    <desc language="en-US">sulindac</desc>
                </concept>
                <concept code="M01AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolmetin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolmetin" type="fsn">tolmetin</designation>
                    <desc language="en-US">tolmetin</desc>
                </concept>
                <concept code="M01AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zomepirac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zomepirac" type="fsn">zomepirac</designation>
                    <desc language="en-US">zomepirac</desc>
                </concept>
                <concept code="M01AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diclofenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diclofenac" type="fsn">diclofenac</designation>
                    <desc language="en-US">diclofenac</desc>
                </concept>
                <concept code="M01AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alclofenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alclofenac" type="fsn">alclofenac</designation>
                    <desc language="en-US">alclofenac</desc>
                </concept>
                <concept code="M01AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bumadizone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bumadizone" type="fsn">bumadizone</designation>
                    <desc language="en-US">bumadizone</desc>
                </concept>
                <concept code="M01AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etodolac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etodolac" type="fsn">etodolac</designation>
                    <desc language="en-US">etodolac</desc>
                </concept>
                <concept code="M01AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lonazolac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lonazolac" type="fsn">lonazolac</designation>
                    <desc language="en-US">lonazolac</desc>
                </concept>
                <concept code="M01AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fentiazac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fentiazac" type="fsn">fentiazac</designation>
                    <desc language="en-US">fentiazac</desc>
                </concept>
                <concept code="M01AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acemetacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acemetacin" type="fsn">acemetacin</designation>
                    <desc language="en-US">acemetacin</desc>
                </concept>
                <concept code="M01AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="difenpiramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="difenpiramide" type="fsn">difenpiramide</designation>
                    <desc language="en-US">difenpiramide</desc>
                </concept>
                <concept code="M01AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxametacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxametacin" type="fsn">oxametacin</designation>
                    <desc language="en-US">oxametacin</desc>
                </concept>
                <concept code="M01AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proglumetacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proglumetacin" type="fsn">proglumetacin</designation>
                    <desc language="en-US">proglumetacin</desc>
                </concept>
                <concept code="M01AB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketorolac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketorolac" type="fsn">ketorolac</designation>
                    <desc language="en-US">ketorolac</desc>
                </concept>
                <concept code="M01AB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aceclofenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aceclofenac" type="fsn">aceclofenac</designation>
                    <desc language="en-US">aceclofenac</desc>
                </concept>
                <concept code="M01AB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bufexamac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bufexamac" type="fsn">bufexamac</designation>
                    <desc language="en-US">bufexamac</desc>
                </concept>
                <concept code="M01AB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indometacin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indometacin, combinations" type="fsn">indometacin, combinations</designation>
                    <desc language="en-US">indometacin, combinations</desc>
                </concept>
                <concept code="M01AB55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diclofenac, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diclofenac, combinations" type="fsn">diclofenac, combinations</designation>
                    <desc language="en-US">diclofenac, combinations</desc>
                </concept>
                <concept code="M01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Oxicams"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Oxicams" type="fsn">Oxicams</designation>
                    <desc language="en-US">Oxicams</desc>
                </concept>
                <concept code="M01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piroxicam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piroxicam" type="fsn">piroxicam</designation>
                    <desc language="en-US">piroxicam</desc>
                </concept>
                <concept code="M01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tenoxicam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tenoxicam" type="fsn">tenoxicam</designation>
                    <desc language="en-US">tenoxicam</desc>
                </concept>
                <concept code="M01AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="droxicam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="droxicam" type="fsn">droxicam</designation>
                    <desc language="en-US">droxicam</desc>
                </concept>
                <concept code="M01AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lornoxicam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lornoxicam" type="fsn">lornoxicam</designation>
                    <desc language="en-US">lornoxicam</desc>
                </concept>
                <concept code="M01AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meloxicam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meloxicam" type="fsn">meloxicam</designation>
                    <desc language="en-US">meloxicam</desc>
                </concept>
                <concept code="M01AC56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meloxicam, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meloxicam, combinations" type="fsn">meloxicam, combinations</designation>
                    <desc language="en-US">meloxicam, combinations</desc>
                </concept>
                <concept code="M01AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Propionic acid derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Propionic acid derivatives"
                         type="fsn">Propionic acid derivatives</designation>
                    <desc language="en-US">Propionic acid derivatives</desc>
                </concept>
                <concept code="M01AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibuprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibuprofen" type="fsn">ibuprofen</designation>
                    <desc language="en-US">ibuprofen</desc>
                </concept>
                <concept code="M01AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naproxen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naproxen" type="fsn">naproxen</designation>
                    <desc language="en-US">naproxen</desc>
                </concept>
                <concept code="M01AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketoprofen" type="fsn">ketoprofen</designation>
                    <desc language="en-US">ketoprofen</desc>
                </concept>
                <concept code="M01AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenoprofen" type="fsn">fenoprofen</designation>
                    <desc language="en-US">fenoprofen</desc>
                </concept>
                <concept code="M01AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenbufen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenbufen" type="fsn">fenbufen</designation>
                    <desc language="en-US">fenbufen</desc>
                </concept>
                <concept code="M01AE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benoxaprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benoxaprofen" type="fsn">benoxaprofen</designation>
                    <desc language="en-US">benoxaprofen</desc>
                </concept>
                <concept code="M01AE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="suprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="suprofen" type="fsn">suprofen</designation>
                    <desc language="en-US">suprofen</desc>
                </concept>
                <concept code="M01AE08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pirprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pirprofen" type="fsn">pirprofen</designation>
                    <desc language="en-US">pirprofen</desc>
                </concept>
                <concept code="M01AE09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flurbiprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flurbiprofen" type="fsn">flurbiprofen</designation>
                    <desc language="en-US">flurbiprofen</desc>
                </concept>
                <concept code="M01AE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indoprofen" type="fsn">indoprofen</designation>
                    <desc language="en-US">indoprofen</desc>
                </concept>
                <concept code="M01AE11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiaprofenic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiaprofenic acid" type="fsn">tiaprofenic acid</designation>
                    <desc language="en-US">tiaprofenic acid</desc>
                </concept>
                <concept code="M01AE12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxaprozin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxaprozin" type="fsn">oxaprozin</designation>
                    <desc language="en-US">oxaprozin</desc>
                </concept>
                <concept code="M01AE13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibuproxam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibuproxam" type="fsn">ibuproxam</designation>
                    <desc language="en-US">ibuproxam</desc>
                </concept>
                <concept code="M01AE14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexibuprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexibuprofen" type="fsn">dexibuprofen</designation>
                    <desc language="en-US">dexibuprofen</desc>
                </concept>
                <concept code="M01AE15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flunoxaprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flunoxaprofen" type="fsn">flunoxaprofen</designation>
                    <desc language="en-US">flunoxaprofen</desc>
                </concept>
                <concept code="M01AE16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alminoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alminoprofen" type="fsn">alminoprofen</designation>
                    <desc language="en-US">alminoprofen</desc>
                </concept>
                <concept code="M01AE17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexketoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexketoprofen" type="fsn">dexketoprofen</designation>
                    <desc language="en-US">dexketoprofen</desc>
                </concept>
                <concept code="M01AE18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naproxcinod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naproxcinod" type="fsn">naproxcinod</designation>
                    <desc language="en-US">naproxcinod</desc>
                </concept>
                <concept code="M01AE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibuprofen, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibuprofen, combinations" type="fsn">ibuprofen, combinations</designation>
                    <desc language="en-US">ibuprofen, combinations</desc>
                </concept>
                <concept code="M01AE52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naproxen and esomeprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naproxen and esomeprazole" type="fsn">naproxen and esomeprazole</designation>
                    <desc language="en-US">naproxen and esomeprazole</desc>
                </concept>
                <concept code="M01AE53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketoprofen, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketoprofen, combinations" type="fsn">ketoprofen, combinations</designation>
                    <desc language="en-US">ketoprofen, combinations</desc>
                </concept>
                <concept code="M01AE56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naproxen and misoprostol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naproxen and misoprostol" type="fsn">naproxen and misoprostol</designation>
                    <desc language="en-US">naproxen and misoprostol</desc>
                </concept>
                <concept code="M01AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fenamates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Fenamates" type="fsn">Fenamates</designation>
                    <desc language="en-US">Fenamates</desc>
                </concept>
                <concept code="M01AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mefenamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mefenamic acid" type="fsn">mefenamic acid</designation>
                    <desc language="en-US">mefenamic acid</desc>
                </concept>
                <concept code="M01AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolfenamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolfenamic acid" type="fsn">tolfenamic acid</designation>
                    <desc language="en-US">tolfenamic acid</desc>
                </concept>
                <concept code="M01AG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flufenamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flufenamic acid" type="fsn">flufenamic acid</designation>
                    <desc language="en-US">flufenamic acid</desc>
                </concept>
                <concept code="M01AG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meclofenamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meclofenamic acid" type="fsn">meclofenamic acid</designation>
                    <desc language="en-US">meclofenamic acid</desc>
                </concept>
                <concept code="M01AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Coxibs"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Coxibs" type="fsn">Coxibs</designation>
                    <desc language="en-US">Coxibs</desc>
                </concept>
                <concept code="M01AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="celecoxib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="celecoxib" type="fsn">celecoxib</designation>
                    <desc language="en-US">celecoxib</desc>
                </concept>
                <concept code="M01AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rofecoxib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rofecoxib" type="fsn">rofecoxib</designation>
                    <desc language="en-US">rofecoxib</desc>
                </concept>
                <concept code="M01AH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valdecoxib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valdecoxib" type="fsn">valdecoxib</designation>
                    <desc language="en-US">valdecoxib</desc>
                </concept>
                <concept code="M01AH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="parecoxib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="parecoxib" type="fsn">parecoxib</designation>
                    <desc language="en-US">parecoxib</desc>
                </concept>
                <concept code="M01AH05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etoricoxib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etoricoxib" type="fsn">etoricoxib</designation>
                    <desc language="en-US">etoricoxib</desc>
                </concept>
                <concept code="M01AH06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lumiracoxib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lumiracoxib" type="fsn">lumiracoxib</designation>
                    <desc language="en-US">lumiracoxib</desc>
                </concept>
                <concept code="M01AH07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polmacoxib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polmacoxib" type="fsn">polmacoxib</designation>
                    <desc language="en-US">polmacoxib</desc>
                </concept>
                <concept code="M01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiinflammatory and antirheumatic agents, non-steroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antiinflammatory and antirheumatic agents, non-steroids"
                         type="fsn">Other antiinflammatory and antirheumatic agents, non-steroids</designation>
                    <desc language="en-US">Other antiinflammatory and antirheumatic agents, non-steroids</desc>
                </concept>
                <concept code="M01AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nabumetone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nabumetone" type="fsn">nabumetone</designation>
                    <desc language="en-US">nabumetone</desc>
                </concept>
                <concept code="M01AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="niflumic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="niflumic acid" type="fsn">niflumic acid</designation>
                    <desc language="en-US">niflumic acid</desc>
                </concept>
                <concept code="M01AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azapropazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azapropazone" type="fsn">azapropazone</designation>
                    <desc language="en-US">azapropazone</desc>
                </concept>
                <concept code="M01AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glucosamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glucosamine" type="fsn">glucosamine</designation>
                    <desc language="en-US">glucosamine</desc>
                </concept>
                <concept code="M01AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzydamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzydamine" type="fsn">benzydamine</designation>
                    <desc language="en-US">benzydamine</desc>
                </concept>
                <concept code="M01AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glucosaminoglycan polysulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="glucosaminoglycan polysulfate"
                         type="fsn">glucosaminoglycan polysulfate</designation>
                    <desc language="en-US">glucosaminoglycan polysulfate</desc>
                </concept>
                <concept code="M01AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proquazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proquazone" type="fsn">proquazone</designation>
                    <desc language="en-US">proquazone</desc>
                </concept>
                <concept code="M01AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="orgotein"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="orgotein" type="fsn">orgotein</designation>
                    <desc language="en-US">orgotein</desc>
                </concept>
                <concept code="M01AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nimesulide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nimesulide" type="fsn">nimesulide</designation>
                    <desc language="en-US">nimesulide</desc>
                </concept>
                <concept code="M01AX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="feprazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="feprazone" type="fsn">feprazone</designation>
                    <desc language="en-US">feprazone</desc>
                </concept>
                <concept code="M01AX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diacerein"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diacerein" type="fsn">diacerein</designation>
                    <desc language="en-US">diacerein</desc>
                </concept>
                <concept code="M01AX22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="morniflumate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="morniflumate" type="fsn">morniflumate</designation>
                    <desc language="en-US">morniflumate</desc>
                </concept>
                <concept code="M01AX23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tenidap"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tenidap" type="fsn">tenidap</designation>
                    <desc language="en-US">tenidap</desc>
                </concept>
                <concept code="M01AX24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxaceprol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxaceprol" type="fsn">oxaceprol</designation>
                    <desc language="en-US">oxaceprol</desc>
                </concept>
                <concept code="M01AX25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chondroitin sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chondroitin sulfate" type="fsn">chondroitin sulfate</designation>
                    <desc language="en-US">chondroitin sulfate</desc>
                </concept>
                <concept code="M01AX26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="avocado and soyabean oil, unsaponifiables"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="avocado and soyabean oil, unsaponifiables"
                         type="fsn">avocado and soyabean oil, unsaponifiables</designation>
                    <desc language="en-US">avocado and soyabean oil, unsaponifiables</desc>
                </concept>
                <concept code="M01AX68"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="feprazone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="feprazone, combinations" type="fsn">feprazone, combinations</designation>
                    <desc language="en-US">feprazone, combinations</desc>
                </concept>
                <concept code="M01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION"
                         type="fsn">ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION</designation>
                    <desc language="en-US">ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION</desc>
                </concept>
                <concept code="M01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinflammatory/antirheumatic agents in combination with corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiinflammatory/antirheumatic agents in combination with corticosteroids"
                         type="fsn">Antiinflammatory/antirheumatic agents in combination with corticosteroids</designation>
                    <desc language="en-US">Antiinflammatory/antirheumatic agents in combination with corticosteroids</desc>
                </concept>
                <concept code="M01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylbutazone and corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenylbutazone and corticosteroids"
                         type="fsn">phenylbutazone and corticosteroids</designation>
                    <desc language="en-US">phenylbutazone and corticosteroids</desc>
                </concept>
                <concept code="M01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dipyrocetyl and corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dipyrocetyl and corticosteroids"
                         type="fsn">dipyrocetyl and corticosteroids</designation>
                    <desc language="en-US">dipyrocetyl and corticosteroids</desc>
                </concept>
                <concept code="M01BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylsalicylic acid and corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="acetylsalicylic acid and corticosteroids"
                         type="fsn">acetylsalicylic acid and corticosteroids</designation>
                    <desc language="en-US">acetylsalicylic acid and corticosteroids</desc>
                </concept>
                <concept code="M01BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiinflammatory/antirheumatic agents in combination with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antiinflammatory/antirheumatic agents in combination with other drugs"
                         type="fsn">Other antiinflammatory/antirheumatic agents in combination with other drugs</designation>
                    <desc language="en-US">Other antiinflammatory/antirheumatic agents in combination with other drugs</desc>
                </concept>
                <concept code="M01C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SPECIFIC ANTIRHEUMATIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="SPECIFIC ANTIRHEUMATIC AGENTS"
                         type="fsn">SPECIFIC ANTIRHEUMATIC AGENTS</designation>
                    <desc language="en-US">SPECIFIC ANTIRHEUMATIC AGENTS</desc>
                </concept>
                <concept code="M01CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Quinolines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Quinolines" type="fsn">Quinolines</designation>
                    <desc language="en-US">Quinolines</desc>
                </concept>
                <concept code="M01CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxycinchophen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxycinchophen" type="fsn">oxycinchophen</designation>
                    <desc language="en-US">oxycinchophen</desc>
                </concept>
                <concept code="M01CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Gold preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Gold preparations" type="fsn">Gold preparations</designation>
                    <desc language="en-US">Gold preparations</desc>
                </concept>
                <concept code="M01CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium aurothiomalate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium aurothiomalate" type="fsn">sodium aurothiomalate</designation>
                    <desc language="en-US">sodium aurothiomalate</desc>
                </concept>
                <concept code="M01CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium aurotiosulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium aurotiosulfate" type="fsn">sodium aurotiosulfate</designation>
                    <desc language="en-US">sodium aurotiosulfate</desc>
                </concept>
                <concept code="M01CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="auranofin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="auranofin" type="fsn">auranofin</designation>
                    <desc language="en-US">auranofin</desc>
                </concept>
                <concept code="M01CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aurothioglucose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aurothioglucose" type="fsn">aurothioglucose</designation>
                    <desc language="en-US">aurothioglucose</desc>
                </concept>
                <concept code="M01CB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aurotioprol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aurotioprol" type="fsn">aurotioprol</designation>
                    <desc language="en-US">aurotioprol</desc>
                </concept>
                <concept code="M01CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Penicillamine and similar agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Penicillamine and similar agents"
                         type="fsn">Penicillamine and similar agents</designation>
                    <desc language="en-US">Penicillamine and similar agents</desc>
                </concept>
                <concept code="M01CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penicillamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="penicillamine" type="fsn">penicillamine</designation>
                    <desc language="en-US">penicillamine</desc>
                </concept>
                <concept code="M01CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bucillamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bucillamine" type="fsn">bucillamine</designation>
                    <desc language="en-US">bucillamine</desc>
                </concept>
                <concept code="M01CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other specific antirheumatic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other specific antirheumatic agents"
                         type="fsn">Other specific antirheumatic agents</designation>
                    <desc language="en-US">Other specific antirheumatic agents</desc>
                </concept>
                <concept code="M02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN"
                         type="fsn">TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN</designation>
                    <desc language="en-US">TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN</desc>
                </concept>
                <concept code="M02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN"
                         type="fsn">TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN</designation>
                    <desc language="en-US">TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN</desc>
                </concept>
                <concept code="M02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinflammatory preparations, non-steroids for topical use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiinflammatory preparations, non-steroids for topical use"
                         type="fsn">Antiinflammatory preparations, non-steroids for topical use</designation>
                    <desc language="en-US">Antiinflammatory preparations, non-steroids for topical use</desc>
                </concept>
                <concept code="M02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylbutazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylbutazone" type="fsn">phenylbutazone</designation>
                    <desc language="en-US">phenylbutazone</desc>
                </concept>
                <concept code="M02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mofebutazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mofebutazone" type="fsn">mofebutazone</designation>
                    <desc language="en-US">mofebutazone</desc>
                </concept>
                <concept code="M02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofezone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofezone" type="fsn">clofezone</designation>
                    <desc language="en-US">clofezone</desc>
                </concept>
                <concept code="M02AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyphenbutazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyphenbutazone" type="fsn">oxyphenbutazone</designation>
                    <desc language="en-US">oxyphenbutazone</desc>
                </concept>
                <concept code="M02AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzydamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzydamine" type="fsn">benzydamine</designation>
                    <desc language="en-US">benzydamine</desc>
                </concept>
                <concept code="M02AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etofenamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etofenamate" type="fsn">etofenamate</designation>
                    <desc language="en-US">etofenamate</desc>
                </concept>
                <concept code="M02AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piroxicam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piroxicam" type="fsn">piroxicam</designation>
                    <desc language="en-US">piroxicam</desc>
                </concept>
                <concept code="M02AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="felbinac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="felbinac" type="fsn">felbinac</designation>
                    <desc language="en-US">felbinac</desc>
                </concept>
                <concept code="M02AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bufexamac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bufexamac" type="fsn">bufexamac</designation>
                    <desc language="en-US">bufexamac</desc>
                </concept>
                <concept code="M02AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketoprofen" type="fsn">ketoprofen</designation>
                    <desc language="en-US">ketoprofen</desc>
                </concept>
                <concept code="M02AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bendazac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bendazac" type="fsn">bendazac</designation>
                    <desc language="en-US">bendazac</desc>
                </concept>
                <concept code="M02AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naproxen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naproxen" type="fsn">naproxen</designation>
                    <desc language="en-US">naproxen</desc>
                </concept>
                <concept code="M02AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibuprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibuprofen" type="fsn">ibuprofen</designation>
                    <desc language="en-US">ibuprofen</desc>
                </concept>
                <concept code="M02AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fentiazac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fentiazac" type="fsn">fentiazac</designation>
                    <desc language="en-US">fentiazac</desc>
                </concept>
                <concept code="M02AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diclofenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diclofenac" type="fsn">diclofenac</designation>
                    <desc language="en-US">diclofenac</desc>
                </concept>
                <concept code="M02AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="feprazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="feprazone" type="fsn">feprazone</designation>
                    <desc language="en-US">feprazone</desc>
                </concept>
                <concept code="M02AA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="niflumic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="niflumic acid" type="fsn">niflumic acid</designation>
                    <desc language="en-US">niflumic acid</desc>
                </concept>
                <concept code="M02AA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meclofenamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meclofenamic acid" type="fsn">meclofenamic acid</designation>
                    <desc language="en-US">meclofenamic acid</desc>
                </concept>
                <concept code="M02AA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flurbiprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flurbiprofen" type="fsn">flurbiprofen</designation>
                    <desc language="en-US">flurbiprofen</desc>
                </concept>
                <concept code="M02AA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolmetin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolmetin" type="fsn">tolmetin</designation>
                    <desc language="en-US">tolmetin</desc>
                </concept>
                <concept code="M02AA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="suxibuzone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="suxibuzone" type="fsn">suxibuzone</designation>
                    <desc language="en-US">suxibuzone</desc>
                </concept>
                <concept code="M02AA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indometacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indometacin" type="fsn">indometacin</designation>
                    <desc language="en-US">indometacin</desc>
                </concept>
                <concept code="M02AA24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifenazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifenazone" type="fsn">nifenazone</designation>
                    <desc language="en-US">nifenazone</desc>
                </concept>
                <concept code="M02AA25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aceclofenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aceclofenac" type="fsn">aceclofenac</designation>
                    <desc language="en-US">aceclofenac</desc>
                </concept>
                <concept code="M02AA26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nimesulide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nimesulide" type="fsn">nimesulide</designation>
                    <desc language="en-US">nimesulide</desc>
                </concept>
                <concept code="M02AA27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexketoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexketoprofen" type="fsn">dexketoprofen</designation>
                    <desc language="en-US">dexketoprofen</desc>
                </concept>
                <concept code="M02AA28"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piketoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piketoprofen" type="fsn">piketoprofen</designation>
                    <desc language="en-US">piketoprofen</desc>
                </concept>
                <concept code="M02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Capsaicin and similar agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Capsaicin and similar agents"
                         type="fsn">Capsaicin and similar agents</designation>
                    <desc language="en-US">Capsaicin and similar agents</desc>
                </concept>
                <concept code="M02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="capsaicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="capsaicin" type="fsn">capsaicin</designation>
                    <desc language="en-US">capsaicin</desc>
                </concept>
                <concept code="M02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zucapsaicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zucapsaicin" type="fsn">zucapsaicin</designation>
                    <desc language="en-US">zucapsaicin</desc>
                </concept>
                <concept code="M02AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Preparations with salicylic acid derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Preparations with salicylic acid derivatives"
                         type="fsn">Preparations with salicylic acid derivatives</designation>
                    <desc language="en-US">Preparations with salicylic acid derivatives</desc>
                </concept>
                <concept code="M02AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other topical products for joint and muscular pain"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other topical products for joint and muscular pain"
                         type="fsn">Other topical products for joint and muscular pain</designation>
                    <desc language="en-US">Other topical products for joint and muscular pain</desc>
                </concept>
                <concept code="M02AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolazoline" type="fsn">tolazoline</designation>
                    <desc language="en-US">tolazoline</desc>
                </concept>
                <concept code="M02AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimethyl sulfoxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimethyl sulfoxide" type="fsn">dimethyl sulfoxide</designation>
                    <desc language="en-US">dimethyl sulfoxide</desc>
                </concept>
                <concept code="M02AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idrocilamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idrocilamide" type="fsn">idrocilamide</designation>
                    <desc language="en-US">idrocilamide</desc>
                </concept>
                <concept code="M02AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolperisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolperisone" type="fsn">tolperisone</designation>
                    <desc language="en-US">tolperisone</desc>
                </concept>
                <concept code="M02AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="various"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="various" type="fsn">various</designation>
                    <desc language="en-US">various</desc>
                </concept>
                <concept code="M03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MUSCLE RELAXANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="MUSCLE RELAXANTS" type="fsn">MUSCLE RELAXANTS</designation>
                    <desc language="en-US">MUSCLE RELAXANTS</desc>
                </concept>
                <concept code="M03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS"
                         type="fsn">MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS</designation>
                    <desc language="en-US">MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS</desc>
                </concept>
                <concept code="M03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Curare alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Curare alkaloids" type="fsn">Curare alkaloids</designation>
                    <desc language="en-US">Curare alkaloids</desc>
                </concept>
                <concept code="M03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alcuronium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alcuronium" type="fsn">alcuronium</designation>
                    <desc language="en-US">alcuronium</desc>
                </concept>
                <concept code="M03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tubocurarine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tubocurarine" type="fsn">tubocurarine</designation>
                    <desc language="en-US">tubocurarine</desc>
                </concept>
                <concept code="M03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimethyltubocurarine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimethyltubocurarine" type="fsn">dimethyltubocurarine</designation>
                    <desc language="en-US">dimethyltubocurarine</desc>
                </concept>
                <concept code="M03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Choline derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Choline derivatives" type="fsn">Choline derivatives</designation>
                    <desc language="en-US">Choline derivatives</desc>
                </concept>
                <concept code="M03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="suxamethonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="suxamethonium" type="fsn">suxamethonium</designation>
                    <desc language="en-US">suxamethonium</desc>
                </concept>
                <concept code="M03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other quaternary ammonium compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other quaternary ammonium compounds"
                         type="fsn">Other quaternary ammonium compounds</designation>
                    <desc language="en-US">Other quaternary ammonium compounds</desc>
                </concept>
                <concept code="M03AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pancuronium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pancuronium" type="fsn">pancuronium</designation>
                    <desc language="en-US">pancuronium</desc>
                </concept>
                <concept code="M03AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gallamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gallamine" type="fsn">gallamine</designation>
                    <desc language="en-US">gallamine</desc>
                </concept>
                <concept code="M03AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vecuronium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vecuronium" type="fsn">vecuronium</designation>
                    <desc language="en-US">vecuronium</desc>
                </concept>
                <concept code="M03AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atracurium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atracurium" type="fsn">atracurium</designation>
                    <desc language="en-US">atracurium</desc>
                </concept>
                <concept code="M03AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexafluronium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexafluronium" type="fsn">hexafluronium</designation>
                    <desc language="en-US">hexafluronium</desc>
                </concept>
                <concept code="M03AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipecuronium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pipecuronium bromide" type="fsn">pipecuronium bromide</designation>
                    <desc language="en-US">pipecuronium bromide</desc>
                </concept>
                <concept code="M03AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxacurium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxacurium chloride" type="fsn">doxacurium chloride</designation>
                    <desc language="en-US">doxacurium chloride</desc>
                </concept>
                <concept code="M03AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fazadinium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fazadinium bromide" type="fsn">fazadinium bromide</designation>
                    <desc language="en-US">fazadinium bromide</desc>
                </concept>
                <concept code="M03AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rocuronium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rocuronium bromide" type="fsn">rocuronium bromide</designation>
                    <desc language="en-US">rocuronium bromide</desc>
                </concept>
                <concept code="M03AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mivacurium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mivacurium chloride" type="fsn">mivacurium chloride</designation>
                    <desc language="en-US">mivacurium chloride</desc>
                </concept>
                <concept code="M03AC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cisatracurium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cisatracurium" type="fsn">cisatracurium</designation>
                    <desc language="en-US">cisatracurium</desc>
                </concept>
                <concept code="M03AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other muscle relaxants, peripherally acting agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other muscle relaxants, peripherally acting agents"
                         type="fsn">Other muscle relaxants, peripherally acting agents</designation>
                    <desc language="en-US">Other muscle relaxants, peripherally acting agents</desc>
                </concept>
                <concept code="M03AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="botulinum toxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="botulinum toxin" type="fsn">botulinum toxin</designation>
                    <desc language="en-US">botulinum toxin</desc>
                </concept>
                <concept code="M03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS"
                         type="fsn">MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS</designation>
                    <desc language="en-US">MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS</desc>
                </concept>
                <concept code="M03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Carbamic acid esters"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Carbamic acid esters" type="fsn">Carbamic acid esters</designation>
                    <desc language="en-US">Carbamic acid esters</desc>
                </concept>
                <concept code="M03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenprobamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenprobamate" type="fsn">phenprobamate</designation>
                    <desc language="en-US">phenprobamate</desc>
                </concept>
                <concept code="M03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carisoprodol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carisoprodol" type="fsn">carisoprodol</designation>
                    <desc language="en-US">carisoprodol</desc>
                </concept>
                <concept code="M03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methocarbamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methocarbamol" type="fsn">methocarbamol</designation>
                    <desc language="en-US">methocarbamol</desc>
                </concept>
                <concept code="M03BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="styramate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="styramate" type="fsn">styramate</designation>
                    <desc language="en-US">styramate</desc>
                </concept>
                <concept code="M03BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="febarbamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="febarbamate" type="fsn">febarbamate</designation>
                    <desc language="en-US">febarbamate</desc>
                </concept>
                <concept code="M03BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenprobamate, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenprobamate, combinations excl. psycholeptics"
                         type="fsn">phenprobamate, combinations excl. psycholeptics</designation>
                    <desc language="en-US">phenprobamate, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="M03BA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carisoprodol, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="carisoprodol, combinations excl. psycholeptics"
                         type="fsn">carisoprodol, combinations excl. psycholeptics</designation>
                    <desc language="en-US">carisoprodol, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="M03BA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methocarbamol, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methocarbamol, combinations excl. psycholeptics"
                         type="fsn">methocarbamol, combinations excl. psycholeptics</designation>
                    <desc language="en-US">methocarbamol, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="M03BA71"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenprobamate, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenprobamate, combinations with psycholeptics"
                         type="fsn">phenprobamate, combinations with psycholeptics</designation>
                    <desc language="en-US">phenprobamate, combinations with psycholeptics</desc>
                </concept>
                <concept code="M03BA72"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carisoprodol, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="carisoprodol, combinations with psycholeptics"
                         type="fsn">carisoprodol, combinations with psycholeptics</designation>
                    <desc language="en-US">carisoprodol, combinations with psycholeptics</desc>
                </concept>
                <concept code="M03BA73"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methocarbamol, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methocarbamol, combinations with psycholeptics"
                         type="fsn">methocarbamol, combinations with psycholeptics</designation>
                    <desc language="en-US">methocarbamol, combinations with psycholeptics</desc>
                </concept>
                <concept code="M03BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Oxazol, thiazine, and triazine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Oxazol, thiazine, and triazine derivatives"
                         type="fsn">Oxazol, thiazine, and triazine derivatives</designation>
                    <desc language="en-US">Oxazol, thiazine, and triazine derivatives</desc>
                </concept>
                <concept code="M03BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormezanone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlormezanone" type="fsn">chlormezanone</designation>
                    <desc language="en-US">chlormezanone</desc>
                </concept>
                <concept code="M03BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorzoxazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorzoxazone" type="fsn">chlorzoxazone</designation>
                    <desc language="en-US">chlorzoxazone</desc>
                </concept>
                <concept code="M03BB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormezanone, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlormezanone, combinations excl. psycholeptics"
                         type="fsn">chlormezanone, combinations excl. psycholeptics</designation>
                    <desc language="en-US">chlormezanone, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="M03BB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorzoxazone, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlorzoxazone, combinations excl. psycholeptics"
                         type="fsn">chlorzoxazone, combinations excl. psycholeptics</designation>
                    <desc language="en-US">chlorzoxazone, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="M03BB72"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlormezanone, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlormezanone, combinations with psycholeptics"
                         type="fsn">chlormezanone, combinations with psycholeptics</designation>
                    <desc language="en-US">chlormezanone, combinations with psycholeptics</desc>
                </concept>
                <concept code="M03BB73"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorzoxazone, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlorzoxazone, combinations with psycholeptics"
                         type="fsn">chlorzoxazone, combinations with psycholeptics</designation>
                    <desc language="en-US">chlorzoxazone, combinations with psycholeptics</desc>
                </concept>
                <concept code="M03BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ethers, chemically close to antihistamines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Ethers, chemically close to antihistamines"
                         type="fsn">Ethers, chemically close to antihistamines</designation>
                    <desc language="en-US">Ethers, chemically close to antihistamines</desc>
                </concept>
                <concept code="M03BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="orphenadrine (citrate)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="orphenadrine (citrate)" type="fsn">orphenadrine (citrate)</designation>
                    <desc language="en-US">orphenadrine (citrate)</desc>
                </concept>
                <concept code="M03BC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="orphenadrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="orphenadrine, combinations"
                         type="fsn">orphenadrine, combinations</designation>
                    <desc language="en-US">orphenadrine, combinations</desc>
                </concept>
                <concept code="M03BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other centrally acting agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other centrally acting agents"
                         type="fsn">Other centrally acting agents</designation>
                    <desc language="en-US">Other centrally acting agents</desc>
                </concept>
                <concept code="M03BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="baclofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="baclofen" type="fsn">baclofen</designation>
                    <desc language="en-US">baclofen</desc>
                </concept>
                <concept code="M03BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tizanidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tizanidine" type="fsn">tizanidine</designation>
                    <desc language="en-US">tizanidine</desc>
                </concept>
                <concept code="M03BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pridinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pridinol" type="fsn">pridinol</designation>
                    <desc language="en-US">pridinol</desc>
                </concept>
                <concept code="M03BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolperisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolperisone" type="fsn">tolperisone</designation>
                    <desc language="en-US">tolperisone</desc>
                </concept>
                <concept code="M03BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiocolchicoside"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiocolchicoside" type="fsn">thiocolchicoside</designation>
                    <desc language="en-US">thiocolchicoside</desc>
                </concept>
                <concept code="M03BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mephenesin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mephenesin" type="fsn">mephenesin</designation>
                    <desc language="en-US">mephenesin</desc>
                </concept>
                <concept code="M03BX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetrazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetrazepam" type="fsn">tetrazepam</designation>
                    <desc language="en-US">tetrazepam</desc>
                </concept>
                <concept code="M03BX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclobenzaprine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclobenzaprine" type="fsn">cyclobenzaprine</designation>
                    <desc language="en-US">cyclobenzaprine</desc>
                </concept>
                <concept code="M03BX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eperisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eperisone" type="fsn">eperisone</designation>
                    <desc language="en-US">eperisone</desc>
                </concept>
                <concept code="M03BX30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenyramidol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenyramidol" type="fsn">fenyramidol</designation>
                    <desc language="en-US">fenyramidol</desc>
                </concept>
                <concept code="M03BX55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiocolchicoside, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="thiocolchicoside, combinations"
                         type="fsn">thiocolchicoside, combinations</designation>
                    <desc language="en-US">thiocolchicoside, combinations</desc>
                </concept>
                <concept code="M03C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS"
                         type="fsn">MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS</designation>
                    <desc language="en-US">MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS</desc>
                </concept>
                <concept code="M03CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Dantrolene and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Dantrolene and derivatives"
                         type="fsn">Dantrolene and derivatives</designation>
                    <desc language="en-US">Dantrolene and derivatives</desc>
                </concept>
                <concept code="M03CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dantrolene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dantrolene" type="fsn">dantrolene</designation>
                    <desc language="en-US">dantrolene</desc>
                </concept>
                <concept code="M04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIGOUT PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIGOUT PREPARATIONS" type="fsn">ANTIGOUT PREPARATIONS</designation>
                    <desc language="en-US">ANTIGOUT PREPARATIONS</desc>
                </concept>
                <concept code="M04A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIGOUT PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIGOUT PREPARATIONS" type="fsn">ANTIGOUT PREPARATIONS</designation>
                    <desc language="en-US">ANTIGOUT PREPARATIONS</desc>
                </concept>
                <concept code="M04AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Preparations inhibiting uric acid production"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Preparations inhibiting uric acid production"
                         type="fsn">Preparations inhibiting uric acid production</designation>
                    <desc language="en-US">Preparations inhibiting uric acid production</desc>
                </concept>
                <concept code="M04AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="allopurinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="allopurinol" type="fsn">allopurinol</designation>
                    <desc language="en-US">allopurinol</desc>
                </concept>
                <concept code="M04AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tisopurine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tisopurine" type="fsn">tisopurine</designation>
                    <desc language="en-US">tisopurine</desc>
                </concept>
                <concept code="M04AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="febuxostat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="febuxostat" type="fsn">febuxostat</designation>
                    <desc language="en-US">febuxostat</desc>
                </concept>
                <concept code="M04AA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="allopurinol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="allopurinol, combinations" type="fsn">allopurinol, combinations</designation>
                    <desc language="en-US">allopurinol, combinations</desc>
                </concept>
                <concept code="M04AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Preparations increasing uric acid excretion"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Preparations increasing uric acid excretion"
                         type="fsn">Preparations increasing uric acid excretion</designation>
                    <desc language="en-US">Preparations increasing uric acid excretion</desc>
                </concept>
                <concept code="M04AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="probenecid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="probenecid" type="fsn">probenecid</designation>
                    <desc language="en-US">probenecid</desc>
                </concept>
                <concept code="M04AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfinpyrazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfinpyrazone" type="fsn">sulfinpyrazone</designation>
                    <desc language="en-US">sulfinpyrazone</desc>
                </concept>
                <concept code="M04AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzbromarone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzbromarone" type="fsn">benzbromarone</designation>
                    <desc language="en-US">benzbromarone</desc>
                </concept>
                <concept code="M04AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isobromindione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isobromindione" type="fsn">isobromindione</designation>
                    <desc language="en-US">isobromindione</desc>
                </concept>
                <concept code="M04AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lesinurad"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lesinurad" type="fsn">lesinurad</designation>
                    <desc language="en-US">lesinurad</desc>
                </concept>
                <concept code="M04AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Preparations with no effect on uric acid metabolism"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Preparations with no effect on uric acid metabolism"
                         type="fsn">Preparations with no effect on uric acid metabolism</designation>
                    <desc language="en-US">Preparations with no effect on uric acid metabolism</desc>
                </concept>
                <concept code="M04AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colchicine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colchicine" type="fsn">colchicine</designation>
                    <desc language="en-US">colchicine</desc>
                </concept>
                <concept code="M04AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinchophen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinchophen" type="fsn">cinchophen</designation>
                    <desc language="en-US">cinchophen</desc>
                </concept>
                <concept code="M04AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antigout preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antigout preparations"
                         type="fsn">Other antigout preparations</designation>
                    <desc language="en-US">Other antigout preparations</desc>
                </concept>
                <concept code="M04AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="urate oxidase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="urate oxidase" type="fsn">urate oxidase</designation>
                    <desc language="en-US">urate oxidase</desc>
                </concept>
                <concept code="M04AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pegloticase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pegloticase" type="fsn">pegloticase</designation>
                    <desc language="en-US">pegloticase</desc>
                </concept>
                <concept code="M05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR TREATMENT OF BONE DISEASES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR TREATMENT OF BONE DISEASES"
                         type="fsn">DRUGS FOR TREATMENT OF BONE DISEASES</designation>
                    <desc language="en-US">DRUGS FOR TREATMENT OF BONE DISEASES</desc>
                </concept>
                <concept code="M05B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION"
                         type="fsn">DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION</designation>
                    <desc language="en-US">DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION</desc>
                </concept>
                <concept code="M05BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bisphosphonates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Bisphosphonates" type="fsn">Bisphosphonates</designation>
                    <desc language="en-US">Bisphosphonates</desc>
                </concept>
                <concept code="M05BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etidronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etidronic acid" type="fsn">etidronic acid</designation>
                    <desc language="en-US">etidronic acid</desc>
                </concept>
                <concept code="M05BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clodronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clodronic acid" type="fsn">clodronic acid</designation>
                    <desc language="en-US">clodronic acid</desc>
                </concept>
                <concept code="M05BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pamidronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pamidronic acid" type="fsn">pamidronic acid</designation>
                    <desc language="en-US">pamidronic acid</desc>
                </concept>
                <concept code="M05BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alendronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alendronic acid" type="fsn">alendronic acid</designation>
                    <desc language="en-US">alendronic acid</desc>
                </concept>
                <concept code="M05BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiludronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiludronic acid" type="fsn">tiludronic acid</designation>
                    <desc language="en-US">tiludronic acid</desc>
                </concept>
                <concept code="M05BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibandronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibandronic acid" type="fsn">ibandronic acid</designation>
                    <desc language="en-US">ibandronic acid</desc>
                </concept>
                <concept code="M05BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="risedronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="risedronic acid" type="fsn">risedronic acid</designation>
                    <desc language="en-US">risedronic acid</desc>
                </concept>
                <concept code="M05BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zoledronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zoledronic acid" type="fsn">zoledronic acid</designation>
                    <desc language="en-US">zoledronic acid</desc>
                </concept>
                <concept code="M05BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bisphosphonates, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Bisphosphonates, combinations"
                         type="fsn">Bisphosphonates, combinations</designation>
                    <desc language="en-US">Bisphosphonates, combinations</desc>
                </concept>
                <concept code="M05BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etidronic acid and calcium, sequential"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="etidronic acid and calcium, sequential"
                         type="fsn">etidronic acid and calcium, sequential</designation>
                    <desc language="en-US">etidronic acid and calcium, sequential</desc>
                </concept>
                <concept code="M05BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="risedronic acid and calcium, sequential"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="risedronic acid and calcium, sequential"
                         type="fsn">risedronic acid and calcium, sequential</designation>
                    <desc language="en-US">risedronic acid and calcium, sequential</desc>
                </concept>
                <concept code="M05BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alendronic acid and colecalciferol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="alendronic acid and colecalciferol"
                         type="fsn">alendronic acid and colecalciferol</designation>
                    <desc language="en-US">alendronic acid and colecalciferol</desc>
                </concept>
                <concept code="M05BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="risedronic acid, calcium and colecalciferol, sequential"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="risedronic acid, calcium and colecalciferol, sequential"
                         type="fsn">risedronic acid, calcium and colecalciferol, sequential</designation>
                    <desc language="en-US">risedronic acid, calcium and colecalciferol, sequential</desc>
                </concept>
                <concept code="M05BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alendronic acid, calcium and colecalciferol, sequential"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="alendronic acid, calcium and colecalciferol, sequential"
                         type="fsn">alendronic acid, calcium and colecalciferol, sequential</designation>
                    <desc language="en-US">alendronic acid, calcium and colecalciferol, sequential</desc>
                </concept>
                <concept code="M05BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alendronic acid and alfacalcidol, sequential"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="alendronic acid and alfacalcidol, sequential"
                         type="fsn">alendronic acid and alfacalcidol, sequential</designation>
                    <desc language="en-US">alendronic acid and alfacalcidol, sequential</desc>
                </concept>
                <concept code="M05BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="risedronic acid and colecalciferol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="risedronic acid and colecalciferol"
                         type="fsn">risedronic acid and colecalciferol</designation>
                    <desc language="en-US">risedronic acid and colecalciferol</desc>
                </concept>
                <concept code="M05BB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zoledronic acid, calcium and colecalciferol, sequential"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="zoledronic acid, calcium and colecalciferol, sequential"
                         type="fsn">zoledronic acid, calcium and colecalciferol, sequential</designation>
                    <desc language="en-US">zoledronic acid, calcium and colecalciferol, sequential</desc>
                </concept>
                <concept code="M05BB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibandronic acid and colecalciferol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ibandronic acid and colecalciferol"
                         type="fsn">ibandronic acid and colecalciferol</designation>
                    <desc language="en-US">ibandronic acid and colecalciferol</desc>
                </concept>
                <concept code="M05BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Bone morphogenetic proteins"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Bone morphogenetic proteins"
                         type="fsn">Bone morphogenetic proteins</designation>
                    <desc language="en-US">Bone morphogenetic proteins</desc>
                </concept>
                <concept code="M05BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibotermin alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibotermin alfa" type="fsn">dibotermin alfa</designation>
                    <desc language="en-US">dibotermin alfa</desc>
                </concept>
                <concept code="M05BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eptotermin alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eptotermin alfa" type="fsn">eptotermin alfa</designation>
                    <desc language="en-US">eptotermin alfa</desc>
                </concept>
                <concept code="M05BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs affecting bone structure and mineralization"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs affecting bone structure and mineralization"
                         type="fsn">Other drugs affecting bone structure and mineralization</designation>
                    <desc language="en-US">Other drugs affecting bone structure and mineralization</desc>
                </concept>
                <concept code="M05BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ipriflavone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ipriflavone" type="fsn">ipriflavone</designation>
                    <desc language="en-US">ipriflavone</desc>
                </concept>
                <concept code="M05BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium chlorohydrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium chlorohydrate" type="fsn">aluminium chlorohydrate</designation>
                    <desc language="en-US">aluminium chlorohydrate</desc>
                </concept>
                <concept code="M05BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="strontium ranelate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="strontium ranelate" type="fsn">strontium ranelate</designation>
                    <desc language="en-US">strontium ranelate</desc>
                </concept>
                <concept code="M05BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="denosumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="denosumab" type="fsn">denosumab</designation>
                    <desc language="en-US">denosumab</desc>
                </concept>
                <concept code="M05BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="burosumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="burosumab" type="fsn">burosumab</designation>
                    <desc language="en-US">burosumab</desc>
                </concept>
                <concept code="M05BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="romosozumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="romosozumab" type="fsn">romosozumab</designation>
                    <desc language="en-US">romosozumab</desc>
                </concept>
                <concept code="M05BX53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="strontium ranelate and colecalciferol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="strontium ranelate and colecalciferol"
                         type="fsn">strontium ranelate and colecalciferol</designation>
                    <desc language="en-US">strontium ranelate and colecalciferol</desc>
                </concept>
                <concept code="M09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM"
                         type="fsn">OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM</designation>
                    <desc language="en-US">OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM</desc>
                </concept>
                <concept code="M09A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM"
                         type="fsn">OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM</designation>
                    <desc language="en-US">OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM</desc>
                </concept>
                <concept code="M09AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Quinine and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Quinine and derivatives" type="fsn">Quinine and derivatives</designation>
                    <desc language="en-US">Quinine and derivatives</desc>
                </concept>
                <concept code="M09AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroquinine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroquinine" type="fsn">hydroquinine</designation>
                    <desc language="en-US">hydroquinine</desc>
                </concept>
                <concept code="M09AA72"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinine, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="quinine, combinations with psycholeptics"
                         type="fsn">quinine, combinations with psycholeptics</designation>
                    <desc language="en-US">quinine, combinations with psycholeptics</desc>
                </concept>
                <concept code="M09AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Enzymes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Enzymes" type="fsn">Enzymes</designation>
                    <desc language="en-US">Enzymes</desc>
                </concept>
                <concept code="M09AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chymopapain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chymopapain" type="fsn">chymopapain</designation>
                    <desc language="en-US">chymopapain</desc>
                </concept>
                <concept code="M09AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="collagenase clostridium histolyticum"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="collagenase clostridium histolyticum"
                         type="fsn">collagenase clostridium histolyticum</designation>
                    <desc language="en-US">collagenase clostridium histolyticum</desc>
                </concept>
                <concept code="M09AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromelains"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromelains" type="fsn">bromelains</designation>
                    <desc language="en-US">bromelains</desc>
                </concept>
                <concept code="M09AB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trypsin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trypsin, combinations" type="fsn">trypsin, combinations</designation>
                    <desc language="en-US">trypsin, combinations</desc>
                </concept>
                <concept code="M09AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs for disorders of the musculo-skeletal system"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs for disorders of the musculo-skeletal system"
                         type="fsn">Other drugs for disorders of the musculo-skeletal system</designation>
                    <desc language="en-US">Other drugs for disorders of the musculo-skeletal system</desc>
                </concept>
                <concept code="M09AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hyaluronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hyaluronic acid" type="fsn">hyaluronic acid</designation>
                    <desc language="en-US">hyaluronic acid</desc>
                </concept>
                <concept code="M09AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chondrocytes, autologous"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chondrocytes, autologous" type="fsn">chondrocytes, autologous</designation>
                    <desc language="en-US">chondrocytes, autologous</desc>
                </concept>
                <concept code="M09AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ataluren"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ataluren" type="fsn">ataluren</designation>
                    <desc language="en-US">ataluren</desc>
                </concept>
                <concept code="M09AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="drisapersen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="drisapersen" type="fsn">drisapersen</designation>
                    <desc language="en-US">drisapersen</desc>
                </concept>
                <concept code="M09AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aceneuramic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aceneuramic acid" type="fsn">aceneuramic acid</designation>
                    <desc language="en-US">aceneuramic acid</desc>
                </concept>
                <concept code="M09AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eteplirsen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eteplirsen" type="fsn">eteplirsen</designation>
                    <desc language="en-US">eteplirsen</desc>
                </concept>
                <concept code="M09AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nusinersen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nusinersen" type="fsn">nusinersen</designation>
                    <desc language="en-US">nusinersen</desc>
                </concept>
                <concept code="N"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="NERVOUS SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="NERVOUS SYSTEM" type="fsn">NERVOUS SYSTEM</designation>
                    <desc language="en-US">NERVOUS SYSTEM</desc>
                </concept>
                <concept code="N01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANESTHETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANESTHETICS" type="fsn">ANESTHETICS</designation>
                    <desc language="en-US">ANESTHETICS</desc>
                </concept>
                <concept code="N01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANESTHETICS, GENERAL"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANESTHETICS, GENERAL" type="fsn">ANESTHETICS, GENERAL</designation>
                    <desc language="en-US">ANESTHETICS, GENERAL</desc>
                </concept>
                <concept code="N01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ethers"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Ethers" type="fsn">Ethers</designation>
                    <desc language="en-US">Ethers</desc>
                </concept>
                <concept code="N01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diethyl ether"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diethyl ether" type="fsn">diethyl ether</designation>
                    <desc language="en-US">diethyl ether</desc>
                </concept>
                <concept code="N01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vinyl ether"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vinyl ether" type="fsn">vinyl ether</designation>
                    <desc language="en-US">vinyl ether</desc>
                </concept>
                <concept code="N01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Halogenated hydrocarbons"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Halogenated hydrocarbons" type="fsn">Halogenated hydrocarbons</designation>
                    <desc language="en-US">Halogenated hydrocarbons</desc>
                </concept>
                <concept code="N01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="halothane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="halothane" type="fsn">halothane</designation>
                    <desc language="en-US">halothane</desc>
                </concept>
                <concept code="N01AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloroform"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloroform" type="fsn">chloroform</designation>
                    <desc language="en-US">chloroform</desc>
                </concept>
                <concept code="N01AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="enflurane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="enflurane" type="fsn">enflurane</designation>
                    <desc language="en-US">enflurane</desc>
                </concept>
                <concept code="N01AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trichloroethylene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trichloroethylene" type="fsn">trichloroethylene</designation>
                    <desc language="en-US">trichloroethylene</desc>
                </concept>
                <concept code="N01AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoflurane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoflurane" type="fsn">isoflurane</designation>
                    <desc language="en-US">isoflurane</desc>
                </concept>
                <concept code="N01AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desflurane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desflurane" type="fsn">desflurane</designation>
                    <desc language="en-US">desflurane</desc>
                </concept>
                <concept code="N01AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sevoflurane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sevoflurane" type="fsn">sevoflurane</designation>
                    <desc language="en-US">sevoflurane</desc>
                </concept>
                <concept code="N01AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Barbiturates, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Barbiturates, plain" type="fsn">Barbiturates, plain</designation>
                    <desc language="en-US">Barbiturates, plain</desc>
                </concept>
                <concept code="N01AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methohexital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methohexital" type="fsn">methohexital</designation>
                    <desc language="en-US">methohexital</desc>
                </concept>
                <concept code="N01AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexobarbital" type="fsn">hexobarbital</designation>
                    <desc language="en-US">hexobarbital</desc>
                </concept>
                <concept code="N01AF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiopental"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiopental" type="fsn">thiopental</designation>
                    <desc language="en-US">thiopental</desc>
                </concept>
                <concept code="N01AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Barbiturates in combination with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Barbiturates in combination with other drugs"
                         type="fsn">Barbiturates in combination with other drugs</designation>
                    <desc language="en-US">Barbiturates in combination with other drugs</desc>
                </concept>
                <concept code="N01AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="narcobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="narcobarbital" type="fsn">narcobarbital</designation>
                    <desc language="en-US">narcobarbital</desc>
                </concept>
                <concept code="N01AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Opioid anesthetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Opioid anesthetics" type="fsn">Opioid anesthetics</designation>
                    <desc language="en-US">Opioid anesthetics</desc>
                </concept>
                <concept code="N01AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fentanyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fentanyl" type="fsn">fentanyl</designation>
                    <desc language="en-US">fentanyl</desc>
                </concept>
                <concept code="N01AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alfentanil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alfentanil" type="fsn">alfentanil</designation>
                    <desc language="en-US">alfentanil</desc>
                </concept>
                <concept code="N01AH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sufentanil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sufentanil" type="fsn">sufentanil</designation>
                    <desc language="en-US">sufentanil</desc>
                </concept>
                <concept code="N01AH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenoperidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenoperidine" type="fsn">phenoperidine</designation>
                    <desc language="en-US">phenoperidine</desc>
                </concept>
                <concept code="N01AH05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anileridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anileridine" type="fsn">anileridine</designation>
                    <desc language="en-US">anileridine</desc>
                </concept>
                <concept code="N01AH06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="remifentanil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="remifentanil" type="fsn">remifentanil</designation>
                    <desc language="en-US">remifentanil</desc>
                </concept>
                <concept code="N01AH51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fentanyl, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fentanyl, combinations" type="fsn">fentanyl, combinations</designation>
                    <desc language="en-US">fentanyl, combinations</desc>
                </concept>
                <concept code="N01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other general anesthetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other general anesthetics" type="fsn">Other general anesthetics</designation>
                    <desc language="en-US">Other general anesthetics</desc>
                </concept>
                <concept code="N01AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketamine" type="fsn">ketamine</designation>
                    <desc language="en-US">ketamine</desc>
                </concept>
                <concept code="N01AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propanidid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propanidid" type="fsn">propanidid</designation>
                    <desc language="en-US">propanidid</desc>
                </concept>
                <concept code="N01AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alfaxalone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alfaxalone" type="fsn">alfaxalone</designation>
                    <desc language="en-US">alfaxalone</desc>
                </concept>
                <concept code="N01AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etomidate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etomidate" type="fsn">etomidate</designation>
                    <desc language="en-US">etomidate</desc>
                </concept>
                <concept code="N01AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propofol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propofol" type="fsn">propofol</designation>
                    <desc language="en-US">propofol</desc>
                </concept>
                <concept code="N01AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium oxybate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium oxybate" type="fsn">sodium oxybate</designation>
                    <desc language="en-US">sodium oxybate</desc>
                </concept>
                <concept code="N01AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrous oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrous oxide" type="fsn">nitrous oxide</designation>
                    <desc language="en-US">nitrous oxide</desc>
                </concept>
                <concept code="N01AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="esketamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="esketamine" type="fsn">esketamine</designation>
                    <desc language="en-US">esketamine</desc>
                </concept>
                <concept code="N01AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xenon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xenon" type="fsn">xenon</designation>
                    <desc language="en-US">xenon</desc>
                </concept>
                <concept code="N01AX63"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrous oxide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="nitrous oxide, combinations"
                         type="fsn">nitrous oxide, combinations</designation>
                    <desc language="en-US">nitrous oxide, combinations</desc>
                </concept>
                <concept code="N01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANESTHETICS, LOCAL"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANESTHETICS, LOCAL" type="fsn">ANESTHETICS, LOCAL</designation>
                    <desc language="en-US">ANESTHETICS, LOCAL</desc>
                </concept>
                <concept code="N01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Esters of aminobenzoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Esters of aminobenzoic acid"
                         type="fsn">Esters of aminobenzoic acid</designation>
                    <desc language="en-US">Esters of aminobenzoic acid</desc>
                </concept>
                <concept code="N01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metabutethamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metabutethamine" type="fsn">metabutethamine</designation>
                    <desc language="en-US">metabutethamine</desc>
                </concept>
                <concept code="N01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procaine" type="fsn">procaine</designation>
                    <desc language="en-US">procaine</desc>
                </concept>
                <concept code="N01BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracaine" type="fsn">tetracaine</designation>
                    <desc language="en-US">tetracaine</desc>
                </concept>
                <concept code="N01BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloroprocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloroprocaine" type="fsn">chloroprocaine</designation>
                    <desc language="en-US">chloroprocaine</desc>
                </concept>
                <concept code="N01BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzocaine" type="fsn">benzocaine</designation>
                    <desc language="en-US">benzocaine</desc>
                </concept>
                <concept code="N01BA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procaine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procaine, combinations" type="fsn">procaine, combinations</designation>
                    <desc language="en-US">procaine, combinations</desc>
                </concept>
                <concept code="N01BA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracaine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracaine, combinations" type="fsn">tetracaine, combinations</designation>
                    <desc language="en-US">tetracaine, combinations</desc>
                </concept>
                <concept code="N01BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Amides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Amides" type="fsn">Amides</designation>
                    <desc language="en-US">Amides</desc>
                </concept>
                <concept code="N01BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bupivacaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bupivacaine" type="fsn">bupivacaine</designation>
                    <desc language="en-US">bupivacaine</desc>
                </concept>
                <concept code="N01BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidocaine" type="fsn">lidocaine</designation>
                    <desc language="en-US">lidocaine</desc>
                </concept>
                <concept code="N01BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepivacaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepivacaine" type="fsn">mepivacaine</designation>
                    <desc language="en-US">mepivacaine</desc>
                </concept>
                <concept code="N01BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prilocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prilocaine" type="fsn">prilocaine</designation>
                    <desc language="en-US">prilocaine</desc>
                </concept>
                <concept code="N01BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butanilicaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butanilicaine" type="fsn">butanilicaine</designation>
                    <desc language="en-US">butanilicaine</desc>
                </concept>
                <concept code="N01BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinchocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinchocaine" type="fsn">cinchocaine</designation>
                    <desc language="en-US">cinchocaine</desc>
                </concept>
                <concept code="N01BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etidocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etidocaine" type="fsn">etidocaine</designation>
                    <desc language="en-US">etidocaine</desc>
                </concept>
                <concept code="N01BB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="articaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="articaine" type="fsn">articaine</designation>
                    <desc language="en-US">articaine</desc>
                </concept>
                <concept code="N01BB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ropivacaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ropivacaine" type="fsn">ropivacaine</designation>
                    <desc language="en-US">ropivacaine</desc>
                </concept>
                <concept code="N01BB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levobupivacaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levobupivacaine" type="fsn">levobupivacaine</designation>
                    <desc language="en-US">levobupivacaine</desc>
                </concept>
                <concept code="N01BB20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="N01BB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bupivacaine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bupivacaine, combinations" type="fsn">bupivacaine, combinations</designation>
                    <desc language="en-US">bupivacaine, combinations</desc>
                </concept>
                <concept code="N01BB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidocaine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidocaine, combinations" type="fsn">lidocaine, combinations</designation>
                    <desc language="en-US">lidocaine, combinations</desc>
                </concept>
                <concept code="N01BB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepivacaine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepivacaine, combinations" type="fsn">mepivacaine, combinations</designation>
                    <desc language="en-US">mepivacaine, combinations</desc>
                </concept>
                <concept code="N01BB54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prilocaine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prilocaine, combinations" type="fsn">prilocaine, combinations</designation>
                    <desc language="en-US">prilocaine, combinations</desc>
                </concept>
                <concept code="N01BB57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etidocaine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etidocaine, combinations" type="fsn">etidocaine, combinations</designation>
                    <desc language="en-US">etidocaine, combinations</desc>
                </concept>
                <concept code="N01BB58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="articaine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="articaine, combinations" type="fsn">articaine, combinations</designation>
                    <desc language="en-US">articaine, combinations</desc>
                </concept>
                <concept code="N01BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Esters of benzoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Esters of benzoic acid" type="fsn">Esters of benzoic acid</designation>
                    <desc language="en-US">Esters of benzoic acid</desc>
                </concept>
                <concept code="N01BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cocaine" type="fsn">cocaine</designation>
                    <desc language="en-US">cocaine</desc>
                </concept>
                <concept code="N01BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other local anesthetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other local anesthetics" type="fsn">Other local anesthetics</designation>
                    <desc language="en-US">Other local anesthetics</desc>
                </concept>
                <concept code="N01BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethyl chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethyl chloride" type="fsn">ethyl chloride</designation>
                    <desc language="en-US">ethyl chloride</desc>
                </concept>
                <concept code="N01BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dyclonine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dyclonine" type="fsn">dyclonine</designation>
                    <desc language="en-US">dyclonine</desc>
                </concept>
                <concept code="N01BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenol" type="fsn">phenol</designation>
                    <desc language="en-US">phenol</desc>
                </concept>
                <concept code="N01BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="capsaicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="capsaicin" type="fsn">capsaicin</designation>
                    <desc language="en-US">capsaicin</desc>
                </concept>
                <concept code="N02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANALGESICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANALGESICS" type="fsn">ANALGESICS</designation>
                    <desc language="en-US">ANALGESICS</desc>
                </concept>
                <concept code="N02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OPIOIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OPIOIDS" type="fsn">OPIOIDS</designation>
                    <desc language="en-US">OPIOIDS</desc>
                </concept>
                <concept code="N02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Natural opium alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Natural opium alkaloids" type="fsn">Natural opium alkaloids</designation>
                    <desc language="en-US">Natural opium alkaloids</desc>
                </concept>
                <concept code="N02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="morphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="morphine" type="fsn">morphine</designation>
                    <desc language="en-US">morphine</desc>
                </concept>
                <concept code="N02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="opium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="opium" type="fsn">opium</designation>
                    <desc language="en-US">opium</desc>
                </concept>
                <concept code="N02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydromorphone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydromorphone" type="fsn">hydromorphone</designation>
                    <desc language="en-US">hydromorphone</desc>
                </concept>
                <concept code="N02AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicomorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicomorphine" type="fsn">nicomorphine</designation>
                    <desc language="en-US">nicomorphine</desc>
                </concept>
                <concept code="N02AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxycodone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxycodone" type="fsn">oxycodone</designation>
                    <desc language="en-US">oxycodone</desc>
                </concept>
                <concept code="N02AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydrocodeine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dihydrocodeine" type="fsn">dihydrocodeine</designation>
                    <desc language="en-US">dihydrocodeine</desc>
                </concept>
                <concept code="N02AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="papaveretum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="papaveretum" type="fsn">papaveretum</designation>
                    <desc language="en-US">papaveretum</desc>
                </concept>
                <concept code="N02AA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="morphine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="morphine, combinations" type="fsn">morphine, combinations</designation>
                    <desc language="en-US">morphine, combinations</desc>
                </concept>
                <concept code="N02AA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydromorphone and naloxone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydromorphone and naloxone"
                         type="fsn">hydromorphone and naloxone</designation>
                    <desc language="en-US">hydromorphone and naloxone</desc>
                </concept>
                <concept code="N02AA55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxycodone and naloxone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxycodone and naloxone" type="fsn">oxycodone and naloxone</designation>
                    <desc language="en-US">oxycodone and naloxone</desc>
                </concept>
                <concept code="N02AA56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxycodone and naltrexone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxycodone and naltrexone" type="fsn">oxycodone and naltrexone</designation>
                    <desc language="en-US">oxycodone and naltrexone</desc>
                </concept>
                <concept code="N02AA58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydrocodeine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydrocodeine, combinations"
                         type="fsn">dihydrocodeine, combinations</designation>
                    <desc language="en-US">dihydrocodeine, combinations</desc>
                </concept>
                <concept code="N02AA59"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="codeine, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="codeine, combinations excl. psycholeptics"
                         type="fsn">codeine, combinations excl. psycholeptics</designation>
                    <desc language="en-US">codeine, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02AA79"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="codeine, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="codeine, combinations with psycholeptics"
                         type="fsn">codeine, combinations with psycholeptics</designation>
                    <desc language="en-US">codeine, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phenylpiperidine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Phenylpiperidine derivatives"
                         type="fsn">Phenylpiperidine derivatives</designation>
                    <desc language="en-US">Phenylpiperidine derivatives</desc>
                </concept>
                <concept code="N02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketobemidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketobemidone" type="fsn">ketobemidone</designation>
                    <desc language="en-US">ketobemidone</desc>
                </concept>
                <concept code="N02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pethidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pethidine" type="fsn">pethidine</designation>
                    <desc language="en-US">pethidine</desc>
                </concept>
                <concept code="N02AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fentanyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fentanyl" type="fsn">fentanyl</designation>
                    <desc language="en-US">fentanyl</desc>
                </concept>
                <concept code="N02AB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pethidine, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pethidine, combinations excl. psycholeptics"
                         type="fsn">pethidine, combinations excl. psycholeptics</designation>
                    <desc language="en-US">pethidine, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02AB72"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pethidine, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pethidine, combinations with psycholeptics"
                         type="fsn">pethidine, combinations with psycholeptics</designation>
                    <desc language="en-US">pethidine, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Diphenylpropylamine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Diphenylpropylamine derivatives"
                         type="fsn">Diphenylpropylamine derivatives</designation>
                    <desc language="en-US">Diphenylpropylamine derivatives</desc>
                </concept>
                <concept code="N02AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextromoramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dextromoramide" type="fsn">dextromoramide</designation>
                    <desc language="en-US">dextromoramide</desc>
                </concept>
                <concept code="N02AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piritramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piritramide" type="fsn">piritramide</designation>
                    <desc language="en-US">piritramide</desc>
                </concept>
                <concept code="N02AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextropropoxyphene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dextropropoxyphene" type="fsn">dextropropoxyphene</designation>
                    <desc language="en-US">dextropropoxyphene</desc>
                </concept>
                <concept code="N02AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bezitramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bezitramide" type="fsn">bezitramide</designation>
                    <desc language="en-US">bezitramide</desc>
                </concept>
                <concept code="N02AC52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methadone, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methadone, combinations excl. psycholeptics"
                         type="fsn">methadone, combinations excl. psycholeptics</designation>
                    <desc language="en-US">methadone, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02AC54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextropropoxyphene, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dextropropoxyphene, combinations excl. psycholeptics"
                         type="fsn">dextropropoxyphene, combinations excl. psycholeptics</designation>
                    <desc language="en-US">dextropropoxyphene, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02AC74"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextropropoxyphene, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dextropropoxyphene, combinations with psycholeptics"
                         type="fsn">dextropropoxyphene, combinations with psycholeptics</designation>
                    <desc language="en-US">dextropropoxyphene, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Benzomorphan derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Benzomorphan derivatives" type="fsn">Benzomorphan derivatives</designation>
                    <desc language="en-US">Benzomorphan derivatives</desc>
                </concept>
                <concept code="N02AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentazocine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentazocine" type="fsn">pentazocine</designation>
                    <desc language="en-US">pentazocine</desc>
                </concept>
                <concept code="N02AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenazocine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenazocine" type="fsn">phenazocine</designation>
                    <desc language="en-US">phenazocine</desc>
                </concept>
                <concept code="N02AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Oripavine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Oripavine derivatives" type="fsn">Oripavine derivatives</designation>
                    <desc language="en-US">Oripavine derivatives</desc>
                </concept>
                <concept code="N02AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buprenorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buprenorphine" type="fsn">buprenorphine</designation>
                    <desc language="en-US">buprenorphine</desc>
                </concept>
                <concept code="N02AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Morphinan derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Morphinan derivatives" type="fsn">Morphinan derivatives</designation>
                    <desc language="en-US">Morphinan derivatives</desc>
                </concept>
                <concept code="N02AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butorphanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butorphanol" type="fsn">butorphanol</designation>
                    <desc language="en-US">butorphanol</desc>
                </concept>
                <concept code="N02AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nalbuphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nalbuphine" type="fsn">nalbuphine</designation>
                    <desc language="en-US">nalbuphine</desc>
                </concept>
                <concept code="N02AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Opioids in combination with antispasmodics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Opioids in combination with antispasmodics"
                         type="fsn">Opioids in combination with antispasmodics</designation>
                    <desc language="en-US">Opioids in combination with antispasmodics</desc>
                </concept>
                <concept code="N02AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="morphine and antispasmodics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="morphine and antispasmodics"
                         type="fsn">morphine and antispasmodics</designation>
                    <desc language="en-US">morphine and antispasmodics</desc>
                </concept>
                <concept code="N02AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketobemidone and antispasmodics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ketobemidone and antispasmodics"
                         type="fsn">ketobemidone and antispasmodics</designation>
                    <desc language="en-US">ketobemidone and antispasmodics</desc>
                </concept>
                <concept code="N02AG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pethidine and antispasmodics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pethidine and antispasmodics"
                         type="fsn">pethidine and antispasmodics</designation>
                    <desc language="en-US">pethidine and antispasmodics</desc>
                </concept>
                <concept code="N02AG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydromorphone and antispasmodics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydromorphone and antispasmodics"
                         type="fsn">hydromorphone and antispasmodics</designation>
                    <desc language="en-US">hydromorphone and antispasmodics</desc>
                </concept>
                <concept code="N02AJ"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Opioids in combination with non-opioid analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Opioids in combination with non-opioid analgesics"
                         type="fsn">Opioids in combination with non-opioid analgesics</designation>
                    <desc language="en-US">Opioids in combination with non-opioid analgesics</desc>
                </concept>
                <concept code="N02AJ01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydrocodeine and paracetamol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydrocodeine and paracetamol"
                         type="fsn">dihydrocodeine and paracetamol</designation>
                    <desc language="en-US">dihydrocodeine and paracetamol</desc>
                </concept>
                <concept code="N02AJ02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydrocodeine and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydrocodeine and acetylsalicylic acid"
                         type="fsn">dihydrocodeine and acetylsalicylic acid</designation>
                    <desc language="en-US">dihydrocodeine and acetylsalicylic acid</desc>
                </concept>
                <concept code="N02AJ03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydrocodeine and other non-opioid analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydrocodeine and other non-opioid analgesics"
                         type="fsn">dihydrocodeine and other non-opioid analgesics</designation>
                    <desc language="en-US">dihydrocodeine and other non-opioid analgesics</desc>
                </concept>
                <concept code="N02AJ06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="codeine and paracetamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="codeine and paracetamol" type="fsn">codeine and paracetamol</designation>
                    <desc language="en-US">codeine and paracetamol</desc>
                </concept>
                <concept code="N02AJ07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="codeine and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="codeine and acetylsalicylic acid"
                         type="fsn">codeine and acetylsalicylic acid</designation>
                    <desc language="en-US">codeine and acetylsalicylic acid</desc>
                </concept>
                <concept code="N02AJ08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="codeine and ibuprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="codeine and ibuprofen" type="fsn">codeine and ibuprofen</designation>
                    <desc language="en-US">codeine and ibuprofen</desc>
                </concept>
                <concept code="N02AJ09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="codeine and other non-opioid analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="codeine and other non-opioid analgesics"
                         type="fsn">codeine and other non-opioid analgesics</designation>
                    <desc language="en-US">codeine and other non-opioid analgesics</desc>
                </concept>
                <concept code="N02AJ13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tramadol and paracetamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tramadol and paracetamol" type="fsn">tramadol and paracetamol</designation>
                    <desc language="en-US">tramadol and paracetamol</desc>
                </concept>
                <concept code="N02AJ14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tramadol and dexketoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tramadol and dexketoprofen"
                         type="fsn">tramadol and dexketoprofen</designation>
                    <desc language="en-US">tramadol and dexketoprofen</desc>
                </concept>
                <concept code="N02AJ15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tramadol and other non-opioid analgesics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tramadol and other non-opioid analgesics"
                         type="fsn">tramadol and other non-opioid analgesics</designation>
                    <desc language="en-US">tramadol and other non-opioid analgesics</desc>
                </concept>
                <concept code="N02AJ17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxycodone and paracetamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxycodone and paracetamol" type="fsn">oxycodone and paracetamol</designation>
                    <desc language="en-US">oxycodone and paracetamol</desc>
                </concept>
                <concept code="N02AJ18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxycodone and acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="oxycodone and acetylsalicylic acid"
                         type="fsn">oxycodone and acetylsalicylic acid</designation>
                    <desc language="en-US">oxycodone and acetylsalicylic acid</desc>
                </concept>
                <concept code="N02AJ19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxycodone and ibuprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxycodone and ibuprofen" type="fsn">oxycodone and ibuprofen</designation>
                    <desc language="en-US">oxycodone and ibuprofen</desc>
                </concept>
                <concept code="N02AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other opioids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other opioids" type="fsn">Other opioids</designation>
                    <desc language="en-US">Other opioids</desc>
                </concept>
                <concept code="N02AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tilidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tilidine" type="fsn">tilidine</designation>
                    <desc language="en-US">tilidine</desc>
                </concept>
                <concept code="N02AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tramadol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tramadol" type="fsn">tramadol</designation>
                    <desc language="en-US">tramadol</desc>
                </concept>
                <concept code="N02AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dezocine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dezocine" type="fsn">dezocine</designation>
                    <desc language="en-US">dezocine</desc>
                </concept>
                <concept code="N02AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meptazinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meptazinol" type="fsn">meptazinol</designation>
                    <desc language="en-US">meptazinol</desc>
                </concept>
                <concept code="N02AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tapentadol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tapentadol" type="fsn">tapentadol</designation>
                    <desc language="en-US">tapentadol</desc>
                </concept>
                <concept code="N02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER ANALGESICS AND ANTIPYRETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER ANALGESICS AND ANTIPYRETICS"
                         type="fsn">OTHER ANALGESICS AND ANTIPYRETICS</designation>
                    <desc language="en-US">OTHER ANALGESICS AND ANTIPYRETICS</desc>
                </concept>
                <concept code="N02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Salicylic acid and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Salicylic acid and derivatives"
                         type="fsn">Salicylic acid and derivatives</designation>
                    <desc language="en-US">Salicylic acid and derivatives</desc>
                </concept>
                <concept code="N02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylsalicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylsalicylic acid" type="fsn">acetylsalicylic acid</designation>
                    <desc language="en-US">acetylsalicylic acid</desc>
                </concept>
                <concept code="N02BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aloxiprin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aloxiprin" type="fsn">aloxiprin</designation>
                    <desc language="en-US">aloxiprin</desc>
                </concept>
                <concept code="N02BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="choline salicylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="choline salicylate" type="fsn">choline salicylate</designation>
                    <desc language="en-US">choline salicylate</desc>
                </concept>
                <concept code="N02BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium salicylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium salicylate" type="fsn">sodium salicylate</designation>
                    <desc language="en-US">sodium salicylate</desc>
                </concept>
                <concept code="N02BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salicylamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="salicylamide" type="fsn">salicylamide</designation>
                    <desc language="en-US">salicylamide</desc>
                </concept>
                <concept code="N02BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salsalate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="salsalate" type="fsn">salsalate</designation>
                    <desc language="en-US">salsalate</desc>
                </concept>
                <concept code="N02BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethenzamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethenzamide" type="fsn">ethenzamide</designation>
                    <desc language="en-US">ethenzamide</desc>
                </concept>
                <concept code="N02BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="morpholine salicylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="morpholine salicylate" type="fsn">morpholine salicylate</designation>
                    <desc language="en-US">morpholine salicylate</desc>
                </concept>
                <concept code="N02BA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dipyrocetyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dipyrocetyl" type="fsn">dipyrocetyl</designation>
                    <desc language="en-US">dipyrocetyl</desc>
                </concept>
                <concept code="N02BA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benorilate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benorilate" type="fsn">benorilate</designation>
                    <desc language="en-US">benorilate</desc>
                </concept>
                <concept code="N02BA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diflunisal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diflunisal" type="fsn">diflunisal</designation>
                    <desc language="en-US">diflunisal</desc>
                </concept>
                <concept code="N02BA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium salicylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium salicylate" type="fsn">potassium salicylate</designation>
                    <desc language="en-US">potassium salicylate</desc>
                </concept>
                <concept code="N02BA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guacetisal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guacetisal" type="fsn">guacetisal</designation>
                    <desc language="en-US">guacetisal</desc>
                </concept>
                <concept code="N02BA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbasalate calcium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbasalate calcium" type="fsn">carbasalate calcium</designation>
                    <desc language="en-US">carbasalate calcium</desc>
                </concept>
                <concept code="N02BA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imidazole salicylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imidazole salicylate" type="fsn">imidazole salicylate</designation>
                    <desc language="en-US">imidazole salicylate</desc>
                </concept>
                <concept code="N02BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylsalicylic acid, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="acetylsalicylic acid, combinations excl. psycholeptics"
                         type="fsn">acetylsalicylic acid, combinations excl. psycholeptics</designation>
                    <desc language="en-US">acetylsalicylic acid, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BA55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salicylamide, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="salicylamide, combinations excl. psycholeptics"
                         type="fsn">salicylamide, combinations excl. psycholeptics</designation>
                    <desc language="en-US">salicylamide, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BA57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethenzamide, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ethenzamide, combinations excl. psycholeptics"
                         type="fsn">ethenzamide, combinations excl. psycholeptics</designation>
                    <desc language="en-US">ethenzamide, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BA59"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dipyrocetyl, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dipyrocetyl, combinations excl. psycholeptics"
                         type="fsn">dipyrocetyl, combinations excl. psycholeptics</designation>
                    <desc language="en-US">dipyrocetyl, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BA65"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbasalate calcium combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="carbasalate calcium combinations excl. psycholeptics"
                         type="fsn">carbasalate calcium combinations excl. psycholeptics</designation>
                    <desc language="en-US">carbasalate calcium combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BA71"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylsalicylic acid, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="acetylsalicylic acid, combinations with psycholeptics"
                         type="fsn">acetylsalicylic acid, combinations with psycholeptics</designation>
                    <desc language="en-US">acetylsalicylic acid, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BA75"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salicylamide, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="salicylamide, combinations with psycholeptics"
                         type="fsn">salicylamide, combinations with psycholeptics</designation>
                    <desc language="en-US">salicylamide, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BA77"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethenzamide, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ethenzamide, combinations with psycholeptics"
                         type="fsn">ethenzamide, combinations with psycholeptics</designation>
                    <desc language="en-US">ethenzamide, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BA79"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dipyrocetyl, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dipyrocetyl, combinations with psycholeptics"
                         type="fsn">dipyrocetyl, combinations with psycholeptics</designation>
                    <desc language="en-US">dipyrocetyl, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pyrazolones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pyrazolones" type="fsn">Pyrazolones</designation>
                    <desc language="en-US">Pyrazolones</desc>
                </concept>
                <concept code="N02BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenazone" type="fsn">phenazone</designation>
                    <desc language="en-US">phenazone</desc>
                </concept>
                <concept code="N02BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metamizole sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metamizole sodium" type="fsn">metamizole sodium</designation>
                    <desc language="en-US">metamizole sodium</desc>
                </concept>
                <concept code="N02BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminophenazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminophenazone" type="fsn">aminophenazone</designation>
                    <desc language="en-US">aminophenazone</desc>
                </concept>
                <concept code="N02BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propyphenazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propyphenazone" type="fsn">propyphenazone</designation>
                    <desc language="en-US">propyphenazone</desc>
                </concept>
                <concept code="N02BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifenazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifenazone" type="fsn">nifenazone</designation>
                    <desc language="en-US">nifenazone</desc>
                </concept>
                <concept code="N02BB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenazone, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenazone, combinations excl. psycholeptics"
                         type="fsn">phenazone, combinations excl. psycholeptics</designation>
                    <desc language="en-US">phenazone, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metamizole sodium, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metamizole sodium, combinations excl. psycholeptics"
                         type="fsn">metamizole sodium, combinations excl. psycholeptics</designation>
                    <desc language="en-US">metamizole sodium, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminophenazone, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="aminophenazone, combinations excl. psycholeptics"
                         type="fsn">aminophenazone, combinations excl. psycholeptics</designation>
                    <desc language="en-US">aminophenazone, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BB54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propyphenazone, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="propyphenazone, combinations excl. psycholeptics"
                         type="fsn">propyphenazone, combinations excl. psycholeptics</designation>
                    <desc language="en-US">propyphenazone, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BB71"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenazone, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenazone, combinations with psycholeptics"
                         type="fsn">phenazone, combinations with psycholeptics</designation>
                    <desc language="en-US">phenazone, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BB72"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metamizole sodium, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metamizole sodium, combinations with psycholeptics"
                         type="fsn">metamizole sodium, combinations with psycholeptics</designation>
                    <desc language="en-US">metamizole sodium, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BB73"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminophenazone, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="aminophenazone, combinations with psycholeptics"
                         type="fsn">aminophenazone, combinations with psycholeptics</designation>
                    <desc language="en-US">aminophenazone, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BB74"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propyphenazone, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="propyphenazone, combinations with psycholeptics"
                         type="fsn">propyphenazone, combinations with psycholeptics</designation>
                    <desc language="en-US">propyphenazone, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anilides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anilides" type="fsn">Anilides</designation>
                    <desc language="en-US">Anilides</desc>
                </concept>
                <concept code="N02BE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paracetamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paracetamol" type="fsn">paracetamol</designation>
                    <desc language="en-US">paracetamol</desc>
                </concept>
                <concept code="N02BE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenacetin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenacetin" type="fsn">phenacetin</designation>
                    <desc language="en-US">phenacetin</desc>
                </concept>
                <concept code="N02BE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bucetin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bucetin" type="fsn">bucetin</designation>
                    <desc language="en-US">bucetin</desc>
                </concept>
                <concept code="N02BE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propacetamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propacetamol" type="fsn">propacetamol</designation>
                    <desc language="en-US">propacetamol</desc>
                </concept>
                <concept code="N02BE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paracetamol, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="paracetamol, combinations excl. psycholeptics"
                         type="fsn">paracetamol, combinations excl. psycholeptics</designation>
                    <desc language="en-US">paracetamol, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BE53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenacetin, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenacetin, combinations excl. psycholeptics"
                         type="fsn">phenacetin, combinations excl. psycholeptics</designation>
                    <desc language="en-US">phenacetin, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BE54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bucetin, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bucetin, combinations excl. psycholeptics"
                         type="fsn">bucetin, combinations excl. psycholeptics</designation>
                    <desc language="en-US">bucetin, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02BE71"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paracetamol, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="paracetamol, combinations with psycholeptics"
                         type="fsn">paracetamol, combinations with psycholeptics</designation>
                    <desc language="en-US">paracetamol, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BE73"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenacetin, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenacetin, combinations with psycholeptics"
                         type="fsn">phenacetin, combinations with psycholeptics</designation>
                    <desc language="en-US">phenacetin, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BE74"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bucetin, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bucetin, combinations with psycholeptics"
                         type="fsn">bucetin, combinations with psycholeptics</designation>
                    <desc language="en-US">bucetin, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02BG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other analgesics and antipyretics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other analgesics and antipyretics"
                         type="fsn">Other analgesics and antipyretics</designation>
                    <desc language="en-US">Other analgesics and antipyretics</desc>
                </concept>
                <concept code="N02BG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rimazolium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rimazolium" type="fsn">rimazolium</designation>
                    <desc language="en-US">rimazolium</desc>
                </concept>
                <concept code="N02BG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glafenine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glafenine" type="fsn">glafenine</designation>
                    <desc language="en-US">glafenine</desc>
                </concept>
                <concept code="N02BG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="floctafenine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="floctafenine" type="fsn">floctafenine</designation>
                    <desc language="en-US">floctafenine</desc>
                </concept>
                <concept code="N02BG05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="viminol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="viminol" type="fsn">viminol</designation>
                    <desc language="en-US">viminol</desc>
                </concept>
                <concept code="N02BG06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nefopam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nefopam" type="fsn">nefopam</designation>
                    <desc language="en-US">nefopam</desc>
                </concept>
                <concept code="N02BG07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flupirtine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flupirtine" type="fsn">flupirtine</designation>
                    <desc language="en-US">flupirtine</desc>
                </concept>
                <concept code="N02BG08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ziconotide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ziconotide" type="fsn">ziconotide</designation>
                    <desc language="en-US">ziconotide</desc>
                </concept>
                <concept code="N02BG09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methoxyflurane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methoxyflurane" type="fsn">methoxyflurane</designation>
                    <desc language="en-US">methoxyflurane</desc>
                </concept>
                <concept code="N02BG10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cannabinoids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cannabinoids" type="fsn">cannabinoids</designation>
                    <desc language="en-US">cannabinoids</desc>
                </concept>
                <concept code="N02C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIMIGRAINE PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIMIGRAINE PREPARATIONS" type="fsn">ANTIMIGRAINE PREPARATIONS</designation>
                    <desc language="en-US">ANTIMIGRAINE PREPARATIONS</desc>
                </concept>
                <concept code="N02CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ergot alkaloids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Ergot alkaloids" type="fsn">Ergot alkaloids</designation>
                    <desc language="en-US">Ergot alkaloids</desc>
                </concept>
                <concept code="N02CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydroergotamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dihydroergotamine" type="fsn">dihydroergotamine</designation>
                    <desc language="en-US">dihydroergotamine</desc>
                </concept>
                <concept code="N02CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ergotamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ergotamine" type="fsn">ergotamine</designation>
                    <desc language="en-US">ergotamine</desc>
                </concept>
                <concept code="N02CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methysergide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methysergide" type="fsn">methysergide</designation>
                    <desc language="en-US">methysergide</desc>
                </concept>
                <concept code="N02CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lisuride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lisuride" type="fsn">lisuride</designation>
                    <desc language="en-US">lisuride</desc>
                </concept>
                <concept code="N02CA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydroergotamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydroergotamine, combinations"
                         type="fsn">dihydroergotamine, combinations</designation>
                    <desc language="en-US">dihydroergotamine, combinations</desc>
                </concept>
                <concept code="N02CA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ergotamine, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ergotamine, combinations excl. psycholeptics"
                         type="fsn">ergotamine, combinations excl. psycholeptics</designation>
                    <desc language="en-US">ergotamine, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="N02CA72"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ergotamine, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ergotamine, combinations with psycholeptics"
                         type="fsn">ergotamine, combinations with psycholeptics</designation>
                    <desc language="en-US">ergotamine, combinations with psycholeptics</desc>
                </concept>
                <concept code="N02CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroid derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroid derivatives"
                         type="fsn">Corticosteroid derivatives</designation>
                    <desc language="en-US">Corticosteroid derivatives</desc>
                </concept>
                <concept code="N02CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flumedroxone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flumedroxone" type="fsn">flumedroxone</designation>
                    <desc language="en-US">flumedroxone</desc>
                </concept>
                <concept code="N02CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Selective serotonin (5HT1) agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Selective serotonin (5HT1) agonists"
                         type="fsn">Selective serotonin (5HT1) agonists</designation>
                    <desc language="en-US">Selective serotonin (5HT1) agonists</desc>
                </concept>
                <concept code="N02CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sumatriptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sumatriptan" type="fsn">sumatriptan</designation>
                    <desc language="en-US">sumatriptan</desc>
                </concept>
                <concept code="N02CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naratriptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naratriptan" type="fsn">naratriptan</designation>
                    <desc language="en-US">naratriptan</desc>
                </concept>
                <concept code="N02CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zolmitriptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zolmitriptan" type="fsn">zolmitriptan</designation>
                    <desc language="en-US">zolmitriptan</desc>
                </concept>
                <concept code="N02CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rizatriptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rizatriptan" type="fsn">rizatriptan</designation>
                    <desc language="en-US">rizatriptan</desc>
                </concept>
                <concept code="N02CC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="almotriptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="almotriptan" type="fsn">almotriptan</designation>
                    <desc language="en-US">almotriptan</desc>
                </concept>
                <concept code="N02CC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eletriptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eletriptan" type="fsn">eletriptan</designation>
                    <desc language="en-US">eletriptan</desc>
                </concept>
                <concept code="N02CC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="frovatriptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="frovatriptan" type="fsn">frovatriptan</designation>
                    <desc language="en-US">frovatriptan</desc>
                </concept>
                <concept code="N02CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antimigraine preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antimigraine preparations"
                         type="fsn">Other antimigraine preparations</designation>
                    <desc language="en-US">Other antimigraine preparations</desc>
                </concept>
                <concept code="N02CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pizotifen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pizotifen" type="fsn">pizotifen</designation>
                    <desc language="en-US">pizotifen</desc>
                </concept>
                <concept code="N02CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clonidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clonidine" type="fsn">clonidine</designation>
                    <desc language="en-US">clonidine</desc>
                </concept>
                <concept code="N02CX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iprazochrome"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iprazochrome" type="fsn">iprazochrome</designation>
                    <desc language="en-US">iprazochrome</desc>
                </concept>
                <concept code="N02CX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimetotiazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimetotiazine" type="fsn">dimetotiazine</designation>
                    <desc language="en-US">dimetotiazine</desc>
                </concept>
                <concept code="N02CX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxetorone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxetorone" type="fsn">oxetorone</designation>
                    <desc language="en-US">oxetorone</desc>
                </concept>
                <concept code="N02CX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erenumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="erenumab" type="fsn">erenumab</designation>
                    <desc language="en-US">erenumab</desc>
                </concept>
                <concept code="N02CX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="galcanezumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="galcanezumab" type="fsn">galcanezumab</designation>
                    <desc language="en-US">galcanezumab</desc>
                </concept>
                <concept code="N03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIEPILEPTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIEPILEPTICS" type="fsn">ANTIEPILEPTICS</designation>
                    <desc language="en-US">ANTIEPILEPTICS</desc>
                </concept>
                <concept code="N03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIEPILEPTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIEPILEPTICS" type="fsn">ANTIEPILEPTICS</designation>
                    <desc language="en-US">ANTIEPILEPTICS</desc>
                </concept>
                <concept code="N03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Barbiturates and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Barbiturates and derivatives"
                         type="fsn">Barbiturates and derivatives</designation>
                    <desc language="en-US">Barbiturates and derivatives</desc>
                </concept>
                <concept code="N03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylphenobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylphenobarbital" type="fsn">methylphenobarbital</designation>
                    <desc language="en-US">methylphenobarbital</desc>
                </concept>
                <concept code="N03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenobarbital" type="fsn">phenobarbital</designation>
                    <desc language="en-US">phenobarbital</desc>
                </concept>
                <concept code="N03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="primidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="primidone" type="fsn">primidone</designation>
                    <desc language="en-US">primidone</desc>
                </concept>
                <concept code="N03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="barbexaclone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="barbexaclone" type="fsn">barbexaclone</designation>
                    <desc language="en-US">barbexaclone</desc>
                </concept>
                <concept code="N03AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metharbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metharbital" type="fsn">metharbital</designation>
                    <desc language="en-US">metharbital</desc>
                </concept>
                <concept code="N03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hydantoin derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Hydantoin derivatives" type="fsn">Hydantoin derivatives</designation>
                    <desc language="en-US">Hydantoin derivatives</desc>
                </concept>
                <concept code="N03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethotoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethotoin" type="fsn">ethotoin</designation>
                    <desc language="en-US">ethotoin</desc>
                </concept>
                <concept code="N03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenytoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenytoin" type="fsn">phenytoin</designation>
                    <desc language="en-US">phenytoin</desc>
                </concept>
                <concept code="N03AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amino(diphenylhydantoin) valeric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="amino(diphenylhydantoin) valeric acid"
                         type="fsn">amino(diphenylhydantoin) valeric acid</designation>
                    <desc language="en-US">amino(diphenylhydantoin) valeric acid</desc>
                </concept>
                <concept code="N03AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mephenytoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mephenytoin" type="fsn">mephenytoin</designation>
                    <desc language="en-US">mephenytoin</desc>
                </concept>
                <concept code="N03AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fosphenytoin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fosphenytoin" type="fsn">fosphenytoin</designation>
                    <desc language="en-US">fosphenytoin</desc>
                </concept>
                <concept code="N03AB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenytoin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenytoin, combinations" type="fsn">phenytoin, combinations</designation>
                    <desc language="en-US">phenytoin, combinations</desc>
                </concept>
                <concept code="N03AB54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mephenytoin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mephenytoin, combinations" type="fsn">mephenytoin, combinations</designation>
                    <desc language="en-US">mephenytoin, combinations</desc>
                </concept>
                <concept code="N03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Oxazolidine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Oxazolidine derivatives" type="fsn">Oxazolidine derivatives</designation>
                    <desc language="en-US">Oxazolidine derivatives</desc>
                </concept>
                <concept code="N03AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paramethadione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paramethadione" type="fsn">paramethadione</designation>
                    <desc language="en-US">paramethadione</desc>
                </concept>
                <concept code="N03AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimethadione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimethadione" type="fsn">trimethadione</designation>
                    <desc language="en-US">trimethadione</desc>
                </concept>
                <concept code="N03AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethadione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethadione" type="fsn">ethadione</designation>
                    <desc language="en-US">ethadione</desc>
                </concept>
                <concept code="N03AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Succinimide derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Succinimide derivatives" type="fsn">Succinimide derivatives</designation>
                    <desc language="en-US">Succinimide derivatives</desc>
                </concept>
                <concept code="N03AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethosuximide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethosuximide" type="fsn">ethosuximide</designation>
                    <desc language="en-US">ethosuximide</desc>
                </concept>
                <concept code="N03AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phensuximide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phensuximide" type="fsn">phensuximide</designation>
                    <desc language="en-US">phensuximide</desc>
                </concept>
                <concept code="N03AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mesuximide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mesuximide" type="fsn">mesuximide</designation>
                    <desc language="en-US">mesuximide</desc>
                </concept>
                <concept code="N03AD51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethosuximide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ethosuximide, combinations"
                         type="fsn">ethosuximide, combinations</designation>
                    <desc language="en-US">ethosuximide, combinations</desc>
                </concept>
                <concept code="N03AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Benzodiazepine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Benzodiazepine derivatives"
                         type="fsn">Benzodiazepine derivatives</designation>
                    <desc language="en-US">Benzodiazepine derivatives</desc>
                </concept>
                <concept code="N03AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clonazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clonazepam" type="fsn">clonazepam</designation>
                    <desc language="en-US">clonazepam</desc>
                </concept>
                <concept code="N03AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Carboxamide derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Carboxamide derivatives" type="fsn">Carboxamide derivatives</designation>
                    <desc language="en-US">Carboxamide derivatives</desc>
                </concept>
                <concept code="N03AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbamazepine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbamazepine" type="fsn">carbamazepine</designation>
                    <desc language="en-US">carbamazepine</desc>
                </concept>
                <concept code="N03AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxcarbazepine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxcarbazepine" type="fsn">oxcarbazepine</designation>
                    <desc language="en-US">oxcarbazepine</desc>
                </concept>
                <concept code="N03AF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rufinamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rufinamide" type="fsn">rufinamide</designation>
                    <desc language="en-US">rufinamide</desc>
                </concept>
                <concept code="N03AF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eslicarbazepine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eslicarbazepine" type="fsn">eslicarbazepine</designation>
                    <desc language="en-US">eslicarbazepine</desc>
                </concept>
                <concept code="N03AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fatty acid derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Fatty acid derivatives" type="fsn">Fatty acid derivatives</designation>
                    <desc language="en-US">Fatty acid derivatives</desc>
                </concept>
                <concept code="N03AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valproic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valproic acid" type="fsn">valproic acid</designation>
                    <desc language="en-US">valproic acid</desc>
                </concept>
                <concept code="N03AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valpromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valpromide" type="fsn">valpromide</designation>
                    <desc language="en-US">valpromide</desc>
                </concept>
                <concept code="N03AG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminobutyric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminobutyric acid" type="fsn">aminobutyric acid</designation>
                    <desc language="en-US">aminobutyric acid</desc>
                </concept>
                <concept code="N03AG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vigabatrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vigabatrin" type="fsn">vigabatrin</designation>
                    <desc language="en-US">vigabatrin</desc>
                </concept>
                <concept code="N03AG05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="progabide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="progabide" type="fsn">progabide</designation>
                    <desc language="en-US">progabide</desc>
                </concept>
                <concept code="N03AG06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiagabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiagabine" type="fsn">tiagabine</designation>
                    <desc language="en-US">tiagabine</desc>
                </concept>
                <concept code="N03AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiepileptics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antiepileptics" type="fsn">Other antiepileptics</designation>
                    <desc language="en-US">Other antiepileptics</desc>
                </concept>
                <concept code="N03AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sultiame"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sultiame" type="fsn">sultiame</designation>
                    <desc language="en-US">sultiame</desc>
                </concept>
                <concept code="N03AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenacemide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenacemide" type="fsn">phenacemide</designation>
                    <desc language="en-US">phenacemide</desc>
                </concept>
                <concept code="N03AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lamotrigine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lamotrigine" type="fsn">lamotrigine</designation>
                    <desc language="en-US">lamotrigine</desc>
                </concept>
                <concept code="N03AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="felbamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="felbamate" type="fsn">felbamate</designation>
                    <desc language="en-US">felbamate</desc>
                </concept>
                <concept code="N03AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="topiramate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="topiramate" type="fsn">topiramate</designation>
                    <desc language="en-US">topiramate</desc>
                </concept>
                <concept code="N03AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gabapentin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gabapentin" type="fsn">gabapentin</designation>
                    <desc language="en-US">gabapentin</desc>
                </concept>
                <concept code="N03AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pheneturide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pheneturide" type="fsn">pheneturide</designation>
                    <desc language="en-US">pheneturide</desc>
                </concept>
                <concept code="N03AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levetiracetam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levetiracetam" type="fsn">levetiracetam</designation>
                    <desc language="en-US">levetiracetam</desc>
                </concept>
                <concept code="N03AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zonisamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zonisamide" type="fsn">zonisamide</designation>
                    <desc language="en-US">zonisamide</desc>
                </concept>
                <concept code="N03AX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pregabalin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pregabalin" type="fsn">pregabalin</designation>
                    <desc language="en-US">pregabalin</desc>
                </concept>
                <concept code="N03AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stiripentol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="stiripentol" type="fsn">stiripentol</designation>
                    <desc language="en-US">stiripentol</desc>
                </concept>
                <concept code="N03AX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lacosamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lacosamide" type="fsn">lacosamide</designation>
                    <desc language="en-US">lacosamide</desc>
                </concept>
                <concept code="N03AX19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carisbamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carisbamate" type="fsn">carisbamate</designation>
                    <desc language="en-US">carisbamate</desc>
                </concept>
                <concept code="N03AX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="retigabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="retigabine" type="fsn">retigabine</designation>
                    <desc language="en-US">retigabine</desc>
                </concept>
                <concept code="N03AX22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perampanel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="perampanel" type="fsn">perampanel</designation>
                    <desc language="en-US">perampanel</desc>
                </concept>
                <concept code="N03AX23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brivaracetam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brivaracetam" type="fsn">brivaracetam</designation>
                    <desc language="en-US">brivaracetam</desc>
                </concept>
                <concept code="N03AX24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cannabidiol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cannabidiol" type="fsn">cannabidiol</designation>
                    <desc language="en-US">cannabidiol</desc>
                </concept>
                <concept code="N03AX30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="beclamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="beclamide" type="fsn">beclamide</designation>
                    <desc language="en-US">beclamide</desc>
                </concept>
                <concept code="N04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTI-PARKINSON DRUGS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTI-PARKINSON DRUGS" type="fsn">ANTI-PARKINSON DRUGS</designation>
                    <desc language="en-US">ANTI-PARKINSON DRUGS</desc>
                </concept>
                <concept code="N04A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTICHOLINERGIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTICHOLINERGIC AGENTS" type="fsn">ANTICHOLINERGIC AGENTS</designation>
                    <desc language="en-US">ANTICHOLINERGIC AGENTS</desc>
                </concept>
                <concept code="N04AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tertiary amines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tertiary amines" type="fsn">Tertiary amines</designation>
                    <desc language="en-US">Tertiary amines</desc>
                </concept>
                <concept code="N04AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trihexyphenidyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trihexyphenidyl" type="fsn">trihexyphenidyl</designation>
                    <desc language="en-US">trihexyphenidyl</desc>
                </concept>
                <concept code="N04AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="biperiden"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="biperiden" type="fsn">biperiden</designation>
                    <desc language="en-US">biperiden</desc>
                </concept>
                <concept code="N04AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metixene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metixene" type="fsn">metixene</designation>
                    <desc language="en-US">metixene</desc>
                </concept>
                <concept code="N04AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procyclidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procyclidine" type="fsn">procyclidine</designation>
                    <desc language="en-US">procyclidine</desc>
                </concept>
                <concept code="N04AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="profenamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="profenamine" type="fsn">profenamine</designation>
                    <desc language="en-US">profenamine</desc>
                </concept>
                <concept code="N04AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexetimide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexetimide" type="fsn">dexetimide</designation>
                    <desc language="en-US">dexetimide</desc>
                </concept>
                <concept code="N04AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenglutarimide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenglutarimide" type="fsn">phenglutarimide</designation>
                    <desc language="en-US">phenglutarimide</desc>
                </concept>
                <concept code="N04AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mazaticol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mazaticol" type="fsn">mazaticol</designation>
                    <desc language="en-US">mazaticol</desc>
                </concept>
                <concept code="N04AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bornaprine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bornaprine" type="fsn">bornaprine</designation>
                    <desc language="en-US">bornaprine</desc>
                </concept>
                <concept code="N04AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tropatepine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tropatepine" type="fsn">tropatepine</designation>
                    <desc language="en-US">tropatepine</desc>
                </concept>
                <concept code="N04AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ethers chemically close to antihistamines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Ethers chemically close to antihistamines"
                         type="fsn">Ethers chemically close to antihistamines</designation>
                    <desc language="en-US">Ethers chemically close to antihistamines</desc>
                </concept>
                <concept code="N04AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etanautine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etanautine" type="fsn">etanautine</designation>
                    <desc language="en-US">etanautine</desc>
                </concept>
                <concept code="N04AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="orphenadrine (chloride)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="orphenadrine (chloride)" type="fsn">orphenadrine (chloride)</designation>
                    <desc language="en-US">orphenadrine (chloride)</desc>
                </concept>
                <concept code="N04AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ethers of tropine or tropine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Ethers of tropine or tropine derivatives"
                         type="fsn">Ethers of tropine or tropine derivatives</designation>
                    <desc language="en-US">Ethers of tropine or tropine derivatives</desc>
                </concept>
                <concept code="N04AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzatropine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzatropine" type="fsn">benzatropine</designation>
                    <desc language="en-US">benzatropine</desc>
                </concept>
                <concept code="N04AC30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etybenzatropine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etybenzatropine" type="fsn">etybenzatropine</designation>
                    <desc language="en-US">etybenzatropine</desc>
                </concept>
                <concept code="N04B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DOPAMINERGIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DOPAMINERGIC AGENTS" type="fsn">DOPAMINERGIC AGENTS</designation>
                    <desc language="en-US">DOPAMINERGIC AGENTS</desc>
                </concept>
                <concept code="N04BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Dopa and dopa derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Dopa and dopa derivatives" type="fsn">Dopa and dopa derivatives</designation>
                    <desc language="en-US">Dopa and dopa derivatives</desc>
                </concept>
                <concept code="N04BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levodopa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levodopa" type="fsn">levodopa</designation>
                    <desc language="en-US">levodopa</desc>
                </concept>
                <concept code="N04BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levodopa and decarboxylase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="levodopa and decarboxylase inhibitor"
                         type="fsn">levodopa and decarboxylase inhibitor</designation>
                    <desc language="en-US">levodopa and decarboxylase inhibitor</desc>
                </concept>
                <concept code="N04BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levodopa, decarboxylase inhibitor and COMT inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="levodopa, decarboxylase inhibitor and COMT inhibitor"
                         type="fsn">levodopa, decarboxylase inhibitor and COMT inhibitor</designation>
                    <desc language="en-US">levodopa, decarboxylase inhibitor and COMT inhibitor</desc>
                </concept>
                <concept code="N04BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melevodopa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="melevodopa" type="fsn">melevodopa</designation>
                    <desc language="en-US">melevodopa</desc>
                </concept>
                <concept code="N04BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melevodopa and decarboxylase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="melevodopa and decarboxylase inhibitor"
                         type="fsn">melevodopa and decarboxylase inhibitor</designation>
                    <desc language="en-US">melevodopa and decarboxylase inhibitor</desc>
                </concept>
                <concept code="N04BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etilevodopa and decarboxylase inhibitor"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="etilevodopa and decarboxylase inhibitor"
                         type="fsn">etilevodopa and decarboxylase inhibitor</designation>
                    <desc language="en-US">etilevodopa and decarboxylase inhibitor</desc>
                </concept>
                <concept code="N04BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Adamantane derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Adamantane derivatives" type="fsn">Adamantane derivatives</designation>
                    <desc language="en-US">Adamantane derivatives</desc>
                </concept>
                <concept code="N04BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amantadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amantadine" type="fsn">amantadine</designation>
                    <desc language="en-US">amantadine</desc>
                </concept>
                <concept code="N04BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Dopamine agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Dopamine agonists" type="fsn">Dopamine agonists</designation>
                    <desc language="en-US">Dopamine agonists</desc>
                </concept>
                <concept code="N04BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromocriptine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromocriptine" type="fsn">bromocriptine</designation>
                    <desc language="en-US">bromocriptine</desc>
                </concept>
                <concept code="N04BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pergolide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pergolide" type="fsn">pergolide</designation>
                    <desc language="en-US">pergolide</desc>
                </concept>
                <concept code="N04BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydroergocryptine mesylate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dihydroergocryptine mesylate"
                         type="fsn">dihydroergocryptine mesylate</designation>
                    <desc language="en-US">dihydroergocryptine mesylate</desc>
                </concept>
                <concept code="N04BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ropinirole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ropinirole" type="fsn">ropinirole</designation>
                    <desc language="en-US">ropinirole</desc>
                </concept>
                <concept code="N04BC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pramipexole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pramipexole" type="fsn">pramipexole</designation>
                    <desc language="en-US">pramipexole</desc>
                </concept>
                <concept code="N04BC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cabergoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cabergoline" type="fsn">cabergoline</designation>
                    <desc language="en-US">cabergoline</desc>
                </concept>
                <concept code="N04BC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="apomorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="apomorphine" type="fsn">apomorphine</designation>
                    <desc language="en-US">apomorphine</desc>
                </concept>
                <concept code="N04BC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piribedil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piribedil" type="fsn">piribedil</designation>
                    <desc language="en-US">piribedil</desc>
                </concept>
                <concept code="N04BC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rotigotine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rotigotine" type="fsn">rotigotine</designation>
                    <desc language="en-US">rotigotine</desc>
                </concept>
                <concept code="N04BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Monoamine oxidase B inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Monoamine oxidase B inhibitors"
                         type="fsn">Monoamine oxidase B inhibitors</designation>
                    <desc language="en-US">Monoamine oxidase B inhibitors</desc>
                </concept>
                <concept code="N04BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="selegiline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="selegiline" type="fsn">selegiline</designation>
                    <desc language="en-US">selegiline</desc>
                </concept>
                <concept code="N04BD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rasagiline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rasagiline" type="fsn">rasagiline</designation>
                    <desc language="en-US">rasagiline</desc>
                </concept>
                <concept code="N04BD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="safinamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="safinamide" type="fsn">safinamide</designation>
                    <desc language="en-US">safinamide</desc>
                </concept>
                <concept code="N04BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other dopaminergic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other dopaminergic agents" type="fsn">Other dopaminergic agents</designation>
                    <desc language="en-US">Other dopaminergic agents</desc>
                </concept>
                <concept code="N04BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolcapone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolcapone" type="fsn">tolcapone</designation>
                    <desc language="en-US">tolcapone</desc>
                </concept>
                <concept code="N04BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="entacapone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="entacapone" type="fsn">entacapone</designation>
                    <desc language="en-US">entacapone</desc>
                </concept>
                <concept code="N04BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="budipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="budipine" type="fsn">budipine</designation>
                    <desc language="en-US">budipine</desc>
                </concept>
                <concept code="N04BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="opicapone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="opicapone" type="fsn">opicapone</designation>
                    <desc language="en-US">opicapone</desc>
                </concept>
                <concept code="N05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PSYCHOLEPTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PSYCHOLEPTICS" type="fsn">PSYCHOLEPTICS</designation>
                    <desc language="en-US">PSYCHOLEPTICS</desc>
                </concept>
                <concept code="N05A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPSYCHOTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIPSYCHOTICS" type="fsn">ANTIPSYCHOTICS</designation>
                    <desc language="en-US">ANTIPSYCHOTICS</desc>
                </concept>
                <concept code="N05AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phenothiazines with aliphatic side-chain"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Phenothiazines with aliphatic side-chain"
                         type="fsn">Phenothiazines with aliphatic side-chain</designation>
                    <desc language="en-US">Phenothiazines with aliphatic side-chain</desc>
                </concept>
                <concept code="N05AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorpromazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorpromazine" type="fsn">chlorpromazine</designation>
                    <desc language="en-US">chlorpromazine</desc>
                </concept>
                <concept code="N05AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levomepromazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levomepromazine" type="fsn">levomepromazine</designation>
                    <desc language="en-US">levomepromazine</desc>
                </concept>
                <concept code="N05AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="promazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="promazine" type="fsn">promazine</designation>
                    <desc language="en-US">promazine</desc>
                </concept>
                <concept code="N05AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acepromazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acepromazine" type="fsn">acepromazine</designation>
                    <desc language="en-US">acepromazine</desc>
                </concept>
                <concept code="N05AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triflupromazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triflupromazine" type="fsn">triflupromazine</designation>
                    <desc language="en-US">triflupromazine</desc>
                </concept>
                <concept code="N05AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyamemazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyamemazine" type="fsn">cyamemazine</designation>
                    <desc language="en-US">cyamemazine</desc>
                </concept>
                <concept code="N05AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorproethazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorproethazine" type="fsn">chlorproethazine</designation>
                    <desc language="en-US">chlorproethazine</desc>
                </concept>
                <concept code="N05AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phenothiazines with piperazine structure"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Phenothiazines with piperazine structure"
                         type="fsn">Phenothiazines with piperazine structure</designation>
                    <desc language="en-US">Phenothiazines with piperazine structure</desc>
                </concept>
                <concept code="N05AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dixyrazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dixyrazine" type="fsn">dixyrazine</designation>
                    <desc language="en-US">dixyrazine</desc>
                </concept>
                <concept code="N05AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluphenazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluphenazine" type="fsn">fluphenazine</designation>
                    <desc language="en-US">fluphenazine</desc>
                </concept>
                <concept code="N05AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perphenazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="perphenazine" type="fsn">perphenazine</designation>
                    <desc language="en-US">perphenazine</desc>
                </concept>
                <concept code="N05AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prochlorperazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prochlorperazine" type="fsn">prochlorperazine</designation>
                    <desc language="en-US">prochlorperazine</desc>
                </concept>
                <concept code="N05AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiopropazate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiopropazate" type="fsn">thiopropazate</designation>
                    <desc language="en-US">thiopropazate</desc>
                </concept>
                <concept code="N05AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trifluoperazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trifluoperazine" type="fsn">trifluoperazine</designation>
                    <desc language="en-US">trifluoperazine</desc>
                </concept>
                <concept code="N05AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetophenazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetophenazine" type="fsn">acetophenazine</designation>
                    <desc language="en-US">acetophenazine</desc>
                </concept>
                <concept code="N05AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thioproperazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thioproperazine" type="fsn">thioproperazine</designation>
                    <desc language="en-US">thioproperazine</desc>
                </concept>
                <concept code="N05AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butaperazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butaperazine" type="fsn">butaperazine</designation>
                    <desc language="en-US">butaperazine</desc>
                </concept>
                <concept code="N05AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="perazine" type="fsn">perazine</designation>
                    <desc language="en-US">perazine</desc>
                </concept>
                <concept code="N05AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phenothiazines with piperidine structure"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Phenothiazines with piperidine structure"
                         type="fsn">Phenothiazines with piperidine structure</designation>
                    <desc language="en-US">Phenothiazines with piperidine structure</desc>
                </concept>
                <concept code="N05AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="periciazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="periciazine" type="fsn">periciazine</designation>
                    <desc language="en-US">periciazine</desc>
                </concept>
                <concept code="N05AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thioridazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thioridazine" type="fsn">thioridazine</designation>
                    <desc language="en-US">thioridazine</desc>
                </concept>
                <concept code="N05AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mesoridazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mesoridazine" type="fsn">mesoridazine</designation>
                    <desc language="en-US">mesoridazine</desc>
                </concept>
                <concept code="N05AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipotiazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pipotiazine" type="fsn">pipotiazine</designation>
                    <desc language="en-US">pipotiazine</desc>
                </concept>
                <concept code="N05AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Butyrophenone derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Butyrophenone derivatives" type="fsn">Butyrophenone derivatives</designation>
                    <desc language="en-US">Butyrophenone derivatives</desc>
                </concept>
                <concept code="N05AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="haloperidol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="haloperidol" type="fsn">haloperidol</designation>
                    <desc language="en-US">haloperidol</desc>
                </concept>
                <concept code="N05AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trifluperidol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trifluperidol" type="fsn">trifluperidol</designation>
                    <desc language="en-US">trifluperidol</desc>
                </concept>
                <concept code="N05AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melperone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="melperone" type="fsn">melperone</designation>
                    <desc language="en-US">melperone</desc>
                </concept>
                <concept code="N05AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moperone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moperone" type="fsn">moperone</designation>
                    <desc language="en-US">moperone</desc>
                </concept>
                <concept code="N05AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipamperone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pipamperone" type="fsn">pipamperone</designation>
                    <desc language="en-US">pipamperone</desc>
                </concept>
                <concept code="N05AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromperidol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromperidol" type="fsn">bromperidol</designation>
                    <desc language="en-US">bromperidol</desc>
                </concept>
                <concept code="N05AD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benperidol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benperidol" type="fsn">benperidol</designation>
                    <desc language="en-US">benperidol</desc>
                </concept>
                <concept code="N05AD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="droperidol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="droperidol" type="fsn">droperidol</designation>
                    <desc language="en-US">droperidol</desc>
                </concept>
                <concept code="N05AD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluanisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluanisone" type="fsn">fluanisone</designation>
                    <desc language="en-US">fluanisone</desc>
                </concept>
                <concept code="N05AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Indole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Indole derivatives" type="fsn">Indole derivatives</designation>
                    <desc language="en-US">Indole derivatives</desc>
                </concept>
                <concept code="N05AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxypertine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxypertine" type="fsn">oxypertine</designation>
                    <desc language="en-US">oxypertine</desc>
                </concept>
                <concept code="N05AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="molindone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="molindone" type="fsn">molindone</designation>
                    <desc language="en-US">molindone</desc>
                </concept>
                <concept code="N05AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sertindole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sertindole" type="fsn">sertindole</designation>
                    <desc language="en-US">sertindole</desc>
                </concept>
                <concept code="N05AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ziprasidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ziprasidone" type="fsn">ziprasidone</designation>
                    <desc language="en-US">ziprasidone</desc>
                </concept>
                <concept code="N05AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lurasidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lurasidone" type="fsn">lurasidone</designation>
                    <desc language="en-US">lurasidone</desc>
                </concept>
                <concept code="N05AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Thioxanthene derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Thioxanthene derivatives" type="fsn">Thioxanthene derivatives</designation>
                    <desc language="en-US">Thioxanthene derivatives</desc>
                </concept>
                <concept code="N05AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flupentixol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flupentixol" type="fsn">flupentixol</designation>
                    <desc language="en-US">flupentixol</desc>
                </concept>
                <concept code="N05AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clopenthixol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clopenthixol" type="fsn">clopenthixol</designation>
                    <desc language="en-US">clopenthixol</desc>
                </concept>
                <concept code="N05AF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorprothixene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorprothixene" type="fsn">chlorprothixene</designation>
                    <desc language="en-US">chlorprothixene</desc>
                </concept>
                <concept code="N05AF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiotixene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiotixene" type="fsn">tiotixene</designation>
                    <desc language="en-US">tiotixene</desc>
                </concept>
                <concept code="N05AF05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zuclopenthixol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zuclopenthixol" type="fsn">zuclopenthixol</designation>
                    <desc language="en-US">zuclopenthixol</desc>
                </concept>
                <concept code="N05AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Diphenylbutylpiperidine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Diphenylbutylpiperidine derivatives"
                         type="fsn">Diphenylbutylpiperidine derivatives</designation>
                    <desc language="en-US">Diphenylbutylpiperidine derivatives</desc>
                </concept>
                <concept code="N05AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluspirilene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluspirilene" type="fsn">fluspirilene</designation>
                    <desc language="en-US">fluspirilene</desc>
                </concept>
                <concept code="N05AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pimozide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pimozide" type="fsn">pimozide</designation>
                    <desc language="en-US">pimozide</desc>
                </concept>
                <concept code="N05AG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="penfluridol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="penfluridol" type="fsn">penfluridol</designation>
                    <desc language="en-US">penfluridol</desc>
                </concept>
                <concept code="N05AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Diazepines, oxazepines, thiazepines and oxepines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Diazepines, oxazepines, thiazepines and oxepines"
                         type="fsn">Diazepines, oxazepines, thiazepines and oxepines</designation>
                    <desc language="en-US">Diazepines, oxazepines, thiazepines and oxepines</desc>
                </concept>
                <concept code="N05AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="loxapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="loxapine" type="fsn">loxapine</designation>
                    <desc language="en-US">loxapine</desc>
                </concept>
                <concept code="N05AH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clozapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clozapine" type="fsn">clozapine</designation>
                    <desc language="en-US">clozapine</desc>
                </concept>
                <concept code="N05AH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olanzapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olanzapine" type="fsn">olanzapine</designation>
                    <desc language="en-US">olanzapine</desc>
                </concept>
                <concept code="N05AH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quetiapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quetiapine" type="fsn">quetiapine</designation>
                    <desc language="en-US">quetiapine</desc>
                </concept>
                <concept code="N05AH05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="asenapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="asenapine" type="fsn">asenapine</designation>
                    <desc language="en-US">asenapine</desc>
                </concept>
                <concept code="N05AH06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clotiapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clotiapine" type="fsn">clotiapine</designation>
                    <desc language="en-US">clotiapine</desc>
                </concept>
                <concept code="N05AL"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Benzamides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Benzamides" type="fsn">Benzamides</designation>
                    <desc language="en-US">Benzamides</desc>
                </concept>
                <concept code="N05AL01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulpiride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulpiride" type="fsn">sulpiride</designation>
                    <desc language="en-US">sulpiride</desc>
                </concept>
                <concept code="N05AL02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sultopride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sultopride" type="fsn">sultopride</designation>
                    <desc language="en-US">sultopride</desc>
                </concept>
                <concept code="N05AL03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiapride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiapride" type="fsn">tiapride</designation>
                    <desc language="en-US">tiapride</desc>
                </concept>
                <concept code="N05AL04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="remoxipride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="remoxipride" type="fsn">remoxipride</designation>
                    <desc language="en-US">remoxipride</desc>
                </concept>
                <concept code="N05AL05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amisulpride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amisulpride" type="fsn">amisulpride</designation>
                    <desc language="en-US">amisulpride</desc>
                </concept>
                <concept code="N05AL06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="veralipride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="veralipride" type="fsn">veralipride</designation>
                    <desc language="en-US">veralipride</desc>
                </concept>
                <concept code="N05AL07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levosulpiride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levosulpiride" type="fsn">levosulpiride</designation>
                    <desc language="en-US">levosulpiride</desc>
                </concept>
                <concept code="N05AN"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Lithium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Lithium" type="fsn">Lithium</designation>
                    <desc language="en-US">Lithium</desc>
                </concept>
                <concept code="N05AN01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lithium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lithium" type="fsn">lithium</designation>
                    <desc language="en-US">lithium</desc>
                </concept>
                <concept code="N05AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antipsychotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antipsychotics" type="fsn">Other antipsychotics</designation>
                    <desc language="en-US">Other antipsychotics</desc>
                </concept>
                <concept code="N05AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prothipendyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prothipendyl" type="fsn">prothipendyl</designation>
                    <desc language="en-US">prothipendyl</desc>
                </concept>
                <concept code="N05AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="risperidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="risperidone" type="fsn">risperidone</designation>
                    <desc language="en-US">risperidone</desc>
                </concept>
                <concept code="N05AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mosapramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mosapramine" type="fsn">mosapramine</designation>
                    <desc language="en-US">mosapramine</desc>
                </concept>
                <concept code="N05AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zotepine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zotepine" type="fsn">zotepine</designation>
                    <desc language="en-US">zotepine</desc>
                </concept>
                <concept code="N05AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aripiprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aripiprazole" type="fsn">aripiprazole</designation>
                    <desc language="en-US">aripiprazole</desc>
                </concept>
                <concept code="N05AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paliperidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paliperidone" type="fsn">paliperidone</designation>
                    <desc language="en-US">paliperidone</desc>
                </concept>
                <concept code="N05AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iloperidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iloperidone" type="fsn">iloperidone</designation>
                    <desc language="en-US">iloperidone</desc>
                </concept>
                <concept code="N05AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cariprazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cariprazine" type="fsn">cariprazine</designation>
                    <desc language="en-US">cariprazine</desc>
                </concept>
                <concept code="N05AX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brexpiprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brexpiprazole" type="fsn">brexpiprazole</designation>
                    <desc language="en-US">brexpiprazole</desc>
                </concept>
                <concept code="N05AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pimavanserin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pimavanserin" type="fsn">pimavanserin</designation>
                    <desc language="en-US">pimavanserin</desc>
                </concept>
                <concept code="N05B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANXIOLYTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANXIOLYTICS" type="fsn">ANXIOLYTICS</designation>
                    <desc language="en-US">ANXIOLYTICS</desc>
                </concept>
                <concept code="N05BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Benzodiazepine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Benzodiazepine derivatives"
                         type="fsn">Benzodiazepine derivatives</designation>
                    <desc language="en-US">Benzodiazepine derivatives</desc>
                </concept>
                <concept code="N05BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diazepam" type="fsn">diazepam</designation>
                    <desc language="en-US">diazepam</desc>
                </concept>
                <concept code="N05BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlordiazepoxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlordiazepoxide" type="fsn">chlordiazepoxide</designation>
                    <desc language="en-US">chlordiazepoxide</desc>
                </concept>
                <concept code="N05BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medazepam" type="fsn">medazepam</designation>
                    <desc language="en-US">medazepam</desc>
                </concept>
                <concept code="N05BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxazepam" type="fsn">oxazepam</designation>
                    <desc language="en-US">oxazepam</desc>
                </concept>
                <concept code="N05BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium clorazepate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium clorazepate" type="fsn">potassium clorazepate</designation>
                    <desc language="en-US">potassium clorazepate</desc>
                </concept>
                <concept code="N05BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lorazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lorazepam" type="fsn">lorazepam</designation>
                    <desc language="en-US">lorazepam</desc>
                </concept>
                <concept code="N05BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adinazolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adinazolam" type="fsn">adinazolam</designation>
                    <desc language="en-US">adinazolam</desc>
                </concept>
                <concept code="N05BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromazepam" type="fsn">bromazepam</designation>
                    <desc language="en-US">bromazepam</desc>
                </concept>
                <concept code="N05BA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clobazam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clobazam" type="fsn">clobazam</designation>
                    <desc language="en-US">clobazam</desc>
                </concept>
                <concept code="N05BA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketazolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketazolam" type="fsn">ketazolam</designation>
                    <desc language="en-US">ketazolam</desc>
                </concept>
                <concept code="N05BA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prazepam" type="fsn">prazepam</designation>
                    <desc language="en-US">prazepam</desc>
                </concept>
                <concept code="N05BA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alprazolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alprazolam" type="fsn">alprazolam</designation>
                    <desc language="en-US">alprazolam</desc>
                </concept>
                <concept code="N05BA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="halazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="halazepam" type="fsn">halazepam</designation>
                    <desc language="en-US">halazepam</desc>
                </concept>
                <concept code="N05BA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pinazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pinazepam" type="fsn">pinazepam</designation>
                    <desc language="en-US">pinazepam</desc>
                </concept>
                <concept code="N05BA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="camazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="camazepam" type="fsn">camazepam</designation>
                    <desc language="en-US">camazepam</desc>
                </concept>
                <concept code="N05BA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nordazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nordazepam" type="fsn">nordazepam</designation>
                    <desc language="en-US">nordazepam</desc>
                </concept>
                <concept code="N05BA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludiazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fludiazepam" type="fsn">fludiazepam</designation>
                    <desc language="en-US">fludiazepam</desc>
                </concept>
                <concept code="N05BA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethyl loflazepate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethyl loflazepate" type="fsn">ethyl loflazepate</designation>
                    <desc language="en-US">ethyl loflazepate</desc>
                </concept>
                <concept code="N05BA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etizolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etizolam" type="fsn">etizolam</designation>
                    <desc language="en-US">etizolam</desc>
                </concept>
                <concept code="N05BA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clotiazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clotiazepam" type="fsn">clotiazepam</designation>
                    <desc language="en-US">clotiazepam</desc>
                </concept>
                <concept code="N05BA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cloxazolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cloxazolam" type="fsn">cloxazolam</designation>
                    <desc language="en-US">cloxazolam</desc>
                </concept>
                <concept code="N05BA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tofisopam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tofisopam" type="fsn">tofisopam</designation>
                    <desc language="en-US">tofisopam</desc>
                </concept>
                <concept code="N05BA24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bentazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bentazepam" type="fsn">bentazepam</designation>
                    <desc language="en-US">bentazepam</desc>
                </concept>
                <concept code="N05BA56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lorazepam, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lorazepam, combinations" type="fsn">lorazepam, combinations</designation>
                    <desc language="en-US">lorazepam, combinations</desc>
                </concept>
                <concept code="N05BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Diphenylmethane derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Diphenylmethane derivatives"
                         type="fsn">Diphenylmethane derivatives</designation>
                    <desc language="en-US">Diphenylmethane derivatives</desc>
                </concept>
                <concept code="N05BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxyzine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxyzine" type="fsn">hydroxyzine</designation>
                    <desc language="en-US">hydroxyzine</desc>
                </concept>
                <concept code="N05BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="captodiame"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="captodiame" type="fsn">captodiame</designation>
                    <desc language="en-US">captodiame</desc>
                </concept>
                <concept code="N05BB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxyzine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxyzine, combinations" type="fsn">hydroxyzine, combinations</designation>
                    <desc language="en-US">hydroxyzine, combinations</desc>
                </concept>
                <concept code="N05BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Carbamates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Carbamates" type="fsn">Carbamates</designation>
                    <desc language="en-US">Carbamates</desc>
                </concept>
                <concept code="N05BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meprobamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meprobamate" type="fsn">meprobamate</designation>
                    <desc language="en-US">meprobamate</desc>
                </concept>
                <concept code="N05BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emylcamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emylcamate" type="fsn">emylcamate</designation>
                    <desc language="en-US">emylcamate</desc>
                </concept>
                <concept code="N05BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mebutamate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mebutamate" type="fsn">mebutamate</designation>
                    <desc language="en-US">mebutamate</desc>
                </concept>
                <concept code="N05BC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meprobamate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meprobamate, combinations" type="fsn">meprobamate, combinations</designation>
                    <desc language="en-US">meprobamate, combinations</desc>
                </concept>
                <concept code="N05BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Dibenzo-bicyclo-octadiene derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Dibenzo-bicyclo-octadiene derivatives"
                         type="fsn">Dibenzo-bicyclo-octadiene derivatives</designation>
                    <desc language="en-US">Dibenzo-bicyclo-octadiene derivatives</desc>
                </concept>
                <concept code="N05BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzoctamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzoctamine" type="fsn">benzoctamine</designation>
                    <desc language="en-US">benzoctamine</desc>
                </concept>
                <concept code="N05BE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Azaspirodecanedione derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Azaspirodecanedione derivatives"
                         type="fsn">Azaspirodecanedione derivatives</designation>
                    <desc language="en-US">Azaspirodecanedione derivatives</desc>
                </concept>
                <concept code="N05BE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buspirone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buspirone" type="fsn">buspirone</designation>
                    <desc language="en-US">buspirone</desc>
                </concept>
                <concept code="N05BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other anxiolytics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other anxiolytics" type="fsn">Other anxiolytics</designation>
                    <desc language="en-US">Other anxiolytics</desc>
                </concept>
                <concept code="N05BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mephenoxalone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mephenoxalone" type="fsn">mephenoxalone</designation>
                    <desc language="en-US">mephenoxalone</desc>
                </concept>
                <concept code="N05BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gedocarnil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gedocarnil" type="fsn">gedocarnil</designation>
                    <desc language="en-US">gedocarnil</desc>
                </concept>
                <concept code="N05BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etifoxine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etifoxine" type="fsn">etifoxine</designation>
                    <desc language="en-US">etifoxine</desc>
                </concept>
                <concept code="N05BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fabomotizole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fabomotizole" type="fsn">fabomotizole</designation>
                    <desc language="en-US">fabomotizole</desc>
                </concept>
                <concept code="N05BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Lavandulae aetheroleum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Lavandulae aetheroleum" type="fsn">Lavandulae aetheroleum</designation>
                    <desc language="en-US">Lavandulae aetheroleum</desc>
                </concept>
                <concept code="N05C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HYPNOTICS AND SEDATIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="HYPNOTICS AND SEDATIVES" type="fsn">HYPNOTICS AND SEDATIVES</designation>
                    <desc language="en-US">HYPNOTICS AND SEDATIVES</desc>
                </concept>
                <concept code="N05CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Barbiturates, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Barbiturates, plain" type="fsn">Barbiturates, plain</designation>
                    <desc language="en-US">Barbiturates, plain</desc>
                </concept>
                <concept code="N05CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentobarbital" type="fsn">pentobarbital</designation>
                    <desc language="en-US">pentobarbital</desc>
                </concept>
                <concept code="N05CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amobarbital" type="fsn">amobarbital</designation>
                    <desc language="en-US">amobarbital</desc>
                </concept>
                <concept code="N05CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butobarbital" type="fsn">butobarbital</designation>
                    <desc language="en-US">butobarbital</desc>
                </concept>
                <concept code="N05CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="barbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="barbital" type="fsn">barbital</designation>
                    <desc language="en-US">barbital</desc>
                </concept>
                <concept code="N05CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aprobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aprobarbital" type="fsn">aprobarbital</designation>
                    <desc language="en-US">aprobarbital</desc>
                </concept>
                <concept code="N05CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="secobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="secobarbital" type="fsn">secobarbital</designation>
                    <desc language="en-US">secobarbital</desc>
                </concept>
                <concept code="N05CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="talbutal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="talbutal" type="fsn">talbutal</designation>
                    <desc language="en-US">talbutal</desc>
                </concept>
                <concept code="N05CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vinylbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vinylbital" type="fsn">vinylbital</designation>
                    <desc language="en-US">vinylbital</desc>
                </concept>
                <concept code="N05CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vinbarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vinbarbital" type="fsn">vinbarbital</designation>
                    <desc language="en-US">vinbarbital</desc>
                </concept>
                <concept code="N05CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclobarbital" type="fsn">cyclobarbital</designation>
                    <desc language="en-US">cyclobarbital</desc>
                </concept>
                <concept code="N05CA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="heptabarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="heptabarbital" type="fsn">heptabarbital</designation>
                    <desc language="en-US">heptabarbital</desc>
                </concept>
                <concept code="N05CA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reposal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reposal" type="fsn">reposal</designation>
                    <desc language="en-US">reposal</desc>
                </concept>
                <concept code="N05CA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methohexital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methohexital" type="fsn">methohexital</designation>
                    <desc language="en-US">methohexital</desc>
                </concept>
                <concept code="N05CA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexobarbital" type="fsn">hexobarbital</designation>
                    <desc language="en-US">hexobarbital</desc>
                </concept>
                <concept code="N05CA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiopental"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiopental" type="fsn">thiopental</designation>
                    <desc language="en-US">thiopental</desc>
                </concept>
                <concept code="N05CA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etallobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etallobarbital" type="fsn">etallobarbital</designation>
                    <desc language="en-US">etallobarbital</desc>
                </concept>
                <concept code="N05CA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="allobarbital"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="allobarbital" type="fsn">allobarbital</designation>
                    <desc language="en-US">allobarbital</desc>
                </concept>
                <concept code="N05CA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proxibarbal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proxibarbal" type="fsn">proxibarbal</designation>
                    <desc language="en-US">proxibarbal</desc>
                </concept>
                <concept code="N05CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Barbiturates, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Barbiturates, combinations"
                         type="fsn">Barbiturates, combinations</designation>
                    <desc language="en-US">Barbiturates, combinations</desc>
                </concept>
                <concept code="N05CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of barbiturates"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of barbiturates"
                         type="fsn">combinations of barbiturates</designation>
                    <desc language="en-US">combinations of barbiturates</desc>
                </concept>
                <concept code="N05CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="barbiturates in combination with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="barbiturates in combination with other drugs"
                         type="fsn">barbiturates in combination with other drugs</designation>
                    <desc language="en-US">barbiturates in combination with other drugs</desc>
                </concept>
                <concept code="N05CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aldehydes and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Aldehydes and derivatives" type="fsn">Aldehydes and derivatives</designation>
                    <desc language="en-US">Aldehydes and derivatives</desc>
                </concept>
                <concept code="N05CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloral hydrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloral hydrate" type="fsn">chloral hydrate</designation>
                    <desc language="en-US">chloral hydrate</desc>
                </concept>
                <concept code="N05CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloralodol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloralodol" type="fsn">chloralodol</designation>
                    <desc language="en-US">chloralodol</desc>
                </concept>
                <concept code="N05CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylglycinamide chloral hydrate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="acetylglycinamide chloral hydrate"
                         type="fsn">acetylglycinamide chloral hydrate</designation>
                    <desc language="en-US">acetylglycinamide chloral hydrate</desc>
                </concept>
                <concept code="N05CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dichloralphenazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dichloralphenazone" type="fsn">dichloralphenazone</designation>
                    <desc language="en-US">dichloralphenazone</desc>
                </concept>
                <concept code="N05CC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paraldehyde"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paraldehyde" type="fsn">paraldehyde</designation>
                    <desc language="en-US">paraldehyde</desc>
                </concept>
                <concept code="N05CD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Benzodiazepine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Benzodiazepine derivatives"
                         type="fsn">Benzodiazepine derivatives</designation>
                    <desc language="en-US">Benzodiazepine derivatives</desc>
                </concept>
                <concept code="N05CD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flurazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flurazepam" type="fsn">flurazepam</designation>
                    <desc language="en-US">flurazepam</desc>
                </concept>
                <concept code="N05CD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrazepam" type="fsn">nitrazepam</designation>
                    <desc language="en-US">nitrazepam</desc>
                </concept>
                <concept code="N05CD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flunitrazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flunitrazepam" type="fsn">flunitrazepam</designation>
                    <desc language="en-US">flunitrazepam</desc>
                </concept>
                <concept code="N05CD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="estazolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="estazolam" type="fsn">estazolam</designation>
                    <desc language="en-US">estazolam</desc>
                </concept>
                <concept code="N05CD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triazolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triazolam" type="fsn">triazolam</designation>
                    <desc language="en-US">triazolam</desc>
                </concept>
                <concept code="N05CD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lormetazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lormetazepam" type="fsn">lormetazepam</designation>
                    <desc language="en-US">lormetazepam</desc>
                </concept>
                <concept code="N05CD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="temazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="temazepam" type="fsn">temazepam</designation>
                    <desc language="en-US">temazepam</desc>
                </concept>
                <concept code="N05CD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="midazolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="midazolam" type="fsn">midazolam</designation>
                    <desc language="en-US">midazolam</desc>
                </concept>
                <concept code="N05CD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brotizolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brotizolam" type="fsn">brotizolam</designation>
                    <desc language="en-US">brotizolam</desc>
                </concept>
                <concept code="N05CD10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quazepam" type="fsn">quazepam</designation>
                    <desc language="en-US">quazepam</desc>
                </concept>
                <concept code="N05CD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="loprazolam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="loprazolam" type="fsn">loprazolam</designation>
                    <desc language="en-US">loprazolam</desc>
                </concept>
                <concept code="N05CD12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxefazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxefazepam" type="fsn">doxefazepam</designation>
                    <desc language="en-US">doxefazepam</desc>
                </concept>
                <concept code="N05CD13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinolazepam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinolazepam" type="fsn">cinolazepam</designation>
                    <desc language="en-US">cinolazepam</desc>
                </concept>
                <concept code="N05CE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Piperidinedione derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Piperidinedione derivatives"
                         type="fsn">Piperidinedione derivatives</designation>
                    <desc language="en-US">Piperidinedione derivatives</desc>
                </concept>
                <concept code="N05CE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glutethimide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glutethimide" type="fsn">glutethimide</designation>
                    <desc language="en-US">glutethimide</desc>
                </concept>
                <concept code="N05CE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methyprylon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methyprylon" type="fsn">methyprylon</designation>
                    <desc language="en-US">methyprylon</desc>
                </concept>
                <concept code="N05CE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrithyldione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrithyldione" type="fsn">pyrithyldione</designation>
                    <desc language="en-US">pyrithyldione</desc>
                </concept>
                <concept code="N05CF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Benzodiazepine related drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Benzodiazepine related drugs"
                         type="fsn">Benzodiazepine related drugs</designation>
                    <desc language="en-US">Benzodiazepine related drugs</desc>
                </concept>
                <concept code="N05CF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zopiclone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zopiclone" type="fsn">zopiclone</designation>
                    <desc language="en-US">zopiclone</desc>
                </concept>
                <concept code="N05CF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zolpidem"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zolpidem" type="fsn">zolpidem</designation>
                    <desc language="en-US">zolpidem</desc>
                </concept>
                <concept code="N05CF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zaleplon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zaleplon" type="fsn">zaleplon</designation>
                    <desc language="en-US">zaleplon</desc>
                </concept>
                <concept code="N05CF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eszopiclone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eszopiclone" type="fsn">eszopiclone</designation>
                    <desc language="en-US">eszopiclone</desc>
                </concept>
                <concept code="N05CH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Melatonin receptor agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Melatonin receptor agonists"
                         type="fsn">Melatonin receptor agonists</designation>
                    <desc language="en-US">Melatonin receptor agonists</desc>
                </concept>
                <concept code="N05CH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melatonin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="melatonin" type="fsn">melatonin</designation>
                    <desc language="en-US">melatonin</desc>
                </concept>
                <concept code="N05CH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ramelteon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ramelteon" type="fsn">ramelteon</designation>
                    <desc language="en-US">ramelteon</desc>
                </concept>
                <concept code="N05CH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tasimelteon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tasimelteon" type="fsn">tasimelteon</designation>
                    <desc language="en-US">tasimelteon</desc>
                </concept>
                <concept code="N05CM"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other hypnotics and sedatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other hypnotics and sedatives"
                         type="fsn">Other hypnotics and sedatives</designation>
                    <desc language="en-US">Other hypnotics and sedatives</desc>
                </concept>
                <concept code="N05CM01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methaqualone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methaqualone" type="fsn">methaqualone</designation>
                    <desc language="en-US">methaqualone</desc>
                </concept>
                <concept code="N05CM02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clomethiazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clomethiazole" type="fsn">clomethiazole</designation>
                    <desc language="en-US">clomethiazole</desc>
                </concept>
                <concept code="N05CM03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromisoval"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromisoval" type="fsn">bromisoval</designation>
                    <desc language="en-US">bromisoval</desc>
                </concept>
                <concept code="N05CM04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbromal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbromal" type="fsn">carbromal</designation>
                    <desc language="en-US">carbromal</desc>
                </concept>
                <concept code="N05CM05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="scopolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="scopolamine" type="fsn">scopolamine</designation>
                    <desc language="en-US">scopolamine</desc>
                </concept>
                <concept code="N05CM06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propiomazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propiomazine" type="fsn">propiomazine</designation>
                    <desc language="en-US">propiomazine</desc>
                </concept>
                <concept code="N05CM07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triclofos"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triclofos" type="fsn">triclofos</designation>
                    <desc language="en-US">triclofos</desc>
                </concept>
                <concept code="N05CM08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethchlorvynol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethchlorvynol" type="fsn">ethchlorvynol</designation>
                    <desc language="en-US">ethchlorvynol</desc>
                </concept>
                <concept code="N05CM09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Valerianae radix"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Valerianae radix" type="fsn">Valerianae radix</designation>
                    <desc language="en-US">Valerianae radix</desc>
                </concept>
                <concept code="N05CM10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexapropymate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexapropymate" type="fsn">hexapropymate</designation>
                    <desc language="en-US">hexapropymate</desc>
                </concept>
                <concept code="N05CM11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromides" type="fsn">bromides</designation>
                    <desc language="en-US">bromides</desc>
                </concept>
                <concept code="N05CM12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="apronal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="apronal" type="fsn">apronal</designation>
                    <desc language="en-US">apronal</desc>
                </concept>
                <concept code="N05CM13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valnoctamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valnoctamide" type="fsn">valnoctamide</designation>
                    <desc language="en-US">valnoctamide</desc>
                </concept>
                <concept code="N05CM15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylpentynol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylpentynol" type="fsn">methylpentynol</designation>
                    <desc language="en-US">methylpentynol</desc>
                </concept>
                <concept code="N05CM16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="niaprazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="niaprazine" type="fsn">niaprazine</designation>
                    <desc language="en-US">niaprazine</desc>
                </concept>
                <concept code="N05CM18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexmedetomidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexmedetomidine" type="fsn">dexmedetomidine</designation>
                    <desc language="en-US">dexmedetomidine</desc>
                </concept>
                <concept code="N05CM19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="suvorexant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="suvorexant" type="fsn">suvorexant</designation>
                    <desc language="en-US">suvorexant</desc>
                </concept>
                <concept code="N05CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hypnotics and sedatives in combination, excl. barbiturates"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Hypnotics and sedatives in combination, excl. barbiturates"
                         type="fsn">Hypnotics and sedatives in combination, excl. barbiturates</designation>
                    <desc language="en-US">Hypnotics and sedatives in combination, excl. barbiturates</desc>
                </concept>
                <concept code="N05CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meprobamate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meprobamate, combinations" type="fsn">meprobamate, combinations</designation>
                    <desc language="en-US">meprobamate, combinations</desc>
                </concept>
                <concept code="N05CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methaqualone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methaqualone, combinations"
                         type="fsn">methaqualone, combinations</designation>
                    <desc language="en-US">methaqualone, combinations</desc>
                </concept>
                <concept code="N05CX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylpentynol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylpentynol, combinations"
                         type="fsn">methylpentynol, combinations</designation>
                    <desc language="en-US">methylpentynol, combinations</desc>
                </concept>
                <concept code="N05CX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clomethiazole, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="clomethiazole, combinations"
                         type="fsn">clomethiazole, combinations</designation>
                    <desc language="en-US">clomethiazole, combinations</desc>
                </concept>
                <concept code="N05CX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emepronium, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emepronium, combinations" type="fsn">emepronium, combinations</designation>
                    <desc language="en-US">emepronium, combinations</desc>
                </concept>
                <concept code="N05CX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dipiperonylaminoethanol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dipiperonylaminoethanol, combinations"
                         type="fsn">dipiperonylaminoethanol, combinations</designation>
                    <desc language="en-US">dipiperonylaminoethanol, combinations</desc>
                </concept>
                <concept code="N06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PSYCHOANALEPTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PSYCHOANALEPTICS" type="fsn">PSYCHOANALEPTICS</designation>
                    <desc language="en-US">PSYCHOANALEPTICS</desc>
                </concept>
                <concept code="N06A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIDEPRESSANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIDEPRESSANTS" type="fsn">ANTIDEPRESSANTS</designation>
                    <desc language="en-US">ANTIDEPRESSANTS</desc>
                </concept>
                <concept code="N06AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Non-selective monoamine reuptake inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Non-selective monoamine reuptake inhibitors"
                         type="fsn">Non-selective monoamine reuptake inhibitors</designation>
                    <desc language="en-US">Non-selective monoamine reuptake inhibitors</desc>
                </concept>
                <concept code="N06AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desipramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desipramine" type="fsn">desipramine</designation>
                    <desc language="en-US">desipramine</desc>
                </concept>
                <concept code="N06AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imipramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imipramine" type="fsn">imipramine</designation>
                    <desc language="en-US">imipramine</desc>
                </concept>
                <concept code="N06AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="imipramine oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="imipramine oxide" type="fsn">imipramine oxide</designation>
                    <desc language="en-US">imipramine oxide</desc>
                </concept>
                <concept code="N06AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clomipramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clomipramine" type="fsn">clomipramine</designation>
                    <desc language="en-US">clomipramine</desc>
                </concept>
                <concept code="N06AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="opipramol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="opipramol" type="fsn">opipramol</designation>
                    <desc language="en-US">opipramol</desc>
                </concept>
                <concept code="N06AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimipramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimipramine" type="fsn">trimipramine</designation>
                    <desc language="en-US">trimipramine</desc>
                </concept>
                <concept code="N06AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lofepramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lofepramine" type="fsn">lofepramine</designation>
                    <desc language="en-US">lofepramine</desc>
                </concept>
                <concept code="N06AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibenzepin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibenzepin" type="fsn">dibenzepin</designation>
                    <desc language="en-US">dibenzepin</desc>
                </concept>
                <concept code="N06AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amitriptyline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amitriptyline" type="fsn">amitriptyline</designation>
                    <desc language="en-US">amitriptyline</desc>
                </concept>
                <concept code="N06AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nortriptyline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nortriptyline" type="fsn">nortriptyline</designation>
                    <desc language="en-US">nortriptyline</desc>
                </concept>
                <concept code="N06AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="protriptyline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="protriptyline" type="fsn">protriptyline</designation>
                    <desc language="en-US">protriptyline</desc>
                </concept>
                <concept code="N06AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxepin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxepin" type="fsn">doxepin</designation>
                    <desc language="en-US">doxepin</desc>
                </concept>
                <concept code="N06AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iprindole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iprindole" type="fsn">iprindole</designation>
                    <desc language="en-US">iprindole</desc>
                </concept>
                <concept code="N06AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melitracen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="melitracen" type="fsn">melitracen</designation>
                    <desc language="en-US">melitracen</desc>
                </concept>
                <concept code="N06AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butriptyline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butriptyline" type="fsn">butriptyline</designation>
                    <desc language="en-US">butriptyline</desc>
                </concept>
                <concept code="N06AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dosulepin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dosulepin" type="fsn">dosulepin</designation>
                    <desc language="en-US">dosulepin</desc>
                </concept>
                <concept code="N06AA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amoxapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amoxapine" type="fsn">amoxapine</designation>
                    <desc language="en-US">amoxapine</desc>
                </concept>
                <concept code="N06AA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimetacrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimetacrine" type="fsn">dimetacrine</designation>
                    <desc language="en-US">dimetacrine</desc>
                </concept>
                <concept code="N06AA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amineptine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amineptine" type="fsn">amineptine</designation>
                    <desc language="en-US">amineptine</desc>
                </concept>
                <concept code="N06AA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="maprotiline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="maprotiline" type="fsn">maprotiline</designation>
                    <desc language="en-US">maprotiline</desc>
                </concept>
                <concept code="N06AA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinupramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinupramine" type="fsn">quinupramine</designation>
                    <desc language="en-US">quinupramine</desc>
                </concept>
                <concept code="N06AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Selective serotonin reuptake inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Selective serotonin reuptake inhibitors"
                         type="fsn">Selective serotonin reuptake inhibitors</designation>
                    <desc language="en-US">Selective serotonin reuptake inhibitors</desc>
                </concept>
                <concept code="N06AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zimeldine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zimeldine" type="fsn">zimeldine</designation>
                    <desc language="en-US">zimeldine</desc>
                </concept>
                <concept code="N06AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluoxetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluoxetine" type="fsn">fluoxetine</designation>
                    <desc language="en-US">fluoxetine</desc>
                </concept>
                <concept code="N06AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="citalopram"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="citalopram" type="fsn">citalopram</designation>
                    <desc language="en-US">citalopram</desc>
                </concept>
                <concept code="N06AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paroxetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paroxetine" type="fsn">paroxetine</designation>
                    <desc language="en-US">paroxetine</desc>
                </concept>
                <concept code="N06AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sertraline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sertraline" type="fsn">sertraline</designation>
                    <desc language="en-US">sertraline</desc>
                </concept>
                <concept code="N06AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alaproclate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alaproclate" type="fsn">alaproclate</designation>
                    <desc language="en-US">alaproclate</desc>
                </concept>
                <concept code="N06AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluvoxamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluvoxamine" type="fsn">fluvoxamine</designation>
                    <desc language="en-US">fluvoxamine</desc>
                </concept>
                <concept code="N06AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etoperidone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etoperidone" type="fsn">etoperidone</designation>
                    <desc language="en-US">etoperidone</desc>
                </concept>
                <concept code="N06AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="escitalopram"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="escitalopram" type="fsn">escitalopram</designation>
                    <desc language="en-US">escitalopram</desc>
                </concept>
                <concept code="N06AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Monoamine oxidase inhibitors, non-selective"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Monoamine oxidase inhibitors, non-selective"
                         type="fsn">Monoamine oxidase inhibitors, non-selective</designation>
                    <desc language="en-US">Monoamine oxidase inhibitors, non-selective</desc>
                </concept>
                <concept code="N06AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isocarboxazid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isocarboxazid" type="fsn">isocarboxazid</designation>
                    <desc language="en-US">isocarboxazid</desc>
                </concept>
                <concept code="N06AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nialamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nialamide" type="fsn">nialamide</designation>
                    <desc language="en-US">nialamide</desc>
                </concept>
                <concept code="N06AF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenelzine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenelzine" type="fsn">phenelzine</designation>
                    <desc language="en-US">phenelzine</desc>
                </concept>
                <concept code="N06AF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tranylcypromine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tranylcypromine" type="fsn">tranylcypromine</designation>
                    <desc language="en-US">tranylcypromine</desc>
                </concept>
                <concept code="N06AF05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iproniazide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iproniazide" type="fsn">iproniazide</designation>
                    <desc language="en-US">iproniazide</desc>
                </concept>
                <concept code="N06AF06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iproclozide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iproclozide" type="fsn">iproclozide</designation>
                    <desc language="en-US">iproclozide</desc>
                </concept>
                <concept code="N06AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Monoamine oxidase A inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Monoamine oxidase A inhibitors"
                         type="fsn">Monoamine oxidase A inhibitors</designation>
                    <desc language="en-US">Monoamine oxidase A inhibitors</desc>
                </concept>
                <concept code="N06AG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moclobemide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moclobemide" type="fsn">moclobemide</designation>
                    <desc language="en-US">moclobemide</desc>
                </concept>
                <concept code="N06AG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="toloxatone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="toloxatone" type="fsn">toloxatone</designation>
                    <desc language="en-US">toloxatone</desc>
                </concept>
                <concept code="N06AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antidepressants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antidepressants" type="fsn">Other antidepressants</designation>
                    <desc language="en-US">Other antidepressants</desc>
                </concept>
                <concept code="N06AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxitriptan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxitriptan" type="fsn">oxitriptan</designation>
                    <desc language="en-US">oxitriptan</desc>
                </concept>
                <concept code="N06AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tryptophan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tryptophan" type="fsn">tryptophan</designation>
                    <desc language="en-US">tryptophan</desc>
                </concept>
                <concept code="N06AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mianserin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mianserin" type="fsn">mianserin</designation>
                    <desc language="en-US">mianserin</desc>
                </concept>
                <concept code="N06AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nomifensine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nomifensine" type="fsn">nomifensine</designation>
                    <desc language="en-US">nomifensine</desc>
                </concept>
                <concept code="N06AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trazodone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trazodone" type="fsn">trazodone</designation>
                    <desc language="en-US">trazodone</desc>
                </concept>
                <concept code="N06AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nefazodone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nefazodone" type="fsn">nefazodone</designation>
                    <desc language="en-US">nefazodone</desc>
                </concept>
                <concept code="N06AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="minaprine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="minaprine" type="fsn">minaprine</designation>
                    <desc language="en-US">minaprine</desc>
                </concept>
                <concept code="N06AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bifemelane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bifemelane" type="fsn">bifemelane</designation>
                    <desc language="en-US">bifemelane</desc>
                </concept>
                <concept code="N06AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="viloxazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="viloxazine" type="fsn">viloxazine</designation>
                    <desc language="en-US">viloxazine</desc>
                </concept>
                <concept code="N06AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxaflozane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxaflozane" type="fsn">oxaflozane</designation>
                    <desc language="en-US">oxaflozane</desc>
                </concept>
                <concept code="N06AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mirtazapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mirtazapine" type="fsn">mirtazapine</designation>
                    <desc language="en-US">mirtazapine</desc>
                </concept>
                <concept code="N06AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bupropion"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bupropion" type="fsn">bupropion</designation>
                    <desc language="en-US">bupropion</desc>
                </concept>
                <concept code="N06AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medifoxamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medifoxamine" type="fsn">medifoxamine</designation>
                    <desc language="en-US">medifoxamine</desc>
                </concept>
                <concept code="N06AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tianeptine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tianeptine" type="fsn">tianeptine</designation>
                    <desc language="en-US">tianeptine</desc>
                </concept>
                <concept code="N06AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pivagabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pivagabine" type="fsn">pivagabine</designation>
                    <desc language="en-US">pivagabine</desc>
                </concept>
                <concept code="N06AX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="venlafaxine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="venlafaxine" type="fsn">venlafaxine</designation>
                    <desc language="en-US">venlafaxine</desc>
                </concept>
                <concept code="N06AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="milnacipran"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="milnacipran" type="fsn">milnacipran</designation>
                    <desc language="en-US">milnacipran</desc>
                </concept>
                <concept code="N06AX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reboxetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reboxetine" type="fsn">reboxetine</designation>
                    <desc language="en-US">reboxetine</desc>
                </concept>
                <concept code="N06AX19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gepirone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gepirone" type="fsn">gepirone</designation>
                    <desc language="en-US">gepirone</desc>
                </concept>
                <concept code="N06AX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="duloxetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="duloxetine" type="fsn">duloxetine</designation>
                    <desc language="en-US">duloxetine</desc>
                </concept>
                <concept code="N06AX22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="agomelatine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="agomelatine" type="fsn">agomelatine</designation>
                    <desc language="en-US">agomelatine</desc>
                </concept>
                <concept code="N06AX23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desvenlafaxine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desvenlafaxine" type="fsn">desvenlafaxine</designation>
                    <desc language="en-US">desvenlafaxine</desc>
                </concept>
                <concept code="N06AX24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vilazodone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vilazodone" type="fsn">vilazodone</designation>
                    <desc language="en-US">vilazodone</desc>
                </concept>
                <concept code="N06AX25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hyperici herba"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Hyperici herba" type="fsn">Hyperici herba</designation>
                    <desc language="en-US">Hyperici herba</desc>
                </concept>
                <concept code="N06AX26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vortioxetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vortioxetine" type="fsn">vortioxetine</designation>
                    <desc language="en-US">vortioxetine</desc>
                </concept>
                <concept code="N06B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS"
                         type="fsn">PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS</designation>
                    <desc language="en-US">PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS</desc>
                </concept>
                <concept code="N06BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Centrally acting sympathomimetics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Centrally acting sympathomimetics"
                         type="fsn">Centrally acting sympathomimetics</designation>
                    <desc language="en-US">Centrally acting sympathomimetics</desc>
                </concept>
                <concept code="N06BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amfetamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amfetamine" type="fsn">amfetamine</designation>
                    <desc language="en-US">amfetamine</desc>
                </concept>
                <concept code="N06BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamfetamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamfetamine" type="fsn">dexamfetamine</designation>
                    <desc language="en-US">dexamfetamine</desc>
                </concept>
                <concept code="N06BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metamfetamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metamfetamine" type="fsn">metamfetamine</designation>
                    <desc language="en-US">metamfetamine</desc>
                </concept>
                <concept code="N06BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylphenidate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylphenidate" type="fsn">methylphenidate</designation>
                    <desc language="en-US">methylphenidate</desc>
                </concept>
                <concept code="N06BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pemoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pemoline" type="fsn">pemoline</designation>
                    <desc language="en-US">pemoline</desc>
                </concept>
                <concept code="N06BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fencamfamin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fencamfamin" type="fsn">fencamfamin</designation>
                    <desc language="en-US">fencamfamin</desc>
                </concept>
                <concept code="N06BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="modafinil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="modafinil" type="fsn">modafinil</designation>
                    <desc language="en-US">modafinil</desc>
                </concept>
                <concept code="N06BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenozolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenozolone" type="fsn">fenozolone</designation>
                    <desc language="en-US">fenozolone</desc>
                </concept>
                <concept code="N06BA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atomoxetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atomoxetine" type="fsn">atomoxetine</designation>
                    <desc language="en-US">atomoxetine</desc>
                </concept>
                <concept code="N06BA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenetylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenetylline" type="fsn">fenetylline</designation>
                    <desc language="en-US">fenetylline</desc>
                </concept>
                <concept code="N06BA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexmethylphenidate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexmethylphenidate" type="fsn">dexmethylphenidate</designation>
                    <desc language="en-US">dexmethylphenidate</desc>
                </concept>
                <concept code="N06BA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lisdexamfetamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lisdexamfetamine" type="fsn">lisdexamfetamine</designation>
                    <desc language="en-US">lisdexamfetamine</desc>
                </concept>
                <concept code="N06BA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="armodafinil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="armodafinil" type="fsn">armodafinil</designation>
                    <desc language="en-US">armodafinil</desc>
                </concept>
                <concept code="N06BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Xanthine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Xanthine derivatives" type="fsn">Xanthine derivatives</designation>
                    <desc language="en-US">Xanthine derivatives</desc>
                </concept>
                <concept code="N06BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="caffeine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="caffeine" type="fsn">caffeine</designation>
                    <desc language="en-US">caffeine</desc>
                </concept>
                <concept code="N06BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propentofylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propentofylline" type="fsn">propentofylline</designation>
                    <desc language="en-US">propentofylline</desc>
                </concept>
                <concept code="N06BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other psychostimulants and nootropics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other psychostimulants and nootropics"
                         type="fsn">Other psychostimulants and nootropics</designation>
                    <desc language="en-US">Other psychostimulants and nootropics</desc>
                </concept>
                <concept code="N06BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meclofenoxate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meclofenoxate" type="fsn">meclofenoxate</designation>
                    <desc language="en-US">meclofenoxate</desc>
                </concept>
                <concept code="N06BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyritinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyritinol" type="fsn">pyritinol</designation>
                    <desc language="en-US">pyritinol</desc>
                </concept>
                <concept code="N06BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piracetam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piracetam" type="fsn">piracetam</designation>
                    <desc language="en-US">piracetam</desc>
                </concept>
                <concept code="N06BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deanol" type="fsn">deanol</designation>
                    <desc language="en-US">deanol</desc>
                </concept>
                <concept code="N06BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fipexide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fipexide" type="fsn">fipexide</designation>
                    <desc language="en-US">fipexide</desc>
                </concept>
                <concept code="N06BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="citicoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="citicoline" type="fsn">citicoline</designation>
                    <desc language="en-US">citicoline</desc>
                </concept>
                <concept code="N06BX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxiracetam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxiracetam" type="fsn">oxiracetam</designation>
                    <desc language="en-US">oxiracetam</desc>
                </concept>
                <concept code="N06BX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pirisudanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pirisudanol" type="fsn">pirisudanol</designation>
                    <desc language="en-US">pirisudanol</desc>
                </concept>
                <concept code="N06BX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="linopirdine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="linopirdine" type="fsn">linopirdine</designation>
                    <desc language="en-US">linopirdine</desc>
                </concept>
                <concept code="N06BX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nizofenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nizofenone" type="fsn">nizofenone</designation>
                    <desc language="en-US">nizofenone</desc>
                </concept>
                <concept code="N06BX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aniracetam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aniracetam" type="fsn">aniracetam</designation>
                    <desc language="en-US">aniracetam</desc>
                </concept>
                <concept code="N06BX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylcarnitine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylcarnitine" type="fsn">acetylcarnitine</designation>
                    <desc language="en-US">acetylcarnitine</desc>
                </concept>
                <concept code="N06BX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idebenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idebenone" type="fsn">idebenone</designation>
                    <desc language="en-US">idebenone</desc>
                </concept>
                <concept code="N06BX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prolintane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prolintane" type="fsn">prolintane</designation>
                    <desc language="en-US">prolintane</desc>
                </concept>
                <concept code="N06BX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipradrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pipradrol" type="fsn">pipradrol</designation>
                    <desc language="en-US">pipradrol</desc>
                </concept>
                <concept code="N06BX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pramiracetam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pramiracetam" type="fsn">pramiracetam</designation>
                    <desc language="en-US">pramiracetam</desc>
                </concept>
                <concept code="N06BX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adrafinil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adrafinil" type="fsn">adrafinil</designation>
                    <desc language="en-US">adrafinil</desc>
                </concept>
                <concept code="N06BX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vinpocetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vinpocetine" type="fsn">vinpocetine</designation>
                    <desc language="en-US">vinpocetine</desc>
                </concept>
                <concept code="N06BX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mebicar"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mebicar" type="fsn">mebicar</designation>
                    <desc language="en-US">mebicar</desc>
                </concept>
                <concept code="N06BX22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenibut"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenibut" type="fsn">phenibut</designation>
                    <desc language="en-US">phenibut</desc>
                </concept>
                <concept code="N06C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION"
                         type="fsn">PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION</designation>
                    <desc language="en-US">PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION</desc>
                </concept>
                <concept code="N06CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antidepressants in combination with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antidepressants in combination with psycholeptics"
                         type="fsn">Antidepressants in combination with psycholeptics</designation>
                    <desc language="en-US">Antidepressants in combination with psycholeptics</desc>
                </concept>
                <concept code="N06CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amitriptyline and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="amitriptyline and psycholeptics"
                         type="fsn">amitriptyline and psycholeptics</designation>
                    <desc language="en-US">amitriptyline and psycholeptics</desc>
                </concept>
                <concept code="N06CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melitracen and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="melitracen and psycholeptics"
                         type="fsn">melitracen and psycholeptics</designation>
                    <desc language="en-US">melitracen and psycholeptics</desc>
                </concept>
                <concept code="N06CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluoxetine and psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluoxetine and psycholeptics"
                         type="fsn">fluoxetine and psycholeptics</designation>
                    <desc language="en-US">fluoxetine and psycholeptics</desc>
                </concept>
                <concept code="N06CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Psychostimulants in combination with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Psychostimulants in combination with psycholeptics"
                         type="fsn">Psychostimulants in combination with psycholeptics</designation>
                    <desc language="en-US">Psychostimulants in combination with psycholeptics</desc>
                </concept>
                <concept code="N06D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTI-DEMENTIA DRUGS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTI-DEMENTIA DRUGS" type="fsn">ANTI-DEMENTIA DRUGS</designation>
                    <desc language="en-US">ANTI-DEMENTIA DRUGS</desc>
                </concept>
                <concept code="N06DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anticholinesterases"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anticholinesterases" type="fsn">Anticholinesterases</designation>
                    <desc language="en-US">Anticholinesterases</desc>
                </concept>
                <concept code="N06DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tacrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tacrine" type="fsn">tacrine</designation>
                    <desc language="en-US">tacrine</desc>
                </concept>
                <concept code="N06DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="donepezil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="donepezil" type="fsn">donepezil</designation>
                    <desc language="en-US">donepezil</desc>
                </concept>
                <concept code="N06DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rivastigmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rivastigmine" type="fsn">rivastigmine</designation>
                    <desc language="en-US">rivastigmine</desc>
                </concept>
                <concept code="N06DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="galantamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="galantamine" type="fsn">galantamine</designation>
                    <desc language="en-US">galantamine</desc>
                </concept>
                <concept code="N06DA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ipidacrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ipidacrine" type="fsn">ipidacrine</designation>
                    <desc language="en-US">ipidacrine</desc>
                </concept>
                <concept code="N06DA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="donepezil and memantine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="donepezil and memantine" type="fsn">donepezil and memantine</designation>
                    <desc language="en-US">donepezil and memantine</desc>
                </concept>
                <concept code="N06DA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="donepezil, memantine and Ginkgo folium"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="donepezil, memantine and Ginkgo folium"
                         type="fsn">donepezil, memantine and Ginkgo folium</designation>
                    <desc language="en-US">donepezil, memantine and Ginkgo folium</desc>
                </concept>
                <concept code="N06DX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other anti-dementia drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other anti-dementia drugs" type="fsn">Other anti-dementia drugs</designation>
                    <desc language="en-US">Other anti-dementia drugs</desc>
                </concept>
                <concept code="N06DX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="memantine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="memantine" type="fsn">memantine</designation>
                    <desc language="en-US">memantine</desc>
                </concept>
                <concept code="N06DX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ginkgo folium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Ginkgo folium" type="fsn">Ginkgo folium</designation>
                    <desc language="en-US">Ginkgo folium</desc>
                </concept>
                <concept code="N06DX30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="N07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER NERVOUS SYSTEM DRUGS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER NERVOUS SYSTEM DRUGS"
                         type="fsn">OTHER NERVOUS SYSTEM DRUGS</designation>
                    <desc language="en-US">OTHER NERVOUS SYSTEM DRUGS</desc>
                </concept>
                <concept code="N07A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PARASYMPATHOMIMETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PARASYMPATHOMIMETICS" type="fsn">PARASYMPATHOMIMETICS</designation>
                    <desc language="en-US">PARASYMPATHOMIMETICS</desc>
                </concept>
                <concept code="N07AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anticholinesterases"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anticholinesterases" type="fsn">Anticholinesterases</designation>
                    <desc language="en-US">Anticholinesterases</desc>
                </concept>
                <concept code="N07AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neostigmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neostigmine" type="fsn">neostigmine</designation>
                    <desc language="en-US">neostigmine</desc>
                </concept>
                <concept code="N07AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyridostigmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyridostigmine" type="fsn">pyridostigmine</designation>
                    <desc language="en-US">pyridostigmine</desc>
                </concept>
                <concept code="N07AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="distigmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="distigmine" type="fsn">distigmine</designation>
                    <desc language="en-US">distigmine</desc>
                </concept>
                <concept code="N07AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ambenonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ambenonium" type="fsn">ambenonium</designation>
                    <desc language="en-US">ambenonium</desc>
                </concept>
                <concept code="N07AA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neostigmine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neostigmine, combinations" type="fsn">neostigmine, combinations</designation>
                    <desc language="en-US">neostigmine, combinations</desc>
                </concept>
                <concept code="N07AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Choline esters"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Choline esters" type="fsn">Choline esters</designation>
                    <desc language="en-US">Choline esters</desc>
                </concept>
                <concept code="N07AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbachol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbachol" type="fsn">carbachol</designation>
                    <desc language="en-US">carbachol</desc>
                </concept>
                <concept code="N07AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bethanechol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bethanechol" type="fsn">bethanechol</designation>
                    <desc language="en-US">bethanechol</desc>
                </concept>
                <concept code="N07AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other parasympathomimetics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other parasympathomimetics"
                         type="fsn">Other parasympathomimetics</designation>
                    <desc language="en-US">Other parasympathomimetics</desc>
                </concept>
                <concept code="N07AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pilocarpine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pilocarpine" type="fsn">pilocarpine</designation>
                    <desc language="en-US">pilocarpine</desc>
                </concept>
                <concept code="N07AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="choline alfoscerate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="choline alfoscerate" type="fsn">choline alfoscerate</designation>
                    <desc language="en-US">choline alfoscerate</desc>
                </concept>
                <concept code="N07AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cevimeline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cevimeline" type="fsn">cevimeline</designation>
                    <desc language="en-US">cevimeline</desc>
                </concept>
                <concept code="N07B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS USED IN ADDICTIVE DISORDERS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS USED IN ADDICTIVE DISORDERS"
                         type="fsn">DRUGS USED IN ADDICTIVE DISORDERS</designation>
                    <desc language="en-US">DRUGS USED IN ADDICTIVE DISORDERS</desc>
                </concept>
                <concept code="N07BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs used in nicotine dependence"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs used in nicotine dependence"
                         type="fsn">Drugs used in nicotine dependence</designation>
                    <desc language="en-US">Drugs used in nicotine dependence</desc>
                </concept>
                <concept code="N07BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nicotine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nicotine" type="fsn">nicotine</designation>
                    <desc language="en-US">nicotine</desc>
                </concept>
                <concept code="N07BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="varenicline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="varenicline" type="fsn">varenicline</designation>
                    <desc language="en-US">varenicline</desc>
                </concept>
                <concept code="N07BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cytisine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cytisine" type="fsn">cytisine</designation>
                    <desc language="en-US">cytisine</desc>
                </concept>
                <concept code="N07BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs used in alcohol dependence"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs used in alcohol dependence"
                         type="fsn">Drugs used in alcohol dependence</designation>
                    <desc language="en-US">Drugs used in alcohol dependence</desc>
                </concept>
                <concept code="N07BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="disulfiram"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="disulfiram" type="fsn">disulfiram</designation>
                    <desc language="en-US">disulfiram</desc>
                </concept>
                <concept code="N07BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium carbimide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium carbimide" type="fsn">calcium carbimide</designation>
                    <desc language="en-US">calcium carbimide</desc>
                </concept>
                <concept code="N07BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acamprosate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acamprosate" type="fsn">acamprosate</designation>
                    <desc language="en-US">acamprosate</desc>
                </concept>
                <concept code="N07BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naltrexone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naltrexone" type="fsn">naltrexone</designation>
                    <desc language="en-US">naltrexone</desc>
                </concept>
                <concept code="N07BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nalmefene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nalmefene" type="fsn">nalmefene</designation>
                    <desc language="en-US">nalmefene</desc>
                </concept>
                <concept code="N07BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs used in opioid dependence"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs used in opioid dependence"
                         type="fsn">Drugs used in opioid dependence</designation>
                    <desc language="en-US">Drugs used in opioid dependence</desc>
                </concept>
                <concept code="N07BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buprenorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buprenorphine" type="fsn">buprenorphine</designation>
                    <desc language="en-US">buprenorphine</desc>
                </concept>
                <concept code="N07BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methadone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methadone" type="fsn">methadone</designation>
                    <desc language="en-US">methadone</desc>
                </concept>
                <concept code="N07BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levacetylmethadol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levacetylmethadol" type="fsn">levacetylmethadol</designation>
                    <desc language="en-US">levacetylmethadol</desc>
                </concept>
                <concept code="N07BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lofexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lofexidine" type="fsn">lofexidine</designation>
                    <desc language="en-US">lofexidine</desc>
                </concept>
                <concept code="N07BC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levomethadone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levomethadone" type="fsn">levomethadone</designation>
                    <desc language="en-US">levomethadone</desc>
                </concept>
                <concept code="N07BC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diamorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diamorphine" type="fsn">diamorphine</designation>
                    <desc language="en-US">diamorphine</desc>
                </concept>
                <concept code="N07BC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buprenorphine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="buprenorphine, combinations"
                         type="fsn">buprenorphine, combinations</designation>
                    <desc language="en-US">buprenorphine, combinations</desc>
                </concept>
                <concept code="N07C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIVERTIGO PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIVERTIGO PREPARATIONS" type="fsn">ANTIVERTIGO PREPARATIONS</designation>
                    <desc language="en-US">ANTIVERTIGO PREPARATIONS</desc>
                </concept>
                <concept code="N07CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antivertigo preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antivertigo preparations" type="fsn">Antivertigo preparations</designation>
                    <desc language="en-US">Antivertigo preparations</desc>
                </concept>
                <concept code="N07CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betahistine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betahistine" type="fsn">betahistine</designation>
                    <desc language="en-US">betahistine</desc>
                </concept>
                <concept code="N07CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinnarizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinnarizine" type="fsn">cinnarizine</designation>
                    <desc language="en-US">cinnarizine</desc>
                </concept>
                <concept code="N07CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flunarizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flunarizine" type="fsn">flunarizine</designation>
                    <desc language="en-US">flunarizine</desc>
                </concept>
                <concept code="N07CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylleucine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylleucine" type="fsn">acetylleucine</designation>
                    <desc language="en-US">acetylleucine</desc>
                </concept>
                <concept code="N07CA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinnarizine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinnarizine, combinations" type="fsn">cinnarizine, combinations</designation>
                    <desc language="en-US">cinnarizine, combinations</desc>
                </concept>
                <concept code="N07X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER NERVOUS SYSTEM DRUGS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER NERVOUS SYSTEM DRUGS"
                         type="fsn">OTHER NERVOUS SYSTEM DRUGS</designation>
                    <desc language="en-US">OTHER NERVOUS SYSTEM DRUGS</desc>
                </concept>
                <concept code="N07XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Gangliosides and ganglioside derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Gangliosides and ganglioside derivatives"
                         type="fsn">Gangliosides and ganglioside derivatives</designation>
                    <desc language="en-US">Gangliosides and ganglioside derivatives</desc>
                </concept>
                <concept code="N07XX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other nervous system drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other nervous system drugs"
                         type="fsn">Other nervous system drugs</designation>
                    <desc language="en-US">Other nervous system drugs</desc>
                </concept>
                <concept code="N07XX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tirilazad"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tirilazad" type="fsn">tirilazad</designation>
                    <desc language="en-US">tirilazad</desc>
                </concept>
                <concept code="N07XX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="riluzole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="riluzole" type="fsn">riluzole</designation>
                    <desc language="en-US">riluzole</desc>
                </concept>
                <concept code="N07XX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xaliproden"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xaliproden" type="fsn">xaliproden</designation>
                    <desc language="en-US">xaliproden</desc>
                </concept>
                <concept code="N07XX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium oxybate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium oxybate" type="fsn">sodium oxybate</designation>
                    <desc language="en-US">sodium oxybate</desc>
                </concept>
                <concept code="N07XX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amifampridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amifampridine" type="fsn">amifampridine</designation>
                    <desc language="en-US">amifampridine</desc>
                </concept>
                <concept code="N07XX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetrabenazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetrabenazine" type="fsn">tetrabenazine</designation>
                    <desc language="en-US">tetrabenazine</desc>
                </concept>
                <concept code="N07XX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fampridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fampridine" type="fsn">fampridine</designation>
                    <desc language="en-US">fampridine</desc>
                </concept>
                <concept code="N07XX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tafamidis"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tafamidis" type="fsn">tafamidis</designation>
                    <desc language="en-US">tafamidis</desc>
                </concept>
                <concept code="N07XX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="laquinimod"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="laquinimod" type="fsn">laquinimod</designation>
                    <desc language="en-US">laquinimod</desc>
                </concept>
                <concept code="N07XX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pitolisant"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pitolisant" type="fsn">pitolisant</designation>
                    <desc language="en-US">pitolisant</desc>
                </concept>
                <concept code="N07XX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="patisiran"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="patisiran" type="fsn">patisiran</designation>
                    <desc language="en-US">patisiran</desc>
                </concept>
                <concept code="N07XX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="valbenazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="valbenazine" type="fsn">valbenazine</designation>
                    <desc language="en-US">valbenazine</desc>
                </concept>
                <concept code="N07XX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="edaravone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="edaravone" type="fsn">edaravone</designation>
                    <desc language="en-US">edaravone</desc>
                </concept>
                <concept code="N07XX59"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextromethorphan, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dextromethorphan, combinations"
                         type="fsn">dextromethorphan, combinations</designation>
                    <desc language="en-US">dextromethorphan, combinations</desc>
                </concept>
                <concept code="P"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
                         type="fsn">ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS</designation>
                    <desc language="en-US">ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS</desc>
                </concept>
                <concept code="P01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIPROTOZOALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIPROTOZOALS" type="fsn">ANTIPROTOZOALS</designation>
                    <desc language="en-US">ANTIPROTOZOALS</desc>
                </concept>
                <concept code="P01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES"
                         type="fsn">AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES</designation>
                    <desc language="en-US">AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES</desc>
                </concept>
                <concept code="P01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hydroxyquinoline derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Hydroxyquinoline derivatives"
                         type="fsn">Hydroxyquinoline derivatives</designation>
                    <desc language="en-US">Hydroxyquinoline derivatives</desc>
                </concept>
                <concept code="P01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="broxyquinoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="broxyquinoline" type="fsn">broxyquinoline</designation>
                    <desc language="en-US">broxyquinoline</desc>
                </concept>
                <concept code="P01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clioquinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clioquinol" type="fsn">clioquinol</designation>
                    <desc language="en-US">clioquinol</desc>
                </concept>
                <concept code="P01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorquinaldol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorquinaldol" type="fsn">chlorquinaldol</designation>
                    <desc language="en-US">chlorquinaldol</desc>
                </concept>
                <concept code="P01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tilbroquinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tilbroquinol" type="fsn">tilbroquinol</designation>
                    <desc language="en-US">tilbroquinol</desc>
                </concept>
                <concept code="P01AA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clioquinol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clioquinol, combinations" type="fsn">clioquinol, combinations</designation>
                    <desc language="en-US">clioquinol, combinations</desc>
                </concept>
                <concept code="P01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nitroimidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nitroimidazole derivatives"
                         type="fsn">Nitroimidazole derivatives</designation>
                    <desc language="en-US">Nitroimidazole derivatives</desc>
                </concept>
                <concept code="P01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metronidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metronidazole" type="fsn">metronidazole</designation>
                    <desc language="en-US">metronidazole</desc>
                </concept>
                <concept code="P01AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tinidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tinidazole" type="fsn">tinidazole</designation>
                    <desc language="en-US">tinidazole</desc>
                </concept>
                <concept code="P01AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ornidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ornidazole" type="fsn">ornidazole</designation>
                    <desc language="en-US">ornidazole</desc>
                </concept>
                <concept code="P01AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azanidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azanidazole" type="fsn">azanidazole</designation>
                    <desc language="en-US">azanidazole</desc>
                </concept>
                <concept code="P01AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propenidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propenidazole" type="fsn">propenidazole</designation>
                    <desc language="en-US">propenidazole</desc>
                </concept>
                <concept code="P01AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nimorazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nimorazole" type="fsn">nimorazole</designation>
                    <desc language="en-US">nimorazole</desc>
                </concept>
                <concept code="P01AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="secnidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="secnidazole" type="fsn">secnidazole</designation>
                    <desc language="en-US">secnidazole</desc>
                </concept>
                <concept code="P01AB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metronidazole, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metronidazole, combinations"
                         type="fsn">metronidazole, combinations</designation>
                    <desc language="en-US">metronidazole, combinations</desc>
                </concept>
                <concept code="P01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Dichloroacetamide derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Dichloroacetamide derivatives"
                         type="fsn">Dichloroacetamide derivatives</designation>
                    <desc language="en-US">Dichloroacetamide derivatives</desc>
                </concept>
                <concept code="P01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diloxanide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diloxanide" type="fsn">diloxanide</designation>
                    <desc language="en-US">diloxanide</desc>
                </concept>
                <concept code="P01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clefamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clefamide" type="fsn">clefamide</designation>
                    <desc language="en-US">clefamide</desc>
                </concept>
                <concept code="P01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etofamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etofamide" type="fsn">etofamide</designation>
                    <desc language="en-US">etofamide</desc>
                </concept>
                <concept code="P01AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="teclozan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="teclozan" type="fsn">teclozan</designation>
                    <desc language="en-US">teclozan</desc>
                </concept>
                <concept code="P01AR"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Arsenic compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Arsenic compounds" type="fsn">Arsenic compounds</designation>
                    <desc language="en-US">Arsenic compounds</desc>
                </concept>
                <concept code="P01AR01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="arsthinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="arsthinol" type="fsn">arsthinol</designation>
                    <desc language="en-US">arsthinol</desc>
                </concept>
                <concept code="P01AR02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="difetarsone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="difetarsone" type="fsn">difetarsone</designation>
                    <desc language="en-US">difetarsone</desc>
                </concept>
                <concept code="P01AR03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycobiarsol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glycobiarsol" type="fsn">glycobiarsol</designation>
                    <desc language="en-US">glycobiarsol</desc>
                </concept>
                <concept code="P01AR53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycobiarsol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="glycobiarsol, combinations"
                         type="fsn">glycobiarsol, combinations</designation>
                    <desc language="en-US">glycobiarsol, combinations</desc>
                </concept>
                <concept code="P01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other agents against amoebiasis and other protozoal diseases"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other agents against amoebiasis and other protozoal diseases"
                         type="fsn">Other agents against amoebiasis and other protozoal diseases</designation>
                    <desc language="en-US">Other agents against amoebiasis and other protozoal diseases</desc>
                </concept>
                <concept code="P01AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chiniofon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chiniofon" type="fsn">chiniofon</designation>
                    <desc language="en-US">chiniofon</desc>
                </concept>
                <concept code="P01AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emetine" type="fsn">emetine</designation>
                    <desc language="en-US">emetine</desc>
                </concept>
                <concept code="P01AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phanquinone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phanquinone" type="fsn">phanquinone</designation>
                    <desc language="en-US">phanquinone</desc>
                </concept>
                <concept code="P01AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepacrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepacrine" type="fsn">mepacrine</designation>
                    <desc language="en-US">mepacrine</desc>
                </concept>
                <concept code="P01AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atovaquone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atovaquone" type="fsn">atovaquone</designation>
                    <desc language="en-US">atovaquone</desc>
                </concept>
                <concept code="P01AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimetrexate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimetrexate" type="fsn">trimetrexate</designation>
                    <desc language="en-US">trimetrexate</desc>
                </concept>
                <concept code="P01AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tenonitrozole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tenonitrozole" type="fsn">tenonitrozole</designation>
                    <desc language="en-US">tenonitrozole</desc>
                </concept>
                <concept code="P01AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dehydroemetine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dehydroemetine" type="fsn">dehydroemetine</designation>
                    <desc language="en-US">dehydroemetine</desc>
                </concept>
                <concept code="P01AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fumagillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fumagillin" type="fsn">fumagillin</designation>
                    <desc language="en-US">fumagillin</desc>
                </concept>
                <concept code="P01AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitazoxanide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitazoxanide" type="fsn">nitazoxanide</designation>
                    <desc language="en-US">nitazoxanide</desc>
                </concept>
                <concept code="P01AX52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emetine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emetine, combinations" type="fsn">emetine, combinations</designation>
                    <desc language="en-US">emetine, combinations</desc>
                </concept>
                <concept code="P01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIMALARIALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIMALARIALS" type="fsn">ANTIMALARIALS</designation>
                    <desc language="en-US">ANTIMALARIALS</desc>
                </concept>
                <concept code="P01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aminoquinolines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Aminoquinolines" type="fsn">Aminoquinolines</designation>
                    <desc language="en-US">Aminoquinolines</desc>
                </concept>
                <concept code="P01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloroquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloroquine" type="fsn">chloroquine</designation>
                    <desc language="en-US">chloroquine</desc>
                </concept>
                <concept code="P01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxychloroquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxychloroquine" type="fsn">hydroxychloroquine</designation>
                    <desc language="en-US">hydroxychloroquine</desc>
                </concept>
                <concept code="P01BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="primaquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="primaquine" type="fsn">primaquine</designation>
                    <desc language="en-US">primaquine</desc>
                </concept>
                <concept code="P01BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amodiaquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amodiaquine" type="fsn">amodiaquine</designation>
                    <desc language="en-US">amodiaquine</desc>
                </concept>
                <concept code="P01BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Biguanides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Biguanides" type="fsn">Biguanides</designation>
                    <desc language="en-US">Biguanides</desc>
                </concept>
                <concept code="P01BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proguanil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proguanil" type="fsn">proguanil</designation>
                    <desc language="en-US">proguanil</desc>
                </concept>
                <concept code="P01BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cycloguanil embonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cycloguanil embonate" type="fsn">cycloguanil embonate</designation>
                    <desc language="en-US">cycloguanil embonate</desc>
                </concept>
                <concept code="P01BB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proguanil, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proguanil, combinations" type="fsn">proguanil, combinations</designation>
                    <desc language="en-US">proguanil, combinations</desc>
                </concept>
                <concept code="P01BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Methanolquinolines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Methanolquinolines" type="fsn">Methanolquinolines</designation>
                    <desc language="en-US">Methanolquinolines</desc>
                </concept>
                <concept code="P01BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quinine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quinine" type="fsn">quinine</designation>
                    <desc language="en-US">quinine</desc>
                </concept>
                <concept code="P01BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mefloquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mefloquine" type="fsn">mefloquine</designation>
                    <desc language="en-US">mefloquine</desc>
                </concept>
                <concept code="P01BD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Diaminopyrimidines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Diaminopyrimidines" type="fsn">Diaminopyrimidines</designation>
                    <desc language="en-US">Diaminopyrimidines</desc>
                </concept>
                <concept code="P01BD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrimethamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrimethamine" type="fsn">pyrimethamine</designation>
                    <desc language="en-US">pyrimethamine</desc>
                </concept>
                <concept code="P01BD51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrimethamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pyrimethamine, combinations"
                         type="fsn">pyrimethamine, combinations</designation>
                    <desc language="en-US">pyrimethamine, combinations</desc>
                </concept>
                <concept code="P01BE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Artemisinin and derivatives, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Artemisinin and derivatives, plain"
                         type="fsn">Artemisinin and derivatives, plain</designation>
                    <desc language="en-US">Artemisinin and derivatives, plain</desc>
                </concept>
                <concept code="P01BE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artemisinin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="artemisinin" type="fsn">artemisinin</designation>
                    <desc language="en-US">artemisinin</desc>
                </concept>
                <concept code="P01BE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artemether"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="artemether" type="fsn">artemether</designation>
                    <desc language="en-US">artemether</desc>
                </concept>
                <concept code="P01BE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artesunate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="artesunate" type="fsn">artesunate</designation>
                    <desc language="en-US">artesunate</desc>
                </concept>
                <concept code="P01BE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artemotil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="artemotil" type="fsn">artemotil</designation>
                    <desc language="en-US">artemotil</desc>
                </concept>
                <concept code="P01BE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artenimol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="artenimol" type="fsn">artenimol</designation>
                    <desc language="en-US">artenimol</desc>
                </concept>
                <concept code="P01BF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Artemisinin and derivatives, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Artemisinin and derivatives, combinations"
                         type="fsn">Artemisinin and derivatives, combinations</designation>
                    <desc language="en-US">Artemisinin and derivatives, combinations</desc>
                </concept>
                <concept code="P01BF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artemether and lumefantrine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="artemether and lumefantrine"
                         type="fsn">artemether and lumefantrine</designation>
                    <desc language="en-US">artemether and lumefantrine</desc>
                </concept>
                <concept code="P01BF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artesunate and mefloquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="artesunate and mefloquine" type="fsn">artesunate and mefloquine</designation>
                    <desc language="en-US">artesunate and mefloquine</desc>
                </concept>
                <concept code="P01BF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artesunate and amodiaquine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="artesunate and amodiaquine"
                         type="fsn">artesunate and amodiaquine</designation>
                    <desc language="en-US">artesunate and amodiaquine</desc>
                </concept>
                <concept code="P01BF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artesunate, sulphamethopyrazine and pyrimethamine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="artesunate, sulphamethopyrazine and pyrimethamine"
                         type="fsn">artesunate, sulphamethopyrazine and pyrimethamine</designation>
                    <desc language="en-US">artesunate, sulphamethopyrazine and pyrimethamine</desc>
                </concept>
                <concept code="P01BF05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artenimol and piperaquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="artenimol and piperaquine" type="fsn">artenimol and piperaquine</designation>
                    <desc language="en-US">artenimol and piperaquine</desc>
                </concept>
                <concept code="P01BF06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artesunate and pyronaridine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="artesunate and pyronaridine"
                         type="fsn">artesunate and pyronaridine</designation>
                    <desc language="en-US">artesunate and pyronaridine</desc>
                </concept>
                <concept code="P01BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antimalarials"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antimalarials" type="fsn">Other antimalarials</designation>
                    <desc language="en-US">Other antimalarials</desc>
                </concept>
                <concept code="P01BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="halofantrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="halofantrine" type="fsn">halofantrine</designation>
                    <desc language="en-US">halofantrine</desc>
                </concept>
                <concept code="P01BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="arterolane and piperaquine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="arterolane and piperaquine"
                         type="fsn">arterolane and piperaquine</designation>
                    <desc language="en-US">arterolane and piperaquine</desc>
                </concept>
                <concept code="P01C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS"
                         type="fsn">AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS</designation>
                    <desc language="en-US">AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS</desc>
                </concept>
                <concept code="P01CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nitroimidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nitroimidazole derivatives"
                         type="fsn">Nitroimidazole derivatives</designation>
                    <desc language="en-US">Nitroimidazole derivatives</desc>
                </concept>
                <concept code="P01CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benznidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benznidazole" type="fsn">benznidazole</designation>
                    <desc language="en-US">benznidazole</desc>
                </concept>
                <concept code="P01CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fexinidazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fexinidazole" type="fsn">fexinidazole</designation>
                    <desc language="en-US">fexinidazole</desc>
                </concept>
                <concept code="P01CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antimony compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antimony compounds" type="fsn">Antimony compounds</designation>
                    <desc language="en-US">Antimony compounds</desc>
                </concept>
                <concept code="P01CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meglumine antimonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meglumine antimonate" type="fsn">meglumine antimonate</designation>
                    <desc language="en-US">meglumine antimonate</desc>
                </concept>
                <concept code="P01CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium stibogluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium stibogluconate" type="fsn">sodium stibogluconate</designation>
                    <desc language="en-US">sodium stibogluconate</desc>
                </concept>
                <concept code="P01CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nitrofuran derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Nitrofuran derivatives" type="fsn">Nitrofuran derivatives</designation>
                    <desc language="en-US">Nitrofuran derivatives</desc>
                </concept>
                <concept code="P01CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nifurtimox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nifurtimox" type="fsn">nifurtimox</designation>
                    <desc language="en-US">nifurtimox</desc>
                </concept>
                <concept code="P01CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrofural"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrofural" type="fsn">nitrofural</designation>
                    <desc language="en-US">nitrofural</desc>
                </concept>
                <concept code="P01CD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Arsenic compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Arsenic compounds" type="fsn">Arsenic compounds</designation>
                    <desc language="en-US">Arsenic compounds</desc>
                </concept>
                <concept code="P01CD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="melarsoprol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="melarsoprol" type="fsn">melarsoprol</designation>
                    <desc language="en-US">melarsoprol</desc>
                </concept>
                <concept code="P01CD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetarsol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetarsol" type="fsn">acetarsol</designation>
                    <desc language="en-US">acetarsol</desc>
                </concept>
                <concept code="P01CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other agents against leishmaniasis and trypanosomiasis"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other agents against leishmaniasis and trypanosomiasis"
                         type="fsn">Other agents against leishmaniasis and trypanosomiasis</designation>
                    <desc language="en-US">Other agents against leishmaniasis and trypanosomiasis</desc>
                </concept>
                <concept code="P01CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentamidine isethionate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentamidine isethionate" type="fsn">pentamidine isethionate</designation>
                    <desc language="en-US">pentamidine isethionate</desc>
                </concept>
                <concept code="P01CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="suramin sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="suramin sodium" type="fsn">suramin sodium</designation>
                    <desc language="en-US">suramin sodium</desc>
                </concept>
                <concept code="P01CX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eflornithine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eflornithine" type="fsn">eflornithine</designation>
                    <desc language="en-US">eflornithine</desc>
                </concept>
                <concept code="P02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTHELMINTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTHELMINTICS" type="fsn">ANTHELMINTICS</designation>
                    <desc language="en-US">ANTHELMINTICS</desc>
                </concept>
                <concept code="P02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTITREMATODALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTITREMATODALS" type="fsn">ANTITREMATODALS</designation>
                    <desc language="en-US">ANTITREMATODALS</desc>
                </concept>
                <concept code="P02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Quinoline derivatives and related substances"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Quinoline derivatives and related substances"
                         type="fsn">Quinoline derivatives and related substances</designation>
                    <desc language="en-US">Quinoline derivatives and related substances</desc>
                </concept>
                <concept code="P02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="praziquantel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="praziquantel" type="fsn">praziquantel</designation>
                    <desc language="en-US">praziquantel</desc>
                </concept>
                <concept code="P02BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxamniquine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxamniquine" type="fsn">oxamniquine</designation>
                    <desc language="en-US">oxamniquine</desc>
                </concept>
                <concept code="P02BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Organophosphorous compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Organophosphorous compounds"
                         type="fsn">Organophosphorous compounds</designation>
                    <desc language="en-US">Organophosphorous compounds</desc>
                </concept>
                <concept code="P02BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metrifonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metrifonate" type="fsn">metrifonate</designation>
                    <desc language="en-US">metrifonate</desc>
                </concept>
                <concept code="P02BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antitrematodal agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antitrematodal agents"
                         type="fsn">Other antitrematodal agents</designation>
                    <desc language="en-US">Other antitrematodal agents</desc>
                </concept>
                <concept code="P02BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bithionol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bithionol" type="fsn">bithionol</designation>
                    <desc language="en-US">bithionol</desc>
                </concept>
                <concept code="P02BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="niridazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="niridazole" type="fsn">niridazole</designation>
                    <desc language="en-US">niridazole</desc>
                </concept>
                <concept code="P02BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stibophen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="stibophen" type="fsn">stibophen</designation>
                    <desc language="en-US">stibophen</desc>
                </concept>
                <concept code="P02BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triclabendazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triclabendazole" type="fsn">triclabendazole</designation>
                    <desc language="en-US">triclabendazole</desc>
                </concept>
                <concept code="P02C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTINEMATODAL AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTINEMATODAL AGENTS" type="fsn">ANTINEMATODAL AGENTS</designation>
                    <desc language="en-US">ANTINEMATODAL AGENTS</desc>
                </concept>
                <concept code="P02CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Benzimidazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Benzimidazole derivatives" type="fsn">Benzimidazole derivatives</designation>
                    <desc language="en-US">Benzimidazole derivatives</desc>
                </concept>
                <concept code="P02CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mebendazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mebendazole" type="fsn">mebendazole</designation>
                    <desc language="en-US">mebendazole</desc>
                </concept>
                <concept code="P02CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiabendazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiabendazole" type="fsn">tiabendazole</designation>
                    <desc language="en-US">tiabendazole</desc>
                </concept>
                <concept code="P02CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="albendazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="albendazole" type="fsn">albendazole</designation>
                    <desc language="en-US">albendazole</desc>
                </concept>
                <concept code="P02CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclobendazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclobendazole" type="fsn">ciclobendazole</designation>
                    <desc language="en-US">ciclobendazole</desc>
                </concept>
                <concept code="P02CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flubendazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flubendazole" type="fsn">flubendazole</designation>
                    <desc language="en-US">flubendazole</desc>
                </concept>
                <concept code="P02CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenbendazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenbendazole" type="fsn">fenbendazole</designation>
                    <desc language="en-US">fenbendazole</desc>
                </concept>
                <concept code="P02CA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mebendazole, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mebendazole, combinations" type="fsn">mebendazole, combinations</designation>
                    <desc language="en-US">mebendazole, combinations</desc>
                </concept>
                <concept code="P02CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Piperazine and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Piperazine and derivatives"
                         type="fsn">Piperazine and derivatives</designation>
                    <desc language="en-US">Piperazine and derivatives</desc>
                </concept>
                <concept code="P02CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piperazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piperazine" type="fsn">piperazine</designation>
                    <desc language="en-US">piperazine</desc>
                </concept>
                <concept code="P02CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diethylcarbamazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diethylcarbamazine" type="fsn">diethylcarbamazine</designation>
                    <desc language="en-US">diethylcarbamazine</desc>
                </concept>
                <concept code="P02CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tetrahydropyrimidine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tetrahydropyrimidine derivatives"
                         type="fsn">Tetrahydropyrimidine derivatives</designation>
                    <desc language="en-US">Tetrahydropyrimidine derivatives</desc>
                </concept>
                <concept code="P02CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrantel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrantel" type="fsn">pyrantel</designation>
                    <desc language="en-US">pyrantel</desc>
                </concept>
                <concept code="P02CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxantel"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxantel" type="fsn">oxantel</designation>
                    <desc language="en-US">oxantel</desc>
                </concept>
                <concept code="P02CE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Imidazothiazole derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Imidazothiazole derivatives"
                         type="fsn">Imidazothiazole derivatives</designation>
                    <desc language="en-US">Imidazothiazole derivatives</desc>
                </concept>
                <concept code="P02CE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levamisole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levamisole" type="fsn">levamisole</designation>
                    <desc language="en-US">levamisole</desc>
                </concept>
                <concept code="P02CF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Avermectines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Avermectines" type="fsn">Avermectines</designation>
                    <desc language="en-US">Avermectines</desc>
                </concept>
                <concept code="P02CF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ivermectin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ivermectin" type="fsn">ivermectin</designation>
                    <desc language="en-US">ivermectin</desc>
                </concept>
                <concept code="P02CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antinematodals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antinematodals" type="fsn">Other antinematodals</designation>
                    <desc language="en-US">Other antinematodals</desc>
                </concept>
                <concept code="P02CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrvinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrvinium" type="fsn">pyrvinium</designation>
                    <desc language="en-US">pyrvinium</desc>
                </concept>
                <concept code="P02CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bephenium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bephenium" type="fsn">bephenium</designation>
                    <desc language="en-US">bephenium</desc>
                </concept>
                <concept code="P02D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTICESTODALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTICESTODALS" type="fsn">ANTICESTODALS</designation>
                    <desc language="en-US">ANTICESTODALS</desc>
                </concept>
                <concept code="P02DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Salicylic acid derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Salicylic acid derivatives"
                         type="fsn">Salicylic acid derivatives</designation>
                    <desc language="en-US">Salicylic acid derivatives</desc>
                </concept>
                <concept code="P02DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="niclosamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="niclosamide" type="fsn">niclosamide</designation>
                    <desc language="en-US">niclosamide</desc>
                </concept>
                <concept code="P02DX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other anticestodals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other anticestodals" type="fsn">Other anticestodals</designation>
                    <desc language="en-US">Other anticestodals</desc>
                </concept>
                <concept code="P02DX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desaspidin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desaspidin" type="fsn">desaspidin</designation>
                    <desc language="en-US">desaspidin</desc>
                </concept>
                <concept code="P02DX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dichlorophen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dichlorophen" type="fsn">dichlorophen</designation>
                    <desc language="en-US">dichlorophen</desc>
                </concept>
                <concept code="P03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS"
                         type="fsn">ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS</designation>
                    <desc language="en-US">ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS</desc>
                </concept>
                <concept code="P03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ECTOPARASITICIDES, INCL. SCABICIDES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ECTOPARASITICIDES, INCL. SCABICIDES"
                         type="fsn">ECTOPARASITICIDES, INCL. SCABICIDES</designation>
                    <desc language="en-US">ECTOPARASITICIDES, INCL. SCABICIDES</desc>
                </concept>
                <concept code="P03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfur containing products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sulfur containing products"
                         type="fsn">Sulfur containing products</designation>
                    <desc language="en-US">Sulfur containing products</desc>
                </concept>
                <concept code="P03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dixanthogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dixanthogen" type="fsn">dixanthogen</designation>
                    <desc language="en-US">dixanthogen</desc>
                </concept>
                <concept code="P03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium polysulfide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium polysulfide" type="fsn">potassium polysulfide</designation>
                    <desc language="en-US">potassium polysulfide</desc>
                </concept>
                <concept code="P03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mesulfen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mesulfen" type="fsn">mesulfen</designation>
                    <desc language="en-US">mesulfen</desc>
                </concept>
                <concept code="P03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="disulfiram"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="disulfiram" type="fsn">disulfiram</designation>
                    <desc language="en-US">disulfiram</desc>
                </concept>
                <concept code="P03AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiram"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiram" type="fsn">thiram</designation>
                    <desc language="en-US">thiram</desc>
                </concept>
                <concept code="P03AA54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="disulfiram, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="disulfiram, combinations" type="fsn">disulfiram, combinations</designation>
                    <desc language="en-US">disulfiram, combinations</desc>
                </concept>
                <concept code="P03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Chlorine containing products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Chlorine containing products"
                         type="fsn">Chlorine containing products</designation>
                    <desc language="en-US">Chlorine containing products</desc>
                </concept>
                <concept code="P03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofenotane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofenotane" type="fsn">clofenotane</designation>
                    <desc language="en-US">clofenotane</desc>
                </concept>
                <concept code="P03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lindane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lindane" type="fsn">lindane</designation>
                    <desc language="en-US">lindane</desc>
                </concept>
                <concept code="P03AB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofenotane, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofenotane, combinations" type="fsn">clofenotane, combinations</designation>
                    <desc language="en-US">clofenotane, combinations</desc>
                </concept>
                <concept code="P03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pyrethrines, incl. synthetic compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Pyrethrines, incl. synthetic compounds"
                         type="fsn">Pyrethrines, incl. synthetic compounds</designation>
                    <desc language="en-US">Pyrethrines, incl. synthetic compounds</desc>
                </concept>
                <concept code="P03AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrethrum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrethrum" type="fsn">pyrethrum</designation>
                    <desc language="en-US">pyrethrum</desc>
                </concept>
                <concept code="P03AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bioallethrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bioallethrin" type="fsn">bioallethrin</designation>
                    <desc language="en-US">bioallethrin</desc>
                </concept>
                <concept code="P03AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenothrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenothrin" type="fsn">phenothrin</designation>
                    <desc language="en-US">phenothrin</desc>
                </concept>
                <concept code="P03AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="permethrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="permethrin" type="fsn">permethrin</designation>
                    <desc language="en-US">permethrin</desc>
                </concept>
                <concept code="P03AC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrethrum, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrethrum, combinations" type="fsn">pyrethrum, combinations</designation>
                    <desc language="en-US">pyrethrum, combinations</desc>
                </concept>
                <concept code="P03AC52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bioallethrin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="bioallethrin, combinations"
                         type="fsn">bioallethrin, combinations</designation>
                    <desc language="en-US">bioallethrin, combinations</desc>
                </concept>
                <concept code="P03AC53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenothrin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenothrin, combinations" type="fsn">phenothrin, combinations</designation>
                    <desc language="en-US">phenothrin, combinations</desc>
                </concept>
                <concept code="P03AC54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="permethrin, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="permethrin, combinations" type="fsn">permethrin, combinations</designation>
                    <desc language="en-US">permethrin, combinations</desc>
                </concept>
                <concept code="P03AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other ectoparasiticides, incl. scabicides"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other ectoparasiticides, incl. scabicides"
                         type="fsn">Other ectoparasiticides, incl. scabicides</designation>
                    <desc language="en-US">Other ectoparasiticides, incl. scabicides</desc>
                </concept>
                <concept code="P03AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzyl benzoate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzyl benzoate" type="fsn">benzyl benzoate</designation>
                    <desc language="en-US">benzyl benzoate</desc>
                </concept>
                <concept code="P03AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="copper oleinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="copper oleinate" type="fsn">copper oleinate</designation>
                    <desc language="en-US">copper oleinate</desc>
                </concept>
                <concept code="P03AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="malathion"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="malathion" type="fsn">malathion</designation>
                    <desc language="en-US">malathion</desc>
                </concept>
                <concept code="P03AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quassia"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quassia" type="fsn">quassia</designation>
                    <desc language="en-US">quassia</desc>
                </concept>
                <concept code="P03AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimeticone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimeticone" type="fsn">dimeticone</designation>
                    <desc language="en-US">dimeticone</desc>
                </concept>
                <concept code="P03AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzyl alcohol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzyl alcohol" type="fsn">benzyl alcohol</designation>
                    <desc language="en-US">benzyl alcohol</desc>
                </concept>
                <concept code="P03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="INSECTICIDES AND REPELLENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="INSECTICIDES AND REPELLENTS"
                         type="fsn">INSECTICIDES AND REPELLENTS</designation>
                    <desc language="en-US">INSECTICIDES AND REPELLENTS</desc>
                </concept>
                <concept code="P03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Pyrethrines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Pyrethrines" type="fsn">Pyrethrines</designation>
                    <desc language="en-US">Pyrethrines</desc>
                </concept>
                <concept code="P03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyfluthrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyfluthrin" type="fsn">cyfluthrin</designation>
                    <desc language="en-US">cyfluthrin</desc>
                </concept>
                <concept code="P03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cypermethrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cypermethrin" type="fsn">cypermethrin</designation>
                    <desc language="en-US">cypermethrin</desc>
                </concept>
                <concept code="P03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="decamethrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="decamethrin" type="fsn">decamethrin</designation>
                    <desc language="en-US">decamethrin</desc>
                </concept>
                <concept code="P03BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetramethrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetramethrin" type="fsn">tetramethrin</designation>
                    <desc language="en-US">tetramethrin</desc>
                </concept>
                <concept code="P03BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other insecticides and repellents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other insecticides and repellents"
                         type="fsn">Other insecticides and repellents</designation>
                    <desc language="en-US">Other insecticides and repellents</desc>
                </concept>
                <concept code="P03BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diethyltoluamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diethyltoluamide" type="fsn">diethyltoluamide</designation>
                    <desc language="en-US">diethyltoluamide</desc>
                </concept>
                <concept code="P03BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimethylphthalate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimethylphthalate" type="fsn">dimethylphthalate</designation>
                    <desc language="en-US">dimethylphthalate</desc>
                </concept>
                <concept code="P03BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibutylphthalate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibutylphthalate" type="fsn">dibutylphthalate</designation>
                    <desc language="en-US">dibutylphthalate</desc>
                </concept>
                <concept code="P03BX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibutylsuccinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibutylsuccinate" type="fsn">dibutylsuccinate</designation>
                    <desc language="en-US">dibutylsuccinate</desc>
                </concept>
                <concept code="P03BX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimethylcarbate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimethylcarbate" type="fsn">dimethylcarbate</designation>
                    <desc language="en-US">dimethylcarbate</desc>
                </concept>
                <concept code="P03BX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etohexadiol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etohexadiol" type="fsn">etohexadiol</designation>
                    <desc language="en-US">etohexadiol</desc>
                </concept>
                <concept code="R"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="RESPIRATORY SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="RESPIRATORY SYSTEM" type="fsn">RESPIRATORY SYSTEM</designation>
                    <desc language="en-US">RESPIRATORY SYSTEM</desc>
                </concept>
                <concept code="R01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="NASAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="NASAL PREPARATIONS" type="fsn">NASAL PREPARATIONS</designation>
                    <desc language="en-US">NASAL PREPARATIONS</desc>
                </concept>
                <concept code="R01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE"
                         type="fsn">DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE</designation>
                    <desc language="en-US">DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE</desc>
                </concept>
                <concept code="R01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sympathomimetics, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sympathomimetics, plain" type="fsn">Sympathomimetics, plain</designation>
                    <desc language="en-US">Sympathomimetics, plain</desc>
                </concept>
                <concept code="R01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclopentamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclopentamine" type="fsn">cyclopentamine</designation>
                    <desc language="en-US">cyclopentamine</desc>
                </concept>
                <concept code="R01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ephedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ephedrine" type="fsn">ephedrine</designation>
                    <desc language="en-US">ephedrine</desc>
                </concept>
                <concept code="R01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylephrine" type="fsn">phenylephrine</designation>
                    <desc language="en-US">phenylephrine</desc>
                </concept>
                <concept code="R01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxymetazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxymetazoline" type="fsn">oxymetazoline</designation>
                    <desc language="en-US">oxymetazoline</desc>
                </concept>
                <concept code="R01AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetryzoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetryzoline" type="fsn">tetryzoline</designation>
                    <desc language="en-US">tetryzoline</desc>
                </concept>
                <concept code="R01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xylometazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xylometazoline" type="fsn">xylometazoline</designation>
                    <desc language="en-US">xylometazoline</desc>
                </concept>
                <concept code="R01AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naphazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naphazoline" type="fsn">naphazoline</designation>
                    <desc language="en-US">naphazoline</desc>
                </concept>
                <concept code="R01AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tramazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tramazoline" type="fsn">tramazoline</designation>
                    <desc language="en-US">tramazoline</desc>
                </concept>
                <concept code="R01AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metizoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metizoline" type="fsn">metizoline</designation>
                    <desc language="en-US">metizoline</desc>
                </concept>
                <concept code="R01AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tuaminoheptane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tuaminoheptane" type="fsn">tuaminoheptane</designation>
                    <desc language="en-US">tuaminoheptane</desc>
                </concept>
                <concept code="R01AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenoxazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenoxazoline" type="fsn">fenoxazoline</designation>
                    <desc language="en-US">fenoxazoline</desc>
                </concept>
                <concept code="R01AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tymazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tymazoline" type="fsn">tymazoline</designation>
                    <desc language="en-US">tymazoline</desc>
                </concept>
                <concept code="R01AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinephrine" type="fsn">epinephrine</designation>
                    <desc language="en-US">epinephrine</desc>
                </concept>
                <concept code="R01AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indanazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indanazoline" type="fsn">indanazoline</designation>
                    <desc language="en-US">indanazoline</desc>
                </concept>
                <concept code="R01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sympathomimetics, combinations excl. corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sympathomimetics, combinations excl. corticosteroids"
                         type="fsn">Sympathomimetics, combinations excl. corticosteroids</designation>
                    <desc language="en-US">Sympathomimetics, combinations excl. corticosteroids</desc>
                </concept>
                <concept code="R01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylephrine" type="fsn">phenylephrine</designation>
                    <desc language="en-US">phenylephrine</desc>
                </concept>
                <concept code="R01AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naphazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naphazoline" type="fsn">naphazoline</designation>
                    <desc language="en-US">naphazoline</desc>
                </concept>
                <concept code="R01AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetryzoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetryzoline" type="fsn">tetryzoline</designation>
                    <desc language="en-US">tetryzoline</desc>
                </concept>
                <concept code="R01AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ephedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ephedrine" type="fsn">ephedrine</designation>
                    <desc language="en-US">ephedrine</desc>
                </concept>
                <concept code="R01AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xylometazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xylometazoline" type="fsn">xylometazoline</designation>
                    <desc language="en-US">xylometazoline</desc>
                </concept>
                <concept code="R01AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxymetazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxymetazoline" type="fsn">oxymetazoline</designation>
                    <desc language="en-US">oxymetazoline</desc>
                </concept>
                <concept code="R01AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tuaminoheptane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tuaminoheptane" type="fsn">tuaminoheptane</designation>
                    <desc language="en-US">tuaminoheptane</desc>
                </concept>
                <concept code="R01AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiallergic agents, excl. corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiallergic agents, excl. corticosteroids"
                         type="fsn">Antiallergic agents, excl. corticosteroids</designation>
                    <desc language="en-US">Antiallergic agents, excl. corticosteroids</desc>
                </concept>
                <concept code="R01AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cromoglicic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cromoglicic acid" type="fsn">cromoglicic acid</designation>
                    <desc language="en-US">cromoglicic acid</desc>
                </concept>
                <concept code="R01AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levocabastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levocabastine" type="fsn">levocabastine</designation>
                    <desc language="en-US">levocabastine</desc>
                </concept>
                <concept code="R01AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azelastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azelastine" type="fsn">azelastine</designation>
                    <desc language="en-US">azelastine</desc>
                </concept>
                <concept code="R01AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="antazoline" type="fsn">antazoline</designation>
                    <desc language="en-US">antazoline</desc>
                </concept>
                <concept code="R01AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="spaglumic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="spaglumic acid" type="fsn">spaglumic acid</designation>
                    <desc language="en-US">spaglumic acid</desc>
                </concept>
                <concept code="R01AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thonzylamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thonzylamine" type="fsn">thonzylamine</designation>
                    <desc language="en-US">thonzylamine</desc>
                </concept>
                <concept code="R01AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nedocromil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nedocromil" type="fsn">nedocromil</designation>
                    <desc language="en-US">nedocromil</desc>
                </concept>
                <concept code="R01AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olopatadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olopatadine" type="fsn">olopatadine</designation>
                    <desc language="en-US">olopatadine</desc>
                </concept>
                <concept code="R01AC51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cromoglicic acid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cromoglicic acid, combinations"
                         type="fsn">cromoglicic acid, combinations</designation>
                    <desc language="en-US">cromoglicic acid, combinations</desc>
                </concept>
                <concept code="R01AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Corticosteroids" type="fsn">Corticosteroids</designation>
                    <desc language="en-US">Corticosteroids</desc>
                </concept>
                <concept code="R01AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="beclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="beclometasone" type="fsn">beclometasone</designation>
                    <desc language="en-US">beclometasone</desc>
                </concept>
                <concept code="R01AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="R01AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="R01AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flunisolide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flunisolide" type="fsn">flunisolide</designation>
                    <desc language="en-US">flunisolide</desc>
                </concept>
                <concept code="R01AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="budesonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="budesonide" type="fsn">budesonide</designation>
                    <desc language="en-US">budesonide</desc>
                </concept>
                <concept code="R01AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="R01AD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tixocortol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tixocortol" type="fsn">tixocortol</designation>
                    <desc language="en-US">tixocortol</desc>
                </concept>
                <concept code="R01AD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluticasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluticasone" type="fsn">fluticasone</designation>
                    <desc language="en-US">fluticasone</desc>
                </concept>
                <concept code="R01AD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mometasone" type="fsn">mometasone</designation>
                    <desc language="en-US">mometasone</desc>
                </concept>
                <concept code="R01AD11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamcinolone" type="fsn">triamcinolone</designation>
                    <desc language="en-US">triamcinolone</desc>
                </concept>
                <concept code="R01AD12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluticasone furoate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluticasone furoate" type="fsn">fluticasone furoate</designation>
                    <desc language="en-US">fluticasone furoate</desc>
                </concept>
                <concept code="R01AD13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclesonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclesonide" type="fsn">ciclesonide</designation>
                    <desc language="en-US">ciclesonide</desc>
                </concept>
                <concept code="R01AD52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone, combinations"
                         type="fsn">prednisolone, combinations</designation>
                    <desc language="en-US">prednisolone, combinations</desc>
                </concept>
                <concept code="R01AD53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dexamethasone, combinations"
                         type="fsn">dexamethasone, combinations</designation>
                    <desc language="en-US">dexamethasone, combinations</desc>
                </concept>
                <concept code="R01AD57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tixocortol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tixocortol, combinations" type="fsn">tixocortol, combinations</designation>
                    <desc language="en-US">tixocortol, combinations</desc>
                </concept>
                <concept code="R01AD58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluticasone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluticasone, combinations" type="fsn">fluticasone, combinations</designation>
                    <desc language="en-US">fluticasone, combinations</desc>
                </concept>
                <concept code="R01AD60"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrocortisone, combinations"
                         type="fsn">hydrocortisone, combinations</designation>
                    <desc language="en-US">hydrocortisone, combinations</desc>
                </concept>
                <concept code="R01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other nasal preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other nasal preparations" type="fsn">Other nasal preparations</designation>
                    <desc language="en-US">Other nasal preparations</desc>
                </concept>
                <concept code="R01AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium hexamine thiocyanate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="calcium hexamine thiocyanate"
                         type="fsn">calcium hexamine thiocyanate</designation>
                    <desc language="en-US">calcium hexamine thiocyanate</desc>
                </concept>
                <concept code="R01AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="retinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="retinol" type="fsn">retinol</designation>
                    <desc language="en-US">retinol</desc>
                </concept>
                <concept code="R01AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ipratropium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ipratropium bromide" type="fsn">ipratropium bromide</designation>
                    <desc language="en-US">ipratropium bromide</desc>
                </concept>
                <concept code="R01AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ritiometan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ritiometan" type="fsn">ritiometan</designation>
                    <desc language="en-US">ritiometan</desc>
                </concept>
                <concept code="R01AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mupirocin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mupirocin" type="fsn">mupirocin</designation>
                    <desc language="en-US">mupirocin</desc>
                </concept>
                <concept code="R01AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexamidine" type="fsn">hexamidine</designation>
                    <desc language="en-US">hexamidine</desc>
                </concept>
                <concept code="R01AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="framycetin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="framycetin" type="fsn">framycetin</designation>
                    <desc language="en-US">framycetin</desc>
                </concept>
                <concept code="R01AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hyaluronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hyaluronic acid" type="fsn">hyaluronic acid</designation>
                    <desc language="en-US">hyaluronic acid</desc>
                </concept>
                <concept code="R01AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="various"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="various" type="fsn">various</designation>
                    <desc language="en-US">various</desc>
                </concept>
                <concept code="R01AX30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="R01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="NASAL DECONGESTANTS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="NASAL DECONGESTANTS FOR SYSTEMIC USE"
                         type="fsn">NASAL DECONGESTANTS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">NASAL DECONGESTANTS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="R01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sympathomimetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sympathomimetics" type="fsn">Sympathomimetics</designation>
                    <desc language="en-US">Sympathomimetics</desc>
                </concept>
                <concept code="R01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylpropanolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylpropanolamine" type="fsn">phenylpropanolamine</designation>
                    <desc language="en-US">phenylpropanolamine</desc>
                </concept>
                <concept code="R01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pseudoephedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pseudoephedrine" type="fsn">pseudoephedrine</designation>
                    <desc language="en-US">pseudoephedrine</desc>
                </concept>
                <concept code="R01BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylephrine" type="fsn">phenylephrine</designation>
                    <desc language="en-US">phenylephrine</desc>
                </concept>
                <concept code="R01BA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylpropanolamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenylpropanolamine, combinations"
                         type="fsn">phenylpropanolamine, combinations</designation>
                    <desc language="en-US">phenylpropanolamine, combinations</desc>
                </concept>
                <concept code="R01BA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pseudoephedrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pseudoephedrine, combinations"
                         type="fsn">pseudoephedrine, combinations</designation>
                    <desc language="en-US">pseudoephedrine, combinations</desc>
                </concept>
                <concept code="R01BA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenylephrine, combinations"
                         type="fsn">phenylephrine, combinations</designation>
                    <desc language="en-US">phenylephrine, combinations</desc>
                </concept>
                <concept code="R02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="THROAT PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="THROAT PREPARATIONS" type="fsn">THROAT PREPARATIONS</designation>
                    <desc language="en-US">THROAT PREPARATIONS</desc>
                </concept>
                <concept code="R02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="THROAT PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="THROAT PREPARATIONS" type="fsn">THROAT PREPARATIONS</designation>
                    <desc language="en-US">THROAT PREPARATIONS</desc>
                </concept>
                <concept code="R02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiseptics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antiseptics" type="fsn">Antiseptics</designation>
                    <desc language="en-US">Antiseptics</desc>
                </concept>
                <concept code="R02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ambazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ambazone" type="fsn">ambazone</designation>
                    <desc language="en-US">ambazone</desc>
                </concept>
                <concept code="R02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dequalinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dequalinium" type="fsn">dequalinium</designation>
                    <desc language="en-US">dequalinium</desc>
                </concept>
                <concept code="R02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dichlorobenzyl alcohol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dichlorobenzyl alcohol" type="fsn">dichlorobenzyl alcohol</designation>
                    <desc language="en-US">dichlorobenzyl alcohol</desc>
                </concept>
                <concept code="R02AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorhexidine" type="fsn">chlorhexidine</designation>
                    <desc language="en-US">chlorhexidine</desc>
                </concept>
                <concept code="R02AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetylpyridinium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetylpyridinium" type="fsn">cetylpyridinium</designation>
                    <desc language="en-US">cetylpyridinium</desc>
                </concept>
                <concept code="R02AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzethonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzethonium" type="fsn">benzethonium</designation>
                    <desc language="en-US">benzethonium</desc>
                </concept>
                <concept code="R02AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="myristyl-benzalkonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="myristyl-benzalkonium" type="fsn">myristyl-benzalkonium</designation>
                    <desc language="en-US">myristyl-benzalkonium</desc>
                </concept>
                <concept code="R02AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorquinaldol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorquinaldol" type="fsn">chlorquinaldol</designation>
                    <desc language="en-US">chlorquinaldol</desc>
                </concept>
                <concept code="R02AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexylresorcinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexylresorcinol" type="fsn">hexylresorcinol</designation>
                    <desc language="en-US">hexylresorcinol</desc>
                </concept>
                <concept code="R02AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acriflavinium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acriflavinium chloride" type="fsn">acriflavinium chloride</designation>
                    <desc language="en-US">acriflavinium chloride</desc>
                </concept>
                <concept code="R02AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyquinoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyquinoline" type="fsn">oxyquinoline</designation>
                    <desc language="en-US">oxyquinoline</desc>
                </concept>
                <concept code="R02AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="povidone-iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="povidone-iodine" type="fsn">povidone-iodine</designation>
                    <desc language="en-US">povidone-iodine</desc>
                </concept>
                <concept code="R02AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzalkonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzalkonium" type="fsn">benzalkonium</designation>
                    <desc language="en-US">benzalkonium</desc>
                </concept>
                <concept code="R02AA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetrimonium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetrimonium" type="fsn">cetrimonium</designation>
                    <desc language="en-US">cetrimonium</desc>
                </concept>
                <concept code="R02AA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexamidine" type="fsn">hexamidine</designation>
                    <desc language="en-US">hexamidine</desc>
                </concept>
                <concept code="R02AA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenol" type="fsn">phenol</designation>
                    <desc language="en-US">phenol</desc>
                </concept>
                <concept code="R02AA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="various"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="various" type="fsn">various</designation>
                    <desc language="en-US">various</desc>
                </concept>
                <concept code="R02AA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="octenidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="octenidine" type="fsn">octenidine</designation>
                    <desc language="en-US">octenidine</desc>
                </concept>
                <concept code="R02AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antibiotics" type="fsn">Antibiotics</designation>
                    <desc language="en-US">Antibiotics</desc>
                </concept>
                <concept code="R02AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="R02AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tyrothricin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tyrothricin" type="fsn">tyrothricin</designation>
                    <desc language="en-US">tyrothricin</desc>
                </concept>
                <concept code="R02AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fusafungine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fusafungine" type="fsn">fusafungine</designation>
                    <desc language="en-US">fusafungine</desc>
                </concept>
                <concept code="R02AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bacitracin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bacitracin" type="fsn">bacitracin</designation>
                    <desc language="en-US">bacitracin</desc>
                </concept>
                <concept code="R02AB30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gramicidin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gramicidin" type="fsn">gramicidin</designation>
                    <desc language="en-US">gramicidin</desc>
                </concept>
                <concept code="R02AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anesthetics, local"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anesthetics, local" type="fsn">Anesthetics, local</designation>
                    <desc language="en-US">Anesthetics, local</desc>
                </concept>
                <concept code="R02AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzocaine" type="fsn">benzocaine</designation>
                    <desc language="en-US">benzocaine</desc>
                </concept>
                <concept code="R02AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidocaine" type="fsn">lidocaine</designation>
                    <desc language="en-US">lidocaine</desc>
                </concept>
                <concept code="R02AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cocaine" type="fsn">cocaine</designation>
                    <desc language="en-US">cocaine</desc>
                </concept>
                <concept code="R02AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dyclonine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dyclonine" type="fsn">dyclonine</designation>
                    <desc language="en-US">dyclonine</desc>
                </concept>
                <concept code="R02AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other throat preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other throat preparations" type="fsn">Other throat preparations</designation>
                    <desc language="en-US">Other throat preparations</desc>
                </concept>
                <concept code="R02AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flurbiprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flurbiprofen" type="fsn">flurbiprofen</designation>
                    <desc language="en-US">flurbiprofen</desc>
                </concept>
                <concept code="R02AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibuprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibuprofen" type="fsn">ibuprofen</designation>
                    <desc language="en-US">ibuprofen</desc>
                </concept>
                <concept code="R02AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzydamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzydamine" type="fsn">benzydamine</designation>
                    <desc language="en-US">benzydamine</desc>
                </concept>
                <concept code="R03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES"
                         type="fsn">DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</designation>
                    <desc language="en-US">DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</desc>
                </concept>
                <concept code="R03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ADRENERGICS, INHALANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ADRENERGICS, INHALANTS" type="fsn">ADRENERGICS, INHALANTS</designation>
                    <desc language="en-US">ADRENERGICS, INHALANTS</desc>
                </concept>
                <concept code="R03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha- and beta-adrenoreceptor agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha- and beta-adrenoreceptor agonists"
                         type="fsn">Alpha- and beta-adrenoreceptor agonists</designation>
                    <desc language="en-US">Alpha- and beta-adrenoreceptor agonists</desc>
                </concept>
                <concept code="R03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinephrine" type="fsn">epinephrine</designation>
                    <desc language="en-US">epinephrine</desc>
                </concept>
                <concept code="R03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Non-selective beta-adrenoreceptor agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Non-selective beta-adrenoreceptor agonists"
                         type="fsn">Non-selective beta-adrenoreceptor agonists</designation>
                    <desc language="en-US">Non-selective beta-adrenoreceptor agonists</desc>
                </concept>
                <concept code="R03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoprenaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoprenaline" type="fsn">isoprenaline</designation>
                    <desc language="en-US">isoprenaline</desc>
                </concept>
                <concept code="R03AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="orciprenaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="orciprenaline" type="fsn">orciprenaline</designation>
                    <desc language="en-US">orciprenaline</desc>
                </concept>
                <concept code="R03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Selective beta-2-adrenoreceptor agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Selective beta-2-adrenoreceptor agonists"
                         type="fsn">Selective beta-2-adrenoreceptor agonists</designation>
                    <desc language="en-US">Selective beta-2-adrenoreceptor agonists</desc>
                </concept>
                <concept code="R03AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salbutamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="salbutamol" type="fsn">salbutamol</designation>
                    <desc language="en-US">salbutamol</desc>
                </concept>
                <concept code="R03AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terbutaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terbutaline" type="fsn">terbutaline</designation>
                    <desc language="en-US">terbutaline</desc>
                </concept>
                <concept code="R03AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenoterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenoterol" type="fsn">fenoterol</designation>
                    <desc language="en-US">fenoterol</desc>
                </concept>
                <concept code="R03AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rimiterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rimiterol" type="fsn">rimiterol</designation>
                    <desc language="en-US">rimiterol</desc>
                </concept>
                <concept code="R03AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexoprenaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexoprenaline" type="fsn">hexoprenaline</designation>
                    <desc language="en-US">hexoprenaline</desc>
                </concept>
                <concept code="R03AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoetarine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoetarine" type="fsn">isoetarine</designation>
                    <desc language="en-US">isoetarine</desc>
                </concept>
                <concept code="R03AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pirbuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pirbuterol" type="fsn">pirbuterol</designation>
                    <desc language="en-US">pirbuterol</desc>
                </concept>
                <concept code="R03AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tretoquinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tretoquinol" type="fsn">tretoquinol</designation>
                    <desc language="en-US">tretoquinol</desc>
                </concept>
                <concept code="R03AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbuterol" type="fsn">carbuterol</designation>
                    <desc language="en-US">carbuterol</desc>
                </concept>
                <concept code="R03AC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tulobuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tulobuterol" type="fsn">tulobuterol</designation>
                    <desc language="en-US">tulobuterol</desc>
                </concept>
                <concept code="R03AC12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salmeterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="salmeterol" type="fsn">salmeterol</designation>
                    <desc language="en-US">salmeterol</desc>
                </concept>
                <concept code="R03AC13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formoterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="formoterol" type="fsn">formoterol</designation>
                    <desc language="en-US">formoterol</desc>
                </concept>
                <concept code="R03AC14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clenbuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clenbuterol" type="fsn">clenbuterol</designation>
                    <desc language="en-US">clenbuterol</desc>
                </concept>
                <concept code="R03AC15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reproterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reproterol" type="fsn">reproterol</designation>
                    <desc language="en-US">reproterol</desc>
                </concept>
                <concept code="R03AC16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procaterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procaterol" type="fsn">procaterol</designation>
                    <desc language="en-US">procaterol</desc>
                </concept>
                <concept code="R03AC17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bitolterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bitolterol" type="fsn">bitolterol</designation>
                    <desc language="en-US">bitolterol</desc>
                </concept>
                <concept code="R03AC18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indacaterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indacaterol" type="fsn">indacaterol</designation>
                    <desc language="en-US">indacaterol</desc>
                </concept>
                <concept code="R03AC19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olodaterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olodaterol" type="fsn">olodaterol</designation>
                    <desc language="en-US">olodaterol</desc>
                </concept>
                <concept code="R03AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of adrenergics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations of adrenergics"
                         type="fsn">Combinations of adrenergics</designation>
                    <desc language="en-US">Combinations of adrenergics</desc>
                </concept>
                <concept code="R03AK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics"
                         type="fsn">Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics</designation>
                    <desc language="en-US">Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics</desc>
                </concept>
                <concept code="R03AK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinephrine and other drugs for obstructive airway diseases"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="epinephrine and other drugs for obstructive airway diseases"
                         type="fsn">epinephrine and other drugs for obstructive airway diseases</designation>
                    <desc language="en-US">epinephrine and other drugs for obstructive airway diseases</desc>
                </concept>
                <concept code="R03AK02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoprenaline and other drugs for obstructive airway diseases"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="isoprenaline and other drugs for obstructive airway diseases"
                         type="fsn">isoprenaline and other drugs for obstructive airway diseases</designation>
                    <desc language="en-US">isoprenaline and other drugs for obstructive airway diseases</desc>
                </concept>
                <concept code="R03AK04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salbutamol and sodium cromoglicate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="salbutamol and sodium cromoglicate"
                         type="fsn">salbutamol and sodium cromoglicate</designation>
                    <desc language="en-US">salbutamol and sodium cromoglicate</desc>
                </concept>
                <concept code="R03AK05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reproterol and sodium cromoglicate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="reproterol and sodium cromoglicate"
                         type="fsn">reproterol and sodium cromoglicate</designation>
                    <desc language="en-US">reproterol and sodium cromoglicate</desc>
                </concept>
                <concept code="R03AK06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salmeterol and fluticasone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="salmeterol and fluticasone"
                         type="fsn">salmeterol and fluticasone</designation>
                    <desc language="en-US">salmeterol and fluticasone</desc>
                </concept>
                <concept code="R03AK07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formoterol and budesonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="formoterol and budesonide" type="fsn">formoterol and budesonide</designation>
                    <desc language="en-US">formoterol and budesonide</desc>
                </concept>
                <concept code="R03AK08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formoterol and beclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="formoterol and beclometasone"
                         type="fsn">formoterol and beclometasone</designation>
                    <desc language="en-US">formoterol and beclometasone</desc>
                </concept>
                <concept code="R03AK09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formoterol and mometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="formoterol and mometasone" type="fsn">formoterol and mometasone</designation>
                    <desc language="en-US">formoterol and mometasone</desc>
                </concept>
                <concept code="R03AK10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vilanterol and fluticasone furoate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="vilanterol and fluticasone furoate"
                         type="fsn">vilanterol and fluticasone furoate</designation>
                    <desc language="en-US">vilanterol and fluticasone furoate</desc>
                </concept>
                <concept code="R03AK11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formoterol and fluticasone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="formoterol and fluticasone"
                         type="fsn">formoterol and fluticasone</designation>
                    <desc language="en-US">formoterol and fluticasone</desc>
                </concept>
                <concept code="R03AK12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salmeterol and budesonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="salmeterol and budesonide" type="fsn">salmeterol and budesonide</designation>
                    <desc language="en-US">salmeterol and budesonide</desc>
                </concept>
                <concept code="R03AK13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salbutamol and beclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="salbutamol and beclometasone"
                         type="fsn">salbutamol and beclometasone</designation>
                    <desc language="en-US">salbutamol and beclometasone</desc>
                </concept>
                <concept code="R03AL"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids"
                         type="fsn">Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids</designation>
                    <desc language="en-US">Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids</desc>
                </concept>
                <concept code="R03AL01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenoterol and ipratropium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fenoterol and ipratropium bromide"
                         type="fsn">fenoterol and ipratropium bromide</designation>
                    <desc language="en-US">fenoterol and ipratropium bromide</desc>
                </concept>
                <concept code="R03AL02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salbutamol and ipratropium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="salbutamol and ipratropium bromide"
                         type="fsn">salbutamol and ipratropium bromide</designation>
                    <desc language="en-US">salbutamol and ipratropium bromide</desc>
                </concept>
                <concept code="R03AL03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vilanterol and umeclidinium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="vilanterol and umeclidinium bromide"
                         type="fsn">vilanterol and umeclidinium bromide</designation>
                    <desc language="en-US">vilanterol and umeclidinium bromide</desc>
                </concept>
                <concept code="R03AL04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indacaterol and glycopyrronium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indacaterol and glycopyrronium bromide"
                         type="fsn">indacaterol and glycopyrronium bromide</designation>
                    <desc language="en-US">indacaterol and glycopyrronium bromide</desc>
                </concept>
                <concept code="R03AL05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formoterol and aclidinium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="formoterol and aclidinium bromide"
                         type="fsn">formoterol and aclidinium bromide</designation>
                    <desc language="en-US">formoterol and aclidinium bromide</desc>
                </concept>
                <concept code="R03AL06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olodaterol and tiotropium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="olodaterol and tiotropium bromide"
                         type="fsn">olodaterol and tiotropium bromide</designation>
                    <desc language="en-US">olodaterol and tiotropium bromide</desc>
                </concept>
                <concept code="R03AL07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formoterol and glycopyrronium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="formoterol and glycopyrronium bromide"
                         type="fsn">formoterol and glycopyrronium bromide</designation>
                    <desc language="en-US">formoterol and glycopyrronium bromide</desc>
                </concept>
                <concept code="R03AL08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vilanterol, umeclidinium bromide and fluticasone furoate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="vilanterol, umeclidinium bromide and fluticasone furoate"
                         type="fsn">vilanterol, umeclidinium bromide and fluticasone furoate</designation>
                    <desc language="en-US">vilanterol, umeclidinium bromide and fluticasone furoate</desc>
                </concept>
                <concept code="R03AL09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formoterol, glycopyrronium bromide and beclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="formoterol, glycopyrronium bromide and beclometasone"
                         type="fsn">formoterol, glycopyrronium bromide and beclometasone</designation>
                    <desc language="en-US">formoterol, glycopyrronium bromide and beclometasone</desc>
                </concept>
                <concept code="R03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS"
                         type="fsn">OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS</designation>
                    <desc language="en-US">OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS</desc>
                </concept>
                <concept code="R03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Glucocorticoids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Glucocorticoids" type="fsn">Glucocorticoids</designation>
                    <desc language="en-US">Glucocorticoids</desc>
                </concept>
                <concept code="R03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="beclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="beclometasone" type="fsn">beclometasone</designation>
                    <desc language="en-US">beclometasone</desc>
                </concept>
                <concept code="R03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="budesonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="budesonide" type="fsn">budesonide</designation>
                    <desc language="en-US">budesonide</desc>
                </concept>
                <concept code="R03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flunisolide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flunisolide" type="fsn">flunisolide</designation>
                    <desc language="en-US">flunisolide</desc>
                </concept>
                <concept code="R03BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="R03BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluticasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluticasone" type="fsn">fluticasone</designation>
                    <desc language="en-US">fluticasone</desc>
                </concept>
                <concept code="R03BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamcinolone" type="fsn">triamcinolone</designation>
                    <desc language="en-US">triamcinolone</desc>
                </concept>
                <concept code="R03BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mometasone" type="fsn">mometasone</designation>
                    <desc language="en-US">mometasone</desc>
                </concept>
                <concept code="R03BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclesonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclesonide" type="fsn">ciclesonide</designation>
                    <desc language="en-US">ciclesonide</desc>
                </concept>
                <concept code="R03BA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluticasone furoate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluticasone furoate" type="fsn">fluticasone furoate</designation>
                    <desc language="en-US">fluticasone furoate</desc>
                </concept>
                <concept code="R03BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anticholinergics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anticholinergics" type="fsn">Anticholinergics</designation>
                    <desc language="en-US">Anticholinergics</desc>
                </concept>
                <concept code="R03BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ipratropium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ipratropium bromide" type="fsn">ipratropium bromide</designation>
                    <desc language="en-US">ipratropium bromide</desc>
                </concept>
                <concept code="R03BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxitropium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxitropium bromide" type="fsn">oxitropium bromide</designation>
                    <desc language="en-US">oxitropium bromide</desc>
                </concept>
                <concept code="R03BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stramoni preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="stramoni preparations" type="fsn">stramoni preparations</designation>
                    <desc language="en-US">stramoni preparations</desc>
                </concept>
                <concept code="R03BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiotropium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tiotropium bromide" type="fsn">tiotropium bromide</designation>
                    <desc language="en-US">tiotropium bromide</desc>
                </concept>
                <concept code="R03BB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aclidinium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aclidinium bromide" type="fsn">aclidinium bromide</designation>
                    <desc language="en-US">aclidinium bromide</desc>
                </concept>
                <concept code="R03BB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glycopyrronium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glycopyrronium bromide" type="fsn">glycopyrronium bromide</designation>
                    <desc language="en-US">glycopyrronium bromide</desc>
                </concept>
                <concept code="R03BB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="umeclidinium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="umeclidinium bromide" type="fsn">umeclidinium bromide</designation>
                    <desc language="en-US">umeclidinium bromide</desc>
                </concept>
                <concept code="R03BB54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tiotropium bromide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tiotropium bromide, combinations"
                         type="fsn">tiotropium bromide, combinations</designation>
                    <desc language="en-US">tiotropium bromide, combinations</desc>
                </concept>
                <concept code="R03BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiallergic agents, excl. corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiallergic agents, excl. corticosteroids"
                         type="fsn">Antiallergic agents, excl. corticosteroids</designation>
                    <desc language="en-US">Antiallergic agents, excl. corticosteroids</desc>
                </concept>
                <concept code="R03BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cromoglicic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cromoglicic acid" type="fsn">cromoglicic acid</designation>
                    <desc language="en-US">cromoglicic acid</desc>
                </concept>
                <concept code="R03BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nedocromil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nedocromil" type="fsn">nedocromil</designation>
                    <desc language="en-US">nedocromil</desc>
                </concept>
                <concept code="R03BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other drugs for obstructive airway diseases, inhalants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other drugs for obstructive airway diseases, inhalants"
                         type="fsn">Other drugs for obstructive airway diseases, inhalants</designation>
                    <desc language="en-US">Other drugs for obstructive airway diseases, inhalants</desc>
                </concept>
                <concept code="R03BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenspiride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenspiride" type="fsn">fenspiride</designation>
                    <desc language="en-US">fenspiride</desc>
                </concept>
                <concept code="R03C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ADRENERGICS FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ADRENERGICS FOR SYSTEMIC USE"
                         type="fsn">ADRENERGICS FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ADRENERGICS FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="R03CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Alpha- and beta-adrenoreceptor agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Alpha- and beta-adrenoreceptor agonists"
                         type="fsn">Alpha- and beta-adrenoreceptor agonists</designation>
                    <desc language="en-US">Alpha- and beta-adrenoreceptor agonists</desc>
                </concept>
                <concept code="R03CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ephedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ephedrine" type="fsn">ephedrine</designation>
                    <desc language="en-US">ephedrine</desc>
                </concept>
                <concept code="R03CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Non-selective beta-adrenoreceptor agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Non-selective beta-adrenoreceptor agonists"
                         type="fsn">Non-selective beta-adrenoreceptor agonists</designation>
                    <desc language="en-US">Non-selective beta-adrenoreceptor agonists</desc>
                </concept>
                <concept code="R03CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoprenaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoprenaline" type="fsn">isoprenaline</designation>
                    <desc language="en-US">isoprenaline</desc>
                </concept>
                <concept code="R03CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methoxyphenamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methoxyphenamine" type="fsn">methoxyphenamine</designation>
                    <desc language="en-US">methoxyphenamine</desc>
                </concept>
                <concept code="R03CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="orciprenaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="orciprenaline" type="fsn">orciprenaline</designation>
                    <desc language="en-US">orciprenaline</desc>
                </concept>
                <concept code="R03CB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoprenaline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="isoprenaline, combinations"
                         type="fsn">isoprenaline, combinations</designation>
                    <desc language="en-US">isoprenaline, combinations</desc>
                </concept>
                <concept code="R03CB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="orciprenaline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="orciprenaline, combinations"
                         type="fsn">orciprenaline, combinations</designation>
                    <desc language="en-US">orciprenaline, combinations</desc>
                </concept>
                <concept code="R03CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Selective beta-2-adrenoreceptor agonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Selective beta-2-adrenoreceptor agonists"
                         type="fsn">Selective beta-2-adrenoreceptor agonists</designation>
                    <desc language="en-US">Selective beta-2-adrenoreceptor agonists</desc>
                </concept>
                <concept code="R03CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salbutamol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="salbutamol" type="fsn">salbutamol</designation>
                    <desc language="en-US">salbutamol</desc>
                </concept>
                <concept code="R03CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terbutaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terbutaline" type="fsn">terbutaline</designation>
                    <desc language="en-US">terbutaline</desc>
                </concept>
                <concept code="R03CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenoterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenoterol" type="fsn">fenoterol</designation>
                    <desc language="en-US">fenoterol</desc>
                </concept>
                <concept code="R03CC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexoprenaline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexoprenaline" type="fsn">hexoprenaline</designation>
                    <desc language="en-US">hexoprenaline</desc>
                </concept>
                <concept code="R03CC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoetarine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoetarine" type="fsn">isoetarine</designation>
                    <desc language="en-US">isoetarine</desc>
                </concept>
                <concept code="R03CC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pirbuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pirbuterol" type="fsn">pirbuterol</designation>
                    <desc language="en-US">pirbuterol</desc>
                </concept>
                <concept code="R03CC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procaterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procaterol" type="fsn">procaterol</designation>
                    <desc language="en-US">procaterol</desc>
                </concept>
                <concept code="R03CC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tretoquinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tretoquinol" type="fsn">tretoquinol</designation>
                    <desc language="en-US">tretoquinol</desc>
                </concept>
                <concept code="R03CC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbuterol" type="fsn">carbuterol</designation>
                    <desc language="en-US">carbuterol</desc>
                </concept>
                <concept code="R03CC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tulobuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tulobuterol" type="fsn">tulobuterol</designation>
                    <desc language="en-US">tulobuterol</desc>
                </concept>
                <concept code="R03CC12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bambuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bambuterol" type="fsn">bambuterol</designation>
                    <desc language="en-US">bambuterol</desc>
                </concept>
                <concept code="R03CC13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clenbuterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clenbuterol" type="fsn">clenbuterol</designation>
                    <desc language="en-US">clenbuterol</desc>
                </concept>
                <concept code="R03CC14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reproterol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reproterol" type="fsn">reproterol</designation>
                    <desc language="en-US">reproterol</desc>
                </concept>
                <concept code="R03CC53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terbutaline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terbutaline, combinations" type="fsn">terbutaline, combinations</designation>
                    <desc language="en-US">terbutaline, combinations</desc>
                </concept>
                <concept code="R03CC63"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clenbuterol and ambroxol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clenbuterol and ambroxol" type="fsn">clenbuterol and ambroxol</designation>
                    <desc language="en-US">clenbuterol and ambroxol</desc>
                </concept>
                <concept code="R03CK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Adrenergics and other drugs for obstructive airway diseases"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Adrenergics and other drugs for obstructive airway diseases"
                         type="fsn">Adrenergics and other drugs for obstructive airway diseases</designation>
                    <desc language="en-US">Adrenergics and other drugs for obstructive airway diseases</desc>
                </concept>
                <concept code="R03D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES"
                         type="fsn">OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</designation>
                    <desc language="en-US">OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</desc>
                </concept>
                <concept code="R03DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Xanthines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Xanthines" type="fsn">Xanthines</designation>
                    <desc language="en-US">Xanthines</desc>
                </concept>
                <concept code="R03DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diprophylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diprophylline" type="fsn">diprophylline</designation>
                    <desc language="en-US">diprophylline</desc>
                </concept>
                <concept code="R03DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="choline theophyllinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="choline theophyllinate" type="fsn">choline theophyllinate</designation>
                    <desc language="en-US">choline theophyllinate</desc>
                </concept>
                <concept code="R03DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proxyphylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proxyphylline" type="fsn">proxyphylline</designation>
                    <desc language="en-US">proxyphylline</desc>
                </concept>
                <concept code="R03DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="theophylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="theophylline" type="fsn">theophylline</designation>
                    <desc language="en-US">theophylline</desc>
                </concept>
                <concept code="R03DA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminophylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminophylline" type="fsn">aminophylline</designation>
                    <desc language="en-US">aminophylline</desc>
                </concept>
                <concept code="R03DA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etamiphylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etamiphylline" type="fsn">etamiphylline</designation>
                    <desc language="en-US">etamiphylline</desc>
                </concept>
                <concept code="R03DA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="theobromine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="theobromine" type="fsn">theobromine</designation>
                    <desc language="en-US">theobromine</desc>
                </concept>
                <concept code="R03DA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bamifylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bamifylline" type="fsn">bamifylline</designation>
                    <desc language="en-US">bamifylline</desc>
                </concept>
                <concept code="R03DA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acefylline piperazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acefylline piperazine" type="fsn">acefylline piperazine</designation>
                    <desc language="en-US">acefylline piperazine</desc>
                </concept>
                <concept code="R03DA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bufylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bufylline" type="fsn">bufylline</designation>
                    <desc language="en-US">bufylline</desc>
                </concept>
                <concept code="R03DA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxofylline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxofylline" type="fsn">doxofylline</designation>
                    <desc language="en-US">doxofylline</desc>
                </concept>
                <concept code="R03DA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepyramine theophyllinacetate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="mepyramine theophyllinacetate"
                         type="fsn">mepyramine theophyllinacetate</designation>
                    <desc language="en-US">mepyramine theophyllinacetate</desc>
                </concept>
                <concept code="R03DA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of xanthines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations of xanthines" type="fsn">combinations of xanthines</designation>
                    <desc language="en-US">combinations of xanthines</desc>
                </concept>
                <concept code="R03DA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diprophylline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diprophylline, combinations"
                         type="fsn">diprophylline, combinations</designation>
                    <desc language="en-US">diprophylline, combinations</desc>
                </concept>
                <concept code="R03DA54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="theophylline, combinations excl. psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="theophylline, combinations excl. psycholeptics"
                         type="fsn">theophylline, combinations excl. psycholeptics</designation>
                    <desc language="en-US">theophylline, combinations excl. psycholeptics</desc>
                </concept>
                <concept code="R03DA55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminophylline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="aminophylline, combinations"
                         type="fsn">aminophylline, combinations</designation>
                    <desc language="en-US">aminophylline, combinations</desc>
                </concept>
                <concept code="R03DA57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="theobromine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="theobromine, combinations" type="fsn">theobromine, combinations</designation>
                    <desc language="en-US">theobromine, combinations</desc>
                </concept>
                <concept code="R03DA74"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="theophylline, combinations with psycholeptics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="theophylline, combinations with psycholeptics"
                         type="fsn">theophylline, combinations with psycholeptics</designation>
                    <desc language="en-US">theophylline, combinations with psycholeptics</desc>
                </concept>
                <concept code="R03DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Xanthines and adrenergics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Xanthines and adrenergics" type="fsn">Xanthines and adrenergics</designation>
                    <desc language="en-US">Xanthines and adrenergics</desc>
                </concept>
                <concept code="R03DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diprophylline and adrenergics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diprophylline and adrenergics"
                         type="fsn">diprophylline and adrenergics</designation>
                    <desc language="en-US">diprophylline and adrenergics</desc>
                </concept>
                <concept code="R03DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="choline theophyllinate and adrenergics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="choline theophyllinate and adrenergics"
                         type="fsn">choline theophyllinate and adrenergics</designation>
                    <desc language="en-US">choline theophyllinate and adrenergics</desc>
                </concept>
                <concept code="R03DB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proxyphylline and adrenergics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="proxyphylline and adrenergics"
                         type="fsn">proxyphylline and adrenergics</designation>
                    <desc language="en-US">proxyphylline and adrenergics</desc>
                </concept>
                <concept code="R03DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="theophylline and adrenergics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="theophylline and adrenergics"
                         type="fsn">theophylline and adrenergics</designation>
                    <desc language="en-US">theophylline and adrenergics</desc>
                </concept>
                <concept code="R03DB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminophylline and adrenergics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="aminophylline and adrenergics"
                         type="fsn">aminophylline and adrenergics</designation>
                    <desc language="en-US">aminophylline and adrenergics</desc>
                </concept>
                <concept code="R03DB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etamiphylline and adrenergics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="etamiphylline and adrenergics"
                         type="fsn">etamiphylline and adrenergics</designation>
                    <desc language="en-US">etamiphylline and adrenergics</desc>
                </concept>
                <concept code="R03DC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Leukotriene receptor antagonists"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Leukotriene receptor antagonists"
                         type="fsn">Leukotriene receptor antagonists</designation>
                    <desc language="en-US">Leukotriene receptor antagonists</desc>
                </concept>
                <concept code="R03DC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zafirlukast"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zafirlukast" type="fsn">zafirlukast</designation>
                    <desc language="en-US">zafirlukast</desc>
                </concept>
                <concept code="R03DC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pranlukast"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pranlukast" type="fsn">pranlukast</designation>
                    <desc language="en-US">pranlukast</desc>
                </concept>
                <concept code="R03DC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="montelukast"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="montelukast" type="fsn">montelukast</designation>
                    <desc language="en-US">montelukast</desc>
                </concept>
                <concept code="R03DC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibudilast"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibudilast" type="fsn">ibudilast</designation>
                    <desc language="en-US">ibudilast</desc>
                </concept>
                <concept code="R03DC53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="montelukast, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="montelukast, combinations" type="fsn">montelukast, combinations</designation>
                    <desc language="en-US">montelukast, combinations</desc>
                </concept>
                <concept code="R03DX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other systemic drugs for obstructive airway diseases"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other systemic drugs for obstructive airway diseases"
                         type="fsn">Other systemic drugs for obstructive airway diseases</designation>
                    <desc language="en-US">Other systemic drugs for obstructive airway diseases</desc>
                </concept>
                <concept code="R03DX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amlexanox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amlexanox" type="fsn">amlexanox</designation>
                    <desc language="en-US">amlexanox</desc>
                </concept>
                <concept code="R03DX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eprozinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eprozinol" type="fsn">eprozinol</designation>
                    <desc language="en-US">eprozinol</desc>
                </concept>
                <concept code="R03DX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fenspiride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fenspiride" type="fsn">fenspiride</designation>
                    <desc language="en-US">fenspiride</desc>
                </concept>
                <concept code="R03DX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omalizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="omalizumab" type="fsn">omalizumab</designation>
                    <desc language="en-US">omalizumab</desc>
                </concept>
                <concept code="R03DX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="seratrodast"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="seratrodast" type="fsn">seratrodast</designation>
                    <desc language="en-US">seratrodast</desc>
                </concept>
                <concept code="R03DX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="roflumilast"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="roflumilast" type="fsn">roflumilast</designation>
                    <desc language="en-US">roflumilast</desc>
                </concept>
                <concept code="R03DX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="reslizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="reslizumab" type="fsn">reslizumab</designation>
                    <desc language="en-US">reslizumab</desc>
                </concept>
                <concept code="R03DX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepolizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepolizumab" type="fsn">mepolizumab</designation>
                    <desc language="en-US">mepolizumab</desc>
                </concept>
                <concept code="R03DX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benralizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benralizumab" type="fsn">benralizumab</designation>
                    <desc language="en-US">benralizumab</desc>
                </concept>
                <concept code="R05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="COUGH AND COLD PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="COUGH AND COLD PREPARATIONS"
                         type="fsn">COUGH AND COLD PREPARATIONS</designation>
                    <desc language="en-US">COUGH AND COLD PREPARATIONS</desc>
                </concept>
                <concept code="R05C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS"
                         type="fsn">EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS</designation>
                    <desc language="en-US">EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS</desc>
                </concept>
                <concept code="R05CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Expectorants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Expectorants" type="fsn">Expectorants</designation>
                    <desc language="en-US">Expectorants</desc>
                </concept>
                <concept code="R05CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tyloxapol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tyloxapol" type="fsn">tyloxapol</designation>
                    <desc language="en-US">tyloxapol</desc>
                </concept>
                <concept code="R05CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium iodide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium iodide" type="fsn">potassium iodide</designation>
                    <desc language="en-US">potassium iodide</desc>
                </concept>
                <concept code="R05CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guaifenesin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guaifenesin" type="fsn">guaifenesin</designation>
                    <desc language="en-US">guaifenesin</desc>
                </concept>
                <concept code="R05CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ipecacuanha"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ipecacuanha" type="fsn">ipecacuanha</designation>
                    <desc language="en-US">ipecacuanha</desc>
                </concept>
                <concept code="R05CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="althea root"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="althea root" type="fsn">althea root</designation>
                    <desc language="en-US">althea root</desc>
                </concept>
                <concept code="R05CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="senega"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="senega" type="fsn">senega</designation>
                    <desc language="en-US">senega</desc>
                </concept>
                <concept code="R05CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antimony pentasulfide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="antimony pentasulfide" type="fsn">antimony pentasulfide</designation>
                    <desc language="en-US">antimony pentasulfide</desc>
                </concept>
                <concept code="R05CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="creosote"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="creosote" type="fsn">creosote</designation>
                    <desc language="en-US">creosote</desc>
                </concept>
                <concept code="R05CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guaiacolsulfonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guaiacolsulfonate" type="fsn">guaiacolsulfonate</designation>
                    <desc language="en-US">guaiacolsulfonate</desc>
                </concept>
                <concept code="R05CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="R05CA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levoverbenone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levoverbenone" type="fsn">levoverbenone</designation>
                    <desc language="en-US">levoverbenone</desc>
                </concept>
                <concept code="R05CA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Hederae helicis folium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Hederae helicis folium" type="fsn">Hederae helicis folium</designation>
                    <desc language="en-US">Hederae helicis folium</desc>
                </concept>
                <concept code="R05CA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cineole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cineole" type="fsn">cineole</designation>
                    <desc language="en-US">cineole</desc>
                </concept>
                <concept code="R05CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Mucolytics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Mucolytics" type="fsn">Mucolytics</designation>
                    <desc language="en-US">Mucolytics</desc>
                </concept>
                <concept code="R05CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylcysteine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylcysteine" type="fsn">acetylcysteine</designation>
                    <desc language="en-US">acetylcysteine</desc>
                </concept>
                <concept code="R05CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromhexine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromhexine" type="fsn">bromhexine</designation>
                    <desc language="en-US">bromhexine</desc>
                </concept>
                <concept code="R05CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbocisteine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbocisteine" type="fsn">carbocisteine</designation>
                    <desc language="en-US">carbocisteine</desc>
                </concept>
                <concept code="R05CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="eprazinone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="eprazinone" type="fsn">eprazinone</designation>
                    <desc language="en-US">eprazinone</desc>
                </concept>
                <concept code="R05CB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mesna"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mesna" type="fsn">mesna</designation>
                    <desc language="en-US">mesna</desc>
                </concept>
                <concept code="R05CB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ambroxol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ambroxol" type="fsn">ambroxol</designation>
                    <desc language="en-US">ambroxol</desc>
                </concept>
                <concept code="R05CB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sobrerol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sobrerol" type="fsn">sobrerol</designation>
                    <desc language="en-US">sobrerol</desc>
                </concept>
                <concept code="R05CB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="domiodol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="domiodol" type="fsn">domiodol</designation>
                    <desc language="en-US">domiodol</desc>
                </concept>
                <concept code="R05CB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="letosteine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="letosteine" type="fsn">letosteine</designation>
                    <desc language="en-US">letosteine</desc>
                </concept>
                <concept code="R05CB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="R05CB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="stepronin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="stepronin" type="fsn">stepronin</designation>
                    <desc language="en-US">stepronin</desc>
                </concept>
                <concept code="R05CB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dornase alfa (desoxyribonuclease)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dornase alfa (desoxyribonuclease)"
                         type="fsn">dornase alfa (desoxyribonuclease)</designation>
                    <desc language="en-US">dornase alfa (desoxyribonuclease)</desc>
                </concept>
                <concept code="R05CB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neltenexine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neltenexine" type="fsn">neltenexine</designation>
                    <desc language="en-US">neltenexine</desc>
                </concept>
                <concept code="R05CB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erdosteine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="erdosteine" type="fsn">erdosteine</designation>
                    <desc language="en-US">erdosteine</desc>
                </concept>
                <concept code="R05CB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mannitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mannitol" type="fsn">mannitol</designation>
                    <desc language="en-US">mannitol</desc>
                </concept>
                <concept code="R05D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS"
                         type="fsn">COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS</designation>
                    <desc language="en-US">COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS</desc>
                </concept>
                <concept code="R05DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Opium alkaloids and derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Opium alkaloids and derivatives"
                         type="fsn">Opium alkaloids and derivatives</designation>
                    <desc language="en-US">Opium alkaloids and derivatives</desc>
                </concept>
                <concept code="R05DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethylmorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethylmorphine" type="fsn">ethylmorphine</designation>
                    <desc language="en-US">ethylmorphine</desc>
                </concept>
                <concept code="R05DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocodone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocodone" type="fsn">hydrocodone</designation>
                    <desc language="en-US">hydrocodone</desc>
                </concept>
                <concept code="R05DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="codeine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="codeine" type="fsn">codeine</designation>
                    <desc language="en-US">codeine</desc>
                </concept>
                <concept code="R05DA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="opium alkaloids with morphine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="opium alkaloids with morphine"
                         type="fsn">opium alkaloids with morphine</designation>
                    <desc language="en-US">opium alkaloids with morphine</desc>
                </concept>
                <concept code="R05DA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="normethadone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="normethadone" type="fsn">normethadone</designation>
                    <desc language="en-US">normethadone</desc>
                </concept>
                <concept code="R05DA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="noscapine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="noscapine" type="fsn">noscapine</designation>
                    <desc language="en-US">noscapine</desc>
                </concept>
                <concept code="R05DA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pholcodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pholcodine" type="fsn">pholcodine</designation>
                    <desc language="en-US">pholcodine</desc>
                </concept>
                <concept code="R05DA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dextromethorphan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dextromethorphan" type="fsn">dextromethorphan</designation>
                    <desc language="en-US">dextromethorphan</desc>
                </concept>
                <concept code="R05DA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thebacon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thebacon" type="fsn">thebacon</designation>
                    <desc language="en-US">thebacon</desc>
                </concept>
                <concept code="R05DA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimemorfan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimemorfan" type="fsn">dimemorfan</designation>
                    <desc language="en-US">dimemorfan</desc>
                </concept>
                <concept code="R05DA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetyldihydrocodeine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetyldihydrocodeine" type="fsn">acetyldihydrocodeine</designation>
                    <desc language="en-US">acetyldihydrocodeine</desc>
                </concept>
                <concept code="R05DA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="R05DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cough suppressants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other cough suppressants" type="fsn">Other cough suppressants</designation>
                    <desc language="en-US">Other cough suppressants</desc>
                </concept>
                <concept code="R05DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzonatate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzonatate" type="fsn">benzonatate</designation>
                    <desc language="en-US">benzonatate</desc>
                </concept>
                <concept code="R05DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benproperine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benproperine" type="fsn">benproperine</designation>
                    <desc language="en-US">benproperine</desc>
                </concept>
                <concept code="R05DB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clobutinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clobutinol" type="fsn">clobutinol</designation>
                    <desc language="en-US">clobutinol</desc>
                </concept>
                <concept code="R05DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isoaminile"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isoaminile" type="fsn">isoaminile</designation>
                    <desc language="en-US">isoaminile</desc>
                </concept>
                <concept code="R05DB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentoxyverine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentoxyverine" type="fsn">pentoxyverine</designation>
                    <desc language="en-US">pentoxyverine</desc>
                </concept>
                <concept code="R05DB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxolamine" type="fsn">oxolamine</designation>
                    <desc language="en-US">oxolamine</desc>
                </concept>
                <concept code="R05DB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxeladin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxeladin" type="fsn">oxeladin</designation>
                    <desc language="en-US">oxeladin</desc>
                </concept>
                <concept code="R05DB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clofedanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clofedanol" type="fsn">clofedanol</designation>
                    <desc language="en-US">clofedanol</desc>
                </concept>
                <concept code="R05DB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pipazetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pipazetate" type="fsn">pipazetate</designation>
                    <desc language="en-US">pipazetate</desc>
                </concept>
                <concept code="R05DB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bibenzonium bromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bibenzonium bromide" type="fsn">bibenzonium bromide</designation>
                    <desc language="en-US">bibenzonium bromide</desc>
                </concept>
                <concept code="R05DB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="butamirate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="butamirate" type="fsn">butamirate</designation>
                    <desc language="en-US">butamirate</desc>
                </concept>
                <concept code="R05DB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fedrilate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fedrilate" type="fsn">fedrilate</designation>
                    <desc language="en-US">fedrilate</desc>
                </concept>
                <concept code="R05DB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zipeprol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zipeprol" type="fsn">zipeprol</designation>
                    <desc language="en-US">zipeprol</desc>
                </concept>
                <concept code="R05DB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibunate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibunate" type="fsn">dibunate</designation>
                    <desc language="en-US">dibunate</desc>
                </concept>
                <concept code="R05DB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="droxypropine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="droxypropine" type="fsn">droxypropine</designation>
                    <desc language="en-US">droxypropine</desc>
                </concept>
                <concept code="R05DB18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prenoxdiazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prenoxdiazine" type="fsn">prenoxdiazine</designation>
                    <desc language="en-US">prenoxdiazine</desc>
                </concept>
                <concept code="R05DB19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dropropizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dropropizine" type="fsn">dropropizine</designation>
                    <desc language="en-US">dropropizine</desc>
                </concept>
                <concept code="R05DB20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="R05DB21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cloperastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cloperastine" type="fsn">cloperastine</designation>
                    <desc language="en-US">cloperastine</desc>
                </concept>
                <concept code="R05DB22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meprotixol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meprotixol" type="fsn">meprotixol</designation>
                    <desc language="en-US">meprotixol</desc>
                </concept>
                <concept code="R05DB23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piperidione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piperidione" type="fsn">piperidione</designation>
                    <desc language="en-US">piperidione</desc>
                </concept>
                <concept code="R05DB24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tipepidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tipepidine" type="fsn">tipepidine</designation>
                    <desc language="en-US">tipepidine</desc>
                </concept>
                <concept code="R05DB25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="morclofone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="morclofone" type="fsn">morclofone</designation>
                    <desc language="en-US">morclofone</desc>
                </concept>
                <concept code="R05DB26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nepinalone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nepinalone" type="fsn">nepinalone</designation>
                    <desc language="en-US">nepinalone</desc>
                </concept>
                <concept code="R05DB27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levodropropizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levodropropizine" type="fsn">levodropropizine</designation>
                    <desc language="en-US">levodropropizine</desc>
                </concept>
                <concept code="R05DB28"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimethoxanate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimethoxanate" type="fsn">dimethoxanate</designation>
                    <desc language="en-US">dimethoxanate</desc>
                </concept>
                <concept code="R05F"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS"
                         type="fsn">COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS</designation>
                    <desc language="en-US">COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS</desc>
                </concept>
                <concept code="R05FA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Opium derivatives and expectorants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Opium derivatives and expectorants"
                         type="fsn">Opium derivatives and expectorants</designation>
                    <desc language="en-US">Opium derivatives and expectorants</desc>
                </concept>
                <concept code="R05FA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="opium derivatives and mucolytics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="opium derivatives and mucolytics"
                         type="fsn">opium derivatives and mucolytics</designation>
                    <desc language="en-US">opium derivatives and mucolytics</desc>
                </concept>
                <concept code="R05FA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="opium derivatives and expectorants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="opium derivatives and expectorants"
                         type="fsn">opium derivatives and expectorants</designation>
                    <desc language="en-US">opium derivatives and expectorants</desc>
                </concept>
                <concept code="R05FB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cough suppressants and expectorants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other cough suppressants and expectorants"
                         type="fsn">Other cough suppressants and expectorants</designation>
                    <desc language="en-US">Other cough suppressants and expectorants</desc>
                </concept>
                <concept code="R05FB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cough suppressants and mucolytics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cough suppressants and mucolytics"
                         type="fsn">cough suppressants and mucolytics</designation>
                    <desc language="en-US">cough suppressants and mucolytics</desc>
                </concept>
                <concept code="R05FB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cough suppressants and expectorants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cough suppressants and expectorants"
                         type="fsn">cough suppressants and expectorants</designation>
                    <desc language="en-US">cough suppressants and expectorants</desc>
                </concept>
                <concept code="R05X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER COLD PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER COLD PREPARATIONS" type="fsn">OTHER COLD PREPARATIONS</designation>
                    <desc language="en-US">OTHER COLD PREPARATIONS</desc>
                </concept>
                <concept code="R06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIHISTAMINES FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIHISTAMINES FOR SYSTEMIC USE"
                         type="fsn">ANTIHISTAMINES FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIHISTAMINES FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="R06A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIHISTAMINES FOR SYSTEMIC USE"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIHISTAMINES FOR SYSTEMIC USE"
                         type="fsn">ANTIHISTAMINES FOR SYSTEMIC USE</designation>
                    <desc language="en-US">ANTIHISTAMINES FOR SYSTEMIC USE</desc>
                </concept>
                <concept code="R06AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Aminoalkyl ethers"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Aminoalkyl ethers" type="fsn">Aminoalkyl ethers</designation>
                    <desc language="en-US">Aminoalkyl ethers</desc>
                </concept>
                <concept code="R06AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromazine" type="fsn">bromazine</designation>
                    <desc language="en-US">bromazine</desc>
                </concept>
                <concept code="R06AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphenhydramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphenhydramine" type="fsn">diphenhydramine</designation>
                    <desc language="en-US">diphenhydramine</desc>
                </concept>
                <concept code="R06AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clemastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clemastine" type="fsn">clemastine</designation>
                    <desc language="en-US">clemastine</desc>
                </concept>
                <concept code="R06AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorphenoxamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorphenoxamine" type="fsn">chlorphenoxamine</designation>
                    <desc language="en-US">chlorphenoxamine</desc>
                </concept>
                <concept code="R06AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphenylpyraline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diphenylpyraline" type="fsn">diphenylpyraline</designation>
                    <desc language="en-US">diphenylpyraline</desc>
                </concept>
                <concept code="R06AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbinoxamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbinoxamine" type="fsn">carbinoxamine</designation>
                    <desc language="en-US">carbinoxamine</desc>
                </concept>
                <concept code="R06AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxylamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxylamine" type="fsn">doxylamine</designation>
                    <desc language="en-US">doxylamine</desc>
                </concept>
                <concept code="R06AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trimethobenzamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trimethobenzamide" type="fsn">trimethobenzamide</designation>
                    <desc language="en-US">trimethobenzamide</desc>
                </concept>
                <concept code="R06AA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphenhydramine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphenhydramine, combinations"
                         type="fsn">diphenhydramine, combinations</designation>
                    <desc language="en-US">diphenhydramine, combinations</desc>
                </concept>
                <concept code="R06AA54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clemastine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clemastine, combinations" type="fsn">clemastine, combinations</designation>
                    <desc language="en-US">clemastine, combinations</desc>
                </concept>
                <concept code="R06AA56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorphenoxamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlorphenoxamine, combinations"
                         type="fsn">chlorphenoxamine, combinations</designation>
                    <desc language="en-US">chlorphenoxamine, combinations</desc>
                </concept>
                <concept code="R06AA57"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diphenylpyraline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diphenylpyraline, combinations"
                         type="fsn">diphenylpyraline, combinations</designation>
                    <desc language="en-US">diphenylpyraline, combinations</desc>
                </concept>
                <concept code="R06AA59"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxylamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxylamine, combinations" type="fsn">doxylamine, combinations</designation>
                    <desc language="en-US">doxylamine, combinations</desc>
                </concept>
                <concept code="R06AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Substituted alkylamines"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Substituted alkylamines" type="fsn">Substituted alkylamines</designation>
                    <desc language="en-US">Substituted alkylamines</desc>
                </concept>
                <concept code="R06AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brompheniramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brompheniramine" type="fsn">brompheniramine</designation>
                    <desc language="en-US">brompheniramine</desc>
                </concept>
                <concept code="R06AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexchlorpheniramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexchlorpheniramine" type="fsn">dexchlorpheniramine</designation>
                    <desc language="en-US">dexchlorpheniramine</desc>
                </concept>
                <concept code="R06AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimetindene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimetindene" type="fsn">dimetindene</designation>
                    <desc language="en-US">dimetindene</desc>
                </concept>
                <concept code="R06AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorphenamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorphenamine" type="fsn">chlorphenamine</designation>
                    <desc language="en-US">chlorphenamine</desc>
                </concept>
                <concept code="R06AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pheniramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pheniramine" type="fsn">pheniramine</designation>
                    <desc language="en-US">pheniramine</desc>
                </concept>
                <concept code="R06AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexbrompheniramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexbrompheniramine" type="fsn">dexbrompheniramine</designation>
                    <desc language="en-US">dexbrompheniramine</desc>
                </concept>
                <concept code="R06AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="talastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="talastine" type="fsn">talastine</designation>
                    <desc language="en-US">talastine</desc>
                </concept>
                <concept code="R06AB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brompheniramine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="brompheniramine, combinations"
                         type="fsn">brompheniramine, combinations</designation>
                    <desc language="en-US">brompheniramine, combinations</desc>
                </concept>
                <concept code="R06AB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexchlorpheniramine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dexchlorpheniramine, combinations"
                         type="fsn">dexchlorpheniramine, combinations</designation>
                    <desc language="en-US">dexchlorpheniramine, combinations</desc>
                </concept>
                <concept code="R06AB54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorphenamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chlorphenamine, combinations"
                         type="fsn">chlorphenamine, combinations</designation>
                    <desc language="en-US">chlorphenamine, combinations</desc>
                </concept>
                <concept code="R06AB56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexbrompheniramine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dexbrompheniramine, combinations"
                         type="fsn">dexbrompheniramine, combinations</designation>
                    <desc language="en-US">dexbrompheniramine, combinations</desc>
                </concept>
                <concept code="R06AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Substituted ethylene diamines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Substituted ethylene diamines"
                         type="fsn">Substituted ethylene diamines</designation>
                    <desc language="en-US">Substituted ethylene diamines</desc>
                </concept>
                <concept code="R06AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepyramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepyramine" type="fsn">mepyramine</designation>
                    <desc language="en-US">mepyramine</desc>
                </concept>
                <concept code="R06AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="histapyrrodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="histapyrrodine" type="fsn">histapyrrodine</designation>
                    <desc language="en-US">histapyrrodine</desc>
                </concept>
                <concept code="R06AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloropyramine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloropyramine" type="fsn">chloropyramine</designation>
                    <desc language="en-US">chloropyramine</desc>
                </concept>
                <concept code="R06AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tripelennamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tripelennamine" type="fsn">tripelennamine</designation>
                    <desc language="en-US">tripelennamine</desc>
                </concept>
                <concept code="R06AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methapyrilene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methapyrilene" type="fsn">methapyrilene</designation>
                    <desc language="en-US">methapyrilene</desc>
                </concept>
                <concept code="R06AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thonzylamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thonzylamine" type="fsn">thonzylamine</designation>
                    <desc language="en-US">thonzylamine</desc>
                </concept>
                <concept code="R06AC52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="histapyrrodine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="histapyrrodine, combinations"
                         type="fsn">histapyrrodine, combinations</designation>
                    <desc language="en-US">histapyrrodine, combinations</desc>
                </concept>
                <concept code="R06AC53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloropyramine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chloropyramine, combinations"
                         type="fsn">chloropyramine, combinations</designation>
                    <desc language="en-US">chloropyramine, combinations</desc>
                </concept>
                <concept code="R06AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Phenothiazine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Phenothiazine derivatives" type="fsn">Phenothiazine derivatives</designation>
                    <desc language="en-US">Phenothiazine derivatives</desc>
                </concept>
                <concept code="R06AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alimemazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alimemazine" type="fsn">alimemazine</designation>
                    <desc language="en-US">alimemazine</desc>
                </concept>
                <concept code="R06AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="promethazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="promethazine" type="fsn">promethazine</designation>
                    <desc language="en-US">promethazine</desc>
                </concept>
                <concept code="R06AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiethylperazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiethylperazine" type="fsn">thiethylperazine</designation>
                    <desc language="en-US">thiethylperazine</desc>
                </concept>
                <concept code="R06AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methdilazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methdilazine" type="fsn">methdilazine</designation>
                    <desc language="en-US">methdilazine</desc>
                </concept>
                <concept code="R06AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxyethylpromethazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxyethylpromethazine" type="fsn">hydroxyethylpromethazine</designation>
                    <desc language="en-US">hydroxyethylpromethazine</desc>
                </concept>
                <concept code="R06AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiazinam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiazinam" type="fsn">thiazinam</designation>
                    <desc language="en-US">thiazinam</desc>
                </concept>
                <concept code="R06AD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mequitazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mequitazine" type="fsn">mequitazine</designation>
                    <desc language="en-US">mequitazine</desc>
                </concept>
                <concept code="R06AD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxomemazine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxomemazine" type="fsn">oxomemazine</designation>
                    <desc language="en-US">oxomemazine</desc>
                </concept>
                <concept code="R06AD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="isothipendyl"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="isothipendyl" type="fsn">isothipendyl</designation>
                    <desc language="en-US">isothipendyl</desc>
                </concept>
                <concept code="R06AD52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="promethazine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="promethazine, combinations"
                         type="fsn">promethazine, combinations</designation>
                    <desc language="en-US">promethazine, combinations</desc>
                </concept>
                <concept code="R06AD55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxyethylpromethazine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydroxyethylpromethazine, combinations"
                         type="fsn">hydroxyethylpromethazine, combinations</designation>
                    <desc language="en-US">hydroxyethylpromethazine, combinations</desc>
                </concept>
                <concept code="R06AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Piperazine derivatives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Piperazine derivatives" type="fsn">Piperazine derivatives</designation>
                    <desc language="en-US">Piperazine derivatives</desc>
                </concept>
                <concept code="R06AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buclizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buclizine" type="fsn">buclizine</designation>
                    <desc language="en-US">buclizine</desc>
                </concept>
                <concept code="R06AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclizine" type="fsn">cyclizine</designation>
                    <desc language="en-US">cyclizine</desc>
                </concept>
                <concept code="R06AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorcyclizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorcyclizine" type="fsn">chlorcyclizine</designation>
                    <desc language="en-US">chlorcyclizine</desc>
                </concept>
                <concept code="R06AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meclozine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meclozine" type="fsn">meclozine</designation>
                    <desc language="en-US">meclozine</desc>
                </concept>
                <concept code="R06AE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxatomide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxatomide" type="fsn">oxatomide</designation>
                    <desc language="en-US">oxatomide</desc>
                </concept>
                <concept code="R06AE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cetirizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cetirizine" type="fsn">cetirizine</designation>
                    <desc language="en-US">cetirizine</desc>
                </concept>
                <concept code="R06AE09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levocetirizine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levocetirizine" type="fsn">levocetirizine</designation>
                    <desc language="en-US">levocetirizine</desc>
                </concept>
                <concept code="R06AE51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="buclizine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="buclizine, combinations" type="fsn">buclizine, combinations</designation>
                    <desc language="en-US">buclizine, combinations</desc>
                </concept>
                <concept code="R06AE53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclizine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclizine, combinations" type="fsn">cyclizine, combinations</designation>
                    <desc language="en-US">cyclizine, combinations</desc>
                </concept>
                <concept code="R06AE55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="meclozine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="meclozine, combinations" type="fsn">meclozine, combinations</designation>
                    <desc language="en-US">meclozine, combinations</desc>
                </concept>
                <concept code="R06AK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Combinations of antihistamines"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Combinations of antihistamines"
                         type="fsn">Combinations of antihistamines</designation>
                    <desc language="en-US">Combinations of antihistamines</desc>
                </concept>
                <concept code="R06AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antihistamines for systemic use"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antihistamines for systemic use"
                         type="fsn">Other antihistamines for systemic use</designation>
                    <desc language="en-US">Other antihistamines for systemic use</desc>
                </concept>
                <concept code="R06AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bamipine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bamipine" type="fsn">bamipine</designation>
                    <desc language="en-US">bamipine</desc>
                </concept>
                <concept code="R06AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyproheptadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyproheptadine" type="fsn">cyproheptadine</designation>
                    <desc language="en-US">cyproheptadine</desc>
                </concept>
                <concept code="R06AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thenalidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thenalidine" type="fsn">thenalidine</designation>
                    <desc language="en-US">thenalidine</desc>
                </concept>
                <concept code="R06AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenindamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenindamine" type="fsn">phenindamine</designation>
                    <desc language="en-US">phenindamine</desc>
                </concept>
                <concept code="R06AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="antazoline" type="fsn">antazoline</designation>
                    <desc language="en-US">antazoline</desc>
                </concept>
                <concept code="R06AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triprolidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triprolidine" type="fsn">triprolidine</designation>
                    <desc language="en-US">triprolidine</desc>
                </concept>
                <concept code="R06AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrrobutamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pyrrobutamine" type="fsn">pyrrobutamine</designation>
                    <desc language="en-US">pyrrobutamine</desc>
                </concept>
                <concept code="R06AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azatadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azatadine" type="fsn">azatadine</designation>
                    <desc language="en-US">azatadine</desc>
                </concept>
                <concept code="R06AX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="astemizole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="astemizole" type="fsn">astemizole</designation>
                    <desc language="en-US">astemizole</desc>
                </concept>
                <concept code="R06AX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="terfenadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="terfenadine" type="fsn">terfenadine</designation>
                    <desc language="en-US">terfenadin
            e</desc>
                </concept>
                <concept code="R06AX13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="loratadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="loratadine" type="fsn">loratadine</designation>
                    <desc language="en-US">loratadine</desc>
                </concept>
                <concept code="R06AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mebhydrolin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mebhydrolin" type="fsn">mebhydrolin</designation>
                    <desc language="en-US">mebhydrolin</desc>
                </concept>
                <concept code="R06AX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deptropine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deptropine" type="fsn">deptropine</designation>
                    <desc language="en-US">deptropine</desc>
                </concept>
                <concept code="R06AX17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketotifen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketotifen" type="fsn">ketotifen</designation>
                    <desc language="en-US">ketotifen</desc>
                </concept>
                <concept code="R06AX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acrivastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acrivastine" type="fsn">acrivastine</designation>
                    <desc language="en-US">acrivastine</desc>
                </concept>
                <concept code="R06AX19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azelastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azelastine" type="fsn">azelastine</designation>
                    <desc language="en-US">azelastine</desc>
                </concept>
                <concept code="R06AX21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tritoqualine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tritoqualine" type="fsn">tritoqualine</designation>
                    <desc language="en-US">tritoqualine</desc>
                </concept>
                <concept code="R06AX22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ebastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ebastine" type="fsn">ebastine</designation>
                    <desc language="en-US">ebastine</desc>
                </concept>
                <concept code="R06AX23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pimethixene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pimethixene" type="fsn">pimethixene</designation>
                    <desc language="en-US">pimethixene</desc>
                </concept>
                <concept code="R06AX24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinastine" type="fsn">epinastine</designation>
                    <desc language="en-US">epinastine</desc>
                </concept>
                <concept code="R06AX25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mizolastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mizolastine" type="fsn">mizolastine</designation>
                    <desc language="en-US">mizolastine</desc>
                </concept>
                <concept code="R06AX26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fexofenadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fexofenadine" type="fsn">fexofenadine</designation>
                    <desc language="en-US">fexofenadine</desc>
                </concept>
                <concept code="R06AX27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desloratadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desloratadine" type="fsn">desloratadine</designation>
                    <desc language="en-US">desloratadine</desc>
                </concept>
                <concept code="R06AX28"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rupatadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rupatadine" type="fsn">rupatadine</designation>
                    <desc language="en-US">rupatadine</desc>
                </concept>
                <concept code="R06AX29"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bilastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bilastine" type="fsn">bilastine</designation>
                    <desc language="en-US">bilastine</desc>
                </concept>
                <concept code="R06AX31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="quifenadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="quifenadine" type="fsn">quifenadine</designation>
                    <desc language="en-US">quifenadine</desc>
                </concept>
                <concept code="R06AX32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sequifenadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sequifenadine" type="fsn">sequifenadine</designation>
                    <desc language="en-US">sequifenadine</desc>
                </concept>
                <concept code="R06AX53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thenalidine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thenalidine, combinations" type="fsn">thenalidine, combinations</designation>
                    <desc language="en-US">thenalidine, combinations</desc>
                </concept>
                <concept code="R06AX58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pyrrobutamine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pyrrobutamine, combinations"
                         type="fsn">pyrrobutamine, combinations</designation>
                    <desc language="en-US">pyrrobutamine, combinations</desc>
                </concept>
                <concept code="R07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER RESPIRATORY SYSTEM PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER RESPIRATORY SYSTEM PRODUCTS"
                         type="fsn">OTHER RESPIRATORY SYSTEM PRODUCTS</designation>
                    <desc language="en-US">OTHER RESPIRATORY SYSTEM PRODUCTS</desc>
                </concept>
                <concept code="R07A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER RESPIRATORY SYSTEM PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER RESPIRATORY SYSTEM PRODUCTS"
                         type="fsn">OTHER RESPIRATORY SYSTEM PRODUCTS</designation>
                    <desc language="en-US">OTHER RESPIRATORY SYSTEM PRODUCTS</desc>
                </concept>
                <concept code="R07AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Lung surfactants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Lung surfactants" type="fsn">Lung surfactants</designation>
                    <desc language="en-US">Lung surfactants</desc>
                </concept>
                <concept code="R07AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colfosceril palmitate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colfosceril palmitate" type="fsn">colfosceril palmitate</designation>
                    <desc language="en-US">colfosceril palmitate</desc>
                </concept>
                <concept code="R07AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="natural phospholipids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="natural phospholipids" type="fsn">natural phospholipids</designation>
                    <desc language="en-US">natural phospholipids</desc>
                </concept>
                <concept code="R07AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="R07AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Respiratory stimulants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Respiratory stimulants" type="fsn">Respiratory stimulants</designation>
                    <desc language="en-US">Respiratory stimulants</desc>
                </concept>
                <concept code="R07AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="doxapram"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="doxapram" type="fsn">doxapram</designation>
                    <desc language="en-US">doxapram</desc>
                </concept>
                <concept code="R07AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nikethamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nikethamide" type="fsn">nikethamide</designation>
                    <desc language="en-US">nikethamide</desc>
                </concept>
                <concept code="R07AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentetrazol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentetrazol" type="fsn">pentetrazol</designation>
                    <desc language="en-US">pentetrazol</desc>
                </concept>
                <concept code="R07AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="etamivan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="etamivan" type="fsn">etamivan</designation>
                    <desc language="en-US">etamivan</desc>
                </concept>
                <concept code="R07AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bemegride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bemegride" type="fsn">bemegride</designation>
                    <desc language="en-US">bemegride</desc>
                </concept>
                <concept code="R07AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prethcamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prethcamide" type="fsn">prethcamide</designation>
                    <desc language="en-US">prethcamide</desc>
                </concept>
                <concept code="R07AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="almitrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="almitrine" type="fsn">almitrine</designation>
                    <desc language="en-US">almitrine</desc>
                </concept>
                <concept code="R07AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimefline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimefline" type="fsn">dimefline</designation>
                    <desc language="en-US">dimefline</desc>
                </concept>
                <concept code="R07AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mepixanox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mepixanox" type="fsn">mepixanox</designation>
                    <desc language="en-US">mepixanox</desc>
                </concept>
                <concept code="R07AB52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nikethamide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nikethamide, combinations" type="fsn">nikethamide, combinations</designation>
                    <desc language="en-US">nikethamide, combinations</desc>
                </concept>
                <concept code="R07AB53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentetrazol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentetrazol, combinations" type="fsn">pentetrazol, combinations</designation>
                    <desc language="en-US">pentetrazol, combinations</desc>
                </concept>
                <concept code="R07AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other respiratory system products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other respiratory system products"
                         type="fsn">Other respiratory system products</designation>
                    <desc language="en-US">Other respiratory system products</desc>
                </concept>
                <concept code="R07AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitric oxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitric oxide" type="fsn">nitric oxide</designation>
                    <desc language="en-US">nitric oxide</desc>
                </concept>
                <concept code="R07AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ivacaftor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ivacaftor" type="fsn">ivacaftor</designation>
                    <desc language="en-US">ivacaftor</desc>
                </concept>
                <concept code="R07AX30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ivacaftor and lumacaftor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ivacaftor and lumacaftor" type="fsn">ivacaftor and lumacaftor</designation>
                    <desc language="en-US">ivacaftor and lumacaftor</desc>
                </concept>
                <concept code="R07AX31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ivacaftor and tezacaftor"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ivacaftor and tezacaftor" type="fsn">ivacaftor and tezacaftor</designation>
                    <desc language="en-US">ivacaftor and tezacaftor</desc>
                </concept>
                <concept code="S"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SENSORY ORGANS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="SENSORY ORGANS" type="fsn">SENSORY ORGANS</designation>
                    <desc language="en-US">SENSORY ORGANS</desc>
                </concept>
                <concept code="S01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OPHTHALMOLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OPHTHALMOLOGICALS" type="fsn">OPHTHALMOLOGICALS</designation>
                    <desc language="en-US">OPHTHALMOLOGICALS</desc>
                </concept>
                <concept code="S01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFECTIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIINFECTIVES" type="fsn">ANTIINFECTIVES</designation>
                    <desc language="en-US">ANTIINFECTIVES</desc>
                </concept>
                <concept code="S01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antibiotics" type="fsn">Antibiotics</designation>
                    <desc language="en-US">Antibiotics</desc>
                </concept>
                <concept code="S01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloramphenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloramphenicol" type="fsn">chloramphenicol</designation>
                    <desc language="en-US">chloramphenicol</desc>
                </concept>
                <concept code="S01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlortetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlortetracycline" type="fsn">chlortetracycline</designation>
                    <desc language="en-US">chlortetracycline</desc>
                </concept>
                <concept code="S01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="S01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxytetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxytetracycline" type="fsn">oxytetracycline</designation>
                    <desc language="en-US">oxytetracycline</desc>
                </concept>
                <concept code="S01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tyrothricin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tyrothricin" type="fsn">tyrothricin</designation>
                    <desc language="en-US">tyrothricin</desc>
                </concept>
                <concept code="S01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="framycetin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="framycetin" type="fsn">framycetin</designation>
                    <desc language="en-US">framycetin</desc>
                </concept>
                <concept code="S01AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracycline" type="fsn">tetracycline</designation>
                    <desc language="en-US">tetracycline</desc>
                </concept>
                <concept code="S01AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="natamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="natamycin" type="fsn">natamycin</designation>
                    <desc language="en-US">natamycin</desc>
                </concept>
                <concept code="S01AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gentamicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gentamicin" type="fsn">gentamicin</designation>
                    <desc language="en-US">gentamicin</desc>
                </concept>
                <concept code="S01AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tobramycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tobramycin" type="fsn">tobramycin</designation>
                    <desc language="en-US">tobramycin</desc>
                </concept>
                <concept code="S01AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fusidic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fusidic acid" type="fsn">fusidic acid</designation>
                    <desc language="en-US">fusidic acid</desc>
                </concept>
                <concept code="S01AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="benzylpenicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="benzylpenicillin" type="fsn">benzylpenicillin</designation>
                    <desc language="en-US">benzylpenicillin</desc>
                </concept>
                <concept code="S01AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dihydrostreptomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dihydrostreptomycin" type="fsn">dihydrostreptomycin</designation>
                    <desc language="en-US">dihydrostreptomycin</desc>
                </concept>
                <concept code="S01AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifamycin" type="fsn">rifamycin</designation>
                    <desc language="en-US">rifamycin</desc>
                </concept>
                <concept code="S01AA17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erythromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="erythromycin" type="fsn">erythromycin</designation>
                    <desc language="en-US">erythromycin</desc>
                </concept>
                <concept code="S01AA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polymyxin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polymyxin B" type="fsn">polymyxin B</designation>
                    <desc language="en-US">polymyxin B</desc>
                </concept>
                <concept code="S01AA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ampicillin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ampicillin" type="fsn">ampicillin</designation>
                    <desc language="en-US">ampicillin</desc>
                </concept>
                <concept code="S01AA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antibiotics in combination with other drugs"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="antibiotics in combination with other drugs"
                         type="fsn">antibiotics in combination with other drugs</designation>
                    <desc language="en-US">antibiotics in combination with other drugs</desc>
                </concept>
                <concept code="S01AA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amikacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amikacin" type="fsn">amikacin</designation>
                    <desc language="en-US">amikacin</desc>
                </concept>
                <concept code="S01AA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="micronomicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="micronomicin" type="fsn">micronomicin</designation>
                    <desc language="en-US">micronomicin</desc>
                </concept>
                <concept code="S01AA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="netilmicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="netilmicin" type="fsn">netilmicin</designation>
                    <desc language="en-US">netilmicin</desc>
                </concept>
                <concept code="S01AA24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="kanamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="kanamycin" type="fsn">kanamycin</designation>
                    <desc language="en-US">kanamycin</desc>
                </concept>
                <concept code="S01AA25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azidamfenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azidamfenicol" type="fsn">azidamfenicol</designation>
                    <desc language="en-US">azidamfenicol</desc>
                </concept>
                <concept code="S01AA26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azithromycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azithromycin" type="fsn">azithromycin</designation>
                    <desc language="en-US">azithromycin</desc>
                </concept>
                <concept code="S01AA27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cefuroxime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cefuroxime" type="fsn">cefuroxime</designation>
                    <desc language="en-US">cefuroxime</desc>
                </concept>
                <concept code="S01AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations of different antibiotics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="combinations of different antibiotics"
                         type="fsn">combinations of different antibiotics</designation>
                    <desc language="en-US">combinations of different antibiotics</desc>
                </concept>
                <concept code="S01AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sulfonamides"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Sulfonamides" type="fsn">Sulfonamides</designation>
                    <desc language="en-US">Sulfonamides</desc>
                </concept>
                <concept code="S01AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfamethizole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfamethizole" type="fsn">sulfamethizole</designation>
                    <desc language="en-US">sulfamethizole</desc>
                </concept>
                <concept code="S01AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfafurazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfafurazole" type="fsn">sulfafurazole</designation>
                    <desc language="en-US">sulfafurazole</desc>
                </concept>
                <concept code="S01AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfadicramide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfadicramide" type="fsn">sulfadicramide</designation>
                    <desc language="en-US">sulfadicramide</desc>
                </concept>
                <concept code="S01AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfacetamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfacetamide" type="fsn">sulfacetamide</designation>
                    <desc language="en-US">sulfacetamide</desc>
                </concept>
                <concept code="S01AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfafenazol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfafenazol" type="fsn">sulfafenazol</designation>
                    <desc language="en-US">sulfafenazol</desc>
                </concept>
                <concept code="S01AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antivirals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antivirals" type="fsn">Antivirals</designation>
                    <desc language="en-US">Antivirals</desc>
                </concept>
                <concept code="S01AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idoxuridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idoxuridine" type="fsn">idoxuridine</designation>
                    <desc language="en-US">idoxuridine</desc>
                </concept>
                <concept code="S01AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="trifluridine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="trifluridine" type="fsn">trifluridine</designation>
                    <desc language="en-US">trifluridine</desc>
                </concept>
                <concept code="S01AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aciclovir" type="fsn">aciclovir</designation>
                    <desc language="en-US">aciclovir</desc>
                </concept>
                <concept code="S01AD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="interferon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="interferon" type="fsn">interferon</designation>
                    <desc language="en-US">interferon</desc>
                </concept>
                <concept code="S01AD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vidarabine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vidarabine" type="fsn">vidarabine</designation>
                    <desc language="en-US">vidarabine</desc>
                </concept>
                <concept code="S01AD07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="famciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="famciclovir" type="fsn">famciclovir</designation>
                    <desc language="en-US">famciclovir</desc>
                </concept>
                <concept code="S01AD08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fomivirsen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fomivirsen" type="fsn">fomivirsen</designation>
                    <desc language="en-US">fomivirsen</desc>
                </concept>
                <concept code="S01AD09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ganciclovir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ganciclovir" type="fsn">ganciclovir</designation>
                    <desc language="en-US">ganciclovir</desc>
                </concept>
                <concept code="S01AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fluoroquinolones"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Fluoroquinolones" type="fsn">Fluoroquinolones</designation>
                    <desc language="en-US">Fluoroquinolones</desc>
                </concept>
                <concept code="S01AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ofloxacin" type="fsn">ofloxacin</designation>
                    <desc language="en-US">ofloxacin</desc>
                </concept>
                <concept code="S01AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="norfloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="norfloxacin" type="fsn">norfloxacin</designation>
                    <desc language="en-US">norfloxacin</desc>
                </concept>
                <concept code="S01AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciprofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciprofloxacin" type="fsn">ciprofloxacin</designation>
                    <desc language="en-US">ciprofloxacin</desc>
                </concept>
                <concept code="S01AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lomefloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lomefloxacin" type="fsn">lomefloxacin</designation>
                    <desc language="en-US">lomefloxacin</desc>
                </concept>
                <concept code="S01AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levofloxacin" type="fsn">levofloxacin</designation>
                    <desc language="en-US">levofloxacin</desc>
                </concept>
                <concept code="S01AE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gatifloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gatifloxacin" type="fsn">gatifloxacin</designation>
                    <desc language="en-US">gatifloxacin</desc>
                </concept>
                <concept code="S01AE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="moxifloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="moxifloxacin" type="fsn">moxifloxacin</designation>
                    <desc language="en-US">moxifloxacin</desc>
                </concept>
                <concept code="S01AE08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="besifloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="besifloxacin" type="fsn">besifloxacin</designation>
                    <desc language="en-US">besifloxacin</desc>
                </concept>
                <concept code="S01AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antiinfectives" type="fsn">Other antiinfectives</designation>
                    <desc language="en-US">Other antiinfectives</desc>
                </concept>
                <concept code="S01AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mercury compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mercury compounds" type="fsn">mercury compounds</designation>
                    <desc language="en-US">mercury compounds</desc>
                </concept>
                <concept code="S01AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="silver compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="silver compounds" type="fsn">silver compounds</designation>
                    <desc language="en-US">silver compounds</desc>
                </concept>
                <concept code="S01AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="zinc compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="zinc compounds" type="fsn">zinc compounds</designation>
                    <desc language="en-US">zinc compounds</desc>
                </concept>
                <concept code="S01AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrofural"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrofural" type="fsn">nitrofural</designation>
                    <desc language="en-US">nitrofural</desc>
                </concept>
                <concept code="S01AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bibrocathol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bibrocathol" type="fsn">bibrocathol</designation>
                    <desc language="en-US">bibrocathol</desc>
                </concept>
                <concept code="S01AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="resorcinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="resorcinol" type="fsn">resorcinol</designation>
                    <desc language="en-US">resorcinol</desc>
                </concept>
                <concept code="S01AX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium borate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium borate" type="fsn">sodium borate</designation>
                    <desc language="en-US">sodium borate</desc>
                </concept>
                <concept code="S01AX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexamidine" type="fsn">hexamidine</designation>
                    <desc language="en-US">hexamidine</desc>
                </concept>
                <concept code="S01AX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorhexidine" type="fsn">chlorhexidine</designation>
                    <desc language="en-US">chlorhexidine</desc>
                </concept>
                <concept code="S01AX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium propionate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium propionate" type="fsn">sodium propionate</designation>
                    <desc language="en-US">sodium propionate</desc>
                </concept>
                <concept code="S01AX14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dibrompropamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dibrompropamidine" type="fsn">dibrompropamidine</designation>
                    <desc language="en-US">dibrompropamidine</desc>
                </concept>
                <concept code="S01AX15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propamidine" type="fsn">propamidine</designation>
                    <desc language="en-US">propamidine</desc>
                </concept>
                <concept code="S01AX16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="picloxydine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="picloxydine" type="fsn">picloxydine</designation>
                    <desc language="en-US">picloxydine</desc>
                </concept>
                <concept code="S01AX18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="povidone-iodine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="povidone-iodine" type="fsn">povidone-iodine</designation>
                    <desc language="en-US">povidone-iodine</desc>
                </concept>
                <concept code="S01B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFLAMMATORY AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIINFLAMMATORY AGENTS" type="fsn">ANTIINFLAMMATORY AGENTS</designation>
                    <desc language="en-US">ANTIINFLAMMATORY AGENTS</desc>
                </concept>
                <concept code="S01BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids, plain"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Corticosteroids, plain" type="fsn">Corticosteroids, plain</designation>
                    <desc language="en-US">Corticosteroids, plain</desc>
                </concept>
                <concept code="S01BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="S01BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="S01BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cortisone" type="fsn">cortisone</designation>
                    <desc language="en-US">cortisone</desc>
                </concept>
                <concept code="S01BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="S01BA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="triamcinolone" type="fsn">triamcinolone</designation>
                    <desc language="en-US">triamcinolone</desc>
                </concept>
                <concept code="S01BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="S01BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorometholone" type="fsn">fluorometholone</designation>
                    <desc language="en-US">fluorometholone</desc>
                </concept>
                <concept code="S01BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medrysone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medrysone" type="fsn">medrysone</designation>
                    <desc language="en-US">medrysone</desc>
                </concept>
                <concept code="S01BA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clobetasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clobetasone" type="fsn">clobetasone</designation>
                    <desc language="en-US">clobetasone</desc>
                </concept>
                <concept code="S01BA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alclometasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alclometasone" type="fsn">alclometasone</designation>
                    <desc language="en-US">alclometasone</desc>
                </concept>
                <concept code="S01BA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="desonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="desonide" type="fsn">desonide</designation>
                    <desc language="en-US">desonide</desc>
                </concept>
                <concept code="S01BA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="formocortal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="formocortal" type="fsn">formocortal</designation>
                    <desc language="en-US">formocortal</desc>
                </concept>
                <concept code="S01BA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rimexolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rimexolone" type="fsn">rimexolone</designation>
                    <desc language="en-US">rimexolone</desc>
                </concept>
                <concept code="S01BA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="loteprednol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="loteprednol" type="fsn">loteprednol</designation>
                    <desc language="en-US">loteprednol</desc>
                </concept>
                <concept code="S01BA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinolone acetonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocinolone acetonide" type="fsn">fluocinolone acetonide</designation>
                    <desc language="en-US">fluocinolone acetonide</desc>
                </concept>
                <concept code="S01BB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids and mydriatics in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids and mydriatics in combination"
                         type="fsn">Corticosteroids and mydriatics in combination</designation>
                    <desc language="en-US">Corticosteroids and mydriatics in combination</desc>
                </concept>
                <concept code="S01BB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone and mydriatics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrocortisone and mydriatics"
                         type="fsn">hydrocortisone and mydriatics</designation>
                    <desc language="en-US">hydrocortisone and mydriatics</desc>
                </concept>
                <concept code="S01BB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone and mydriatics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone and mydriatics"
                         type="fsn">prednisolone and mydriatics</designation>
                    <desc language="en-US">prednisolone and mydriatics</desc>
                </concept>
                <concept code="S01BB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone and mydriatics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluorometholone and mydriatics"
                         type="fsn">fluorometholone and mydriatics</designation>
                    <desc language="en-US">fluorometholone and mydriatics</desc>
                </concept>
                <concept code="S01BB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone and mydriatics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="betamethasone and mydriatics"
                         type="fsn">betamethasone and mydriatics</designation>
                    <desc language="en-US">betamethasone and mydriatics</desc>
                </concept>
                <concept code="S01BC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinflammatory agents, non-steroids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiinflammatory agents, non-steroids"
                         type="fsn">Antiinflammatory agents, non-steroids</designation>
                    <desc language="en-US">Antiinflammatory agents, non-steroids</desc>
                </concept>
                <concept code="S01BC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indometacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indometacin" type="fsn">indometacin</designation>
                    <desc language="en-US">indometacin</desc>
                </concept>
                <concept code="S01BC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxyphenbutazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxyphenbutazone" type="fsn">oxyphenbutazone</designation>
                    <desc language="en-US">oxyphenbutazone</desc>
                </concept>
                <concept code="S01BC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diclofenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diclofenac" type="fsn">diclofenac</designation>
                    <desc language="en-US">diclofenac</desc>
                </concept>
                <concept code="S01BC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flurbiprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flurbiprofen" type="fsn">flurbiprofen</designation>
                    <desc language="en-US">flurbiprofen</desc>
                </concept>
                <concept code="S01BC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketorolac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketorolac" type="fsn">ketorolac</designation>
                    <desc language="en-US">ketorolac</desc>
                </concept>
                <concept code="S01BC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="piroxicam"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="piroxicam" type="fsn">piroxicam</designation>
                    <desc language="en-US">piroxicam</desc>
                </concept>
                <concept code="S01BC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bendazac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bendazac" type="fsn">bendazac</designation>
                    <desc language="en-US">bendazac</desc>
                </concept>
                <concept code="S01BC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="salicylic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="salicylic acid" type="fsn">salicylic acid</designation>
                    <desc language="en-US">salicylic acid</desc>
                </concept>
                <concept code="S01BC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pranoprofen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pranoprofen" type="fsn">pranoprofen</designation>
                    <desc language="en-US">pranoprofen</desc>
                </concept>
                <concept code="S01BC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nepafenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nepafenac" type="fsn">nepafenac</designation>
                    <desc language="en-US">nepafenac</desc>
                </concept>
                <concept code="S01BC11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bromfenac"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bromfenac" type="fsn">bromfenac</designation>
                    <desc language="en-US">bromfenac</desc>
                </concept>
                <concept code="S01C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION"
                         type="fsn">ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION</designation>
                    <desc language="en-US">ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION</desc>
                </concept>
                <concept code="S01CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids and antiinfectives in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids and antiinfectives in combination"
                         type="fsn">Corticosteroids and antiinfectives in combination</designation>
                    <desc language="en-US">Corticosteroids and antiinfectives in combination</desc>
                </concept>
                <concept code="S01CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dexamethasone and antiinfectives"
                         type="fsn">dexamethasone and antiinfectives</designation>
                    <desc language="en-US">dexamethasone and antiinfectives</desc>
                </concept>
                <concept code="S01CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone and antiinfectives"
                         type="fsn">prednisolone and antiinfectives</designation>
                    <desc language="en-US">prednisolone and antiinfectives</desc>
                </concept>
                <concept code="S01CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrocortisone and antiinfectives"
                         type="fsn">hydrocortisone and antiinfectives</designation>
                    <desc language="en-US">hydrocortisone and antiinfectives</desc>
                </concept>
                <concept code="S01CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocortolone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluocortolone and antiinfectives"
                         type="fsn">fluocortolone and antiinfectives</designation>
                    <desc language="en-US">fluocortolone and antiinfectives</desc>
                </concept>
                <concept code="S01CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="betamethasone and antiinfectives"
                         type="fsn">betamethasone and antiinfectives</designation>
                    <desc language="en-US">betamethasone and antiinfectives</desc>
                </concept>
                <concept code="S01CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludrocortisone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fludrocortisone and antiinfectives"
                         type="fsn">fludrocortisone and antiinfectives</designation>
                    <desc language="en-US">fludrocortisone and antiinfectives</desc>
                </concept>
                <concept code="S01CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluorometholone and antiinfectives"
                         type="fsn">fluorometholone and antiinfectives</designation>
                    <desc language="en-US">fluorometholone and antiinfectives</desc>
                </concept>
                <concept code="S01CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylprednisolone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="methylprednisolone and antiinfectives"
                         type="fsn">methylprednisolone and antiinfectives</designation>
                    <desc language="en-US">methylprednisolone and antiinfectives</desc>
                </concept>
                <concept code="S01CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloroprednisone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chloroprednisone and antiinfectives"
                         type="fsn">chloroprednisone and antiinfectives</designation>
                    <desc language="en-US">chloroprednisone and antiinfectives</desc>
                </concept>
                <concept code="S01CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinolone acetonide and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluocinolone acetonide and antiinfectives"
                         type="fsn">fluocinolone acetonide and antiinfectives</designation>
                    <desc language="en-US">fluocinolone acetonide and antiinfectives</desc>
                </concept>
                <concept code="S01CA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clobetasone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="clobetasone and antiinfectives"
                         type="fsn">clobetasone and antiinfectives</designation>
                    <desc language="en-US">clobetasone and antiinfectives</desc>
                </concept>
                <concept code="S01CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids/antiinfectives/mydriatics in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids/antiinfectives/mydriatics in combination"
                         type="fsn">Corticosteroids/antiinfectives/mydriatics in combination</designation>
                    <desc language="en-US">Corticosteroids/antiinfectives/mydriatics in combination</desc>
                </concept>
                <concept code="S01CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="S01CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="S01CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="S01CB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="S01CB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorometholone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorometholone" type="fsn">fluorometholone</designation>
                    <desc language="en-US">fluorometholone</desc>
                </concept>
                <concept code="S01CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinflammatory agents, non-steroids and antiinfectives in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antiinflammatory agents, non-steroids and antiinfectives in combination"
                         type="fsn">Antiinflammatory agents, non-steroids and antiinfectives in combination</designation>
                    <desc language="en-US">Antiinflammatory agents, non-steroids and antiinfectives in combination</desc>
                </concept>
                <concept code="S01CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diclofenac and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="diclofenac and antiinfectives"
                         type="fsn">diclofenac and antiinfectives</designation>
                    <desc language="en-US">diclofenac and antiinfectives</desc>
                </concept>
                <concept code="S01CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indometacin and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indometacin and antiinfectives"
                         type="fsn">indometacin and antiinfectives</designation>
                    <desc language="en-US">indometacin and antiinfectives</desc>
                </concept>
                <concept code="S01E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIGLAUCOMA PREPARATIONS AND MIOTICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ANTIGLAUCOMA PREPARATIONS AND MIOTICS"
                         type="fsn">ANTIGLAUCOMA PREPARATIONS AND MIOTICS</designation>
                    <desc language="en-US">ANTIGLAUCOMA PREPARATIONS AND MIOTICS</desc>
                </concept>
                <concept code="S01EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sympathomimetics in glaucoma therapy1)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sympathomimetics in glaucoma therapy1)"
                         type="fsn">Sympathomimetics in glaucoma therapy1)</designation>
                    <desc language="en-US">Sympathomimetics in glaucoma therapy1)</desc>
                </concept>
                <concept code="S01EA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinephrine" type="fsn">epinephrine</designation>
                    <desc language="en-US">epinephrine</desc>
                </concept>
                <concept code="S01EA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dipivefrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dipivefrine" type="fsn">dipivefrine</designation>
                    <desc language="en-US">dipivefrine</desc>
                </concept>
                <concept code="S01EA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="apraclonidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="apraclonidine" type="fsn">apraclonidine</designation>
                    <desc language="en-US">apraclonidine</desc>
                </concept>
                <concept code="S01EA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clonidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clonidine" type="fsn">clonidine</designation>
                    <desc language="en-US">clonidine</desc>
                </concept>
                <concept code="S01EA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brimonidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brimonidine" type="fsn">brimonidine</designation>
                    <desc language="en-US">brimonidine</desc>
                </concept>
                <concept code="S01EA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinephrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinephrine, combinations" type="fsn">epinephrine, combinations</designation>
                    <desc language="en-US">epinephrine, combinations</desc>
                </concept>
                <concept code="S01EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Parasympathomimetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Parasympathomimetics" type="fsn">Parasympathomimetics</designation>
                    <desc language="en-US">Parasympathomimetics</desc>
                </concept>
                <concept code="S01EB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pilocarpine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pilocarpine" type="fsn">pilocarpine</designation>
                    <desc language="en-US">pilocarpine</desc>
                </concept>
                <concept code="S01EB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbachol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbachol" type="fsn">carbachol</designation>
                    <desc language="en-US">carbachol</desc>
                </concept>
                <concept code="S01EB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ecothiopate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ecothiopate" type="fsn">ecothiopate</designation>
                    <desc language="en-US">ecothiopate</desc>
                </concept>
                <concept code="S01EB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="demecarium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="demecarium" type="fsn">demecarium</designation>
                    <desc language="en-US">demecarium</desc>
                </concept>
                <concept code="S01EB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="physostigmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="physostigmine" type="fsn">physostigmine</designation>
                    <desc language="en-US">physostigmine</desc>
                </concept>
                <concept code="S01EB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neostigmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neostigmine" type="fsn">neostigmine</designation>
                    <desc language="en-US">neostigmine</desc>
                </concept>
                <concept code="S01EB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluostigmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluostigmine" type="fsn">fluostigmine</designation>
                    <desc language="en-US">fluostigmine</desc>
                </concept>
                <concept code="S01EB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aceclidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aceclidine" type="fsn">aceclidine</designation>
                    <desc language="en-US">aceclidine</desc>
                </concept>
                <concept code="S01EB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylcholine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylcholine" type="fsn">acetylcholine</designation>
                    <desc language="en-US">acetylcholine</desc>
                </concept>
                <concept code="S01EB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="paraoxon"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="paraoxon" type="fsn">paraoxon</designation>
                    <desc language="en-US">paraoxon</desc>
                </concept>
                <concept code="S01EB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pilocarpine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pilocarpine, combinations" type="fsn">pilocarpine, combinations</designation>
                    <desc language="en-US">pilocarpine, combinations</desc>
                </concept>
                <concept code="S01EB58"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aceclidine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aceclidine, combinations" type="fsn">aceclidine, combinations</designation>
                    <desc language="en-US">aceclidine, combinations</desc>
                </concept>
                <concept code="S01EC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Carbonic anhydrase inhibitors"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Carbonic anhydrase inhibitors"
                         type="fsn">Carbonic anhydrase inhibitors</designation>
                    <desc language="en-US">Carbonic anhydrase inhibitors</desc>
                </concept>
                <concept code="S01EC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetazolamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetazolamide" type="fsn">acetazolamide</designation>
                    <desc language="en-US">acetazolamide</desc>
                </concept>
                <concept code="S01EC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diclofenamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diclofenamide" type="fsn">diclofenamide</designation>
                    <desc language="en-US">diclofenamide</desc>
                </concept>
                <concept code="S01EC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dorzolamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dorzolamide" type="fsn">dorzolamide</designation>
                    <desc language="en-US">dorzolamide</desc>
                </concept>
                <concept code="S01EC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brinzolamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="brinzolamide" type="fsn">brinzolamide</designation>
                    <desc language="en-US">brinzolamide</desc>
                </concept>
                <concept code="S01EC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methazolamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methazolamide" type="fsn">methazolamide</designation>
                    <desc language="en-US">methazolamide</desc>
                </concept>
                <concept code="S01EC54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="brinzolamide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="brinzolamide, combinations"
                         type="fsn">brinzolamide, combinations</designation>
                    <desc language="en-US">brinzolamide, combinations</desc>
                </concept>
                <concept code="S01ED"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Beta blocking agents1)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Beta blocking agents1)" type="fsn">Beta blocking agents1)</designation>
                    <desc language="en-US">Beta blocking agents1)</desc>
                </concept>
                <concept code="S01ED01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="timolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="timolol" type="fsn">timolol</designation>
                    <desc language="en-US">timolol</desc>
                </concept>
                <concept code="S01ED02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betaxolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betaxolol" type="fsn">betaxolol</designation>
                    <desc language="en-US">betaxolol</desc>
                </concept>
                <concept code="S01ED03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levobunolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levobunolol" type="fsn">levobunolol</designation>
                    <desc language="en-US">levobunolol</desc>
                </concept>
                <concept code="S01ED04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metipranolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metipranolol" type="fsn">metipranolol</designation>
                    <desc language="en-US">metipranolol</desc>
                </concept>
                <concept code="S01ED05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carteolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carteolol" type="fsn">carteolol</designation>
                    <desc language="en-US">carteolol</desc>
                </concept>
                <concept code="S01ED06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="befunolol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="befunolol" type="fsn">befunolol</designation>
                    <desc language="en-US">befunolol</desc>
                </concept>
                <concept code="S01ED51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="timolol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="timolol, combinations" type="fsn">timolol, combinations</designation>
                    <desc language="en-US">timolol, combinations</desc>
                </concept>
                <concept code="S01ED52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betaxolol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betaxolol, combinations" type="fsn">betaxolol, combinations</designation>
                    <desc language="en-US">betaxolol, combinations</desc>
                </concept>
                <concept code="S01ED54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metipranolol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="metipranolol, combinations"
                         type="fsn">metipranolol, combinations</designation>
                    <desc language="en-US">metipranolol, combinations</desc>
                </concept>
                <concept code="S01ED55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carteolol, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carteolol, combinations" type="fsn">carteolol, combinations</designation>
                    <desc language="en-US">carteolol, combinations</desc>
                </concept>
                <concept code="S01EE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Prostaglandin analogues1)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Prostaglandin analogues1)" type="fsn">Prostaglandin analogues1)</designation>
                    <desc language="en-US">Prostaglandin analogues1)</desc>
                </concept>
                <concept code="S01EE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="latanoprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="latanoprost" type="fsn">latanoprost</designation>
                    <desc language="en-US">latanoprost</desc>
                </concept>
                <concept code="S01EE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="unoprostone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="unoprostone" type="fsn">unoprostone</designation>
                    <desc language="en-US">unoprostone</desc>
                </concept>
                <concept code="S01EE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bimatoprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bimatoprost" type="fsn">bimatoprost</designation>
                    <desc language="en-US">bimatoprost</desc>
                </concept>
                <concept code="S01EE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="travoprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="travoprost" type="fsn">travoprost</designation>
                    <desc language="en-US">travoprost</desc>
                </concept>
                <concept code="S01EE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tafluprost"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tafluprost" type="fsn">tafluprost</designation>
                    <desc language="en-US">tafluprost</desc>
                </concept>
                <concept code="S01EX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiglaucoma preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antiglaucoma preparations"
                         type="fsn">Other antiglaucoma preparations</designation>
                    <desc language="en-US">Other antiglaucoma preparations</desc>
                </concept>
                <concept code="S01EX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guanethidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guanethidine" type="fsn">guanethidine</designation>
                    <desc language="en-US">guanethidine</desc>
                </concept>
                <concept code="S01EX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dapiprazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dapiprazole" type="fsn">dapiprazole</designation>
                    <desc language="en-US">dapiprazole</desc>
                </concept>
                <concept code="S01EX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="netarsudil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="netarsudil" type="fsn">netarsudil</designation>
                    <desc language="en-US">netarsudil</desc>
                </concept>
                <concept code="S01EX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="omidenepag"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="omidenepag" type="fsn">omidenepag</designation>
                    <desc language="en-US">omidenepag</desc>
                </concept>
                <concept code="S01F"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MYDRIATICS AND CYCLOPLEGICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="MYDRIATICS AND CYCLOPLEGICS"
                         type="fsn">MYDRIATICS AND CYCLOPLEGICS</designation>
                    <desc language="en-US">MYDRIATICS AND CYCLOPLEGICS</desc>
                </concept>
                <concept code="S01FA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Anticholinergics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Anticholinergics" type="fsn">Anticholinergics</designation>
                    <desc language="en-US">Anticholinergics</desc>
                </concept>
                <concept code="S01FA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="atropine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="atropine" type="fsn">atropine</designation>
                    <desc language="en-US">atropine</desc>
                </concept>
                <concept code="S01FA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="scopolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="scopolamine" type="fsn">scopolamine</designation>
                    <desc language="en-US">scopolamine</desc>
                </concept>
                <concept code="S01FA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylscopolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylscopolamine" type="fsn">methylscopolamine</designation>
                    <desc language="en-US">methylscopolamine</desc>
                </concept>
                <concept code="S01FA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclopentolate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cyclopentolate" type="fsn">cyclopentolate</designation>
                    <desc language="en-US">cyclopentolate</desc>
                </concept>
                <concept code="S01FA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="homatropine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="homatropine" type="fsn">homatropine</designation>
                    <desc language="en-US">homatropine</desc>
                </concept>
                <concept code="S01FA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tropicamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tropicamide" type="fsn">tropicamide</designation>
                    <desc language="en-US">tropicamide</desc>
                </concept>
                <concept code="S01FA54"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cyclopentolate, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cyclopentolate, combinations"
                         type="fsn">cyclopentolate, combinations</designation>
                    <desc language="en-US">cyclopentolate, combinations</desc>
                </concept>
                <concept code="S01FA56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tropicamide, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tropicamide, combinations" type="fsn">tropicamide, combinations</designation>
                    <desc language="en-US">tropicamide, combinations</desc>
                </concept>
                <concept code="S01FB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sympathomimetics excl. antiglaucoma preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sympathomimetics excl. antiglaucoma preparations"
                         type="fsn">Sympathomimetics excl. antiglaucoma preparations</designation>
                    <desc language="en-US">Sympathomimetics excl. antiglaucoma preparations</desc>
                </concept>
                <concept code="S01FB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylephrine" type="fsn">phenylephrine</designation>
                    <desc language="en-US">phenylephrine</desc>
                </concept>
                <concept code="S01FB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ephedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ephedrine" type="fsn">ephedrine</designation>
                    <desc language="en-US">ephedrine</desc>
                </concept>
                <concept code="S01FB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibopamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ibopamine" type="fsn">ibopamine</designation>
                    <desc language="en-US">ibopamine</desc>
                </concept>
                <concept code="S01FB51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine and ketorolac"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenylephrine and ketorolac"
                         type="fsn">phenylephrine and ketorolac</designation>
                    <desc language="en-US">phenylephrine and ketorolac</desc>
                </concept>
                <concept code="S01G"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DECONGESTANTS AND ANTIALLERGICS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DECONGESTANTS AND ANTIALLERGICS"
                         type="fsn">DECONGESTANTS AND ANTIALLERGICS</designation>
                    <desc language="en-US">DECONGESTANTS AND ANTIALLERGICS</desc>
                </concept>
                <concept code="S01GA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sympathomimetics used as decongestants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sympathomimetics used as decongestants"
                         type="fsn">Sympathomimetics used as decongestants</designation>
                    <desc language="en-US">Sympathomimetics used as decongestants</desc>
                </concept>
                <concept code="S01GA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naphazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naphazoline" type="fsn">naphazoline</designation>
                    <desc language="en-US">naphazoline</desc>
                </concept>
                <concept code="S01GA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetryzoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetryzoline" type="fsn">tetryzoline</designation>
                    <desc language="en-US">tetryzoline</desc>
                </concept>
                <concept code="S01GA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xylometazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xylometazoline" type="fsn">xylometazoline</designation>
                    <desc language="en-US">xylometazoline</desc>
                </concept>
                <concept code="S01GA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxymetazoline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxymetazoline" type="fsn">oxymetazoline</designation>
                    <desc language="en-US">oxymetazoline</desc>
                </concept>
                <concept code="S01GA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenylephrine" type="fsn">phenylephrine</designation>
                    <desc language="en-US">phenylephrine</desc>
                </concept>
                <concept code="S01GA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxedrine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxedrine" type="fsn">oxedrine</designation>
                    <desc language="en-US">oxedrine</desc>
                </concept>
                <concept code="S01GA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naphazoline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naphazoline, combinations" type="fsn">naphazoline, combinations</designation>
                    <desc language="en-US">naphazoline, combinations</desc>
                </concept>
                <concept code="S01GA52"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetryzoline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetryzoline, combinations" type="fsn">tetryzoline, combinations</designation>
                    <desc language="en-US">tetryzoline, combinations</desc>
                </concept>
                <concept code="S01GA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xylometazoline, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="xylometazoline, combinations"
                         type="fsn">xylometazoline, combinations</designation>
                    <desc language="en-US">xylometazoline, combinations</desc>
                </concept>
                <concept code="S01GA55"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenylephrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phenylephrine, combinations"
                         type="fsn">phenylephrine, combinations</designation>
                    <desc language="en-US">phenylephrine, combinations</desc>
                </concept>
                <concept code="S01GA56"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxedrine, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxedrine, combinations" type="fsn">oxedrine, combinations</designation>
                    <desc language="en-US">oxedrine, combinations</desc>
                </concept>
                <concept code="S01GX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiallergics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other antiallergics" type="fsn">Other antiallergics</designation>
                    <desc language="en-US">Other antiallergics</desc>
                </concept>
                <concept code="S01GX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cromoglicic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cromoglicic acid" type="fsn">cromoglicic acid</designation>
                    <desc language="en-US">cromoglicic acid</desc>
                </concept>
                <concept code="S01GX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="levocabastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="levocabastine" type="fsn">levocabastine</designation>
                    <desc language="en-US">levocabastine</desc>
                </concept>
                <concept code="S01GX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="spaglumic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="spaglumic acid" type="fsn">spaglumic acid</designation>
                    <desc language="en-US">spaglumic acid</desc>
                </concept>
                <concept code="S01GX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nedocromil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nedocromil" type="fsn">nedocromil</designation>
                    <desc language="en-US">nedocromil</desc>
                </concept>
                <concept code="S01GX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lodoxamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lodoxamide" type="fsn">lodoxamide</designation>
                    <desc language="en-US">lodoxamide</desc>
                </concept>
                <concept code="S01GX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="emedastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="emedastine" type="fsn">emedastine</designation>
                    <desc language="en-US">emedastine</desc>
                </concept>
                <concept code="S01GX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="azelastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="azelastine" type="fsn">azelastine</designation>
                    <desc language="en-US">azelastine</desc>
                </concept>
                <concept code="S01GX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ketotifen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ketotifen" type="fsn">ketotifen</designation>
                    <desc language="en-US">ketotifen</desc>
                </concept>
                <concept code="S01GX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="olopatadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="olopatadine" type="fsn">olopatadine</designation>
                    <desc language="en-US">olopatadine</desc>
                </concept>
                <concept code="S01GX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="epinastine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="epinastine" type="fsn">epinastine</designation>
                    <desc language="en-US">epinastine</desc>
                </concept>
                <concept code="S01GX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alcaftadine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alcaftadine" type="fsn">alcaftadine</designation>
                    <desc language="en-US">alcaftadine</desc>
                </concept>
                <concept code="S01GX51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cromoglicic acid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cromoglicic acid, combinations"
                         type="fsn">cromoglicic acid, combinations</designation>
                    <desc language="en-US">cromoglicic acid, combinations</desc>
                </concept>
                <concept code="S01H"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="LOCAL ANESTHETICS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="LOCAL ANESTHETICS" type="fsn">LOCAL ANESTHETICS</designation>
                    <desc language="en-US">LOCAL ANESTHETICS</desc>
                </concept>
                <concept code="S01HA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Local anesthetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Local anesthetics" type="fsn">Local anesthetics</designation>
                    <desc language="en-US">Local anesthetics</desc>
                </concept>
                <concept code="S01HA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cocaine" type="fsn">cocaine</designation>
                    <desc language="en-US">cocaine</desc>
                </concept>
                <concept code="S01HA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxybuprocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxybuprocaine" type="fsn">oxybuprocaine</designation>
                    <desc language="en-US">oxybuprocaine</desc>
                </concept>
                <concept code="S01HA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracaine" type="fsn">tetracaine</designation>
                    <desc language="en-US">tetracaine</desc>
                </concept>
                <concept code="S01HA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="proxymetacaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="proxymetacaine" type="fsn">proxymetacaine</designation>
                    <desc language="en-US">proxymetacaine</desc>
                </concept>
                <concept code="S01HA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="procaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="procaine" type="fsn">procaine</designation>
                    <desc language="en-US">procaine</desc>
                </concept>
                <concept code="S01HA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinchocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinchocaine" type="fsn">cinchocaine</designation>
                    <desc language="en-US">cinchocaine</desc>
                </concept>
                <concept code="S01HA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidocaine" type="fsn">lidocaine</designation>
                    <desc language="en-US">lidocaine</desc>
                </concept>
                <concept code="S01HA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="S01J"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIAGNOSTIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DIAGNOSTIC AGENTS" type="fsn">DIAGNOSTIC AGENTS</designation>
                    <desc language="en-US">DIAGNOSTIC AGENTS</desc>
                </concept>
                <concept code="S01JA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Colouring agents"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Colouring agents" type="fsn">Colouring agents</designation>
                    <desc language="en-US">Colouring agents</desc>
                </concept>
                <concept code="S01JA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorescein"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorescein" type="fsn">fluorescein</designation>
                    <desc language="en-US">fluorescein</desc>
                </concept>
                <concept code="S01JA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rose bengal sodium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rose bengal sodium" type="fsn">rose bengal sodium</designation>
                    <desc language="en-US">rose bengal sodium</desc>
                </concept>
                <concept code="S01JA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorescein, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorescein, combinations" type="fsn">fluorescein, combinations</designation>
                    <desc language="en-US">fluorescein, combinations</desc>
                </concept>
                <concept code="S01JX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other ophthalmological diagnostic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other ophthalmological diagnostic agents"
                         type="fsn">Other ophthalmological diagnostic agents</designation>
                    <desc language="en-US">Other ophthalmological diagnostic agents</desc>
                </concept>
                <concept code="S01K"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SURGICAL AIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="SURGICAL AIDS" type="fsn">SURGICAL AIDS</designation>
                    <desc language="en-US">SURGICAL AIDS</desc>
                </concept>
                <concept code="S01KA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Viscoelastic substances"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Viscoelastic substances" type="fsn">Viscoelastic substances</designation>
                    <desc language="en-US">Viscoelastic substances</desc>
                </concept>
                <concept code="S01KA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hyaluronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hyaluronic acid" type="fsn">hyaluronic acid</designation>
                    <desc language="en-US">hyaluronic acid</desc>
                </concept>
                <concept code="S01KA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hypromellose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hypromellose" type="fsn">hypromellose</designation>
                    <desc language="en-US">hypromellose</desc>
                </concept>
                <concept code="S01KA51"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hyaluronic acid, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hyaluronic acid, combinations"
                         type="fsn">hyaluronic acid, combinations</designation>
                    <desc language="en-US">hyaluronic acid, combinations</desc>
                </concept>
                <concept code="S01KX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other surgical aids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other surgical aids" type="fsn">Other surgical aids</designation>
                    <desc language="en-US">Other surgical aids</desc>
                </concept>
                <concept code="S01KX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chymotrypsin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chymotrypsin" type="fsn">chymotrypsin</designation>
                    <desc language="en-US">chymotrypsin</desc>
                </concept>
                <concept code="S01L"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OCULAR VASCULAR DISORDER AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OCULAR VASCULAR DISORDER AGENTS"
                         type="fsn">OCULAR VASCULAR DISORDER AGENTS</designation>
                    <desc language="en-US">OCULAR VASCULAR DISORDER AGENTS</desc>
                </concept>
                <concept code="S01LA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antineovascularisation agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Antineovascularisation agents"
                         type="fsn">Antineovascularisation agents</designation>
                    <desc language="en-US">Antineovascularisation agents</desc>
                </concept>
                <concept code="S01LA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="verteporfin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="verteporfin" type="fsn">verteporfin</designation>
                    <desc language="en-US">verteporfin</desc>
                </concept>
                <concept code="S01LA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="anecortave"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="anecortave" type="fsn">anecortave</designation>
                    <desc language="en-US">anecortave</desc>
                </concept>
                <concept code="S01LA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pegaptanib"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pegaptanib" type="fsn">pegaptanib</designation>
                    <desc language="en-US">pegaptanib</desc>
                </concept>
                <concept code="S01LA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ranibizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ranibizumab" type="fsn">ranibizumab</designation>
                    <desc language="en-US">ranibizumab</desc>
                </concept>
                <concept code="S01LA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aflibercept"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aflibercept" type="fsn">aflibercept</designation>
                    <desc language="en-US">aflibercept</desc>
                </concept>
                <concept code="S01X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER OPHTHALMOLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER OPHTHALMOLOGICALS" type="fsn">OTHER OPHTHALMOLOGICALS</designation>
                    <desc language="en-US">OTHER OPHTHALMOLOGICALS</desc>
                </concept>
                <concept code="S01XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other ophthalmologicals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other ophthalmologicals" type="fsn">Other ophthalmologicals</designation>
                    <desc language="en-US">Other ophthalmologicals</desc>
                </concept>
                <concept code="S01XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="guaiazulen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="guaiazulen" type="fsn">guaiazulen</designation>
                    <desc language="en-US">guaiazulen</desc>
                </concept>
                <concept code="S01XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="retinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="retinol" type="fsn">retinol</designation>
                    <desc language="en-US">retinol</desc>
                </concept>
                <concept code="S01XA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium chloride, hypertonic"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium chloride, hypertonic"
                         type="fsn">sodium chloride, hypertonic</designation>
                    <desc language="en-US">sodium chloride, hypertonic</desc>
                </concept>
                <concept code="S01XA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium iodide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium iodide" type="fsn">potassium iodide</designation>
                    <desc language="en-US">potassium iodide</desc>
                </concept>
                <concept code="S01XA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium edetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium edetate" type="fsn">sodium edetate</designation>
                    <desc language="en-US">sodium edetate</desc>
                </concept>
                <concept code="S01XA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethylmorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethylmorphine" type="fsn">ethylmorphine</designation>
                    <desc language="en-US">ethylmorphine</desc>
                </concept>
                <concept code="S01XA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alum"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alum" type="fsn">alum</designation>
                    <desc language="en-US">alum</desc>
                </concept>
                <concept code="S01XA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylcysteine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylcysteine" type="fsn">acetylcysteine</designation>
                    <desc language="en-US">acetylcysteine</desc>
                </concept>
                <concept code="S01XA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodoheparinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodoheparinate" type="fsn">iodoheparinate</designation>
                    <desc language="en-US">iodoheparinate</desc>
                </concept>
                <concept code="S01XA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="inosine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="inosine" type="fsn">inosine</designation>
                    <desc language="en-US">inosine</desc>
                </concept>
                <concept code="S01XA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nandrolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nandrolone" type="fsn">nandrolone</designation>
                    <desc language="en-US">nandrolone</desc>
                </concept>
                <concept code="S01XA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexpanthenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexpanthenol" type="fsn">dexpanthenol</designation>
                    <desc language="en-US">dexpanthenol</desc>
                </concept>
                <concept code="S01XA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alteplase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alteplase" type="fsn">alteplase</designation>
                    <desc language="en-US">alteplase</desc>
                </concept>
                <concept code="S01XA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="heparin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="heparin" type="fsn">heparin</designation>
                    <desc language="en-US">heparin</desc>
                </concept>
                <concept code="S01XA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ascorbic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ascorbic acid" type="fsn">ascorbic acid</designation>
                    <desc language="en-US">ascorbic acid</desc>
                </concept>
                <concept code="S01XA18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciclosporin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciclosporin" type="fsn">ciclosporin</designation>
                    <desc language="en-US">ciclosporin</desc>
                </concept>
                <concept code="S01XA19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="limbal stem cells, autologous"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="limbal stem cells, autologous"
                         type="fsn">limbal stem cells, autologous</designation>
                    <desc language="en-US">limbal stem cells, autologous</desc>
                </concept>
                <concept code="S01XA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="artificial tears and other indifferent preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="artificial tears and other indifferent preparations"
                         type="fsn">artificial tears and other indifferent preparations</designation>
                    <desc language="en-US">artificial tears and other indifferent preparations</desc>
                </concept>
                <concept code="S01XA21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mercaptamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mercaptamine" type="fsn">mercaptamine</designation>
                    <desc language="en-US">mercaptamine</desc>
                </concept>
                <concept code="S01XA22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ocriplasmin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ocriplasmin" type="fsn">ocriplasmin</designation>
                    <desc language="en-US">ocriplasmin</desc>
                </concept>
                <concept code="S01XA23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sirolimus"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sirolimus" type="fsn">sirolimus</designation>
                    <desc language="en-US">sirolimus</desc>
                </concept>
                <concept code="S01XA24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cenegermin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cenegermin" type="fsn">cenegermin</designation>
                    <desc language="en-US">cenegermin</desc>
                </concept>
                <concept code="S01XA25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lifitegrast"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lifitegrast" type="fsn">lifitegrast</designation>
                    <desc language="en-US">lifitegrast</desc>
                </concept>
                <concept code="S01XA26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="riboflavin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="riboflavin" type="fsn">riboflavin</designation>
                    <desc language="en-US">riboflavin</desc>
                </concept>
                <concept code="S02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTOLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTOLOGICALS" type="fsn">OTOLOGICALS</designation>
                    <desc language="en-US">OTOLOGICALS</desc>
                </concept>
                <concept code="S02A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFECTIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIINFECTIVES" type="fsn">ANTIINFECTIVES</designation>
                    <desc language="en-US">ANTIINFECTIVES</desc>
                </concept>
                <concept code="S02AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antiinfectives" type="fsn">Antiinfectives</designation>
                    <desc language="en-US">Antiinfectives</desc>
                </concept>
                <concept code="S02AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloramphenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloramphenicol" type="fsn">chloramphenicol</designation>
                    <desc language="en-US">chloramphenicol</desc>
                </concept>
                <concept code="S02AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrofural"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrofural" type="fsn">nitrofural</designation>
                    <desc language="en-US">nitrofural</desc>
                </concept>
                <concept code="S02AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="boric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="boric acid" type="fsn">boric acid</designation>
                    <desc language="en-US">boric acid</desc>
                </concept>
                <concept code="S02AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aluminium acetotartrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aluminium acetotartrate" type="fsn">aluminium acetotartrate</designation>
                    <desc language="en-US">aluminium acetotartrate</desc>
                </concept>
                <concept code="S02AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="clioquinol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="clioquinol" type="fsn">clioquinol</designation>
                    <desc language="en-US">clioquinol</desc>
                </concept>
                <concept code="S02AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrogen peroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrogen peroxide" type="fsn">hydrogen peroxide</designation>
                    <desc language="en-US">hydrogen peroxide</desc>
                </concept>
                <concept code="S02AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="S02AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracycline" type="fsn">tetracycline</designation>
                    <desc language="en-US">tetracycline</desc>
                </concept>
                <concept code="S02AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorhexidine" type="fsn">chlorhexidine</designation>
                    <desc language="en-US">chlorhexidine</desc>
                </concept>
                <concept code="S02AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetic acid" type="fsn">acetic acid</designation>
                    <desc language="en-US">acetic acid</desc>
                </concept>
                <concept code="S02AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polymyxin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polymyxin B" type="fsn">polymyxin B</designation>
                    <desc language="en-US">polymyxin B</desc>
                </concept>
                <concept code="S02AA12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rifamycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rifamycin" type="fsn">rifamycin</designation>
                    <desc language="en-US">rifamycin</desc>
                </concept>
                <concept code="S02AA13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="miconazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="miconazole" type="fsn">miconazole</designation>
                    <desc language="en-US">miconazole</desc>
                </concept>
                <concept code="S02AA14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gentamicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gentamicin" type="fsn">gentamicin</designation>
                    <desc language="en-US">gentamicin</desc>
                </concept>
                <concept code="S02AA15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciprofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciprofloxacin" type="fsn">ciprofloxacin</designation>
                    <desc language="en-US">ciprofloxacin</desc>
                </concept>
                <concept code="S02AA16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ofloxacin" type="fsn">ofloxacin</designation>
                    <desc language="en-US">ofloxacin</desc>
                </concept>
                <concept code="S02AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antiinfectives, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="antiinfectives, combinations"
                         type="fsn">antiinfectives, combinations</designation>
                    <desc language="en-US">antiinfectives, combinations</desc>
                </concept>
                <concept code="S02B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CORTICOSTEROIDS" type="fsn">CORTICOSTEROIDS</designation>
                    <desc language="en-US">CORTICOSTEROIDS</desc>
                </concept>
                <concept code="S02BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Corticosteroids" type="fsn">Corticosteroids</designation>
                    <desc language="en-US">Corticosteroids</desc>
                </concept>
                <concept code="S02BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydrocortisone" type="fsn">hydrocortisone</designation>
                    <desc language="en-US">hydrocortisone</desc>
                </concept>
                <concept code="S02BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="S02BA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="S02BA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="S02BA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinolone acetonide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluocinolone acetonide" type="fsn">fluocinolone acetonide</designation>
                    <desc language="en-US">fluocinolone acetonide</desc>
                </concept>
                <concept code="S02C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION"
                         type="fsn">CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION</designation>
                    <desc language="en-US">CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION</desc>
                </concept>
                <concept code="S02CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids and antiinfectives in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids and antiinfectives in combination"
                         type="fsn">Corticosteroids and antiinfectives in combination</designation>
                    <desc language="en-US">Corticosteroids and antiinfectives in combination</desc>
                </concept>
                <concept code="S02CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone and antiinfectives"
                         type="fsn">prednisolone and antiinfectives</designation>
                    <desc language="en-US">prednisolone and antiinfectives</desc>
                </concept>
                <concept code="S02CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flumetasone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="flumetasone and antiinfectives"
                         type="fsn">flumetasone and antiinfectives</designation>
                    <desc language="en-US">flumetasone and antiinfectives</desc>
                </concept>
                <concept code="S02CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrocortisone and antiinfectives"
                         type="fsn">hydrocortisone and antiinfectives</designation>
                    <desc language="en-US">hydrocortisone and antiinfectives</desc>
                </concept>
                <concept code="S02CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="triamcinolone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="triamcinolone and antiinfectives"
                         type="fsn">triamcinolone and antiinfectives</designation>
                    <desc language="en-US">triamcinolone and antiinfectives</desc>
                </concept>
                <concept code="S02CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluocinolone acetonide and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluocinolone acetonide and antiinfectives"
                         type="fsn">fluocinolone acetonide and antiinfectives</designation>
                    <desc language="en-US">fluocinolone acetonide and antiinfectives</desc>
                </concept>
                <concept code="S02CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dexamethasone and antiinfectives"
                         type="fsn">dexamethasone and antiinfectives</designation>
                    <desc language="en-US">dexamethasone and antiinfectives</desc>
                </concept>
                <concept code="S02CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludrocortisone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fludrocortisone and antiinfectives"
                         type="fsn">fludrocortisone and antiinfectives</designation>
                    <desc language="en-US">fludrocortisone and antiinfectives</desc>
                </concept>
                <concept code="S02D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER OTOLOGICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER OTOLOGICALS" type="fsn">OTHER OTOLOGICALS</designation>
                    <desc language="en-US">OTHER OTOLOGICALS</desc>
                </concept>
                <concept code="S02DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Analgesics and anesthetics"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Analgesics and anesthetics"
                         type="fsn">Analgesics and anesthetics</designation>
                    <desc language="en-US">Analgesics and anesthetics</desc>
                </concept>
                <concept code="S02DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lidocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lidocaine" type="fsn">lidocaine</designation>
                    <desc language="en-US">lidocaine</desc>
                </concept>
                <concept code="S02DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cocaine" type="fsn">cocaine</designation>
                    <desc language="en-US">cocaine</desc>
                </concept>
                <concept code="S02DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenazone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenazone" type="fsn">phenazone</designation>
                    <desc language="en-US">phenazone</desc>
                </concept>
                <concept code="S02DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cinchocaine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cinchocaine" type="fsn">cinchocaine</designation>
                    <desc language="en-US">cinchocaine</desc>
                </concept>
                <concept code="S02DA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="combinations" type="fsn">combinations</designation>
                    <desc language="en-US">combinations</desc>
                </concept>
                <concept code="S02DC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Indifferent preparations"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Indifferent preparations" type="fsn">Indifferent preparations</designation>
                    <desc language="en-US">Indifferent preparations</desc>
                </concept>
                <concept code="S03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS"
                         type="fsn">OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS</designation>
                    <desc language="en-US">OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS</desc>
                </concept>
                <concept code="S03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFECTIVES"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIINFECTIVES" type="fsn">ANTIINFECTIVES</designation>
                    <desc language="en-US">ANTIINFECTIVES</desc>
                </concept>
                <concept code="S03AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antiinfectives" type="fsn">Antiinfectives</designation>
                    <desc language="en-US">Antiinfectives</desc>
                </concept>
                <concept code="S03AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="neomycin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="neomycin" type="fsn">neomycin</designation>
                    <desc language="en-US">neomycin</desc>
                </concept>
                <concept code="S03AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tetracycline"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tetracycline" type="fsn">tetracycline</designation>
                    <desc language="en-US">tetracycline</desc>
                </concept>
                <concept code="S03AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polymyxin B"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polymyxin B" type="fsn">polymyxin B</designation>
                    <desc language="en-US">polymyxin B</desc>
                </concept>
                <concept code="S03AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chlorhexidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chlorhexidine" type="fsn">chlorhexidine</designation>
                    <desc language="en-US">chlorhexidine</desc>
                </concept>
                <concept code="S03AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hexamidine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hexamidine" type="fsn">hexamidine</designation>
                    <desc language="en-US">hexamidine</desc>
                </concept>
                <concept code="S03AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gentamicin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gentamicin" type="fsn">gentamicin</designation>
                    <desc language="en-US">gentamicin</desc>
                </concept>
                <concept code="S03AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ciprofloxacin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ciprofloxacin" type="fsn">ciprofloxacin</designation>
                    <desc language="en-US">ciprofloxacin</desc>
                </concept>
                <concept code="S03AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chloramphenicol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chloramphenicol" type="fsn">chloramphenicol</designation>
                    <desc language="en-US">chloramphenicol</desc>
                </concept>
                <concept code="S03AA30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="antiinfectives, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="antiinfectives, combinations"
                         type="fsn">antiinfectives, combinations</designation>
                    <desc language="en-US">antiinfectives, combinations</desc>
                </concept>
                <concept code="S03B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CORTICOSTEROIDS" type="fsn">CORTICOSTEROIDS</designation>
                    <desc language="en-US">CORTICOSTEROIDS</desc>
                </concept>
                <concept code="S03BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Corticosteroids" type="fsn">Corticosteroids</designation>
                    <desc language="en-US">Corticosteroids</desc>
                </concept>
                <concept code="S03BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexamethasone" type="fsn">dexamethasone</designation>
                    <desc language="en-US">dexamethasone</desc>
                </concept>
                <concept code="S03BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prednisolone" type="fsn">prednisolone</designation>
                    <desc language="en-US">prednisolone</desc>
                </concept>
                <concept code="S03BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betamethasone" type="fsn">betamethasone</designation>
                    <desc language="en-US">betamethasone</desc>
                </concept>
                <concept code="S03C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION"
                         type="fsn">CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION</designation>
                    <desc language="en-US">CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION</desc>
                </concept>
                <concept code="S03CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Corticosteroids and antiinfectives in combination"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Corticosteroids and antiinfectives in combination"
                         type="fsn">Corticosteroids and antiinfectives in combination</designation>
                    <desc language="en-US">Corticosteroids and antiinfectives in combination</desc>
                </concept>
                <concept code="S03CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexamethasone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dexamethasone and antiinfectives"
                         type="fsn">dexamethasone and antiinfectives</designation>
                    <desc language="en-US">dexamethasone and antiinfectives</desc>
                </concept>
                <concept code="S03CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone and antiinfectives"
                         type="fsn">prednisolone and antiinfectives</designation>
                    <desc language="en-US">prednisolone and antiinfectives</desc>
                </concept>
                <concept code="S03CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydrocortisone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="hydrocortisone and antiinfectives"
                         type="fsn">hydrocortisone and antiinfectives</designation>
                    <desc language="en-US">hydrocortisone and antiinfectives</desc>
                </concept>
                <concept code="S03CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludrocortisone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fludrocortisone and antiinfectives"
                         type="fsn">fludrocortisone and antiinfectives</designation>
                    <desc language="en-US">fludrocortisone and antiinfectives</desc>
                </concept>
                <concept code="S03CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betamethasone and antiinfectives"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="betamethasone and antiinfectives"
                         type="fsn">betamethasone and antiinfectives</designation>
                    <desc language="en-US">betamethasone and antiinfectives</desc>
                </concept>
                <concept code="S03D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS"
                         type="fsn">OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS</designation>
                    <desc language="en-US">OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS</desc>
                </concept>
                <concept code="V"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="VARIOUS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="VARIOUS" type="fsn">VARIOUS</designation>
                    <desc language="en-US">VARIOUS</desc>
                </concept>
                <concept code="V01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ALLERGENS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ALLERGENS" type="fsn">ALLERGENS</designation>
                    <desc language="en-US">ALLERGENS</desc>
                </concept>
                <concept code="V01A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ALLERGENS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ALLERGENS" type="fsn">ALLERGENS</designation>
                    <desc language="en-US">ALLERGENS</desc>
                </concept>
                <concept code="V01AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Allergen extracts"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Allergen extracts" type="fsn">Allergen extracts</designation>
                    <desc language="en-US">Allergen extracts</desc>
                </concept>
                <concept code="V01AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="feather"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="feather" type="fsn">feather</designation>
                    <desc language="en-US">feather</desc>
                </concept>
                <concept code="V01AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="grass pollen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="grass pollen" type="fsn">grass pollen</designation>
                    <desc language="en-US">grass pollen</desc>
                </concept>
                <concept code="V01AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="house dust mites"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="house dust mites" type="fsn">house dust mites</designation>
                    <desc language="en-US">house dust mites</desc>
                </concept>
                <concept code="V01AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mould fungus and yeast fungus"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="mould fungus and yeast fungus"
                         type="fsn">mould fungus and yeast fungus</designation>
                    <desc language="en-US">mould fungus and yeast fungus</desc>
                </concept>
                <concept code="V01AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tree pollen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tree pollen" type="fsn">tree pollen</designation>
                    <desc language="en-US">tree pollen</desc>
                </concept>
                <concept code="V01AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="insects"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="insects" type="fsn">insects</designation>
                    <desc language="en-US">insects</desc>
                </concept>
                <concept code="V01AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="food"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="food" type="fsn">food</designation>
                    <desc language="en-US">food</desc>
                </concept>
                <concept code="V01AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="textiles"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="textiles" type="fsn">textiles</designation>
                    <desc language="en-US">textiles</desc>
                </concept>
                <concept code="V01AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flowers"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flowers" type="fsn">flowers</designation>
                    <desc language="en-US">flowers</desc>
                </concept>
                <concept code="V01AA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="animals"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="animals" type="fsn">animals</designation>
                    <desc language="en-US">animals</desc>
                </concept>
                <concept code="V01AA20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="various"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="various" type="fsn">various</designation>
                    <desc language="en-US">various</desc>
                </concept>
                <concept code="V03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ALL OTHER THERAPEUTIC PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ALL OTHER THERAPEUTIC PRODUCTS"
                         type="fsn">ALL OTHER THERAPEUTIC PRODUCTS</designation>
                    <desc language="en-US">ALL OTHER THERAPEUTIC PRODUCTS</desc>
                </concept>
                <concept code="V03A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ALL OTHER THERAPEUTIC PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ALL OTHER THERAPEUTIC PRODUCTS"
                         type="fsn">ALL OTHER THERAPEUTIC PRODUCTS</designation>
                    <desc language="en-US">ALL OTHER THERAPEUTIC PRODUCTS</desc>
                </concept>
                <concept code="V03AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Antidotes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Antidotes" type="fsn">Antidotes</designation>
                    <desc language="en-US">Antidotes</desc>
                </concept>
                <concept code="V03AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ipecacuanha"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ipecacuanha" type="fsn">ipecacuanha</designation>
                    <desc language="en-US">ipecacuanha</desc>
                </concept>
                <concept code="V03AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nalorphine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nalorphine" type="fsn">nalorphine</designation>
                    <desc language="en-US">nalorphine</desc>
                </concept>
                <concept code="V03AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="edetates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="edetates" type="fsn">edetates</designation>
                    <desc language="en-US">edetates</desc>
                </concept>
                <concept code="V03AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pralidoxime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pralidoxime" type="fsn">pralidoxime</designation>
                    <desc language="en-US">pralidoxime</desc>
                </concept>
                <concept code="V03AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prednisolone and promethazine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="prednisolone and promethazine"
                         type="fsn">prednisolone and promethazine</designation>
                    <desc language="en-US">prednisolone and promethazine</desc>
                </concept>
                <concept code="V03AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thiosulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thiosulfate" type="fsn">thiosulfate</designation>
                    <desc language="en-US">thiosulfate</desc>
                </concept>
                <concept code="V03AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium nitrite"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium nitrite" type="fsn">sodium nitrite</designation>
                    <desc language="en-US">sodium nitrite</desc>
                </concept>
                <concept code="V03AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dimercaprol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dimercaprol" type="fsn">dimercaprol</designation>
                    <desc language="en-US">dimercaprol</desc>
                </concept>
                <concept code="V03AB13"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="obidoxime"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="obidoxime" type="fsn">obidoxime</designation>
                    <desc language="en-US">obidoxime</desc>
                </concept>
                <concept code="V03AB14"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="protamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="protamine" type="fsn">protamine</designation>
                    <desc language="en-US">protamine</desc>
                </concept>
                <concept code="V03AB15"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="naloxone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="naloxone" type="fsn">naloxone</designation>
                    <desc language="en-US">naloxone</desc>
                </concept>
                <concept code="V03AB16"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethanol" type="fsn">ethanol</designation>
                    <desc language="en-US">ethanol</desc>
                </concept>
                <concept code="V03AB17"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylthioninium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylthioninium chloride" type="fsn">methylthioninium chloride</designation>
                    <desc language="en-US">methylthioninium chloride</desc>
                </concept>
                <concept code="V03AB18"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium permanganate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium permanganate" type="fsn">potassium permanganate</designation>
                    <desc language="en-US">potassium permanganate</desc>
                </concept>
                <concept code="V03AB19"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="physostigmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="physostigmine" type="fsn">physostigmine</designation>
                    <desc language="en-US">physostigmine</desc>
                </concept>
                <concept code="V03AB20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="copper sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="copper sulfate" type="fsn">copper sulfate</designation>
                    <desc language="en-US">copper sulfate</desc>
                </concept>
                <concept code="V03AB21"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="potassium iodide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="potassium iodide" type="fsn">potassium iodide</designation>
                    <desc language="en-US">potassium iodide</desc>
                </concept>
                <concept code="V03AB22"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amyl nitrite"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amyl nitrite" type="fsn">amyl nitrite</designation>
                    <desc language="en-US">amyl nitrite</desc>
                </concept>
                <concept code="V03AB23"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetylcysteine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetylcysteine" type="fsn">acetylcysteine</designation>
                    <desc language="en-US">acetylcysteine</desc>
                </concept>
                <concept code="V03AB24"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="digitalis antitoxin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="digitalis antitoxin" type="fsn">digitalis antitoxin</designation>
                    <desc language="en-US">digitalis antitoxin</desc>
                </concept>
                <concept code="V03AB25"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flumazenil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flumazenil" type="fsn">flumazenil</designation>
                    <desc language="en-US">flumazenil</desc>
                </concept>
                <concept code="V03AB26"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methionine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methionine" type="fsn">methionine</designation>
                    <desc language="en-US">methionine</desc>
                </concept>
                <concept code="V03AB27"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="4-dimethylaminophenol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="4-dimethylaminophenol" type="fsn">4-dimethylaminophenol</designation>
                    <desc language="en-US">4-dimethylaminophenol</desc>
                </concept>
                <concept code="V03AB29"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cholinesterase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cholinesterase" type="fsn">cholinesterase</designation>
                    <desc language="en-US">cholinesterase</desc>
                </concept>
                <concept code="V03AB31"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="prussian blue"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="prussian blue" type="fsn">prussian blue</designation>
                    <desc language="en-US">prussian blue</desc>
                </concept>
                <concept code="V03AB32"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glutathione"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glutathione" type="fsn">glutathione</designation>
                    <desc language="en-US">glutathione</desc>
                </concept>
                <concept code="V03AB33"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="hydroxocobalamin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="hydroxocobalamin" type="fsn">hydroxocobalamin</designation>
                    <desc language="en-US">hydroxocobalamin</desc>
                </concept>
                <concept code="V03AB34"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fomepizole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fomepizole" type="fsn">fomepizole</designation>
                    <desc language="en-US">fomepizole</desc>
                </concept>
                <concept code="V03AB35"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sugammadex"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sugammadex" type="fsn">sugammadex</designation>
                    <desc language="en-US">sugammadex</desc>
                </concept>
                <concept code="V03AB36"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phentolamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phentolamine" type="fsn">phentolamine</designation>
                    <desc language="en-US">phentolamine</desc>
                </concept>
                <concept code="V03AB37"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="idarucizumab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="idarucizumab" type="fsn">idarucizumab</designation>
                    <desc language="en-US">idarucizumab</desc>
                </concept>
                <concept code="V03AB38"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="andexanet alfa"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="andexanet alfa" type="fsn">andexanet alfa</designation>
                    <desc language="en-US">andexanet alfa</desc>
                </concept>
                <concept code="V03AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iron chelating agents"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Iron chelating agents" type="fsn">Iron chelating agents</designation>
                    <desc language="en-US">Iron chelating agents</desc>
                </concept>
                <concept code="V03AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deferoxamine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deferoxamine" type="fsn">deferoxamine</designation>
                    <desc language="en-US">deferoxamine</desc>
                </concept>
                <concept code="V03AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deferiprone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deferiprone" type="fsn">deferiprone</designation>
                    <desc language="en-US">deferiprone</desc>
                </concept>
                <concept code="V03AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="deferasirox"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="deferasirox" type="fsn">deferasirox</designation>
                    <desc language="en-US">deferasirox</desc>
                </concept>
                <concept code="V03AE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs for treatment of hyperkalemia and hyperphosphatemia"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs for treatment of hyperkalemia and hyperphosphatemia"
                         type="fsn">Drugs for treatment of hyperkalemia and hyperphosphatemia</designation>
                    <desc language="en-US">Drugs for treatment of hyperkalemia and hyperphosphatemia</desc>
                </concept>
                <concept code="V03AE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="polystyrene sulfonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="polystyrene sulfonate" type="fsn">polystyrene sulfonate</designation>
                    <desc language="en-US">polystyrene sulfonate</desc>
                </concept>
                <concept code="V03AE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sevelamer"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sevelamer" type="fsn">sevelamer</designation>
                    <desc language="en-US">sevelamer</desc>
                </concept>
                <concept code="V03AE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lanthanum carbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="lanthanum carbonate" type="fsn">lanthanum carbonate</designation>
                    <desc language="en-US">lanthanum carbonate</desc>
                </concept>
                <concept code="V03AE04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium acetate and magnesium carbonate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="calcium acetate and magnesium carbonate"
                         type="fsn">calcium acetate and magnesium carbonate</designation>
                    <desc language="en-US">calcium acetate and magnesium carbonate</desc>
                </concept>
                <concept code="V03AE05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sucroferric oxyhydroxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sucroferric oxyhydroxide" type="fsn">sucroferric oxyhydroxide</designation>
                    <desc language="en-US">sucroferric oxyhydroxide</desc>
                </concept>
                <concept code="V03AE06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="colestilan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="colestilan" type="fsn">colestilan</designation>
                    <desc language="en-US">colestilan</desc>
                </concept>
                <concept code="V03AE07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium acetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium acetate" type="fsn">calcium acetate</designation>
                    <desc language="en-US">calcium acetate</desc>
                </concept>
                <concept code="V03AE08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferric citrate" type="fsn">ferric citrate</designation>
                    <desc language="en-US">ferric citrate</desc>
                </concept>
                <concept code="V03AE09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="patiromer calcium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="patiromer calcium" type="fsn">patiromer calcium</designation>
                    <desc language="en-US">patiromer calcium</desc>
                </concept>
                <concept code="V03AE10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium zirconium cyclosilicate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium zirconium cyclosilicate"
                         type="fsn">sodium zirconium cyclosilicate</designation>
                    <desc language="en-US">sodium zirconium cyclosilicate</desc>
                </concept>
                <concept code="V03AF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Detoxifying agents for antineoplastic treatment"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Detoxifying agents for antineoplastic treatment"
                         type="fsn">Detoxifying agents for antineoplastic treatment</designation>
                    <desc language="en-US">Detoxifying agents for antineoplastic treatment</desc>
                </concept>
                <concept code="V03AF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mesna"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mesna" type="fsn">mesna</designation>
                    <desc language="en-US">mesna</desc>
                </concept>
                <concept code="V03AF02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dexrazoxane"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="dexrazoxane" type="fsn">dexrazoxane</designation>
                    <desc language="en-US">dexrazoxane</desc>
                </concept>
                <concept code="V03AF03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium folinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium folinate" type="fsn">calcium folinate</designation>
                    <desc language="en-US">calcium folinate</desc>
                </concept>
                <concept code="V03AF04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium levofolinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium levofolinate" type="fsn">calcium levofolinate</designation>
                    <desc language="en-US">calcium levofolinate</desc>
                </concept>
                <concept code="V03AF05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="amifostine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="amifostine" type="fsn">amifostine</designation>
                    <desc language="en-US">amifostine</desc>
                </concept>
                <concept code="V03AF06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium folinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium folinate" type="fsn">sodium folinate</designation>
                    <desc language="en-US">sodium folinate</desc>
                </concept>
                <concept code="V03AF07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rasburicase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rasburicase" type="fsn">rasburicase</designation>
                    <desc language="en-US">rasburicase</desc>
                </concept>
                <concept code="V03AF08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="palifermin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="palifermin" type="fsn">palifermin</designation>
                    <desc language="en-US">palifermin</desc>
                </concept>
                <concept code="V03AF09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glucarpidase"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glucarpidase" type="fsn">glucarpidase</designation>
                    <desc language="en-US">glucarpidase</desc>
                </concept>
                <concept code="V03AF10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium levofolinate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium levofolinate" type="fsn">sodium levofolinate</designation>
                    <desc language="en-US">sodium levofolinate</desc>
                </concept>
                <concept code="V03AG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs for treatment of hypercalcemia"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs for treatment of hypercalcemia"
                         type="fsn">Drugs for treatment of hypercalcemia</designation>
                    <desc language="en-US">Drugs for treatment of hypercalcemia</desc>
                </concept>
                <concept code="V03AG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium cellulose phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium cellulose phosphate"
                         type="fsn">sodium cellulose phosphate</designation>
                    <desc language="en-US">sodium cellulose phosphate</desc>
                </concept>
                <concept code="V03AH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs for treatment of hypoglycemia"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Drugs for treatment of hypoglycemia"
                         type="fsn">Drugs for treatment of hypoglycemia</designation>
                    <desc language="en-US">Drugs for treatment of hypoglycemia</desc>
                </concept>
                <concept code="V03AH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diazoxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diazoxide" type="fsn">diazoxide</designation>
                    <desc language="en-US">diazoxide</desc>
                </concept>
                <concept code="V03AK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tissue adhesives"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tissue adhesives" type="fsn">Tissue adhesives</designation>
                    <desc language="en-US">Tissue adhesives</desc>
                </concept>
                <concept code="V03AM"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Drugs for embolisation"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Drugs for embolisation" type="fsn">Drugs for embolisation</designation>
                    <desc language="en-US">Drugs for embolisation</desc>
                </concept>
                <concept code="V03AN"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Medical gases"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Medical gases" type="fsn">Medical gases</designation>
                    <desc language="en-US">Medical gases</desc>
                </concept>
                <concept code="V03AN01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="oxygen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="oxygen" type="fsn">oxygen</designation>
                    <desc language="en-US">oxygen</desc>
                </concept>
                <concept code="V03AN02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="carbon dioxide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="carbon dioxide" type="fsn">carbon dioxide</designation>
                    <desc language="en-US">carbon dioxide</desc>
                </concept>
                <concept code="V03AN03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="helium"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="helium" type="fsn">helium</designation>
                    <desc language="en-US">helium</desc>
                </concept>
                <concept code="V03AN04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nitrogen"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nitrogen" type="fsn">nitrogen</designation>
                    <desc language="en-US">nitrogen</desc>
                </concept>
                <concept code="V03AN05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="medical air"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="medical air" type="fsn">medical air</designation>
                    <desc language="en-US">medical air</desc>
                </concept>
                <concept code="V03AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other therapeutic products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other therapeutic products"
                         type="fsn">Other therapeutic products</designation>
                    <desc language="en-US">Other therapeutic products</desc>
                </concept>
                <concept code="V03AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="nalfurafine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="nalfurafine" type="fsn">nalfurafine</designation>
                    <desc language="en-US">nalfurafine</desc>
                </concept>
                <concept code="V03AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cobicistat"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cobicistat" type="fsn">cobicistat</designation>
                    <desc language="en-US">cobicistat</desc>
                </concept>
                <concept code="V03AZ"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nerve depressants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Nerve depressants" type="fsn">Nerve depressants</designation>
                    <desc language="en-US">Nerve depressants</desc>
                </concept>
                <concept code="V03AZ01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ethanol" type="fsn">ethanol</designation>
                    <desc language="en-US">ethanol</desc>
                </concept>
                <concept code="V04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIAGNOSTIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="DIAGNOSTIC AGENTS" type="fsn">DIAGNOSTIC AGENTS</designation>
                    <desc language="en-US">DIAGNOSTIC AGENTS</desc>
                </concept>
                <concept code="V04B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="URINE TESTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="URINE TESTS" type="fsn">URINE TESTS</designation>
                    <desc language="en-US">URINE TESTS</desc>
                </concept>
                <concept code="V04C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DIAGNOSTIC AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER DIAGNOSTIC AGENTS" type="fsn">OTHER DIAGNOSTIC AGENTS</designation>
                    <desc language="en-US">OTHER DIAGNOSTIC AGENTS</desc>
                </concept>
                <concept code="V04CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for diabetes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tests for diabetes" type="fsn">Tests for diabetes</designation>
                    <desc language="en-US">Tests for diabetes</desc>
                </concept>
                <concept code="V04CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tolbutamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tolbutamide" type="fsn">tolbutamide</designation>
                    <desc language="en-US">tolbutamide</desc>
                </concept>
                <concept code="V04CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glucose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glucose" type="fsn">glucose</designation>
                    <desc language="en-US">glucose</desc>
                </concept>
                <concept code="V04CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for fat absorption"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tests for fat absorption" type="fsn">Tests for fat absorption</designation>
                    <desc language="en-US">Tests for fat absorption</desc>
                </concept>
                <concept code="V04CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="vitamin A concentrates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="vitamin A concentrates" type="fsn">vitamin A concentrates</designation>
                    <desc language="en-US">vitamin A concentrates</desc>
                </concept>
                <concept code="V04CC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for bile duct patency"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for bile duct patency"
                         type="fsn">Tests for bile duct patency</designation>
                    <desc language="en-US">Tests for bile duct patency</desc>
                </concept>
                <concept code="V04CC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sorbitol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sorbitol" type="fsn">sorbitol</designation>
                    <desc language="en-US">sorbitol</desc>
                </concept>
                <concept code="V04CC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="magnesium sulfate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="magnesium sulfate" type="fsn">magnesium sulfate</designation>
                    <desc language="en-US">magnesium sulfate</desc>
                </concept>
                <concept code="V04CC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sincalide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sincalide" type="fsn">sincalide</designation>
                    <desc language="en-US">sincalide</desc>
                </concept>
                <concept code="V04CC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ceruletide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ceruletide" type="fsn">ceruletide</designation>
                    <desc language="en-US">ceruletide</desc>
                </concept>
                <concept code="V04CD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for pituitary function"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for pituitary function"
                         type="fsn">Tests for pituitary function</designation>
                    <desc language="en-US">Tests for pituitary function</desc>
                </concept>
                <concept code="V04CD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metyrapone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metyrapone" type="fsn">metyrapone</designation>
                    <desc language="en-US">metyrapone</desc>
                </concept>
                <concept code="V04CD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sermorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sermorelin" type="fsn">sermorelin</designation>
                    <desc language="en-US">sermorelin</desc>
                </concept>
                <concept code="V04CD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="corticorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="corticorelin" type="fsn">corticorelin</designation>
                    <desc language="en-US">corticorelin</desc>
                </concept>
                <concept code="V04CD05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="somatorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="somatorelin" type="fsn">somatorelin</designation>
                    <desc language="en-US">somatorelin</desc>
                </concept>
                <concept code="V04CD06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="macimorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="macimorelin" type="fsn">macimorelin</designation>
                    <desc language="en-US">macimorelin</desc>
                </concept>
                <concept code="V04CE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for liver functional capacity"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for liver functional capacity"
                         type="fsn">Tests for liver functional capacity</designation>
                    <desc language="en-US">Tests for liver functional capacity</desc>
                </concept>
                <concept code="V04CE01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="galactose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="galactose" type="fsn">galactose</designation>
                    <desc language="en-US">galactose</desc>
                </concept>
                <concept code="V04CE02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfobromophthalein"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfobromophthalein" type="fsn">sulfobromophthalein</designation>
                    <desc language="en-US">sulfobromophthalein</desc>
                </concept>
                <concept code="V04CE03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methacetin (13C)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methacetin (13C)" type="fsn">methacetin (13C)</designation>
                    <desc language="en-US">methacetin (13C)</desc>
                </concept>
                <concept code="V04CF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tuberculosis diagnostics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Tuberculosis diagnostics" type="fsn">Tuberculosis diagnostics</designation>
                    <desc language="en-US">Tuberculosis diagnostics</desc>
                </concept>
                <concept code="V04CF01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tuberculin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tuberculin" type="fsn">tuberculin</designation>
                    <desc language="en-US">tuberculin</desc>
                </concept>
                <concept code="V04CG"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for gastric secretion"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for gastric secretion"
                         type="fsn">Tests for gastric secretion</designation>
                    <desc language="en-US">Tests for gastric secretion</desc>
                </concept>
                <concept code="V04CG01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cation exchange resins"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="cation exchange resins" type="fsn">cation exchange resins</designation>
                    <desc language="en-US">cation exchange resins</desc>
                </concept>
                <concept code="V04CG02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="betazole"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="betazole" type="fsn">betazole</designation>
                    <desc language="en-US">betazole</desc>
                </concept>
                <concept code="V04CG03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="histamine phosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="histamine phosphate" type="fsn">histamine phosphate</designation>
                    <desc language="en-US">histamine phosphate</desc>
                </concept>
                <concept code="V04CG04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pentagastrin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="pentagastrin" type="fsn">pentagastrin</designation>
                    <desc language="en-US">pentagastrin</desc>
                </concept>
                <concept code="V04CG05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methylthioninium chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methylthioninium chloride" type="fsn">methylthioninium chloride</designation>
                    <desc language="en-US">methylthioninium chloride</desc>
                </concept>
                <concept code="V04CG30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="caffeine and sodium benzoate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="caffeine and sodium benzoate"
                         type="fsn">caffeine and sodium benzoate</designation>
                    <desc language="en-US">caffeine and sodium benzoate</desc>
                </concept>
                <concept code="V04CH"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for renal function and ureteral injuries"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for renal function and ureteral injuries"
                         type="fsn">Tests for renal function and ureteral injuries</designation>
                    <desc language="en-US">Tests for renal function and ureteral injuries</desc>
                </concept>
                <concept code="V04CH01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="inulin and other polyfructosans"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="inulin and other polyfructosans"
                         type="fsn">inulin and other polyfructosans</designation>
                    <desc language="en-US">inulin and other polyfructosans</desc>
                </concept>
                <concept code="V04CH02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indigo carmine"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indigo carmine" type="fsn">indigo carmine</designation>
                    <desc language="en-US">indigo carmine</desc>
                </concept>
                <concept code="V04CH03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phenolsulfonphthalein"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="phenolsulfonphthalein" type="fsn">phenolsulfonphthalein</designation>
                    <desc language="en-US">phenolsulfonphthalein</desc>
                </concept>
                <concept code="V04CH04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="alsactide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="alsactide" type="fsn">alsactide</designation>
                    <desc language="en-US">alsactide</desc>
                </concept>
                <concept code="V04CH30"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="aminohippuric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="aminohippuric acid" type="fsn">aminohippuric acid</designation>
                    <desc language="en-US">aminohippuric acid</desc>
                </concept>
                <concept code="V04CJ"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for thyreoidea function"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for thyreoidea function"
                         type="fsn">Tests for thyreoidea function</designation>
                    <desc language="en-US">Tests for thyreoidea function</desc>
                </concept>
                <concept code="V04CJ01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thyrotropin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thyrotropin" type="fsn">thyrotropin</designation>
                    <desc language="en-US">thyrotropin</desc>
                </concept>
                <concept code="V04CJ02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="protirelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="protirelin" type="fsn">protirelin</designation>
                    <desc language="en-US">protirelin</desc>
                </concept>
                <concept code="V04CK"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for pancreatic function"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for pancreatic function"
                         type="fsn">Tests for pancreatic function</designation>
                    <desc language="en-US">Tests for pancreatic function</desc>
                </concept>
                <concept code="V04CK01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="secretin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="secretin" type="fsn">secretin</designation>
                    <desc language="en-US">secretin</desc>
                </concept>
                <concept code="V04CK02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="pancreozymin (cholecystokinin)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="pancreozymin (cholecystokinin)"
                         type="fsn">pancreozymin (cholecystokinin)</designation>
                    <desc language="en-US">pancreozymin (cholecystokinin)</desc>
                </concept>
                <concept code="V04CK03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="bentiromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="bentiromide" type="fsn">bentiromide</designation>
                    <desc language="en-US">bentiromide</desc>
                </concept>
                <concept code="V04CL"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for allergic diseases"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for allergic diseases"
                         type="fsn">Tests for allergic diseases</designation>
                    <desc language="en-US">Tests for allergic diseases</desc>
                </concept>
                <concept code="V04CM"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Tests for fertility disturbances"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Tests for fertility disturbances"
                         type="fsn">Tests for fertility disturbances</designation>
                    <desc language="en-US">Tests for fertility disturbances</desc>
                </concept>
                <concept code="V04CM01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gonadorelin"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gonadorelin" type="fsn">gonadorelin</designation>
                    <desc language="en-US">gonadorelin</desc>
                </concept>
                <concept code="V04CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other diagnostic agents"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Other diagnostic agents" type="fsn">Other diagnostic agents</designation>
                    <desc language="en-US">Other diagnostic agents</desc>
                </concept>
                <concept code="V04CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indocyanine green"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indocyanine green" type="fsn">indocyanine green</designation>
                    <desc language="en-US">indocyanine green</desc>
                </concept>
                <concept code="V06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="GENERAL NUTRIENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="GENERAL NUTRIENTS" type="fsn">GENERAL NUTRIENTS</designation>
                    <desc language="en-US">GENERAL NUTRIENTS</desc>
                </concept>
                <concept code="V06A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIET FORMULATIONS FOR TREATMENT OF OBESITY"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DIET FORMULATIONS FOR TREATMENT OF OBESITY"
                         type="fsn">DIET FORMULATIONS FOR TREATMENT OF OBESITY</designation>
                    <desc language="en-US">DIET FORMULATIONS FOR TREATMENT OF OBESITY</desc>
                </concept>
                <concept code="V06AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Low-energy diets"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Low-energy diets" type="fsn">Low-energy diets</designation>
                    <desc language="en-US">Low-energy diets</desc>
                </concept>
                <concept code="V06B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PROTEIN SUPPLEMENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="PROTEIN SUPPLEMENTS" type="fsn">PROTEIN SUPPLEMENTS</designation>
                    <desc language="en-US">PROTEIN SUPPLEMENTS</desc>
                </concept>
                <concept code="V06C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="INFANT FORMULAS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="INFANT FORMULAS" type="fsn">INFANT FORMULAS</designation>
                    <desc language="en-US">INFANT FORMULAS</desc>
                </concept>
                <concept code="V06CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Nutrients without phenylalanine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Nutrients without phenylalanine"
                         type="fsn">Nutrients without phenylalanine</designation>
                    <desc language="en-US">Nutrients without phenylalanine</desc>
                </concept>
                <concept code="V06D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER NUTRIENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="OTHER NUTRIENTS" type="fsn">OTHER NUTRIENTS</designation>
                    <desc language="en-US">OTHER NUTRIENTS</desc>
                </concept>
                <concept code="V06DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Carbohydrates/proteins/minerals/vitamins, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Carbohydrates/proteins/minerals/vitamins, combinations"
                         type="fsn">Carbohydrates/proteins/minerals/vitamins, combinations</designation>
                    <desc language="en-US">Carbohydrates/proteins/minerals/vitamins, combinations</desc>
                </concept>
                <concept code="V06DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Fat/carbohydrates/proteins/minerals/vitamins, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Fat/carbohydrates/proteins/minerals/vitamins, combinations"
                         type="fsn">Fat/carbohydrates/proteins/minerals/vitamins, combinations</designation>
                    <desc language="en-US">Fat/carbohydrates/proteins/minerals/vitamins, combinations</desc>
                </concept>
                <concept code="V06DC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Carbohydrates"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Carbohydrates" type="fsn">Carbohydrates</designation>
                    <desc language="en-US">Carbohydrates</desc>
                </concept>
                <concept code="V06DC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="glucose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="glucose" type="fsn">glucose</designation>
                    <desc language="en-US">glucose</desc>
                </concept>
                <concept code="V06DC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fructose"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fructose" type="fsn">fructose</designation>
                    <desc language="en-US">fructose</desc>
                </concept>
                <concept code="V06DD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Amino acids, incl. combinations with polypeptides"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Amino acids, incl. combinations with polypeptides"
                         type="fsn">Amino acids, incl. combinations with polypeptides</designation>
                    <desc language="en-US">Amino acids, incl. combinations with polypeptides</desc>
                </concept>
                <concept code="V06DE"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Amino acids/carbohydrates/minerals/vitamins, combinations"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Amino acids/carbohydrates/minerals/vitamins, combinations"
                         type="fsn">Amino acids/carbohydrates/minerals/vitamins, combinations</designation>
                    <desc language="en-US">Amino acids/carbohydrates/minerals/vitamins, combinations</desc>
                </concept>
                <concept code="V06DF"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Milk substitutes"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Milk substitutes" type="fsn">Milk substitutes</designation>
                    <desc language="en-US">Milk substitutes</desc>
                </concept>
                <concept code="V06DX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other combinations of nutrients"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other combinations of nutrients"
                         type="fsn">Other combinations of nutrients</designation>
                    <desc language="en-US">Other combinations of nutrients</desc>
                </concept>
                <concept code="V07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ALL OTHER NON-THERAPEUTIC PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ALL OTHER NON-THERAPEUTIC PRODUCTS"
                         type="fsn">ALL OTHER NON-THERAPEUTIC PRODUCTS</designation>
                    <desc language="en-US">ALL OTHER NON-THERAPEUTIC PRODUCTS</desc>
                </concept>
                <concept code="V07A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ALL OTHER NON-THERAPEUTIC PRODUCTS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ALL OTHER NON-THERAPEUTIC PRODUCTS"
                         type="fsn">ALL OTHER NON-THERAPEUTIC PRODUCTS</designation>
                    <desc language="en-US">ALL OTHER NON-THERAPEUTIC PRODUCTS</desc>
                </concept>
                <concept code="V07AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Plasters"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Plasters" type="fsn">Plasters</designation>
                    <desc language="en-US">Plasters</desc>
                </concept>
                <concept code="V07AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Solvents and diluting agents, incl. irrigating solutions"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Solvents and diluting agents, incl. irrigating solutions"
                         type="fsn">Solvents and diluting agents, incl. irrigating solutions</designation>
                    <desc language="en-US">Solvents and diluting agents, incl. irrigating solutions</desc>
                </concept>
                <concept code="V07AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Blood transfusion, auxiliary products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Blood transfusion, auxiliary products"
                         type="fsn">Blood transfusion, auxiliary products</designation>
                    <desc language="en-US">Blood transfusion, auxiliary products</desc>
                </concept>
                <concept code="V07AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Blood tests, auxiliary products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Blood tests, auxiliary products"
                         type="fsn">Blood tests, auxiliary products</designation>
                    <desc language="en-US">Blood tests, auxiliary products</desc>
                </concept>
                <concept code="V07AN"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Incontinence equipment"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Incontinence equipment" type="fsn">Incontinence equipment</designation>
                    <desc language="en-US">Incontinence equipment</desc>
                </concept>
                <concept code="V07AR"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Sensitivity tests, discs and tablets"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Sensitivity tests, discs and tablets"
                         type="fsn">Sensitivity tests, discs and tablets</designation>
                    <desc language="en-US">Sensitivity tests, discs and tablets</desc>
                </concept>
                <concept code="V07AS"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Stomi equipment"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Stomi equipment" type="fsn">Stomi equipment</designation>
                    <desc language="en-US">Stomi equipment</desc>
                </concept>
                <concept code="V07AT"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Cosmetics"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Cosmetics" type="fsn">Cosmetics</designation>
                    <desc language="en-US">Cosmetics</desc>
                </concept>
                <concept code="V07AV"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technical disinfectants"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Technical disinfectants" type="fsn">Technical disinfectants</designation>
                    <desc language="en-US">Technical disinfectants</desc>
                </concept>
                <concept code="V07AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Washing agents etc."
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Washing agents etc." type="fsn">Washing agents etc.</designation>
                    <desc language="en-US">Washing agents etc.</desc>
                </concept>
                <concept code="V07AY"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other non-therapeutic auxiliary products"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other non-therapeutic auxiliary products"
                         type="fsn">Other non-therapeutic auxiliary products</designation>
                    <desc language="en-US">Other non-therapeutic auxiliary products</desc>
                </concept>
                <concept code="V07AZ"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Chemicals and reagents for analysis"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Chemicals and reagents for analysis"
                         type="fsn">Chemicals and reagents for analysis</designation>
                    <desc language="en-US">Chemicals and reagents for analysis</desc>
                </concept>
                <concept code="V08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CONTRAST MEDIA"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CONTRAST MEDIA" type="fsn">CONTRAST MEDIA</designation>
                    <desc language="en-US">CONTRAST MEDIA</desc>
                </concept>
                <concept code="V08A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="X-RAY CONTRAST MEDIA, IODINATED"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="X-RAY CONTRAST MEDIA, IODINATED"
                         type="fsn">X-RAY CONTRAST MEDIA, IODINATED</designation>
                    <desc language="en-US">X-RAY CONTRAST MEDIA, IODINATED</desc>
                </concept>
                <concept code="V08AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Watersoluble, nephrotropic, high osmolar X-ray contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Watersoluble, nephrotropic, high osmolar X-ray contrast media"
                         type="fsn">Watersoluble, nephrotropic, high osmolar X-ray contrast media</designation>
                    <desc language="en-US">Watersoluble, nephrotropic, high osmolar X-ray contrast media</desc>
                </concept>
                <concept code="V08AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diatrizoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diatrizoic acid" type="fsn">diatrizoic acid</designation>
                    <desc language="en-US">diatrizoic acid</desc>
                </concept>
                <concept code="V08AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metrizoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metrizoic acid" type="fsn">metrizoic acid</designation>
                    <desc language="en-US">metrizoic acid</desc>
                </concept>
                <concept code="V08AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodamide" type="fsn">iodamide</designation>
                    <desc language="en-US">iodamide</desc>
                </concept>
                <concept code="V08AA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iotalamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iotalamic acid" type="fsn">iotalamic acid</designation>
                    <desc language="en-US">iotalamic acid</desc>
                </concept>
                <concept code="V08AA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ioxitalamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ioxitalamic acid" type="fsn">ioxitalamic acid</designation>
                    <desc language="en-US">ioxitalamic acid</desc>
                </concept>
                <concept code="V08AA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ioglicic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ioglicic acid" type="fsn">ioglicic acid</designation>
                    <desc language="en-US">ioglicic acid</desc>
                </concept>
                <concept code="V08AA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="acetrizoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="acetrizoic acid" type="fsn">acetrizoic acid</designation>
                    <desc language="en-US">acetrizoic acid</desc>
                </concept>
                <concept code="V08AA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iocarmic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iocarmic acid" type="fsn">iocarmic acid</designation>
                    <desc language="en-US">iocarmic acid</desc>
                </concept>
                <concept code="V08AA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="methiodal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="methiodal" type="fsn">methiodal</designation>
                    <desc language="en-US">methiodal</desc>
                </concept>
                <concept code="V08AA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="diodone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="diodone" type="fsn">diodone</designation>
                    <desc language="en-US">diodone</desc>
                </concept>
                <concept code="V08AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Watersoluble, nephrotropic, low osmolar X-ray contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Watersoluble, nephrotropic, low osmolar X-ray contrast media"
                         type="fsn">Watersoluble, nephrotropic, low osmolar X-ray contrast media</designation>
                    <desc language="en-US">Watersoluble, nephrotropic, low osmolar X-ray contrast media</desc>
                </concept>
                <concept code="V08AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="metrizamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="metrizamide" type="fsn">metrizamide</designation>
                    <desc language="en-US">metrizamide</desc>
                </concept>
                <concept code="V08AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iohexol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iohexol" type="fsn">iohexol</designation>
                    <desc language="en-US">iohexol</desc>
                </concept>
                <concept code="V08AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ioxaglic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ioxaglic acid" type="fsn">ioxaglic acid</designation>
                    <desc language="en-US">ioxaglic acid</desc>
                </concept>
                <concept code="V08AB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iopamidol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iopamidol" type="fsn">iopamidol</designation>
                    <desc language="en-US">iopamidol</desc>
                </concept>
                <concept code="V08AB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iopromide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iopromide" type="fsn">iopromide</designation>
                    <desc language="en-US">iopromide</desc>
                </concept>
                <concept code="V08AB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iotrolan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iotrolan" type="fsn">iotrolan</designation>
                    <desc language="en-US">iotrolan</desc>
                </concept>
                <concept code="V08AB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ioversol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ioversol" type="fsn">ioversol</designation>
                    <desc language="en-US">ioversol</desc>
                </concept>
                <concept code="V08AB08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iopentol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iopentol" type="fsn">iopentol</designation>
                    <desc language="en-US">iopentol</desc>
                </concept>
                <concept code="V08AB09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodixanol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodixanol" type="fsn">iodixanol</designation>
                    <desc language="en-US">iodixanol</desc>
                </concept>
                <concept code="V08AB10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iomeprol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iomeprol" type="fsn">iomeprol</designation>
                    <desc language="en-US">iomeprol</desc>
                </concept>
                <concept code="V08AB11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iobitridol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iobitridol" type="fsn">iobitridol</designation>
                    <desc language="en-US">iobitridol</desc>
                </concept>
                <concept code="V08AB12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ioxilan"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ioxilan" type="fsn">ioxilan</designation>
                    <desc language="en-US">ioxilan</desc>
                </concept>
                <concept code="V08AC"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Watersoluble, hepatotropic X-ray contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Watersoluble, hepatotropic X-ray contrast media"
                         type="fsn">Watersoluble, hepatotropic X-ray contrast media</designation>
                    <desc language="en-US">Watersoluble, hepatotropic X-ray contrast media</desc>
                </concept>
                <concept code="V08AC01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodoxamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodoxamic acid" type="fsn">iodoxamic acid</designation>
                    <desc language="en-US">iodoxamic acid</desc>
                </concept>
                <concept code="V08AC02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iotroxic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iotroxic acid" type="fsn">iotroxic acid</designation>
                    <desc language="en-US">iotroxic acid</desc>
                </concept>
                <concept code="V08AC03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ioglycamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ioglycamic acid" type="fsn">ioglycamic acid</designation>
                    <desc language="en-US">ioglycamic acid</desc>
                </concept>
                <concept code="V08AC04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="adipiodone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="adipiodone" type="fsn">adipiodone</designation>
                    <desc language="en-US">adipiodone</desc>
                </concept>
                <concept code="V08AC05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iobenzamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iobenzamic acid" type="fsn">iobenzamic acid</designation>
                    <desc language="en-US">iobenzamic acid</desc>
                </concept>
                <concept code="V08AC06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iopanoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iopanoic acid" type="fsn">iopanoic acid</designation>
                    <desc language="en-US">iopanoic acid</desc>
                </concept>
                <concept code="V08AC07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iocetamic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iocetamic acid" type="fsn">iocetamic acid</designation>
                    <desc language="en-US">iocetamic acid</desc>
                </concept>
                <concept code="V08AC08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium iopodate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium iopodate" type="fsn">sodium iopodate</designation>
                    <desc language="en-US">sodium iopodate</desc>
                </concept>
                <concept code="V08AC09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tyropanoic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="tyropanoic acid" type="fsn">tyropanoic acid</designation>
                    <desc language="en-US">tyropanoic acid</desc>
                </concept>
                <concept code="V08AC10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="calcium iopodate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="calcium iopodate" type="fsn">calcium iopodate</designation>
                    <desc language="en-US">calcium iopodate</desc>
                </concept>
                <concept code="V08AD"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Non-watersoluble X-ray contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Non-watersoluble X-ray contrast media"
                         type="fsn">Non-watersoluble X-ray contrast media</designation>
                    <desc language="en-US">Non-watersoluble X-ray contrast media</desc>
                </concept>
                <concept code="V08AD01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ethyl esters of iodised fatty acids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ethyl esters of iodised fatty acids"
                         type="fsn">ethyl esters of iodised fatty acids</designation>
                    <desc language="en-US">ethyl esters of iodised fatty acids</desc>
                </concept>
                <concept code="V08AD02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iopydol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iopydol" type="fsn">iopydol</designation>
                    <desc language="en-US">iopydol</desc>
                </concept>
                <concept code="V08AD03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="propyliodone"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="propyliodone" type="fsn">propyliodone</designation>
                    <desc language="en-US">propyliodone</desc>
                </concept>
                <concept code="V08AD04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iofendylate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iofendylate" type="fsn">iofendylate</designation>
                    <desc language="en-US">iofendylate</desc>
                </concept>
                <concept code="V08B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="X-RAY CONTRAST MEDIA, NON-IODINATED"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="X-RAY CONTRAST MEDIA, NON-IODINATED"
                         type="fsn">X-RAY CONTRAST MEDIA, NON-IODINATED</designation>
                    <desc language="en-US">X-RAY CONTRAST MEDIA, NON-IODINATED</desc>
                </concept>
                <concept code="V08BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Barium sulfate containing X-ray contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Barium sulfate containing X-ray contrast media"
                         type="fsn">Barium sulfate containing X-ray contrast media</designation>
                    <desc language="en-US">Barium sulfate containing X-ray contrast media</desc>
                </concept>
                <concept code="V08BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="barium sulfate with suspending agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="barium sulfate with suspending agents"
                         type="fsn">barium sulfate with suspending agents</designation>
                    <desc language="en-US">barium sulfate with suspending agents</desc>
                </concept>
                <concept code="V08BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="barium sulfate without suspending agents"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="barium sulfate without suspending agents"
                         type="fsn">barium sulfate without suspending agents</designation>
                    <desc language="en-US">barium sulfate without suspending agents</desc>
                </concept>
                <concept code="V08C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="MAGNETIC RESONANCE IMAGING CONTRAST MEDIA"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="MAGNETIC RESONANCE IMAGING CONTRAST MEDIA"
                         type="fsn">MAGNETIC RESONANCE IMAGING CONTRAST MEDIA</designation>
                    <desc language="en-US">MAGNETIC RESONANCE IMAGING CONTRAST MEDIA</desc>
                </concept>
                <concept code="V08CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Paramagnetic contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Paramagnetic contrast media"
                         type="fsn">Paramagnetic contrast media</designation>
                    <desc language="en-US">Paramagnetic contrast media</desc>
                </concept>
                <concept code="V08CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadopentetic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadopentetic acid" type="fsn">gadopentetic acid</designation>
                    <desc language="en-US">gadopentetic acid</desc>
                </concept>
                <concept code="V08CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadoteric acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadoteric acid" type="fsn">gadoteric acid</designation>
                    <desc language="en-US">gadoteric acid</desc>
                </concept>
                <concept code="V08CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadodiamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadodiamide" type="fsn">gadodiamide</designation>
                    <desc language="en-US">gadodiamide</desc>
                </concept>
                <concept code="V08CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadoteridol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadoteridol" type="fsn">gadoteridol</designation>
                    <desc language="en-US">gadoteridol</desc>
                </concept>
                <concept code="V08CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="mangafodipir"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="mangafodipir" type="fsn">mangafodipir</designation>
                    <desc language="en-US">mangafodipir</desc>
                </concept>
                <concept code="V08CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadoversetamide"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadoversetamide" type="fsn">gadoversetamide</designation>
                    <desc language="en-US">gadoversetamide</desc>
                </concept>
                <concept code="V08CA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric ammonium citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferric ammonium citrate" type="fsn">ferric ammonium citrate</designation>
                    <desc language="en-US">ferric ammonium citrate</desc>
                </concept>
                <concept code="V08CA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadobenic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadobenic acid" type="fsn">gadobenic acid</designation>
                    <desc language="en-US">gadobenic acid</desc>
                </concept>
                <concept code="V08CA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadobutrol"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadobutrol" type="fsn">gadobutrol</designation>
                    <desc language="en-US">gadobutrol</desc>
                </concept>
                <concept code="V08CA10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadoxetic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadoxetic acid" type="fsn">gadoxetic acid</designation>
                    <desc language="en-US">gadoxetic acid</desc>
                </concept>
                <concept code="V08CA11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gadofosveset"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gadofosveset" type="fsn">gadofosveset</designation>
                    <desc language="en-US">gadofosveset</desc>
                </concept>
                <concept code="V08CB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Superparamagnetic contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Superparamagnetic contrast media"
                         type="fsn">Superparamagnetic contrast media</designation>
                    <desc language="en-US">Superparamagnetic contrast media</desc>
                </concept>
                <concept code="V08CB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferumoxsil"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferumoxsil" type="fsn">ferumoxsil</designation>
                    <desc language="en-US">ferumoxsil</desc>
                </concept>
                <concept code="V08CB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferristene"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferristene" type="fsn">ferristene</designation>
                    <desc language="en-US">ferristene</desc>
                </concept>
                <concept code="V08CB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iron oxide, nanoparticles"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iron oxide, nanoparticles" type="fsn">iron oxide, nanoparticles</designation>
                    <desc language="en-US">iron oxide, nanoparticles</desc>
                </concept>
                <concept code="V08CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other magnetic resonance imaging contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other magnetic resonance imaging contrast media"
                         type="fsn">Other magnetic resonance imaging contrast media</designation>
                    <desc language="en-US">Other magnetic resonance imaging contrast media</desc>
                </concept>
                <concept code="V08CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perflubron"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="perflubron" type="fsn">perflubron</designation>
                    <desc language="en-US">perflubron</desc>
                </concept>
                <concept code="V08D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ULTRASOUND CONTRAST MEDIA"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ULTRASOUND CONTRAST MEDIA" type="fsn">ULTRASOUND CONTRAST MEDIA</designation>
                    <desc language="en-US">ULTRASOUND CONTRAST MEDIA</desc>
                </concept>
                <concept code="V08DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Ultrasound contrast media"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Ultrasound contrast media" type="fsn">Ultrasound contrast media</designation>
                    <desc language="en-US">Ultrasound contrast media</desc>
                </concept>
                <concept code="V08DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="microspheres of human albumin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="microspheres of human albumin"
                         type="fsn">microspheres of human albumin</designation>
                    <desc language="en-US">microspheres of human albumin</desc>
                </concept>
                <concept code="V08DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="microparticles of galactose"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="microparticles of galactose"
                         type="fsn">microparticles of galactose</designation>
                    <desc language="en-US">microparticles of galactose</desc>
                </concept>
                <concept code="V08DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perflenapent"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="perflenapent" type="fsn">perflenapent</designation>
                    <desc language="en-US">perflenapent</desc>
                </concept>
                <concept code="V08DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="microspheres of phospholipids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="microspheres of phospholipids"
                         type="fsn">microspheres of phospholipids</designation>
                    <desc language="en-US">microspheres of phospholipids</desc>
                </concept>
                <concept code="V08DA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sulfur hexafluoride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sulfur hexafluoride" type="fsn">sulfur hexafluoride</designation>
                    <desc language="en-US">sulfur hexafluoride</desc>
                </concept>
                <concept code="V08DA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="perflubutane polymer microspheres"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="perflubutane polymer microspheres"
                         type="fsn">perflubutane polymer microspheres</designation>
                    <desc language="en-US">perflubutane polymer microspheres</desc>
                </concept>
                <concept code="V09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="DIAGNOSTIC RADIOPHARMACEUTICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="DIAGNOSTIC RADIOPHARMACEUTICALS"
                         type="fsn">DIAGNOSTIC RADIOPHARMACEUTICALS</designation>
                    <desc language="en-US">DIAGNOSTIC RADIOPHARMACEUTICALS</desc>
                </concept>
                <concept code="V09A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CENTRAL NERVOUS SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CENTRAL NERVOUS SYSTEM" type="fsn">CENTRAL NERVOUS SYSTEM</designation>
                    <desc language="en-US">CENTRAL NERVOUS SYSTEM</desc>
                </concept>
                <concept code="V09AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc) compounds"
                         type="fsn">Technetium (99mTc) compounds</designation>
                    <desc language="en-US">Technetium (99mTc) compounds</desc>
                </concept>
                <concept code="V09AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) exametazime"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) exametazime"
                         type="fsn">technetium (99mTc) exametazime</designation>
                    <desc language="en-US">technetium (99mTc) exametazime</desc>
                </concept>
                <concept code="V09AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) bicisate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) bicisate"
                         type="fsn">technetium (99mTc) bicisate</designation>
                    <desc language="en-US">technetium (99mTc) bicisate</desc>
                </concept>
                <concept code="V09AB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iodine (123I) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Iodine (123I) compounds" type="fsn">Iodine (123I) compounds</designation>
                    <desc language="en-US">Iodine (123I) compounds</desc>
                </concept>
                <concept code="V09AB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine iofetamine (123I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodine iofetamine (123I)" type="fsn">iodine iofetamine (123I)</designation>
                    <desc language="en-US">iodine iofetamine (123I)</desc>
                </concept>
                <concept code="V09AB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine iolopride (123I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodine iolopride (123I)" type="fsn">iodine iolopride (123I)</designation>
                    <desc language="en-US">iodine iolopride (123I)</desc>
                </concept>
                <concept code="V09AB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine ioflupane (123I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodine ioflupane (123I)" type="fsn">iodine ioflupane (123I)</designation>
                    <desc language="en-US">iodine ioflupane (123I)</desc>
                </concept>
                <concept code="V09AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other central nervous system diagnostic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other central nervous system diagnostic radiopharmaceuticals"
                         type="fsn">Other central nervous system diagnostic radiopharmaceuticals</designation>
                    <desc language="en-US">Other central nervous system diagnostic radiopharmaceuticals</desc>
                </concept>
                <concept code="V09AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indium (111In) pentetic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indium (111In) pentetic acid"
                         type="fsn">indium (111In) pentetic acid</designation>
                    <desc language="en-US">indium (111In) pentetic acid</desc>
                </concept>
                <concept code="V09AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane"
                         type="fsn">iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane</designation>
                    <desc language="en-US">iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane</desc>
                </concept>
                <concept code="V09AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="flutemetamol (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="flutemetamol (18F)" type="fsn">flutemetamol (18F)</designation>
                    <desc language="en-US">flutemetamol (18F)</desc>
                </concept>
                <concept code="V09AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="florbetapir (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="florbetapir (18F)" type="fsn">florbetapir (18F)</designation>
                    <desc language="en-US">florbetapir (18F)</desc>
                </concept>
                <concept code="V09AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="florbetaben (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="florbetaben (18F)" type="fsn">florbetaben (18F)</designation>
                    <desc language="en-US">florbetaben (18F)</desc>
                </concept>
                <concept code="V09B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SKELETON"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="SKELETON" type="fsn">SKELETON</designation>
                    <desc language="en-US">SKELETON</desc>
                </concept>
                <concept code="V09BA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc) compounds"
                         type="fsn">Technetium (99mTc) compounds</designation>
                    <desc language="en-US">Technetium (99mTc) compounds</desc>
                </concept>
                <concept code="V09BA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) oxidronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) oxidronic acid"
                         type="fsn">technetium (99mTc) oxidronic acid</designation>
                    <desc language="en-US">technetium (99mTc) oxidronic acid</desc>
                </concept>
                <concept code="V09BA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) medronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) medronic acid"
                         type="fsn">technetium (99mTc) medronic acid</designation>
                    <desc language="en-US">technetium (99mTc) medronic acid</desc>
                </concept>
                <concept code="V09BA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) pyrophosphate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) pyrophosphate"
                         type="fsn">technetium (99mTc) pyrophosphate</designation>
                    <desc language="en-US">technetium (99mTc) pyrophosphate</desc>
                </concept>
                <concept code="V09BA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) butedronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) butedronic acid"
                         type="fsn">technetium (99mTc) butedronic acid</designation>
                    <desc language="en-US">technetium (99mTc) butedronic acid</desc>
                </concept>
                <concept code="V09C"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="RENAL SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="RENAL SYSTEM" type="fsn">RENAL SYSTEM</designation>
                    <desc language="en-US">RENAL SYSTEM</desc>
                </concept>
                <concept code="V09CA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc) compounds"
                         type="fsn">Technetium (99mTc) compounds</designation>
                    <desc language="en-US">Technetium (99mTc) compounds</desc>
                </concept>
                <concept code="V09CA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) pentetic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) pentetic acid"
                         type="fsn">technetium (99mTc) pentetic acid</designation>
                    <desc language="en-US">technetium (99mTc) pentetic acid</desc>
                </concept>
                <concept code="V09CA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) succimer"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) succimer"
                         type="fsn">technetium (99mTc) succimer</designation>
                    <desc language="en-US">technetium (99mTc) succimer</desc>
                </concept>
                <concept code="V09CA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) mertiatide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) mertiatide"
                         type="fsn">technetium (99mTc) mertiatide</designation>
                    <desc language="en-US">technetium (99mTc) mertiatide</desc>
                </concept>
                <concept code="V09CA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) gluceptate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) gluceptate"
                         type="fsn">technetium (99mTc) gluceptate</designation>
                    <desc language="en-US">technetium (99mTc) gluceptate</desc>
                </concept>
                <concept code="V09CA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) gluconate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) gluconate"
                         type="fsn">technetium (99mTc) gluconate</designation>
                    <desc language="en-US">technetium (99mTc) gluconate</desc>
                </concept>
                <concept code="V09CA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) ethylenedicysteine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) ethylenedicysteine"
                         type="fsn">technetium (99mTc) ethylenedicysteine</designation>
                    <desc language="en-US">technetium (99mTc) ethylenedicysteine</desc>
                </concept>
                <concept code="V09CX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other renal system diagnostic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other renal system diagnostic radiopharmaceuticals"
                         type="fsn">Other renal system diagnostic radiopharmaceuticals</designation>
                    <desc language="en-US">Other renal system diagnostic radiopharmaceuticals</desc>
                </concept>
                <concept code="V09CX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium iodohippurate (123I)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium iodohippurate (123I)"
                         type="fsn">sodium iodohippurate (123I)</designation>
                    <desc language="en-US">sodium iodohippurate (123I)</desc>
                </concept>
                <concept code="V09CX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium iodohippurate (131I)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="sodium iodohippurate (131I)"
                         type="fsn">sodium iodohippurate (131I)</designation>
                    <desc language="en-US">sodium iodohippurate (131I)</desc>
                </concept>
                <concept code="V09CX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium iothalamate (125I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium iothalamate (125I)" type="fsn">sodium iothalamate (125I)</designation>
                    <desc language="en-US">sodium iothalamate (125I)</desc>
                </concept>
                <concept code="V09CX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chromium (51Cr) edetate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="chromium (51Cr) edetate" type="fsn">chromium (51Cr) edetate</designation>
                    <desc language="en-US">chromium (51Cr) edetate</desc>
                </concept>
                <concept code="V09D"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="HEPATIC AND RETICULO ENDOTHELIAL SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="HEPATIC AND RETICULO ENDOTHELIAL SYSTEM"
                         type="fsn">HEPATIC AND RETICULO ENDOTHELIAL SYSTEM</designation>
                    <desc language="en-US">HEPATIC AND RETICULO ENDOTHELIAL SYSTEM</desc>
                </concept>
                <concept code="V09DA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc) compounds"
                         type="fsn">Technetium (99mTc) compounds</designation>
                    <desc language="en-US">Technetium (99mTc) compounds</desc>
                </concept>
                <concept code="V09DA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) disofenin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) disofenin"
                         type="fsn">technetium (99mTc) disofenin</designation>
                    <desc language="en-US">technetium (99mTc) disofenin</desc>
                </concept>
                <concept code="V09DA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) etifenin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) etifenin"
                         type="fsn">technetium (99mTc) etifenin</designation>
                    <desc language="en-US">technetium (99mTc) etifenin</desc>
                </concept>
                <concept code="V09DA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) lidofenin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) lidofenin"
                         type="fsn">technetium (99mTc) lidofenin</designation>
                    <desc language="en-US">technetium (99mTc) lidofenin</desc>
                </concept>
                <concept code="V09DA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) mebrofenin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) mebrofenin"
                         type="fsn">technetium (99mTc) mebrofenin</designation>
                    <desc language="en-US">technetium (99mTc) mebrofenin</desc>
                </concept>
                <concept code="V09DA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) galtifenin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) galtifenin"
                         type="fsn">technetium (99mTc) galtifenin</designation>
                    <desc language="en-US">technetium (99mTc) galtifenin</desc>
                </concept>
                <concept code="V09DB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc), particles and colloids"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc), particles and colloids"
                         type="fsn">Technetium (99mTc), particles and colloids</designation>
                    <desc language="en-US">Technetium (99mTc), particles and colloids</desc>
                </concept>
                <concept code="V09DB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) nanocolloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) nanocolloid"
                         type="fsn">technetium (99mTc) nanocolloid</designation>
                    <desc language="en-US">technetium (99mTc) nanocolloid</desc>
                </concept>
                <concept code="V09DB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) microcolloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) microcolloid"
                         type="fsn">technetium (99mTc) microcolloid</designation>
                    <desc language="en-US">technetium (99mTc) microcolloid</desc>
                </concept>
                <concept code="V09DB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) millimicrospheres"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) millimicrospheres"
                         type="fsn">technetium (99mTc) millimicrospheres</designation>
                    <desc language="en-US">technetium (99mTc) millimicrospheres</desc>
                </concept>
                <concept code="V09DB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) tin colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) tin colloid"
                         type="fsn">technetium (99mTc) tin colloid</designation>
                    <desc language="en-US">technetium (99mTc) tin colloid</desc>
                </concept>
                <concept code="V09DB05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) sulfur colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) sulfur colloid"
                         type="fsn">technetium (99mTc) sulfur colloid</designation>
                    <desc language="en-US">technetium (99mTc) sulfur colloid</desc>
                </concept>
                <concept code="V09DB06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) rheniumsulfide colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) rheniumsulfide colloid"
                         type="fsn">technetium (99mTc) rheniumsulfide colloid</designation>
                    <desc language="en-US">technetium (99mTc) rheniumsulfide colloid</desc>
                </concept>
                <concept code="V09DB07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) phytate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) phytate"
                         type="fsn">technetium (99mTc) phytate</designation>
                    <desc language="en-US">technetium (99mTc) phytate</desc>
                </concept>
                <concept code="V09DX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals"
                         type="fsn">Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals</designation>
                    <desc language="en-US">Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals</desc>
                </concept>
                <concept code="V09DX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="selenium (75Se) tauroselcholic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="selenium (75Se) tauroselcholic acid"
                         type="fsn">selenium (75Se) tauroselcholic acid</designation>
                    <desc language="en-US">selenium (75Se) tauroselcholic acid</desc>
                </concept>
                <concept code="V09E"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="RESPIRATORY SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="RESPIRATORY SYSTEM" type="fsn">RESPIRATORY SYSTEM</designation>
                    <desc language="en-US">RESPIRATORY SYSTEM</desc>
                </concept>
                <concept code="V09EA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc), inhalants"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc), inhalants"
                         type="fsn">Technetium (99mTc), inhalants</designation>
                    <desc language="en-US">Technetium (99mTc), inhalants</desc>
                </concept>
                <concept code="V09EA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) pentetic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) pentetic acid"
                         type="fsn">technetium (99mTc) pentetic acid</designation>
                    <desc language="en-US">technetium (99mTc) pentetic acid</desc>
                </concept>
                <concept code="V09EA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) technegas"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) technegas"
                         type="fsn">technetium (99mTc) technegas</designation>
                    <desc language="en-US">technetium (99mTc) technegas</desc>
                </concept>
                <concept code="V09EA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) nanocolloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) nanocolloid"
                         type="fsn">technetium (99mTc) nanocolloid</designation>
                    <desc language="en-US">technetium (99mTc) nanocolloid</desc>
                </concept>
                <concept code="V09EB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc), particles for injection"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc), particles for injection"
                         type="fsn">Technetium (99mTc), particles for injection</designation>
                    <desc language="en-US">Technetium (99mTc), particles for injection</desc>
                </concept>
                <concept code="V09EB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) macrosalb"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) macrosalb"
                         type="fsn">technetium (99mTc) macrosalb</designation>
                    <desc language="en-US">technetium (99mTc) macrosalb</desc>
                </concept>
                <concept code="V09EB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) microspheres"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) microspheres"
                         type="fsn">technetium (99mTc) microspheres</designation>
                    <desc language="en-US">technetium (99mTc) microspheres</desc>
                </concept>
                <concept code="V09EX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other respiratory system diagnostic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other respiratory system diagnostic radiopharmaceuticals"
                         type="fsn">Other respiratory system diagnostic radiopharmaceuticals</designation>
                    <desc language="en-US">Other respiratory system diagnostic radiopharmaceuticals</desc>
                </concept>
                <concept code="V09EX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="krypton (81mKr) gas"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="krypton (81mKr) gas" type="fsn">krypton (81mKr) gas</designation>
                    <desc language="en-US">krypton (81mKr) gas</desc>
                </concept>
                <concept code="V09EX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xenon (127Xe) gas"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xenon (127Xe) gas" type="fsn">xenon (127Xe) gas</designation>
                    <desc language="en-US">xenon (127Xe) gas</desc>
                </concept>
                <concept code="V09EX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="xenon (133Xe) gas"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="xenon (133Xe) gas" type="fsn">xenon (133Xe) gas</designation>
                    <desc language="en-US">xenon (133Xe) gas</desc>
                </concept>
                <concept code="V09F"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="THYROID"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="THYROID" type="fsn">THYROID</designation>
                    <desc language="en-US">THYROID</desc>
                </concept>
                <concept code="V09FX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Various thyroid diagnostic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Various thyroid diagnostic radiopharmaceuticals"
                         type="fsn">Various thyroid diagnostic radiopharmaceuticals</designation>
                    <desc language="en-US">Various thyroid diagnostic radiopharmaceuticals</desc>
                </concept>
                <concept code="V09FX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) pertechnetate"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) pertechnetate"
                         type="fsn">technetium (99mTc) pertechnetate</designation>
                    <desc language="en-US">technetium (99mTc) pertechnetate</desc>
                </concept>
                <concept code="V09FX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium iodide (123I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium iodide (123I)" type="fsn">sodium iodide (123I)</designation>
                    <desc language="en-US">sodium iodide (123I)</desc>
                </concept>
                <concept code="V09FX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium iodide (131I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium iodide (131I)" type="fsn">sodium iodide (131I)</designation>
                    <desc language="en-US">sodium iodide (131I)</desc>
                </concept>
                <concept code="V09FX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium iodide (124I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium iodide (124I)" type="fsn">sodium iodide (124I)</designation>
                    <desc language="en-US">sodium iodide (124I)</desc>
                </concept>
                <concept code="V09G"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="CARDIOVASCULAR SYSTEM"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="CARDIOVASCULAR SYSTEM" type="fsn">CARDIOVASCULAR SYSTEM</designation>
                    <desc language="en-US">CARDIOVASCULAR SYSTEM</desc>
                </concept>
                <concept code="V09GA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc) compounds"
                         type="fsn">Technetium (99mTc) compounds</designation>
                    <desc language="en-US">Technetium (99mTc) compounds</desc>
                </concept>
                <concept code="V09GA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) sestamibi"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) sestamibi"
                         type="fsn">technetium (99mTc) sestamibi</designation>
                    <desc language="en-US">technetium (99mTc) sestamibi</desc>
                </concept>
                <concept code="V09GA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) tetrofosmin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) tetrofosmin"
                         type="fsn">technetium (99mTc) tetrofosmin</designation>
                    <desc language="en-US">technetium (99mTc) tetrofosmin</desc>
                </concept>
                <concept code="V09GA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) teboroxime"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) teboroxime"
                         type="fsn">technetium (99mTc) teboroxime</designation>
                    <desc language="en-US">technetium (99mTc) teboroxime</desc>
                </concept>
                <concept code="V09GA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) human albumin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) human albumin"
                         type="fsn">technetium (99mTc) human albumin</designation>
                    <desc language="en-US">technetium (99mTc) human albumin</desc>
                </concept>
                <concept code="V09GA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) furifosmin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) furifosmin"
                         type="fsn">technetium (99mTc) furifosmin</designation>
                    <desc language="en-US">technetium (99mTc) furifosmin</desc>
                </concept>
                <concept code="V09GA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) stannous agent labelled cells"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) stannous agent labelled cells"
                         type="fsn">technetium (99mTc) stannous agent labelled cells</designation>
                    <desc language="en-US">technetium (99mTc) stannous agent labelled cells</desc>
                </concept>
                <concept code="V09GA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) apcitide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) apcitide"
                         type="fsn">technetium (99mTc) apcitide</designation>
                    <desc language="en-US">technetium (99mTc) apcitide</desc>
                </concept>
                <concept code="V09GB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iodine (125I) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Iodine (125I) compounds" type="fsn">Iodine (125I) compounds</designation>
                    <desc language="en-US">Iodine (125I) compounds</desc>
                </concept>
                <concept code="V09GB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fibrinogen (125I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fibrinogen (125I)" type="fsn">fibrinogen (125I)</designation>
                    <desc language="en-US">fibrinogen (125I)</desc>
                </concept>
                <concept code="V09GB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine (125I) human albumin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iodine (125I) human albumin"
                         type="fsn">iodine (125I) human albumin</designation>
                    <desc language="en-US">iodine (125I) human albumin</desc>
                </concept>
                <concept code="V09GX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other cardiovascular system diagnostic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other cardiovascular system diagnostic radiopharmaceuticals"
                         type="fsn">Other cardiovascular system diagnostic radiopharmaceuticals</designation>
                    <desc language="en-US">Other cardiovascular system diagnostic radiopharmaceuticals</desc>
                </concept>
                <concept code="V09GX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="thallium (201Tl) chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="thallium (201Tl) chloride" type="fsn">thallium (201Tl) chloride</designation>
                    <desc language="en-US">thallium (201Tl) chloride</desc>
                </concept>
                <concept code="V09GX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indium (111In) imciromab"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="indium (111In) imciromab" type="fsn">indium (111In) imciromab</designation>
                    <desc language="en-US">indium (111In) imciromab</desc>
                </concept>
                <concept code="V09GX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="chromium (51Cr) chromate labelled cells"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="chromium (51Cr) chromate labelled cells"
                         type="fsn">chromium (51Cr) chromate labelled cells</designation>
                    <desc language="en-US">chromium (51Cr) chromate labelled cells</desc>
                </concept>
                <concept code="V09GX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rubidium (82Rb) chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="rubidium (82Rb) chloride" type="fsn">rubidium (82Rb) chloride</designation>
                    <desc language="en-US">rubidium (82Rb) chloride</desc>
                </concept>
                <concept code="V09H"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="INFLAMMATION AND INFECTION DETECTION"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="INFLAMMATION AND INFECTION DETECTION"
                         type="fsn">INFLAMMATION AND INFECTION DETECTION</designation>
                    <desc language="en-US">INFLAMMATION AND INFECTION DETECTION</desc>
                </concept>
                <concept code="V09HA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc) compounds"
                         type="fsn">Technetium (99mTc) compounds</designation>
                    <desc language="en-US">Technetium (99mTc) compounds</desc>
                </concept>
                <concept code="V09HA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) human immunoglobulin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) human immunoglobulin"
                         type="fsn">technetium (99mTc) human immunoglobulin</designation>
                    <desc language="en-US">technetium (99mTc) human immunoglobulin</desc>
                </concept>
                <concept code="V09HA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) exametazime labelled cells"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) exametazime labelled cells"
                         type="fsn">technetium (99mTc) exametazime labelled cells</designation>
                    <desc language="en-US">technetium (99mTc) exametazime labelled cells</desc>
                </concept>
                <concept code="V09HA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) antigranulocyte antibody"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) antigranulocyte antibody"
                         type="fsn">technetium (99mTc) antigranulocyte antibody</designation>
                    <desc language="en-US">technetium (99mTc) antigranulocyte antibody</desc>
                </concept>
                <concept code="V09HA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) sulesomab"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) sulesomab"
                         type="fsn">technetium (99mTc) sulesomab</designation>
                    <desc language="en-US">technetium (99mTc) sulesomab</desc>
                </concept>
                <concept code="V09HB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Indium (111In) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Indium (111In) compounds" type="fsn">Indium (111In) compounds</designation>
                    <desc language="en-US">Indium (111In) compounds</desc>
                </concept>
                <concept code="V09HB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indium (111In) oxinate labelled cells"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indium (111In) oxinate labelled cells"
                         type="fsn">indium (111In) oxinate labelled cells</designation>
                    <desc language="en-US">indium (111In) oxinate labelled cells</desc>
                </concept>
                <concept code="V09HB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indium (111In) tropolonate labelled cells"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indium (111In) tropolonate labelled cells"
                         type="fsn">indium (111In) tropolonate labelled cells</designation>
                    <desc language="en-US">indium (111In) tropolonate labelled cells</desc>
                </concept>
                <concept code="V09HX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other diagnostic radiopharmaceuticals for inflammation and infection detection"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other diagnostic radiopharmaceuticals for inflammation and infection detection"
                         type="fsn">Other diagnostic radiopharmaceuticals for inflammation and infection detection</designation>
                    <desc language="en-US">Other diagnostic radiopharmaceuticals for inflammation and infection detection</desc>
                </concept>
                <concept code="V09HX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gallium (67Ga) citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gallium (67Ga) citrate" type="fsn">gallium (67Ga) citrate</designation>
                    <desc language="en-US">gallium (67Ga) citrate</desc>
                </concept>
                <concept code="V09I"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="TUMOUR DETECTION"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="TUMOUR DETECTION" type="fsn">TUMOUR DETECTION</designation>
                    <desc language="en-US">TUMOUR DETECTION</desc>
                </concept>
                <concept code="V09IA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Technetium (99mTc) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Technetium (99mTc) compounds"
                         type="fsn">Technetium (99mTc) compounds</designation>
                    <desc language="en-US">Technetium (99mTc) compounds</desc>
                </concept>
                <concept code="V09IA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) antiCarcinoEmbryonicAntigen antibody"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) antiCarcinoEmbryonicAntigen antibody"
                         type="fsn">technetium (99mTc) antiCarcinoEmbryonicAntigen antibody</designation>
                    <desc language="en-US">technetium (99mTc) antiCarcinoEmbryonicAntigen antibody</desc>
                </concept>
                <concept code="V09IA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) antimelanoma antibody"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) antimelanoma antibody"
                         type="fsn">technetium (99mTc) antimelanoma antibody</designation>
                    <desc language="en-US">technetium (99mTc) antimelanoma antibody</desc>
                </concept>
                <concept code="V09IA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) pentavalent succimer"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) pentavalent succimer"
                         type="fsn">technetium (99mTc) pentavalent succimer</designation>
                    <desc language="en-US">technetium (99mTc) pentavalent succimer</desc>
                </concept>
                <concept code="V09IA04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) votumumab"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) votumumab"
                         type="fsn">technetium (99mTc) votumumab</designation>
                    <desc language="en-US">technetium (99mTc) votumumab</desc>
                </concept>
                <concept code="V09IA05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) depreotide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) depreotide"
                         type="fsn">technetium (99mTc) depreotide</designation>
                    <desc language="en-US">technetium (99mTc) depreotide</desc>
                </concept>
                <concept code="V09IA06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) arcitumomab"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) arcitumomab"
                         type="fsn">technetium (99mTc) arcitumomab</designation>
                    <desc language="en-US">technetium (99mTc) arcitumomab</desc>
                </concept>
                <concept code="V09IA07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) hynic-octreotide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) hynic-octreotide"
                         type="fsn">technetium (99mTc) hynic-octreotide</designation>
                    <desc language="en-US">technetium (99mTc) hynic-octreotide</desc>
                </concept>
                <concept code="V09IA08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) etarfolatide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) etarfolatide"
                         type="fsn">technetium (99mTc) etarfolatide</designation>
                    <desc language="en-US">technetium (99mTc) etarfolatide</desc>
                </concept>
                <concept code="V09IA09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="technetium (99mTc) tilmanocept"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="technetium (99mTc) tilmanocept"
                         type="fsn">technetium (99mTc) tilmanocept</designation>
                    <desc language="en-US">technetium (99mTc) tilmanocept</desc>
                </concept>
                <concept code="V09IB"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Indium (111In) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Indium (111In) compounds" type="fsn">Indium (111In) compounds</designation>
                    <desc language="en-US">Indium (111In) compounds</desc>
                </concept>
                <concept code="V09IB01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indium (111In) pentetreotide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indium (111In) pentetreotide"
                         type="fsn">indium (111In) pentetreotide</designation>
                    <desc language="en-US">indium (111In) pentetreotide</desc>
                </concept>
                <concept code="V09IB02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indium (111In) satumomab pendetide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indium (111In) satumomab pendetide"
                         type="fsn">indium (111In) satumomab pendetide</designation>
                    <desc language="en-US">indium (111In) satumomab pendetide</desc>
                </concept>
                <concept code="V09IB03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indium (111In) antiovariumcarcinoma antibody"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indium (111In) antiovariumcarcinoma antibody"
                         type="fsn">indium (111In) antiovariumcarcinoma antibody</designation>
                    <desc language="en-US">indium (111In) antiovariumcarcinoma antibody</desc>
                </concept>
                <concept code="V09IB04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="indium (111In) capromab pendetide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="indium (111In) capromab pendetide"
                         type="fsn">indium (111In) capromab pendetide</designation>
                    <desc language="en-US">indium (111In) capromab pendetide</desc>
                </concept>
                <concept code="V09IX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other diagnostic radiopharmaceuticals for tumour detection"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other diagnostic radiopharmaceuticals for tumour detection"
                         type="fsn">Other diagnostic radiopharmaceuticals for tumour detection</designation>
                    <desc language="en-US">Other diagnostic radiopharmaceuticals for tumour detection</desc>
                </concept>
                <concept code="V09IX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iobenguane (123I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iobenguane (123I)" type="fsn">iobenguane (123I)</designation>
                    <desc language="en-US">iobenguane (123I)</desc>
                </concept>
                <concept code="V09IX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iobenguane (131I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iobenguane (131I)" type="fsn">iobenguane (131I)</designation>
                    <desc language="en-US">iobenguane (131I)</desc>
                </concept>
                <concept code="V09IX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine (125I) CC49-monoclonal antibody"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iodine (125I) CC49-monoclonal antibody"
                         type="fsn">iodine (125I) CC49-monoclonal antibody</designation>
                    <desc language="en-US">iodine (125I) CC49-monoclonal antibody</desc>
                </concept>
                <concept code="V09IX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fludeoxyglucose (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fludeoxyglucose (18F)" type="fsn">fludeoxyglucose (18F)</designation>
                    <desc language="en-US">fludeoxyglucose (18F)</desc>
                </concept>
                <concept code="V09IX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorodopa (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorodopa (18F)" type="fsn">fluorodopa (18F)</designation>
                    <desc language="en-US">fluorodopa (18F)</desc>
                </concept>
                <concept code="V09IX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium fluoride (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium fluoride (18F)" type="fsn">sodium fluoride (18F)</designation>
                    <desc language="en-US">sodium fluoride (18F)</desc>
                </concept>
                <concept code="V09IX07"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluorocholine(18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluorocholine(18F)" type="fsn">fluorocholine(18F)</designation>
                    <desc language="en-US">fluorocholine(18F)</desc>
                </concept>
                <concept code="V09IX08"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluoroethylcholine (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluoroethylcholine (18F)" type="fsn">fluoroethylcholine (18F)</designation>
                    <desc language="en-US">fluoroethylcholine (18F)</desc>
                </concept>
                <concept code="V09IX09"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gallium (68Ga) edotreotide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="gallium (68Ga) edotreotide"
                         type="fsn">gallium (68Ga) edotreotide</designation>
                    <desc language="en-US">gallium (68Ga) edotreotide</desc>
                </concept>
                <concept code="V09IX10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluoroethyl-L-tyrosine (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="fluoroethyl-L-tyrosine (18F)"
                         type="fsn">fluoroethyl-L-tyrosine (18F)</designation>
                    <desc language="en-US">fluoroethyl-L-tyrosine (18F)</desc>
                </concept>
                <concept code="V09IX11"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluoroestradiol (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluoroestradiol (18F)" type="fsn">fluoroestradiol (18F)</designation>
                    <desc language="en-US">fluoroestradiol (18F)</desc>
                </concept>
                <concept code="V09IX12"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="fluciclovine (18F)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="fluciclovine (18F)" type="fsn">fluciclovine (18F)</designation>
                    <desc language="en-US">fluciclovine (18F)</desc>
                </concept>
                <concept code="V09X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER DIAGNOSTIC RADIOPHARMACEUTICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER DIAGNOSTIC RADIOPHARMACEUTICALS"
                         type="fsn">OTHER DIAGNOSTIC RADIOPHARMACEUTICALS</designation>
                    <desc language="en-US">OTHER DIAGNOSTIC RADIOPHARMACEUTICALS</desc>
                </concept>
                <concept code="V09XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iodine (131I) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Iodine (131I) compounds" type="fsn">Iodine (131I) compounds</designation>
                    <desc language="en-US">Iodine (131I) compounds</desc>
                </concept>
                <concept code="V09XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine (131I) norcholesterol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iodine (131I) norcholesterol"
                         type="fsn">iodine (131I) norcholesterol</designation>
                    <desc language="en-US">iodine (131I) norcholesterol</desc>
                </concept>
                <concept code="V09XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodocholesterol (131I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iodocholesterol (131I)" type="fsn">iodocholesterol (131I)</designation>
                    <desc language="en-US">iodocholesterol (131I)</desc>
                </concept>
                <concept code="V09XA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iodine (131I) human albumin"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="iodine (131I) human albumin"
                         type="fsn">iodine (131I) human albumin</designation>
                    <desc language="en-US">iodine (131I) human albumin</desc>
                </concept>
                <concept code="V09XX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Various diagnostic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Various diagnostic radiopharmaceuticals"
                         type="fsn">Various diagnostic radiopharmaceuticals</designation>
                    <desc language="en-US">Various diagnostic radiopharmaceuticals</desc>
                </concept>
                <concept code="V09XX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cobalt (57Co) cyanocobalamine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cobalt (57Co) cyanocobalamine"
                         type="fsn">cobalt (57Co) cyanocobalamine</designation>
                    <desc language="en-US">cobalt (57Co) cyanocobalamine</desc>
                </concept>
                <concept code="V09XX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="cobalt (58Co) cyanocobalamine"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="cobalt (58Co) cyanocobalamine"
                         type="fsn">cobalt (58Co) cyanocobalamine</designation>
                    <desc language="en-US">cobalt (58Co) cyanocobalamine</desc>
                </concept>
                <concept code="V09XX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="selenium (75Se) norcholesterol"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="selenium (75Se) norcholesterol"
                         type="fsn">selenium (75Se) norcholesterol</designation>
                    <desc language="en-US">selenium (75Se) norcholesterol</desc>
                </concept>
                <concept code="V09XX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ferric (59Fe) citrate"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ferric (59Fe) citrate" type="fsn">ferric (59Fe) citrate</designation>
                    <desc language="en-US">ferric (59Fe) citrate</desc>
                </concept>
                <concept code="V10"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="THERAPEUTIC RADIOPHARMACEUTICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="THERAPEUTIC RADIOPHARMACEUTICALS"
                         type="fsn">THERAPEUTIC RADIOPHARMACEUTICALS</designation>
                    <desc language="en-US">THERAPEUTIC RADIOPHARMACEUTICALS</desc>
                </concept>
                <concept code="V10A"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ANTIINFLAMMATORY AGENTS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="ANTIINFLAMMATORY AGENTS" type="fsn">ANTIINFLAMMATORY AGENTS</designation>
                    <desc language="en-US">ANTIINFLAMMATORY AGENTS</desc>
                </concept>
                <concept code="V10AA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Yttrium (90Y) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Yttrium (90Y) compounds" type="fsn">Yttrium (90Y) compounds</designation>
                    <desc language="en-US">Yttrium (90Y) compounds</desc>
                </concept>
                <concept code="V10AA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="yttrium (90Y) citrate colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="yttrium (90Y) citrate colloid"
                         type="fsn">yttrium (90Y) citrate colloid</designation>
                    <desc language="en-US">yttrium (90Y) citrate colloid</desc>
                </concept>
                <concept code="V10AA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="yttrium (90Y) ferrihydroxide colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="yttrium (90Y) ferrihydroxide colloid"
                         type="fsn">yttrium (90Y) ferrihydroxide colloid</designation>
                    <desc language="en-US">yttrium (90Y) ferrihydroxide colloid</desc>
                </concept>
                <concept code="V10AA03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="yttrium (90Y) silicate colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="yttrium (90Y) silicate colloid"
                         type="fsn">yttrium (90Y) silicate colloid</designation>
                    <desc language="en-US">yttrium (90Y) silicate colloid</desc>
                </concept>
                <concept code="V10AX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Other antiinflammatory therapeutic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Other antiinflammatory therapeutic radiopharmaceuticals"
                         type="fsn">Other antiinflammatory therapeutic radiopharmaceuticals</designation>
                    <desc language="en-US">Other antiinflammatory therapeutic radiopharmaceuticals</desc>
                </concept>
                <concept code="V10AX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="phosphorous (32P) chromicphosphate colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="phosphorous (32P) chromicphosphate colloid"
                         type="fsn">phosphorous (32P) chromicphosphate colloid</designation>
                    <desc language="en-US">phosphorous (32P) chromicphosphate colloid</desc>
                </concept>
                <concept code="V10AX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="samarium (153Sm) hydroxyapatite colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="samarium (153Sm) hydroxyapatite colloid"
                         type="fsn">samarium (153Sm) hydroxyapatite colloid</designation>
                    <desc language="en-US">samarium (153Sm) hydroxyapatite colloid</desc>
                </concept>
                <concept code="V10AX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="dysprosium (165Dy) colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="dysprosium (165Dy) colloid"
                         type="fsn">dysprosium (165Dy) colloid</designation>
                    <desc language="en-US">dysprosium (165Dy) colloid</desc>
                </concept>
                <concept code="V10AX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="erbium (169Er) citrate colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="erbium (169Er) citrate colloid"
                         type="fsn">erbium (169Er) citrate colloid</designation>
                    <desc language="en-US">erbium (169Er) citrate colloid</desc>
                </concept>
                <concept code="V10AX05"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rhenium (186Re) sulfide colloid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rhenium (186Re) sulfide colloid"
                         type="fsn">rhenium (186Re) sulfide colloid</designation>
                    <desc language="en-US">rhenium (186Re) sulfide colloid</desc>
                </concept>
                <concept code="V10AX06"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="gold (198Au) colloidal"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="gold (198Au) colloidal" type="fsn">gold (198Au) colloidal</designation>
                    <desc language="en-US">gold (198Au) colloidal</desc>
                </concept>
                <concept code="V10B"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="PAIN PALLIATION (BONE SEEKING AGENTS)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="PAIN PALLIATION (BONE SEEKING AGENTS)"
                         type="fsn">PAIN PALLIATION (BONE SEEKING AGENTS)</designation>
                    <desc language="en-US">PAIN PALLIATION (BONE SEEKING AGENTS)</desc>
                </concept>
                <concept code="V10BX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Various pain palliation radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Various pain palliation radiopharmaceuticals"
                         type="fsn">Various pain palliation radiopharmaceuticals</designation>
                    <desc language="en-US">Various pain palliation radiopharmaceuticals</desc>
                </concept>
                <concept code="V10BX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="strontium (89Sr) chloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="strontium (89Sr) chloride" type="fsn">strontium (89Sr) chloride</designation>
                    <desc language="en-US">strontium (89Sr) chloride</desc>
                </concept>
                <concept code="V10BX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="samarium (153Sm) lexidronam"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="samarium (153Sm) lexidronam"
                         type="fsn">samarium (153Sm) lexidronam</designation>
                    <desc language="en-US">samarium (153Sm) lexidronam</desc>
                </concept>
                <concept code="V10BX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="rhenium (186Re) etidronic acid"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="rhenium (186Re) etidronic acid"
                         type="fsn">rhenium (186Re) etidronic acid</designation>
                    <desc language="en-US">rhenium (186Re) etidronic acid</desc>
                </concept>
                <concept code="V10X"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="OTHER THERAPEUTIC RADIOPHARMACEUTICALS"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="OTHER THERAPEUTIC RADIOPHARMACEUTICALS"
                         type="fsn">OTHER THERAPEUTIC RADIOPHARMACEUTICALS</designation>
                    <desc language="en-US">OTHER THERAPEUTIC RADIOPHARMACEUTICALS</desc>
                </concept>
                <concept code="V10XA"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Iodine (131I) compounds"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="Iodine (131I) compounds" type="fsn">Iodine (131I) compounds</designation>
                    <desc language="en-US">Iodine (131I) compounds</desc>
                </concept>
                <concept code="V10XA01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium iodide (131I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium iodide (131I)" type="fsn">sodium iodide (131I)</designation>
                    <desc language="en-US">sodium iodide (131I)</desc>
                </concept>
                <concept code="V10XA02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="iobenguane (131I)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="iobenguane (131I)" type="fsn">iobenguane (131I)</designation>
                    <desc language="en-US">iobenguane (131I)</desc>
                </concept>
                <concept code="V10XA53"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="tositumomab/iodine (131I) tositumomab"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="tositumomab/iodine (131I) tositumomab"
                         type="fsn">tositumomab/iodine (131I) tositumomab</designation>
                    <desc language="en-US">tositumomab/iodine (131I) tositumomab</desc>
                </concept>
                <concept code="V10XX"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="Various therapeutic radiopharmaceuticals"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="Various therapeutic radiopharmaceuticals"
                         type="fsn">Various therapeutic radiopharmaceuticals</designation>
                    <desc language="en-US">Various therapeutic radiopharmaceuticals</desc>
                </concept>
                <concept code="V10XX01"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="sodium phosphate (32P)"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="sodium phosphate (32P)" type="fsn">sodium phosphate (32P)</designation>
                    <desc language="en-US">sodium phosphate (32P)</desc>
                </concept>
                <concept code="V10XX02"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="ibritumomab tiuxetan (90Y)"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="ibritumomab tiuxetan (90Y)"
                         type="fsn">ibritumomab tiuxetan (90Y)</designation>
                    <desc language="en-US">ibritumomab tiuxetan (90Y)</desc>
                </concept>
                <concept code="V10XX03"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="radium (223Ra) dichloride"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="radium (223Ra) dichloride" type="fsn">radium (223Ra) dichloride</designation>
                    <desc language="en-US">radium (223Ra) dichloride</desc>
                </concept>
                <concept code="V10XX04"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="lutetium (177Lu) oxodotreotide"
                  level="0"
                  type="L">
                    <designation language="en-GB"
                         displayName="lutetium (177Lu) oxodotreotide"
                         type="fsn">lutetium (177Lu) oxodotreotide</designation>
                    <desc language="en-US">lutetium (177Lu) oxodotreotide</desc>
                </concept>
                <concept code="V20"
                  codeSystem="2.16.840.1.113883.6.73"
                  displayName="SURGICAL DRESSINGS"
                  level="0"
                  type="L">
                    <designation language="en-GB" displayName="SURGICAL DRESSINGS" type="fsn">SURGICAL DRESSINGS</designation>
                    <desc language="en-US">SURGICAL DRESSINGS</desc>
                </concept>
            </conceptList>
   </valueSet>
</valueSets>
